data_2l17_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l17 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.9 mmm . . . . . 0 N--CA 1.501 2.084 0 N-CA-C 111.483 0.179 . . . . 0.0 111.483 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.538 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -58.44 132.57 54.11 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 172.337 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 53.1 mtpt -99.05 138.85 35.56 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -172.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.1 t -134.11 153.66 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 123.005 0.522 . . . . 0.0 109.716 -171.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.4 tpp -139.53 147.95 41.93 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.627 0.771 . . . . 0.0 109.792 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -132.1 112.21 12.13 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.46 1.504 . . . . 0.0 107.611 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.1 t -97.1 137.42 24.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -172.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 m -120.08 146.59 45.78 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -169.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -150.75 164.71 35.52 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.465 1.906 . . . . 0.0 108.602 174.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.75 -146.1 0.58 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.668 1.587 . . . . 0.0 108.589 -169.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -65.55 99.37 0.43 Allowed 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 173.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.7 m -64.36 -4.01 3.45 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 68.4 m -48.0 -38.65 17.53 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 119.309 0.959 . . . . 0.0 113.062 169.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -62.91 -41.08 99.32 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 120.051 1.296 . . . . 0.0 111.909 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.41 -37.07 12.78 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.766 0.826 . . . . 0.0 109.613 -169.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -66.84 -31.15 71.58 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.102 -0.998 . . . . 0.0 110.127 169.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.438 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.9 tpt -62.88 -37.44 86.9 Favored 'General case' 0 CA--C 1.51 -0.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.448 171.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.99 90.5 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -64.84 -38.04 89.64 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.153 169.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.9 -42.32 96.99 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 120.931 1.696 . . . . 0.0 111.811 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -66.73 -37.44 84.68 Favored 'General case' 0 C--O 1.222 -0.356 0 O-C-N 121.861 -0.788 . . . . 0.0 109.296 170.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.05 -35.19 69.25 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 119.539 1.063 . . . . 0.0 111.652 -175.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -66.93 -34.39 77.66 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 121.382 1.901 . . . . 0.0 111.425 171.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.2 m -69.39 -50.61 44.4 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.509 1.524 . . . . 0.0 110.343 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.0 mt -91.83 -25.55 18.93 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.079 1.352 . . . . 0.0 111.905 -169.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.97 8.72 76.09 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 126.675 2.083 . . . . 0.0 112.195 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.51 121.88 13.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.393 1.077 . . . . 0.0 110.064 -170.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.91 9.93 85.12 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 119.975 -0.347 . . . . 0.0 113.477 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -122.18 -36.8 2.91 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 125.947 1.699 . . . . 0.0 109.192 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.9 pt -138.44 162.96 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.873 1.269 . . . . 0.0 108.987 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.44 132.78 53.81 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 169.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.41 140.65 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 119.745 1.157 . . . . 0.0 113.308 -168.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.4 m -142.58 166.94 23.3 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.51 1.524 . . . . 0.0 109.903 -169.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.8 p -136.69 158.83 43.54 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.721 1.208 . . . . 0.0 110.069 176.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.434 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 27.5 p -151.81 158.66 43.58 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 122.83 0.452 . . . . 0.0 110.479 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.112 0 N-CA-C 106.857 -2.497 . . . . 0.0 106.857 -168.104 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.5 m . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -128.73 111.11 18.89 Favored Pre-proline 0 C--O 1.233 0.194 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -171.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -51.54 -30.44 35.82 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.855 3.037 . . . . 0.0 114.913 -174.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -60.42 -39.13 86.32 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.995 0.816 . . . . 0.0 110.964 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.72 -44.85 76.65 Favored 'General case' 0 CA--C 1.513 -0.444 0 O-C-N 121.448 -0.782 . . . . 0.0 109.062 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.02 -44.39 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.45 -43.91 96.37 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.507 0.594 . . . . 0.0 111.525 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.8 mmt -65.67 -18.74 65.55 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 118.879 -0.582 . . . . 0.0 112.3 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.438 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.8 OUTLIER -96.4 -31.64 12.75 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -178.138 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -63.08 -33.4 75.36 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.166 1.386 . . . . 0.0 110.003 169.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -58.49 -15.97 13.29 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.114 1.766 . . . . 0.0 111.845 172.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.4 m -130.62 12.84 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 126.156 1.783 . . . . 0.0 111.683 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.4 42.84 80.86 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 121.173 -0.955 . . . . 0.0 113.772 175.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.3 mt -124.69 155.27 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.81 1.644 . . . . 0.0 107.73 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -123.84 125.55 44.87 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.826 1.25 . . . . 0.0 108.296 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.9 pt -128.53 9.99 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.51 1.124 . . . . 0.0 112.339 173.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.65 -30.47 41.28 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.521 1.528 . . . . 0.0 111.935 174.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.43 -12.87 73.61 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 118.097 0.408 . . . . 0.0 112.679 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -76.86 153.0 35.22 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.773 1.229 . . . . 0.0 109.654 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.7 p -150.47 168.74 23.29 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.4 m -64.19 138.56 58.5 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.851 1.661 . . . . 0.0 111.393 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -163.1 123.25 1.42 Allowed Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 169.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -75.83 150.55 34.84 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.573 2.182 . . . . 0.0 113.315 -168.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.7 tt -55.96 -35.62 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.702 1.601 . . . . 0.0 111.395 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -68.75 -21.58 64.36 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.204 0.601 . . . . 0.0 112.177 -174.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.2 -10.55 57.62 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.336 0.654 . . . . 0.0 111.999 173.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.434 ' CE2' ' HB3' ' A' ' 35' ' ' CYS . 67.0 m-85 -92.69 168.49 11.18 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.908 0.861 . . . . 0.0 110.418 176.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -145.79 89.86 1.94 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 -171.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.45 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -51.47 -24.73 5.39 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -20.64 8.73 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.02 0.528 . . . . 0.0 111.528 173.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -107.02 13.76 27.17 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.383 1.873 . . . . 0.0 112.374 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 38.6 m-85 -135.24 108.85 7.95 Favored 'General case' 0 CA--C 1.516 -0.332 0 O-C-N 120.805 -1.184 . . . . 0.0 108.578 172.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.77 -16.05 36.27 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -170.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.9 t -144.85 121.31 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 -170.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.66 132.13 64.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 O-C-N 120.521 -1.362 . . . . 0.0 108.85 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.0 mm -125.68 96.93 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 -171.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.6 t -72.31 164.68 25.89 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 169.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mp -142.69 38.04 1.48 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 170.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 76.9 m -96.2 4.4 52.45 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.566 1.147 . . . . 0.0 111.291 -169.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.77 20.9 17.66 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 111.329 -0.709 . . . . 0.0 111.329 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.434 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 5.2 t 46.33 39.94 7.06 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.104 1.762 . . . . 0.0 112.314 -176.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -150.23 33.46 1.02 Allowed Glycine 0 C--N 1.339 0.7 0 C-N-CA 123.754 0.692 . . . . 0.0 111.795 -172.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.9 t -121.85 136.58 58.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 125.183 1.393 . . . . 0.0 107.652 177.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -82.35 67.59 8.44 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.182 0.993 . . . . 0.0 109.836 -172.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.8 mt -58.6 142.3 83.2 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -53.14 154.06 14.76 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.758 2.306 . . . . 0.0 111.63 171.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.19 -19.15 56.83 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 121.646 1.564 . . . . 0.0 114.403 -170.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.81 -26.95 68.86 Favored 'General case' 0 C--O 1.225 -0.233 0 O-C-N 121.205 -0.934 . . . . 0.0 110.983 175.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.45 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 71.8 m95 -68.08 -4.82 14.78 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.089 -1.007 . . . . 0.0 112.651 174.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -108.61 -28.96 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 120.04 1.291 . . . . 0.0 111.025 -174.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.5 p -76.91 -16.58 59.34 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.574 0.954 . . . . 0.0 113.574 -169.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -52.88 161.04 0.83 Allowed 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 129.354 3.062 . . . . 0.0 113.949 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -62.17 -38.96 91.03 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.084 1.354 . . . . 0.0 108.754 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 33.5 mm -126.17 138.01 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 169.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -139.67 112.26 7.84 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 101.359 -3.571 . . . . 0.0 101.359 167.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -135.16 167.78 20.36 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.434 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 9.7 t70 -139.33 104.69 5.04 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 171.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -83.73 77.99 9.78 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -54.54 41.79 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 131.6 3.96 . . . . 0.0 113.796 171.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.63 -176.6 3.33 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.961 1.304 . . . . 0.0 112.637 -168.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -51.43 169.09 0.06 Allowed 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 127.477 2.311 . . . . 0.0 112.529 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -127.21 107.92 21.55 Favored Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 125.975 1.71 . . . . 0.0 108.558 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -82.31 -2.1 10.99 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.044 1.83 . . . . 0.0 112.985 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.3 t0 20.06 -91.85 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 128.869 2.868 . . . . 0.0 114.408 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.95 42.11 1.36 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 126.015 1.769 . . . . 0.0 110.532 172.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -78.31 -176.8 4.86 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.26 1.424 . . . . 0.0 113.297 -171.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.7 p -64.15 162.79 13.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 113.859 -1.519 . . . . 0.0 110.269 173.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.1 mt -55.68 -33.91 64.57 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 122.819 0.448 . . . . 0.0 110.542 175.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -62.64 -38.11 88.98 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.774 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.3 t -73.98 -45.1 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 119.515 1.052 . . . . 0.0 108.777 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -52.01 -38.0 55.32 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.765 1.166 . . . . 0.0 112.832 172.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -68.99 -46.3 68.41 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 119.778 1.172 . . . . 0.0 112.188 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.5 m -71.69 -42.46 67.38 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 119.342 -0.361 . . . . 0.0 110.357 -169.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.8 t -67.82 -44.52 85.45 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -173.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -47.16 -53.27 13.41 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 124.853 1.261 . . . . 0.0 110.386 169.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.86 -45.39 96.29 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 119.325 0.966 . . . . 0.0 111.538 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -66.29 -36.9 84.15 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 121.683 -0.892 . . . . 0.0 111.418 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.8 t -62.66 -43.31 98.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 174.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -36.13 78.32 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 119.781 1.173 . . . . 0.0 111.56 -174.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -68.14 -42.34 80.27 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.432 -0.794 . . . . 0.0 110.131 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -63.07 -43.57 98.2 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.748 1.158 . . . . 0.0 110.431 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 75.9 t -54.81 -52.55 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 123.607 0.763 . . . . 0.0 109.582 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -66.77 -32.65 74.08 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 121.862 -0.524 . . . . 0.0 111.503 -175.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -62.3 -48.34 80.32 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 123.239 0.616 . . . . 0.0 111.22 171.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.93 -46.6 78.45 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.361 0.528 . . . . 0.0 110.13 176.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.4 mt -58.38 -43.64 86.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 124.34 1.056 . . . . 0.0 109.779 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.88 -29.81 69.78 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.3 0.955 . . . . 0.0 111.894 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -72.13 -39.61 68.7 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.573 0.624 . . . . 0.0 111.509 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.9 pt -103.35 -48.71 10.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 116.703 2.112 . . . . 0.0 116.703 -168.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 40.6 m . . . . . 0 C--O 1.252 1.232 0 C-N-CA 124.308 1.043 . . . . 0.0 110.653 -170.264 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 tpt . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 118.518 -0.753 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.437 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -60.32 118.4 6.38 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 120.98 1.718 . . . . 0.0 108.541 -173.508 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.0 mtpt -90.58 134.24 34.52 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -169.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.0 t -116.01 155.32 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.07 140.54 43.86 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -125.63 120.37 30.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 177.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.1 t -118.72 112.49 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 118.736 0.698 . . . . 0.0 110.404 -168.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.6 171.79 13.67 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.801 1.286 . . . . 0.0 113.616 -174.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -152.36 130.99 12.3 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 100.779 -3.785 . . . . 0.0 100.779 168.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.415 ' CG ' ' H ' ' A' ' 11' ' ' ASN . 27.2 ttm180 63.47 176.53 0.16 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.755 1.161 . . . . 0.0 109.955 -169.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.415 ' H ' ' CG ' ' A' ' 10' ' ' ARG . 33.6 t-20 -40.57 137.2 1.17 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.138 2.175 . . . . 0.0 113.652 -169.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.9 m -52.41 -20.4 2.8 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 129.856 3.262 . . . . 0.0 115.417 -171.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.9 m -59.44 -5.34 0.77 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.946 2.098 . . . . 0.0 114.802 -171.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.291 31.5 ptt180 -111.41 -61.3 1.72 Allowed 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 116.801 -1.571 . . . . 0.0 111.079 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.7 p -74.97 -44.6 47.44 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 122.688 2.495 . . . . 0.0 111.316 -175.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.29 2.0 mt-30 -75.65 -24.75 56.41 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -172.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.463 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.2 tpt -65.79 -41.89 91.39 Favored 'General case' 0 C--O 1.222 -0.363 0 O-C-N 121.003 -1.061 . . . . 0.0 108.19 167.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.54 -36.77 79.26 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.745 -0.597 . . . . 0.0 109.602 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -63.25 -39.1 93.64 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 118.378 -0.82 . . . . 0.0 110.823 169.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.38 -45.15 94.15 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 120.5 1.5 . . . . 0.0 111.115 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -65.55 -38.29 89.18 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 173.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.45 -37.63 68.5 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 119.758 1.163 . . . . 0.0 110.929 -173.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -71.08 -19.73 62.44 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 120.214 1.37 . . . . 0.0 112.065 174.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.3 m -82.02 -51.05 8.42 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.845 1.658 . . . . 0.0 109.56 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.2 mt -89.42 -25.73 21.36 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.334 1.454 . . . . 0.0 112.176 -169.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.76 13.75 56.32 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.885 2.183 . . . . 0.0 111.846 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.28 122.02 14.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.675 1.19 . . . . 0.0 109.723 -173.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.12 8.44 87.84 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.66 -0.522 . . . . 0.0 113.626 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -123.22 -31.69 3.54 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.506 1.522 . . . . 0.0 109.001 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.7 pt -141.37 173.37 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 125.457 1.503 . . . . 0.0 109.598 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.42 144.08 43.88 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 103.879 -2.638 . . . . 0.0 103.879 168.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 t -133.33 139.94 48.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 123.279 0.631 . . . . 0.0 110.283 -168.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.14 158.59 44.16 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.836 1.254 . . . . 0.0 109.254 -173.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 63.8 p -155.46 165.99 34.9 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 120.016 1.28 . . . . 0.0 113.257 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.3 p -154.61 166.45 33.32 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.164 1.386 . . . . 0.0 109.197 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.652 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.02 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 C--O 1.235 0.33 0 CA-C-O 121.816 0.817 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -113.12 106.6 54.77 Favored Pre-proline 0 N--CA 1.446 -0.665 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -170.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -63.87 -29.25 67.55 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.264 2.643 . . . . 0.0 111.83 -169.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.2 m -64.51 -37.41 87.45 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.743 0.701 . . . . 0.0 109.213 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.24 -44.43 83.78 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.26 -46.58 85.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 CA-C-O 118.632 -0.699 . . . . 0.0 109.135 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.41 -43.96 97.56 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.859 0.754 . . . . 0.0 111.101 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.0 mmt -60.05 -26.16 65.91 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 118.76 -0.638 . . . . 0.0 111.6 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.463 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -94.09 -27.0 16.5 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -177.132 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -64.34 -30.74 71.78 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.93 1.292 . . . . 0.0 110.067 169.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.43 -21.75 38.8 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.297 0.639 . . . . 0.0 112.002 171.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.0 m -123.61 9.53 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 125.75 1.62 . . . . 0.0 111.138 -177.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.81 40.94 74.84 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.372 0.987 . . . . 0.0 113.007 174.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.7 mt -122.94 152.39 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.542 1.537 . . . . 0.0 108.077 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -118.55 122.13 41.9 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.924 1.29 . . . . 0.0 108.677 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 43.8 pt -127.02 12.91 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 124.271 1.028 . . . . 0.0 111.481 169.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.58 -25.0 45.18 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.23 1.812 . . . . 0.0 112.459 172.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.6 -8.06 85.93 Favored Glycine 0 CA--C 1.537 1.423 0 CA-C-N 118.603 0.638 . . . . 0.0 112.946 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -76.56 166.77 22.93 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.776 1.23 . . . . 0.0 111.557 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.6 p -144.86 -177.95 5.78 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.813 1.645 . . . . 0.0 109.949 174.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.98 173.32 6.41 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.206 1.002 . . . . 0.0 109.615 170.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.28 146.37 7.15 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 169.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.64 141.94 97.96 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.706 2.271 . . . . 0.0 111.834 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.5 tt -59.93 -37.73 73.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 123.491 0.716 . . . . 0.0 110.718 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -73.04 -18.38 61.34 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.416 0.686 . . . . 0.0 112.336 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.05 -25.58 61.85 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 118.939 -0.553 . . . . 0.0 111.274 170.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -79.11 170.51 16.56 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 122.191 0.996 . . . . 0.0 111.318 -172.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.44 68.75 1.39 Allowed 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 125.827 1.651 . . . . 0.0 106.891 -177.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.406 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -51.3 -24.21 4.36 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 124.524 1.129 . . . . 0.0 113.749 -178.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -44.1 -41.27 5.48 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.005 0.922 . . . . 0.0 110.794 172.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.37 -14.74 58.08 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.746 1.218 . . . . 0.0 113.842 -175.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -105.72 112.73 25.92 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 119.64 1.109 . . . . 0.0 108.405 -173.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -65.51 -12.14 49.99 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -168.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.3 t -146.56 124.31 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 -171.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.1 t -123.13 130.76 74.18 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.2 mm -124.42 92.65 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 173.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.9 t -76.85 166.85 22.79 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 169.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mp -140.76 32.18 1.82 Allowed 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.185 -1.572 . . . . 0.0 108.025 174.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 92.5 m -76.99 -3.71 40.36 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.203 1.001 . . . . 0.0 111.707 -177.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.19 35.49 3.63 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 119.572 1.078 . . . . 0.0 111.084 172.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 32.0 p 35.88 45.03 0.26 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 128.02 2.528 . . . . 0.0 114.216 -175.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.73 47.4 0.48 Allowed Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -173.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.2 p -125.72 159.11 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 126.102 1.761 . . . . 0.0 109.786 -171.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -118.09 56.35 0.86 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.785 1.234 . . . . 0.0 108.745 -174.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.6 mt -59.33 143.9 84.59 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.36 151.49 22.98 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.198 1.932 . . . . 0.0 111.95 171.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -55.86 -27.57 63.42 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.194 1.93 . . . . 0.0 115.541 -173.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.41 -21.14 66.21 Favored 'General case' 0 N--CA 1.456 -0.175 0 O-C-N 121.009 -1.057 . . . . 0.0 112.361 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.406 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 73.4 m95 -73.65 -17.89 61.1 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 117.952 -1.023 . . . . 0.0 112.659 175.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.8 m -110.77 -13.54 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 120.064 1.302 . . . . 0.0 113.461 -169.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.4 p -83.26 -8.11 59.5 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.367 1.067 . . . . 0.0 113.255 -173.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -64.96 173.04 2.52 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 130.054 3.341 . . . . 0.0 113.569 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -67.45 -41.47 84.64 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 16.8 mm -120.25 136.9 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 169.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -143.45 111.82 6.31 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 103.03 -2.952 . . . . 0.0 103.03 166.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -136.63 164.64 27.74 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -132.59 102.17 5.6 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 169.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.3 m0 -76.94 89.06 3.5 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.6 33.99 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 128.508 2.723 . . . . 0.0 113.827 173.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.26 178.39 1.94 Allowed 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.086 -1.009 . . . . 0.0 112.832 -169.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -52.51 164.91 0.29 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 126.26 1.824 . . . . 0.0 112.525 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -120.9 102.74 43.86 Favored Pre-proline 0 C--N 1.325 -0.478 0 C-N-CA 127.278 2.231 . . . . 0.0 108.163 -175.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -82.13 -1.93 10.99 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.769 2.313 . . . . 0.0 112.592 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.4 t0 26.42 -99.04 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 128.372 2.669 . . . . 0.0 113.533 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.86 38.99 1.74 Allowed Glycine 0 CA--C 1.532 1.151 0 C-N-CA 127.278 2.371 . . . . 0.0 109.285 169.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -70.18 -176.99 1.28 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.413 1.885 . . . . 0.0 112.937 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.9 m -63.6 156.66 25.99 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.235 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.1 mt -56.35 -31.16 63.49 Favored 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 123.129 0.572 . . . . 0.0 110.933 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.62 -41.15 97.06 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 118.528 0.604 . . . . 0.0 110.768 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 40.1 t -72.85 -42.12 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 117.284 -1.341 . . . . 0.0 109.061 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -48.42 -49.47 34.96 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 120.318 1.417 . . . . 0.0 111.379 169.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -60.16 -44.11 95.26 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.976 0.807 . . . . 0.0 111.055 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 87.3 m -68.95 -43.83 74.23 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 118.885 -0.579 . . . . 0.0 109.486 -173.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 42.0 t -68.43 -46.71 80.03 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -174.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -45.45 -55.74 5.79 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.864 1.266 . . . . 0.0 110.97 169.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.71 -43.03 98.41 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 119.321 0.964 . . . . 0.0 111.525 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -63.27 -37.44 87.26 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.381 1.09 . . . . 0.0 111.394 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 37.4 t -62.96 -41.41 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 118.067 -0.968 . . . . 0.0 109.033 173.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.14 -37.56 74.89 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 120.009 1.277 . . . . 0.0 111.029 -177.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -68.88 -43.3 75.57 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.208 0.603 . . . . 0.0 110.585 177.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -68.17 -42.43 80.02 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.415 1.007 . . . . 0.0 110.392 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.1 t -53.54 -53.54 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 124.007 0.923 . . . . 0.0 108.988 171.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.77 -33.01 74.98 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.954 -0.466 . . . . 0.0 111.815 -175.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -62.62 -47.98 81.41 Favored 'General case' 0 C--O 1.227 -0.084 0 C-N-CA 122.934 0.494 . . . . 0.0 111.284 171.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.86 -47.24 77.65 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.11 0.564 . . . . 0.0 109.552 176.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.2 mt -58.25 -42.91 84.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 124.292 1.037 . . . . 0.0 110.147 176.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.43 -29.45 69.01 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.609 0.64 . . . . 0.0 111.864 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -74.12 -40.43 62.67 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 118.594 0.633 . . . . 0.0 111.814 175.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.3 pt -101.55 -42.4 9.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 117.251 2.315 . . . . 0.0 117.251 -168.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 C--O 1.254 1.335 0 CA-C-N 119.05 0.841 . . . . 0.0 110.394 -171.967 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.1 mmm . . . . . 0 N--CA 1.5 2.054 0 CA-C-O 119.972 -0.061 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.523 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -58.97 136.33 57.89 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 171.172 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.8 mtpt -109.18 145.89 35.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 119.638 1.108 . . . . 0.0 108.357 -171.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.2 t -127.21 153.9 36.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 123.693 0.797 . . . . 0.0 108.896 -174.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 59.6 tpp -135.87 138.47 42.51 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -124.56 106.69 10.34 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.0 t -84.39 122.48 38.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -172.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 86.5 m -68.77 156.78 37.7 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.282 2.233 . . . . 0.0 111.279 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -144.32 -125.17 0.08 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 169.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.59 115.24 1.27 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.078 1.351 . . . . 0.0 112.009 -169.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.9 t30 45.59 26.86 0.36 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.897 2.079 . . . . 0.0 113.973 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.2 m 56.94 -22.34 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 119.106 3.002 . . . . 0.0 119.106 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 85.2 m -48.78 -55.72 10.72 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 125.69 1.596 . . . . 0.0 113.348 -168.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -58.77 -47.03 86.09 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.334 0.97 . . . . 0.0 112.329 -169.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.77 -31.81 19.44 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.709 -0.619 . . . . 0.0 111.138 -170.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.48 HE22 ' CG2' ' A' ' 42' ' ' VAL . 4.8 pt20 -65.62 -36.47 83.81 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 172.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.456 ' SD ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -63.09 -39.75 95.63 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 120.703 -1.248 . . . . 0.0 110.109 172.451 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.39 -36.1 75.16 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.757 -0.589 . . . . 0.0 110.698 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -64.69 -38.84 92.35 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.802 -0.618 . . . . 0.0 111.104 169.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.92 -43.9 92.84 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 120.491 1.496 . . . . 0.0 110.86 -178.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.456 ' CD2' ' SD ' ' A' ' 17' ' ' MET . 5.0 m-85 -64.81 -40.52 95.35 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 118.68 1.24 . . . . 0.0 109.428 171.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.88 -37.11 75.94 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 119.661 1.119 . . . . 0.0 111.104 -173.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -74.1 -25.14 59.62 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 120.142 1.337 . . . . 0.0 111.922 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 m -72.36 -50.8 23.97 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.173 1.389 . . . . 0.0 110.166 173.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.0 mt -87.86 -26.66 22.67 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 124.617 1.167 . . . . 0.0 112.647 -169.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.55 14.01 59.4 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 126.45 1.976 . . . . 0.0 111.602 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.23 125.18 22.8 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.227 1.411 . . . . 0.0 109.41 -172.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.68 8.42 87.2 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-O 119.732 -0.482 . . . . 0.0 113.647 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -125.47 -44.32 1.85 Allowed 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 125.161 1.385 . . . . 0.0 108.69 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.7 pp -140.25 150.27 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.463 1.105 . . . . 0.0 109.782 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.71 152.28 20.27 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 t -142.5 137.57 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 118.393 0.542 . . . . 0.0 111.061 -168.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.7 m -143.21 165.51 27.24 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.19 1.396 . . . . 0.0 109.524 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.9 p -141.48 156.27 45.76 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.929 1.292 . . . . 0.0 108.698 175.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 29.6 p -159.73 173.39 16.11 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.001 0.818 . . . . 0.0 112.201 -173.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.75 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 177.52 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.48 ' CG2' HE22 ' A' ' 16' ' ' GLN . 0.5 OUTLIER . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -137.22 117.08 10.45 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -172.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -69.24 -25.98 30.49 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.537 2.825 . . . . 0.0 113.179 -169.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.0 m -62.19 -36.21 81.21 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.177 0.899 . . . . 0.0 109.153 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.98 -41.89 90.58 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -58.59 -49.89 80.89 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 CA-C-O 118.312 -0.852 . . . . 0.0 108.874 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.5 -43.81 96.65 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 119.362 0.983 . . . . 0.0 110.916 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.7 mmt -64.51 -17.12 63.59 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.867 0.867 . . . . 0.0 112.723 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 3.4 mmt -97.99 -26.95 14.46 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 119.457 1.026 . . . . 0.0 110.656 173.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -65.0 -27.66 68.98 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.976 0.91 . . . . 0.0 110.164 172.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -56.37 -25.3 49.04 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.187 0.995 . . . . 0.0 112.603 169.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.1 m -127.24 14.56 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.468 1.507 . . . . 0.0 111.211 -171.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.1 39.11 84.06 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.941 0.782 . . . . 0.0 112.717 174.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.3 mt -126.99 156.65 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -136.85 143.35 43.03 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.39 1.076 . . . . 0.0 109.033 175.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.7 pt -140.59 15.83 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 126.778 2.031 . . . . 0.0 111.288 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.6 p -69.87 -40.91 75.43 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 120.767 -1.208 . . . . 0.0 112.414 173.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.18 8.05 41.28 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 123.819 0.723 . . . . 0.0 113.075 -177.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -73.96 -176.54 2.53 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.561 1.145 . . . . 0.0 112.132 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -69.3 170.27 10.62 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.533 1.933 . . . . 0.0 112.758 -170.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.4 m -159.16 57.18 0.41 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 104.042 -2.577 . . . . 0.0 104.042 171.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -143.38 147.96 42.15 Favored Pre-proline 0 C--N 1.345 0.389 0 C-N-CA 123.166 0.586 . . . . 0.0 110.351 -167.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -82.82 159.5 16.13 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.397 2.732 . . . . 0.0 112.438 -174.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.2 tt -58.75 -34.77 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.056 1.342 . . . . 0.0 111.371 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -69.16 -22.52 63.92 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.19 0.596 . . . . 0.0 112.309 -174.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -13.85 59.54 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 119.103 -0.475 . . . . 0.0 111.741 172.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -98.98 172.18 7.57 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.212 1.005 . . . . 0.0 110.789 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.71 99.06 3.06 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 125.21 1.404 . . . . 0.0 107.774 -178.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.83 -23.53 1.93 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 171.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -51.36 -25.69 6.45 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.885 0.874 . . . . 0.0 111.524 173.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -107.1 15.28 25.38 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.72 1.208 . . . . 0.0 113.491 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -134.88 111.07 9.58 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 120.243 1.383 . . . . 0.0 109.16 173.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.29 -17.28 52.86 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 124.643 1.177 . . . . 0.0 113.422 -169.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.6 t -143.09 130.44 18.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 -170.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.3 t -135.96 131.84 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 -169.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.3 mm -133.83 100.62 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 103.031 -2.951 . . . . 0.0 103.031 -172.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.476 ' C ' ' H ' ' A' ' 80' ' ' CYS . 6.3 m -111.29 85.56 2.15 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 121.853 -0.529 . . . . 0.0 111.034 -168.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.9 mp -73.12 25.51 0.06 Allowed 'General case' 0 C--N 1.343 0.291 0 C-N-CA 127.969 2.508 . . . . 0.0 110.547 -174.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.476 ' H ' ' C ' ' A' ' 78' ' ' SER . 4.4 m -64.12 1.02 0.78 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.89 2.076 . . . . 0.0 111.411 170.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.22 26.4 28.48 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 118.742 0.701 . . . . 0.0 111.658 174.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 49.91 20.09 0.53 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.761 2.025 . . . . 0.0 114.771 -175.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -109.46 24.53 20.0 Favored Glycine 0 C--N 1.338 0.658 0 C-N-CA 124.43 1.014 . . . . 0.0 111.213 -176.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.1 t -132.29 121.43 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -174.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.32 -40.45 85.96 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.806 0.842 . . . . 0.0 110.893 -177.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.1 mt 64.48 152.63 0.12 Allowed Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 127.921 2.488 . . . . 0.0 112.64 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.04 151.45 50.1 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 121.926 1.75 . . . . 0.0 110.219 169.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.4 -19.61 55.31 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.634 1.556 . . . . 0.0 114.436 -169.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -64.52 -26.51 68.45 Favored 'General case' 0 C--O 1.224 -0.246 0 O-C-N 121.019 -1.051 . . . . 0.0 110.879 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -67.63 -8.61 36.09 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.197 -0.939 . . . . 0.0 112.622 175.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.4 t -108.68 -30.09 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.968 1.307 . . . . 0.0 111.105 -171.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.5 p -75.37 -17.25 60.27 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.21 1.004 . . . . 0.0 113.483 -169.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -51.67 160.68 0.61 Allowed 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 129.403 3.081 . . . . 0.0 114.033 176.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -62.47 -38.9 91.63 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.608 1.563 . . . . 0.0 108.762 177.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 30.5 mm -125.02 135.44 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 169.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -136.57 104.88 5.7 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 101.758 -3.423 . . . . 0.0 101.758 166.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -128.27 177.57 6.85 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 125.62 1.568 . . . . 0.0 106.901 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.24 -56.9 1.42 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -174.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 24.1 m0 56.02 65.7 1.38 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.072 0.949 . . . . 0.0 110.662 -169.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -56.39 46.28 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 130.274 3.429 . . . . 0.0 113.54 169.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.81 -177.65 2.03 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.615 -1.303 . . . . 0.0 113.422 -168.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -55.88 168.86 0.41 Allowed 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 127.253 2.221 . . . . 0.0 112.323 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -115.04 102.99 54.95 Favored Pre-proline 0 C--N 1.323 -0.566 0 C-N-CA 126.272 1.829 . . . . 0.0 109.243 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -83.75 -4.37 10.66 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.577 2.185 . . . . 0.0 112.814 175.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.7 t0 25.18 -101.27 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 128.246 2.618 . . . . 0.0 113.025 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -136.88 42.3 1.33 Allowed Glycine 0 CA--C 1.533 1.16 0 C-N-CA 128.188 2.804 . . . . 0.0 107.11 169.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -68.91 -174.48 0.6 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.619 1.968 . . . . 0.0 112.069 -174.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.5 p -57.39 152.84 13.58 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.962 -1.472 . . . . 0.0 108.433 169.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.1 mt -59.14 -30.37 68.1 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.625 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -61.41 -41.25 96.86 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 119.001 -0.523 . . . . 0.0 110.791 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.17 -42.28 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 117.647 -1.168 . . . . 0.0 109.305 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -50.35 -49.4 54.19 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.276 1.398 . . . . 0.0 111.765 171.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -59.05 -44.18 91.76 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.694 0.679 . . . . 0.0 111.36 176.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 91.7 m -68.48 -45.6 71.97 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -173.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.6 t -67.41 -47.59 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -173.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -43.43 -54.5 4.72 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.93 1.292 . . . . 0.0 110.665 169.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.87 -43.43 98.93 Favored Glycine 0 CA--C 1.522 0.503 0 CA-C-N 119.844 1.202 . . . . 0.0 112.065 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -67.91 -34.38 76.51 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 120.797 -1.413 . . . . 0.0 111.398 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.59 -42.23 93.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 170.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -43.52 85.35 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.995 1.27 . . . . 0.0 110.258 -174.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -66.44 -43.78 84.68 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 119.1 -0.476 . . . . 0.0 110.038 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -64.97 -42.42 94.6 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.136 0.88 . . . . 0.0 110.944 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 52.9 t -56.66 -52.29 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -64.95 -32.89 74.83 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 121.846 -0.534 . . . . 0.0 111.667 -175.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -62.84 -46.66 86.9 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 123.58 0.752 . . . . 0.0 111.15 172.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.84 -46.68 84.42 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 122.807 0.443 . . . . 0.0 110.101 175.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.5 mt -58.75 -41.8 83.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 123.918 0.887 . . . . 0.0 110.233 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.31 -28.87 68.47 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.216 0.916 . . . . 0.0 111.637 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -75.2 -40.73 58.99 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.538 0.608 . . . . 0.0 111.85 176.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.4 pt -101.85 -35.89 4.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 116.496 2.035 . . . . 0.0 116.496 -168.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 C--O 1.255 1.365 0 C-N-CA 124.438 1.095 . . . . 0.0 111.608 -170.269 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 tpt . . . . . 0 N--CA 1.5 2.034 0 CA-C-O 118.594 -0.717 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.46 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -60.79 120.54 10.32 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 120.895 1.679 . . . . 0.0 108.39 -174.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -93.37 134.64 35.38 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -170.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.6 t -116.6 154.81 18.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 53.6 tpp -136.03 136.17 40.05 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -118.53 106.63 12.85 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.7 t -91.06 119.43 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -170.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.9 m -91.61 162.33 14.56 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.947 0.499 . . . . 0.0 111.52 -173.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -160.13 151.42 19.48 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.535 1.934 . . . . 0.0 106.258 169.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.46 -165.16 0.2 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.484 1.113 . . . . 0.0 109.527 -169.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.536 HD22 ' CG ' ' A' ' 43' ' ' HIS . 51.9 t-20 -61.5 109.02 1.06 Allowed 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.3 m -61.41 2.53 0.15 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 -168.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 35.4 m -44.51 -47.62 10.11 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 120.099 1.318 . . . . 0.0 111.854 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -63.66 -39.46 94.4 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 118.992 0.815 . . . . 0.0 112.654 -175.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.27 -40.4 10.0 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.989 1.316 . . . . 0.0 111.298 -169.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -65.67 -34.58 78.54 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.551 -0.718 . . . . 0.0 109.908 170.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.446 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.3 tpt -62.9 -39.87 95.85 Favored 'General case' 0 CA--C 1.512 -0.506 0 O-C-N 121.238 -0.914 . . . . 0.0 110.135 171.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.88 -39.22 84.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -64.28 -39.28 93.6 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.302 170.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.21 -45.59 85.55 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 120.726 1.603 . . . . 0.0 111.333 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -63.88 -39.63 94.63 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.59 -39.34 80.98 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 119.868 1.213 . . . . 0.0 110.99 -175.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -70.36 -26.47 63.74 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 120.532 1.514 . . . . 0.0 112.096 175.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 m -73.01 -51.04 19.73 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.369 1.467 . . . . 0.0 110.741 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.9 mt -88.82 -27.18 21.26 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.351 1.46 . . . . 0.0 112.307 -169.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.89 13.33 59.14 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 126.445 1.974 . . . . 0.0 111.682 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.52 122.81 14.97 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.039 1.335 . . . . 0.0 109.76 -174.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.31 9.13 86.99 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 119.887 -0.396 . . . . 0.0 113.649 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -123.88 -32.11 3.32 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.407 1.483 . . . . 0.0 109.275 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.8 pt -142.75 174.75 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 125.443 1.497 . . . . 0.0 109.439 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.87 146.07 43.16 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 168.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.58 142.12 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 123.168 0.587 . . . . 0.0 110.878 -168.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.03 159.63 44.42 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.92 0.888 . . . . 0.0 110.559 -176.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.0 p -133.83 156.26 48.37 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.873 1.269 . . . . 0.0 109.272 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.4 p -151.64 167.27 28.68 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.469 0.707 . . . . 0.0 111.234 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.958 0 C-N-CA 123.501 0.572 . . . . 0.0 112.913 173.284 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 CA--C 1.531 0.23 0 CA-C-O 121.192 0.52 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.536 ' CG ' HD22 ' A' ' 11' ' ' ASN . 13.5 t-80 -132.96 98.88 15.5 Favored Pre-proline 0 CA--C 1.53 0.2 0 C-N-CA 123.311 0.645 . . . . 0.0 109.672 -169.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -42.28 -33.18 2.37 Favored 'Trans proline' 0 CA--C 1.534 0.499 1 C-N-CA 125.846 4.364 . . . . 0.0 116.377 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.4 m -64.0 -39.29 93.79 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.792 1.178 . . . . 0.0 110.798 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.55 -43.48 80.6 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 121.133 -0.979 . . . . 0.0 109.218 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.88 -44.3 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.27 -43.23 99.22 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.429 0.559 . . . . 0.0 111.701 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.4 mmt -65.44 -21.61 66.67 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.166 0.439 . . . . 0.0 111.893 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.446 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.4 OUTLIER -93.4 -33.65 13.76 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -177.245 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -61.76 -34.13 75.3 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.954 1.302 . . . . 0.0 109.941 169.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.54 -8.31 4.17 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.601 1.961 . . . . 0.0 112.347 172.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.2 p -134.56 12.44 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 125.484 1.513 . . . . 0.0 110.91 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.81 36.87 66.15 Favored Glycine 0 CA--C 1.534 1.268 0 O-C-N 120.841 -1.162 . . . . 0.0 113.599 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.5 mt -120.46 154.71 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.319 1.448 . . . . 0.0 108.639 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.8 126.8 53.1 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.882 1.673 . . . . 0.0 109.571 -177.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.6 pt -134.59 8.19 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 125.501 1.52 . . . . 0.0 110.59 168.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.42 -37.41 68.64 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.404 1.882 . . . . 0.0 111.567 177.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.27 -6.81 89.04 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 123.471 0.558 . . . . 0.0 113.32 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -72.48 156.31 39.18 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.939 1.296 . . . . 0.0 109.874 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -150.97 164.98 35.1 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.5 m -68.08 141.28 56.19 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 126.999 2.119 . . . . 0.0 112.131 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -162.38 127.67 2.17 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 169.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.88 152.17 28.36 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.648 2.232 . . . . 0.0 113.38 -169.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.5 tt -59.3 -37.12 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.478 1.511 . . . . 0.0 111.366 -173.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -70.92 -19.67 62.56 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.126 0.57 . . . . 0.0 112.11 -173.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -15.68 54.54 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 118.762 -0.637 . . . . 0.0 111.85 173.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -84.03 168.49 15.88 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.225 1.012 . . . . 0.0 110.804 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -140.16 86.17 2.06 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 102.634 -3.098 . . . . 0.0 102.634 -178.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.449 ' HB3' ' CD2' ' A' ' 90' ' ' TRP . . . -54.37 -23.23 14.76 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.58 -27.55 17.31 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.279 0.632 . . . . 0.0 111.184 172.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -84.48 -7.6 59.23 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.25 1.02 . . . . 0.0 113.16 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -126.09 113.74 17.48 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 120.132 1.333 . . . . 0.0 108.912 -171.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -66.1 -12.21 54.09 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -168.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.9 t -145.25 123.24 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -170.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.3 t -118.74 129.63 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.2 mm -120.55 96.87 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 169.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.7 p -74.43 160.45 30.96 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 169.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -138.39 42.07 2.21 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 170.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.7 m -80.69 11.03 4.11 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.43 1.492 . . . . 0.0 111.177 -172.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.81 26.95 70.02 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 -174.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 2.0 t 52.78 -176.26 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.631 1.972 . . . . 0.0 111.314 -169.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.04 -33.79 1.07 Allowed Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.009 1.29 . . . . 0.0 114.677 172.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.5 t -57.61 119.32 2.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 125.198 1.399 . . . . 0.0 107.522 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -73.78 146.79 44.0 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 171.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.3 mt -127.09 153.41 76.62 Favored Pre-proline 0 C--O 1.237 0.439 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -53.08 151.94 19.88 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.26 1.973 . . . . 0.0 111.079 170.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -65.93 -19.8 58.07 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.574 1.516 . . . . 0.0 114.302 -169.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.58 -27.0 68.65 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.135 -0.978 . . . . 0.0 110.917 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.449 ' CD2' ' HB3' ' A' ' 70' ' ' ALA . 70.8 m95 -67.01 -12.47 59.97 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.046 -1.034 . . . . 0.0 112.819 175.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.8 t -104.74 -29.63 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.79 1.236 . . . . 0.0 111.127 -170.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.4 p -75.01 -13.38 60.5 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.365 1.066 . . . . 0.0 113.775 -169.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -55.78 163.6 1.36 Allowed 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 129.562 3.145 . . . . 0.0 113.761 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.62 -41.42 96.19 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.676 1.19 . . . . 0.0 108.373 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.0 mm -119.92 136.02 58.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 169.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -142.42 109.52 5.55 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 103.96 -2.607 . . . . 0.0 103.96 165.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -137.28 166.3 24.1 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 125.852 1.661 . . . . 0.0 106.765 178.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -133.07 130.16 38.98 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 169.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -111.31 83.12 1.71 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.485 ' H ' ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -66.81 46.49 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.481 2.312 . . . . 0.0 112.856 178.142 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.73 169.67 15.17 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.21 -0.931 . . . . 0.0 111.154 -173.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -46.93 142.57 3.39 Favored 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 126.03 1.732 . . . . 0.0 112.221 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -87.58 111.58 42.77 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.915 1.286 . . . . 0.0 108.759 176.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -83.38 -7.44 10.83 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.489 2.126 . . . . 0.0 112.416 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.4 t0 23.88 -96.96 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 128.233 2.613 . . . . 0.0 113.961 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.57 44.1 1.22 Allowed Glycine 0 CA--C 1.533 1.205 0 C-N-CA 126.944 2.211 . . . . 0.0 110.607 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -70.44 -175.39 1.02 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.847 1.659 . . . . 0.0 113.274 -175.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.2 p -69.08 162.38 27.05 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.44 169.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 22.8 mt -55.84 -37.0 68.14 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.942 0.497 . . . . 0.0 111.026 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.47 -37.32 77.9 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 123.262 0.625 . . . . 0.0 110.39 -174.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.4 t -74.2 -41.68 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -55.94 -34.74 65.93 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.451 1.023 . . . . 0.0 112.138 171.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.8 mtp85 -73.0 -44.87 60.51 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 119.705 1.139 . . . . 0.0 111.606 173.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 91.3 m -75.46 -38.21 59.82 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.372 0.669 . . . . 0.0 112.021 -169.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 87.4 t -71.49 -45.2 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -176.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -43.51 -53.02 5.81 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 125.886 1.675 . . . . 0.0 111.236 169.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.53 -40.18 97.44 Favored Glycine 0 N--CA 1.467 0.721 0 CA-C-N 119.785 1.175 . . . . 0.0 111.96 -175.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -65.17 -38.65 91.21 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 121.492 -1.005 . . . . 0.0 110.359 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.18 -40.44 89.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 175.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -36.89 76.04 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.454 1.025 . . . . 0.0 111.292 -177.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -69.85 -42.93 72.91 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 118.743 -0.646 . . . . 0.0 110.448 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -63.47 -43.18 98.09 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.88 1.218 . . . . 0.0 110.388 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 63.9 t -54.98 -53.66 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 123.475 0.71 . . . . 0.0 109.627 173.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -64.77 -32.77 74.61 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 122.151 -0.343 . . . . 0.0 111.419 -175.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -62.8 -47.73 82.19 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 123.363 0.665 . . . . 0.0 111.208 172.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.92 -47.75 76.95 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.454 0.57 . . . . 0.0 109.589 175.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -57.89 -42.49 82.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 124.452 1.101 . . . . 0.0 110.091 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.07 -28.94 68.22 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.885 0.766 . . . . 0.0 111.94 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -75.49 -40.56 57.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.614 0.643 . . . . 0.0 111.759 175.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 pt -101.33 -42.45 9.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -168.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 C--O 1.253 1.287 0 CA-C-N 119.089 0.859 . . . . 0.0 110.237 -173.423 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 tpt . . . . . 0 N--CA 1.497 1.918 0 CA-C-O 117.957 -1.02 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.432 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -48.75 121.87 5.08 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 120.597 1.544 . . . . 0.0 109.863 -174.044 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -97.8 135.83 39.0 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -169.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.8 t -113.52 156.52 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 59.2 tpp -135.67 137.49 41.87 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -119.78 117.07 27.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 177.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.5 t -99.55 132.39 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -169.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.8 t -111.79 131.22 55.47 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.962 0.887 . . . . 0.0 112.892 -169.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -140.15 150.93 44.84 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 129.08 2.952 . . . . 0.0 103.503 169.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 58.0 -170.8 0.11 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.799 0.84 . . . . 0.0 109.79 -168.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.424 HD22 ' CD2' ' A' ' 43' ' ' HIS . 15.1 t-20 -58.0 130.03 44.69 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -168.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.9 m -35.0 -35.41 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.997 1.719 . . . . 0.0 115.636 169.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.1 p -61.41 -9.6 5.82 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -99.96 -52.97 3.28 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 120.369 1.44 . . . . 0.0 110.823 171.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 p -94.21 -51.26 4.9 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 120.703 -1.248 . . . . 0.0 113.736 -168.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.32 -21.64 63.83 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 118.069 -1.452 . . . . 0.0 110.031 173.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.468 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 0.8 OUTLIER -63.39 -39.57 94.88 Favored 'General case' 0 CA--C 1.512 -0.498 0 O-C-N 120.899 -1.126 . . . . 0.0 109.056 168.364 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.9 -37.91 74.86 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 118.753 -0.641 . . . . 0.0 109.866 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -61.44 -40.07 93.12 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.942 169.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.33 -42.9 93.76 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 120.242 1.383 . . . . 0.0 111.454 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -67.23 -39.01 86.15 Favored 'General case' 0 CA--C 1.518 -0.274 0 O-C-N 121.554 -0.968 . . . . 0.0 108.705 173.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.06 -40.28 71.73 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 119.525 1.057 . . . . 0.0 110.433 -173.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -72.03 -15.5 62.03 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.449 1.022 . . . . 0.0 112.327 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 m -85.08 -50.54 7.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.798 1.639 . . . . 0.0 109.469 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.6 mt -88.85 -26.21 21.76 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.515 1.126 . . . . 0.0 112.7 -169.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.91 13.87 57.5 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 126.161 1.839 . . . . 0.0 112.076 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.01 125.16 23.05 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.635 1.174 . . . . 0.0 108.825 -174.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.2 7.79 88.21 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.711 -0.494 . . . . 0.0 113.795 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt -125.64 -42.78 1.91 Allowed 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 125.731 1.612 . . . . 0.0 108.988 -176.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.7 pp -143.29 152.04 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 124.642 1.177 . . . . 0.0 109.301 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.12 152.2 21.24 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 172.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 t -139.33 139.86 38.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 121.819 -0.551 . . . . 0.0 110.157 -168.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.98 159.23 43.82 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.337 1.055 . . . . 0.0 109.135 -172.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.2 t -146.88 156.08 42.81 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 119.376 0.989 . . . . 0.0 110.251 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.3 p -147.37 153.61 39.87 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.842 0.857 . . . . 0.0 109.707 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.709 0 N-CA-C 106.542 -2.623 . . . . 0.0 106.542 -169.334 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.236 0.345 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.424 ' CD2' HD22 ' A' ' 11' ' ' ASN . 80.0 t60 -132.98 108.47 12.71 Favored Pre-proline 0 C--O 1.234 0.251 0 C-N-CA 123.187 0.595 . . . . 0.0 109.414 -169.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -64.37 -30.38 62.92 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.157 2.571 . . . . 0.0 112.234 -168.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.5 m -65.73 -36.53 83.85 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 119.296 0.953 . . . . 0.0 109.246 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.97 -44.6 84.46 Favored 'General case' 0 C--N 1.346 0.424 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -58.05 -48.8 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.96 96.26 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.713 0.688 . . . . 0.0 110.906 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.6 mmt -58.66 -25.89 63.24 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.873 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.468 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.5 OUTLIER -95.87 -26.33 15.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 119.178 0.899 . . . . 0.0 108.932 -177.579 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -64.74 -29.64 70.63 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.546 1.138 . . . . 0.0 110.445 169.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -57.63 -22.82 47.8 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.386 0.674 . . . . 0.0 112.186 171.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.9 m -124.09 11.59 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 125.708 1.603 . . . . 0.0 111.279 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.41 40.92 86.63 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.0 0.81 . . . . 0.0 113.012 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.7 mt -124.87 154.29 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.542 1.537 . . . . 0.0 107.758 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -122.6 126.37 47.55 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.013 1.325 . . . . 0.0 109.014 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.8 pt -129.47 16.38 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 125.14 1.376 . . . . 0.0 111.268 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.51 -24.89 45.56 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.762 1.625 . . . . 0.0 112.226 169.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.27 -13.13 81.63 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 118.136 0.426 . . . . 0.0 112.399 174.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -73.12 163.09 28.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.697 1.199 . . . . 0.0 110.545 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.7 p -148.3 168.06 23.56 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.727 1.211 . . . . 0.0 110.791 170.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.35 143.88 51.81 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.714 1.206 . . . . 0.0 109.801 174.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -161.04 127.93 2.56 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 117.225 -1.369 . . . . 0.0 107.751 173.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -65.52 152.33 82.17 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.136 2.557 . . . . 0.0 114.468 -172.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.1 tt -62.05 -41.13 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 124.438 1.095 . . . . 0.0 111.083 174.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -70.42 -20.82 62.89 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.085 0.554 . . . . 0.0 111.891 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.98 -19.04 60.78 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.548 0.739 . . . . 0.0 111.642 171.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -92.54 169.8 10.25 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.912 0.863 . . . . 0.0 110.954 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -140.94 88.58 2.19 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 -173.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.442 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -53.95 -24.15 15.53 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -28.58 16.06 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.355 0.662 . . . . 0.0 111.372 173.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -82.3 -13.71 56.53 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.311 1.044 . . . . 0.0 113.302 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -121.64 113.63 20.02 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 120.081 1.309 . . . . 0.0 109.383 -169.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.4 -16.03 52.43 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -169.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.3 t -144.8 127.13 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -170.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.7 t -121.26 127.39 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.2 mm -119.72 95.05 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 169.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.2 t -74.45 165.96 24.31 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 168.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.88 26.14 2.29 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.61 -1.306 . . . . 0.0 109.128 171.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 57.0 m -83.52 -1.32 53.43 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.167 -0.958 . . . . 0.0 112.476 -170.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.96 23.89 6.86 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 123.783 0.706 . . . . 0.0 111.73 175.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.417 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 3.2 t 44.32 45.16 7.18 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.148 1.779 . . . . 0.0 112.336 -174.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -155.6 35.82 0.63 Allowed Glycine 0 C--N 1.339 0.743 0 CA-C-O 119.735 -0.481 . . . . 0.0 112.319 -171.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 86.6 t -122.87 141.91 41.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 125.058 1.343 . . . . 0.0 108.6 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -81.95 60.09 4.63 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.37 1.068 . . . . 0.0 109.966 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 68.4 mt -56.63 134.35 77.89 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -54.57 155.36 17.22 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.552 2.168 . . . . 0.0 112.568 178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -54.9 -28.82 60.71 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.76 2.306 . . . . 0.0 116.099 -171.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -66.53 -24.36 66.37 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.153 -0.967 . . . . 0.0 111.607 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.442 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 66.9 m95 -70.97 -13.93 62.18 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 117.892 -1.051 . . . . 0.0 113.14 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.9 m -113.52 -10.93 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 120.107 1.321 . . . . 0.0 113.165 -171.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.4 p -84.05 -16.41 43.93 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.615 0.766 . . . . 0.0 112.739 -175.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -50.45 161.86 0.28 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 130.017 3.327 . . . . 0.0 114.377 174.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -62.36 -39.32 92.79 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.454 1.502 . . . . 0.0 108.801 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 23.4 mm -122.85 136.83 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 169.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -141.14 111.89 7.07 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 100.926 -3.731 . . . . 0.0 100.926 166.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.92 164.32 28.22 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 174.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.417 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.8 t70 -134.56 100.31 4.6 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 170.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -77.2 78.32 3.73 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -55.62 33.43 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.953 1 C-N-CA 131.745 4.018 . . . . 0.0 113.761 170.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.93 172.15 5.85 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.083 1.353 . . . . 0.0 111.717 -169.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -49.88 155.52 0.87 Allowed 'General case' 0 C--O 1.231 0.088 0 C-N-CA 125.354 1.462 . . . . 0.0 112.632 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -107.24 110.58 63.31 Favored Pre-proline 0 N--CA 1.448 -0.538 0 C-N-CA 126.556 1.942 . . . . 0.0 109.062 175.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -95.31 1.03 2.49 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 124.068 3.179 . . . . 0.0 112.631 175.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -51.37 -37.09 46.32 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -168.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -109.38 25.05 18.96 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.48 -1.178 . . . . 0.0 112.677 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -122.34 174.65 6.87 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 118.999 1.4 . . . . 0.0 113.95 -169.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.1 m -73.14 166.79 22.46 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 112.947 -1.933 . . . . 0.0 110.144 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.6 mt -55.51 -31.61 62.2 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 123.189 0.596 . . . . 0.0 110.951 175.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -62.28 -41.16 98.25 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 118.298 0.499 . . . . 0.0 110.567 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.2 t -76.48 -39.82 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 117.322 -1.323 . . . . 0.0 108.784 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -47.23 -48.57 24.25 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 120.264 1.393 . . . . 0.0 110.949 168.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -61.21 -46.1 91.82 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.261 0.937 . . . . 0.0 111.184 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.5 m -68.21 -37.37 80.81 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 122.865 0.466 . . . . 0.0 110.16 -171.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 40.3 t -75.93 -44.01 38.8 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -177.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -45.59 -51.09 12.53 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 124.795 1.238 . . . . 0.0 111.193 170.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.18 -42.97 97.75 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 119.506 1.048 . . . . 0.0 112.19 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -65.61 -35.56 81.17 Favored 'General case' 0 CA--C 1.52 -0.192 0 O-C-N 120.942 -1.328 . . . . 0.0 110.832 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.2 -42.63 97.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 173.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.15 -39.65 83.09 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.422 1.465 . . . . 0.0 111.369 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.7 -44.62 73.59 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.393 1.477 . . . . 0.0 109.743 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -66.89 -41.34 87.36 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.574 -0.704 . . . . 0.0 112.039 177.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 38.9 t -54.77 -53.02 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -64.08 -32.74 74.41 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 122.043 -0.411 . . . . 0.0 111.647 -175.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -63.13 -46.09 88.88 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 121.612 -0.68 . . . . 0.0 111.392 172.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.11 -47.58 82.82 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 175.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -58.02 -41.37 80.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 123.896 0.878 . . . . 0.0 109.825 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.26 -27.39 68.42 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.868 0.758 . . . . 0.0 112.093 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -76.82 -41.21 45.22 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 118.616 -0.706 . . . . 0.0 112.315 174.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.8 pt -101.13 -35.11 4.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 -168.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 28.2 m . . . . . 0 C--O 1.256 1.401 0 CA-C-N 119.304 0.956 . . . . 0.0 111.497 -177.107 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 tpt . . . . . 0 N--CA 1.499 2.011 0 CA-C-O 118.53 -0.747 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.422 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -60.94 119.28 7.95 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 120.842 1.655 . . . . 0.0 108.679 -174.566 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -90.37 138.08 31.83 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -172.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.7 t -116.37 153.74 17.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 O-C-N 124.25 0.969 . . . . 0.0 108.386 174.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.25 142.09 50.94 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 175.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -121.5 103.92 9.28 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.544 -1.651 . . . . 0.0 106.544 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 t -89.32 134.52 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -169.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 82.4 m -91.84 169.15 10.92 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -169.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -147.52 -160.45 1.17 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 128.159 2.584 . . . . 0.0 105.476 168.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.8 ttm105 -46.38 141.46 3.53 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.916 1.235 . . . . 0.0 111.504 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.537 HD22 ' CD2' ' A' ' 43' ' ' HIS . 9.0 t-20 44.34 67.62 0.66 Allowed 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 127.964 2.506 . . . . 0.0 109.694 -172.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 p -51.4 -20.61 1.85 Allowed 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 126.522 1.929 . . . . 0.0 114.71 -171.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 77.1 m -61.0 -17.64 53.26 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 116.734 -1.603 . . . . 0.0 113.658 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -65.45 -37.14 86.01 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 122.978 2.626 . . . . 0.0 111.334 169.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.63 -39.91 15.64 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.409 -0.807 . . . . 0.0 108.901 -174.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -66.89 -25.28 66.31 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 120.902 -1.124 . . . . 0.0 110.875 169.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.437 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.8 tpt -67.03 -37.89 84.94 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 119.884 -1.76 . . . . 0.0 109.153 169.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.58 89.73 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -61.87 -40.19 94.5 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.49 -0.766 . . . . 0.0 110.533 169.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.31 -35.65 63.59 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 120.894 1.679 . . . . 0.0 112.676 -175.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -71.87 -37.81 70.13 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 118.329 1.065 . . . . 0.0 108.724 169.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.53 -39.27 70.84 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 120.567 -1.333 . . . . 0.0 111.275 -174.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -63.45 -23.95 67.62 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.054 1.297 . . . . 0.0 111.979 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 m -84.94 -50.42 7.51 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.146 2.178 . . . . 0.0 109.581 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.6 mt -88.45 -25.12 22.79 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.377 1.471 . . . . 0.0 112.022 -169.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -106.5 15.75 41.74 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 126.715 2.102 . . . . 0.0 111.73 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.35 123.09 16.79 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.595 1.158 . . . . 0.0 109.442 -175.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.24 8.38 87.5 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 123.07 0.367 . . . . 0.0 113.786 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.2 mmtt -120.66 -34.82 3.5 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 126.117 1.767 . . . . 0.0 109.278 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.5 pt -142.38 172.77 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 124.912 1.285 . . . . 0.0 109.307 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.8 145.98 39.65 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 168.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.57 141.26 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 123.163 0.585 . . . . 0.0 110.782 -168.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.01 160.51 42.06 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.129 0.972 . . . . 0.0 109.826 -173.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.5 p -135.51 168.14 19.78 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.124 1.329 . . . . 0.0 109.443 169.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.3 p -153.61 157.01 39.01 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.6 -0.687 . . . . 0.0 112.005 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.815 0 C-N-CA 125.693 1.616 . . . . 0.0 110.626 173.869 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 121.292 0.568 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.537 ' CD2' HD22 ' A' ' 11' ' ' ASN . 77.4 t60 -123.25 110.8 30.59 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 124.312 1.045 . . . . 0.0 110.147 -169.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.48 -25.03 41.8 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.389 2.726 . . . . 0.0 115.113 -169.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -59.73 -37.63 79.48 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 120.538 1.517 . . . . 0.0 110.775 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.41 -44.51 71.25 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.13 -44.19 78.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 CA-C-O 118.616 -0.707 . . . . 0.0 109.137 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.05 -42.77 81.15 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.689 0.677 . . . . 0.0 110.974 177.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 30.4 mmt -66.78 -22.47 66.03 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.779 -0.629 . . . . 0.0 112.311 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.437 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 1.8 mmt -90.18 -36.32 14.86 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -65.38 -34.86 79.31 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.368 1.067 . . . . 0.0 110.267 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.26 1.0 OUTLIER -76.31 5.21 7.38 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.3 0.64 . . . . 0.0 112.289 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.0 m -129.07 -23.02 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.831 1.252 . . . . 0.0 112.707 169.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.72 31.11 0.91 Allowed Glycine 0 CA--C 1.532 1.125 0 CA-C-N 119.739 1.154 . . . . 0.0 114.422 170.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.0 mt -130.13 161.62 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.534 1.534 . . . . 0.0 107.112 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -140.36 146.81 38.9 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 169.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.6 pt -138.37 5.71 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.486 1.914 . . . . 0.0 110.618 -176.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.6 p -64.04 145.12 56.45 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.172 -0.955 . . . . 0.0 110.138 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.2 6.02 18.2 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 118.253 -1.304 . . . . 0.0 113.811 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -57.14 -44.76 83.71 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 119.521 1.66 . . . . 0.0 113.205 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -149.53 162.24 40.54 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 124.232 0.958 . . . . 0.0 110.626 -168.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.3 p -170.5 27.4 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.702 0.801 . . . . 0.0 111.994 -170.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -139.33 147.08 51.41 Favored Pre-proline 0 N--CA 1.475 0.809 0 O-C-N 120.604 -1.31 . . . . 0.0 111.614 -169.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -83.08 161.67 15.59 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.872 3.048 . . . . 0.0 112.558 -174.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.7 tt -59.76 -37.24 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.666 1.186 . . . . 0.0 111.545 -177.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -70.5 -20.69 62.82 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.275 0.63 . . . . 0.0 112.134 -173.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -19.05 59.26 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 118.872 -0.585 . . . . 0.0 111.338 171.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -97.72 167.32 11.02 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.934 0.874 . . . . 0.0 110.637 -176.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -141.46 89.61 2.23 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 -172.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.94 -30.66 15.45 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.53 -29.56 10.92 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.134 0.974 . . . . 0.0 112.459 174.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -71.53 -18.58 62.26 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -107.64 171.03 7.62 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 128.398 2.679 . . . . 0.0 108.707 -172.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -111.42 -22.6 11.22 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-O 117.792 -1.099 . . . . 0.0 113.274 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.453 ' CG1' ' HB ' ' A' ' 95' ' ' ILE . 37.7 t -137.4 133.92 46.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 121.544 1.975 . . . . 0.0 108.585 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.0 t -116.5 129.89 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 173.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.3 mm -122.89 96.82 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 101.76 -3.422 . . . . 0.0 101.76 169.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . 0.254 22.0 p -74.32 166.39 23.55 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 117.649 -1.62 . . . . 0.0 108.257 169.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.4 mp -136.36 37.86 2.71 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 170.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 63.8 m -95.91 7.59 45.93 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.869 2.067 . . . . 0.0 110.932 -169.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.85 31.78 6.83 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 119.246 -0.752 . . . . 0.0 112.221 172.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 31.5 p 40.26 37.85 0.47 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.644 2.378 . . . . 0.0 116.041 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.86 24.46 0.49 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 123.896 0.76 . . . . 0.0 112.566 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 p -78.21 143.75 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 124.615 1.166 . . . . 0.0 108.897 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -92.96 58.85 3.05 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.476 1.11 . . . . 0.0 109.239 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.8 mt -61.29 147.47 87.14 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -175.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -56.41 157.58 17.95 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.895 2.397 . . . . 0.0 111.89 170.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.3 -25.34 64.37 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 121.853 1.702 . . . . 0.0 114.875 -169.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.47 -24.68 67.22 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.49 -1.382 . . . . 0.0 111.636 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -72.65 -9.26 58.4 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 117.855 -1.069 . . . . 0.0 112.686 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.8 m -117.49 -16.06 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 119.926 1.239 . . . . 0.0 113.166 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.9 p -76.06 -11.18 59.9 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.15 0.886 . . . . 0.0 112.352 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -43.38 156.1 0.06 Allowed 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 130.618 3.567 . . . . 0.0 111.826 169.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -62.12 -36.18 80.97 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.725 1.61 . . . . 0.0 109.731 171.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.453 ' HB ' ' CG1' ' A' ' 75' ' ' VAL . 24.4 mm -131.98 137.0 55.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -135.46 112.62 10.43 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 102.07 -3.307 . . . . 0.0 102.07 166.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -136.31 168.42 19.46 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -141.94 118.68 11.08 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 170.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -95.52 79.59 3.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.31 18.74 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 129.022 2.929 . . . . 0.0 116.411 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -61.76 128.8 37.97 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 120.615 -1.303 . . . . 0.0 113.857 -168.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 46.94 -157.74 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 128.403 2.681 . . . . 0.0 114.161 169.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -163.51 74.47 1.84 Allowed Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 127.871 2.468 . . . . 0.0 108.054 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.5 -13.35 32.72 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.365 2.71 . . . . 0.0 115.834 -169.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.0 t70 26.17 -92.37 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.001 2.52 . . . . 0.0 114.045 172.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.89 45.23 1.01 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 126.888 2.185 . . . . 0.0 109.771 171.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -66.45 175.04 2.41 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.712 2.005 . . . . 0.0 114.133 -172.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.0 m -66.21 152.05 45.69 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 113.217 -1.811 . . . . 0.0 109.657 169.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.3 mt -57.18 -35.24 69.34 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.262 0.625 . . . . 0.0 111.077 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -61.3 -36.35 79.85 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 122.862 0.465 . . . . 0.0 110.794 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 23.3 t -74.83 -40.75 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-O 117.849 -1.072 . . . . 0.0 108.76 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -54.84 -42.55 72.11 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 120.432 1.469 . . . . 0.0 110.748 172.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 59.0 mtt85 -62.21 -46.01 90.81 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.227 0.921 . . . . 0.0 111.743 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.4 m -69.89 -43.64 71.37 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -172.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.8 t -65.9 -45.67 90.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -173.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -47.55 -53.77 13.55 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.997 1.319 . . . . 0.0 110.566 169.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.78 -42.15 99.71 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 119.328 0.967 . . . . 0.0 111.998 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -64.88 -39.71 93.97 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 121.425 -1.044 . . . . 0.0 110.607 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 45.0 t -62.82 -42.34 95.98 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -36.64 78.89 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 120.128 1.331 . . . . 0.0 111.475 -174.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -68.57 -42.69 77.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.691 -0.671 . . . . 0.0 109.869 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -63.41 -42.36 98.76 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 119.831 1.196 . . . . 0.0 110.412 177.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 56.7 t -54.7 -52.93 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 123.469 0.708 . . . . 0.0 109.114 174.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -66.29 -32.85 74.51 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 122.046 -0.409 . . . . 0.0 111.461 -175.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -62.16 -47.87 82.62 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 123.906 0.883 . . . . 0.0 110.966 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -48.03 80.51 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 176.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -57.39 -42.16 79.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 124.447 1.099 . . . . 0.0 109.769 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.68 -27.88 68.19 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.714 0.688 . . . . 0.0 112.154 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -77.01 -41.86 40.97 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.491 0.587 . . . . 0.0 111.951 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.8 pt -99.33 -40.02 8.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 -168.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 40.4 m . . . . . 0 C--O 1.255 1.366 0 CA-C-N 119.005 0.821 . . . . 0.0 110.891 -174.351 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 tpt . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 117.513 -1.232 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.98 123.57 14.78 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 121.566 1.985 . . . . 0.0 109.996 -172.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -93.47 142.13 27.68 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -169.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.1 t -121.57 153.91 25.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.289 0.993 . . . . 0.0 108.56 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 59.9 tpp -136.32 135.05 38.56 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -117.22 109.88 17.43 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.2 t -96.98 141.74 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -169.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.9 t -125.81 156.7 39.12 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.335 0.97 . . . . 0.0 111.316 173.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp -140.11 34.67 1.92 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.664 1.586 . . . . 0.0 109.197 172.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -156.43 171.6 19.98 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 128.006 2.522 . . . . 0.0 105.156 -170.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -42.2 125.41 3.06 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 169.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.0 p -41.52 -29.46 0.17 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 117.277 2.325 . . . . 0.0 117.277 -169.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.7 m -34.16 -62.16 0.33 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 127.367 2.267 . . . . 0.0 115.148 -169.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -64.6 -52.0 59.79 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.056 0.844 . . . . 0.0 112.529 -168.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -81.67 -34.09 30.92 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 121.514 -0.741 . . . . 0.0 111.417 -172.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.27 -30.76 65.14 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.454 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.7 tpt -64.88 -40.88 95.8 Favored 'General case' 0 CA--C 1.514 -0.419 0 O-C-N 121.018 -1.051 . . . . 0.0 109.094 168.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.67 -36.79 79.59 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -62.03 -42.96 99.73 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.83 -0.605 . . . . 0.0 111.313 169.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.14 -45.61 91.0 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-N 119.936 1.244 . . . . 0.0 110.907 -176.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -63.09 -39.98 96.31 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 117.934 0.867 . . . . 0.0 109.364 172.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.28 -35.82 76.43 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 119.58 1.082 . . . . 0.0 111.561 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -81.93 -13.91 56.85 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 120.311 1.414 . . . . 0.0 113.244 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.9 m -78.18 -50.69 11.47 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.229 1.412 . . . . 0.0 109.397 169.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.3 mt -89.56 -27.4 20.28 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.16 1.384 . . . . 0.0 112.423 -169.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.78 14.63 57.47 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 126.661 2.077 . . . . 0.0 111.685 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.34 120.45 9.32 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.579 1.151 . . . . 0.0 110.054 -172.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.58 9.5 86.13 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 119.81 -0.439 . . . . 0.0 113.467 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -123.27 -24.87 4.56 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 125.159 1.384 . . . . 0.0 109.701 -177.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.1 pt -144.29 172.0 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 125.962 1.705 . . . . 0.0 110.42 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.31 144.71 38.62 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 103.836 -2.653 . . . . 0.0 103.836 168.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 t -135.59 140.42 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 123.47 0.708 . . . . 0.0 110.743 -168.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.6 160.63 42.49 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.127 0.971 . . . . 0.0 109.939 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.5 p -139.02 163.64 31.85 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.288 1.404 . . . . 0.0 111.221 174.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.7 p -149.64 160.49 43.46 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.151 0.58 . . . . 0.0 111.339 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.696 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 -177.608 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -121.28 111.28 33.71 Favored Pre-proline 0 N--CA 1.454 -0.268 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -169.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -66.08 -27.11 49.92 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.385 2.724 . . . . 0.0 112.343 -169.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.9 m -63.32 -37.11 85.99 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.64 0.655 . . . . 0.0 109.249 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.39 -44.15 88.43 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.08 -49.66 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.22 -42.86 99.34 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.487 0.585 . . . . 0.0 111.119 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.6 mmt -61.89 -24.75 67.14 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.353 -0.832 . . . . 0.0 111.967 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.454 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.6 OUTLIER -94.4 -27.61 15.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 119.151 0.887 . . . . 0.0 108.688 -179.194 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.59 -30.42 71.53 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.371 1.068 . . . . 0.0 110.408 170.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -56.84 -23.19 42.26 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.457 0.703 . . . . 0.0 112.098 171.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.8 m -123.64 12.01 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 125.445 1.498 . . . . 0.0 111.142 -175.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.36 39.65 87.46 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 123.815 0.722 . . . . 0.0 112.759 174.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.6 mt -122.98 154.56 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.428 1.491 . . . . 0.0 107.19 175.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -127.84 128.11 44.65 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 124.552 1.141 . . . . 0.0 108.795 -177.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 46.3 pt -134.64 15.31 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 126.661 1.984 . . . . 0.0 109.752 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.65 160.16 27.66 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 167.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.17 -15.86 2.34 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 118.958 -0.912 . . . . 0.0 112.456 -174.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -61.58 147.46 45.55 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.757 1.279 . . . . 0.0 107.903 169.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.06 169.64 17.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -169.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.3 m -73.06 145.11 46.8 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.663 1.585 . . . . 0.0 111.937 -170.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -166.32 123.8 1.03 Allowed Pre-proline 0 C--O 1.237 0.442 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 169.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -76.87 161.12 33.54 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.115 1.876 . . . . 0.0 111.454 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.8 tt -56.17 -37.79 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.217 1.007 . . . . 0.0 111.142 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -68.86 -21.27 64.28 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.586 0.754 . . . . 0.0 112.16 -176.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.79 -22.43 63.33 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.637 -0.697 . . . . 0.0 111.203 171.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -107.45 165.9 11.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.578 1.18 . . . . 0.0 112.018 -172.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.86 89.8 2.28 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 102.658 -3.09 . . . . 0.0 102.658 -170.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.402 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -49.4 -32.14 11.01 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.275 0.63 . . . . 0.0 112.283 -177.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.08 -28.29 10.18 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.26 1.024 . . . . 0.0 112.868 174.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.04 -23.2 61.34 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.366 0.666 . . . . 0.0 112.208 176.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -104.12 178.89 4.43 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.618 2.767 . . . . 0.0 108.659 -175.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -123.57 -17.4 6.47 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 118.601 -0.714 . . . . 0.0 112.579 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.5 t -143.72 124.25 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -169.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.6 t -117.41 130.09 72.86 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.782 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.0 mm -119.35 92.44 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 103.026 -2.953 . . . . 0.0 103.026 169.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.9 t -72.42 161.38 30.9 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 169.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.6 mp -141.32 46.87 1.71 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 169.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 72.2 m -89.76 2.06 55.34 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.992 0.917 . . . . 0.0 110.682 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.12 42.69 5.22 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 172.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.2 p 37.75 44.72 0.59 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.321 2.248 . . . . 0.0 114.638 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -157.56 47.89 0.45 Allowed Glycine 0 C--N 1.34 0.757 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -172.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.9 p -128.09 161.92 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.873 1.669 . . . . 0.0 109.99 -172.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -123.21 45.31 2.45 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.177 2.191 . . . . 0.0 109.445 -170.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.8 mt -54.42 140.98 54.82 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.2 1.0 . . . . 0.0 109.245 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -53.88 153.39 20.13 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.596 2.197 . . . . 0.0 112.554 173.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -55.53 -26.82 56.43 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.515 2.143 . . . . 0.0 116.006 -173.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -64.75 -25.09 67.78 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.915 -1.116 . . . . 0.0 111.865 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.402 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 70.0 m95 -71.43 -9.19 57.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.661 1.184 . . . . 0.0 112.323 173.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.27 -29.8 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.663 1.585 . . . . 0.0 110.294 -173.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.0 p -75.25 -9.63 58.73 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.758 0.823 . . . . 0.0 112.738 -175.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -45.21 155.67 0.12 Allowed 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 129.916 3.287 . . . . 0.0 111.722 169.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -62.19 -39.23 92.0 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.803 1.641 . . . . 0.0 109.561 170.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.8 mm -122.56 134.64 65.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 169.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -137.92 111.78 8.33 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 103.892 -2.633 . . . . 0.0 103.892 166.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -137.39 165.72 25.54 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -133.41 105.04 6.71 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.441 1.096 . . . . 0.0 108.157 171.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -79.35 72.82 5.98 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.181 1.392 . . . . 0.0 108.613 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -51.94 34.05 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.952 1 C-N-CA 132.43 4.292 . . . . 0.0 116.015 169.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.87 -175.0 1.6 Allowed 'General case' 0 CA--C 1.544 0.742 0 O-C-N 120.958 -1.088 . . . . 0.0 110.162 -174.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -42.21 164.51 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 127.735 2.414 . . . . 0.0 113.213 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -126.58 63.17 52.24 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 125.779 1.632 . . . . 0.0 112.802 -168.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -79.94 69.06 8.1 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 124.164 3.243 . . . . 0.0 112.549 -169.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.35 -38.56 89.99 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.799 -1.188 . . . . 0.0 112.404 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -162.8 42.56 0.35 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.259 1.409 . . . . 0.0 110.763 -176.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -71.88 171.58 11.47 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -169.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.3 m -69.25 154.2 42.43 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 113.103 -1.862 . . . . 0.0 108.194 168.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 24.6 mt -59.17 -32.48 69.94 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.911 -0.493 . . . . 0.0 111.438 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -62.81 -39.75 95.24 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 118.611 0.642 . . . . 0.0 111.005 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.7 t -72.02 -42.13 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 116.37 -1.776 . . . . 0.0 108.526 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -50.38 -49.13 55.21 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 121.086 1.766 . . . . 0.0 111.1 172.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -58.67 -44.33 90.17 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.371 0.532 . . . . 0.0 110.762 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 88.0 m -66.15 -44.6 83.66 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 118.642 -0.694 . . . . 0.0 109.432 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.3 t -67.36 -49.16 74.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -172.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -44.29 -56.36 4.22 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.332 1.453 . . . . 0.0 111.269 170.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.81 -42.77 96.9 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 119.231 0.923 . . . . 0.0 111.416 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -62.2 -39.35 92.45 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.503 -0.998 . . . . 0.0 111.409 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.0 t -62.72 -41.52 92.68 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 CA-C-O 117.842 -1.075 . . . . 0.0 108.212 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -38.3 75.9 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 120.208 1.367 . . . . 0.0 111.048 -177.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -69.79 -43.76 71.47 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.988 -0.529 . . . . 0.0 110.219 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -66.36 -42.9 87.35 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.381 0.991 . . . . 0.0 110.357 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.8 t -52.72 -54.53 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 123.833 0.853 . . . . 0.0 108.983 172.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -65.1 -32.54 74.29 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 122.121 -0.362 . . . . 0.0 111.301 -174.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -62.41 -47.74 82.8 Favored 'General case' 0 C--O 1.225 -0.188 0 O-C-N 121.806 -0.559 . . . . 0.0 111.185 172.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.63 -47.57 79.41 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 176.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.2 mt -57.97 -42.71 83.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 123.895 0.878 . . . . 0.0 109.697 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.3 -32.0 71.85 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.961 0.801 . . . . 0.0 111.957 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -72.36 -42.25 65.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.611 173.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.3 pt -103.93 -44.7 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 118.942 2.941 . . . . 0.0 118.942 -168.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 71.8 m . . . . . 0 C--O 1.252 1.228 0 CA-C-N 119.733 1.152 . . . . 0.0 111.561 -169.336 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 tpt . . . . . 0 N--CA 1.498 1.942 0 CA-C-O 118.724 -0.655 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.404 ' HE2' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -64.31 128.13 34.47 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.892 1.678 . . . . 0.0 108.891 -174.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -94.24 145.8 24.47 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -170.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.2 t -124.28 153.52 30.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 O-C-N 124.495 1.122 . . . . 0.0 108.142 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 56.5 tpp -134.59 146.24 49.42 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 175.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -127.0 106.53 9.34 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.0 t -93.47 136.52 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -169.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.5 m -108.55 171.62 7.31 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.133 0.573 . . . . 0.0 110.748 -174.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -149.69 -52.36 0.15 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.451 0.7 . . . . 0.0 109.395 169.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.412 ' CG ' ' H ' ' A' ' 11' ' ' ASN . 30.9 ttm180 -103.92 -176.44 3.08 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.387 1.075 . . . . 0.0 108.293 169.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.474 HD22 ' CD2' ' A' ' 43' ' ' HIS . 27.4 t-20 -36.07 125.24 0.75 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 127.821 2.448 . . . . 0.0 113.65 -169.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.78 -19.56 6.65 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 129.243 3.017 . . . . 0.0 113.818 -173.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 p -58.17 -12.41 3.52 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 177.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -101.54 -43.91 5.75 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 120.597 1.544 . . . . 0.0 111.509 169.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.0 p -93.23 -52.88 4.34 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.964 1.306 . . . . 0.0 113.542 -168.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -65.87 -28.03 68.66 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.667 -1.271 . . . . 0.0 110.068 169.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.464 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.7 tpt -62.47 -39.81 94.61 Favored 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 121.267 -0.896 . . . . 0.0 110.741 169.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.03 -37.52 80.02 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 118.834 -0.603 . . . . 0.0 109.678 178.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -62.22 -41.29 98.25 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 118.721 -0.657 . . . . 0.0 110.915 169.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.87 -43.02 84.83 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 120.255 1.388 . . . . 0.0 111.686 -175.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -65.31 -37.53 87.41 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 121.742 -0.858 . . . . 0.0 108.733 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.66 -38.0 67.76 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 119.752 1.16 . . . . 0.0 111.358 -174.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -68.42 -26.75 65.69 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.869 1.213 . . . . 0.0 111.627 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.0 m -77.21 -52.32 9.44 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.967 1.707 . . . . 0.0 110.235 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.1 mt -88.2 -26.44 22.38 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.008 1.323 . . . . 0.0 111.695 -169.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.13 13.77 58.63 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 126.431 1.967 . . . . 0.0 111.673 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.6 119.5 7.68 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.414 1.086 . . . . 0.0 109.548 -174.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.07 8.3 87.93 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 119.754 -0.47 . . . . 0.0 113.564 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.404 ' O ' ' HE2' ' A' ' 2' ' ' LYS . 75.6 mmtt -123.51 -26.22 4.25 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 125.568 1.547 . . . . 0.0 109.977 -177.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.1 pt -145.92 170.58 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 125.058 1.343 . . . . 0.0 109.589 176.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.12 145.82 35.08 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 167.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 t -136.43 140.24 43.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 119.05 0.841 . . . . 0.0 111.263 -167.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 m -150.7 160.78 43.61 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 124.209 1.003 . . . . 0.0 110.682 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 64.6 p -133.2 161.86 33.3 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.057 1.299 . . . . 0.0 109.746 169.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.8 p -154.39 169.8 22.87 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.063 0.459 . . . . 0.0 111.879 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.44 0 C-N-CA 125.471 1.51 . . . . 0.0 111.846 -174.008 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 t . . . . . 0 CA--C 1.531 0.246 0 CA-C-O 122.115 0.96 . . . . 0.0 112.285 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.474 ' CD2' HD22 ' A' ' 11' ' ' ASN . 85.9 t60 -127.74 114.62 20.79 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 125.76 1.624 . . . . 0.0 108.321 -172.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -68.35 -27.04 34.62 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 124.021 3.147 . . . . 0.0 113.241 -169.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.0 m -62.65 -34.37 76.94 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.134 0.879 . . . . 0.0 109.206 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.12 -45.97 86.23 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.48 -46.7 92.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.128 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.96 -43.57 98.57 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 119.091 0.86 . . . . 0.0 111.077 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.4 mmt -59.74 -25.45 64.86 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.204 0.602 . . . . 0.0 111.986 175.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.464 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -93.09 -29.32 15.84 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -176.88 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -63.25 -31.47 72.63 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.328 1.451 . . . . 0.0 110.212 171.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -56.83 -20.81 24.79 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.794 0.838 . . . . 0.0 112.516 171.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.8 p -126.25 14.15 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 125.191 1.397 . . . . 0.0 110.253 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.8 33.76 66.32 Favored Glycine 0 CA--C 1.531 1.069 0 O-C-N 121.053 -1.029 . . . . 0.0 112.842 173.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.8 mt -121.01 159.04 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 126.08 1.752 . . . . 0.0 106.944 176.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -140.09 146.99 39.62 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.2 pt -135.15 8.77 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 126.262 1.825 . . . . 0.0 111.183 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.5 t -70.73 161.31 31.07 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 168.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.7 -25.53 1.43 Allowed Glycine 0 CA--C 1.533 1.199 0 CA-C-O 119.029 -0.873 . . . . 0.0 111.942 -173.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -76.85 137.95 39.5 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 103.397 -2.816 . . . . 0.0 103.397 168.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -146.84 165.19 30.45 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -168.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.1 m -68.0 141.37 56.27 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.961 2.105 . . . . 0.0 111.01 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -164.56 132.19 2.5 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.66 147.61 35.78 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.887 2.392 . . . . 0.0 113.753 -168.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.5 tt -60.48 -34.25 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.087 1.355 . . . . 0.0 111.238 -171.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.28 -13.17 61.44 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.211 0.604 . . . . 0.0 112.541 -171.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -91.58 -10.29 41.09 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.027 0.931 . . . . 0.0 112.173 171.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -84.0 171.07 13.3 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 122.015 0.912 . . . . 0.0 111.161 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.77 83.2 1.52 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.787 1.635 . . . . 0.0 107.638 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.1 -30.96 7.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -50.65 -32.6 19.61 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.143 0.977 . . . . 0.0 112.627 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -71.11 -24.85 62.37 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -94.36 177.28 6.0 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 127.402 2.281 . . . . 0.0 109.064 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -116.14 -19.23 10.36 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 118.257 -0.878 . . . . 0.0 112.585 173.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.2 t -143.2 132.41 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 120.685 1.584 . . . . 0.0 106.939 -169.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.8 m -132.99 130.15 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.0 mm -116.96 99.96 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 102.749 -3.056 . . . . 0.0 102.749 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.3 t -72.85 161.38 30.79 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 169.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.2 mp -140.1 34.29 1.92 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 169.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 85.5 m -74.01 -5.79 43.5 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.388 1.075 . . . . 0.0 111.6 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.33 27.32 18.41 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -173.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.459 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 3.1 t 53.96 -173.13 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.287 1.835 . . . . 0.0 111.095 -169.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.93 -34.4 1.25 Allowed Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.414 1.483 . . . . 0.0 114.818 173.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 78.2 t -58.67 126.07 15.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 118.502 1.151 . . . . 0.0 108.679 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -82.04 73.31 9.09 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.455 1.102 . . . . 0.0 110.317 -169.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.2 mt -58.9 143.01 84.16 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 118.28 -0.867 . . . . 0.0 108.871 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.1 156.59 9.76 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.208 2.605 . . . . 0.0 112.458 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.57 -20.46 65.67 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.72 1.613 . . . . 0.0 115.172 -169.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.83 -24.8 66.2 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 120.576 -1.328 . . . . 0.0 112.067 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -70.33 -8.9 54.1 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.215 1.006 . . . . 0.0 111.884 171.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.2 t -105.83 -30.56 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 119.831 1.196 . . . . 0.0 110.517 -174.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.8 p -73.8 -14.48 61.11 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.114 0.966 . . . . 0.0 112.911 -174.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -44.25 154.19 0.12 Allowed 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 129.835 3.254 . . . . 0.0 112.075 169.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -63.01 -38.72 92.32 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.735 1.614 . . . . 0.0 109.45 169.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.5 mt -126.95 131.11 71.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -137.95 109.84 7.18 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 101.126 -3.657 . . . . 0.0 101.126 166.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.86 165.99 23.72 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.459 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 11.1 t70 -130.62 103.91 6.9 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 169.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 53.0 m0 -76.35 73.12 3.13 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 174.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -58.99 42.9 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.87 1 C-N-CA 131.865 4.066 . . . . 0.0 111.755 169.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.36 -172.69 1.2 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.714 1.206 . . . . 0.0 112.128 -168.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -50.96 161.64 0.35 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.344 1.458 . . . . 0.0 111.745 172.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -117.42 101.22 52.83 Favored Pre-proline 0 C--N 1.323 -0.557 0 C-N-CA 126.313 1.845 . . . . 0.0 108.766 -176.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -79.08 -4.5 13.91 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.071 2.514 . . . . 0.0 113.064 175.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.8 t70 23.26 -96.6 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 128.536 2.735 . . . . 0.0 114.238 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.84 38.31 1.83 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 127.105 2.288 . . . . 0.0 109.51 169.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -71.67 -178.0 2.09 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.238 1.815 . . . . 0.0 112.775 -174.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.0 m -62.55 155.2 26.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 113.52 -1.673 . . . . 0.0 109.047 172.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 27.0 mt -56.43 -30.82 63.3 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 123.09 0.556 . . . . 0.0 110.805 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.35 -40.04 92.81 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 118.636 0.653 . . . . 0.0 110.811 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.4 t -72.32 -44.02 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 117.361 -1.304 . . . . 0.0 108.781 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -48.01 -48.71 32.58 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 120.181 1.355 . . . . 0.0 111.383 170.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -60.64 -45.13 95.23 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.948 0.795 . . . . 0.0 111.364 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.7 m -68.58 -44.32 74.66 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -173.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 19.7 t -67.68 -43.47 86.65 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -174.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -47.37 -56.4 6.98 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 124.638 1.175 . . . . 0.0 110.825 171.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.66 -42.49 99.68 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 119.546 1.066 . . . . 0.0 111.869 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -63.7 -38.74 92.26 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 121.317 -1.108 . . . . 0.0 111.803 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.5 t -62.52 -41.42 91.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -37.29 76.75 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 119.805 1.184 . . . . 0.0 111.184 -175.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -70.11 -41.05 74.5 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 118.695 -0.669 . . . . 0.0 110.722 176.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -64.4 -43.74 93.46 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.948 1.249 . . . . 0.0 110.214 177.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 66.7 t -54.38 -52.02 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 123.782 0.833 . . . . 0.0 109.536 173.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -66.29 -34.46 78.04 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 118.057 0.39 . . . . 0.0 111.634 -175.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -61.74 -48.91 78.58 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.313 0.645 . . . . 0.0 110.897 172.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.5 -45.06 89.53 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 122.882 0.473 . . . . 0.0 109.937 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.6 mt -58.38 -42.71 84.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 123.489 0.715 . . . . 0.0 109.576 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.04 -28.11 68.61 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -68.19 -53.53 24.26 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.022 0.828 . . . . 0.0 110.431 172.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -84.33 -40.5 15.48 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 -169.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--O 1.255 1.345 0 CA-C-N 119.554 1.07 . . . . 0.0 112.486 -169.638 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.5 2.03 0 CA-C-O 117.491 -1.242 . . . . 0.0 109.208 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.44 123.54 15.07 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 121.509 1.959 . . . . 0.0 109.812 -172.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -92.47 142.05 27.84 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -170.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.5 t -123.66 152.21 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 O-C-N 124.381 1.051 . . . . 0.0 108.385 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 53.8 tpp -137.29 143.94 42.4 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -126.23 119.56 27.77 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.8 t -103.86 131.14 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -169.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.8 t -123.56 -174.76 3.04 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.624 1.57 . . . . 0.0 110.314 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -158.59 -63.63 0.08 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 169.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.3 ttm105 -70.66 135.15 48.15 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 122.333 0.253 . . . . 0.0 111.272 -175.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 65.4 t30 42.91 25.74 0.06 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.72 2.808 . . . . 0.0 115.877 168.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.4 m 29.45 64.87 0.13 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.177 2.191 . . . . 0.0 114.395 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 p -139.38 -71.88 0.39 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 116.593 -1.67 . . . . 0.0 115.129 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.262 20.0 ptt180 -44.18 -45.68 8.48 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 122.355 2.343 . . . . 0.0 116.035 -168.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.04 -30.69 15.17 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.486 -0.759 . . . . 0.0 111.215 -174.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -62.11 -37.14 83.97 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.857 -1.152 . . . . 0.0 108.677 169.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.423 ' SD ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -64.25 -39.49 94.06 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 121.146 -0.971 . . . . 0.0 110.681 172.203 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.56 -34.5 74.26 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 118.633 -0.699 . . . . 0.0 110.326 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -64.24 -40.78 96.72 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-N 118.979 0.809 . . . . 0.0 110.172 169.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.29 -43.55 98.92 Favored Glycine 0 C--N 1.339 0.697 0 CA-C-N 120.009 1.277 . . . . 0.0 111.33 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.423 ' CD2' ' SD ' ' A' ' 17' ' ' MET . 7.2 m-85 -68.24 -38.31 81.69 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 118.571 1.186 . . . . 0.0 109.847 172.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.83 -37.11 70.36 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 119.642 1.11 . . . . 0.0 111.171 -172.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.4 pttt -71.34 -27.14 63.16 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 119.868 1.213 . . . . 0.0 111.867 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 m -72.58 -50.8 22.98 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.184 1.794 . . . . 0.0 110.331 175.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.1 mt -88.76 -28.36 20.54 Favored 'General case' 0 CA--C 1.53 0.212 0 C-N-CA 124.74 1.216 . . . . 0.0 112.056 -169.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.59 15.14 60.17 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.878 2.18 . . . . 0.0 111.423 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.56 120.11 8.81 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.706 1.203 . . . . 0.0 110.012 -173.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.65 9.05 87.12 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.692 -0.504 . . . . 0.0 113.48 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -123.1 -24.02 4.81 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.348 1.459 . . . . 0.0 110.026 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.9 pt -146.08 171.85 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 125.972 1.709 . . . . 0.0 110.124 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.82 143.81 42.15 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 168.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.6 t -137.34 138.14 45.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 118.907 0.776 . . . . 0.0 111.178 -168.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.4 m -144.86 166.42 25.31 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.203 1.401 . . . . 0.0 109.841 178.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.5 p -136.37 161.78 34.87 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.594 -1.316 . . . . 0.0 108.899 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.4 p -159.07 176.27 12.47 Favored 'General case' 0 C--O 1.233 0.226 0 O-C-N 121.556 -0.715 . . . . 0.0 109.491 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.6 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -176.433 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.445 -0.703 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -149.55 116.17 3.62 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -65.35 -29.35 54.39 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.018 2.479 . . . . 0.0 112.176 -169.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.6 m -64.21 -37.5 87.69 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.91 -42.25 90.42 Favored 'General case' 0 C--O 1.219 -0.536 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.73 -48.4 86.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 118.457 -0.783 . . . . 0.0 109.286 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.98 -42.74 98.93 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.228 0.922 . . . . 0.0 110.992 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 24.6 mmt -64.87 -21.24 66.77 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.962 0.905 . . . . 0.0 112.102 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.1 mmt -91.49 -29.16 17.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 119.305 0.957 . . . . 0.0 110.175 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.24 -29.38 70.16 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.897 0.879 . . . . 0.0 110.491 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -56.39 -25.58 50.34 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.047 0.939 . . . . 0.0 112.489 170.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.5 m -121.95 12.74 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.987 1.315 . . . . 0.0 111.056 -173.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.2 37.4 81.25 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.361 -0.688 . . . . 0.0 112.385 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.6 mt -121.87 153.74 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -129.92 127.63 40.52 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 37.3 pt -132.02 9.73 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 C-N-CA 123.303 0.641 . . . . 0.0 111.931 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.16 -32.18 61.22 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.355 1.462 . . . . 0.0 112.456 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.06 3.83 69.33 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.551 -0.583 . . . . 0.0 112.841 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -76.1 -175.42 3.1 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.225 1.01 . . . . 0.0 111.847 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.43 171.14 1.14 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.013 2.525 . . . . 0.0 114.999 -169.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.2 m -144.74 21.55 1.63 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.426 1.49 . . . . 0.0 111.699 -169.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -139.59 160.13 62.63 Favored Pre-proline 0 N--CA 1.471 0.578 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -168.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.7 165.58 24.61 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 124.724 3.616 . . . . 0.0 112.454 175.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.4 tt -59.93 -34.55 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.384 1.474 . . . . 0.0 111.971 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -68.89 -21.56 64.23 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -169.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.49 -16.44 56.04 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.161 172.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -89.67 171.3 9.76 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.237 0.926 . . . . 0.0 110.706 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.24 88.57 1.73 Allowed 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.236 1.414 . . . . 0.0 108.912 -173.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.86 -29.71 8.59 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.805 0.842 . . . . 0.0 113.168 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -48.76 -33.98 11.35 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.282 1.033 . . . . 0.0 112.034 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -73.51 -23.11 59.98 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -99.43 -177.66 3.66 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 127.547 2.339 . . . . 0.0 109.796 -174.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -123.19 -20.52 5.67 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.1 t -142.86 130.09 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 -169.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.8 m -135.27 135.76 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 O-C-N 120.825 -1.172 . . . . 0.0 108.368 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.1 mm -130.37 100.27 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 -172.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 77.4 p -80.83 159.91 24.96 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 119.042 -1.063 . . . . 0.0 109.461 173.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.4 mp -137.39 53.54 1.86 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 103.009 -2.96 . . . . 0.0 103.009 169.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 60.1 m -107.9 18.86 20.79 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.623 1.969 . . . . 0.0 108.774 -176.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.46 21.86 76.24 Favored Glycine 0 C--N 1.344 0.972 0 CA-C-O 118.785 -1.008 . . . . 0.0 112.548 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.4 p 53.52 -8.7 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.504 3.122 . . . . 0.0 117.418 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.97 -27.94 73.47 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 119.248 0.931 . . . . 0.0 112.005 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.0 t -65.99 113.63 2.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -76.19 105.59 7.32 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 104.154 -2.536 . . . . 0.0 104.154 168.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.5 mt -72.9 154.61 90.95 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.26 158.29 12.44 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.906 2.404 . . . . 0.0 112.487 173.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.84 -24.02 68.41 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 121.727 1.618 . . . . 0.0 115.717 -169.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -67.99 -24.3 65.12 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 120.705 -1.247 . . . . 0.0 111.835 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -72.6 -7.57 50.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.318 1.047 . . . . 0.0 111.756 172.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.2 t -105.34 -30.52 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 120.213 1.37 . . . . 0.0 110.309 -174.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.9 p -74.19 -13.11 60.75 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.242 1.017 . . . . 0.0 112.88 -175.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -45.29 154.64 0.16 Allowed 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 129.898 3.279 . . . . 0.0 112.468 169.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -64.33 -39.03 93.08 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.203 1.801 . . . . 0.0 109.347 170.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 31.1 mm -127.44 135.65 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 171.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -137.67 104.27 5.26 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 100.773 -3.788 . . . . 0.0 100.773 166.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -127.25 169.93 12.99 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 174.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -142.44 137.12 30.13 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 169.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -107.19 6.29 28.57 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -172.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 42.88 -70.78 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 131.282 3.833 . . . . 0.0 112.678 -172.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.423 ' CD1' ' H ' ' A' ' 102' ' ' GLU 0.26 0.3 OUTLIER 52.69 -174.41 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.507 1 C-N-CA 132.977 4.511 . . . . 0.0 114.891 177.012 . . . . . . . . 5 4 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.423 ' H ' ' CD1' ' A' ' 101' ' ' LEU . 27.0 mt-10 -62.19 172.28 1.51 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.065 1.746 . . . . 0.0 109.867 -175.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -129.15 72.23 81.99 Favored Pre-proline 0 C--N 1.323 -0.556 0 C-N-CA 125.135 1.374 . . . . 0.0 111.249 -168.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.6 68.25 5.43 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 124.481 3.454 . . . . 0.0 113.489 -172.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -64.68 -33.01 74.95 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.348 1.059 . . . . 0.0 112.902 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 154.46 92.35 0.09 OUTLIER Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.933 1.73 . . . . 0.0 109.209 -175.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.85 -167.94 1.8 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.458 1.503 . . . . 0.0 111.451 -169.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.2 p -70.89 157.92 37.32 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 113.424 -1.717 . . . . 0.0 108.162 168.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.1 mt -61.07 -31.63 71.29 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 121.842 -0.536 . . . . 0.0 111.292 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -58.58 -38.61 78.26 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.279 0.632 . . . . 0.0 111.088 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 42.9 t -72.93 -43.6 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 117.172 -1.394 . . . . 0.0 108.594 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -52.78 -46.73 67.73 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.757 1.617 . . . . 0.0 111.591 171.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -58.86 -43.68 90.88 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.758 0.708 . . . . 0.0 111.04 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.0 m -68.13 -44.23 76.55 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -175.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.1 t -62.5 -52.82 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -42.25 -58.99 1.96 Allowed 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 126.1 1.76 . . . . 0.0 110.974 169.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.46 -43.23 99.6 Favored Glycine 0 CA--C 1.524 0.607 0 CA-C-N 119.796 1.18 . . . . 0.0 111.632 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -63.93 -38.87 92.69 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 120.616 -1.52 . . . . 0.0 111.563 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.5 t -60.28 -40.48 83.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 118.374 -0.822 . . . . 0.0 108.835 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -42.58 76.62 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.623 1.101 . . . . 0.0 110.425 -177.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -65.86 -43.34 88.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 119.426 -0.321 . . . . 0.0 110.385 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -70.55 -41.2 72.8 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.919 0.782 . . . . 0.0 109.844 -176.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 64.8 t -53.37 -52.92 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 123.31 0.644 . . . . 0.0 109.486 172.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.99 -33.1 75.23 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 122.212 -0.305 . . . . 0.0 111.491 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -61.81 -47.54 84.65 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.078 0.551 . . . . 0.0 111.135 172.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -46.93 84.39 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 118.259 0.482 . . . . 0.0 110.089 176.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -57.81 -42.22 81.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 123.473 0.709 . . . . 0.0 109.557 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.03 -30.26 70.84 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 118.909 0.777 . . . . 0.0 111.798 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -72.89 -44.23 61.53 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 118.346 -0.835 . . . . 0.0 111.623 172.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 21.3 pt -101.96 -43.85 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 118.465 2.765 . . . . 0.0 118.465 -168.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.0 m . . . . . 0 C--O 1.254 1.317 0 CA-C-O 116.692 -1.623 . . . . 0.0 111.536 -169.236 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.498 1.958 0 CA-C-O 118.91 -0.566 . . . . 0.0 109.848 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -64.65 128.58 36.39 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.565 1.53 . . . . 0.0 107.967 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -94.89 143.06 26.77 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -173.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.3 t -121.78 153.23 25.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 O-C-N 124.457 1.098 . . . . 0.0 108.631 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.4 mmt -129.13 138.78 52.0 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -119.7 100.09 7.05 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 170.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.7 t -84.64 116.78 28.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -168.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.9 m -82.75 167.5 18.11 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.848 0.833 . . . . 0.0 112.339 -171.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.0 mtpp -159.02 170.88 21.09 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 127.57 2.348 . . . . 0.0 105.6 169.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.02 -143.66 0.73 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.081 0.952 . . . . 0.0 108.49 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.441 HD22 ' CG ' ' A' ' 43' ' ' HIS . 60.6 t30 -72.67 1.78 7.72 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.405 -0.809 . . . . 0.0 112.426 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.3 m 65.57 -1.49 1.0 Allowed 'General case' 0 C--N 1.348 0.526 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 169.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 p -59.02 -45.94 89.46 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 119.953 1.251 . . . . 0.0 111.613 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -58.38 -35.34 71.84 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 119.406 1.003 . . . . 0.0 113.039 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.79 -40.49 10.17 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.565 1.146 . . . . 0.0 110.942 -169.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -64.53 -35.05 79.71 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.511 0.724 . . . . 0.0 110.01 169.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.459 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.6 tpt -63.05 -39.77 95.73 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 121.394 -0.816 . . . . 0.0 110.983 169.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.48 -36.98 79.58 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 118.439 -0.791 . . . . 0.0 109.647 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -63.11 -42.5 99.56 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.938 0.79 . . . . 0.0 110.373 169.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.24 -42.14 99.72 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 120.385 1.448 . . . . 0.0 112.226 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -69.26 -41.18 77.25 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 117.983 0.891 . . . . 0.0 109.322 172.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.63 -35.44 70.43 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 119.747 1.158 . . . . 0.0 111.565 -172.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -72.58 -21.89 61.07 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.809 1.186 . . . . 0.0 112.177 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 m -80.68 -50.63 9.66 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.352 1.861 . . . . 0.0 109.693 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.1 mt -88.55 -26.96 21.7 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.13 1.372 . . . . 0.0 111.599 -169.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.05 17.71 47.81 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 127.121 2.296 . . . . 0.0 111.525 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.74 121.56 12.57 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.628 1.171 . . . . 0.0 109.739 -172.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.38 9.29 85.91 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 119.869 -0.406 . . . . 0.0 113.54 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.402 ' O ' ' HE2' ' A' ' 2' ' ' LYS . 31.3 mmtp -124.44 -28.51 3.62 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 125.868 1.667 . . . . 0.0 110.532 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.2 pt -141.55 162.32 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 124.308 1.043 . . . . 0.0 109.222 173.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.25 144.43 29.28 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 103.339 -2.838 . . . . 0.0 103.339 167.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 t -133.43 142.06 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 118.821 0.737 . . . . 0.0 111.275 -167.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.31 148.96 28.8 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.936 0.894 . . . . 0.0 110.202 -175.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.7 p -131.75 117.01 18.02 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 175.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.1 m -141.93 165.46 27.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 119.186 0.903 . . . . 0.0 111.044 -169.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.79 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -169.775 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 m . . . . . 0 C--O 1.234 0.253 0 CA-C-O 122.055 0.931 . . . . 0.0 111.4 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.441 ' CG ' HD22 ' A' ' 11' ' ' ASN . 85.0 t60 -133.45 120.78 15.99 Favored Pre-proline 0 N--CA 1.448 -0.562 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -66.69 -26.16 46.05 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.559 2.839 . . . . 0.0 112.321 -169.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.6 m -61.01 -37.05 81.18 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.004 0.82 . . . . 0.0 109.154 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.18 -44.12 84.94 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.3 -48.08 85.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 CA-C-O 118.278 -0.868 . . . . 0.0 108.874 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.92 98.3 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.293 0.951 . . . . 0.0 111.182 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.5 mmt -60.66 -25.22 66.18 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.395 1.078 . . . . 0.0 112.974 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.459 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -95.39 -33.1 12.63 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -178.074 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -61.77 -37.23 83.55 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.305 1.042 . . . . 0.0 110.158 174.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -71.64 0.37 8.86 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.7 m -130.14 13.87 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 125.983 1.713 . . . . 0.0 111.435 169.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.26 33.56 48.68 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 121.134 -0.979 . . . . 0.0 114.159 171.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.7 mt -125.41 160.79 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.994 1.718 . . . . 0.0 107.367 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -139.98 140.52 36.32 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.221 1.008 . . . . 0.0 108.928 175.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.8 pt -138.27 11.96 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 126.633 1.973 . . . . 0.0 110.001 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.9 p -62.27 145.01 54.86 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.945 0.793 . . . . 0.0 110.669 175.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.23 8.21 6.23 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 117.094 -1.948 . . . . 0.0 114.659 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -50.08 -61.03 2.39 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-N 120.067 1.933 . . . . 0.0 113.08 -172.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -159.01 159.33 34.65 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.461 1.104 . . . . 0.0 108.794 -169.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.5 m -163.04 43.96 0.12 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.862 1.665 . . . . 0.0 107.699 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -134.8 149.68 71.31 Favored Pre-proline 0 N--CA 1.47 0.563 0 O-C-N 121.493 -0.754 . . . . 0.0 111.847 -168.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -83.12 158.33 15.29 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 124.144 3.229 . . . . 0.0 112.282 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.4 tt -62.98 -35.64 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 125.235 1.414 . . . . 0.0 112.198 -175.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -70.0 -20.55 63.28 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.611 0.364 . . . . 0.0 111.917 -171.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.51 -13.98 59.57 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 118.853 -0.594 . . . . 0.0 112.236 172.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -101.2 168.79 9.34 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.26 1.024 . . . . 0.0 110.853 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.73 91.67 2.33 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 -170.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.403 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -50.96 -31.94 19.44 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.52 -28.46 13.66 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.379 1.072 . . . . 0.0 112.177 176.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -70.88 -20.85 62.47 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.204 0.601 . . . . 0.0 112.368 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -106.9 175.13 5.6 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 128.624 2.77 . . . . 0.0 108.292 -174.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -118.64 -17.09 9.35 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.3 t -142.19 129.01 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -169.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.6 t -124.44 128.4 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.7 mm -121.68 96.63 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 102.119 -3.289 . . . . 0.0 102.119 169.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.4 p -72.66 164.11 27.01 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 118.019 -1.472 . . . . 0.0 107.884 169.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.6 mp -135.66 36.29 2.9 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 172.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 35.5 m -90.92 5.65 47.77 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.76 1.624 . . . . 0.0 110.761 -172.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.55 22.29 26.89 Favored Glycine 0 C--N 1.339 0.725 0 CA-C-O 119.565 -0.575 . . . . 0.0 111.955 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.406 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 5.4 t 46.88 40.68 9.49 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.941 1.696 . . . . 0.0 112.344 -177.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -149.79 35.33 1.02 Allowed Glycine 0 C--N 1.34 0.759 0 C-N-CA 123.793 0.711 . . . . 0.0 111.661 -171.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.2 t -121.18 130.09 75.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 124.965 1.306 . . . . 0.0 107.948 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -78.93 70.58 5.29 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 173.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.28 145.46 81.31 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-O 118.488 -0.768 . . . . 0.0 109.1 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -54.07 157.07 11.55 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.973 2.448 . . . . 0.0 111.924 172.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.3 -24.42 65.03 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 121.866 1.71 . . . . 0.0 114.949 -169.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -64.71 -23.68 67.33 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 120.63 -1.293 . . . . 0.0 111.974 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.403 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 77.4 m95 -73.42 -11.34 60.44 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.649 1.18 . . . . 0.0 112.866 176.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.2 m -118.53 -14.84 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 119.715 1.143 . . . . 0.0 112.822 -176.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.1 p -77.56 -11.12 59.82 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.968 0.804 . . . . 0.0 112.061 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -47.15 156.29 0.24 Allowed 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 129.675 3.19 . . . . 0.0 111.138 169.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -64.04 -38.43 91.03 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.828 1.651 . . . . 0.0 109.872 171.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mt -122.35 133.98 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 173.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -142.96 111.64 6.35 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 103.555 -2.757 . . . . 0.0 103.555 167.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -138.99 170.6 15.69 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 173.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.406 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.8 t70 -136.62 108.35 7.03 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 169.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.426 ' C ' ' H ' ' A' ' 101' ' ' LEU . 49.2 m0 -81.85 70.57 8.78 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -49.49 13.86 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 131.488 3.915 . . . . 0.0 115.916 170.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.426 ' H ' ' C ' ' A' ' 99' ' ' TRP . 3.7 mm? -60.02 124.69 20.98 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 126.075 1.75 . . . . 0.0 112.622 -168.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 48.08 -161.44 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.344 2.258 . . . . 0.0 114.915 169.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -156.48 77.95 4.18 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 128.371 2.668 . . . . 0.0 107.448 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.71 -15.03 15.48 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.495 2.13 . . . . 0.0 112.99 -172.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.3 t0 27.56 -101.7 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.565 2.346 . . . . 0.0 113.092 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.51 43.43 1.28 Allowed Glycine 0 CA--C 1.532 1.129 0 C-N-CA 126.734 2.111 . . . . 0.0 109.431 171.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -67.5 -176.73 0.64 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.881 1.672 . . . . 0.0 112.614 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.5 m -59.54 154.12 18.12 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.884 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.4 mt -56.67 -30.33 63.28 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 122.957 0.503 . . . . 0.0 111.038 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.93 -40.66 96.24 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 118.677 -0.678 . . . . 0.0 110.926 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 42.0 t -72.81 -41.35 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 117.803 -1.094 . . . . 0.0 108.867 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -49.37 -51.68 33.27 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.717 1.144 . . . . 0.0 110.921 169.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -59.45 -45.14 92.42 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.799 0.727 . . . . 0.0 111.37 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 94.5 m -69.78 -45.76 67.27 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -171.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.6 t -69.6 -42.16 80.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 -172.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.9 ttp180 -48.09 -53.63 15.9 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 124.853 1.261 . . . . 0.0 110.612 169.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.86 -40.58 99.42 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 119.296 0.953 . . . . 0.0 112.042 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -65.37 -38.51 90.27 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.321 -1.105 . . . . 0.0 111.066 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 48.5 t -62.69 -41.65 93.1 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -38.33 84.59 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 119.779 1.172 . . . . 0.0 111.661 -173.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -68.82 -42.77 76.77 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 119.101 -0.475 . . . . 0.0 109.762 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.2 mtt180 -65.93 -40.3 91.29 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.187 0.903 . . . . 0.0 111.156 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.4 t -54.82 -51.7 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 172.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -64.84 -33.55 76.26 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 122.099 -0.375 . . . . 0.0 111.822 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -65.08 -46.06 82.67 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 123.002 0.521 . . . . 0.0 111.269 174.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -45.63 91.14 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.7 mt -58.47 -39.94 76.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.32 -26.65 68.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.924 0.784 . . . . 0.0 112.488 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -72.52 -46.32 55.15 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 119.163 0.892 . . . . 0.0 111.783 173.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.8 pt -103.67 -33.89 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 117.75 2.5 . . . . 0.0 117.75 -168.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 C--O 1.255 1.392 0 CA-C-N 119.529 1.059 . . . . 0.0 111.066 -174.747 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.927 0 CA-C-O 118.868 -0.587 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.437 ' HE2' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -66.11 137.63 57.18 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.641 1.564 . . . . 0.0 107.59 175.328 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -105.99 140.93 38.23 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -171.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.8 t -118.31 151.73 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.5 tpp -137.94 141.55 40.55 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 177.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -116.54 150.29 38.2 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 172.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 t -134.18 137.77 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 120.491 1.496 . . . . 0.0 107.118 -170.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 t -126.47 156.39 40.76 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.522 0.729 . . . . 0.0 110.601 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -135.84 33.02 2.94 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.176 1.39 . . . . 0.0 109.474 170.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.57 -178.77 6.74 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 127.95 2.5 . . . . 0.0 106.186 -175.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -48.51 124.06 7.6 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 170.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.0 m -33.7 -30.06 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 129.592 3.157 . . . . 0.0 117.711 -174.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.3 m -38.87 -61.0 0.78 Allowed 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 126.714 2.006 . . . . 0.0 114.69 -169.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.259 39.4 ptt180 -63.17 -46.37 87.47 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.229 1.377 . . . . 0.0 113.161 -169.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.63 -28.53 19.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 118.776 0.716 . . . . 0.0 111.368 -172.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -74.0 -27.95 61.21 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 120.828 -1.17 . . . . 0.0 110.605 171.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.461 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.8 tpt -64.49 -40.67 96.09 Favored 'General case' 0 CA--C 1.51 -0.586 0 O-C-N 120.844 -1.16 . . . . 0.0 108.37 169.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.48 -38.26 83.71 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -61.26 -39.96 92.29 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 118.63 -0.7 . . . . 0.0 111.156 169.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.07 -44.91 86.69 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 120.448 1.476 . . . . 0.0 112.392 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -65.32 -39.98 93.14 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.06 -37.09 69.72 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 118.951 0.796 . . . . 0.0 111.221 -173.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -68.97 -28.61 66.78 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.076 1.307 . . . . 0.0 111.74 174.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.8 m -74.76 -51.73 13.38 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.845 1.658 . . . . 0.0 110.35 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.4 mt -88.22 -26.51 22.33 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.727 1.211 . . . . 0.0 112.057 -169.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.65 17.21 50.5 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.796 2.141 . . . . 0.0 111.454 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.35 120.8 9.98 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.909 1.284 . . . . 0.0 109.954 -172.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.53 11.42 84.38 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 119.505 -0.608 . . . . 0.0 113.439 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.437 ' O ' ' HE2' ' A' ' 2' ' ' LYS . 74.6 mmtt -127.11 -26.95 3.04 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 125.346 1.459 . . . . 0.0 110.535 -176.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.6 pt -141.37 161.09 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 124.531 1.132 . . . . 0.0 108.66 172.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.6 144.55 27.78 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 167.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.42 142.56 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 118.93 0.786 . . . . 0.0 111.333 -168.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.26 159.5 40.08 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.097 -174.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.4 p -136.88 162.65 32.67 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 121.433 1.924 . . . . 0.0 110.106 169.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.3 p -151.22 165.39 34.08 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.761 1.164 . . . . 0.0 111.262 -177.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.34 0 N-CA-C 105.51 -3.036 . . . . 0.0 105.51 -172.895 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.7 t . . . . . 0 C--O 1.234 0.244 0 CA-C-O 121.957 0.884 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -127.07 115.37 21.89 Favored Pre-proline 0 N--CA 1.448 -0.53 0 C-N-CA 125.332 1.453 . . . . 0.0 107.683 -173.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -69.16 -24.96 31.82 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.429 2.753 . . . . 0.0 113.257 -168.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.5 m -62.75 -39.49 94.29 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-N 119.94 1.245 . . . . 0.0 108.415 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.72 98.78 Favored 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.14 -48.92 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 118.297 -0.858 . . . . 0.0 109.544 177.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.75 -43.64 85.56 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 119.08 0.855 . . . . 0.0 110.627 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -20.21 65.17 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.483 0.713 . . . . 0.0 110.635 -175.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.461 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -96.38 -28.43 14.47 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.355 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.25 -29.23 70.6 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.755 1.222 . . . . 0.0 110.376 170.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -56.6 -23.18 39.0 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.855 0.862 . . . . 0.0 112.301 170.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.0 m -126.71 13.7 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 125.963 1.705 . . . . 0.0 111.166 -175.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.58 37.93 78.2 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 119.16 -0.8 . . . . 0.0 113.209 174.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.4 mt -125.76 154.61 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.708 1.603 . . . . 0.0 107.403 176.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -126.8 143.92 51.12 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.702 1.601 . . . . 0.0 108.639 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.3 pt -138.07 9.06 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 125.551 1.54 . . . . 0.0 110.915 174.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.47 151.39 45.17 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.624 1.17 . . . . 0.0 107.944 168.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.04 -3.24 14.24 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.585 -1.119 . . . . 0.0 113.474 -175.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -69.46 -175.96 0.91 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.498 1.649 . . . . 0.0 109.956 169.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.4 p -50.46 164.54 0.12 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.887 2.475 . . . . 0.0 114.766 -173.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.0 p -156.91 39.99 0.32 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.306 1.842 . . . . 0.0 109.769 177.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -141.03 150.01 57.72 Favored Pre-proline 0 CA--C 1.542 0.67 0 O-C-N 121.354 -0.841 . . . . 0.0 111.683 -169.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.38 165.53 23.16 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.892 3.061 . . . . 0.0 112.518 -174.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.5 tt -57.8 -39.32 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 125.073 1.349 . . . . 0.0 110.843 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.92 -18.13 61.43 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -170.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.23 -22.23 58.06 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 118.858 -0.591 . . . . 0.0 111.446 169.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -92.14 168.38 11.4 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.875 0.845 . . . . 0.0 110.64 -178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -142.34 94.6 2.68 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 103.336 -2.839 . . . . 0.0 103.336 -174.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.31 -28.01 50.77 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -176.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.36 -28.35 19.11 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.995 0.918 . . . . 0.0 112.415 175.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -70.74 -22.63 62.39 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.16 0.436 . . . . 0.0 112.086 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -106.07 -178.7 3.72 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 129.352 3.061 . . . . 0.0 108.286 -174.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -131.74 -2.44 3.74 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 171.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.8 t -141.71 126.92 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.8 m -131.28 135.45 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 O-C-N 120.868 -1.145 . . . . 0.0 108.246 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.7 mm -134.61 80.69 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -169.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.8 t -68.41 164.51 20.8 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.818 177.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -140.75 55.46 1.58 Allowed 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 169.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 81.8 m -106.12 8.9 32.39 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.854 1.262 . . . . 0.0 109.705 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.7 31.5 10.14 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-O 119.209 -0.773 . . . . 0.0 111.639 169.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.8 p 46.59 -10.1 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 130.391 3.476 . . . . 0.0 119.244 -174.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.82 -13.87 82.65 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 120.133 1.333 . . . . 0.0 113.065 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 p -58.9 151.07 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 122.817 1.294 . . . . 0.0 109.202 172.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -124.39 81.28 1.92 Allowed 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 103.741 -2.689 . . . . 0.0 103.741 178.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.8 mt -62.65 150.09 87.38 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.28 158.69 11.67 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.659 2.239 . . . . 0.0 113.316 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.01 -36.3 53.55 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.964 2.443 . . . . 0.0 116.716 -169.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.2 pm0 -67.34 -25.82 66.19 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.323 -0.861 . . . . 0.0 112.133 -176.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -70.44 -9.73 57.23 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.93 1.292 . . . . 0.0 112.088 174.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.2 t -96.62 -29.59 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 119.225 0.921 . . . . 0.0 109.438 175.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.7 p -86.2 56.71 4.11 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.68 1.192 . . . . 0.0 110.502 -174.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -130.47 156.32 44.97 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 128.762 2.825 . . . . 0.0 107.96 -169.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -65.71 -39.23 91.0 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 125.752 1.621 . . . . 0.0 109.005 169.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 25.9 mm -128.7 137.17 58.02 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-O 121.113 0.482 . . . . 0.0 110.294 170.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -135.14 110.03 8.74 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 100.833 -3.765 . . . . 0.0 100.833 166.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.91 165.04 24.79 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 176.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -139.52 105.45 5.18 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 170.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -77.52 87.25 3.85 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 125.223 1.409 . . . . 0.0 107.475 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -65.75 23.07 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 126.613 1.965 . . . . 0.0 114.045 -175.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.16 176.39 0.6 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.628 1.971 . . . . 0.0 111.763 -170.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -54.3 162.44 1.07 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 123.444 1.593 . . . . 0.0 113.582 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -117.68 105.97 46.97 Favored Pre-proline 0 C--N 1.316 -0.866 0 C-N-CA 126.376 1.87 . . . . 0.0 108.396 -170.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.76 16.84 1.23 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.475 2.117 . . . . 0.0 112.181 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -24.84 85.02 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 129.584 3.154 . . . . 0.0 115.441 174.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 44.8 32.03 2.91 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 124.633 1.111 . . . . 0.0 113.959 -174.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -79.72 -179.7 7.05 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 122.492 1.139 . . . . 0.0 112.813 -169.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.1 p -61.07 160.04 10.72 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 113.55 -1.659 . . . . 0.0 109.602 172.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.6 mt -58.03 -30.27 66.0 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 122.667 0.387 . . . . 0.0 110.597 175.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -64.24 -40.0 95.11 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 118.532 -0.746 . . . . 0.0 111.157 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.0 t -72.61 -40.15 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 118.923 -1.111 . . . . 0.0 109.513 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -50.27 -50.68 49.5 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 119.45 1.023 . . . . 0.0 110.524 169.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -60.91 -44.99 96.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.549 0.739 . . . . 0.0 111.31 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.5 m -69.5 -45.59 68.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -172.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 49.3 t -65.75 -46.84 87.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -171.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -42.74 -56.47 3.17 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 125.061 1.344 . . . . 0.0 111.041 169.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.84 -40.93 98.89 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 119.79 1.177 . . . . 0.0 111.908 -175.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -67.55 -38.24 83.86 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 121.298 -1.119 . . . . 0.0 110.941 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.3 t -61.34 -43.0 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 172.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -39.31 87.19 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 119.923 1.238 . . . . 0.0 111.827 -172.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -68.99 -42.03 77.03 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.749 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.7 mtt180 -65.61 -41.7 92.42 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.282 0.946 . . . . 0.0 111.197 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.2 t -54.83 -51.58 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -65.94 -33.73 76.5 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 122.134 -0.354 . . . . 0.0 111.826 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -63.33 -48.71 76.88 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 123.1 0.56 . . . . 0.0 110.345 174.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -45.7 89.48 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 109.614 -0.514 . . . . 0.0 109.614 177.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.3 mt -57.48 -43.01 82.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 123.599 0.759 . . . . 0.0 109.537 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.16 -26.64 68.62 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -71.17 -51.93 22.06 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.57 0.623 . . . . 0.0 110.446 173.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 pt -87.65 -46.1 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 -169.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 63.0 m . . . . . 0 C--O 1.254 1.334 0 CA-C-N 119.057 0.844 . . . . 0.0 110.678 -170.233 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 tpt . . . . . 0 N--CA 1.5 2.049 0 CA-C-O 118.33 -0.843 . . . . 0.0 109.659 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.415 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -57.75 118.62 5.48 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 120.727 1.603 . . . . 0.0 110.074 -169.835 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -87.89 137.61 32.18 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -171.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.2 t -117.9 154.05 19.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 124.398 1.079 . . . . 0.0 108.364 174.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 40.9 tpp -137.63 139.68 40.44 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -120.18 114.61 22.2 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.3 t -101.68 138.81 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 119.621 1.1 . . . . 0.0 108.361 -169.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -125.11 164.77 19.51 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 122.009 0.909 . . . . 0.0 111.808 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -150.27 156.0 40.75 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 129.648 3.179 . . . . 0.0 103.842 169.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.41 ' CG ' ' H ' ' A' ' 11' ' ' ASN . 9.5 ttm180 58.1 -153.66 0.37 Allowed 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -169.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.47 HD22 ' CD2' ' A' ' 43' ' ' HIS . 29.5 t-20 -59.13 123.63 17.28 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.317 0.647 . . . . 0.0 110.114 -169.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.2 m -49.84 -27.93 5.76 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.675 1.99 . . . . 0.0 113.98 -178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 26.3 p -48.55 -48.01 38.89 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 117.954 -1.022 . . . . 0.0 112.98 -169.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -60.3 -45.99 91.43 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.987 1.267 . . . . 0.0 112.721 -170.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.8 -28.27 15.99 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.077 0.853 . . . . 0.0 111.595 -174.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -68.87 -33.0 73.07 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.045 -1.034 . . . . 0.0 109.769 171.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.474 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.7 tpt -65.68 -40.15 92.08 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 121.18 -0.95 . . . . 0.0 109.63 169.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.93 -40.67 89.72 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -60.52 -42.45 96.46 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.7 169.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.45 -45.21 80.33 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 120.598 1.545 . . . . 0.0 111.514 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -63.4 -40.34 96.94 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.34 -36.13 71.42 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 119.313 0.961 . . . . 0.0 111.517 -174.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -73.32 -22.91 60.22 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 120.757 1.617 . . . . 0.0 111.921 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 m -77.02 -50.85 12.2 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.818 1.647 . . . . 0.0 110.285 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.1 mt -86.32 -27.39 24.34 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.882 1.273 . . . . 0.0 112.039 -169.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.07 13.0 55.88 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 126.918 2.199 . . . . 0.0 111.523 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.98 121.85 12.23 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.041 1.336 . . . . 0.0 109.861 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.81 8.82 87.22 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-O 119.769 -0.462 . . . . 0.0 113.462 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -124.01 -31.5 3.37 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.42 1.488 . . . . 0.0 109.068 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.7 pt -142.74 176.46 3.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 125.527 1.531 . . . . 0.0 109.508 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -118.25 149.06 41.76 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 168.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 t -137.82 143.24 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 123.172 0.589 . . . . 0.0 111.412 -167.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.9 m -150.77 161.44 42.65 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.943 1.297 . . . . 0.0 109.745 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.403 ' H ' HG23 ' A' ' 61' ' ' THR . 61.8 p -130.24 163.33 26.97 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.907 1.23 . . . . 0.0 110.241 169.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.6 p -155.45 168.26 27.68 Favored 'General case' 0 N--CA 1.463 0.193 0 O-C-N 121.112 -0.992 . . . . 0.0 110.806 178.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.861 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -177.65 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 CA--C 1.532 0.279 0 CA-C-O 122.066 0.936 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.47 ' CD2' HD22 ' A' ' 11' ' ' ASN . 86.5 t60 -125.7 116.53 24.62 Favored Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -175.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -66.48 -26.09 47.73 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.657 2.905 . . . . 0.0 112.692 -169.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.7 m -60.63 -36.16 77.95 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.15 0.886 . . . . 0.0 109.122 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.38 -45.13 85.27 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -58.69 -47.41 88.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.73 -43.16 98.24 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.923 0.783 . . . . 0.0 111.032 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.4 mmt -61.81 -22.51 65.53 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.367 1.067 . . . . 0.0 112.866 177.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.474 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.3 OUTLIER -99.53 -31.34 11.67 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -177.806 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -63.94 -35.92 82.25 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.437 -0.79 . . . . 0.0 109.786 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.62 6.82 3.47 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.186 0.595 . . . . 0.0 112.542 175.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.6 t -113.32 -43.03 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 126.355 1.862 . . . . 0.0 108.71 169.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.73 26.86 1.86 Allowed Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.088 1.328 . . . . 0.0 111.894 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.5 mt -123.62 158.92 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 125.952 1.701 . . . . 0.0 106.939 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -137.91 125.94 22.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -176.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.6 pt -133.76 5.42 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.326 0 C-N-CA 124.392 1.077 . . . . 0.0 111.404 -171.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.16 143.91 56.32 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.764 1.225 . . . . 0.0 109.376 174.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.06 4.57 11.82 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 117.591 -1.672 . . . . 0.0 113.894 -177.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -53.55 -57.43 10.75 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-N 120.044 1.922 . . . . 0.0 111.785 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.403 HG23 ' H ' ' A' ' 34' ' ' SER . 2.9 p -151.43 162.39 41.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.032 -167.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.1 m -167.13 42.47 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.089 1.755 . . . . 0.0 109.192 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -137.63 150.04 66.88 Favored Pre-proline 0 N--CA 1.475 0.802 0 O-C-N 120.885 -1.135 . . . . 0.0 112.629 -169.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -83.72 162.89 14.27 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 124.213 3.275 . . . . 0.0 112.342 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.2 tt -59.21 -37.69 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.253 1.421 . . . . 0.0 111.351 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.68 -22.71 62.45 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 122.969 0.507 . . . . 0.0 111.93 -171.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -21.19 60.09 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 118.653 -0.689 . . . . 0.0 111.548 172.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -92.34 167.88 11.69 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.865 0.84 . . . . 0.0 111.272 -174.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.44 82.18 1.77 Allowed 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.648 1.579 . . . . 0.0 108.288 -170.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.405 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -52.31 -27.91 17.1 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.811 1.244 . . . . 0.0 113.712 -175.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -54.25 -33.75 59.21 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.459 0.475 . . . . 0.0 111.048 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -71.32 -15.73 62.41 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -106.78 160.77 15.24 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.546 1.938 . . . . 0.0 109.541 -173.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -101.35 -18.76 15.91 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 118.931 -0.557 . . . . 0.0 111.977 -177.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.8 t -147.77 129.85 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 120.716 1.598 . . . . 0.0 106.949 -170.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -125.65 135.08 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.2 mm -133.65 85.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 -177.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.0 t -69.28 160.17 31.73 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.175 -0.953 . . . . 0.0 108.503 171.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.6 mp -129.46 21.41 5.61 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 169.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.6 m -69.27 -8.88 50.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.29 1.036 . . . . 0.0 112.237 -175.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 108.11 23.22 6.81 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 119.15 0.887 . . . . 0.0 111.742 174.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.465 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 2.0 t 55.24 173.63 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.176 2.191 . . . . 0.0 112.685 -169.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.03 16.66 33.65 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.851 1.215 . . . . 0.0 114.423 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.7 p -72.32 136.42 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 125.155 1.382 . . . . 0.0 108.021 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -79.1 61.52 3.27 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.527 1.131 . . . . 0.0 108.547 173.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.1 mt -59.52 148.31 74.45 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 172.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -54.98 155.38 18.69 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.166 1.911 . . . . 0.0 111.919 174.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.81 -1.19 8.1 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.003 2.469 . . . . 0.0 115.853 -169.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' A' ' 91' ' ' VAL . 14.2 pt-20 -84.62 -24.93 28.89 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.788 1.176 . . . . 0.0 112.155 169.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.405 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 24.7 m95 -77.21 24.31 0.18 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.642 1.177 . . . . 0.0 112.164 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.405 ' H ' ' C ' ' A' ' 89' ' ' GLU . 15.0 m -127.92 -2.74 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 125.489 1.516 . . . . 0.0 112.779 169.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.8 p -84.37 -12.32 54.72 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 120.773 1.624 . . . . 0.0 113.516 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.453 ' H ' ' CD ' ' A' ' 93' ' ' GLN . 19.4 mp0 -62.16 160.78 12.19 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 129.808 3.243 . . . . 0.0 110.892 -176.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -64.62 -41.97 95.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.796 1.639 . . . . 0.0 109.137 169.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 33.1 mm -119.15 135.69 58.73 Favored 'Isoleucine or valine' 0 C--N 1.341 0.199 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 170.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -135.45 110.95 9.14 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 100.977 -3.712 . . . . 0.0 100.977 166.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.11 164.67 26.82 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.0 t70 -137.1 99.97 4.15 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 122.118 0.961 . . . . 0.0 108.542 172.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -75.4 73.45 2.46 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.344 1.458 . . . . 0.0 107.811 174.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -54.92 44.3 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 131.278 3.831 . . . . 0.0 114.402 172.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -77.85 -174.15 3.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.337 1.455 . . . . 0.0 111.223 -169.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -50.27 160.94 0.33 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.611 1.565 . . . . 0.0 111.28 176.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -130.1 85.0 58.59 Favored Pre-proline 0 C--N 1.322 -0.59 0 C-N-CA 126.719 2.008 . . . . 0.0 108.364 -169.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.64 67.33 8.43 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 124.9 3.734 . . . . 0.0 111.472 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -64.1 81.05 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.483 1.913 . . . . 0.0 110.874 173.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 59.22 37.42 91.77 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.775 0.702 . . . . 0.0 112.441 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -64.96 170.06 4.69 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -170.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.8 m -68.13 151.89 46.33 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 113.301 -1.772 . . . . 0.0 108.293 168.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.3 mt -57.56 -32.96 67.64 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.91 -0.494 . . . . 0.0 111.808 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.07 -38.63 86.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.533 0.606 . . . . 0.0 111.182 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.8 t -75.18 -40.58 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 116.456 -1.735 . . . . 0.0 108.88 178.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -50.47 -48.49 56.67 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 121.141 1.792 . . . . 0.0 110.636 170.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -58.84 -43.18 90.66 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.535 0.607 . . . . 0.0 110.81 176.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.8 m -69.22 -43.6 73.77 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -174.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.8 t -66.28 -46.53 86.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -173.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -47.79 -56.16 8.03 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.016 1.326 . . . . 0.0 110.89 170.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.99 -40.65 99.56 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 119.795 1.179 . . . . 0.0 111.68 -175.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -64.64 -40.11 94.88 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.321 -1.105 . . . . 0.0 111.428 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.0 t -61.08 -42.09 91.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 174.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.06 -37.95 78.26 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 119.904 1.229 . . . . 0.0 111.448 -175.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -70.0 -42.3 73.22 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.136 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -64.24 -42.83 96.35 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 119.252 0.933 . . . . 0.0 110.14 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.5 t -54.36 -53.71 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 123.901 0.88 . . . . 0.0 109.385 173.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -65.31 -33.09 75.16 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 122.283 -0.261 . . . . 0.0 111.541 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -62.15 -49.17 76.9 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.03 0.532 . . . . 0.0 110.787 173.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.42 -46.05 83.93 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.987 0.515 . . . . 0.0 110.046 177.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.3 mt -57.92 -44.0 85.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 124.395 1.078 . . . . 0.0 110.272 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.07 -28.23 67.63 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.98 0.809 . . . . 0.0 112.151 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -75.95 -44.71 38.68 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.379 0.536 . . . . 0.0 111.605 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.9 pt -94.37 -42.36 12.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -169.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 C--O 1.252 1.232 0 CA-C-N 119.168 0.895 . . . . 0.0 109.929 -172.808 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.0 mmm . . . . . 0 N--CA 1.502 2.142 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.46 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -57.54 134.9 56.51 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.503 1.047 . . . . 0.0 108.891 169.871 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -101.07 140.97 34.63 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.758 1.223 . . . . 0.0 107.757 -169.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.9 t -129.02 152.18 36.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -175.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 58.6 tpp -137.73 145.29 42.32 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -121.81 150.2 42.23 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 171.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.2 t -132.46 134.73 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 120.333 -1.479 . . . . 0.0 108.219 -171.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -131.98 100.09 4.95 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.258 0.935 . . . . 0.0 111.626 -170.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -79.17 -30.76 43.69 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -129.88 141.53 50.8 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 176.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 29.06 101.78 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 129.972 3.309 . . . . 0.0 113.619 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.4 m -33.28 -33.64 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.212 0 C-N-CA 128.671 2.788 . . . . 0.0 115.327 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.4 t -36.52 -64.16 0.35 Allowed 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 125.884 1.673 . . . . 0.0 114.067 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.298 36.1 ptt180 -60.15 -43.66 95.59 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 120.333 1.424 . . . . 0.0 114.127 -168.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.22 -29.0 14.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 119.374 0.988 . . . . 0.0 112.092 -172.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.478 HE22 HG13 ' A' ' 42' ' ' VAL . 50.0 tt0 -72.09 -25.45 61.76 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.79 -1.194 . . . . 0.0 109.924 169.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.47 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.0 tpt -68.97 -42.77 76.15 Favored 'General case' 0 CA--C 1.512 -0.514 0 O-C-N 120.812 -1.18 . . . . 0.0 108.508 168.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.95 -39.41 81.59 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -60.43 -41.41 93.92 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.19 1.396 . . . . 0.0 111.4 169.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.74 -40.36 58.53 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 120.651 1.569 . . . . 0.0 112.895 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -69.96 -38.04 76.0 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 118.527 1.164 . . . . 0.0 109.279 172.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.51 -40.88 66.49 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 120.434 1.47 . . . . 0.0 111.145 -175.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -61.35 -32.27 72.16 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.325 1.42 . . . . 0.0 110.842 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 m -75.39 -51.13 13.85 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.262 2.225 . . . . 0.0 111.131 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.1 mt -88.19 -26.22 22.52 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.494 1.118 . . . . 0.0 111.631 -169.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.69 12.71 62.79 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 126.542 2.02 . . . . 0.0 111.248 177.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.16 121.34 10.47 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.549 1.139 . . . . 0.0 110.241 -173.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.03 9.24 86.87 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 119.864 -0.409 . . . . 0.0 113.325 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -123.82 -31.73 3.39 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 125.222 1.409 . . . . 0.0 109.511 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.0 pt -142.6 168.39 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.539 1.536 . . . . 0.0 109.954 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.35 139.48 46.71 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 168.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.3 t -127.54 146.11 33.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 125.279 1.432 . . . . 0.0 111.207 -170.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.33 160.39 43.76 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.052 1.741 . . . . 0.0 109.725 -174.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -132.99 165.49 24.6 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.334 1.424 . . . . 0.0 109.227 170.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.1 p -158.78 168.8 25.88 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.796 -0.565 . . . . 0.0 111.299 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.406 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 -175.65 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.478 HG13 HE22 ' A' ' 16' ' ' GLN . 2.8 m . . . . . 0 CA--C 1.535 0.384 0 CA-C-O 121.87 0.843 . . . . 0.0 111.486 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -133.07 117.67 14.9 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -174.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -66.03 -30.18 47.95 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.319 2.679 . . . . 0.0 112.432 -169.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.0 m -61.89 -37.04 83.12 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 177.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.45 -44.52 86.98 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.98 -47.8 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.32 -43.04 99.54 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-N 118.938 0.79 . . . . 0.0 111.141 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.7 mmt -61.94 -23.75 66.56 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.553 -0.736 . . . . 0.0 111.828 177.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.47 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.3 OUTLIER -94.98 -27.93 15.4 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.55 -29.4 70.43 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.808 1.243 . . . . 0.0 110.693 171.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -56.2 -24.71 43.58 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.641 0.776 . . . . 0.0 112.487 170.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -126.23 16.3 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.712 0 C-N-CA 125.527 1.531 . . . . 0.0 111.087 -172.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.79 35.69 66.21 Favored Glycine 0 CA--C 1.529 0.952 0 O-C-N 121.516 -0.74 . . . . 0.0 113.395 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.9 mt -125.1 155.85 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -134.42 144.69 48.31 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 170.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.6 pt -137.56 11.17 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 126.513 1.925 . . . . 0.0 110.477 -175.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.2 t -65.69 151.44 46.56 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.529 -0.732 . . . . 0.0 109.496 170.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.98 -0.02 1.31 Allowed Glycine 0 CA--C 1.534 1.223 0 CA-C-O 117.691 -1.616 . . . . 0.0 115.084 -177.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -57.78 -55.47 34.4 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 120.162 1.981 . . . . 0.0 112.633 -171.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.98 161.22 42.76 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.802 -168.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.8 p -170.48 27.02 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.228 0.611 . . . . 0.0 112.288 -171.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -140.48 151.28 63.43 Favored Pre-proline 0 N--CA 1.476 0.847 0 O-C-N 120.818 -1.177 . . . . 0.0 112.828 -169.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.35 160.78 29.04 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 124.062 3.175 . . . . 0.0 112.791 -173.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.2 tt -59.17 -36.78 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.141 1.376 . . . . 0.0 111.671 -176.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -70.45 -22.23 62.72 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.042 0.537 . . . . 0.0 112.27 -172.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.61 -17.61 59.08 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 119.033 -0.508 . . . . 0.0 111.711 171.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -95.89 173.53 7.4 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.146 0.978 . . . . 0.0 110.129 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.83 101.7 3.21 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 125.137 1.375 . . . . 0.0 108.193 -177.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.419 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -49.45 -24.94 2.25 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.801 0.84 . . . . 0.0 113.156 171.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -51.4 -21.53 2.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.044 0.938 . . . . 0.0 112.218 172.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -115.66 17.05 16.37 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.617 1.167 . . . . 0.0 114.009 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -133.04 112.47 11.83 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 119.968 1.258 . . . . 0.0 108.414 170.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -62.99 -14.62 50.06 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -169.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.9 t -145.31 123.05 4.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.455 -2.424 . . . . 0.0 104.455 -169.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.86 133.34 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 O-C-N 121.085 -1.009 . . . . 0.0 108.406 -174.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.8 mm -130.17 92.45 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -168.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.8 t -70.08 161.54 29.95 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.549 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 mp -142.2 52.9 1.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 169.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 59.9 m -114.4 18.35 16.93 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.616 1.566 . . . . 0.0 109.577 -174.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.72 25.3 46.67 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-O 119.356 -0.691 . . . . 0.0 111.999 172.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.404 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 5.7 t 44.37 39.6 3.21 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.947 1.699 . . . . 0.0 112.595 -176.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.85 45.07 0.51 Allowed Glycine 0 C--N 1.34 0.797 0 C-N-CA 123.586 0.612 . . . . 0.0 111.86 -169.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.0 p -124.13 -0.8 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -173.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.8 t30 47.16 60.71 3.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.689 1.596 . . . . 0.0 109.433 175.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.2 mt -56.46 148.09 46.04 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.143 -175.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -55.27 156.01 18.16 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.701 2.267 . . . . 0.0 113.11 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -54.89 -30.11 66.92 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.756 2.304 . . . . 0.0 116.734 -170.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -65.88 -25.03 66.99 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 121.009 -1.057 . . . . 0.0 111.478 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.419 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 72.3 m95 -73.35 -4.46 33.51 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 117.669 -1.158 . . . . 0.0 113.133 178.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.4 m -118.58 -5.48 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 120.757 1.617 . . . . 0.0 113.41 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.3 p -88.73 -17.99 28.75 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.761 0.824 . . . . 0.0 112.416 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -52.59 161.82 0.65 Allowed 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 129.37 3.068 . . . . 0.0 113.906 175.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -64.35 -39.45 93.9 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.493 1.517 . . . . 0.0 108.901 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 33.2 mm -124.95 138.54 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 169.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -137.84 113.89 9.97 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 100.284 -3.969 . . . . 0.0 100.284 167.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -136.09 171.05 15.04 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 172.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.404 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.0 t70 -140.1 122.77 16.33 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 169.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -101.36 77.2 1.76 Allowed 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.24 16.8 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 129.638 3.175 . . . . 0.0 115.06 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -61.22 126.28 26.77 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.673 1.589 . . . . 0.0 111.343 -168.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 52.11 -155.44 0.17 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.3 1.44 . . . . 0.0 112.564 169.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -163.7 57.37 0.61 Allowed Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 127.509 2.324 . . . . 0.0 109.842 -173.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -79.2 59.02 7.22 Favored 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 122.752 2.301 . . . . 0.0 112.251 -169.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -51.46 -46.87 63.22 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.078 -1.014 . . . . 0.0 110.726 176.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -173.23 44.38 0.16 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.714 1.626 . . . . 0.0 110.323 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -68.54 176.42 2.92 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 122.543 1.163 . . . . 0.0 112.633 -177.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.2 m -57.83 152.51 15.69 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 113.956 -1.475 . . . . 0.0 109.857 171.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.3 mt -57.58 -31.59 66.32 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 122.727 0.411 . . . . 0.0 111.228 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.72 -39.64 92.22 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 118.427 0.558 . . . . 0.0 110.968 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 66.1 t -70.53 -45.54 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 117.304 -1.332 . . . . 0.0 108.507 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -48.95 -47.95 43.4 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 120.401 1.455 . . . . 0.0 110.93 172.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -59.81 -45.78 91.29 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.539 0.736 . . . . 0.0 111.303 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 94.2 m -68.36 -45.76 71.95 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -174.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.9 t -65.03 -47.58 87.4 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -173.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -44.65 -55.05 5.56 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 125.225 1.41 . . . . 0.0 110.89 169.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.44 -40.85 99.28 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 119.43 1.014 . . . . 0.0 111.737 -177.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -64.93 -38.46 91.03 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 121.376 -1.073 . . . . 0.0 110.86 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.0 t -62.72 -42.19 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -38.72 84.03 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 120.152 1.342 . . . . 0.0 111.535 -174.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -69.11 -41.31 77.58 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 119.087 -0.482 . . . . 0.0 109.825 177.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -67.24 -38.94 86.0 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 119.299 0.954 . . . . 0.0 111.135 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.8 t -53.85 -54.97 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 169.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -64.86 -32.46 74.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 121.99 -0.444 . . . . 0.0 111.895 -174.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -63.66 -47.41 81.41 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.405 0.682 . . . . 0.0 110.713 172.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -46.6 83.52 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 122.9 0.48 . . . . 0.0 110.062 176.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.0 mt -58.23 -43.18 85.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 124.292 1.037 . . . . 0.0 109.606 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.65 -30.22 70.58 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.101 0.864 . . . . 0.0 111.694 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -72.18 -42.6 65.69 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.635 172.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.1 pt -103.73 -44.8 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 118.902 2.927 . . . . 0.0 118.902 -168.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.3 m . . . . . 0 C--O 1.254 1.299 0 CA-C-O 116.582 -1.675 . . . . 0.0 111.838 -169.084 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 tpt . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.434 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -61.63 121.47 12.85 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 121.227 1.83 . . . . 0.0 108.43 -177.149 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -92.88 134.4 35.12 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -169.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.1 t -120.7 154.33 24.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -174.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 63.2 tpp -139.15 144.84 38.79 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -126.78 125.97 42.62 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 174.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.4 t -118.07 130.68 72.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -169.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 t -118.16 161.01 20.58 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.574 1.149 . . . . 0.0 111.207 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -141.97 34.54 1.56 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.101 1.36 . . . . 0.0 109.483 172.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.1 mmt-85 -141.9 168.13 20.5 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.235 1.414 . . . . 0.0 109.247 -175.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -46.05 121.8 3.48 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.317 1.447 . . . . 0.0 108.458 170.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.5 m -40.44 98.04 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.317 2.247 . . . . 0.0 114.098 -169.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.5 t -158.35 -84.85 0.04 OUTLIER 'General case' 0 C--N 1.343 0.317 0 CA-C-O 118.369 -0.824 . . . . 0.0 112.457 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.347 35.9 ptt180 -45.76 -52.6 10.82 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -167.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.62 -27.02 27.47 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.413 1.006 . . . . 0.0 112.047 -174.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -65.98 -40.72 91.45 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.119 -0.988 . . . . 0.0 109.304 171.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.447 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.1 tpt -62.9 -40.66 98.26 Favored 'General case' 0 CA--C 1.512 -0.489 0 O-C-N 121.735 -0.603 . . . . 0.0 109.821 171.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.34 -36.88 79.0 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 118.969 -0.539 . . . . 0.0 110.017 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -65.95 -39.91 90.85 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.504 170.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.49 -44.98 95.86 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 120.332 1.424 . . . . 0.0 111.055 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -65.49 -41.54 93.14 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 118.022 0.911 . . . . 0.0 109.067 173.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.04 -35.25 74.14 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 119.824 1.193 . . . . 0.0 111.741 -173.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -79.6 -15.83 56.95 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.184 1.356 . . . . 0.0 112.886 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.9 m -79.65 -50.91 9.94 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.896 1.678 . . . . 0.0 109.239 171.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.4 mt -88.48 -28.02 21.11 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.101 1.361 . . . . 0.0 112.384 -169.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.71 12.24 61.1 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.484 1.993 . . . . 0.0 111.751 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.52 121.52 12.34 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.939 1.295 . . . . 0.0 109.762 -172.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.86 11.05 85.79 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 119.755 -0.469 . . . . 0.0 113.538 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -124.9 -29.22 3.39 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.511 1.524 . . . . 0.0 109.153 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.2 pt -143.82 173.03 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.696 1.598 . . . . 0.0 109.677 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.69 144.59 44.24 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 103.836 -2.653 . . . . 0.0 103.836 168.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -133.78 148.64 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 118.536 0.607 . . . . 0.0 111.688 -167.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.95 158.33 44.09 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.342 1.457 . . . . 0.0 110.299 -174.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.4 p -131.17 153.23 49.64 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.633 1.573 . . . . 0.0 109.365 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.2 t -145.9 149.04 33.5 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -174.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.525 0 N-CA-C 107.086 -2.406 . . . . 0.0 107.086 -175.764 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.2 m . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 121.724 0.773 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -132.9 117.89 15.18 Favored Pre-proline 0 N--CA 1.453 -0.309 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -173.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -63.33 -27.53 71.63 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.327 2.685 . . . . 0.0 113.721 -169.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.4 m -61.56 -41.25 97.1 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.231 0.923 . . . . 0.0 109.474 171.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.79 -42.71 97.67 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 120.091 1.314 . . . . 0.0 108.958 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -56.33 -49.55 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 118.728 -0.654 . . . . 0.0 109.346 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.79 -41.32 90.89 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-N 118.723 0.692 . . . . 0.0 111.014 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.7 mmt -65.34 -22.29 66.8 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 123.457 0.703 . . . . 0.0 112.032 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.447 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 1.5 mmt -98.06 -28.41 13.78 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -62.6 -32.43 73.43 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.448 1.099 . . . . 0.0 110.258 170.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -59.24 -16.2 19.81 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.768 1.627 . . . . 0.0 112.292 172.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.3 m -129.07 15.02 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 125.953 1.701 . . . . 0.0 111.37 177.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.79 38.95 86.03 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 119.064 -0.853 . . . . 0.0 113.675 173.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.9 mt -121.13 152.52 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -118.73 126.59 52.22 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 124.865 1.266 . . . . 0.0 108.002 176.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.9 pt -128.23 17.87 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 124.064 0.946 . . . . 0.0 111.746 171.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.3 -33.07 59.07 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.671 1.188 . . . . 0.0 112.157 173.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.22 -3.47 81.93 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 123.302 0.477 . . . . 0.0 112.873 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -67.15 153.0 44.72 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.165 0.986 . . . . 0.0 111.185 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.0 p -147.1 157.76 43.72 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.97 1.708 . . . . 0.0 107.601 169.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.2 m -154.47 173.48 16.21 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.166 1.386 . . . . 0.0 108.41 -169.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -154.8 167.55 13.76 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-O 117.778 -1.106 . . . . 0.0 108.186 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.06 165.25 21.83 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.286 1.991 . . . . 0.0 112.853 -171.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.6 tt -63.78 -34.4 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 123.716 0.806 . . . . 0.0 110.622 -170.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.49 -19.04 61.62 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.757 0.823 . . . . 0.0 112.608 -174.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.85 -24.67 58.63 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.091 0.556 . . . . 0.0 110.945 169.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -95.79 169.77 9.78 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 122.199 0.999 . . . . 0.0 111.245 -169.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.16 97.13 2.73 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.876 1.671 . . . . 0.0 107.183 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.417 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -50.45 -23.07 2.19 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.039 0.936 . . . . 0.0 113.501 173.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -50.65 -22.92 2.27 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.802 0.841 . . . . 0.0 111.908 171.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -114.27 16.16 17.99 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.087 1.355 . . . . 0.0 113.226 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -134.12 112.92 11.53 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 120.526 -1.359 . . . . 0.0 109.598 170.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -67.67 -8.99 39.42 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -169.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.2 t -146.65 119.64 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 -171.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.4 m -133.85 130.97 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 O-C-N 120.409 -1.432 . . . . 0.0 107.962 -174.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.3 mm -126.11 102.16 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 -173.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.7 p -78.03 157.54 29.57 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 171.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.0 mp -133.43 44.38 2.8 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 169.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 69.0 m -93.16 10.51 31.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.81 1.644 . . . . 0.0 110.227 -174.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.41 29.39 33.27 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 170.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 4.9 t 39.33 43.66 0.97 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.705 2.002 . . . . 0.0 112.83 -171.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -144.18 44.13 0.94 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.688 1.137 . . . . 0.0 110.449 -171.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.2 p -134.99 165.06 32.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.38 1.872 . . . . 0.0 109.19 -173.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -129.58 71.54 1.44 Allowed 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 38.8 mt -60.77 149.45 79.8 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.63 153.75 17.87 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.511 2.141 . . . . 0.0 111.611 169.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.33 -18.67 55.67 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.787 1.658 . . . . 0.0 114.79 -169.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.05 -25.69 68.22 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 120.904 -1.122 . . . . 0.0 111.22 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.417 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 68.2 m95 -70.48 -11.12 60.71 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 117.224 -1.37 . . . . 0.0 113.235 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.6 m -110.36 -8.54 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 121.204 1.82 . . . . 0.0 113.285 -175.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.6 p -90.99 -11.2 39.64 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.892 0.877 . . . . 0.0 112.953 -174.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -61.67 167.27 3.64 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 128.763 2.825 . . . . 0.0 112.681 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -68.19 -38.71 82.27 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.217 1.007 . . . . 0.0 108.539 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.5 mt -119.91 135.47 60.11 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 CA-C-O 121.488 0.661 . . . . 0.0 109.632 169.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -148.39 114.84 5.93 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 166.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -143.73 167.51 22.1 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 173.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -126.08 124.56 40.88 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 169.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -100.53 77.4 1.91 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -177.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.51 33.51 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 128.962 2.905 . . . . 0.0 114.19 178.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.58 -177.8 1.62 Allowed 'General case' 0 CA--C 1.535 0.394 0 O-C-N 120.789 -1.194 . . . . 0.0 110.67 -171.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -55.1 161.84 1.57 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 123.814 1.769 . . . . 0.0 113.356 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -115.19 103.06 54.74 Favored Pre-proline 0 C--N 1.318 -0.766 0 C-N-CA 128.853 2.861 . . . . 0.0 107.85 -169.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -82.04 18.58 1.37 Allowed 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.761 2.307 . . . . 0.0 112.477 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -39.61 96.35 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.539 1.935 . . . . 0.0 113.974 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 42.51 31.98 1.15 Allowed Glycine 0 CA--C 1.541 1.663 0 C-N-CA 125.095 1.331 . . . . 0.0 114.172 -172.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -76.85 177.51 7.61 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 122.496 1.141 . . . . 0.0 113.404 -169.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 p -59.88 154.65 18.13 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.731 -1.577 . . . . 0.0 109.355 170.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.8 mt -58.73 -29.49 66.75 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.797 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.62 -40.82 97.86 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 118.676 -0.678 . . . . 0.0 111.044 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.4 t -71.23 -39.96 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 119.469 1.031 . . . . 0.0 109.082 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -52.08 -51.33 58.4 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.527 1.058 . . . . 0.0 111.624 169.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -59.16 -45.23 91.51 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.935 0.789 . . . . 0.0 110.584 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.3 m -69.4 -45.19 69.83 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -173.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.5 t -65.31 -47.95 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -172.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.3 ttp180 -45.53 -53.34 9.12 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 124.732 1.213 . . . . 0.0 110.949 171.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.29 -42.25 97.89 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 119.334 0.97 . . . . 0.0 111.91 -177.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -64.99 -37.3 87.2 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.213 -1.169 . . . . 0.0 110.765 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.7 t -63.14 -42.74 97.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -39.25 83.47 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.201 1.364 . . . . 0.0 111.364 -173.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.27 -42.53 75.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 119.205 -0.426 . . . . 0.0 110.322 177.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -68.03 -39.46 83.1 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.401 1.0 . . . . 0.0 111.469 178.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.3 t -54.97 -52.97 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 171.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.37 -32.91 74.71 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.744 -0.597 . . . . 0.0 111.923 -176.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -63.44 -48.43 77.8 Favored 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 121.615 -0.678 . . . . 0.0 110.719 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -46.57 77.37 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 123.429 0.692 . . . . 0.0 109.659 177.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.1 mt -58.72 -44.3 89.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 124.432 1.093 . . . . 0.0 109.584 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.24 -29.31 68.69 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.876 0.762 . . . . 0.0 111.927 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -74.27 -42.32 59.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.478 0.581 . . . . 0.0 111.533 175.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 pt -98.85 -44.12 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 -168.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 C--O 1.255 1.343 0 CA-C-N 118.997 0.817 . . . . 0.0 110.223 -170.842 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.2 mmm . . . . . 0 N--CA 1.501 2.112 0 CA-C-O 119.937 -0.078 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.426 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -58.5 129.59 42.77 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 173.267 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -91.49 133.45 35.49 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.8 t -112.34 154.08 13.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 51.4 tpp -136.11 145.59 46.07 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -125.35 119.37 28.18 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 175.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.1 t -103.06 126.81 57.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -171.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 m -112.5 156.92 21.79 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.627 0.771 . . . . 0.0 110.628 -172.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -150.44 153.49 36.03 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 169.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.53 ' HG2' ' H ' ' A' ' 11' ' ' ASN . 53.5 ttm-85 58.61 -169.31 0.13 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.456 1.102 . . . . 0.0 108.472 -168.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.53 ' H ' ' HG2' ' A' ' 10' ' ' ARG . 50.9 t-20 -47.29 105.99 0.08 Allowed 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 124.008 0.923 . . . . 0.0 108.671 174.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.0 m -77.34 7.5 5.22 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.379 1.072 . . . . 0.0 112.378 -170.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.4 p -44.33 -56.75 3.95 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 124.309 1.044 . . . . 0.0 110.135 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 25.7 ptt85 -52.49 -44.66 65.78 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.795 1.238 . . . . 0.0 113.57 -177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.6 -32.58 13.36 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.338 -0.851 . . . . 0.0 112.406 -168.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -71.48 -30.24 65.74 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.719 -1.238 . . . . 0.0 109.106 169.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.466 ' SD ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -64.05 -37.79 88.73 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 120.784 -1.198 . . . . 0.0 109.364 168.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.8 -36.77 75.01 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 119.077 -0.487 . . . . 0.0 110.008 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -63.15 -40.0 96.31 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.891 169.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.71 -44.4 92.48 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 120.609 1.549 . . . . 0.0 111.797 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.466 ' CD2' ' SD ' ' A' ' 17' ' ' MET . 5.4 m-85 -62.39 -40.93 98.07 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 118.562 1.181 . . . . 0.0 109.382 170.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.06 -36.19 74.8 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.574 1.079 . . . . 0.0 110.632 -173.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -73.84 -18.35 60.95 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 120.359 1.436 . . . . 0.0 112.584 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 m -82.84 -50.94 8.1 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.745 1.618 . . . . 0.0 109.473 176.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.8 mt -88.07 -26.52 22.5 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.301 1.44 . . . . 0.0 111.672 -169.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.96 11.73 60.65 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.574 2.035 . . . . 0.0 112.218 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.65 124.54 21.27 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.819 1.247 . . . . 0.0 109.179 -171.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.61 8.81 87.45 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 119.47 -0.628 . . . . 0.0 113.806 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -127.52 -31.06 2.53 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.566 1.546 . . . . 0.0 108.56 -177.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.1 pt -143.74 165.87 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 125.767 1.627 . . . . 0.0 110.22 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.58 146.62 35.78 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 103.469 -2.789 . . . . 0.0 103.469 168.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.8 t -134.76 146.25 31.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-N 118.922 0.783 . . . . 0.0 111.488 -168.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.8 162.64 40.7 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.656 1.582 . . . . 0.0 109.545 -174.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.5 p -136.58 165.43 25.89 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 120.395 -1.441 . . . . 0.0 110.215 173.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.3 p -149.78 150.75 32.49 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 123.515 0.726 . . . . 0.0 109.745 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.484 0 N-CA-C 106.861 -2.496 . . . . 0.0 106.861 -170.793 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.7 t . . . . . 0 CA--C 1.535 0.389 0 CA-C-O 121.483 0.658 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -129.67 110.97 17.5 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.722 1.209 . . . . 0.0 108.984 -169.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.3 -30.44 54.08 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.956 3.104 . . . . 0.0 114.701 -168.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.0 m -59.52 -36.61 76.43 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.661 1.119 . . . . 0.0 109.743 175.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.13 -43.8 90.74 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.47 -44.11 92.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.52 -41.93 98.06 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.169 0.895 . . . . 0.0 111.664 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 39.1 mmt -63.77 -29.77 70.94 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 118.943 -0.551 . . . . 0.0 111.682 178.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -85.27 -32.5 22.53 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.92 -33.77 76.05 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.275 1.03 . . . . 0.0 109.994 174.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -62.35 -12.54 21.75 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.72 1.208 . . . . 0.0 112.119 173.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.1 m -127.66 13.51 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 125.937 1.695 . . . . 0.0 111.863 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.48 35.61 59.52 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 121.003 -1.06 . . . . 0.0 114.563 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.3 mt -122.35 156.23 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 171.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -131.57 140.82 49.55 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.723 1.209 . . . . 0.0 108.479 171.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 27.6 pt -133.7 17.4 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.55 1.54 . . . . 0.0 111.146 -175.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.3 p -78.64 -28.64 45.54 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.574 1.15 . . . . 0.0 112.664 171.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.6 -8.12 66.5 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 123.136 0.398 . . . . 0.0 112.234 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -85.84 146.57 26.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.478 1.111 . . . . 0.0 108.335 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.4 p -143.16 154.52 43.98 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 169.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.99 166.03 32.83 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -169.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -147.61 162.67 31.02 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.185 1.794 . . . . 0.0 106.762 -171.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.84 160.14 48.66 Favored 'Trans proline' 0 C--N 1.347 0.488 0 CA-C-N 123.052 2.126 . . . . 0.0 112.728 -170.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.9 tt -57.06 -32.73 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.736 1.214 . . . . 0.0 111.95 -175.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -68.73 -22.66 64.31 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.59 0.756 . . . . 0.0 112.145 -173.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -13.34 59.89 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 118.808 -0.615 . . . . 0.0 112.177 171.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -110.76 172.59 6.78 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 122.274 1.035 . . . . 0.0 112.211 -170.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.77 103.23 2.91 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 126.78 2.032 . . . . 0.0 107.065 -172.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.87 -24.43 23.25 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 123.757 0.823 . . . . 0.0 112.988 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -50.64 -32.42 18.98 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.04 0.936 . . . . 0.0 111.585 172.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -86.6 12.0 11.55 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -136.0 177.68 7.65 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.064 2.146 . . . . 0.0 108.557 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -120.45 -21.88 6.67 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.2 t -142.21 128.34 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 -170.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.58 129.74 61.9 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 O-C-N 120.666 -1.271 . . . . 0.0 108.221 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.1 mm -117.9 134.54 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 176.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.4 t -115.06 156.76 24.57 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 175.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.5 mp -134.06 36.38 3.25 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 173.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 60.2 m -96.7 14.0 26.48 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.395 1.478 . . . . 0.0 110.025 -176.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.94 15.45 81.16 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-O 119.361 -0.689 . . . . 0.0 112.447 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 3.9 t 60.35 -20.07 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.234 2.614 . . . . 0.0 115.632 -178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.13 -26.76 73.95 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 119.457 1.026 . . . . 0.0 112.829 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.8 t -63.21 116.59 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 174.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -66.14 138.17 57.54 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 172.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.4 mt -120.99 141.15 32.13 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.57 157.65 6.94 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.645 2.897 . . . . 0.0 113.163 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.7 -22.4 69.85 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 121.889 1.726 . . . . 0.0 115.222 -169.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -65.73 -24.02 66.88 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 120.188 -1.57 . . . . 0.0 111.746 176.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -70.0 -7.93 44.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 117.344 -1.312 . . . . 0.0 112.487 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.5 m -115.32 -12.25 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 121.273 1.851 . . . . 0.0 113.481 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.8 p -81.83 -13.3 57.84 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.158 0.89 . . . . 0.0 112.23 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -44.29 155.22 0.09 Allowed 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 130.979 3.712 . . . . 0.0 113.009 169.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -62.38 -38.33 89.19 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.673 1.989 . . . . 0.0 108.771 169.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 33.6 mm -130.44 138.11 54.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 C-N-CA 123.055 0.542 . . . . 0.0 109.847 171.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -135.42 117.49 15.38 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 100.707 -3.812 . . . . 0.0 100.707 166.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.65 165.75 26.77 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 175.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -141.85 132.75 25.87 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 169.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.1 m0 -102.35 2.22 36.5 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -172.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 47.19 -68.78 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 131.086 3.754 . . . . 0.0 111.833 -169.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . 0.258 0.8 OUTLIER 45.29 -172.73 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.238 1 C-N-CA 133.294 4.638 . . . . 0.0 114.369 -174.429 . . . . . . . . 4 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -64.83 174.89 1.67 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.356 1.462 . . . . 0.0 113.34 -169.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -132.63 66.62 77.06 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 126.483 1.913 . . . . 0.0 109.75 -169.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -79.21 61.8 8.28 Favored 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 124.276 3.317 . . . . 0.0 111.294 -169.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -55.68 -42.6 75.37 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.026 -1.046 . . . . 0.0 112.521 -175.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -163.69 42.68 0.32 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.0 1.762 . . . . 0.0 109.753 -177.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -69.37 171.5 8.53 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -169.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.5 p -64.8 158.74 24.12 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.001 169.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 27.8 mt -60.24 -32.81 71.49 Favored 'General case' 0 C--O 1.22 -0.449 0 O-C-N 122.007 -0.433 . . . . 0.0 110.295 172.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.19 -43.93 90.04 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 118.484 0.584 . . . . 0.0 110.958 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 63.2 t -68.09 -43.79 84.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 119.156 -1.018 . . . . 0.0 108.47 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -48.41 -48.44 37.11 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.674 1.124 . . . . 0.0 111.739 173.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -62.94 -48.19 79.97 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.622 0.769 . . . . 0.0 111.016 176.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.1 m -65.48 -45.61 82.97 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -171.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.5 t -59.32 -42.73 88.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 124.095 0.958 . . . . 0.0 108.764 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -52.57 -51.67 58.67 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 118.444 0.566 . . . . 0.0 110.249 173.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.38 -38.42 95.8 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 119.544 1.066 . . . . 0.0 112.143 -177.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -63.79 -40.36 96.48 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 120.851 -1.382 . . . . 0.0 110.511 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.9 t -62.04 -39.2 82.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 118.443 -0.789 . . . . 0.0 109.147 173.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -39.49 76.27 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.495 1.043 . . . . 0.0 110.881 -176.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -70.44 -42.26 71.78 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 119.043 -0.504 . . . . 0.0 110.565 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -65.44 -42.0 92.9 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.427 1.012 . . . . 0.0 110.559 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.2 t -55.16 -52.69 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 123.322 0.649 . . . . 0.0 109.728 173.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -63.5 -32.65 74.17 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 122.049 -0.407 . . . . 0.0 111.609 -175.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -62.56 -45.9 90.82 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.375 0.67 . . . . 0.0 111.991 172.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -47.4 81.91 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 174.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -58.74 -43.05 87.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.46 -35.32 78.94 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.526 0.603 . . . . 0.0 111.823 -176.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -77.44 -37.49 51.46 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 117.664 -1.16 . . . . 0.0 112.435 174.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.8 pt -93.32 -41.97 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -171.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 C--O 1.252 1.226 0 CA-C-N 119.19 0.904 . . . . 0.0 110.055 -171.513 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 tpt . . . . . 0 N--CA 1.499 1.977 0 CA-C-O 117.623 -1.18 . . . . 0.0 109.607 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.411 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -47.52 118.19 2.12 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 120.708 1.595 . . . . 0.0 110.188 -171.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -93.51 134.22 36.01 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -169.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.1 t -112.87 153.54 14.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 58.2 tpp -136.6 143.58 43.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -127.58 106.75 9.38 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.2 t -94.7 141.93 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.298 1.039 . . . . 0.0 108.249 -172.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.66 162.81 30.41 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.74 1.155 . . . . 0.0 113.598 175.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -142.36 30.0 1.58 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.378 1.871 . . . . 0.0 109.111 169.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -155.57 -174.76 5.1 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.807 2.043 . . . . 0.0 106.956 -170.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.454 HD22 ' CD2' ' A' ' 43' ' ' HIS . 9.3 t-20 -52.16 141.5 18.57 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 125.016 1.326 . . . . 0.0 111.579 174.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.2 p -67.26 -17.14 64.67 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.109 1.364 . . . . 0.0 113.205 -176.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 32.0 p -61.91 -11.43 13.06 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 117.542 -1.218 . . . . 0.0 113.858 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.252 21.7 ptt180 -100.69 -37.99 8.5 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.032 1.287 . . . . 0.0 111.567 169.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.8 p -98.43 -54.34 3.07 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.757 1.617 . . . . 0.0 114.891 -169.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -66.58 -23.18 66.16 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.137 -0.977 . . . . 0.0 108.652 170.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.473 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.9 tpt -67.56 -44.05 79.19 Favored 'General case' 0 C--O 1.224 -0.251 0 O-C-N 120.791 -1.193 . . . . 0.0 109.978 168.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.14 -39.8 87.6 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -58.61 -44.55 89.95 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.377 1.071 . . . . 0.0 110.623 169.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.53 -39.35 61.09 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 120.594 1.543 . . . . 0.0 112.092 -174.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -66.45 -36.78 83.63 Favored 'General case' 0 C--O 1.223 -0.315 0 O-C-N 121.489 -1.007 . . . . 0.0 108.958 170.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.68 -39.92 66.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.978 1.263 . . . . 0.0 110.899 -174.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -66.3 -27.18 67.72 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 120.664 1.575 . . . . 0.0 111.36 175.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 m -75.43 -50.91 14.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.982 1.713 . . . . 0.0 110.477 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.9 mt -89.48 -27.66 20.19 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.007 1.323 . . . . 0.0 112.485 -169.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.28 12.45 63.49 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 127.064 2.269 . . . . 0.0 111.904 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.52 123.43 17.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.14 1.376 . . . . 0.0 110.012 -171.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.95 8.49 86.77 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.465 -0.631 . . . . 0.0 113.636 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -124.7 -41.18 2.15 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.18 1.392 . . . . 0.0 109.201 -175.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.7 pp -140.44 156.06 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.731 1.213 . . . . 0.0 109.437 176.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.95 154.66 17.17 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 173.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 t -140.55 146.14 24.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-N 119.116 0.871 . . . . 0.0 111.585 -168.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.43 158.24 39.68 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.588 1.155 . . . . 0.0 110.418 -176.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.4 p -133.26 156.08 48.21 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.039 1.29 . . . . 0.0 110.906 176.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.415 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 8.1 p -146.78 145.79 30.05 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.05 0.841 . . . . 0.0 109.759 176.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.118 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 -169.034 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.348 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.454 ' CD2' HD22 ' A' ' 11' ' ' ASN . 82.3 t60 -139.99 112.69 7.51 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -172.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -64.34 -30.19 63.26 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.352 2.701 . . . . 0.0 112.751 -169.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.7 m -64.98 -37.5 87.87 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.98 -44.12 90.37 Favored 'General case' 0 C--N 1.346 0.426 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.87 -49.25 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.12 -42.16 98.03 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.523 0.601 . . . . 0.0 110.808 -177.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.9 mmt -63.44 -24.5 67.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.802 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.473 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -94.92 -31.68 13.56 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -176.63 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -60.56 -34.1 73.67 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.603 1.161 . . . . 0.0 110.054 169.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -63.8 -9.59 15.55 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.419 1.488 . . . . 0.0 112.39 173.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.73 14.32 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 125.949 1.7 . . . . 0.0 111.329 172.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.81 37.94 88.95 Favored Glycine 0 CA--C 1.532 1.121 0 O-C-N 121.452 -0.78 . . . . 0.0 112.982 175.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.4 mt -120.16 152.75 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 125.706 1.602 . . . . 0.0 106.95 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -127.79 124.47 37.72 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -176.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.9 pt -129.12 12.91 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 124.246 1.018 . . . . 0.0 111.232 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.95 -31.31 50.87 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.9 1.68 . . . . 0.0 113.577 -178.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.37 -9.69 73.48 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -83.19 159.27 22.04 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.256 1.022 . . . . 0.0 111.528 -173.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -146.77 158.67 43.96 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 128.373 2.669 . . . . 0.0 105.71 169.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.5 m -147.98 167.75 24.09 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -142.5 162.19 45.97 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -169.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.58 164.25 36.16 Favored 'Trans proline' 0 C--N 1.348 0.504 0 CA-C-N 122.686 1.995 . . . . 0.0 113.163 -169.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.5 tt -57.11 -35.87 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.364 1.465 . . . . 0.0 111.118 -173.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.95 -18.42 62.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.298 0.639 . . . . 0.0 112.699 -169.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -82.18 -16.37 49.95 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.482 170.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' ' 35' ' ' CYS . 46.4 m-85 -96.35 168.84 10.33 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.272 1.029 . . . . 0.0 110.842 -177.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.08 93.57 2.41 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 -169.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.45 ' HB3' ' CD2' ' A' ' 90' ' ' TRP . . . -52.97 -25.03 10.7 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 177.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.87 -21.95 13.12 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.123 0.42 . . . . 0.0 111.275 173.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -99.52 6.72 45.79 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.513 1.525 . . . . 0.0 113.248 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -136.77 113.58 10.36 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 120.284 1.402 . . . . 0.0 108.932 178.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.5 -17.37 59.53 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -169.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.7 t -144.22 122.03 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 -171.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.0 m -129.64 131.36 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 O-C-N 120.845 -1.159 . . . . 0.0 108.763 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.9 mm -126.19 96.72 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 102.977 -2.971 . . . . 0.0 102.977 -170.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.5 t -70.81 166.16 21.6 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -147.38 49.44 1.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 173.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 38.5 m -115.68 10.87 15.59 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.739 1.216 . . . . 0.0 110.786 -170.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.62 21.48 16.53 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 118.486 0.585 . . . . 0.0 112.563 173.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 4.3 t 47.4 41.15 12.16 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.049 1.74 . . . . 0.0 111.771 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -162.51 36.31 0.35 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-O 119.601 -0.555 . . . . 0.0 112.452 -170.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.9 t -117.83 137.4 51.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 173.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -82.72 69.07 9.43 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.131 0.972 . . . . 0.0 109.947 -171.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 18.4 mt -59.57 144.81 84.16 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -52.97 154.99 11.95 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.764 2.309 . . . . 0.0 111.846 170.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.65 -19.48 53.88 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 121.649 1.566 . . . . 0.0 114.362 -170.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.08 -25.95 68.33 Favored 'General case' 0 C--O 1.226 -0.162 0 O-C-N 120.938 -1.101 . . . . 0.0 111.224 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.45 ' CD2' ' HB3' ' A' ' 70' ' ' ALA . 72.3 m95 -68.57 -5.31 19.05 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.271 -0.893 . . . . 0.0 112.554 174.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.8 t -108.07 -28.5 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 119.67 1.123 . . . . 0.0 111.184 -174.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.1 p -77.07 -19.05 57.58 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.87 0.868 . . . . 0.0 113.123 -169.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -49.99 159.55 0.41 Allowed 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 129.2 3.0 . . . . 0.0 113.964 174.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -63.34 -38.83 92.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.674 1.59 . . . . 0.0 109.118 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.5 mm -125.71 138.89 53.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 169.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -139.3 112.19 7.93 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 102.641 -3.096 . . . . 0.0 102.641 167.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -134.68 171.0 14.97 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 174.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -139.49 116.0 10.64 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 170.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -93.74 68.74 3.97 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -36.99 -50.05 0.86 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.856 1.663 . . . . 0.0 110.108 169.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . 0.254 0.5 OUTLIER 38.04 -158.39 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 129.936 3.294 . . . . 0.0 112.734 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -60.4 166.6 2.96 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 122.35 1.071 . . . . 0.0 109.181 169.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -133.17 70.45 77.86 Favored Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 126.362 1.865 . . . . 0.0 109.952 -168.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -77.21 49.74 2.93 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.498 3.465 . . . . 0.0 114.738 -169.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -62.69 102.43 0.34 Allowed 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.981 -1.074 . . . . 0.0 109.424 169.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.55 26.34 66.45 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 123.967 0.794 . . . . 0.0 114.203 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -63.93 167.48 6.16 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -176.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.1 m -67.22 154.07 42.15 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 113.228 -1.806 . . . . 0.0 109.219 169.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 25.7 mt -59.03 -34.88 72.41 Favored 'General case' 0 C--O 1.222 -0.366 0 O-C-N 122.08 -0.387 . . . . 0.0 111.519 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -61.11 -39.79 91.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.339 0.518 . . . . 0.0 110.615 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.96 -40.3 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-O 116.75 -1.595 . . . . 0.0 108.998 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -51.63 -47.23 63.77 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 121.207 1.821 . . . . 0.0 111.033 170.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -59.17 -43.96 92.15 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 118.626 0.648 . . . . 0.0 110.441 177.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 86.7 m -69.27 -42.05 76.05 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -174.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 67.5 t -65.02 -48.68 83.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -174.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -47.21 -51.58 18.2 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.957 1.303 . . . . 0.0 110.69 170.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.81 -43.85 97.06 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 119.764 1.165 . . . . 0.0 112.409 -177.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -66.69 -33.96 76.8 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.838 1.319 . . . . 0.0 111.42 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.4 t -62.94 -41.1 91.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.47 -37.56 81.42 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 120.245 1.384 . . . . 0.0 111.166 -177.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -70.17 -40.19 74.85 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 118.865 -0.588 . . . . 0.0 110.733 175.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -60.76 -46.28 91.08 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.515 1.052 . . . . 0.0 110.078 175.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 69.8 t -57.19 -51.42 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 124.224 1.01 . . . . 0.0 109.451 176.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -67.02 -33.0 74.59 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 119.473 -0.299 . . . . 0.0 111.347 -175.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -61.59 -49.26 77.34 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 123.41 0.684 . . . . 0.0 110.679 172.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -46.14 87.34 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 122.93 0.492 . . . . 0.0 110.219 177.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.1 mt -59.36 -41.0 82.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 124.691 1.196 . . . . 0.0 109.813 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.08 -27.59 67.11 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.068 0.849 . . . . 0.0 111.933 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -75.88 -39.73 55.85 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.776 -0.578 . . . . 0.0 111.786 176.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.1 pt -102.89 -33.14 3.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 -168.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 C--O 1.254 1.3 0 C-N-CA 124.755 1.222 . . . . 0.0 111.679 -171.426 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 tpt . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 118.273 -0.87 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.452 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -50.72 116.14 1.81 Allowed 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 120.285 1.402 . . . . 0.0 110.135 -173.123 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.5 mtpt -91.86 142.29 27.72 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 119.263 0.938 . . . . 0.0 108.693 -170.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.67 154.32 13.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 170.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -138.81 131.95 29.81 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -113.65 132.35 55.8 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.4 t -123.19 112.02 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 120.802 1.637 . . . . 0.0 110.164 -169.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.79 170.78 12.86 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 122.76 1.267 . . . . 0.0 112.835 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.0 mmtp -148.47 148.67 30.53 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 130.971 3.708 . . . . 0.0 101.706 168.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.484 ' CG ' ' H ' ' A' ' 11' ' ' ASN . 26.1 ttm-85 57.51 -160.51 0.24 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.743 1.156 . . . . 0.0 107.908 -168.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.484 ' H ' ' CG ' ' A' ' 10' ' ' ARG . 20.2 t-20 -55.77 133.96 51.32 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.221 0.919 . . . . 0.0 112.308 -169.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.4 m -48.06 -24.96 1.24 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 130.286 3.434 . . . . 0.0 115.125 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.0 m -50.2 -49.41 52.72 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 125.713 1.605 . . . . 0.0 114.107 -169.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.27 34.0 ptt180 -70.02 -42.12 73.4 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 118.23 -0.89 . . . . 0.0 113.21 -168.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 87.9 p -78.38 -39.4 39.29 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 120.528 1.513 . . . . 0.0 110.114 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -70.76 -27.68 64.12 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.628 -0.67 . . . . 0.0 110.003 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.471 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.1 tpt -66.72 -41.76 87.44 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 121.149 -0.97 . . . . 0.0 109.51 169.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.57 -38.46 84.65 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -61.33 -42.55 98.87 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.902 169.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.54 -44.88 88.97 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 120.643 1.565 . . . . 0.0 111.798 -175.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -64.98 -40.83 95.56 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 117.937 0.868 . . . . 0.0 108.836 173.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.19 -37.31 72.14 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 119.622 1.101 . . . . 0.0 111.286 -173.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -69.56 -24.77 63.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 120.567 1.53 . . . . 0.0 111.891 177.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.3 m -78.06 -49.98 12.95 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.345 2.258 . . . . 0.0 110.328 175.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.6 mt -88.01 -27.98 21.69 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.732 1.213 . . . . 0.0 112.355 -169.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.34 12.32 58.47 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 127.251 2.358 . . . . 0.0 111.96 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.06 122.83 15.97 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.264 1.426 . . . . 0.0 109.511 -170.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.94 8.41 87.84 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 119.536 -0.591 . . . . 0.0 113.764 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -124.85 -41.94 2.08 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.998 1.319 . . . . 0.0 108.832 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.8 pp -140.99 162.08 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.979 1.312 . . . . 0.0 109.124 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.84 155.53 18.54 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -143.9 139.4 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 118.622 0.646 . . . . 0.0 111.2 -168.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.5 m -150.09 165.85 31.53 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.232 1.413 . . . . 0.0 108.271 177.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.1 p -139.21 169.67 17.35 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.684 -1.26 . . . . 0.0 110.552 171.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.6 p -160.69 -178.31 6.77 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.103 0.961 . . . . 0.0 109.349 176.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.571 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -178.573 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.234 0.286 0 CA-C-O 121.769 0.795 . . . . 0.0 111.886 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.413 ' CG ' HD22 ' A' ' 11' ' ' ASN . 82.5 t60 -141.08 119.65 8.1 Favored Pre-proline 0 N--CA 1.451 -0.397 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -176.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -66.68 -26.69 45.73 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.534 2.823 . . . . 0.0 113.116 -169.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.8 m -61.85 -35.37 78.08 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.973 0.806 . . . . 0.0 109.464 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.3 -43.71 90.25 Favored 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.09 -47.24 90.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 118.566 -0.731 . . . . 0.0 109.041 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.5 99.25 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 118.759 0.709 . . . . 0.0 110.919 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.2 mmt -61.41 -24.94 66.87 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 123.615 0.766 . . . . 0.0 111.936 176.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.471 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.4 OUTLIER -95.45 -26.96 15.63 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 119.052 0.842 . . . . 0.0 108.965 -179.371 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.29 -29.05 70.44 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.996 0.919 . . . . 0.0 110.149 170.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -56.7 -26.23 56.23 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.24 0.616 . . . . 0.0 111.517 169.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.89 -15.95 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 126.744 2.018 . . . . 0.0 109.874 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.65 29.49 52.11 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.153 0.882 . . . . 0.0 111.099 -169.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.0 mt -109.4 156.91 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.259 1.423 . . . . 0.0 107.884 177.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.63 132.65 51.19 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 126.31 1.844 . . . . 0.0 107.669 -173.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.3 pt -140.71 4.48 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.628 1.171 . . . . 0.0 111.883 175.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.83 144.89 55.12 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.712 1.205 . . . . 0.0 110.262 176.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.82 3.68 4.84 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 117.926 -1.485 . . . . 0.0 114.67 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -56.62 -58.42 8.16 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-N 119.589 1.694 . . . . 0.0 112.745 -172.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.8 165.49 27.32 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.317 -167.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.3 m -163.13 19.7 0.08 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -173.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -141.89 154.0 64.9 Favored Pre-proline 0 N--CA 1.476 0.831 0 CA-C-N 120.803 1.638 . . . . 0.0 113.135 -169.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.13 -177.5 3.54 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 125.241 3.961 . . . . 0.0 113.373 174.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.9 tt -77.21 -33.15 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 126.015 1.726 . . . . 0.0 113.756 -173.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -68.92 -27.75 66.05 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -168.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.54 -7.48 57.56 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 117.579 -1.2 . . . . 0.0 112.776 171.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -102.93 166.13 10.63 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.692 1.587 . . . . 0.0 111.894 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.43 88.53 2.21 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 125.383 1.473 . . . . 0.0 108.884 -169.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.02 -27.75 14.66 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.028 0.931 . . . . 0.0 113.009 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -50.48 -32.51 18.29 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.346 1.058 . . . . 0.0 112.312 174.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -72.1 -20.83 61.58 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -101.68 175.03 5.69 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.104 2.562 . . . . 0.0 109.211 -175.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -117.06 -18.54 10.04 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 117.608 -1.187 . . . . 0.0 113.064 174.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.437 ' CG1' ' HB ' ' A' ' 95' ' ' ILE . 22.3 t -138.06 133.08 43.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 121.478 1.945 . . . . 0.0 108.672 -178.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.9 t -117.65 138.42 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.2 mm -131.54 92.12 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 103.004 -2.961 . . . . 0.0 103.004 172.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.7 t -69.63 164.58 23.04 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 169.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.8 mp -139.24 32.0 2.13 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.7 1.6 . . . . 0.0 106.892 173.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 87.7 m -74.39 -3.06 28.19 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.383 1.073 . . . . 0.0 111.908 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.48 34.36 6.09 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 119.585 1.084 . . . . 0.0 110.864 176.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . 0.25 30.3 p 38.91 45.14 0.93 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.003 2.521 . . . . 0.0 113.809 -178.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -142.88 36.55 1.6 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.404 1.478 . . . . 0.0 111.037 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.14 161.94 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 127.202 2.201 . . . . 0.0 108.949 -177.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -134.98 85.65 2.19 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 174.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.402 ' CD2' ' H ' ' A' ' 86' ' ' LEU . 1.3 mm? -62.08 153.85 72.13 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.708 -171.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.41 157.36 18.54 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.002 1.801 . . . . 0.0 112.272 174.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -52.13 -36.92 68.16 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.772 2.315 . . . . 0.0 116.152 -170.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -67.06 -23.79 65.91 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 120.982 -1.074 . . . . 0.0 112.288 -175.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -75.86 -11.65 60.01 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.745 1.218 . . . . 0.0 112.622 177.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.76 -16.67 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 120.032 1.287 . . . . 0.0 112.314 -177.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.6 p -76.72 -13.46 60.03 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.282 0.946 . . . . 0.0 112.342 177.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -41.67 154.17 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 129.982 3.313 . . . . 0.0 111.793 169.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -60.68 -36.91 79.93 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.096 1.758 . . . . 0.0 109.729 172.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.437 ' HB ' ' CG1' ' A' ' 75' ' ' VAL . 29.1 mm -130.18 136.35 58.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 170.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -133.69 123.03 24.27 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 102.92 -2.993 . . . . 0.0 102.92 166.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.46 167.04 23.43 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 173.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -130.51 102.24 6.07 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 169.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -76.86 80.81 3.44 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.898 1.679 . . . . 0.0 108.807 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.77 22.4 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.263 2.625 . . . . 0.0 115.234 175.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.72 164.91 13.6 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.062 -1.024 . . . . 0.0 111.219 -169.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -51.71 146.86 7.29 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -168.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -80.89 110.29 16.87 Favored Pre-proline 0 C--N 1.321 -0.669 0 C-N-CA 127.72 2.408 . . . . 0.0 109.531 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -84.16 -7.14 10.17 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.882 2.388 . . . . 0.0 112.378 176.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.6 t70 19.8 -101.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 128.758 2.823 . . . . 0.0 113.508 -176.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.81 39.76 1.74 Allowed Glycine 0 CA--C 1.533 1.191 0 C-N-CA 127.138 2.304 . . . . 0.0 108.059 169.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -70.03 -179.51 1.93 Allowed 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.987 1.715 . . . . 0.0 112.397 -173.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.2 p -60.27 154.47 19.94 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 113.142 -1.844 . . . . 0.0 109.04 169.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 27.6 mt -57.35 -29.74 64.25 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 122.799 0.44 . . . . 0.0 110.406 176.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -61.4 -41.08 96.56 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 118.527 -0.749 . . . . 0.0 110.948 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.5 t -72.17 -40.19 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 117.705 -1.14 . . . . 0.0 109.59 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -51.35 -51.31 55.62 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.934 1.243 . . . . 0.0 111.425 169.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 80.2 mtt180 -59.65 -44.27 93.6 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.847 0.749 . . . . 0.0 110.99 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 95.8 m -67.03 -45.93 75.98 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -175.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.1 t -64.95 -48.89 82.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -172.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -43.97 -53.58 6.1 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 125.374 1.47 . . . . 0.0 111.262 169.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.82 -40.41 95.57 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 120.104 1.32 . . . . 0.0 112.526 -177.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -66.05 -37.22 85.28 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 120.819 -1.4 . . . . 0.0 110.261 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.9 t -63.41 -43.7 98.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 CA-C-O 117.997 -1.002 . . . . 0.0 108.439 173.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.52 -40.22 82.31 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.716 1.598 . . . . 0.0 110.842 -175.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -71.26 -44.46 65.22 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 125.382 1.473 . . . . 0.0 109.084 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -66.24 -41.87 89.41 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 120.011 1.278 . . . . 0.0 111.582 177.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.7 t -53.98 -50.13 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 173.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -66.67 -34.4 77.79 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -176.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -61.68 -48.28 81.54 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 118.46 0.573 . . . . 0.0 110.394 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -45.92 90.46 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 123.049 0.54 . . . . 0.0 109.829 177.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.4 mt -58.43 -42.2 83.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.735 1.214 . . . . 0.0 110.195 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.13 -28.38 67.83 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.296 0.498 . . . . 0.0 112.085 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -75.79 -43.54 45.81 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.418 0.554 . . . . 0.0 111.873 174.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 pt -91.92 -37.53 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -169.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.6 m . . . . . 0 C--O 1.255 1.348 0 CA-C-N 120.266 1.393 . . . . 0.0 110.352 179.36 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 tpt . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 118.524 -0.75 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.436 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -61.54 119.7 9.12 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 121.128 1.785 . . . . 0.0 108.035 -176.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 37.1 mtpt -92.25 137.97 31.92 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -170.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 t -122.06 153.77 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 58.9 tpp -138.44 145.12 40.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -129.42 121.82 28.12 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 t -118.5 113.35 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 119.644 1.111 . . . . 0.0 109.252 -169.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.96 167.42 18.92 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 123.32 1.533 . . . . 0.0 113.476 178.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -152.94 141.03 20.37 Favored 'General case' 0 C--O 1.238 0.479 2 N-CA-C 100.032 -4.062 . . . . 0.0 100.032 168.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 62.16 -179.36 0.13 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 120.331 1.423 . . . . 0.0 108.644 -167.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.505 HD22 ' CD2' ' A' ' 43' ' ' HIS . 28.8 t-20 -41.52 123.0 2.07 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 125.131 1.372 . . . . 0.0 112.129 -169.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.3 m -45.78 -26.71 0.7 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 127.868 2.467 . . . . 0.0 115.108 -176.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.5 t -39.78 -54.08 2.15 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 125.557 1.543 . . . . 0.0 112.859 -178.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.289 33.5 ptt180 -65.84 -44.35 85.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 117.784 -1.103 . . . . 0.0 113.454 -168.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 97.5 p -77.3 -41.67 39.79 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 121.094 1.77 . . . . 0.0 110.304 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -70.06 -34.91 73.81 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -172.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.46 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 3.4 tpt -63.72 -41.76 98.03 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 123.496 0.718 . . . . 0.0 110.363 170.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.58 -37.66 82.06 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.494 -177.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -62.51 -42.73 99.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 117.94 -1.028 . . . . 0.0 111.204 170.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.58 -45.23 93.62 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 120.746 1.612 . . . . 0.0 111.284 -175.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -66.77 -40.49 88.22 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.203 172.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.96 78.44 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 120.295 1.407 . . . . 0.0 111.6 -176.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -81.91 -13.82 57.01 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 120.46 1.482 . . . . 0.0 113.11 176.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.6 m -79.95 -52.01 8.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.698 1.199 . . . . 0.0 108.533 169.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.1 mt -84.44 -27.44 27.54 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.899 1.28 . . . . 0.0 111.859 -169.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.87 12.66 57.73 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.675 2.084 . . . . 0.0 111.889 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.53 121.98 12.91 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.585 1.154 . . . . 0.0 109.861 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.38 9.41 86.84 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 119.853 -0.415 . . . . 0.0 113.559 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -123.2 -32.56 3.42 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.849 1.66 . . . . 0.0 109.012 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.4 pt -142.64 174.57 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 125.305 1.442 . . . . 0.0 109.785 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.56 145.27 43.48 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 169.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 t -134.13 143.88 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 118.542 0.61 . . . . 0.0 111.279 -168.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.76 156.18 42.0 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.934 1.294 . . . . 0.0 109.74 -173.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.3 p -139.65 155.34 47.46 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 120.364 1.438 . . . . 0.0 111.069 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.2 p -160.11 -178.54 7.06 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.93 0.892 . . . . 0.0 110.313 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.879 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.01 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 C--O 1.235 0.307 0 CA-C-O 122.067 0.937 . . . . 0.0 112.06 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.505 ' CD2' HD22 ' A' ' 11' ' ' ASN . 81.5 t60 -119.74 110.07 37.29 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.623 -169.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -59.88 -29.1 88.68 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.07 2.513 . . . . 0.0 113.67 -169.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.33 -37.49 80.78 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.475 1.034 . . . . 0.0 110.847 175.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.21 -45.82 72.29 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.5 -45.81 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.5 -43.74 93.27 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.373 0.533 . . . . 0.0 111.438 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.3 mmt -65.86 -19.64 65.95 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 118.969 -0.539 . . . . 0.0 112.1 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.46 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 2.0 mmt -98.63 -28.65 13.45 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.93 -33.67 75.84 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.557 1.143 . . . . 0.0 109.547 169.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -58.51 -15.17 10.01 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.792 1.637 . . . . 0.0 112.067 172.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.0 m -132.45 14.3 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 C-N-CA 126.439 1.896 . . . . 0.0 111.753 177.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.51 43.54 76.9 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-O 118.944 -0.92 . . . . 0.0 114.31 174.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.1 mt -124.25 151.61 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.133 1.373 . . . . 0.0 107.872 171.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -113.81 129.86 56.53 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.293 1.437 . . . . 0.0 109.073 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.1 pt -129.76 14.12 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 125.568 1.547 . . . . 0.0 111.017 171.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.54 -28.1 31.24 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.372 1.469 . . . . 0.0 113.107 175.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.05 -9.5 86.74 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 118.372 0.533 . . . . 0.0 112.902 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -71.79 157.99 36.9 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.63 1.572 . . . . 0.0 109.614 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.48 165.15 31.15 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.54 144.84 49.43 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.682 1.993 . . . . 0.0 112.005 -172.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.65 139.41 1.67 Allowed Pre-proline 0 C--O 1.237 0.409 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 169.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -79.39 158.64 25.94 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.271 1.981 . . . . 0.0 110.845 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.6 tt -57.92 -37.2 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 124.707 1.203 . . . . 0.0 110.641 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -69.76 -21.87 63.4 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.357 0.663 . . . . 0.0 112.344 -174.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -22.2 60.94 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.28 0.491 . . . . 0.0 111.069 171.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -94.01 168.95 10.62 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 122.072 0.939 . . . . 0.0 110.646 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.39 93.41 2.43 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 125.451 1.5 . . . . 0.0 107.516 -175.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.426 ' HB1' ' CD2' ' A' ' 90' ' ' TRP . . . -50.0 -24.31 2.54 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 124.306 1.042 . . . . 0.0 113.392 175.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -50.81 -28.99 10.52 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.136 0.574 . . . . 0.0 111.318 173.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -91.92 -9.34 43.48 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.403 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 12.8 m-85 -120.2 112.93 19.69 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 120.595 1.543 . . . . 0.0 109.332 -173.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -65.54 -14.48 61.16 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -169.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.0 t -143.85 118.19 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 -171.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.3 m -128.19 134.2 65.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 O-C-N 120.875 -1.14 . . . . 0.0 108.718 -174.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.4 mm -127.5 97.14 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 104.203 -2.518 . . . . 0.0 104.203 -169.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.0 t -72.81 166.29 23.21 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 169.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.8 mp -144.27 40.19 1.33 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 173.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 60.9 m -100.04 12.0 37.96 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.334 1.054 . . . . 0.0 111.358 -172.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.7 23.53 28.04 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.512 -0.605 . . . . 0.0 111.862 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.405 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 4.0 t 45.65 45.7 11.1 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.857 1.663 . . . . 0.0 111.945 -177.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -153.53 35.9 0.75 Allowed Glycine 0 C--N 1.341 0.821 0 C-N-CA 123.405 0.526 . . . . 0.0 111.928 -171.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 78.5 t -122.43 133.16 69.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 125.039 1.335 . . . . 0.0 107.737 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -78.42 72.42 4.95 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 172.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.3 mt -57.73 145.98 68.15 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -55.1 155.24 19.65 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.046 1.831 . . . . 0.0 112.432 176.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -54.18 -29.28 55.61 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.549 2.166 . . . . 0.0 115.94 -173.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -66.25 -27.06 67.66 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 120.986 -1.071 . . . . 0.0 111.159 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.426 ' CD2' ' HB1' ' A' ' 70' ' ' ALA . 71.0 m95 -71.47 -3.63 22.12 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 117.91 -1.043 . . . . 0.0 113.165 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.0 m -120.71 -7.17 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 120.575 1.534 . . . . 0.0 113.471 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.8 p -87.28 -16.25 35.7 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.448 1.022 . . . . 0.0 112.632 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -54.02 163.33 0.79 Allowed 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 129.153 2.981 . . . . 0.0 113.605 175.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -64.89 -41.72 95.37 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.673 1.189 . . . . 0.0 108.708 176.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.7 mm -121.64 140.48 45.53 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 CA-C-O 121.58 0.705 . . . . 0.0 110.097 169.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -140.71 114.3 8.8 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 100.946 -3.724 . . . . 0.0 100.946 166.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -135.9 170.28 16.24 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 170.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.405 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.2 t70 -137.31 106.24 5.95 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 172.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.474 ' C ' ' H ' ' A' ' 101' ' ' LEU . 48.7 m0 -85.13 70.48 10.89 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -48.03 7.91 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.208 1 C-N-CA 131.836 4.054 . . . . 0.0 115.324 169.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.474 ' H ' ' C ' ' A' ' 99' ' ' TRP . 3.8 mm? -61.48 126.39 27.17 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 126.798 2.039 . . . . 0.0 111.338 -168.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 51.01 -160.04 0.09 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.826 2.051 . . . . 0.0 113.765 169.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -165.48 70.76 1.32 Allowed Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 128.101 2.561 . . . . 0.0 108.061 -172.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.95 -4.8 16.01 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 122.526 2.15 . . . . 0.0 114.215 -169.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -56.61 -34.19 66.99 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -173.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.35 40.65 1.94 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.651 1.119 . . . . 0.0 112.737 -174.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -116.13 -157.62 0.66 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.085 0.954 . . . . 0.0 111.89 -175.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.9 m -131.11 173.56 10.9 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 128.662 2.785 . . . . 0.0 107.542 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 35.4 mt -54.7 -36.06 64.3 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.962 0.905 . . . . 0.0 110.785 -172.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -60.13 -40.0 88.22 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 123.031 0.532 . . . . 0.0 110.269 -175.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.61 -37.82 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.091 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -53.68 -42.73 68.27 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.948 1.249 . . . . 0.0 111.255 170.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -63.44 -43.76 96.5 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 119.607 1.094 . . . . 0.0 111.141 174.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.1 m -71.91 -43.39 65.42 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -171.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 57.9 t -64.48 -47.19 90.33 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -173.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.3 ttp180 -45.08 -50.38 11.06 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 125.475 1.51 . . . . 0.0 111.026 169.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.69 -43.4 96.34 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 119.576 1.08 . . . . 0.0 112.696 177.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -75.91 -31.68 59.27 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 120.956 -1.32 . . . . 0.0 110.652 -175.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.2 -37.75 80.27 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 170.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -57.8 -47.79 81.57 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 120.595 1.543 . . . . 0.0 110.876 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -62.05 -38.25 88.03 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.021 0.826 . . . . 0.0 109.011 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -68.13 -47.18 68.81 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.404 0.681 . . . . 0.0 110.878 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.6 t -56.49 -52.51 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.87 1.268 . . . . 0.0 108.738 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -68.66 -33.37 73.87 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -171.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -62.16 -49.43 75.87 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 123.099 0.56 . . . . 0.0 110.852 171.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.87 -46.14 78.33 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 122.978 0.511 . . . . 0.0 109.876 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.7 mt -58.85 -43.84 89.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 124.807 1.243 . . . . 0.0 110.687 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.71 -29.06 67.85 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 118.782 0.719 . . . . 0.0 111.726 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -74.71 -40.64 61.2 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 118.538 0.608 . . . . 0.0 112.032 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.9 pt -100.62 -42.38 9.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 116.976 2.213 . . . . 0.0 116.976 -168.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.254 1.307 0 CA-C-N 119.195 0.907 . . . . 0.0 110.304 -171.909 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 tpt . . . . . 0 N--CA 1.499 1.977 0 CA-C-O 117.706 -1.14 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.454 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -54.96 118.02 3.93 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 121.337 1.881 . . . . 0.0 110.377 -169.69 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -86.19 135.47 33.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -170.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.0 t -125.36 153.71 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 61.4 tpp -140.59 131.91 26.69 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -176.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -116.17 107.27 14.68 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.9 t -94.39 144.31 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -169.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.4 t -128.0 -177.76 4.26 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.38 1.072 . . . . 0.0 110.185 172.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -152.4 -45.93 0.1 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.63 1.572 . . . . 0.0 108.688 176.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -167.7 0.17 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.187 0.995 . . . . 0.0 109.017 169.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.473 HD22 ' CD2' ' A' ' 43' ' ' HIS . 26.6 t-20 -47.94 139.58 7.69 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.698 0.799 . . . . 0.0 109.614 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -55.22 -22.9 19.63 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.504 1.522 . . . . 0.0 114.396 -169.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.9 m -42.2 -67.5 0.26 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 127.21 2.204 . . . . 0.0 114.318 -172.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.272 34.9 ptt180 -56.19 -47.67 77.87 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.451 1.478 . . . . 0.0 114.715 -167.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.43 -29.98 21.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 119.005 0.82 . . . . 0.0 111.315 -171.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -70.09 -27.01 64.26 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.112 -0.992 . . . . 0.0 110.023 170.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.473 ' SD ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -69.03 -42.25 76.6 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 120.574 -1.329 . . . . 0.0 109.789 169.439 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.08 -40.21 84.54 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -59.65 -39.09 83.26 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.42 169.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.19 -43.08 56.77 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 120.715 1.598 . . . . 0.0 112.587 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.473 ' CD2' ' SD ' ' A' ' 17' ' ' MET . 10.6 m-85 -64.68 -37.52 87.88 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 119.075 1.438 . . . . 0.0 108.989 170.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.45 -39.17 68.0 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 119.497 1.044 . . . . 0.0 111.118 -173.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -65.27 -33.79 76.81 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 120.371 1.441 . . . . 0.0 110.915 174.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.8 m -69.06 -50.98 43.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.285 1.834 . . . . 0.0 110.232 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.0 mt -90.06 -25.83 20.58 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.55 1.14 . . . . 0.0 112.129 -169.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.23 14.84 58.15 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 126.748 2.118 . . . . 0.0 111.903 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.66 120.82 10.77 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.908 1.283 . . . . 0.0 110.091 -171.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.11 8.53 86.93 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-O 119.811 -0.439 . . . . 0.0 113.511 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -123.1 -28.45 4.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.413 1.485 . . . . 0.0 109.583 -176.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.6 pt -143.35 175.87 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 125.832 1.653 . . . . 0.0 109.386 176.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.56 145.12 46.66 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 103.868 -2.641 . . . . 0.0 103.868 168.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 t -132.17 144.04 38.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 123.851 0.86 . . . . 0.0 111.316 -167.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.75 161.97 41.18 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.799 1.24 . . . . 0.0 109.723 -173.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.9 t -142.18 154.76 45.09 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.688 1.586 . . . . 0.0 109.524 172.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.6 p -157.11 171.03 21.18 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 118.509 0.595 . . . . 0.0 112.312 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.091 0 N-CA-C 107.786 -2.126 . . . . 0.0 107.786 -169.985 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.235 0.33 0 CA-C-O 121.248 0.547 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.473 ' CD2' HD22 ' A' ' 11' ' ' ASN . 20.9 t-80 -139.75 119.52 9.09 Favored Pre-proline 0 N--CA 1.451 -0.403 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -176.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -67.11 -27.28 42.06 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.057 2.505 . . . . 0.0 112.555 -169.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.7 m -62.43 -35.48 79.38 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.967 0.803 . . . . 0.0 109.53 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.23 -43.03 92.77 Favored 'General case' 0 C--O 1.221 -0.447 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.57 -47.84 89.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 118.206 -0.902 . . . . 0.0 109.382 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.35 -42.69 99.1 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 119.633 1.106 . . . . 0.0 110.878 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.0 mmt -64.32 -18.2 64.39 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.765 0.826 . . . . 0.0 112.112 176.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 3.9 mmt -95.02 -28.03 15.33 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 119.387 0.994 . . . . 0.0 110.992 173.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -63.6 -30.01 71.18 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 123.62 0.768 . . . . 0.0 109.694 172.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -57.96 -21.13 42.73 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.535 1.134 . . . . 0.0 113.101 170.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.4 p -121.44 9.03 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 125.229 1.412 . . . . 0.0 110.386 -177.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.32 36.88 85.5 Favored Glycine 0 CA--C 1.531 1.072 0 O-C-N 121.148 -0.97 . . . . 0.0 111.808 177.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 35.3 mt -121.83 157.93 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 126.2 1.8 . . . . 0.0 106.153 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -140.33 145.08 36.73 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 172.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 27.6 pt -138.55 7.7 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 126.354 1.862 . . . . 0.0 111.023 -174.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.3 t -64.28 145.67 55.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.612 -0.68 . . . . 0.0 109.289 172.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.63 3.52 5.75 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 117.802 -1.555 . . . . 0.0 114.552 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -54.6 -58.7 6.49 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-N 119.776 1.788 . . . . 0.0 111.481 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.77 154.03 32.16 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 125.57 1.548 . . . . 0.0 106.986 -169.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.0 m -163.43 68.03 0.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 102.428 -3.175 . . . . 0.0 102.428 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -142.46 141.44 20.82 Favored Pre-proline 0 C--O 1.236 0.347 0 CA-C-O 119.152 -0.451 . . . . 0.0 112.195 -167.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -82.66 159.99 16.58 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.522 2.815 . . . . 0.0 111.268 173.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.63 -36.87 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 124.463 1.105 . . . . 0.0 111.778 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -70.46 -19.96 62.92 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.277 0.631 . . . . 0.0 112.16 -173.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.25 -23.9 62.98 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 118.763 -0.637 . . . . 0.0 111.6 170.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -99.82 169.71 9.04 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 122.128 0.966 . . . . 0.0 111.093 -174.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -142.59 90.69 2.25 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 -170.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.442 ' HB3' ' CD2' ' A' ' 90' ' ' TRP . . . -54.26 -22.79 12.67 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.4 -21.07 5.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 122.943 0.497 . . . . 0.0 111.301 171.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -111.31 17.09 20.54 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.881 2.072 . . . . 0.0 112.346 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -132.82 107.57 8.43 Favored 'General case' 0 C--N 1.345 0.407 0 O-C-N 120.685 -1.259 . . . . 0.0 107.787 170.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -58.94 -18.86 37.45 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -169.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.5 t -143.07 123.43 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -170.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 t -118.06 134.45 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.8 mm -131.98 87.69 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.1 t -68.31 165.8 17.84 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.988 -1.07 . . . . 0.0 108.653 169.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -144.5 53.03 1.25 Allowed 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 170.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.3 m -113.53 15.73 18.93 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.11 0.964 . . . . 0.0 110.583 -176.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.68 24.7 29.73 Favored Glycine 0 C--N 1.339 0.723 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 172.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 6.7 t 44.54 42.44 5.62 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.311 1.844 . . . . 0.0 112.327 -176.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -151.66 37.88 0.82 Allowed Glycine 0 C--N 1.339 0.72 0 C-N-CA 123.53 0.586 . . . . 0.0 112.012 -171.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.5 t -120.24 141.67 39.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 C-N-CA 124.753 1.221 . . . . 0.0 108.612 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -82.03 55.95 2.97 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.588 1.155 . . . . 0.0 110.159 -178.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.4 mt -57.15 133.64 80.73 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.59 154.6 19.6 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.666 2.244 . . . . 0.0 112.758 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -55.0 -27.98 57.33 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.619 2.213 . . . . 0.0 116.208 -172.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -65.45 -25.36 67.48 Favored 'General case' 0 C--O 1.226 -0.147 0 O-C-N 121.284 -0.885 . . . . 0.0 111.288 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.442 ' CD2' ' HB3' ' A' ' 70' ' ' ALA . 61.7 m95 -67.93 -8.66 38.76 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.251 -0.906 . . . . 0.0 112.813 175.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.3 t -107.78 -30.54 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.022 1.329 . . . . 0.0 111.122 -170.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.7 p -74.65 -16.77 60.76 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.37 1.068 . . . . 0.0 113.688 -169.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -50.56 160.76 0.38 Allowed 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 130.213 3.405 . . . . 0.0 114.308 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -60.11 -39.41 86.08 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.414 1.486 . . . . 0.0 108.591 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.2 mm -126.32 137.07 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 169.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -137.49 113.09 9.48 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 102.156 -3.276 . . . . 0.0 102.156 166.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -140.75 166.66 24.15 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -139.67 110.56 6.83 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 169.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -83.04 81.98 8.44 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.33 25.6 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 127.337 2.255 . . . . 0.0 114.564 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.57 175.64 2.77 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.696 -1.253 . . . . 0.0 110.372 -172.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.79 160.46 2.62 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 123.238 1.494 . . . . 0.0 114.542 -170.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -103.91 108.08 58.73 Favored Pre-proline 0 C--N 1.322 -0.608 0 C-N-CA 127.01 2.124 . . . . 0.0 108.717 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -80.85 -6.65 13.32 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.609 2.206 . . . . 0.0 112.014 177.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.7 t0 22.9 -99.33 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 128.389 2.676 . . . . 0.0 113.336 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.64 39.91 1.66 Allowed Glycine 0 CA--C 1.531 1.084 0 C-N-CA 127.119 2.295 . . . . 0.0 108.7 169.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -70.38 -178.07 1.63 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.397 1.879 . . . . 0.0 112.635 -175.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.3 m -61.3 153.67 25.88 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 113.376 -1.738 . . . . 0.0 108.731 171.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.7 mt -56.68 -29.73 62.66 Favored 'General case' 0 C--O 1.221 -0.396 0 C-N-CA 122.954 0.502 . . . . 0.0 110.82 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -61.24 -39.68 91.21 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.058 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.5 t -73.72 -40.02 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.257 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -51.13 -51.45 53.4 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.738 1.154 . . . . 0.0 111.326 169.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -59.05 -45.18 91.41 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.441 0.696 . . . . 0.0 110.958 178.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.1 m -67.58 -45.71 74.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -173.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.3 t -66.02 -48.24 82.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -171.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -44.1 -56.83 3.76 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.783 1.233 . . . . 0.0 110.575 169.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.94 -41.76 99.82 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 119.968 1.258 . . . . 0.0 111.948 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -63.75 -41.73 97.97 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.516 -0.99 . . . . 0.0 110.263 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.35 -39.07 82.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -41.45 83.41 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 120.013 1.279 . . . . 0.0 110.642 -175.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.69 -40.41 80.07 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.633 0.373 . . . . 0.0 110.063 177.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -64.49 -47.11 80.15 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.618 0.644 . . . . 0.0 110.292 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.1 t -56.05 -51.38 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 124.049 0.939 . . . . 0.0 108.469 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -66.01 -32.36 73.79 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 119.353 -0.356 . . . . 0.0 111.5 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -62.51 -48.07 81.16 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 118.612 0.642 . . . . 0.0 111.013 173.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -42.98 91.55 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 123.247 0.619 . . . . 0.0 110.624 176.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.0 mt -62.26 -43.09 97.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 123.102 0.561 . . . . 0.0 110.116 175.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.35 -31.68 71.57 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.311 0.959 . . . . 0.0 112.039 -175.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -81.37 -35.08 31.26 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 117.763 -1.113 . . . . 0.0 112.978 175.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 pt -96.52 -43.66 12.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 115.421 1.638 . . . . 0.0 115.421 -173.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.2 m . . . . . 0 C--O 1.256 1.444 0 C-N-CA 124.636 1.174 . . . . 0.0 111.586 -171.165 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mmm . . . . . 0 N--CA 1.502 2.131 0 CA-C-O 119.257 -0.402 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.482 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -59.31 137.74 57.87 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 169.463 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -112.19 142.06 45.13 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 -169.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.5 t -122.86 155.29 28.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -174.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 57.0 tpp -136.68 134.25 37.05 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -115.74 112.07 21.49 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 t -96.32 136.72 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -169.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.3 m -109.72 149.95 29.02 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.258 1.023 . . . . 0.0 112.237 -169.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.7 mmtt -150.07 146.09 26.74 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.372 1.869 . . . . 0.0 106.054 169.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.511 ' CG ' ' H ' ' A' ' 11' ' ' ASN . 27.0 ttm180 57.01 -172.44 0.08 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.544 1.138 . . . . 0.0 109.307 -168.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.511 ' H ' ' CG ' ' A' ' 10' ' ' ARG . 37.0 t-20 -49.95 105.36 0.09 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.418 1.487 . . . . 0.0 107.857 -177.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 m -62.06 0.15 0.44 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 117.137 2.273 . . . . 0.0 117.137 -167.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.1 m -38.22 -50.57 1.43 Allowed 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 126.36 1.864 . . . . 0.0 111.923 173.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -65.23 -43.25 92.03 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.243 0.545 . . . . 0.0 111.329 -171.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.1 p -88.45 -37.75 15.57 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 124.422 1.089 . . . . 0.0 111.1 -170.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -72.13 -32.08 66.61 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.552 -0.717 . . . . 0.0 109.545 174.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.415 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.5 tpt -62.09 -39.22 91.72 Favored 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 121.158 -0.964 . . . . 0.0 109.685 169.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.07 92.1 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -62.94 -39.16 93.76 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.204 170.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.77 -43.07 68.5 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 120.852 1.66 . . . . 0.0 111.275 -174.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -63.53 -40.4 96.94 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 170.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.29 -40.27 81.84 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 119.58 1.082 . . . . 0.0 111.464 -176.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.4 pttp -70.84 -22.72 62.28 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 120.455 1.48 . . . . 0.0 112.373 176.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.9 m -77.79 -52.13 9.4 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.763 1.625 . . . . 0.0 110.23 175.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 71.1 mt -85.33 -26.49 26.51 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.017 1.327 . . . . 0.0 111.606 -169.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.63 15.27 55.97 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 126.74 2.114 . . . . 0.0 111.707 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.91 121.94 12.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.668 1.187 . . . . 0.0 109.936 -175.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.04 8.05 87.46 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 119.752 -0.471 . . . . 0.0 113.385 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -122.6 -32.25 3.61 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 125.234 1.414 . . . . 0.0 109.36 -177.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.6 pt -141.55 163.92 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 125.018 1.327 . . . . 0.0 110.54 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.74 144.18 31.43 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 168.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.27 135.12 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.472 0.709 . . . . 0.0 110.512 -168.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.7 m -147.31 161.4 41.04 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.776 1.231 . . . . 0.0 109.501 -178.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.5 p -128.09 161.67 28.67 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.726 1.21 . . . . 0.0 109.491 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.5 p -152.31 147.56 26.48 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 121.328 -0.858 . . . . 0.0 111.709 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.621 0 N-CA-C 105.154 -3.178 . . . . 0.0 105.154 -168.328 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.6 m . . . . . 0 C--O 1.234 0.238 0 CA-C-O 121.981 0.896 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.466 ' CD2' HD22 ' A' ' 11' ' ' ASN . 82.9 t60 -134.15 116.23 13.22 Favored Pre-proline 0 N--CA 1.446 -0.671 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 -175.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -64.75 -24.26 62.05 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 123.714 2.942 . . . . 0.0 112.7 -169.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.0 m -61.27 -36.64 80.61 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.106 0.867 . . . . 0.0 109.731 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.15 -45.1 82.17 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -56.37 -49.24 77.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.49 -42.93 99.53 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.41 0.55 . . . . 0.0 111.024 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.6 mmt -61.51 -23.99 66.3 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 124.251 1.021 . . . . 0.0 113.337 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.415 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 4.3 mmt -101.98 -24.11 14.03 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.084 0.856 . . . . 0.0 108.958 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -64.94 -34.75 79.15 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 118.952 0.796 . . . . 0.0 109.435 171.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -72.6 7.1 2.04 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 173.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.3 t -119.29 -39.56 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 127.23 2.212 . . . . 0.0 110.023 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.94 24.14 2.58 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.375 1.464 . . . . 0.0 112.884 -176.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.7 mt -124.42 161.6 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 125.879 1.671 . . . . 0.0 107.222 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -108.19 -61.5 1.58 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -169.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . 0.421 28.7 pt 56.17 1.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 118.245 2.683 . . . . 0.0 118.245 -177.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.76 147.93 43.03 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 120.899 1.681 . . . . 0.0 109.39 169.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.69 1.42 11.45 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 118.248 -1.307 . . . . 0.0 114.777 176.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -48.47 -65.32 0.59 Allowed 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.258 1.529 . . . . 0.0 113.23 -177.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.9 166.15 25.74 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 123.672 0.608 . . . . 0.0 112.548 -168.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.9 p -169.56 22.81 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.91 0.884 . . . . 0.0 112.565 -171.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -139.47 150.36 63.46 Favored Pre-proline 0 N--CA 1.475 0.821 0 CA-C-N 119.895 1.225 . . . . 0.0 112.193 -169.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -84.25 162.54 13.23 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 124.095 3.196 . . . . 0.0 112.909 -170.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.1 tt -57.43 -36.4 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.99 1.716 . . . . 0.0 111.269 -176.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -73.86 -16.37 61.13 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -170.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.16 -17.07 44.19 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 118.691 -0.671 . . . . 0.0 111.793 170.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -88.79 170.47 10.73 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.195 0.907 . . . . 0.0 110.721 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.7 89.91 2.24 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.451 1.501 . . . . 0.0 107.921 -177.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.44 ' HB3' ' CD2' ' A' ' 90' ' ' TRP . . . -52.39 -23.16 5.52 Favored 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 176.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -50.86 -30.2 13.85 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.349 0.66 . . . . 0.0 111.398 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -91.71 4.18 53.35 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -131.83 114.8 15.14 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 120.437 1.471 . . . . 0.0 109.454 -177.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -69.78 -6.91 35.33 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -169.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.7 t -145.02 123.31 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -171.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.0 t -118.51 127.39 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.8 mm -121.45 94.3 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 171.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.2 p -73.95 167.52 21.32 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 118.252 -1.379 . . . . 0.0 107.747 168.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mp -143.02 41.82 1.53 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 173.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 59.1 m -101.03 -5.49 25.71 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.523 1.529 . . . . 0.0 112.188 -168.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.15 15.64 7.09 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-N 119.543 1.065 . . . . 0.0 113.985 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 6.0 t 45.5 56.06 6.07 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.77 1.628 . . . . 0.0 111.172 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -175.52 -26.18 0.03 OUTLIER Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.479 -172.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 78.5 t -56.6 121.21 4.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 169.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -65.41 136.45 56.5 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 173.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.5 mt -123.71 144.34 44.27 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 176.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.25 156.72 9.96 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.6 2.2 . . . . 0.0 112.997 176.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -53.91 -30.39 58.08 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.824 2.349 . . . . 0.0 116.399 -170.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -67.04 -26.0 66.54 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.377 -0.827 . . . . 0.0 111.328 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.44 ' CD2' ' HB3' ' A' ' 70' ' ' ALA . 66.2 m95 -69.67 -13.25 62.21 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 120.87 -1.144 . . . . 0.0 113.388 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.96 -9.35 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 119.721 1.146 . . . . 0.0 112.957 -169.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.1 p -85.79 -10.26 55.76 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.253 1.021 . . . . 0.0 112.714 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -60.46 167.94 2.35 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 128.974 2.91 . . . . 0.0 113.18 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.88 -40.96 87.95 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.651 1.181 . . . . 0.0 108.951 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 26.7 mm -119.93 139.27 47.79 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 CA-C-O 121.163 0.506 . . . . 0.0 109.717 170.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -144.66 106.5 4.29 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 102.16 -3.274 . . . . 0.0 102.16 166.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -132.84 168.21 18.81 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 175.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -139.67 111.66 7.45 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 171.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -92.13 65.65 4.76 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -33.19 -52.07 0.35 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.52 1.928 . . . . 0.0 111.773 177.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 40.1 -170.56 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 129.851 3.261 . . . . 0.0 114.371 -175.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.56 175.61 1.02 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 122.79 1.281 . . . . 0.0 111.887 170.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -127.28 103.83 22.63 Favored Pre-proline 0 C--N 1.321 -0.657 0 C-N-CA 128.232 2.613 . . . . 0.0 107.418 -170.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.3 -4.2 14.49 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.648 2.232 . . . . 0.0 112.602 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.3 t0 20.13 -95.06 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.784 2.834 . . . . 0.0 113.791 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.67 40.39 1.55 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 127.141 2.305 . . . . 0.0 109.151 169.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -75.16 179.01 5.31 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.722 1.609 . . . . 0.0 113.098 -170.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.3 p -62.35 157.38 19.99 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 113.148 -1.842 . . . . 0.0 109.634 171.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 21.7 mt -57.68 -30.42 65.44 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.602 176.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.34 -41.3 98.46 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 118.695 -0.669 . . . . 0.0 111.099 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.2 t -71.78 -40.81 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 117.705 -1.141 . . . . 0.0 109.238 178.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -50.7 -51.42 49.74 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.909 1.232 . . . . 0.0 111.725 169.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -59.05 -45.52 90.57 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.025 0.829 . . . . 0.0 110.931 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.7 m -68.09 -43.01 79.5 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -174.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.9 t -64.83 -49.75 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -175.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -48.08 -56.12 8.55 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.963 1.305 . . . . 0.0 111.017 173.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.09 -41.73 99.72 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 119.111 0.869 . . . . 0.0 111.519 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -66.78 -37.77 85.24 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.205 -1.173 . . . . 0.0 110.532 -178.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.4 t -62.87 -42.71 97.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 173.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -35.95 75.59 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 119.819 1.191 . . . . 0.0 111.352 -174.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -69.01 -43.08 75.52 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.512 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -64.18 -41.66 97.02 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.923 1.238 . . . . 0.0 110.559 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.7 t -54.23 -54.35 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 173.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -64.93 -32.65 74.47 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 122.012 -0.43 . . . . 0.0 111.599 -174.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -62.34 -48.25 80.65 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 123.368 0.667 . . . . 0.0 111.363 171.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -48.35 75.09 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 118.56 0.618 . . . . 0.0 109.562 175.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.7 mt -58.09 -42.19 82.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 123.804 0.842 . . . . 0.0 109.287 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.93 -31.43 71.75 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.797 0.726 . . . . 0.0 111.74 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -72.3 -42.77 65.1 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.554 173.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.2 pt -103.28 -46.2 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 118.607 2.817 . . . . 0.0 118.607 -168.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.5 m . . . . . 0 C--O 1.253 1.247 0 C-N-CA 124.06 0.944 . . . . 0.0 111.883 -169.177 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.9 mmm . . . . . 0 N--CA 1.501 2.084 0 N-CA-C 111.483 0.179 . . . . 0.0 111.483 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.538 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -58.44 132.57 54.11 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 172.337 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 53.1 mtpt -99.05 138.85 35.56 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -172.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.1 t -134.11 153.66 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 123.005 0.522 . . . . 0.0 109.716 -171.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.4 tpp -139.53 147.95 41.93 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.627 0.771 . . . . 0.0 109.792 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -132.1 112.21 12.13 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.46 1.504 . . . . 0.0 107.611 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.1 t -97.1 137.42 24.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -172.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 m -120.08 146.59 45.78 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -169.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -150.75 164.71 35.52 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.465 1.906 . . . . 0.0 108.602 174.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.75 -146.1 0.58 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.668 1.587 . . . . 0.0 108.589 -169.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -65.55 99.37 0.43 Allowed 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 173.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.7 m -64.36 -4.01 3.45 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 68.4 m -48.0 -38.65 17.53 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 119.309 0.959 . . . . 0.0 113.062 169.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -62.91 -41.08 99.32 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 120.051 1.296 . . . . 0.0 111.909 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.41 -37.07 12.78 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.766 0.826 . . . . 0.0 109.613 -169.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -66.84 -31.15 71.58 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.102 -0.998 . . . . 0.0 110.127 169.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.438 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.9 tpt -62.88 -37.44 86.9 Favored 'General case' 0 CA--C 1.51 -0.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.448 171.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.99 90.5 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -64.84 -38.04 89.64 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.153 169.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.9 -42.32 96.99 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 120.931 1.696 . . . . 0.0 111.811 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -66.73 -37.44 84.68 Favored 'General case' 0 C--O 1.222 -0.356 0 O-C-N 121.861 -0.788 . . . . 0.0 109.296 170.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.05 -35.19 69.25 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 119.539 1.063 . . . . 0.0 111.652 -175.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -66.93 -34.39 77.66 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 121.382 1.901 . . . . 0.0 111.425 171.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.2 m -69.39 -50.61 44.4 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.509 1.524 . . . . 0.0 110.343 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.0 mt -91.83 -25.55 18.93 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.079 1.352 . . . . 0.0 111.905 -169.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.97 8.72 76.09 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 126.675 2.083 . . . . 0.0 112.195 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.51 121.88 13.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.393 1.077 . . . . 0.0 110.064 -170.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.91 9.93 85.12 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 119.975 -0.347 . . . . 0.0 113.477 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -122.18 -36.8 2.91 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 125.947 1.699 . . . . 0.0 109.192 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.9 pt -138.44 162.96 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.873 1.269 . . . . 0.0 108.987 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.44 132.78 53.81 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 169.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.41 140.65 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 119.745 1.157 . . . . 0.0 113.308 -168.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.4 m -142.58 166.94 23.3 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.51 1.524 . . . . 0.0 109.903 -169.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.8 p -136.69 158.83 43.54 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.721 1.208 . . . . 0.0 110.069 176.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.434 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 27.5 p -151.81 158.66 43.58 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 122.83 0.452 . . . . 0.0 110.479 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.03 144.59 1.07 Allowed Glycine 0 CA--C 1.532 1.112 0 N-CA-C 106.857 -2.497 . . . . 0.0 106.857 -168.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.8 tp -163.04 61.29 0.19 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 102.751 -3.055 . . . . 0.0 102.751 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -60.8 -15.44 29.88 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.953 1.301 . . . . 0.0 113.828 -168.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 p -78.04 8.48 4.72 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.247 1.019 . . . . 0.0 113.586 173.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.6 m 59.68 -13.22 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 129.782 3.233 . . . . 0.0 115.425 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.22 170.49 22.37 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.858 2.463 . . . . 0.0 106.602 176.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.5 m -73.36 173.37 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 169.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -128.73 111.11 18.89 Favored Pre-proline 0 C--O 1.233 0.194 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -171.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -51.54 -30.44 35.82 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.855 3.037 . . . . 0.0 114.913 -174.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -60.42 -39.13 86.32 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.995 0.816 . . . . 0.0 110.964 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.72 -44.85 76.65 Favored 'General case' 0 CA--C 1.513 -0.444 0 O-C-N 121.448 -0.782 . . . . 0.0 109.062 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.02 -44.39 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.45 -43.91 96.37 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.507 0.594 . . . . 0.0 111.525 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.8 mmt -65.67 -18.74 65.55 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 118.879 -0.582 . . . . 0.0 112.3 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.438 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.8 OUTLIER -96.4 -31.64 12.75 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -178.138 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -63.08 -33.4 75.36 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.166 1.386 . . . . 0.0 110.003 169.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -58.49 -15.97 13.29 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.114 1.766 . . . . 0.0 111.845 172.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.4 m -130.62 12.84 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 126.156 1.783 . . . . 0.0 111.683 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.4 42.84 80.86 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 121.173 -0.955 . . . . 0.0 113.772 175.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.3 mt -124.69 155.27 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.81 1.644 . . . . 0.0 107.73 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -123.84 125.55 44.87 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.826 1.25 . . . . 0.0 108.296 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.9 pt -128.53 9.99 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.51 1.124 . . . . 0.0 112.339 173.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.65 -30.47 41.28 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.521 1.528 . . . . 0.0 111.935 174.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.43 -12.87 73.61 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 118.097 0.408 . . . . 0.0 112.679 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -76.86 153.0 35.22 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.773 1.229 . . . . 0.0 109.654 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.7 p -150.47 168.74 23.29 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.4 m -64.19 138.56 58.5 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.851 1.661 . . . . 0.0 111.393 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -163.1 123.25 1.42 Allowed Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 169.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -75.83 150.55 34.84 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.573 2.182 . . . . 0.0 113.315 -168.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.7 tt -55.96 -35.62 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.702 1.601 . . . . 0.0 111.395 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -68.75 -21.58 64.36 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.204 0.601 . . . . 0.0 112.177 -174.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.2 -10.55 57.62 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.336 0.654 . . . . 0.0 111.999 173.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.434 ' CE2' ' HB3' ' A' ' 35' ' ' CYS . 67.0 m-85 -92.69 168.49 11.18 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.908 0.861 . . . . 0.0 110.418 176.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -145.79 89.86 1.94 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 -171.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.45 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -51.47 -24.73 5.39 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -20.64 8.73 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.02 0.528 . . . . 0.0 111.528 173.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -107.02 13.76 27.17 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.383 1.873 . . . . 0.0 112.374 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 38.6 m-85 -135.24 108.85 7.95 Favored 'General case' 0 CA--C 1.516 -0.332 0 O-C-N 120.805 -1.184 . . . . 0.0 108.578 172.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.77 -16.05 36.27 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -170.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.9 t -144.85 121.31 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 -170.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.66 132.13 64.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 O-C-N 120.521 -1.362 . . . . 0.0 108.85 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.0 mm -125.68 96.93 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 -171.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.6 t -72.31 164.68 25.89 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 169.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mp -142.69 38.04 1.48 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 170.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 76.9 m -96.2 4.4 52.45 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.566 1.147 . . . . 0.0 111.291 -169.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.77 20.9 17.66 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 111.329 -0.709 . . . . 0.0 111.329 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.434 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 5.2 t 46.33 39.94 7.06 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.104 1.762 . . . . 0.0 112.314 -176.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -150.23 33.46 1.02 Allowed Glycine 0 C--N 1.339 0.7 0 C-N-CA 123.754 0.692 . . . . 0.0 111.795 -172.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.9 t -121.85 136.58 58.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 125.183 1.393 . . . . 0.0 107.652 177.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -82.35 67.59 8.44 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.182 0.993 . . . . 0.0 109.836 -172.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.8 mt -58.6 142.3 83.2 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -53.14 154.06 14.76 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.758 2.306 . . . . 0.0 111.63 171.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.19 -19.15 56.83 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 121.646 1.564 . . . . 0.0 114.403 -170.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.81 -26.95 68.86 Favored 'General case' 0 C--O 1.225 -0.233 0 O-C-N 121.205 -0.934 . . . . 0.0 110.983 175.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.45 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 71.8 m95 -68.08 -4.82 14.78 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.089 -1.007 . . . . 0.0 112.651 174.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -108.61 -28.96 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 120.04 1.291 . . . . 0.0 111.025 -174.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.5 p -76.91 -16.58 59.34 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.574 0.954 . . . . 0.0 113.574 -169.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -52.88 161.04 0.83 Allowed 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 129.354 3.062 . . . . 0.0 113.949 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -62.17 -38.96 91.03 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.084 1.354 . . . . 0.0 108.754 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 33.5 mm -126.17 138.01 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 169.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -139.67 112.26 7.84 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 101.359 -3.571 . . . . 0.0 101.359 167.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -135.16 167.78 20.36 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.434 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 9.7 t70 -139.33 104.69 5.04 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 171.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -83.73 77.99 9.78 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -54.54 41.79 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 131.6 3.96 . . . . 0.0 113.796 171.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.63 -176.6 3.33 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.961 1.304 . . . . 0.0 112.637 -168.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -51.43 169.09 0.06 Allowed 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 127.477 2.311 . . . . 0.0 112.529 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -127.21 107.92 21.55 Favored Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 125.975 1.71 . . . . 0.0 108.558 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -82.31 -2.1 10.99 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.044 1.83 . . . . 0.0 112.985 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.3 t0 20.06 -91.85 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 128.869 2.868 . . . . 0.0 114.408 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.95 42.11 1.36 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 126.015 1.769 . . . . 0.0 110.532 172.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -78.31 -176.8 4.86 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.26 1.424 . . . . 0.0 113.297 -171.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.7 p -64.15 162.79 13.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 113.859 -1.519 . . . . 0.0 110.269 173.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.1 mt -55.68 -33.91 64.57 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 122.819 0.448 . . . . 0.0 110.542 175.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -62.64 -38.11 88.98 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.774 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.3 t -73.98 -45.1 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 119.515 1.052 . . . . 0.0 108.777 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -52.01 -38.0 55.32 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.765 1.166 . . . . 0.0 112.832 172.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -68.99 -46.3 68.41 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 119.778 1.172 . . . . 0.0 112.188 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.5 m -71.69 -42.46 67.38 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 119.342 -0.361 . . . . 0.0 110.357 -169.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.8 t -67.82 -44.52 85.45 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -173.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -47.16 -53.27 13.41 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 124.853 1.261 . . . . 0.0 110.386 169.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.86 -45.39 96.29 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 119.325 0.966 . . . . 0.0 111.538 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -66.29 -36.9 84.15 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 121.683 -0.892 . . . . 0.0 111.418 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.8 t -62.66 -43.31 98.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 174.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -36.13 78.32 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 119.781 1.173 . . . . 0.0 111.56 -174.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -68.14 -42.34 80.27 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.432 -0.794 . . . . 0.0 110.131 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -63.07 -43.57 98.2 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.748 1.158 . . . . 0.0 110.431 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 75.9 t -54.81 -52.55 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 123.607 0.763 . . . . 0.0 109.582 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -66.77 -32.65 74.08 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 121.862 -0.524 . . . . 0.0 111.503 -175.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -62.3 -48.34 80.32 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 123.239 0.616 . . . . 0.0 111.22 171.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.93 -46.6 78.45 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.361 0.528 . . . . 0.0 110.13 176.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.4 mt -58.38 -43.64 86.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 124.34 1.056 . . . . 0.0 109.779 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.88 -29.81 69.78 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.3 0.955 . . . . 0.0 111.894 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -72.13 -39.61 68.7 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.573 0.624 . . . . 0.0 111.509 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.9 pt -103.35 -48.71 10.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 116.703 2.112 . . . . 0.0 116.703 -168.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 40.6 m . . . . . 0 C--O 1.252 1.232 0 C-N-CA 124.308 1.043 . . . . 0.0 110.653 -170.264 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 tpt . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 118.518 -0.753 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.437 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -60.32 118.4 6.38 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 120.98 1.718 . . . . 0.0 108.541 -173.508 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.0 mtpt -90.58 134.24 34.52 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -169.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.0 t -116.01 155.32 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.07 140.54 43.86 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -125.63 120.37 30.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 177.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.1 t -118.72 112.49 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 118.736 0.698 . . . . 0.0 110.404 -168.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.6 171.79 13.67 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.801 1.286 . . . . 0.0 113.616 -174.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -152.36 130.99 12.3 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 100.779 -3.785 . . . . 0.0 100.779 168.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.415 ' CG ' ' H ' ' A' ' 11' ' ' ASN . 27.2 ttm180 63.47 176.53 0.16 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.755 1.161 . . . . 0.0 109.955 -169.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.415 ' H ' ' CG ' ' A' ' 10' ' ' ARG . 33.6 t-20 -40.57 137.2 1.17 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.138 2.175 . . . . 0.0 113.652 -169.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.9 m -52.41 -20.4 2.8 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 129.856 3.262 . . . . 0.0 115.417 -171.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.9 m -59.44 -5.34 0.77 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.946 2.098 . . . . 0.0 114.802 -171.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.291 31.5 ptt180 -111.41 -61.3 1.72 Allowed 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 116.801 -1.571 . . . . 0.0 111.079 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.7 p -74.97 -44.6 47.44 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 122.688 2.495 . . . . 0.0 111.316 -175.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.29 2.0 mt-30 -75.65 -24.75 56.41 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -172.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.463 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.2 tpt -65.79 -41.89 91.39 Favored 'General case' 0 C--O 1.222 -0.363 0 O-C-N 121.003 -1.061 . . . . 0.0 108.19 167.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.54 -36.77 79.26 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.745 -0.597 . . . . 0.0 109.602 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -63.25 -39.1 93.64 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 118.378 -0.82 . . . . 0.0 110.823 169.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.38 -45.15 94.15 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 120.5 1.5 . . . . 0.0 111.115 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -65.55 -38.29 89.18 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 173.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.45 -37.63 68.5 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 119.758 1.163 . . . . 0.0 110.929 -173.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -71.08 -19.73 62.44 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 120.214 1.37 . . . . 0.0 112.065 174.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.3 m -82.02 -51.05 8.42 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.845 1.658 . . . . 0.0 109.56 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.2 mt -89.42 -25.73 21.36 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.334 1.454 . . . . 0.0 112.176 -169.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.76 13.75 56.32 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.885 2.183 . . . . 0.0 111.846 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.28 122.02 14.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.675 1.19 . . . . 0.0 109.723 -173.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.12 8.44 87.84 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.66 -0.522 . . . . 0.0 113.626 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -123.22 -31.69 3.54 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.506 1.522 . . . . 0.0 109.001 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.7 pt -141.37 173.37 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 125.457 1.503 . . . . 0.0 109.598 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.42 144.08 43.88 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 103.879 -2.638 . . . . 0.0 103.879 168.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 t -133.33 139.94 48.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 123.279 0.631 . . . . 0.0 110.283 -168.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.14 158.59 44.16 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.836 1.254 . . . . 0.0 109.254 -173.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 63.8 p -155.46 165.99 34.9 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 120.016 1.28 . . . . 0.0 113.257 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.3 p -154.61 166.45 33.32 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.164 1.386 . . . . 0.0 109.197 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.31 53.92 1.79 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 39' ' ' SER . 8.3 tp -88.51 68.69 8.82 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 102.029 -3.322 . . . . 0.0 102.029 -176.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.17 -1.12 0.64 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.86 1.264 . . . . 0.0 111.813 -169.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 37' ' ' LEU . 5.5 p -88.38 7.1 34.17 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.407 1.483 . . . . 0.0 112.82 177.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.6 m 62.08 -29.33 0.07 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 130.063 3.345 . . . . 0.0 114.746 -175.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -132.75 -178.13 4.81 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 128.145 2.578 . . . . 0.0 104.776 169.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.8 m -61.71 158.67 2.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 O-C-N 120.623 -1.298 . . . . 0.0 109.454 171.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -113.12 106.6 54.77 Favored Pre-proline 0 N--CA 1.446 -0.665 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -170.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -63.87 -29.25 67.55 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.264 2.643 . . . . 0.0 111.83 -169.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.2 m -64.51 -37.41 87.45 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.743 0.701 . . . . 0.0 109.213 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.24 -44.43 83.78 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.26 -46.58 85.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 CA-C-O 118.632 -0.699 . . . . 0.0 109.135 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.41 -43.96 97.56 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.859 0.754 . . . . 0.0 111.101 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.0 mmt -60.05 -26.16 65.91 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 118.76 -0.638 . . . . 0.0 111.6 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.463 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -94.09 -27.0 16.5 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -177.132 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -64.34 -30.74 71.78 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.93 1.292 . . . . 0.0 110.067 169.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.43 -21.75 38.8 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.297 0.639 . . . . 0.0 112.002 171.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.0 m -123.61 9.53 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 125.75 1.62 . . . . 0.0 111.138 -177.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.81 40.94 74.84 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.372 0.987 . . . . 0.0 113.007 174.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.7 mt -122.94 152.39 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.542 1.537 . . . . 0.0 108.077 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -118.55 122.13 41.9 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.924 1.29 . . . . 0.0 108.677 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 43.8 pt -127.02 12.91 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 124.271 1.028 . . . . 0.0 111.481 169.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.58 -25.0 45.18 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.23 1.812 . . . . 0.0 112.459 172.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.6 -8.06 85.93 Favored Glycine 0 CA--C 1.537 1.423 0 CA-C-N 118.603 0.638 . . . . 0.0 112.946 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -76.56 166.77 22.93 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.776 1.23 . . . . 0.0 111.557 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.6 p -144.86 -177.95 5.78 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.813 1.645 . . . . 0.0 109.949 174.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.98 173.32 6.41 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.206 1.002 . . . . 0.0 109.615 170.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.28 146.37 7.15 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 169.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.64 141.94 97.96 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.706 2.271 . . . . 0.0 111.834 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.5 tt -59.93 -37.73 73.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 123.491 0.716 . . . . 0.0 110.718 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -73.04 -18.38 61.34 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.416 0.686 . . . . 0.0 112.336 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.05 -25.58 61.85 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 118.939 -0.553 . . . . 0.0 111.274 170.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -79.11 170.51 16.56 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 122.191 0.996 . . . . 0.0 111.318 -172.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.44 68.75 1.39 Allowed 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 125.827 1.651 . . . . 0.0 106.891 -177.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.406 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -51.3 -24.21 4.36 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 124.524 1.129 . . . . 0.0 113.749 -178.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -44.1 -41.27 5.48 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.005 0.922 . . . . 0.0 110.794 172.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.37 -14.74 58.08 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.746 1.218 . . . . 0.0 113.842 -175.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -105.72 112.73 25.92 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 119.64 1.109 . . . . 0.0 108.405 -173.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -65.51 -12.14 49.99 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -168.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.3 t -146.56 124.31 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 -171.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.1 t -123.13 130.76 74.18 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.2 mm -124.42 92.65 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 173.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.9 t -76.85 166.85 22.79 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 169.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mp -140.76 32.18 1.82 Allowed 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.185 -1.572 . . . . 0.0 108.025 174.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 92.5 m -76.99 -3.71 40.36 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.203 1.001 . . . . 0.0 111.707 -177.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.19 35.49 3.63 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 119.572 1.078 . . . . 0.0 111.084 172.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 32.0 p 35.88 45.03 0.26 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 128.02 2.528 . . . . 0.0 114.216 -175.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.73 47.4 0.48 Allowed Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -173.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.2 p -125.72 159.11 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 126.102 1.761 . . . . 0.0 109.786 -171.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -118.09 56.35 0.86 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.785 1.234 . . . . 0.0 108.745 -174.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.6 mt -59.33 143.9 84.59 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.36 151.49 22.98 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.198 1.932 . . . . 0.0 111.95 171.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -55.86 -27.57 63.42 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.194 1.93 . . . . 0.0 115.541 -173.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.41 -21.14 66.21 Favored 'General case' 0 N--CA 1.456 -0.175 0 O-C-N 121.009 -1.057 . . . . 0.0 112.361 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.406 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 73.4 m95 -73.65 -17.89 61.1 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 117.952 -1.023 . . . . 0.0 112.659 175.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.8 m -110.77 -13.54 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 120.064 1.302 . . . . 0.0 113.461 -169.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.4 p -83.26 -8.11 59.5 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.367 1.067 . . . . 0.0 113.255 -173.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -64.96 173.04 2.52 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 130.054 3.341 . . . . 0.0 113.569 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -67.45 -41.47 84.64 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 16.8 mm -120.25 136.9 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 169.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -143.45 111.82 6.31 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 103.03 -2.952 . . . . 0.0 103.03 166.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -136.63 164.64 27.74 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -132.59 102.17 5.6 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 169.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.3 m0 -76.94 89.06 3.5 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.6 33.99 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 128.508 2.723 . . . . 0.0 113.827 173.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.26 178.39 1.94 Allowed 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.086 -1.009 . . . . 0.0 112.832 -169.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -52.51 164.91 0.29 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 126.26 1.824 . . . . 0.0 112.525 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -120.9 102.74 43.86 Favored Pre-proline 0 C--N 1.325 -0.478 0 C-N-CA 127.278 2.231 . . . . 0.0 108.163 -175.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -82.13 -1.93 10.99 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.769 2.313 . . . . 0.0 112.592 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.4 t0 26.42 -99.04 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 128.372 2.669 . . . . 0.0 113.533 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.86 38.99 1.74 Allowed Glycine 0 CA--C 1.532 1.151 0 C-N-CA 127.278 2.371 . . . . 0.0 109.285 169.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -70.18 -176.99 1.28 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.413 1.885 . . . . 0.0 112.937 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.9 m -63.6 156.66 25.99 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.235 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.1 mt -56.35 -31.16 63.49 Favored 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 123.129 0.572 . . . . 0.0 110.933 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.62 -41.15 97.06 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 118.528 0.604 . . . . 0.0 110.768 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 40.1 t -72.85 -42.12 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 117.284 -1.341 . . . . 0.0 109.061 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -48.42 -49.47 34.96 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 120.318 1.417 . . . . 0.0 111.379 169.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -60.16 -44.11 95.26 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.976 0.807 . . . . 0.0 111.055 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 87.3 m -68.95 -43.83 74.23 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 118.885 -0.579 . . . . 0.0 109.486 -173.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 42.0 t -68.43 -46.71 80.03 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -174.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -45.45 -55.74 5.79 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.864 1.266 . . . . 0.0 110.97 169.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.71 -43.03 98.41 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 119.321 0.964 . . . . 0.0 111.525 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -63.27 -37.44 87.26 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.381 1.09 . . . . 0.0 111.394 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 37.4 t -62.96 -41.41 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 118.067 -0.968 . . . . 0.0 109.033 173.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.14 -37.56 74.89 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 120.009 1.277 . . . . 0.0 111.029 -177.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -68.88 -43.3 75.57 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.208 0.603 . . . . 0.0 110.585 177.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -68.17 -42.43 80.02 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.415 1.007 . . . . 0.0 110.392 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.1 t -53.54 -53.54 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 124.007 0.923 . . . . 0.0 108.988 171.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.77 -33.01 74.98 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.954 -0.466 . . . . 0.0 111.815 -175.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -62.62 -47.98 81.41 Favored 'General case' 0 C--O 1.227 -0.084 0 C-N-CA 122.934 0.494 . . . . 0.0 111.284 171.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.86 -47.24 77.65 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.11 0.564 . . . . 0.0 109.552 176.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.2 mt -58.25 -42.91 84.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 124.292 1.037 . . . . 0.0 110.147 176.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.43 -29.45 69.01 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.609 0.64 . . . . 0.0 111.864 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -74.12 -40.43 62.67 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 118.594 0.633 . . . . 0.0 111.814 175.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.3 pt -101.55 -42.4 9.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 117.251 2.315 . . . . 0.0 117.251 -168.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 C--O 1.254 1.335 0 CA-C-N 119.05 0.841 . . . . 0.0 110.394 -171.967 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.1 mmm . . . . . 0 N--CA 1.5 2.054 0 CA-C-O 119.972 -0.061 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.523 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -58.97 136.33 57.89 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 171.172 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.8 mtpt -109.18 145.89 35.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 119.638 1.108 . . . . 0.0 108.357 -171.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.2 t -127.21 153.9 36.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 123.693 0.797 . . . . 0.0 108.896 -174.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 59.6 tpp -135.87 138.47 42.51 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -124.56 106.69 10.34 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.0 t -84.39 122.48 38.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -172.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 86.5 m -68.77 156.78 37.7 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.282 2.233 . . . . 0.0 111.279 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -144.32 -125.17 0.08 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 169.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.59 115.24 1.27 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.078 1.351 . . . . 0.0 112.009 -169.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.9 t30 45.59 26.86 0.36 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.897 2.079 . . . . 0.0 113.973 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.2 m 56.94 -22.34 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 119.106 3.002 . . . . 0.0 119.106 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 85.2 m -48.78 -55.72 10.72 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 125.69 1.596 . . . . 0.0 113.348 -168.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -58.77 -47.03 86.09 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.334 0.97 . . . . 0.0 112.329 -169.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.77 -31.81 19.44 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.709 -0.619 . . . . 0.0 111.138 -170.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.48 HE22 ' CG2' ' A' ' 42' ' ' VAL . 4.8 pt20 -65.62 -36.47 83.81 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 172.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.456 ' SD ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -63.09 -39.75 95.63 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 120.703 -1.248 . . . . 0.0 110.109 172.451 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.39 -36.1 75.16 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.757 -0.589 . . . . 0.0 110.698 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -64.69 -38.84 92.35 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.802 -0.618 . . . . 0.0 111.104 169.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.92 -43.9 92.84 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 120.491 1.496 . . . . 0.0 110.86 -178.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.456 ' CD2' ' SD ' ' A' ' 17' ' ' MET . 5.0 m-85 -64.81 -40.52 95.35 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 118.68 1.24 . . . . 0.0 109.428 171.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.88 -37.11 75.94 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 119.661 1.119 . . . . 0.0 111.104 -173.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -74.1 -25.14 59.62 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 120.142 1.337 . . . . 0.0 111.922 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 m -72.36 -50.8 23.97 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.173 1.389 . . . . 0.0 110.166 173.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.0 mt -87.86 -26.66 22.67 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 124.617 1.167 . . . . 0.0 112.647 -169.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.55 14.01 59.4 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 126.45 1.976 . . . . 0.0 111.602 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.23 125.18 22.8 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.227 1.411 . . . . 0.0 109.41 -172.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.68 8.42 87.2 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-O 119.732 -0.482 . . . . 0.0 113.647 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -125.47 -44.32 1.85 Allowed 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 125.161 1.385 . . . . 0.0 108.69 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.7 pp -140.25 150.27 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.463 1.105 . . . . 0.0 109.782 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.71 152.28 20.27 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 t -142.5 137.57 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 118.393 0.542 . . . . 0.0 111.061 -168.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.7 m -143.21 165.51 27.24 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.19 1.396 . . . . 0.0 109.524 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.9 p -141.48 156.27 45.76 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.929 1.292 . . . . 0.0 108.698 175.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 29.6 p -159.73 173.39 16.11 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.001 0.818 . . . . 0.0 112.201 -173.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.51 34.92 63.14 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.2 mp -61.76 122.54 15.61 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -75.46 3.14 9.8 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 169.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 p -145.24 67.47 1.23 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -175.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.8 m -64.93 60.62 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.847 2.459 . . . . 0.0 111.427 173.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.96 -20.15 0.05 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 129.277 3.031 . . . . 0.0 110.517 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.48 ' CG2' HE22 ' A' ' 16' ' ' GLN . 0.5 OUTLIER 72.88 171.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 127.245 2.218 . . . . 0.0 109.123 -172.615 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -137.22 117.08 10.45 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -172.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -69.24 -25.98 30.49 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.537 2.825 . . . . 0.0 113.179 -169.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.0 m -62.19 -36.21 81.21 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.177 0.899 . . . . 0.0 109.153 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.98 -41.89 90.58 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -58.59 -49.89 80.89 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 CA-C-O 118.312 -0.852 . . . . 0.0 108.874 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.5 -43.81 96.65 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 119.362 0.983 . . . . 0.0 110.916 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.7 mmt -64.51 -17.12 63.59 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.867 0.867 . . . . 0.0 112.723 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 3.4 mmt -97.99 -26.95 14.46 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 119.457 1.026 . . . . 0.0 110.656 173.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -65.0 -27.66 68.98 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.976 0.91 . . . . 0.0 110.164 172.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -56.37 -25.3 49.04 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.187 0.995 . . . . 0.0 112.603 169.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.1 m -127.24 14.56 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.468 1.507 . . . . 0.0 111.211 -171.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.1 39.11 84.06 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.941 0.782 . . . . 0.0 112.717 174.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.3 mt -126.99 156.65 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -136.85 143.35 43.03 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.39 1.076 . . . . 0.0 109.033 175.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.7 pt -140.59 15.83 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 126.778 2.031 . . . . 0.0 111.288 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.6 p -69.87 -40.91 75.43 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 120.767 -1.208 . . . . 0.0 112.414 173.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.18 8.05 41.28 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 123.819 0.723 . . . . 0.0 113.075 -177.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -73.96 -176.54 2.53 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.561 1.145 . . . . 0.0 112.132 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -69.3 170.27 10.62 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.533 1.933 . . . . 0.0 112.758 -170.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.4 m -159.16 57.18 0.41 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 104.042 -2.577 . . . . 0.0 104.042 171.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -143.38 147.96 42.15 Favored Pre-proline 0 C--N 1.345 0.389 0 C-N-CA 123.166 0.586 . . . . 0.0 110.351 -167.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -82.82 159.5 16.13 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.397 2.732 . . . . 0.0 112.438 -174.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.2 tt -58.75 -34.77 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.056 1.342 . . . . 0.0 111.371 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -69.16 -22.52 63.92 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.19 0.596 . . . . 0.0 112.309 -174.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -13.85 59.54 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 119.103 -0.475 . . . . 0.0 111.741 172.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -98.98 172.18 7.57 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.212 1.005 . . . . 0.0 110.789 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.71 99.06 3.06 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 125.21 1.404 . . . . 0.0 107.774 -178.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.83 -23.53 1.93 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 171.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -51.36 -25.69 6.45 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.885 0.874 . . . . 0.0 111.524 173.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -107.1 15.28 25.38 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.72 1.208 . . . . 0.0 113.491 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -134.88 111.07 9.58 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 120.243 1.383 . . . . 0.0 109.16 173.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.29 -17.28 52.86 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 124.643 1.177 . . . . 0.0 113.422 -169.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.6 t -143.09 130.44 18.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 -170.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.3 t -135.96 131.84 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 -169.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.3 mm -133.83 100.62 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 103.031 -2.951 . . . . 0.0 103.031 -172.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.476 ' C ' ' H ' ' A' ' 80' ' ' CYS . 6.3 m -111.29 85.56 2.15 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 121.853 -0.529 . . . . 0.0 111.034 -168.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.9 mp -73.12 25.51 0.06 Allowed 'General case' 0 C--N 1.343 0.291 0 C-N-CA 127.969 2.508 . . . . 0.0 110.547 -174.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.476 ' H ' ' C ' ' A' ' 78' ' ' SER . 4.4 m -64.12 1.02 0.78 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.89 2.076 . . . . 0.0 111.411 170.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.22 26.4 28.48 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 118.742 0.701 . . . . 0.0 111.658 174.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 49.91 20.09 0.53 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.761 2.025 . . . . 0.0 114.771 -175.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -109.46 24.53 20.0 Favored Glycine 0 C--N 1.338 0.658 0 C-N-CA 124.43 1.014 . . . . 0.0 111.213 -176.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.1 t -132.29 121.43 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -174.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.32 -40.45 85.96 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.806 0.842 . . . . 0.0 110.893 -177.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.1 mt 64.48 152.63 0.12 Allowed Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 127.921 2.488 . . . . 0.0 112.64 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.04 151.45 50.1 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 121.926 1.75 . . . . 0.0 110.219 169.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.4 -19.61 55.31 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.634 1.556 . . . . 0.0 114.436 -169.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -64.52 -26.51 68.45 Favored 'General case' 0 C--O 1.224 -0.246 0 O-C-N 121.019 -1.051 . . . . 0.0 110.879 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -67.63 -8.61 36.09 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.197 -0.939 . . . . 0.0 112.622 175.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.4 t -108.68 -30.09 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.968 1.307 . . . . 0.0 111.105 -171.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.5 p -75.37 -17.25 60.27 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.21 1.004 . . . . 0.0 113.483 -169.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -51.67 160.68 0.61 Allowed 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 129.403 3.081 . . . . 0.0 114.033 176.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -62.47 -38.9 91.63 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.608 1.563 . . . . 0.0 108.762 177.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 30.5 mm -125.02 135.44 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 169.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -136.57 104.88 5.7 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 101.758 -3.423 . . . . 0.0 101.758 166.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -128.27 177.57 6.85 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 125.62 1.568 . . . . 0.0 106.901 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.24 -56.9 1.42 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -174.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 24.1 m0 56.02 65.7 1.38 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.072 0.949 . . . . 0.0 110.662 -169.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -56.39 46.28 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 130.274 3.429 . . . . 0.0 113.54 169.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.81 -177.65 2.03 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.615 -1.303 . . . . 0.0 113.422 -168.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -55.88 168.86 0.41 Allowed 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 127.253 2.221 . . . . 0.0 112.323 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -115.04 102.99 54.95 Favored Pre-proline 0 C--N 1.323 -0.566 0 C-N-CA 126.272 1.829 . . . . 0.0 109.243 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -83.75 -4.37 10.66 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.577 2.185 . . . . 0.0 112.814 175.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.7 t0 25.18 -101.27 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 128.246 2.618 . . . . 0.0 113.025 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -136.88 42.3 1.33 Allowed Glycine 0 CA--C 1.533 1.16 0 C-N-CA 128.188 2.804 . . . . 0.0 107.11 169.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -68.91 -174.48 0.6 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.619 1.968 . . . . 0.0 112.069 -174.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.5 p -57.39 152.84 13.58 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.962 -1.472 . . . . 0.0 108.433 169.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.1 mt -59.14 -30.37 68.1 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.625 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -61.41 -41.25 96.86 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 119.001 -0.523 . . . . 0.0 110.791 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.17 -42.28 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 117.647 -1.168 . . . . 0.0 109.305 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -50.35 -49.4 54.19 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.276 1.398 . . . . 0.0 111.765 171.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -59.05 -44.18 91.76 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.694 0.679 . . . . 0.0 111.36 176.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 91.7 m -68.48 -45.6 71.97 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -173.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.6 t -67.41 -47.59 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -173.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -43.43 -54.5 4.72 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.93 1.292 . . . . 0.0 110.665 169.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.87 -43.43 98.93 Favored Glycine 0 CA--C 1.522 0.503 0 CA-C-N 119.844 1.202 . . . . 0.0 112.065 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -67.91 -34.38 76.51 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 120.797 -1.413 . . . . 0.0 111.398 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.59 -42.23 93.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 170.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -43.52 85.35 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.995 1.27 . . . . 0.0 110.258 -174.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -66.44 -43.78 84.68 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 119.1 -0.476 . . . . 0.0 110.038 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -64.97 -42.42 94.6 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.136 0.88 . . . . 0.0 110.944 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 52.9 t -56.66 -52.29 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -64.95 -32.89 74.83 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 121.846 -0.534 . . . . 0.0 111.667 -175.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -62.84 -46.66 86.9 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 123.58 0.752 . . . . 0.0 111.15 172.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.84 -46.68 84.42 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 122.807 0.443 . . . . 0.0 110.101 175.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.5 mt -58.75 -41.8 83.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 123.918 0.887 . . . . 0.0 110.233 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.31 -28.87 68.47 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.216 0.916 . . . . 0.0 111.637 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -75.2 -40.73 58.99 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.538 0.608 . . . . 0.0 111.85 176.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.4 pt -101.85 -35.89 4.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 116.496 2.035 . . . . 0.0 116.496 -168.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 C--O 1.255 1.365 0 C-N-CA 124.438 1.095 . . . . 0.0 111.608 -170.269 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 tpt . . . . . 0 N--CA 1.5 2.034 0 CA-C-O 118.594 -0.717 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.46 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -60.79 120.54 10.32 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 120.895 1.679 . . . . 0.0 108.39 -174.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -93.37 134.64 35.38 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -170.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.6 t -116.6 154.81 18.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 53.6 tpp -136.03 136.17 40.05 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -118.53 106.63 12.85 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.7 t -91.06 119.43 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -170.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.9 m -91.61 162.33 14.56 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.947 0.499 . . . . 0.0 111.52 -173.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -160.13 151.42 19.48 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.535 1.934 . . . . 0.0 106.258 169.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.46 -165.16 0.2 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.484 1.113 . . . . 0.0 109.527 -169.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.536 HD22 ' CG ' ' A' ' 43' ' ' HIS . 51.9 t-20 -61.5 109.02 1.06 Allowed 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.3 m -61.41 2.53 0.15 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 -168.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 35.4 m -44.51 -47.62 10.11 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 120.099 1.318 . . . . 0.0 111.854 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -63.66 -39.46 94.4 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 118.992 0.815 . . . . 0.0 112.654 -175.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.27 -40.4 10.0 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.989 1.316 . . . . 0.0 111.298 -169.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -65.67 -34.58 78.54 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.551 -0.718 . . . . 0.0 109.908 170.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.446 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.3 tpt -62.9 -39.87 95.85 Favored 'General case' 0 CA--C 1.512 -0.506 0 O-C-N 121.238 -0.914 . . . . 0.0 110.135 171.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.88 -39.22 84.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -64.28 -39.28 93.6 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.302 170.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.21 -45.59 85.55 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 120.726 1.603 . . . . 0.0 111.333 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -63.88 -39.63 94.63 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.59 -39.34 80.98 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 119.868 1.213 . . . . 0.0 110.99 -175.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -70.36 -26.47 63.74 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 120.532 1.514 . . . . 0.0 112.096 175.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 m -73.01 -51.04 19.73 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.369 1.467 . . . . 0.0 110.741 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.9 mt -88.82 -27.18 21.26 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.351 1.46 . . . . 0.0 112.307 -169.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.89 13.33 59.14 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 126.445 1.974 . . . . 0.0 111.682 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.52 122.81 14.97 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.039 1.335 . . . . 0.0 109.76 -174.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.31 9.13 86.99 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 119.887 -0.396 . . . . 0.0 113.649 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -123.88 -32.11 3.32 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.407 1.483 . . . . 0.0 109.275 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.8 pt -142.75 174.75 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 125.443 1.497 . . . . 0.0 109.439 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.87 146.07 43.16 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 168.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.58 142.12 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 123.168 0.587 . . . . 0.0 110.878 -168.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.03 159.63 44.42 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.92 0.888 . . . . 0.0 110.559 -176.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.0 p -133.83 156.26 48.37 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.873 1.269 . . . . 0.0 109.272 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.4 p -151.64 167.27 28.68 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.469 0.707 . . . . 0.0 111.234 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.44 38.4 86.77 Favored Glycine 0 N--CA 1.47 0.958 0 C-N-CA 123.501 0.572 . . . . 0.0 112.913 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 tp -69.74 58.56 0.14 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.735 2.014 . . . . 0.0 113.087 -169.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 53.0 7.51 0.08 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.142 2.177 . . . . 0.0 114.852 -170.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.9 m 56.57 33.66 23.08 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.462 1.105 . . . . 0.0 111.127 -169.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.6 m -132.4 -115.23 0.22 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.272 1.429 . . . . 0.0 108.93 -176.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -155.57 176.3 12.78 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.88 1.272 . . . . 0.0 109.354 -177.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.9 m -67.14 174.87 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.634 1.174 . . . . 0.0 111.416 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.536 ' CG ' HD22 ' A' ' 11' ' ' ASN . 13.5 t-80 -132.96 98.88 15.5 Favored Pre-proline 0 CA--C 1.53 0.2 0 C-N-CA 123.311 0.645 . . . . 0.0 109.672 -169.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -42.28 -33.18 2.37 Favored 'Trans proline' 0 CA--C 1.534 0.499 1 C-N-CA 125.846 4.364 . . . . 0.0 116.377 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.4 m -64.0 -39.29 93.79 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.792 1.178 . . . . 0.0 110.798 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.55 -43.48 80.6 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 121.133 -0.979 . . . . 0.0 109.218 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.88 -44.3 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.27 -43.23 99.22 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.429 0.559 . . . . 0.0 111.701 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.4 mmt -65.44 -21.61 66.67 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.166 0.439 . . . . 0.0 111.893 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.446 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.4 OUTLIER -93.4 -33.65 13.76 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -177.245 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -61.76 -34.13 75.3 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.954 1.302 . . . . 0.0 109.941 169.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.54 -8.31 4.17 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.601 1.961 . . . . 0.0 112.347 172.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.2 p -134.56 12.44 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 125.484 1.513 . . . . 0.0 110.91 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.81 36.87 66.15 Favored Glycine 0 CA--C 1.534 1.268 0 O-C-N 120.841 -1.162 . . . . 0.0 113.599 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.5 mt -120.46 154.71 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.319 1.448 . . . . 0.0 108.639 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.8 126.8 53.1 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.882 1.673 . . . . 0.0 109.571 -177.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.6 pt -134.59 8.19 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 125.501 1.52 . . . . 0.0 110.59 168.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.42 -37.41 68.64 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.404 1.882 . . . . 0.0 111.567 177.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.27 -6.81 89.04 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 123.471 0.558 . . . . 0.0 113.32 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -72.48 156.31 39.18 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.939 1.296 . . . . 0.0 109.874 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -150.97 164.98 35.1 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.5 m -68.08 141.28 56.19 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 126.999 2.119 . . . . 0.0 112.131 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -162.38 127.67 2.17 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 169.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.88 152.17 28.36 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.648 2.232 . . . . 0.0 113.38 -169.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.5 tt -59.3 -37.12 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.478 1.511 . . . . 0.0 111.366 -173.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -70.92 -19.67 62.56 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.126 0.57 . . . . 0.0 112.11 -173.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -15.68 54.54 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 118.762 -0.637 . . . . 0.0 111.85 173.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -84.03 168.49 15.88 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.225 1.012 . . . . 0.0 110.804 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -140.16 86.17 2.06 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 102.634 -3.098 . . . . 0.0 102.634 -178.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.449 ' HB3' ' CD2' ' A' ' 90' ' ' TRP . . . -54.37 -23.23 14.76 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.58 -27.55 17.31 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.279 0.632 . . . . 0.0 111.184 172.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -84.48 -7.6 59.23 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.25 1.02 . . . . 0.0 113.16 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -126.09 113.74 17.48 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 120.132 1.333 . . . . 0.0 108.912 -171.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -66.1 -12.21 54.09 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -168.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.9 t -145.25 123.24 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -170.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.3 t -118.74 129.63 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.2 mm -120.55 96.87 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 169.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.7 p -74.43 160.45 30.96 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 169.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -138.39 42.07 2.21 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 170.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.7 m -80.69 11.03 4.11 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.43 1.492 . . . . 0.0 111.177 -172.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.81 26.95 70.02 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 -174.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 2.0 t 52.78 -176.26 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.631 1.972 . . . . 0.0 111.314 -169.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.04 -33.79 1.07 Allowed Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.009 1.29 . . . . 0.0 114.677 172.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.5 t -57.61 119.32 2.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 125.198 1.399 . . . . 0.0 107.522 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -73.78 146.79 44.0 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 171.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.3 mt -127.09 153.41 76.62 Favored Pre-proline 0 C--O 1.237 0.439 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -53.08 151.94 19.88 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.26 1.973 . . . . 0.0 111.079 170.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -65.93 -19.8 58.07 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.574 1.516 . . . . 0.0 114.302 -169.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.58 -27.0 68.65 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.135 -0.978 . . . . 0.0 110.917 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.449 ' CD2' ' HB3' ' A' ' 70' ' ' ALA . 70.8 m95 -67.01 -12.47 59.97 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.046 -1.034 . . . . 0.0 112.819 175.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.8 t -104.74 -29.63 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.79 1.236 . . . . 0.0 111.127 -170.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.4 p -75.01 -13.38 60.5 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.365 1.066 . . . . 0.0 113.775 -169.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -55.78 163.6 1.36 Allowed 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 129.562 3.145 . . . . 0.0 113.761 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.62 -41.42 96.19 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.676 1.19 . . . . 0.0 108.373 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.0 mm -119.92 136.02 58.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 169.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -142.42 109.52 5.55 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 103.96 -2.607 . . . . 0.0 103.96 165.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -137.28 166.3 24.1 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 125.852 1.661 . . . . 0.0 106.765 178.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -133.07 130.16 38.98 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 169.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -111.31 83.12 1.71 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.485 ' H ' ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -66.81 46.49 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.481 2.312 . . . . 0.0 112.856 178.142 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.73 169.67 15.17 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.21 -0.931 . . . . 0.0 111.154 -173.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -46.93 142.57 3.39 Favored 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 126.03 1.732 . . . . 0.0 112.221 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -87.58 111.58 42.77 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.915 1.286 . . . . 0.0 108.759 176.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -83.38 -7.44 10.83 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.489 2.126 . . . . 0.0 112.416 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.4 t0 23.88 -96.96 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 128.233 2.613 . . . . 0.0 113.961 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.57 44.1 1.22 Allowed Glycine 0 CA--C 1.533 1.205 0 C-N-CA 126.944 2.211 . . . . 0.0 110.607 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -70.44 -175.39 1.02 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.847 1.659 . . . . 0.0 113.274 -175.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.2 p -69.08 162.38 27.05 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.44 169.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 22.8 mt -55.84 -37.0 68.14 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.942 0.497 . . . . 0.0 111.026 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.47 -37.32 77.9 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 123.262 0.625 . . . . 0.0 110.39 -174.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.4 t -74.2 -41.68 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -55.94 -34.74 65.93 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.451 1.023 . . . . 0.0 112.138 171.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.8 mtp85 -73.0 -44.87 60.51 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 119.705 1.139 . . . . 0.0 111.606 173.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 91.3 m -75.46 -38.21 59.82 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.372 0.669 . . . . 0.0 112.021 -169.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 87.4 t -71.49 -45.2 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -176.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -43.51 -53.02 5.81 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 125.886 1.675 . . . . 0.0 111.236 169.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.53 -40.18 97.44 Favored Glycine 0 N--CA 1.467 0.721 0 CA-C-N 119.785 1.175 . . . . 0.0 111.96 -175.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -65.17 -38.65 91.21 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 121.492 -1.005 . . . . 0.0 110.359 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.18 -40.44 89.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 175.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -36.89 76.04 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.454 1.025 . . . . 0.0 111.292 -177.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -69.85 -42.93 72.91 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 118.743 -0.646 . . . . 0.0 110.448 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -63.47 -43.18 98.09 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.88 1.218 . . . . 0.0 110.388 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 63.9 t -54.98 -53.66 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 123.475 0.71 . . . . 0.0 109.627 173.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -64.77 -32.77 74.61 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 122.151 -0.343 . . . . 0.0 111.419 -175.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -62.8 -47.73 82.19 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 123.363 0.665 . . . . 0.0 111.208 172.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.92 -47.75 76.95 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.454 0.57 . . . . 0.0 109.589 175.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -57.89 -42.49 82.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 124.452 1.101 . . . . 0.0 110.091 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.07 -28.94 68.22 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.885 0.766 . . . . 0.0 111.94 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -75.49 -40.56 57.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.614 0.643 . . . . 0.0 111.759 175.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 pt -101.33 -42.45 9.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -168.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 C--O 1.253 1.287 0 CA-C-N 119.089 0.859 . . . . 0.0 110.237 -173.423 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 tpt . . . . . 0 N--CA 1.497 1.918 0 CA-C-O 117.957 -1.02 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.432 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -48.75 121.87 5.08 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 120.597 1.544 . . . . 0.0 109.863 -174.044 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -97.8 135.83 39.0 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -169.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.8 t -113.52 156.52 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 59.2 tpp -135.67 137.49 41.87 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -119.78 117.07 27.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 177.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.5 t -99.55 132.39 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -169.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.8 t -111.79 131.22 55.47 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.962 0.887 . . . . 0.0 112.892 -169.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -140.15 150.93 44.84 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 129.08 2.952 . . . . 0.0 103.503 169.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 58.0 -170.8 0.11 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.799 0.84 . . . . 0.0 109.79 -168.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.424 HD22 ' CD2' ' A' ' 43' ' ' HIS . 15.1 t-20 -58.0 130.03 44.69 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -168.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.9 m -35.0 -35.41 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.997 1.719 . . . . 0.0 115.636 169.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.1 p -61.41 -9.6 5.82 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -99.96 -52.97 3.28 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 120.369 1.44 . . . . 0.0 110.823 171.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 p -94.21 -51.26 4.9 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 120.703 -1.248 . . . . 0.0 113.736 -168.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.32 -21.64 63.83 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 118.069 -1.452 . . . . 0.0 110.031 173.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.468 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 0.8 OUTLIER -63.39 -39.57 94.88 Favored 'General case' 0 CA--C 1.512 -0.498 0 O-C-N 120.899 -1.126 . . . . 0.0 109.056 168.364 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.9 -37.91 74.86 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 118.753 -0.641 . . . . 0.0 109.866 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -61.44 -40.07 93.12 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.942 169.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.33 -42.9 93.76 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 120.242 1.383 . . . . 0.0 111.454 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -67.23 -39.01 86.15 Favored 'General case' 0 CA--C 1.518 -0.274 0 O-C-N 121.554 -0.968 . . . . 0.0 108.705 173.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.06 -40.28 71.73 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 119.525 1.057 . . . . 0.0 110.433 -173.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -72.03 -15.5 62.03 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.449 1.022 . . . . 0.0 112.327 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 m -85.08 -50.54 7.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.798 1.639 . . . . 0.0 109.469 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.6 mt -88.85 -26.21 21.76 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.515 1.126 . . . . 0.0 112.7 -169.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.91 13.87 57.5 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 126.161 1.839 . . . . 0.0 112.076 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.01 125.16 23.05 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.635 1.174 . . . . 0.0 108.825 -174.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.2 7.79 88.21 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.711 -0.494 . . . . 0.0 113.795 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt -125.64 -42.78 1.91 Allowed 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 125.731 1.612 . . . . 0.0 108.988 -176.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.7 pp -143.29 152.04 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 124.642 1.177 . . . . 0.0 109.301 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.12 152.2 21.24 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 172.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 t -139.33 139.86 38.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 121.819 -0.551 . . . . 0.0 110.157 -168.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.98 159.23 43.82 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.337 1.055 . . . . 0.0 109.135 -172.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.2 t -146.88 156.08 42.81 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 119.376 0.989 . . . . 0.0 110.251 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.3 p -147.37 153.61 39.87 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.842 0.857 . . . . 0.0 109.707 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.82 -119.4 5.75 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 106.542 -2.623 . . . . 0.0 106.542 -169.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.6 tp 83.59 62.77 0.01 OUTLIER 'General case' 0 C--N 1.346 0.447 0 C-N-CA 127.449 2.299 . . . . 0.0 105.234 -177.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -67.63 -18.25 64.9 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.82 -171.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.8 m -83.79 38.87 0.66 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.469 1.108 . . . . 0.0 112.197 -175.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.5 m 67.82 -169.76 0.19 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.253 1.821 . . . . 0.0 110.712 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -57.65 -25.43 60.17 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -169.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -169.72 159.38 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 126.971 2.108 . . . . 0.0 107.254 169.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.424 ' CD2' HD22 ' A' ' 11' ' ' ASN . 80.0 t60 -132.98 108.47 12.71 Favored Pre-proline 0 C--O 1.234 0.251 0 C-N-CA 123.187 0.595 . . . . 0.0 109.414 -169.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -64.37 -30.38 62.92 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.157 2.571 . . . . 0.0 112.234 -168.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.5 m -65.73 -36.53 83.85 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 119.296 0.953 . . . . 0.0 109.246 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.97 -44.6 84.46 Favored 'General case' 0 C--N 1.346 0.424 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -58.05 -48.8 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.96 96.26 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.713 0.688 . . . . 0.0 110.906 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.6 mmt -58.66 -25.89 63.24 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.873 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.468 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.5 OUTLIER -95.87 -26.33 15.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 119.178 0.899 . . . . 0.0 108.932 -177.579 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -64.74 -29.64 70.63 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.546 1.138 . . . . 0.0 110.445 169.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -57.63 -22.82 47.8 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.386 0.674 . . . . 0.0 112.186 171.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.9 m -124.09 11.59 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 125.708 1.603 . . . . 0.0 111.279 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.41 40.92 86.63 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.0 0.81 . . . . 0.0 113.012 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.7 mt -124.87 154.29 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.542 1.537 . . . . 0.0 107.758 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -122.6 126.37 47.55 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.013 1.325 . . . . 0.0 109.014 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.8 pt -129.47 16.38 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 125.14 1.376 . . . . 0.0 111.268 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.51 -24.89 45.56 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.762 1.625 . . . . 0.0 112.226 169.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.27 -13.13 81.63 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 118.136 0.426 . . . . 0.0 112.399 174.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -73.12 163.09 28.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.697 1.199 . . . . 0.0 110.545 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.7 p -148.3 168.06 23.56 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.727 1.211 . . . . 0.0 110.791 170.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.35 143.88 51.81 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.714 1.206 . . . . 0.0 109.801 174.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -161.04 127.93 2.56 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 117.225 -1.369 . . . . 0.0 107.751 173.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -65.52 152.33 82.17 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.136 2.557 . . . . 0.0 114.468 -172.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.1 tt -62.05 -41.13 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 124.438 1.095 . . . . 0.0 111.083 174.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -70.42 -20.82 62.89 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.085 0.554 . . . . 0.0 111.891 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.98 -19.04 60.78 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.548 0.739 . . . . 0.0 111.642 171.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -92.54 169.8 10.25 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.912 0.863 . . . . 0.0 110.954 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -140.94 88.58 2.19 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 -173.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.442 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -53.95 -24.15 15.53 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -28.58 16.06 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.355 0.662 . . . . 0.0 111.372 173.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -82.3 -13.71 56.53 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.311 1.044 . . . . 0.0 113.302 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -121.64 113.63 20.02 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 120.081 1.309 . . . . 0.0 109.383 -169.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.4 -16.03 52.43 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -169.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.3 t -144.8 127.13 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -170.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.7 t -121.26 127.39 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.2 mm -119.72 95.05 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 169.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.2 t -74.45 165.96 24.31 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 168.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.88 26.14 2.29 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.61 -1.306 . . . . 0.0 109.128 171.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 57.0 m -83.52 -1.32 53.43 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.167 -0.958 . . . . 0.0 112.476 -170.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.96 23.89 6.86 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 123.783 0.706 . . . . 0.0 111.73 175.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.417 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 3.2 t 44.32 45.16 7.18 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.148 1.779 . . . . 0.0 112.336 -174.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -155.6 35.82 0.63 Allowed Glycine 0 C--N 1.339 0.743 0 CA-C-O 119.735 -0.481 . . . . 0.0 112.319 -171.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 86.6 t -122.87 141.91 41.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 125.058 1.343 . . . . 0.0 108.6 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -81.95 60.09 4.63 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.37 1.068 . . . . 0.0 109.966 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 68.4 mt -56.63 134.35 77.89 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -54.57 155.36 17.22 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.552 2.168 . . . . 0.0 112.568 178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -54.9 -28.82 60.71 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.76 2.306 . . . . 0.0 116.099 -171.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -66.53 -24.36 66.37 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.153 -0.967 . . . . 0.0 111.607 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.442 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 66.9 m95 -70.97 -13.93 62.18 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 117.892 -1.051 . . . . 0.0 113.14 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.9 m -113.52 -10.93 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 120.107 1.321 . . . . 0.0 113.165 -171.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.4 p -84.05 -16.41 43.93 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.615 0.766 . . . . 0.0 112.739 -175.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -50.45 161.86 0.28 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 130.017 3.327 . . . . 0.0 114.377 174.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -62.36 -39.32 92.79 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.454 1.502 . . . . 0.0 108.801 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 23.4 mm -122.85 136.83 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 169.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -141.14 111.89 7.07 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 100.926 -3.731 . . . . 0.0 100.926 166.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.92 164.32 28.22 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 174.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.417 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.8 t70 -134.56 100.31 4.6 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 170.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -77.2 78.32 3.73 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -55.62 33.43 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.953 1 C-N-CA 131.745 4.018 . . . . 0.0 113.761 170.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.93 172.15 5.85 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.083 1.353 . . . . 0.0 111.717 -169.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -49.88 155.52 0.87 Allowed 'General case' 0 C--O 1.231 0.088 0 C-N-CA 125.354 1.462 . . . . 0.0 112.632 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -107.24 110.58 63.31 Favored Pre-proline 0 N--CA 1.448 -0.538 0 C-N-CA 126.556 1.942 . . . . 0.0 109.062 175.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -95.31 1.03 2.49 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 124.068 3.179 . . . . 0.0 112.631 175.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -51.37 -37.09 46.32 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -168.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -109.38 25.05 18.96 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.48 -1.178 . . . . 0.0 112.677 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -122.34 174.65 6.87 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 118.999 1.4 . . . . 0.0 113.95 -169.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.1 m -73.14 166.79 22.46 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 112.947 -1.933 . . . . 0.0 110.144 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.6 mt -55.51 -31.61 62.2 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 123.189 0.596 . . . . 0.0 110.951 175.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -62.28 -41.16 98.25 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 118.298 0.499 . . . . 0.0 110.567 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.2 t -76.48 -39.82 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 117.322 -1.323 . . . . 0.0 108.784 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -47.23 -48.57 24.25 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 120.264 1.393 . . . . 0.0 110.949 168.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -61.21 -46.1 91.82 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.261 0.937 . . . . 0.0 111.184 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.5 m -68.21 -37.37 80.81 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 122.865 0.466 . . . . 0.0 110.16 -171.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 40.3 t -75.93 -44.01 38.8 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -177.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -45.59 -51.09 12.53 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 124.795 1.238 . . . . 0.0 111.193 170.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.18 -42.97 97.75 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 119.506 1.048 . . . . 0.0 112.19 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -65.61 -35.56 81.17 Favored 'General case' 0 CA--C 1.52 -0.192 0 O-C-N 120.942 -1.328 . . . . 0.0 110.832 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.2 -42.63 97.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 173.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.15 -39.65 83.09 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.422 1.465 . . . . 0.0 111.369 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.7 -44.62 73.59 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.393 1.477 . . . . 0.0 109.743 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -66.89 -41.34 87.36 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.574 -0.704 . . . . 0.0 112.039 177.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 38.9 t -54.77 -53.02 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -64.08 -32.74 74.41 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 122.043 -0.411 . . . . 0.0 111.647 -175.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -63.13 -46.09 88.88 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 121.612 -0.68 . . . . 0.0 111.392 172.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.11 -47.58 82.82 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 175.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -58.02 -41.37 80.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 123.896 0.878 . . . . 0.0 109.825 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.26 -27.39 68.42 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.868 0.758 . . . . 0.0 112.093 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -76.82 -41.21 45.22 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 118.616 -0.706 . . . . 0.0 112.315 174.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.8 pt -101.13 -35.11 4.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 -168.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 28.2 m . . . . . 0 C--O 1.256 1.401 0 CA-C-N 119.304 0.956 . . . . 0.0 111.497 -177.107 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 tpt . . . . . 0 N--CA 1.499 2.011 0 CA-C-O 118.53 -0.747 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.422 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -60.94 119.28 7.95 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 120.842 1.655 . . . . 0.0 108.679 -174.566 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -90.37 138.08 31.83 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -172.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.7 t -116.37 153.74 17.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 O-C-N 124.25 0.969 . . . . 0.0 108.386 174.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.25 142.09 50.94 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 175.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -121.5 103.92 9.28 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.544 -1.651 . . . . 0.0 106.544 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 t -89.32 134.52 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -169.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 82.4 m -91.84 169.15 10.92 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -169.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -147.52 -160.45 1.17 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 128.159 2.584 . . . . 0.0 105.476 168.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.8 ttm105 -46.38 141.46 3.53 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.916 1.235 . . . . 0.0 111.504 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.537 HD22 ' CD2' ' A' ' 43' ' ' HIS . 9.0 t-20 44.34 67.62 0.66 Allowed 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 127.964 2.506 . . . . 0.0 109.694 -172.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 p -51.4 -20.61 1.85 Allowed 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 126.522 1.929 . . . . 0.0 114.71 -171.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 77.1 m -61.0 -17.64 53.26 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 116.734 -1.603 . . . . 0.0 113.658 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -65.45 -37.14 86.01 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 122.978 2.626 . . . . 0.0 111.334 169.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.63 -39.91 15.64 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.409 -0.807 . . . . 0.0 108.901 -174.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -66.89 -25.28 66.31 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 120.902 -1.124 . . . . 0.0 110.875 169.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.437 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.8 tpt -67.03 -37.89 84.94 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 119.884 -1.76 . . . . 0.0 109.153 169.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.58 89.73 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -61.87 -40.19 94.5 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.49 -0.766 . . . . 0.0 110.533 169.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.31 -35.65 63.59 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 120.894 1.679 . . . . 0.0 112.676 -175.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -71.87 -37.81 70.13 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 118.329 1.065 . . . . 0.0 108.724 169.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.53 -39.27 70.84 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 120.567 -1.333 . . . . 0.0 111.275 -174.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -63.45 -23.95 67.62 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.054 1.297 . . . . 0.0 111.979 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 m -84.94 -50.42 7.51 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.146 2.178 . . . . 0.0 109.581 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.6 mt -88.45 -25.12 22.79 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.377 1.471 . . . . 0.0 112.022 -169.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -106.5 15.75 41.74 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 126.715 2.102 . . . . 0.0 111.73 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.35 123.09 16.79 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.595 1.158 . . . . 0.0 109.442 -175.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.24 8.38 87.5 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 123.07 0.367 . . . . 0.0 113.786 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.2 mmtt -120.66 -34.82 3.5 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 126.117 1.767 . . . . 0.0 109.278 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.5 pt -142.38 172.77 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 124.912 1.285 . . . . 0.0 109.307 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.8 145.98 39.65 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 168.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.57 141.26 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 123.163 0.585 . . . . 0.0 110.782 -168.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.01 160.51 42.06 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.129 0.972 . . . . 0.0 109.826 -173.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.5 p -135.51 168.14 19.78 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.124 1.329 . . . . 0.0 109.443 169.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.3 p -153.61 157.01 39.01 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.6 -0.687 . . . . 0.0 112.005 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.63 -54.14 0.57 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.693 1.616 . . . . 0.0 110.626 173.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 43.83 33.8 0.79 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.703 2.001 . . . . 0.0 114.882 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 55.51 11.53 0.63 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.207 1.403 . . . . 0.0 114.235 -174.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 26.4 m 57.65 33.0 22.69 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.836 1.254 . . . . 0.0 111.727 -169.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.8 m -138.21 178.13 7.36 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.454 1.902 . . . . 0.0 109.738 -176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -72.34 166.8 21.79 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.467 -0.771 . . . . 0.0 109.946 170.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 p -62.58 167.05 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.24 1.416 . . . . 0.0 110.341 175.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.537 ' CD2' HD22 ' A' ' 11' ' ' ASN . 77.4 t60 -123.25 110.8 30.59 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 124.312 1.045 . . . . 0.0 110.147 -169.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.48 -25.03 41.8 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.389 2.726 . . . . 0.0 115.113 -169.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -59.73 -37.63 79.48 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 120.538 1.517 . . . . 0.0 110.775 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.41 -44.51 71.25 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.13 -44.19 78.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 CA-C-O 118.616 -0.707 . . . . 0.0 109.137 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.05 -42.77 81.15 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.689 0.677 . . . . 0.0 110.974 177.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 30.4 mmt -66.78 -22.47 66.03 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.779 -0.629 . . . . 0.0 112.311 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.437 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 1.8 mmt -90.18 -36.32 14.86 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -65.38 -34.86 79.31 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.368 1.067 . . . . 0.0 110.267 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.26 1.0 OUTLIER -76.31 5.21 7.38 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.3 0.64 . . . . 0.0 112.289 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.0 m -129.07 -23.02 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.831 1.252 . . . . 0.0 112.707 169.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.72 31.11 0.91 Allowed Glycine 0 CA--C 1.532 1.125 0 CA-C-N 119.739 1.154 . . . . 0.0 114.422 170.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.0 mt -130.13 161.62 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.534 1.534 . . . . 0.0 107.112 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -140.36 146.81 38.9 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 169.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.6 pt -138.37 5.71 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.486 1.914 . . . . 0.0 110.618 -176.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.6 p -64.04 145.12 56.45 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.172 -0.955 . . . . 0.0 110.138 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.2 6.02 18.2 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 118.253 -1.304 . . . . 0.0 113.811 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -57.14 -44.76 83.71 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 119.521 1.66 . . . . 0.0 113.205 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -149.53 162.24 40.54 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 124.232 0.958 . . . . 0.0 110.626 -168.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.3 p -170.5 27.4 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.702 0.801 . . . . 0.0 111.994 -170.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -139.33 147.08 51.41 Favored Pre-proline 0 N--CA 1.475 0.809 0 O-C-N 120.604 -1.31 . . . . 0.0 111.614 -169.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -83.08 161.67 15.59 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.872 3.048 . . . . 0.0 112.558 -174.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.7 tt -59.76 -37.24 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.666 1.186 . . . . 0.0 111.545 -177.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -70.5 -20.69 62.82 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.275 0.63 . . . . 0.0 112.134 -173.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -19.05 59.26 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 118.872 -0.585 . . . . 0.0 111.338 171.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -97.72 167.32 11.02 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.934 0.874 . . . . 0.0 110.637 -176.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -141.46 89.61 2.23 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 -172.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.94 -30.66 15.45 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.53 -29.56 10.92 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.134 0.974 . . . . 0.0 112.459 174.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -71.53 -18.58 62.26 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -107.64 171.03 7.62 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 128.398 2.679 . . . . 0.0 108.707 -172.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -111.42 -22.6 11.22 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-O 117.792 -1.099 . . . . 0.0 113.274 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.453 ' CG1' ' HB ' ' A' ' 95' ' ' ILE . 37.7 t -137.4 133.92 46.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 121.544 1.975 . . . . 0.0 108.585 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.0 t -116.5 129.89 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 173.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.3 mm -122.89 96.82 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 101.76 -3.422 . . . . 0.0 101.76 169.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . 0.254 22.0 p -74.32 166.39 23.55 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 117.649 -1.62 . . . . 0.0 108.257 169.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.4 mp -136.36 37.86 2.71 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 170.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 63.8 m -95.91 7.59 45.93 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.869 2.067 . . . . 0.0 110.932 -169.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.85 31.78 6.83 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 119.246 -0.752 . . . . 0.0 112.221 172.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 31.5 p 40.26 37.85 0.47 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.644 2.378 . . . . 0.0 116.041 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.86 24.46 0.49 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 123.896 0.76 . . . . 0.0 112.566 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 p -78.21 143.75 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 124.615 1.166 . . . . 0.0 108.897 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -92.96 58.85 3.05 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.476 1.11 . . . . 0.0 109.239 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.8 mt -61.29 147.47 87.14 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -175.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -56.41 157.58 17.95 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.895 2.397 . . . . 0.0 111.89 170.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.3 -25.34 64.37 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 121.853 1.702 . . . . 0.0 114.875 -169.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.47 -24.68 67.22 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.49 -1.382 . . . . 0.0 111.636 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -72.65 -9.26 58.4 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 117.855 -1.069 . . . . 0.0 112.686 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.8 m -117.49 -16.06 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 119.926 1.239 . . . . 0.0 113.166 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.9 p -76.06 -11.18 59.9 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.15 0.886 . . . . 0.0 112.352 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -43.38 156.1 0.06 Allowed 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 130.618 3.567 . . . . 0.0 111.826 169.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -62.12 -36.18 80.97 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.725 1.61 . . . . 0.0 109.731 171.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.453 ' HB ' ' CG1' ' A' ' 75' ' ' VAL . 24.4 mm -131.98 137.0 55.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -135.46 112.62 10.43 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 102.07 -3.307 . . . . 0.0 102.07 166.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -136.31 168.42 19.46 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -141.94 118.68 11.08 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 170.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -95.52 79.59 3.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.31 18.74 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 129.022 2.929 . . . . 0.0 116.411 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -61.76 128.8 37.97 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 120.615 -1.303 . . . . 0.0 113.857 -168.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 46.94 -157.74 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 128.403 2.681 . . . . 0.0 114.161 169.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -163.51 74.47 1.84 Allowed Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 127.871 2.468 . . . . 0.0 108.054 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.5 -13.35 32.72 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.365 2.71 . . . . 0.0 115.834 -169.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.0 t70 26.17 -92.37 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.001 2.52 . . . . 0.0 114.045 172.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.89 45.23 1.01 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 126.888 2.185 . . . . 0.0 109.771 171.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -66.45 175.04 2.41 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.712 2.005 . . . . 0.0 114.133 -172.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.0 m -66.21 152.05 45.69 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 113.217 -1.811 . . . . 0.0 109.657 169.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.3 mt -57.18 -35.24 69.34 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.262 0.625 . . . . 0.0 111.077 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -61.3 -36.35 79.85 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 122.862 0.465 . . . . 0.0 110.794 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 23.3 t -74.83 -40.75 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-O 117.849 -1.072 . . . . 0.0 108.76 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -54.84 -42.55 72.11 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 120.432 1.469 . . . . 0.0 110.748 172.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 59.0 mtt85 -62.21 -46.01 90.81 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.227 0.921 . . . . 0.0 111.743 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.4 m -69.89 -43.64 71.37 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -172.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.8 t -65.9 -45.67 90.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -173.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -47.55 -53.77 13.55 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.997 1.319 . . . . 0.0 110.566 169.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.78 -42.15 99.71 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 119.328 0.967 . . . . 0.0 111.998 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -64.88 -39.71 93.97 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 121.425 -1.044 . . . . 0.0 110.607 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 45.0 t -62.82 -42.34 95.98 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -36.64 78.89 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 120.128 1.331 . . . . 0.0 111.475 -174.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -68.57 -42.69 77.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.691 -0.671 . . . . 0.0 109.869 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -63.41 -42.36 98.76 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 119.831 1.196 . . . . 0.0 110.412 177.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 56.7 t -54.7 -52.93 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 123.469 0.708 . . . . 0.0 109.114 174.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -66.29 -32.85 74.51 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 122.046 -0.409 . . . . 0.0 111.461 -175.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -62.16 -47.87 82.62 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 123.906 0.883 . . . . 0.0 110.966 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -48.03 80.51 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 176.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -57.39 -42.16 79.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 124.447 1.099 . . . . 0.0 109.769 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.68 -27.88 68.19 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.714 0.688 . . . . 0.0 112.154 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -77.01 -41.86 40.97 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.491 0.587 . . . . 0.0 111.951 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.8 pt -99.33 -40.02 8.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 -168.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 40.4 m . . . . . 0 C--O 1.255 1.366 0 CA-C-N 119.005 0.821 . . . . 0.0 110.891 -174.351 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 tpt . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 117.513 -1.232 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.98 123.57 14.78 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 121.566 1.985 . . . . 0.0 109.996 -172.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -93.47 142.13 27.68 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -169.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.1 t -121.57 153.91 25.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.289 0.993 . . . . 0.0 108.56 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 59.9 tpp -136.32 135.05 38.56 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -117.22 109.88 17.43 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.2 t -96.98 141.74 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -169.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.9 t -125.81 156.7 39.12 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.335 0.97 . . . . 0.0 111.316 173.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp -140.11 34.67 1.92 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.664 1.586 . . . . 0.0 109.197 172.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -156.43 171.6 19.98 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 128.006 2.522 . . . . 0.0 105.156 -170.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -42.2 125.41 3.06 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 169.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.0 p -41.52 -29.46 0.17 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 117.277 2.325 . . . . 0.0 117.277 -169.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.7 m -34.16 -62.16 0.33 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 127.367 2.267 . . . . 0.0 115.148 -169.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -64.6 -52.0 59.79 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.056 0.844 . . . . 0.0 112.529 -168.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -81.67 -34.09 30.92 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 121.514 -0.741 . . . . 0.0 111.417 -172.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.27 -30.76 65.14 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.454 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.7 tpt -64.88 -40.88 95.8 Favored 'General case' 0 CA--C 1.514 -0.419 0 O-C-N 121.018 -1.051 . . . . 0.0 109.094 168.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.67 -36.79 79.59 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -62.03 -42.96 99.73 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.83 -0.605 . . . . 0.0 111.313 169.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.14 -45.61 91.0 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-N 119.936 1.244 . . . . 0.0 110.907 -176.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -63.09 -39.98 96.31 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 117.934 0.867 . . . . 0.0 109.364 172.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.28 -35.82 76.43 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 119.58 1.082 . . . . 0.0 111.561 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -81.93 -13.91 56.85 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 120.311 1.414 . . . . 0.0 113.244 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.9 m -78.18 -50.69 11.47 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.229 1.412 . . . . 0.0 109.397 169.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.3 mt -89.56 -27.4 20.28 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.16 1.384 . . . . 0.0 112.423 -169.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.78 14.63 57.47 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 126.661 2.077 . . . . 0.0 111.685 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.34 120.45 9.32 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.579 1.151 . . . . 0.0 110.054 -172.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.58 9.5 86.13 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 119.81 -0.439 . . . . 0.0 113.467 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -123.27 -24.87 4.56 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 125.159 1.384 . . . . 0.0 109.701 -177.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.1 pt -144.29 172.0 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 125.962 1.705 . . . . 0.0 110.42 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.31 144.71 38.62 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 103.836 -2.653 . . . . 0.0 103.836 168.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 t -135.59 140.42 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 123.47 0.708 . . . . 0.0 110.743 -168.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.6 160.63 42.49 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.127 0.971 . . . . 0.0 109.939 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.5 p -139.02 163.64 31.85 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.288 1.404 . . . . 0.0 111.221 174.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.7 p -149.64 160.49 43.46 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.151 0.58 . . . . 0.0 111.339 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.24 -87.16 0.43 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 54.65 50.97 14.73 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 125.264 1.425 . . . . 0.0 109.829 -175.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -61.69 -13.06 19.5 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.85 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 p -71.3 6.41 1.74 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 172.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.4 m 63.05 -20.62 0.05 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 129.641 3.176 . . . . 0.0 115.141 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.91 178.63 10.14 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.548 2.339 . . . . 0.0 106.601 174.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.27 159.16 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -121.28 111.28 33.71 Favored Pre-proline 0 N--CA 1.454 -0.268 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -169.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -66.08 -27.11 49.92 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.385 2.724 . . . . 0.0 112.343 -169.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.9 m -63.32 -37.11 85.99 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.64 0.655 . . . . 0.0 109.249 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.39 -44.15 88.43 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.08 -49.66 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.22 -42.86 99.34 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.487 0.585 . . . . 0.0 111.119 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.6 mmt -61.89 -24.75 67.14 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.353 -0.832 . . . . 0.0 111.967 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.454 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.6 OUTLIER -94.4 -27.61 15.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 119.151 0.887 . . . . 0.0 108.688 -179.194 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.59 -30.42 71.53 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.371 1.068 . . . . 0.0 110.408 170.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -56.84 -23.19 42.26 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.457 0.703 . . . . 0.0 112.098 171.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.8 m -123.64 12.01 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 125.445 1.498 . . . . 0.0 111.142 -175.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.36 39.65 87.46 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 123.815 0.722 . . . . 0.0 112.759 174.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.6 mt -122.98 154.56 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.428 1.491 . . . . 0.0 107.19 175.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -127.84 128.11 44.65 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 124.552 1.141 . . . . 0.0 108.795 -177.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 46.3 pt -134.64 15.31 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 126.661 1.984 . . . . 0.0 109.752 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.65 160.16 27.66 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 167.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.17 -15.86 2.34 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 118.958 -0.912 . . . . 0.0 112.456 -174.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -61.58 147.46 45.55 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.757 1.279 . . . . 0.0 107.903 169.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.06 169.64 17.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -169.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.3 m -73.06 145.11 46.8 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.663 1.585 . . . . 0.0 111.937 -170.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -166.32 123.8 1.03 Allowed Pre-proline 0 C--O 1.237 0.442 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 169.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -76.87 161.12 33.54 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.115 1.876 . . . . 0.0 111.454 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.8 tt -56.17 -37.79 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.217 1.007 . . . . 0.0 111.142 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -68.86 -21.27 64.28 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.586 0.754 . . . . 0.0 112.16 -176.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.79 -22.43 63.33 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.637 -0.697 . . . . 0.0 111.203 171.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -107.45 165.9 11.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.578 1.18 . . . . 0.0 112.018 -172.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.86 89.8 2.28 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 102.658 -3.09 . . . . 0.0 102.658 -170.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.402 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -49.4 -32.14 11.01 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.275 0.63 . . . . 0.0 112.283 -177.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.08 -28.29 10.18 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.26 1.024 . . . . 0.0 112.868 174.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.04 -23.2 61.34 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.366 0.666 . . . . 0.0 112.208 176.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -104.12 178.89 4.43 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.618 2.767 . . . . 0.0 108.659 -175.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -123.57 -17.4 6.47 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 118.601 -0.714 . . . . 0.0 112.579 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.5 t -143.72 124.25 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -169.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.6 t -117.41 130.09 72.86 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.782 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.0 mm -119.35 92.44 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 103.026 -2.953 . . . . 0.0 103.026 169.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.9 t -72.42 161.38 30.9 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 169.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.6 mp -141.32 46.87 1.71 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 169.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 72.2 m -89.76 2.06 55.34 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.992 0.917 . . . . 0.0 110.682 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.12 42.69 5.22 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 172.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.2 p 37.75 44.72 0.59 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.321 2.248 . . . . 0.0 114.638 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -157.56 47.89 0.45 Allowed Glycine 0 C--N 1.34 0.757 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -172.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.9 p -128.09 161.92 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.873 1.669 . . . . 0.0 109.99 -172.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -123.21 45.31 2.45 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.177 2.191 . . . . 0.0 109.445 -170.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.8 mt -54.42 140.98 54.82 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.2 1.0 . . . . 0.0 109.245 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -53.88 153.39 20.13 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.596 2.197 . . . . 0.0 112.554 173.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -55.53 -26.82 56.43 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.515 2.143 . . . . 0.0 116.006 -173.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -64.75 -25.09 67.78 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.915 -1.116 . . . . 0.0 111.865 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.402 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 70.0 m95 -71.43 -9.19 57.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.661 1.184 . . . . 0.0 112.323 173.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.27 -29.8 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.663 1.585 . . . . 0.0 110.294 -173.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.0 p -75.25 -9.63 58.73 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.758 0.823 . . . . 0.0 112.738 -175.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -45.21 155.67 0.12 Allowed 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 129.916 3.287 . . . . 0.0 111.722 169.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -62.19 -39.23 92.0 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.803 1.641 . . . . 0.0 109.561 170.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 21.8 mm -122.56 134.64 65.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 169.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -137.92 111.78 8.33 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 103.892 -2.633 . . . . 0.0 103.892 166.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -137.39 165.72 25.54 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -133.41 105.04 6.71 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.441 1.096 . . . . 0.0 108.157 171.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -79.35 72.82 5.98 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.181 1.392 . . . . 0.0 108.613 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -51.94 34.05 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.952 1 C-N-CA 132.43 4.292 . . . . 0.0 116.015 169.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.87 -175.0 1.6 Allowed 'General case' 0 CA--C 1.544 0.742 0 O-C-N 120.958 -1.088 . . . . 0.0 110.162 -174.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -42.21 164.51 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 127.735 2.414 . . . . 0.0 113.213 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -126.58 63.17 52.24 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 125.779 1.632 . . . . 0.0 112.802 -168.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -79.94 69.06 8.1 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 124.164 3.243 . . . . 0.0 112.549 -169.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.35 -38.56 89.99 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.799 -1.188 . . . . 0.0 112.404 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -162.8 42.56 0.35 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.259 1.409 . . . . 0.0 110.763 -176.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -71.88 171.58 11.47 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -169.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.3 m -69.25 154.2 42.43 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 113.103 -1.862 . . . . 0.0 108.194 168.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 24.6 mt -59.17 -32.48 69.94 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.911 -0.493 . . . . 0.0 111.438 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -62.81 -39.75 95.24 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 118.611 0.642 . . . . 0.0 111.005 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.7 t -72.02 -42.13 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 116.37 -1.776 . . . . 0.0 108.526 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -50.38 -49.13 55.21 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 121.086 1.766 . . . . 0.0 111.1 172.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -58.67 -44.33 90.17 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.371 0.532 . . . . 0.0 110.762 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 88.0 m -66.15 -44.6 83.66 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 118.642 -0.694 . . . . 0.0 109.432 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.3 t -67.36 -49.16 74.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -172.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -44.29 -56.36 4.22 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.332 1.453 . . . . 0.0 111.269 170.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.81 -42.77 96.9 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 119.231 0.923 . . . . 0.0 111.416 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -62.2 -39.35 92.45 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.503 -0.998 . . . . 0.0 111.409 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.0 t -62.72 -41.52 92.68 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 CA-C-O 117.842 -1.075 . . . . 0.0 108.212 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -38.3 75.9 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 120.208 1.367 . . . . 0.0 111.048 -177.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -69.79 -43.76 71.47 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.988 -0.529 . . . . 0.0 110.219 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -66.36 -42.9 87.35 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.381 0.991 . . . . 0.0 110.357 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.8 t -52.72 -54.53 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 123.833 0.853 . . . . 0.0 108.983 172.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -65.1 -32.54 74.29 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 122.121 -0.362 . . . . 0.0 111.301 -174.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -62.41 -47.74 82.8 Favored 'General case' 0 C--O 1.225 -0.188 0 O-C-N 121.806 -0.559 . . . . 0.0 111.185 172.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.63 -47.57 79.41 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 176.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.2 mt -57.97 -42.71 83.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 123.895 0.878 . . . . 0.0 109.697 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.3 -32.0 71.85 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.961 0.801 . . . . 0.0 111.957 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -72.36 -42.25 65.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.611 173.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.3 pt -103.93 -44.7 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 118.942 2.941 . . . . 0.0 118.942 -168.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 71.8 m . . . . . 0 C--O 1.252 1.228 0 CA-C-N 119.733 1.152 . . . . 0.0 111.561 -169.336 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 tpt . . . . . 0 N--CA 1.498 1.942 0 CA-C-O 118.724 -0.655 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.404 ' HE2' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -64.31 128.13 34.47 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.892 1.678 . . . . 0.0 108.891 -174.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -94.24 145.8 24.47 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -170.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.2 t -124.28 153.52 30.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 O-C-N 124.495 1.122 . . . . 0.0 108.142 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 56.5 tpp -134.59 146.24 49.42 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 175.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -127.0 106.53 9.34 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.0 t -93.47 136.52 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -169.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.5 m -108.55 171.62 7.31 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.133 0.573 . . . . 0.0 110.748 -174.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -149.69 -52.36 0.15 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.451 0.7 . . . . 0.0 109.395 169.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.412 ' CG ' ' H ' ' A' ' 11' ' ' ASN . 30.9 ttm180 -103.92 -176.44 3.08 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.387 1.075 . . . . 0.0 108.293 169.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.474 HD22 ' CD2' ' A' ' 43' ' ' HIS . 27.4 t-20 -36.07 125.24 0.75 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 127.821 2.448 . . . . 0.0 113.65 -169.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.78 -19.56 6.65 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 129.243 3.017 . . . . 0.0 113.818 -173.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 p -58.17 -12.41 3.52 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 177.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -101.54 -43.91 5.75 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 120.597 1.544 . . . . 0.0 111.509 169.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.0 p -93.23 -52.88 4.34 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.964 1.306 . . . . 0.0 113.542 -168.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -65.87 -28.03 68.66 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.667 -1.271 . . . . 0.0 110.068 169.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.464 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.7 tpt -62.47 -39.81 94.61 Favored 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 121.267 -0.896 . . . . 0.0 110.741 169.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.03 -37.52 80.02 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 118.834 -0.603 . . . . 0.0 109.678 178.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -62.22 -41.29 98.25 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 118.721 -0.657 . . . . 0.0 110.915 169.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.87 -43.02 84.83 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 120.255 1.388 . . . . 0.0 111.686 -175.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -65.31 -37.53 87.41 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 121.742 -0.858 . . . . 0.0 108.733 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.66 -38.0 67.76 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 119.752 1.16 . . . . 0.0 111.358 -174.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -68.42 -26.75 65.69 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.869 1.213 . . . . 0.0 111.627 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.0 m -77.21 -52.32 9.44 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.967 1.707 . . . . 0.0 110.235 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.1 mt -88.2 -26.44 22.38 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.008 1.323 . . . . 0.0 111.695 -169.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.13 13.77 58.63 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 126.431 1.967 . . . . 0.0 111.673 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.6 119.5 7.68 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.414 1.086 . . . . 0.0 109.548 -174.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.07 8.3 87.93 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 119.754 -0.47 . . . . 0.0 113.564 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.404 ' O ' ' HE2' ' A' ' 2' ' ' LYS . 75.6 mmtt -123.51 -26.22 4.25 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 125.568 1.547 . . . . 0.0 109.977 -177.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.1 pt -145.92 170.58 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 125.058 1.343 . . . . 0.0 109.589 176.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.12 145.82 35.08 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 167.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 t -136.43 140.24 43.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 119.05 0.841 . . . . 0.0 111.263 -167.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 m -150.7 160.78 43.61 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 124.209 1.003 . . . . 0.0 110.682 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 64.6 p -133.2 161.86 33.3 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.057 1.299 . . . . 0.0 109.746 169.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.8 p -154.39 169.8 22.87 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.063 0.459 . . . . 0.0 111.879 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.95 -51.43 2.76 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 125.471 1.51 . . . . 0.0 111.846 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 mp 50.47 -156.25 0.11 Allowed 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -168.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -73.07 11.89 0.63 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.079 1.352 . . . . 0.0 112.472 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.9 m 63.17 24.71 14.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.017 1.327 . . . . 0.0 110.714 -168.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 55.9 m -145.8 168.28 21.15 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 129.307 3.043 . . . . 0.0 106.013 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -70.53 178.79 2.8 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.34 0.656 . . . . 0.0 111.56 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 t -44.89 151.91 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 127.564 2.345 . . . . 0.0 112.285 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.474 ' CD2' HD22 ' A' ' 11' ' ' ASN . 85.9 t60 -127.74 114.62 20.79 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 125.76 1.624 . . . . 0.0 108.321 -172.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -68.35 -27.04 34.62 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 124.021 3.147 . . . . 0.0 113.241 -169.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.0 m -62.65 -34.37 76.94 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.134 0.879 . . . . 0.0 109.206 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.12 -45.97 86.23 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.48 -46.7 92.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.128 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.96 -43.57 98.57 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 119.091 0.86 . . . . 0.0 111.077 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.4 mmt -59.74 -25.45 64.86 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.204 0.602 . . . . 0.0 111.986 175.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.464 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -93.09 -29.32 15.84 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -176.88 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -63.25 -31.47 72.63 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.328 1.451 . . . . 0.0 110.212 171.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -56.83 -20.81 24.79 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.794 0.838 . . . . 0.0 112.516 171.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.8 p -126.25 14.15 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 125.191 1.397 . . . . 0.0 110.253 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.8 33.76 66.32 Favored Glycine 0 CA--C 1.531 1.069 0 O-C-N 121.053 -1.029 . . . . 0.0 112.842 173.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.8 mt -121.01 159.04 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 126.08 1.752 . . . . 0.0 106.944 176.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -140.09 146.99 39.62 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.2 pt -135.15 8.77 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 126.262 1.825 . . . . 0.0 111.183 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.5 t -70.73 161.31 31.07 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 168.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.7 -25.53 1.43 Allowed Glycine 0 CA--C 1.533 1.199 0 CA-C-O 119.029 -0.873 . . . . 0.0 111.942 -173.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -76.85 137.95 39.5 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 103.397 -2.816 . . . . 0.0 103.397 168.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -146.84 165.19 30.45 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -168.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.1 m -68.0 141.37 56.27 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.961 2.105 . . . . 0.0 111.01 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -164.56 132.19 2.5 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.66 147.61 35.78 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.887 2.392 . . . . 0.0 113.753 -168.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.5 tt -60.48 -34.25 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.087 1.355 . . . . 0.0 111.238 -171.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.28 -13.17 61.44 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.211 0.604 . . . . 0.0 112.541 -171.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -91.58 -10.29 41.09 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.027 0.931 . . . . 0.0 112.173 171.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -84.0 171.07 13.3 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 122.015 0.912 . . . . 0.0 111.161 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.77 83.2 1.52 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.787 1.635 . . . . 0.0 107.638 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.1 -30.96 7.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -50.65 -32.6 19.61 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.143 0.977 . . . . 0.0 112.627 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -71.11 -24.85 62.37 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -94.36 177.28 6.0 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 127.402 2.281 . . . . 0.0 109.064 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -116.14 -19.23 10.36 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 118.257 -0.878 . . . . 0.0 112.585 173.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.2 t -143.2 132.41 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 120.685 1.584 . . . . 0.0 106.939 -169.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.8 m -132.99 130.15 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.0 mm -116.96 99.96 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 102.749 -3.056 . . . . 0.0 102.749 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.3 t -72.85 161.38 30.79 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 169.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.2 mp -140.1 34.29 1.92 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 169.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 85.5 m -74.01 -5.79 43.5 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.388 1.075 . . . . 0.0 111.6 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.33 27.32 18.41 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -173.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.459 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 3.1 t 53.96 -173.13 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.287 1.835 . . . . 0.0 111.095 -169.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.93 -34.4 1.25 Allowed Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.414 1.483 . . . . 0.0 114.818 173.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 78.2 t -58.67 126.07 15.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 118.502 1.151 . . . . 0.0 108.679 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -82.04 73.31 9.09 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.455 1.102 . . . . 0.0 110.317 -169.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.2 mt -58.9 143.01 84.16 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 118.28 -0.867 . . . . 0.0 108.871 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.1 156.59 9.76 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.208 2.605 . . . . 0.0 112.458 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.57 -20.46 65.67 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.72 1.613 . . . . 0.0 115.172 -169.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.83 -24.8 66.2 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 120.576 -1.328 . . . . 0.0 112.067 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -70.33 -8.9 54.1 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.215 1.006 . . . . 0.0 111.884 171.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.2 t -105.83 -30.56 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 119.831 1.196 . . . . 0.0 110.517 -174.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.8 p -73.8 -14.48 61.11 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.114 0.966 . . . . 0.0 112.911 -174.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -44.25 154.19 0.12 Allowed 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 129.835 3.254 . . . . 0.0 112.075 169.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -63.01 -38.72 92.32 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.735 1.614 . . . . 0.0 109.45 169.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.5 mt -126.95 131.11 71.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 174.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -137.95 109.84 7.18 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 101.126 -3.657 . . . . 0.0 101.126 166.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.86 165.99 23.72 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.459 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 11.1 t70 -130.62 103.91 6.9 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 169.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 53.0 m0 -76.35 73.12 3.13 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 174.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -58.99 42.9 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.87 1 C-N-CA 131.865 4.066 . . . . 0.0 111.755 169.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.36 -172.69 1.2 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.714 1.206 . . . . 0.0 112.128 -168.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -50.96 161.64 0.35 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.344 1.458 . . . . 0.0 111.745 172.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -117.42 101.22 52.83 Favored Pre-proline 0 C--N 1.323 -0.557 0 C-N-CA 126.313 1.845 . . . . 0.0 108.766 -176.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -79.08 -4.5 13.91 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.071 2.514 . . . . 0.0 113.064 175.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.8 t70 23.26 -96.6 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 128.536 2.735 . . . . 0.0 114.238 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.84 38.31 1.83 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 127.105 2.288 . . . . 0.0 109.51 169.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -71.67 -178.0 2.09 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.238 1.815 . . . . 0.0 112.775 -174.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.0 m -62.55 155.2 26.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 113.52 -1.673 . . . . 0.0 109.047 172.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 27.0 mt -56.43 -30.82 63.3 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 123.09 0.556 . . . . 0.0 110.805 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.35 -40.04 92.81 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 118.636 0.653 . . . . 0.0 110.811 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.4 t -72.32 -44.02 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 117.361 -1.304 . . . . 0.0 108.781 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -48.01 -48.71 32.58 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 120.181 1.355 . . . . 0.0 111.383 170.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -60.64 -45.13 95.23 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.948 0.795 . . . . 0.0 111.364 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.7 m -68.58 -44.32 74.66 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -173.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 19.7 t -67.68 -43.47 86.65 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -174.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -47.37 -56.4 6.98 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 124.638 1.175 . . . . 0.0 110.825 171.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.66 -42.49 99.68 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 119.546 1.066 . . . . 0.0 111.869 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -63.7 -38.74 92.26 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 121.317 -1.108 . . . . 0.0 111.803 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.5 t -62.52 -41.42 91.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -37.29 76.75 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 119.805 1.184 . . . . 0.0 111.184 -175.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -70.11 -41.05 74.5 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 118.695 -0.669 . . . . 0.0 110.722 176.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -64.4 -43.74 93.46 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.948 1.249 . . . . 0.0 110.214 177.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 66.7 t -54.38 -52.02 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 123.782 0.833 . . . . 0.0 109.536 173.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -66.29 -34.46 78.04 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 118.057 0.39 . . . . 0.0 111.634 -175.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -61.74 -48.91 78.58 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.313 0.645 . . . . 0.0 110.897 172.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.5 -45.06 89.53 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 122.882 0.473 . . . . 0.0 109.937 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.6 mt -58.38 -42.71 84.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 123.489 0.715 . . . . 0.0 109.576 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.04 -28.11 68.61 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -68.19 -53.53 24.26 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.022 0.828 . . . . 0.0 110.431 172.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -84.33 -40.5 15.48 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 -169.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--O 1.255 1.345 0 CA-C-N 119.554 1.07 . . . . 0.0 112.486 -169.638 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.5 2.03 0 CA-C-O 117.491 -1.242 . . . . 0.0 109.208 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.44 123.54 15.07 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 121.509 1.959 . . . . 0.0 109.812 -172.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -92.47 142.05 27.84 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -170.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.5 t -123.66 152.21 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 O-C-N 124.381 1.051 . . . . 0.0 108.385 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 53.8 tpp -137.29 143.94 42.4 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -126.23 119.56 27.77 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.8 t -103.86 131.14 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -169.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.8 t -123.56 -174.76 3.04 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.624 1.57 . . . . 0.0 110.314 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -158.59 -63.63 0.08 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 169.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.3 ttm105 -70.66 135.15 48.15 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 122.333 0.253 . . . . 0.0 111.272 -175.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 65.4 t30 42.91 25.74 0.06 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.72 2.808 . . . . 0.0 115.877 168.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.4 m 29.45 64.87 0.13 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.177 2.191 . . . . 0.0 114.395 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 p -139.38 -71.88 0.39 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 116.593 -1.67 . . . . 0.0 115.129 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.262 20.0 ptt180 -44.18 -45.68 8.48 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 122.355 2.343 . . . . 0.0 116.035 -168.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.04 -30.69 15.17 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.486 -0.759 . . . . 0.0 111.215 -174.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -62.11 -37.14 83.97 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.857 -1.152 . . . . 0.0 108.677 169.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.423 ' SD ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -64.25 -39.49 94.06 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 121.146 -0.971 . . . . 0.0 110.681 172.203 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.56 -34.5 74.26 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 118.633 -0.699 . . . . 0.0 110.326 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -64.24 -40.78 96.72 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-N 118.979 0.809 . . . . 0.0 110.172 169.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.29 -43.55 98.92 Favored Glycine 0 C--N 1.339 0.697 0 CA-C-N 120.009 1.277 . . . . 0.0 111.33 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.423 ' CD2' ' SD ' ' A' ' 17' ' ' MET . 7.2 m-85 -68.24 -38.31 81.69 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 118.571 1.186 . . . . 0.0 109.847 172.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.83 -37.11 70.36 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 119.642 1.11 . . . . 0.0 111.171 -172.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.4 pttt -71.34 -27.14 63.16 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 119.868 1.213 . . . . 0.0 111.867 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 m -72.58 -50.8 22.98 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.184 1.794 . . . . 0.0 110.331 175.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.1 mt -88.76 -28.36 20.54 Favored 'General case' 0 CA--C 1.53 0.212 0 C-N-CA 124.74 1.216 . . . . 0.0 112.056 -169.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.59 15.14 60.17 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.878 2.18 . . . . 0.0 111.423 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.56 120.11 8.81 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.706 1.203 . . . . 0.0 110.012 -173.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.65 9.05 87.12 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.692 -0.504 . . . . 0.0 113.48 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -123.1 -24.02 4.81 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.348 1.459 . . . . 0.0 110.026 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.9 pt -146.08 171.85 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 125.972 1.709 . . . . 0.0 110.124 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.82 143.81 42.15 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 168.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.6 t -137.34 138.14 45.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 118.907 0.776 . . . . 0.0 111.178 -168.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.4 m -144.86 166.42 25.31 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.203 1.401 . . . . 0.0 109.841 178.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.5 p -136.37 161.78 34.87 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.594 -1.316 . . . . 0.0 108.899 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.4 p -159.07 176.27 12.47 Favored 'General case' 0 C--O 1.233 0.226 0 O-C-N 121.556 -0.715 . . . . 0.0 109.491 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.2 38.78 38.65 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -176.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.88 139.89 58.76 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 103.052 -2.944 . . . . 0.0 103.052 168.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -54.6 -23.86 18.75 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.24 1.016 . . . . 0.0 112.893 -174.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 89.2 p 129.46 -28.08 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 1 C-N-CA 132.468 4.307 . . . . 0.0 110.817 -169.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.0 m -72.13 141.0 49.14 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 113.448 -1.705 . . . . 0.0 107.606 169.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -83.67 112.32 19.94 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 175.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 m 46.63 -166.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 127.47 2.308 . . . . 0.0 114.423 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -149.55 116.17 3.62 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -65.35 -29.35 54.39 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.018 2.479 . . . . 0.0 112.176 -169.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.6 m -64.21 -37.5 87.69 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.91 -42.25 90.42 Favored 'General case' 0 C--O 1.219 -0.536 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.73 -48.4 86.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 118.457 -0.783 . . . . 0.0 109.286 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.98 -42.74 98.93 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.228 0.922 . . . . 0.0 110.992 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 24.6 mmt -64.87 -21.24 66.77 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.962 0.905 . . . . 0.0 112.102 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.1 mmt -91.49 -29.16 17.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 119.305 0.957 . . . . 0.0 110.175 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.24 -29.38 70.16 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.897 0.879 . . . . 0.0 110.491 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -56.39 -25.58 50.34 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.047 0.939 . . . . 0.0 112.489 170.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.5 m -121.95 12.74 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.987 1.315 . . . . 0.0 111.056 -173.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.2 37.4 81.25 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.361 -0.688 . . . . 0.0 112.385 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.6 mt -121.87 153.74 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -129.92 127.63 40.52 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 37.3 pt -132.02 9.73 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 C-N-CA 123.303 0.641 . . . . 0.0 111.931 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.16 -32.18 61.22 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.355 1.462 . . . . 0.0 112.456 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.06 3.83 69.33 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.551 -0.583 . . . . 0.0 112.841 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -76.1 -175.42 3.1 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.225 1.01 . . . . 0.0 111.847 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.43 171.14 1.14 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.013 2.525 . . . . 0.0 114.999 -169.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.2 m -144.74 21.55 1.63 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.426 1.49 . . . . 0.0 111.699 -169.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -139.59 160.13 62.63 Favored Pre-proline 0 N--CA 1.471 0.578 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -168.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.7 165.58 24.61 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 124.724 3.616 . . . . 0.0 112.454 175.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.4 tt -59.93 -34.55 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.384 1.474 . . . . 0.0 111.971 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -68.89 -21.56 64.23 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -169.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.49 -16.44 56.04 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.161 172.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -89.67 171.3 9.76 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.237 0.926 . . . . 0.0 110.706 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.24 88.57 1.73 Allowed 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.236 1.414 . . . . 0.0 108.912 -173.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -49.86 -29.71 8.59 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.805 0.842 . . . . 0.0 113.168 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -48.76 -33.98 11.35 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.282 1.033 . . . . 0.0 112.034 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -73.51 -23.11 59.98 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -99.43 -177.66 3.66 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 127.547 2.339 . . . . 0.0 109.796 -174.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -123.19 -20.52 5.67 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.1 t -142.86 130.09 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 -169.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.8 m -135.27 135.76 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 O-C-N 120.825 -1.172 . . . . 0.0 108.368 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.1 mm -130.37 100.27 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 -172.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 77.4 p -80.83 159.91 24.96 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 119.042 -1.063 . . . . 0.0 109.461 173.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.4 mp -137.39 53.54 1.86 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 103.009 -2.96 . . . . 0.0 103.009 169.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 60.1 m -107.9 18.86 20.79 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.623 1.969 . . . . 0.0 108.774 -176.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.46 21.86 76.24 Favored Glycine 0 C--N 1.344 0.972 0 CA-C-O 118.785 -1.008 . . . . 0.0 112.548 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.4 p 53.52 -8.7 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.504 3.122 . . . . 0.0 117.418 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.97 -27.94 73.47 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 119.248 0.931 . . . . 0.0 112.005 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.0 t -65.99 113.63 2.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -76.19 105.59 7.32 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 104.154 -2.536 . . . . 0.0 104.154 168.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.5 mt -72.9 154.61 90.95 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.26 158.29 12.44 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.906 2.404 . . . . 0.0 112.487 173.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.84 -24.02 68.41 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 121.727 1.618 . . . . 0.0 115.717 -169.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -67.99 -24.3 65.12 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 120.705 -1.247 . . . . 0.0 111.835 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -72.6 -7.57 50.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.318 1.047 . . . . 0.0 111.756 172.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.2 t -105.34 -30.52 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 120.213 1.37 . . . . 0.0 110.309 -174.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.9 p -74.19 -13.11 60.75 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.242 1.017 . . . . 0.0 112.88 -175.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -45.29 154.64 0.16 Allowed 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 129.898 3.279 . . . . 0.0 112.468 169.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -64.33 -39.03 93.08 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.203 1.801 . . . . 0.0 109.347 170.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 31.1 mm -127.44 135.65 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 171.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -137.67 104.27 5.26 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 100.773 -3.788 . . . . 0.0 100.773 166.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -127.25 169.93 12.99 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 174.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -142.44 137.12 30.13 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 169.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -107.19 6.29 28.57 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -172.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 42.88 -70.78 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 131.282 3.833 . . . . 0.0 112.678 -172.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.423 ' CD1' ' H ' ' A' ' 102' ' ' GLU 0.26 0.3 OUTLIER 52.69 -174.41 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.507 1 C-N-CA 132.977 4.511 . . . . 0.0 114.891 177.012 . . . . . . . . 5 4 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.423 ' H ' ' CD1' ' A' ' 101' ' ' LEU . 27.0 mt-10 -62.19 172.28 1.51 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.065 1.746 . . . . 0.0 109.867 -175.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -129.15 72.23 81.99 Favored Pre-proline 0 C--N 1.323 -0.556 0 C-N-CA 125.135 1.374 . . . . 0.0 111.249 -168.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.6 68.25 5.43 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 124.481 3.454 . . . . 0.0 113.489 -172.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -64.68 -33.01 74.95 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.348 1.059 . . . . 0.0 112.902 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 154.46 92.35 0.09 OUTLIER Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.933 1.73 . . . . 0.0 109.209 -175.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.85 -167.94 1.8 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.458 1.503 . . . . 0.0 111.451 -169.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.2 p -70.89 157.92 37.32 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 113.424 -1.717 . . . . 0.0 108.162 168.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.1 mt -61.07 -31.63 71.29 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 121.842 -0.536 . . . . 0.0 111.292 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -58.58 -38.61 78.26 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.279 0.632 . . . . 0.0 111.088 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 42.9 t -72.93 -43.6 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 117.172 -1.394 . . . . 0.0 108.594 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -52.78 -46.73 67.73 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.757 1.617 . . . . 0.0 111.591 171.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -58.86 -43.68 90.88 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.758 0.708 . . . . 0.0 111.04 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.0 m -68.13 -44.23 76.55 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -175.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.1 t -62.5 -52.82 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -42.25 -58.99 1.96 Allowed 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 126.1 1.76 . . . . 0.0 110.974 169.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.46 -43.23 99.6 Favored Glycine 0 CA--C 1.524 0.607 0 CA-C-N 119.796 1.18 . . . . 0.0 111.632 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -63.93 -38.87 92.69 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 120.616 -1.52 . . . . 0.0 111.563 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.5 t -60.28 -40.48 83.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 118.374 -0.822 . . . . 0.0 108.835 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -42.58 76.62 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.623 1.101 . . . . 0.0 110.425 -177.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -65.86 -43.34 88.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 119.426 -0.321 . . . . 0.0 110.385 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -70.55 -41.2 72.8 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.919 0.782 . . . . 0.0 109.844 -176.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 64.8 t -53.37 -52.92 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 123.31 0.644 . . . . 0.0 109.486 172.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.99 -33.1 75.23 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 122.212 -0.305 . . . . 0.0 111.491 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -61.81 -47.54 84.65 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.078 0.551 . . . . 0.0 111.135 172.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -46.93 84.39 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 118.259 0.482 . . . . 0.0 110.089 176.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -57.81 -42.22 81.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 123.473 0.709 . . . . 0.0 109.557 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.03 -30.26 70.84 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 118.909 0.777 . . . . 0.0 111.798 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -72.89 -44.23 61.53 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 118.346 -0.835 . . . . 0.0 111.623 172.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 21.3 pt -101.96 -43.85 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 118.465 2.765 . . . . 0.0 118.465 -168.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.0 m . . . . . 0 C--O 1.254 1.317 0 CA-C-O 116.692 -1.623 . . . . 0.0 111.536 -169.236 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.498 1.958 0 CA-C-O 118.91 -0.566 . . . . 0.0 109.848 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -64.65 128.58 36.39 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.565 1.53 . . . . 0.0 107.967 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -94.89 143.06 26.77 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -173.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.3 t -121.78 153.23 25.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 O-C-N 124.457 1.098 . . . . 0.0 108.631 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.4 mmt -129.13 138.78 52.0 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -119.7 100.09 7.05 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 170.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.7 t -84.64 116.78 28.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -168.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.9 m -82.75 167.5 18.11 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.848 0.833 . . . . 0.0 112.339 -171.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.0 mtpp -159.02 170.88 21.09 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 127.57 2.348 . . . . 0.0 105.6 169.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.02 -143.66 0.73 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.081 0.952 . . . . 0.0 108.49 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.441 HD22 ' CG ' ' A' ' 43' ' ' HIS . 60.6 t30 -72.67 1.78 7.72 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.405 -0.809 . . . . 0.0 112.426 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.3 m 65.57 -1.49 1.0 Allowed 'General case' 0 C--N 1.348 0.526 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 169.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 p -59.02 -45.94 89.46 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 119.953 1.251 . . . . 0.0 111.613 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -58.38 -35.34 71.84 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 119.406 1.003 . . . . 0.0 113.039 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.79 -40.49 10.17 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.565 1.146 . . . . 0.0 110.942 -169.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -64.53 -35.05 79.71 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.511 0.724 . . . . 0.0 110.01 169.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.459 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.6 tpt -63.05 -39.77 95.73 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 121.394 -0.816 . . . . 0.0 110.983 169.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.48 -36.98 79.58 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 118.439 -0.791 . . . . 0.0 109.647 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -63.11 -42.5 99.56 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.938 0.79 . . . . 0.0 110.373 169.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.24 -42.14 99.72 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 120.385 1.448 . . . . 0.0 112.226 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -69.26 -41.18 77.25 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 117.983 0.891 . . . . 0.0 109.322 172.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.63 -35.44 70.43 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 119.747 1.158 . . . . 0.0 111.565 -172.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -72.58 -21.89 61.07 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.809 1.186 . . . . 0.0 112.177 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 m -80.68 -50.63 9.66 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.352 1.861 . . . . 0.0 109.693 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.1 mt -88.55 -26.96 21.7 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.13 1.372 . . . . 0.0 111.599 -169.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.05 17.71 47.81 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 127.121 2.296 . . . . 0.0 111.525 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.74 121.56 12.57 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.628 1.171 . . . . 0.0 109.739 -172.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.38 9.29 85.91 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 119.869 -0.406 . . . . 0.0 113.54 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.402 ' O ' ' HE2' ' A' ' 2' ' ' LYS . 31.3 mmtp -124.44 -28.51 3.62 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 125.868 1.667 . . . . 0.0 110.532 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.2 pt -141.55 162.32 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 124.308 1.043 . . . . 0.0 109.222 173.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.25 144.43 29.28 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 103.339 -2.838 . . . . 0.0 103.339 167.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 t -133.43 142.06 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 118.821 0.737 . . . . 0.0 111.275 -167.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.31 148.96 28.8 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.936 0.894 . . . . 0.0 110.202 -175.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.7 p -131.75 117.01 18.02 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 175.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.1 m -141.93 165.46 27.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 119.186 0.903 . . . . 0.0 111.044 -169.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.33 33.73 27.85 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -169.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mp -67.05 120.17 13.22 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 101.359 -3.571 . . . . 0.0 101.359 169.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.95 86.91 0.36 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.532 1.06 . . . . 0.0 113.262 -168.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.5 m 48.81 34.1 4.99 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.743 2.017 . . . . 0.0 112.233 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.8 m -144.83 165.94 26.68 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.545 1.538 . . . . 0.0 108.985 -170.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -97.53 -174.99 3.06 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.085 0.954 . . . . 0.0 109.684 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 m -58.09 172.25 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 124.308 1.043 . . . . 0.0 111.4 172.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.441 ' CG ' HD22 ' A' ' 11' ' ' ASN . 85.0 t60 -133.45 120.78 15.99 Favored Pre-proline 0 N--CA 1.448 -0.562 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -66.69 -26.16 46.05 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.559 2.839 . . . . 0.0 112.321 -169.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.6 m -61.01 -37.05 81.18 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.004 0.82 . . . . 0.0 109.154 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.18 -44.12 84.94 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.3 -48.08 85.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 CA-C-O 118.278 -0.868 . . . . 0.0 108.874 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.92 98.3 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.293 0.951 . . . . 0.0 111.182 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.5 mmt -60.66 -25.22 66.18 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.395 1.078 . . . . 0.0 112.974 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.459 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -95.39 -33.1 12.63 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -178.074 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -61.77 -37.23 83.55 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.305 1.042 . . . . 0.0 110.158 174.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -71.64 0.37 8.86 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.7 m -130.14 13.87 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 125.983 1.713 . . . . 0.0 111.435 169.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.26 33.56 48.68 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 121.134 -0.979 . . . . 0.0 114.159 171.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.7 mt -125.41 160.79 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.994 1.718 . . . . 0.0 107.367 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -139.98 140.52 36.32 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.221 1.008 . . . . 0.0 108.928 175.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.8 pt -138.27 11.96 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 126.633 1.973 . . . . 0.0 110.001 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.9 p -62.27 145.01 54.86 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.945 0.793 . . . . 0.0 110.669 175.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.23 8.21 6.23 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 117.094 -1.948 . . . . 0.0 114.659 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -50.08 -61.03 2.39 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-N 120.067 1.933 . . . . 0.0 113.08 -172.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -159.01 159.33 34.65 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.461 1.104 . . . . 0.0 108.794 -169.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.5 m -163.04 43.96 0.12 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.862 1.665 . . . . 0.0 107.699 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -134.8 149.68 71.31 Favored Pre-proline 0 N--CA 1.47 0.563 0 O-C-N 121.493 -0.754 . . . . 0.0 111.847 -168.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -83.12 158.33 15.29 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 124.144 3.229 . . . . 0.0 112.282 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.4 tt -62.98 -35.64 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 125.235 1.414 . . . . 0.0 112.198 -175.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -70.0 -20.55 63.28 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.611 0.364 . . . . 0.0 111.917 -171.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.51 -13.98 59.57 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 118.853 -0.594 . . . . 0.0 112.236 172.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -101.2 168.79 9.34 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.26 1.024 . . . . 0.0 110.853 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.73 91.67 2.33 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 -170.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.403 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -50.96 -31.94 19.44 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.52 -28.46 13.66 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.379 1.072 . . . . 0.0 112.177 176.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -70.88 -20.85 62.47 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.204 0.601 . . . . 0.0 112.368 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -106.9 175.13 5.6 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 128.624 2.77 . . . . 0.0 108.292 -174.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -118.64 -17.09 9.35 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.3 t -142.19 129.01 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -169.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.6 t -124.44 128.4 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.7 mm -121.68 96.63 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 102.119 -3.289 . . . . 0.0 102.119 169.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.4 p -72.66 164.11 27.01 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 118.019 -1.472 . . . . 0.0 107.884 169.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.6 mp -135.66 36.29 2.9 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 172.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 35.5 m -90.92 5.65 47.77 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.76 1.624 . . . . 0.0 110.761 -172.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.55 22.29 26.89 Favored Glycine 0 C--N 1.339 0.725 0 CA-C-O 119.565 -0.575 . . . . 0.0 111.955 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.406 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 5.4 t 46.88 40.68 9.49 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.941 1.696 . . . . 0.0 112.344 -177.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -149.79 35.33 1.02 Allowed Glycine 0 C--N 1.34 0.759 0 C-N-CA 123.793 0.711 . . . . 0.0 111.661 -171.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.2 t -121.18 130.09 75.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 124.965 1.306 . . . . 0.0 107.948 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -78.93 70.58 5.29 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 173.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.28 145.46 81.31 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-O 118.488 -0.768 . . . . 0.0 109.1 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -54.07 157.07 11.55 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.973 2.448 . . . . 0.0 111.924 172.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.3 -24.42 65.03 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 121.866 1.71 . . . . 0.0 114.949 -169.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -64.71 -23.68 67.33 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 120.63 -1.293 . . . . 0.0 111.974 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.403 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 77.4 m95 -73.42 -11.34 60.44 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.649 1.18 . . . . 0.0 112.866 176.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.2 m -118.53 -14.84 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 119.715 1.143 . . . . 0.0 112.822 -176.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.1 p -77.56 -11.12 59.82 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.968 0.804 . . . . 0.0 112.061 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -47.15 156.29 0.24 Allowed 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 129.675 3.19 . . . . 0.0 111.138 169.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -64.04 -38.43 91.03 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.828 1.651 . . . . 0.0 109.872 171.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.1 mt -122.35 133.98 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 173.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -142.96 111.64 6.35 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 103.555 -2.757 . . . . 0.0 103.555 167.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -138.99 170.6 15.69 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 173.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.406 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.8 t70 -136.62 108.35 7.03 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 169.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.426 ' C ' ' H ' ' A' ' 101' ' ' LEU . 49.2 m0 -81.85 70.57 8.78 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -49.49 13.86 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 131.488 3.915 . . . . 0.0 115.916 170.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.426 ' H ' ' C ' ' A' ' 99' ' ' TRP . 3.7 mm? -60.02 124.69 20.98 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 126.075 1.75 . . . . 0.0 112.622 -168.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 48.08 -161.44 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.344 2.258 . . . . 0.0 114.915 169.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -156.48 77.95 4.18 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 128.371 2.668 . . . . 0.0 107.448 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.71 -15.03 15.48 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.495 2.13 . . . . 0.0 112.99 -172.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.3 t0 27.56 -101.7 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.565 2.346 . . . . 0.0 113.092 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.51 43.43 1.28 Allowed Glycine 0 CA--C 1.532 1.129 0 C-N-CA 126.734 2.111 . . . . 0.0 109.431 171.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -67.5 -176.73 0.64 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.881 1.672 . . . . 0.0 112.614 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.5 m -59.54 154.12 18.12 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.884 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.4 mt -56.67 -30.33 63.28 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 122.957 0.503 . . . . 0.0 111.038 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.93 -40.66 96.24 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 118.677 -0.678 . . . . 0.0 110.926 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 42.0 t -72.81 -41.35 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 117.803 -1.094 . . . . 0.0 108.867 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -49.37 -51.68 33.27 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.717 1.144 . . . . 0.0 110.921 169.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -59.45 -45.14 92.42 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.799 0.727 . . . . 0.0 111.37 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 94.5 m -69.78 -45.76 67.27 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -171.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.6 t -69.6 -42.16 80.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 -172.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.9 ttp180 -48.09 -53.63 15.9 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 124.853 1.261 . . . . 0.0 110.612 169.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.86 -40.58 99.42 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 119.296 0.953 . . . . 0.0 112.042 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -65.37 -38.51 90.27 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.321 -1.105 . . . . 0.0 111.066 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 48.5 t -62.69 -41.65 93.1 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -38.33 84.59 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 119.779 1.172 . . . . 0.0 111.661 -173.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -68.82 -42.77 76.77 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 119.101 -0.475 . . . . 0.0 109.762 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.2 mtt180 -65.93 -40.3 91.29 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.187 0.903 . . . . 0.0 111.156 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.4 t -54.82 -51.7 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 172.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -64.84 -33.55 76.26 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 122.099 -0.375 . . . . 0.0 111.822 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -65.08 -46.06 82.67 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 123.002 0.521 . . . . 0.0 111.269 174.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -45.63 91.14 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.7 mt -58.47 -39.94 76.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.32 -26.65 68.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.924 0.784 . . . . 0.0 112.488 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -72.52 -46.32 55.15 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 119.163 0.892 . . . . 0.0 111.783 173.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.8 pt -103.67 -33.89 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 117.75 2.5 . . . . 0.0 117.75 -168.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 C--O 1.255 1.392 0 CA-C-N 119.529 1.059 . . . . 0.0 111.066 -174.747 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.927 0 CA-C-O 118.868 -0.587 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.437 ' HE2' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -66.11 137.63 57.18 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.641 1.564 . . . . 0.0 107.59 175.328 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -105.99 140.93 38.23 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -171.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.8 t -118.31 151.73 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.5 tpp -137.94 141.55 40.55 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 177.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -116.54 150.29 38.2 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 172.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 t -134.18 137.77 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 120.491 1.496 . . . . 0.0 107.118 -170.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 t -126.47 156.39 40.76 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.522 0.729 . . . . 0.0 110.601 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -135.84 33.02 2.94 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.176 1.39 . . . . 0.0 109.474 170.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.57 -178.77 6.74 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 127.95 2.5 . . . . 0.0 106.186 -175.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -48.51 124.06 7.6 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 170.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.0 m -33.7 -30.06 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 129.592 3.157 . . . . 0.0 117.711 -174.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.3 m -38.87 -61.0 0.78 Allowed 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 126.714 2.006 . . . . 0.0 114.69 -169.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.259 39.4 ptt180 -63.17 -46.37 87.47 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.229 1.377 . . . . 0.0 113.161 -169.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.63 -28.53 19.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 118.776 0.716 . . . . 0.0 111.368 -172.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -74.0 -27.95 61.21 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 120.828 -1.17 . . . . 0.0 110.605 171.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.461 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.8 tpt -64.49 -40.67 96.09 Favored 'General case' 0 CA--C 1.51 -0.586 0 O-C-N 120.844 -1.16 . . . . 0.0 108.37 169.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.48 -38.26 83.71 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -61.26 -39.96 92.29 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 118.63 -0.7 . . . . 0.0 111.156 169.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.07 -44.91 86.69 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 120.448 1.476 . . . . 0.0 112.392 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -65.32 -39.98 93.14 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.06 -37.09 69.72 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 118.951 0.796 . . . . 0.0 111.221 -173.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -68.97 -28.61 66.78 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.076 1.307 . . . . 0.0 111.74 174.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.8 m -74.76 -51.73 13.38 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.845 1.658 . . . . 0.0 110.35 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.4 mt -88.22 -26.51 22.33 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.727 1.211 . . . . 0.0 112.057 -169.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.65 17.21 50.5 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.796 2.141 . . . . 0.0 111.454 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.35 120.8 9.98 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.909 1.284 . . . . 0.0 109.954 -172.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.53 11.42 84.38 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 119.505 -0.608 . . . . 0.0 113.439 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.437 ' O ' ' HE2' ' A' ' 2' ' ' LYS . 74.6 mmtt -127.11 -26.95 3.04 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 125.346 1.459 . . . . 0.0 110.535 -176.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.6 pt -141.37 161.09 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 124.531 1.132 . . . . 0.0 108.66 172.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.6 144.55 27.78 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 167.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.42 142.56 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 118.93 0.786 . . . . 0.0 111.333 -168.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.26 159.5 40.08 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.097 -174.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.4 p -136.88 162.65 32.67 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 121.433 1.924 . . . . 0.0 110.106 169.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.3 p -151.22 165.39 34.08 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.761 1.164 . . . . 0.0 111.262 -177.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.83 -85.72 0.41 Allowed Glycine 0 C--N 1.332 0.34 0 N-CA-C 105.51 -3.036 . . . . 0.0 105.51 -172.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 51.9 59.11 4.78 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.376 1.07 . . . . 0.0 108.24 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -66.27 -14.41 61.93 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.282 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.6 p -81.52 19.94 0.95 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.753 0.787 . . . . 0.0 112.202 169.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.6 m 66.46 -38.81 0.32 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 130.857 3.663 . . . . 0.0 114.503 177.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -143.52 -178.97 6.15 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.836 1.654 . . . . 0.0 108.145 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.7 t -48.29 150.83 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 125.269 1.428 . . . . 0.0 110.317 169.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -127.07 115.37 21.89 Favored Pre-proline 0 N--CA 1.448 -0.53 0 C-N-CA 125.332 1.453 . . . . 0.0 107.683 -173.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -69.16 -24.96 31.82 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.429 2.753 . . . . 0.0 113.257 -168.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.5 m -62.75 -39.49 94.29 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-N 119.94 1.245 . . . . 0.0 108.415 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.72 98.78 Favored 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.14 -48.92 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 118.297 -0.858 . . . . 0.0 109.544 177.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.75 -43.64 85.56 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 119.08 0.855 . . . . 0.0 110.627 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -20.21 65.17 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.483 0.713 . . . . 0.0 110.635 -175.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.461 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -96.38 -28.43 14.47 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.355 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.25 -29.23 70.6 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.755 1.222 . . . . 0.0 110.376 170.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -56.6 -23.18 39.0 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.855 0.862 . . . . 0.0 112.301 170.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.0 m -126.71 13.7 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 125.963 1.705 . . . . 0.0 111.166 -175.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.58 37.93 78.2 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 119.16 -0.8 . . . . 0.0 113.209 174.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.4 mt -125.76 154.61 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.708 1.603 . . . . 0.0 107.403 176.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -126.8 143.92 51.12 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.702 1.601 . . . . 0.0 108.639 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.3 pt -138.07 9.06 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 125.551 1.54 . . . . 0.0 110.915 174.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.47 151.39 45.17 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.624 1.17 . . . . 0.0 107.944 168.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.04 -3.24 14.24 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.585 -1.119 . . . . 0.0 113.474 -175.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -69.46 -175.96 0.91 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.498 1.649 . . . . 0.0 109.956 169.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.4 p -50.46 164.54 0.12 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.887 2.475 . . . . 0.0 114.766 -173.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.0 p -156.91 39.99 0.32 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.306 1.842 . . . . 0.0 109.769 177.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -141.03 150.01 57.72 Favored Pre-proline 0 CA--C 1.542 0.67 0 O-C-N 121.354 -0.841 . . . . 0.0 111.683 -169.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.38 165.53 23.16 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.892 3.061 . . . . 0.0 112.518 -174.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.5 tt -57.8 -39.32 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 125.073 1.349 . . . . 0.0 110.843 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.92 -18.13 61.43 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -170.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.23 -22.23 58.06 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 118.858 -0.591 . . . . 0.0 111.446 169.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -92.14 168.38 11.4 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.875 0.845 . . . . 0.0 110.64 -178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -142.34 94.6 2.68 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 103.336 -2.839 . . . . 0.0 103.336 -174.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.31 -28.01 50.77 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -176.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.36 -28.35 19.11 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.995 0.918 . . . . 0.0 112.415 175.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -70.74 -22.63 62.39 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.16 0.436 . . . . 0.0 112.086 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -106.07 -178.7 3.72 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 129.352 3.061 . . . . 0.0 108.286 -174.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -131.74 -2.44 3.74 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 171.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.8 t -141.71 126.92 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 -177.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.8 m -131.28 135.45 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 O-C-N 120.868 -1.145 . . . . 0.0 108.246 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.7 mm -134.61 80.69 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -169.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.8 t -68.41 164.51 20.8 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.818 177.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -140.75 55.46 1.58 Allowed 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 169.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 81.8 m -106.12 8.9 32.39 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.854 1.262 . . . . 0.0 109.705 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.7 31.5 10.14 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-O 119.209 -0.773 . . . . 0.0 111.639 169.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.8 p 46.59 -10.1 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 130.391 3.476 . . . . 0.0 119.244 -174.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.82 -13.87 82.65 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 120.133 1.333 . . . . 0.0 113.065 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 p -58.9 151.07 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 122.817 1.294 . . . . 0.0 109.202 172.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -124.39 81.28 1.92 Allowed 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 103.741 -2.689 . . . . 0.0 103.741 178.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.8 mt -62.65 150.09 87.38 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.28 158.69 11.67 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.659 2.239 . . . . 0.0 113.316 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.01 -36.3 53.55 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.964 2.443 . . . . 0.0 116.716 -169.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.2 pm0 -67.34 -25.82 66.19 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.323 -0.861 . . . . 0.0 112.133 -176.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -70.44 -9.73 57.23 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.93 1.292 . . . . 0.0 112.088 174.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.2 t -96.62 -29.59 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 119.225 0.921 . . . . 0.0 109.438 175.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.7 p -86.2 56.71 4.11 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.68 1.192 . . . . 0.0 110.502 -174.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -130.47 156.32 44.97 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 128.762 2.825 . . . . 0.0 107.96 -169.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -65.71 -39.23 91.0 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 125.752 1.621 . . . . 0.0 109.005 169.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 25.9 mm -128.7 137.17 58.02 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-O 121.113 0.482 . . . . 0.0 110.294 170.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -135.14 110.03 8.74 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 100.833 -3.765 . . . . 0.0 100.833 166.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.91 165.04 24.79 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 176.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -139.52 105.45 5.18 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 170.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -77.52 87.25 3.85 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 125.223 1.409 . . . . 0.0 107.475 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -65.75 23.07 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 126.613 1.965 . . . . 0.0 114.045 -175.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.16 176.39 0.6 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.628 1.971 . . . . 0.0 111.763 -170.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -54.3 162.44 1.07 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 123.444 1.593 . . . . 0.0 113.582 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -117.68 105.97 46.97 Favored Pre-proline 0 C--N 1.316 -0.866 0 C-N-CA 126.376 1.87 . . . . 0.0 108.396 -170.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.76 16.84 1.23 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.475 2.117 . . . . 0.0 112.181 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -24.84 85.02 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 129.584 3.154 . . . . 0.0 115.441 174.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 44.8 32.03 2.91 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 124.633 1.111 . . . . 0.0 113.959 -174.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -79.72 -179.7 7.05 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 122.492 1.139 . . . . 0.0 112.813 -169.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.1 p -61.07 160.04 10.72 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 113.55 -1.659 . . . . 0.0 109.602 172.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.6 mt -58.03 -30.27 66.0 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 122.667 0.387 . . . . 0.0 110.597 175.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -64.24 -40.0 95.11 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 118.532 -0.746 . . . . 0.0 111.157 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.0 t -72.61 -40.15 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 118.923 -1.111 . . . . 0.0 109.513 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -50.27 -50.68 49.5 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 119.45 1.023 . . . . 0.0 110.524 169.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -60.91 -44.99 96.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.549 0.739 . . . . 0.0 111.31 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.5 m -69.5 -45.59 68.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -172.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 49.3 t -65.75 -46.84 87.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -171.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -42.74 -56.47 3.17 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 125.061 1.344 . . . . 0.0 111.041 169.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.84 -40.93 98.89 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 119.79 1.177 . . . . 0.0 111.908 -175.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -67.55 -38.24 83.86 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 121.298 -1.119 . . . . 0.0 110.941 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.3 t -61.34 -43.0 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 172.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -39.31 87.19 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 119.923 1.238 . . . . 0.0 111.827 -172.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -68.99 -42.03 77.03 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.749 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.7 mtt180 -65.61 -41.7 92.42 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.282 0.946 . . . . 0.0 111.197 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 47.2 t -54.83 -51.58 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -65.94 -33.73 76.5 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 122.134 -0.354 . . . . 0.0 111.826 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -63.33 -48.71 76.88 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 123.1 0.56 . . . . 0.0 110.345 174.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -45.7 89.48 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 109.614 -0.514 . . . . 0.0 109.614 177.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.3 mt -57.48 -43.01 82.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 123.599 0.759 . . . . 0.0 109.537 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.16 -26.64 68.62 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -71.17 -51.93 22.06 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.57 0.623 . . . . 0.0 110.446 173.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 pt -87.65 -46.1 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 -169.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 63.0 m . . . . . 0 C--O 1.254 1.334 0 CA-C-N 119.057 0.844 . . . . 0.0 110.678 -170.233 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 tpt . . . . . 0 N--CA 1.5 2.049 0 CA-C-O 118.33 -0.843 . . . . 0.0 109.659 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.415 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -57.75 118.62 5.48 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 120.727 1.603 . . . . 0.0 110.074 -169.835 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -87.89 137.61 32.18 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -171.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.2 t -117.9 154.05 19.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 124.398 1.079 . . . . 0.0 108.364 174.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 40.9 tpp -137.63 139.68 40.44 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -120.18 114.61 22.2 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.3 t -101.68 138.81 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 119.621 1.1 . . . . 0.0 108.361 -169.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -125.11 164.77 19.51 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 122.009 0.909 . . . . 0.0 111.808 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -150.27 156.0 40.75 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 129.648 3.179 . . . . 0.0 103.842 169.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.41 ' CG ' ' H ' ' A' ' 11' ' ' ASN . 9.5 ttm180 58.1 -153.66 0.37 Allowed 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -169.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.47 HD22 ' CD2' ' A' ' 43' ' ' HIS . 29.5 t-20 -59.13 123.63 17.28 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.317 0.647 . . . . 0.0 110.114 -169.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.2 m -49.84 -27.93 5.76 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.675 1.99 . . . . 0.0 113.98 -178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 26.3 p -48.55 -48.01 38.89 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 117.954 -1.022 . . . . 0.0 112.98 -169.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -60.3 -45.99 91.43 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.987 1.267 . . . . 0.0 112.721 -170.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.8 -28.27 15.99 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.077 0.853 . . . . 0.0 111.595 -174.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -68.87 -33.0 73.07 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.045 -1.034 . . . . 0.0 109.769 171.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.474 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.7 tpt -65.68 -40.15 92.08 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 121.18 -0.95 . . . . 0.0 109.63 169.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.93 -40.67 89.72 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -60.52 -42.45 96.46 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.7 169.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.45 -45.21 80.33 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 120.598 1.545 . . . . 0.0 111.514 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -63.4 -40.34 96.94 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.34 -36.13 71.42 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 119.313 0.961 . . . . 0.0 111.517 -174.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -73.32 -22.91 60.22 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 120.757 1.617 . . . . 0.0 111.921 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 m -77.02 -50.85 12.2 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.818 1.647 . . . . 0.0 110.285 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.1 mt -86.32 -27.39 24.34 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.882 1.273 . . . . 0.0 112.039 -169.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.07 13.0 55.88 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 126.918 2.199 . . . . 0.0 111.523 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.98 121.85 12.23 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.041 1.336 . . . . 0.0 109.861 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.81 8.82 87.22 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-O 119.769 -0.462 . . . . 0.0 113.462 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -124.01 -31.5 3.37 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.42 1.488 . . . . 0.0 109.068 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.7 pt -142.74 176.46 3.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 125.527 1.531 . . . . 0.0 109.508 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -118.25 149.06 41.76 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 168.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 t -137.82 143.24 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 123.172 0.589 . . . . 0.0 111.412 -167.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.9 m -150.77 161.44 42.65 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.943 1.297 . . . . 0.0 109.745 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.403 ' H ' HG23 ' A' ' 61' ' ' THR . 61.8 p -130.24 163.33 26.97 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.907 1.23 . . . . 0.0 110.241 169.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.6 p -155.45 168.26 27.68 Favored 'General case' 0 N--CA 1.463 0.193 0 O-C-N 121.112 -0.992 . . . . 0.0 110.806 178.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.97 40.24 52.23 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mp -72.79 62.19 0.57 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.003 1.321 . . . . 0.0 109.851 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 52.11 27.09 4.27 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.797 1.639 . . . . 0.0 112.749 -175.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.7 m 55.7 31.06 16.67 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.214 1.406 . . . . 0.0 111.914 -175.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.6 m -144.25 -171.98 3.69 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.985 2.114 . . . . 0.0 109.509 -169.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.43 -179.25 3.36 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.346 0.593 . . . . 0.0 110.795 172.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.6 m -56.16 170.89 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.947 1.299 . . . . 0.0 111.517 169.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.47 ' CD2' HD22 ' A' ' 11' ' ' ASN . 86.5 t60 -125.7 116.53 24.62 Favored Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -175.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -66.48 -26.09 47.73 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.657 2.905 . . . . 0.0 112.692 -169.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.7 m -60.63 -36.16 77.95 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.15 0.886 . . . . 0.0 109.122 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.38 -45.13 85.27 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -58.69 -47.41 88.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.73 -43.16 98.24 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.923 0.783 . . . . 0.0 111.032 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.4 mmt -61.81 -22.51 65.53 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.367 1.067 . . . . 0.0 112.866 177.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.474 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.3 OUTLIER -99.53 -31.34 11.67 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -177.806 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -63.94 -35.92 82.25 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.437 -0.79 . . . . 0.0 109.786 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.62 6.82 3.47 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.186 0.595 . . . . 0.0 112.542 175.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.6 t -113.32 -43.03 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 126.355 1.862 . . . . 0.0 108.71 169.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.73 26.86 1.86 Allowed Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.088 1.328 . . . . 0.0 111.894 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.5 mt -123.62 158.92 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 125.952 1.701 . . . . 0.0 106.939 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -137.91 125.94 22.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -176.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.6 pt -133.76 5.42 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.326 0 C-N-CA 124.392 1.077 . . . . 0.0 111.404 -171.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.16 143.91 56.32 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.764 1.225 . . . . 0.0 109.376 174.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.06 4.57 11.82 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 117.591 -1.672 . . . . 0.0 113.894 -177.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -53.55 -57.43 10.75 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-N 120.044 1.922 . . . . 0.0 111.785 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.403 HG23 ' H ' ' A' ' 34' ' ' SER . 2.9 p -151.43 162.39 41.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.032 -167.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.1 m -167.13 42.47 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.089 1.755 . . . . 0.0 109.192 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -137.63 150.04 66.88 Favored Pre-proline 0 N--CA 1.475 0.802 0 O-C-N 120.885 -1.135 . . . . 0.0 112.629 -169.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -83.72 162.89 14.27 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 124.213 3.275 . . . . 0.0 112.342 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.2 tt -59.21 -37.69 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.253 1.421 . . . . 0.0 111.351 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.68 -22.71 62.45 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 122.969 0.507 . . . . 0.0 111.93 -171.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -21.19 60.09 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 118.653 -0.689 . . . . 0.0 111.548 172.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -92.34 167.88 11.69 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.865 0.84 . . . . 0.0 111.272 -174.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.44 82.18 1.77 Allowed 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.648 1.579 . . . . 0.0 108.288 -170.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.405 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -52.31 -27.91 17.1 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.811 1.244 . . . . 0.0 113.712 -175.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -54.25 -33.75 59.21 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.459 0.475 . . . . 0.0 111.048 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -71.32 -15.73 62.41 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -106.78 160.77 15.24 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.546 1.938 . . . . 0.0 109.541 -173.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -101.35 -18.76 15.91 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 118.931 -0.557 . . . . 0.0 111.977 -177.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.8 t -147.77 129.85 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 120.716 1.598 . . . . 0.0 106.949 -170.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -125.65 135.08 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.2 mm -133.65 85.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 -177.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.0 t -69.28 160.17 31.73 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.175 -0.953 . . . . 0.0 108.503 171.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.6 mp -129.46 21.41 5.61 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 169.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.6 m -69.27 -8.88 50.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.29 1.036 . . . . 0.0 112.237 -175.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 108.11 23.22 6.81 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 119.15 0.887 . . . . 0.0 111.742 174.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.465 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 2.0 t 55.24 173.63 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.176 2.191 . . . . 0.0 112.685 -169.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.03 16.66 33.65 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.851 1.215 . . . . 0.0 114.423 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.7 p -72.32 136.42 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 125.155 1.382 . . . . 0.0 108.021 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -79.1 61.52 3.27 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.527 1.131 . . . . 0.0 108.547 173.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.1 mt -59.52 148.31 74.45 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 172.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -54.98 155.38 18.69 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.166 1.911 . . . . 0.0 111.919 174.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.81 -1.19 8.1 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.003 2.469 . . . . 0.0 115.853 -169.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' A' ' 91' ' ' VAL . 14.2 pt-20 -84.62 -24.93 28.89 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.788 1.176 . . . . 0.0 112.155 169.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.405 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 24.7 m95 -77.21 24.31 0.18 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.642 1.177 . . . . 0.0 112.164 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.405 ' H ' ' C ' ' A' ' 89' ' ' GLU . 15.0 m -127.92 -2.74 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 125.489 1.516 . . . . 0.0 112.779 169.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.8 p -84.37 -12.32 54.72 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 120.773 1.624 . . . . 0.0 113.516 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.453 ' H ' ' CD ' ' A' ' 93' ' ' GLN . 19.4 mp0 -62.16 160.78 12.19 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 129.808 3.243 . . . . 0.0 110.892 -176.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -64.62 -41.97 95.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.796 1.639 . . . . 0.0 109.137 169.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 33.1 mm -119.15 135.69 58.73 Favored 'Isoleucine or valine' 0 C--N 1.341 0.199 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 170.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -135.45 110.95 9.14 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 100.977 -3.712 . . . . 0.0 100.977 166.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.11 164.67 26.82 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.0 t70 -137.1 99.97 4.15 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 122.118 0.961 . . . . 0.0 108.542 172.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -75.4 73.45 2.46 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.344 1.458 . . . . 0.0 107.811 174.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -54.92 44.3 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 131.278 3.831 . . . . 0.0 114.402 172.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -77.85 -174.15 3.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.337 1.455 . . . . 0.0 111.223 -169.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -50.27 160.94 0.33 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.611 1.565 . . . . 0.0 111.28 176.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -130.1 85.0 58.59 Favored Pre-proline 0 C--N 1.322 -0.59 0 C-N-CA 126.719 2.008 . . . . 0.0 108.364 -169.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.64 67.33 8.43 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 124.9 3.734 . . . . 0.0 111.472 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -64.1 81.05 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.483 1.913 . . . . 0.0 110.874 173.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 59.22 37.42 91.77 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.775 0.702 . . . . 0.0 112.441 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -64.96 170.06 4.69 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -170.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.8 m -68.13 151.89 46.33 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 113.301 -1.772 . . . . 0.0 108.293 168.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.3 mt -57.56 -32.96 67.64 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.91 -0.494 . . . . 0.0 111.808 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.07 -38.63 86.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.533 0.606 . . . . 0.0 111.182 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.8 t -75.18 -40.58 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 116.456 -1.735 . . . . 0.0 108.88 178.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -50.47 -48.49 56.67 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 121.141 1.792 . . . . 0.0 110.636 170.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -58.84 -43.18 90.66 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.535 0.607 . . . . 0.0 110.81 176.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.8 m -69.22 -43.6 73.77 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -174.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.8 t -66.28 -46.53 86.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -173.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -47.79 -56.16 8.03 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.016 1.326 . . . . 0.0 110.89 170.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.99 -40.65 99.56 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 119.795 1.179 . . . . 0.0 111.68 -175.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -64.64 -40.11 94.88 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.321 -1.105 . . . . 0.0 111.428 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.0 t -61.08 -42.09 91.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 174.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.06 -37.95 78.26 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 119.904 1.229 . . . . 0.0 111.448 -175.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -70.0 -42.3 73.22 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.136 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -64.24 -42.83 96.35 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 119.252 0.933 . . . . 0.0 110.14 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.5 t -54.36 -53.71 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 123.901 0.88 . . . . 0.0 109.385 173.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -65.31 -33.09 75.16 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 122.283 -0.261 . . . . 0.0 111.541 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -62.15 -49.17 76.9 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.03 0.532 . . . . 0.0 110.787 173.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.42 -46.05 83.93 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.987 0.515 . . . . 0.0 110.046 177.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.3 mt -57.92 -44.0 85.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 124.395 1.078 . . . . 0.0 110.272 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.07 -28.23 67.63 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.98 0.809 . . . . 0.0 112.151 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -75.95 -44.71 38.68 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.379 0.536 . . . . 0.0 111.605 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.9 pt -94.37 -42.36 12.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -169.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 C--O 1.252 1.232 0 CA-C-N 119.168 0.895 . . . . 0.0 109.929 -172.808 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.0 mmm . . . . . 0 N--CA 1.502 2.142 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.46 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -57.54 134.9 56.51 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.503 1.047 . . . . 0.0 108.891 169.871 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -101.07 140.97 34.63 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.758 1.223 . . . . 0.0 107.757 -169.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.9 t -129.02 152.18 36.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -175.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 58.6 tpp -137.73 145.29 42.32 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -121.81 150.2 42.23 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 171.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.2 t -132.46 134.73 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 120.333 -1.479 . . . . 0.0 108.219 -171.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -131.98 100.09 4.95 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.258 0.935 . . . . 0.0 111.626 -170.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -79.17 -30.76 43.69 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -129.88 141.53 50.8 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 176.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 29.06 101.78 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 129.972 3.309 . . . . 0.0 113.619 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.4 m -33.28 -33.64 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.212 0 C-N-CA 128.671 2.788 . . . . 0.0 115.327 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.4 t -36.52 -64.16 0.35 Allowed 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 125.884 1.673 . . . . 0.0 114.067 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.298 36.1 ptt180 -60.15 -43.66 95.59 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 120.333 1.424 . . . . 0.0 114.127 -168.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.22 -29.0 14.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 119.374 0.988 . . . . 0.0 112.092 -172.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.478 HE22 HG13 ' A' ' 42' ' ' VAL . 50.0 tt0 -72.09 -25.45 61.76 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.79 -1.194 . . . . 0.0 109.924 169.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.47 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.0 tpt -68.97 -42.77 76.15 Favored 'General case' 0 CA--C 1.512 -0.514 0 O-C-N 120.812 -1.18 . . . . 0.0 108.508 168.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.95 -39.41 81.59 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -60.43 -41.41 93.92 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.19 1.396 . . . . 0.0 111.4 169.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.74 -40.36 58.53 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 120.651 1.569 . . . . 0.0 112.895 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -69.96 -38.04 76.0 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 118.527 1.164 . . . . 0.0 109.279 172.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.51 -40.88 66.49 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 120.434 1.47 . . . . 0.0 111.145 -175.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -61.35 -32.27 72.16 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.325 1.42 . . . . 0.0 110.842 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 m -75.39 -51.13 13.85 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.262 2.225 . . . . 0.0 111.131 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.1 mt -88.19 -26.22 22.52 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.494 1.118 . . . . 0.0 111.631 -169.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.69 12.71 62.79 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 126.542 2.02 . . . . 0.0 111.248 177.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.16 121.34 10.47 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.549 1.139 . . . . 0.0 110.241 -173.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.03 9.24 86.87 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 119.864 -0.409 . . . . 0.0 113.325 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -123.82 -31.73 3.39 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 125.222 1.409 . . . . 0.0 109.511 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.0 pt -142.6 168.39 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.539 1.536 . . . . 0.0 109.954 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.35 139.48 46.71 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 168.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.3 t -127.54 146.11 33.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 125.279 1.432 . . . . 0.0 111.207 -170.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.33 160.39 43.76 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.052 1.741 . . . . 0.0 109.725 -174.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -132.99 165.49 24.6 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.334 1.424 . . . . 0.0 109.227 170.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.1 p -158.78 168.8 25.88 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.796 -0.565 . . . . 0.0 111.299 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.39 -73.79 2.55 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 -175.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.6 mp 44.83 41.7 5.38 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.622 1.169 . . . . 0.0 110.904 -176.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 59.76 16.41 5.54 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.587 1.155 . . . . 0.0 113.911 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.9 m 66.59 31.99 7.48 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.418 1.887 . . . . 0.0 111.473 -171.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.1 m -138.48 -168.9 2.48 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.519 2.328 . . . . 0.0 109.091 -175.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -97.99 -165.28 1.23 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.873 1.269 . . . . 0.0 109.092 -176.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.478 HG13 HE22 ' A' ' 16' ' ' GLN . 2.8 m -57.8 170.65 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.511 1.125 . . . . 0.0 111.486 171.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -133.07 117.67 14.9 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -174.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -66.03 -30.18 47.95 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.319 2.679 . . . . 0.0 112.432 -169.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.0 m -61.89 -37.04 83.12 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 177.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.45 -44.52 86.98 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.98 -47.8 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.32 -43.04 99.54 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-N 118.938 0.79 . . . . 0.0 111.141 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.7 mmt -61.94 -23.75 66.56 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.553 -0.736 . . . . 0.0 111.828 177.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.47 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.3 OUTLIER -94.98 -27.93 15.4 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.55 -29.4 70.43 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.808 1.243 . . . . 0.0 110.693 171.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -56.2 -24.71 43.58 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.641 0.776 . . . . 0.0 112.487 170.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -126.23 16.3 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.712 0 C-N-CA 125.527 1.531 . . . . 0.0 111.087 -172.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.79 35.69 66.21 Favored Glycine 0 CA--C 1.529 0.952 0 O-C-N 121.516 -0.74 . . . . 0.0 113.395 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.9 mt -125.1 155.85 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -134.42 144.69 48.31 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 170.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.6 pt -137.56 11.17 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 126.513 1.925 . . . . 0.0 110.477 -175.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.2 t -65.69 151.44 46.56 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.529 -0.732 . . . . 0.0 109.496 170.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.98 -0.02 1.31 Allowed Glycine 0 CA--C 1.534 1.223 0 CA-C-O 117.691 -1.616 . . . . 0.0 115.084 -177.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -57.78 -55.47 34.4 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 120.162 1.981 . . . . 0.0 112.633 -171.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.98 161.22 42.76 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.802 -168.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.8 p -170.48 27.02 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.228 0.611 . . . . 0.0 112.288 -171.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -140.48 151.28 63.43 Favored Pre-proline 0 N--CA 1.476 0.847 0 O-C-N 120.818 -1.177 . . . . 0.0 112.828 -169.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.35 160.78 29.04 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 124.062 3.175 . . . . 0.0 112.791 -173.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.2 tt -59.17 -36.78 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.141 1.376 . . . . 0.0 111.671 -176.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -70.45 -22.23 62.72 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.042 0.537 . . . . 0.0 112.27 -172.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.61 -17.61 59.08 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 119.033 -0.508 . . . . 0.0 111.711 171.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -95.89 173.53 7.4 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.146 0.978 . . . . 0.0 110.129 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.83 101.7 3.21 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 125.137 1.375 . . . . 0.0 108.193 -177.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.419 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -49.45 -24.94 2.25 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.801 0.84 . . . . 0.0 113.156 171.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -51.4 -21.53 2.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.044 0.938 . . . . 0.0 112.218 172.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -115.66 17.05 16.37 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.617 1.167 . . . . 0.0 114.009 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -133.04 112.47 11.83 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 119.968 1.258 . . . . 0.0 108.414 170.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -62.99 -14.62 50.06 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -169.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.9 t -145.31 123.05 4.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.455 -2.424 . . . . 0.0 104.455 -169.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.86 133.34 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 O-C-N 121.085 -1.009 . . . . 0.0 108.406 -174.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.8 mm -130.17 92.45 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -168.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.8 t -70.08 161.54 29.95 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.549 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 mp -142.2 52.9 1.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 169.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 59.9 m -114.4 18.35 16.93 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.616 1.566 . . . . 0.0 109.577 -174.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.72 25.3 46.67 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-O 119.356 -0.691 . . . . 0.0 111.999 172.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.404 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 5.7 t 44.37 39.6 3.21 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.947 1.699 . . . . 0.0 112.595 -176.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.85 45.07 0.51 Allowed Glycine 0 C--N 1.34 0.797 0 C-N-CA 123.586 0.612 . . . . 0.0 111.86 -169.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.0 p -124.13 -0.8 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -173.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.8 t30 47.16 60.71 3.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.689 1.596 . . . . 0.0 109.433 175.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.2 mt -56.46 148.09 46.04 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.143 -175.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -55.27 156.01 18.16 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.701 2.267 . . . . 0.0 113.11 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -54.89 -30.11 66.92 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.756 2.304 . . . . 0.0 116.734 -170.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -65.88 -25.03 66.99 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 121.009 -1.057 . . . . 0.0 111.478 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.419 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 72.3 m95 -73.35 -4.46 33.51 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 117.669 -1.158 . . . . 0.0 113.133 178.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.4 m -118.58 -5.48 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 120.757 1.617 . . . . 0.0 113.41 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.3 p -88.73 -17.99 28.75 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.761 0.824 . . . . 0.0 112.416 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -52.59 161.82 0.65 Allowed 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 129.37 3.068 . . . . 0.0 113.906 175.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -64.35 -39.45 93.9 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.493 1.517 . . . . 0.0 108.901 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 33.2 mm -124.95 138.54 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 169.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -137.84 113.89 9.97 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 100.284 -3.969 . . . . 0.0 100.284 167.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -136.09 171.05 15.04 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 172.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.404 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.0 t70 -140.1 122.77 16.33 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 169.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -101.36 77.2 1.76 Allowed 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.24 16.8 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 129.638 3.175 . . . . 0.0 115.06 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -61.22 126.28 26.77 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.673 1.589 . . . . 0.0 111.343 -168.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 52.11 -155.44 0.17 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.3 1.44 . . . . 0.0 112.564 169.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -163.7 57.37 0.61 Allowed Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 127.509 2.324 . . . . 0.0 109.842 -173.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -79.2 59.02 7.22 Favored 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 122.752 2.301 . . . . 0.0 112.251 -169.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -51.46 -46.87 63.22 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.078 -1.014 . . . . 0.0 110.726 176.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -173.23 44.38 0.16 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.714 1.626 . . . . 0.0 110.323 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -68.54 176.42 2.92 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 122.543 1.163 . . . . 0.0 112.633 -177.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.2 m -57.83 152.51 15.69 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 113.956 -1.475 . . . . 0.0 109.857 171.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.3 mt -57.58 -31.59 66.32 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 122.727 0.411 . . . . 0.0 111.228 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.72 -39.64 92.22 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 118.427 0.558 . . . . 0.0 110.968 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 66.1 t -70.53 -45.54 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 117.304 -1.332 . . . . 0.0 108.507 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -48.95 -47.95 43.4 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 120.401 1.455 . . . . 0.0 110.93 172.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -59.81 -45.78 91.29 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.539 0.736 . . . . 0.0 111.303 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 94.2 m -68.36 -45.76 71.95 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -174.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.9 t -65.03 -47.58 87.4 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -173.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -44.65 -55.05 5.56 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 125.225 1.41 . . . . 0.0 110.89 169.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.44 -40.85 99.28 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 119.43 1.014 . . . . 0.0 111.737 -177.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -64.93 -38.46 91.03 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 121.376 -1.073 . . . . 0.0 110.86 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.0 t -62.72 -42.19 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -38.72 84.03 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 120.152 1.342 . . . . 0.0 111.535 -174.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -69.11 -41.31 77.58 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 119.087 -0.482 . . . . 0.0 109.825 177.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -67.24 -38.94 86.0 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 119.299 0.954 . . . . 0.0 111.135 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.8 t -53.85 -54.97 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 169.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -64.86 -32.46 74.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 121.99 -0.444 . . . . 0.0 111.895 -174.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -63.66 -47.41 81.41 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.405 0.682 . . . . 0.0 110.713 172.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -46.6 83.52 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 122.9 0.48 . . . . 0.0 110.062 176.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.0 mt -58.23 -43.18 85.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 124.292 1.037 . . . . 0.0 109.606 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.65 -30.22 70.58 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.101 0.864 . . . . 0.0 111.694 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -72.18 -42.6 65.69 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.635 172.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.1 pt -103.73 -44.8 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 118.902 2.927 . . . . 0.0 118.902 -168.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.3 m . . . . . 0 C--O 1.254 1.299 0 CA-C-O 116.582 -1.675 . . . . 0.0 111.838 -169.084 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 tpt . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.434 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -61.63 121.47 12.85 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 121.227 1.83 . . . . 0.0 108.43 -177.149 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -92.88 134.4 35.12 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -169.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.1 t -120.7 154.33 24.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -174.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 63.2 tpp -139.15 144.84 38.79 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -126.78 125.97 42.62 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 174.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.4 t -118.07 130.68 72.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -169.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 t -118.16 161.01 20.58 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.574 1.149 . . . . 0.0 111.207 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -141.97 34.54 1.56 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.101 1.36 . . . . 0.0 109.483 172.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.1 mmt-85 -141.9 168.13 20.5 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.235 1.414 . . . . 0.0 109.247 -175.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -46.05 121.8 3.48 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.317 1.447 . . . . 0.0 108.458 170.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.5 m -40.44 98.04 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.317 2.247 . . . . 0.0 114.098 -169.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.5 t -158.35 -84.85 0.04 OUTLIER 'General case' 0 C--N 1.343 0.317 0 CA-C-O 118.369 -0.824 . . . . 0.0 112.457 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.347 35.9 ptt180 -45.76 -52.6 10.82 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -167.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.62 -27.02 27.47 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.413 1.006 . . . . 0.0 112.047 -174.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -65.98 -40.72 91.45 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.119 -0.988 . . . . 0.0 109.304 171.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.447 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.1 tpt -62.9 -40.66 98.26 Favored 'General case' 0 CA--C 1.512 -0.489 0 O-C-N 121.735 -0.603 . . . . 0.0 109.821 171.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.34 -36.88 79.0 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 118.969 -0.539 . . . . 0.0 110.017 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -65.95 -39.91 90.85 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.504 170.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.49 -44.98 95.86 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 120.332 1.424 . . . . 0.0 111.055 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -65.49 -41.54 93.14 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 118.022 0.911 . . . . 0.0 109.067 173.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.04 -35.25 74.14 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 119.824 1.193 . . . . 0.0 111.741 -173.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -79.6 -15.83 56.95 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.184 1.356 . . . . 0.0 112.886 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.9 m -79.65 -50.91 9.94 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.896 1.678 . . . . 0.0 109.239 171.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.4 mt -88.48 -28.02 21.11 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.101 1.361 . . . . 0.0 112.384 -169.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.71 12.24 61.1 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.484 1.993 . . . . 0.0 111.751 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.52 121.52 12.34 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.939 1.295 . . . . 0.0 109.762 -172.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.86 11.05 85.79 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 119.755 -0.469 . . . . 0.0 113.538 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -124.9 -29.22 3.39 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.511 1.524 . . . . 0.0 109.153 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.2 pt -143.82 173.03 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.696 1.598 . . . . 0.0 109.677 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.69 144.59 44.24 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 103.836 -2.653 . . . . 0.0 103.836 168.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -133.78 148.64 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 118.536 0.607 . . . . 0.0 111.688 -167.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.95 158.33 44.09 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.342 1.457 . . . . 0.0 110.299 -174.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.4 p -131.17 153.23 49.64 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.633 1.573 . . . . 0.0 109.365 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.2 t -145.9 149.04 33.5 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -174.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 113.36 -107.3 1.92 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 107.086 -2.406 . . . . 0.0 107.086 -175.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 tp 64.65 50.45 2.1 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -58.17 -23.99 57.4 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 124.767 1.227 . . . . 0.0 111.124 -173.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.7 m -78.65 15.85 0.96 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 m 59.45 -12.44 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 129.705 3.202 . . . . 0.0 115.137 -173.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.59 -173.69 4.41 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.206 2.203 . . . . 0.0 106.965 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.2 m -62.41 173.11 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.329 1.052 . . . . 0.0 111.091 172.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -132.9 117.89 15.18 Favored Pre-proline 0 N--CA 1.453 -0.309 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -173.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -63.33 -27.53 71.63 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.327 2.685 . . . . 0.0 113.721 -169.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.4 m -61.56 -41.25 97.1 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.231 0.923 . . . . 0.0 109.474 171.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.79 -42.71 97.67 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 120.091 1.314 . . . . 0.0 108.958 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -56.33 -49.55 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 118.728 -0.654 . . . . 0.0 109.346 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.79 -41.32 90.89 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-N 118.723 0.692 . . . . 0.0 111.014 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 32.7 mmt -65.34 -22.29 66.8 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 123.457 0.703 . . . . 0.0 112.032 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.447 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 1.5 mmt -98.06 -28.41 13.78 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -62.6 -32.43 73.43 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.448 1.099 . . . . 0.0 110.258 170.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -59.24 -16.2 19.81 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.768 1.627 . . . . 0.0 112.292 172.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.3 m -129.07 15.02 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 125.953 1.701 . . . . 0.0 111.37 177.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.79 38.95 86.03 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 119.064 -0.853 . . . . 0.0 113.675 173.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.9 mt -121.13 152.52 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -118.73 126.59 52.22 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 124.865 1.266 . . . . 0.0 108.002 176.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.9 pt -128.23 17.87 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 124.064 0.946 . . . . 0.0 111.746 171.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.3 -33.07 59.07 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.671 1.188 . . . . 0.0 112.157 173.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.22 -3.47 81.93 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 123.302 0.477 . . . . 0.0 112.873 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -67.15 153.0 44.72 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.165 0.986 . . . . 0.0 111.185 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.0 p -147.1 157.76 43.72 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.97 1.708 . . . . 0.0 107.601 169.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.2 m -154.47 173.48 16.21 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.166 1.386 . . . . 0.0 108.41 -169.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -154.8 167.55 13.76 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-O 117.778 -1.106 . . . . 0.0 108.186 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.06 165.25 21.83 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.286 1.991 . . . . 0.0 112.853 -171.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.6 tt -63.78 -34.4 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 123.716 0.806 . . . . 0.0 110.622 -170.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.49 -19.04 61.62 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.757 0.823 . . . . 0.0 112.608 -174.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.85 -24.67 58.63 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.091 0.556 . . . . 0.0 110.945 169.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -95.79 169.77 9.78 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 122.199 0.999 . . . . 0.0 111.245 -169.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.16 97.13 2.73 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.876 1.671 . . . . 0.0 107.183 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.417 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -50.45 -23.07 2.19 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.039 0.936 . . . . 0.0 113.501 173.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -50.65 -22.92 2.27 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.802 0.841 . . . . 0.0 111.908 171.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -114.27 16.16 17.99 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.087 1.355 . . . . 0.0 113.226 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -134.12 112.92 11.53 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 120.526 -1.359 . . . . 0.0 109.598 170.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -67.67 -8.99 39.42 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -169.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.2 t -146.65 119.64 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 -171.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.4 m -133.85 130.97 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 O-C-N 120.409 -1.432 . . . . 0.0 107.962 -174.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.3 mm -126.11 102.16 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 -173.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.7 p -78.03 157.54 29.57 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 171.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.0 mp -133.43 44.38 2.8 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 169.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 69.0 m -93.16 10.51 31.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.81 1.644 . . . . 0.0 110.227 -174.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.41 29.39 33.27 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 170.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 4.9 t 39.33 43.66 0.97 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.705 2.002 . . . . 0.0 112.83 -171.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -144.18 44.13 0.94 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.688 1.137 . . . . 0.0 110.449 -171.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.2 p -134.99 165.06 32.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.38 1.872 . . . . 0.0 109.19 -173.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -129.58 71.54 1.44 Allowed 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 38.8 mt -60.77 149.45 79.8 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.63 153.75 17.87 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.511 2.141 . . . . 0.0 111.611 169.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.33 -18.67 55.67 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.787 1.658 . . . . 0.0 114.79 -169.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.05 -25.69 68.22 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 120.904 -1.122 . . . . 0.0 111.22 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.417 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 68.2 m95 -70.48 -11.12 60.71 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 117.224 -1.37 . . . . 0.0 113.235 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.6 m -110.36 -8.54 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 121.204 1.82 . . . . 0.0 113.285 -175.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.6 p -90.99 -11.2 39.64 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.892 0.877 . . . . 0.0 112.953 -174.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -61.67 167.27 3.64 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 128.763 2.825 . . . . 0.0 112.681 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -68.19 -38.71 82.27 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.217 1.007 . . . . 0.0 108.539 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.5 mt -119.91 135.47 60.11 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 CA-C-O 121.488 0.661 . . . . 0.0 109.632 169.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -148.39 114.84 5.93 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 166.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -143.73 167.51 22.1 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 173.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -126.08 124.56 40.88 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 169.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -100.53 77.4 1.91 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -177.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.51 33.51 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 128.962 2.905 . . . . 0.0 114.19 178.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.58 -177.8 1.62 Allowed 'General case' 0 CA--C 1.535 0.394 0 O-C-N 120.789 -1.194 . . . . 0.0 110.67 -171.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -55.1 161.84 1.57 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 123.814 1.769 . . . . 0.0 113.356 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -115.19 103.06 54.74 Favored Pre-proline 0 C--N 1.318 -0.766 0 C-N-CA 128.853 2.861 . . . . 0.0 107.85 -169.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -82.04 18.58 1.37 Allowed 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.761 2.307 . . . . 0.0 112.477 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -39.61 96.35 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.539 1.935 . . . . 0.0 113.974 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 42.51 31.98 1.15 Allowed Glycine 0 CA--C 1.541 1.663 0 C-N-CA 125.095 1.331 . . . . 0.0 114.172 -172.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -76.85 177.51 7.61 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 122.496 1.141 . . . . 0.0 113.404 -169.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 p -59.88 154.65 18.13 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.731 -1.577 . . . . 0.0 109.355 170.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.8 mt -58.73 -29.49 66.75 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.797 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.62 -40.82 97.86 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 118.676 -0.678 . . . . 0.0 111.044 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.4 t -71.23 -39.96 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 119.469 1.031 . . . . 0.0 109.082 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -52.08 -51.33 58.4 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.527 1.058 . . . . 0.0 111.624 169.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -59.16 -45.23 91.51 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.935 0.789 . . . . 0.0 110.584 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.3 m -69.4 -45.19 69.83 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -173.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.5 t -65.31 -47.95 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -172.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.3 ttp180 -45.53 -53.34 9.12 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 124.732 1.213 . . . . 0.0 110.949 171.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.29 -42.25 97.89 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 119.334 0.97 . . . . 0.0 111.91 -177.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -64.99 -37.3 87.2 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.213 -1.169 . . . . 0.0 110.765 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.7 t -63.14 -42.74 97.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -39.25 83.47 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.201 1.364 . . . . 0.0 111.364 -173.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.27 -42.53 75.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 119.205 -0.426 . . . . 0.0 110.322 177.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -68.03 -39.46 83.1 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.401 1.0 . . . . 0.0 111.469 178.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.3 t -54.97 -52.97 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 171.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.37 -32.91 74.71 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.744 -0.597 . . . . 0.0 111.923 -176.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -63.44 -48.43 77.8 Favored 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 121.615 -0.678 . . . . 0.0 110.719 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -46.57 77.37 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 123.429 0.692 . . . . 0.0 109.659 177.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.1 mt -58.72 -44.3 89.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 124.432 1.093 . . . . 0.0 109.584 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.24 -29.31 68.69 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.876 0.762 . . . . 0.0 111.927 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -74.27 -42.32 59.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.478 0.581 . . . . 0.0 111.533 175.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 pt -98.85 -44.12 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 -168.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 C--O 1.255 1.343 0 CA-C-N 118.997 0.817 . . . . 0.0 110.223 -170.842 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.2 mmm . . . . . 0 N--CA 1.501 2.112 0 CA-C-O 119.937 -0.078 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.426 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -58.5 129.59 42.77 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 173.267 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -91.49 133.45 35.49 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.8 t -112.34 154.08 13.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 51.4 tpp -136.11 145.59 46.07 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -125.35 119.37 28.18 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 175.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.1 t -103.06 126.81 57.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -171.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 m -112.5 156.92 21.79 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.627 0.771 . . . . 0.0 110.628 -172.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -150.44 153.49 36.03 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 169.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.53 ' HG2' ' H ' ' A' ' 11' ' ' ASN . 53.5 ttm-85 58.61 -169.31 0.13 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.456 1.102 . . . . 0.0 108.472 -168.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.53 ' H ' ' HG2' ' A' ' 10' ' ' ARG . 50.9 t-20 -47.29 105.99 0.08 Allowed 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 124.008 0.923 . . . . 0.0 108.671 174.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.0 m -77.34 7.5 5.22 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.379 1.072 . . . . 0.0 112.378 -170.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.4 p -44.33 -56.75 3.95 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 124.309 1.044 . . . . 0.0 110.135 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 25.7 ptt85 -52.49 -44.66 65.78 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.795 1.238 . . . . 0.0 113.57 -177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.6 -32.58 13.36 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.338 -0.851 . . . . 0.0 112.406 -168.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -71.48 -30.24 65.74 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.719 -1.238 . . . . 0.0 109.106 169.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.466 ' SD ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -64.05 -37.79 88.73 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 120.784 -1.198 . . . . 0.0 109.364 168.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.8 -36.77 75.01 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 119.077 -0.487 . . . . 0.0 110.008 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -63.15 -40.0 96.31 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.891 169.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.71 -44.4 92.48 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 120.609 1.549 . . . . 0.0 111.797 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.466 ' CD2' ' SD ' ' A' ' 17' ' ' MET . 5.4 m-85 -62.39 -40.93 98.07 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 118.562 1.181 . . . . 0.0 109.382 170.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.06 -36.19 74.8 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.574 1.079 . . . . 0.0 110.632 -173.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -73.84 -18.35 60.95 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 120.359 1.436 . . . . 0.0 112.584 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 m -82.84 -50.94 8.1 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.745 1.618 . . . . 0.0 109.473 176.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.8 mt -88.07 -26.52 22.5 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.301 1.44 . . . . 0.0 111.672 -169.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.96 11.73 60.65 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.574 2.035 . . . . 0.0 112.218 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.65 124.54 21.27 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.819 1.247 . . . . 0.0 109.179 -171.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.61 8.81 87.45 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 119.47 -0.628 . . . . 0.0 113.806 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -127.52 -31.06 2.53 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.566 1.546 . . . . 0.0 108.56 -177.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.1 pt -143.74 165.87 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 125.767 1.627 . . . . 0.0 110.22 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.58 146.62 35.78 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 103.469 -2.789 . . . . 0.0 103.469 168.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.8 t -134.76 146.25 31.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-N 118.922 0.783 . . . . 0.0 111.488 -168.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.8 162.64 40.7 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.656 1.582 . . . . 0.0 109.545 -174.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.5 p -136.58 165.43 25.89 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 120.395 -1.441 . . . . 0.0 110.215 173.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.3 p -149.78 150.75 32.49 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 123.515 0.726 . . . . 0.0 109.745 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.8 -99.08 0.83 Allowed Glycine 0 CA--C 1.522 0.484 0 N-CA-C 106.861 -2.496 . . . . 0.0 106.861 -170.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.0 mt 53.12 48.18 22.84 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 122.008 0.909 . . . . 0.0 109.02 -172.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -67.16 -17.36 64.81 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.176 0.99 . . . . 0.0 111.032 -178.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.82 30.28 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 127.645 2.378 . . . . 0.0 113.237 172.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.4 m 57.13 65.18 1.43 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.258 1.823 . . . . 0.0 111.065 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 61.04 -153.54 0.37 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.334 1.054 . . . . 0.0 109.009 -173.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.7 t -54.41 147.23 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.648 1.179 . . . . 0.0 110.378 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -129.67 110.97 17.5 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.722 1.209 . . . . 0.0 108.984 -169.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.3 -30.44 54.08 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.956 3.104 . . . . 0.0 114.701 -168.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.0 m -59.52 -36.61 76.43 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.661 1.119 . . . . 0.0 109.743 175.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.13 -43.8 90.74 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.47 -44.11 92.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.52 -41.93 98.06 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.169 0.895 . . . . 0.0 111.664 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 39.1 mmt -63.77 -29.77 70.94 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 118.943 -0.551 . . . . 0.0 111.682 178.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -85.27 -32.5 22.53 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.92 -33.77 76.05 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.275 1.03 . . . . 0.0 109.994 174.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -62.35 -12.54 21.75 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.72 1.208 . . . . 0.0 112.119 173.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.1 m -127.66 13.51 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 125.937 1.695 . . . . 0.0 111.863 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.48 35.61 59.52 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 121.003 -1.06 . . . . 0.0 114.563 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.3 mt -122.35 156.23 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 171.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -131.57 140.82 49.55 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.723 1.209 . . . . 0.0 108.479 171.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 27.6 pt -133.7 17.4 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.55 1.54 . . . . 0.0 111.146 -175.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.3 p -78.64 -28.64 45.54 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.574 1.15 . . . . 0.0 112.664 171.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.6 -8.12 66.5 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 123.136 0.398 . . . . 0.0 112.234 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -85.84 146.57 26.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.478 1.111 . . . . 0.0 108.335 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.4 p -143.16 154.52 43.98 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 169.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.99 166.03 32.83 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -169.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -147.61 162.67 31.02 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.185 1.794 . . . . 0.0 106.762 -171.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.84 160.14 48.66 Favored 'Trans proline' 0 C--N 1.347 0.488 0 CA-C-N 123.052 2.126 . . . . 0.0 112.728 -170.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.9 tt -57.06 -32.73 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.736 1.214 . . . . 0.0 111.95 -175.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -68.73 -22.66 64.31 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.59 0.756 . . . . 0.0 112.145 -173.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -13.34 59.89 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 118.808 -0.615 . . . . 0.0 112.177 171.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -110.76 172.59 6.78 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 122.274 1.035 . . . . 0.0 112.211 -170.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.77 103.23 2.91 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 126.78 2.032 . . . . 0.0 107.065 -172.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.87 -24.43 23.25 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 123.757 0.823 . . . . 0.0 112.988 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -50.64 -32.42 18.98 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.04 0.936 . . . . 0.0 111.585 172.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -86.6 12.0 11.55 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -136.0 177.68 7.65 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.064 2.146 . . . . 0.0 108.557 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -120.45 -21.88 6.67 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.2 t -142.21 128.34 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 -170.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.58 129.74 61.9 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 O-C-N 120.666 -1.271 . . . . 0.0 108.221 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.1 mm -117.9 134.54 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 176.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.4 t -115.06 156.76 24.57 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 175.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.5 mp -134.06 36.38 3.25 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 173.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 60.2 m -96.7 14.0 26.48 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.395 1.478 . . . . 0.0 110.025 -176.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.94 15.45 81.16 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-O 119.361 -0.689 . . . . 0.0 112.447 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 3.9 t 60.35 -20.07 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.234 2.614 . . . . 0.0 115.632 -178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.13 -26.76 73.95 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 119.457 1.026 . . . . 0.0 112.829 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.8 t -63.21 116.59 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 174.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -66.14 138.17 57.54 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 172.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.4 mt -120.99 141.15 32.13 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.57 157.65 6.94 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.645 2.897 . . . . 0.0 113.163 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.7 -22.4 69.85 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 121.889 1.726 . . . . 0.0 115.222 -169.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -65.73 -24.02 66.88 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 120.188 -1.57 . . . . 0.0 111.746 176.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -70.0 -7.93 44.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 117.344 -1.312 . . . . 0.0 112.487 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.5 m -115.32 -12.25 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 121.273 1.851 . . . . 0.0 113.481 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.8 p -81.83 -13.3 57.84 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.158 0.89 . . . . 0.0 112.23 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -44.29 155.22 0.09 Allowed 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 130.979 3.712 . . . . 0.0 113.009 169.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -62.38 -38.33 89.19 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.673 1.989 . . . . 0.0 108.771 169.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 33.6 mm -130.44 138.11 54.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 C-N-CA 123.055 0.542 . . . . 0.0 109.847 171.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -135.42 117.49 15.38 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 100.707 -3.812 . . . . 0.0 100.707 166.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.65 165.75 26.77 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 175.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -141.85 132.75 25.87 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 169.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.1 m0 -102.35 2.22 36.5 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -172.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 47.19 -68.78 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 131.086 3.754 . . . . 0.0 111.833 -169.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . 0.258 0.8 OUTLIER 45.29 -172.73 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.238 1 C-N-CA 133.294 4.638 . . . . 0.0 114.369 -174.429 . . . . . . . . 4 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -64.83 174.89 1.67 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.356 1.462 . . . . 0.0 113.34 -169.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -132.63 66.62 77.06 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 126.483 1.913 . . . . 0.0 109.75 -169.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -79.21 61.8 8.28 Favored 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 124.276 3.317 . . . . 0.0 111.294 -169.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -55.68 -42.6 75.37 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.026 -1.046 . . . . 0.0 112.521 -175.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -163.69 42.68 0.32 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.0 1.762 . . . . 0.0 109.753 -177.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -69.37 171.5 8.53 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -169.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.5 p -64.8 158.74 24.12 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.001 169.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 27.8 mt -60.24 -32.81 71.49 Favored 'General case' 0 C--O 1.22 -0.449 0 O-C-N 122.007 -0.433 . . . . 0.0 110.295 172.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.19 -43.93 90.04 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 118.484 0.584 . . . . 0.0 110.958 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 63.2 t -68.09 -43.79 84.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 119.156 -1.018 . . . . 0.0 108.47 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -48.41 -48.44 37.11 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.674 1.124 . . . . 0.0 111.739 173.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -62.94 -48.19 79.97 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.622 0.769 . . . . 0.0 111.016 176.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.1 m -65.48 -45.61 82.97 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -171.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.5 t -59.32 -42.73 88.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 124.095 0.958 . . . . 0.0 108.764 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -52.57 -51.67 58.67 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 118.444 0.566 . . . . 0.0 110.249 173.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.38 -38.42 95.8 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 119.544 1.066 . . . . 0.0 112.143 -177.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -63.79 -40.36 96.48 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 120.851 -1.382 . . . . 0.0 110.511 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.9 t -62.04 -39.2 82.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 118.443 -0.789 . . . . 0.0 109.147 173.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -39.49 76.27 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.495 1.043 . . . . 0.0 110.881 -176.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -70.44 -42.26 71.78 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 119.043 -0.504 . . . . 0.0 110.565 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -65.44 -42.0 92.9 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.427 1.012 . . . . 0.0 110.559 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.2 t -55.16 -52.69 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 123.322 0.649 . . . . 0.0 109.728 173.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -63.5 -32.65 74.17 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 122.049 -0.407 . . . . 0.0 111.609 -175.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -62.56 -45.9 90.82 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.375 0.67 . . . . 0.0 111.991 172.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -47.4 81.91 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 174.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -58.74 -43.05 87.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.46 -35.32 78.94 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.526 0.603 . . . . 0.0 111.823 -176.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -77.44 -37.49 51.46 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 117.664 -1.16 . . . . 0.0 112.435 174.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.8 pt -93.32 -41.97 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -171.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 C--O 1.252 1.226 0 CA-C-N 119.19 0.904 . . . . 0.0 110.055 -171.513 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 tpt . . . . . 0 N--CA 1.499 1.977 0 CA-C-O 117.623 -1.18 . . . . 0.0 109.607 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.411 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -47.52 118.19 2.12 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 120.708 1.595 . . . . 0.0 110.188 -171.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -93.51 134.22 36.01 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -169.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.1 t -112.87 153.54 14.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 58.2 tpp -136.6 143.58 43.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -127.58 106.75 9.38 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.2 t -94.7 141.93 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.298 1.039 . . . . 0.0 108.249 -172.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.66 162.81 30.41 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.74 1.155 . . . . 0.0 113.598 175.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -142.36 30.0 1.58 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.378 1.871 . . . . 0.0 109.111 169.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -155.57 -174.76 5.1 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.807 2.043 . . . . 0.0 106.956 -170.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.454 HD22 ' CD2' ' A' ' 43' ' ' HIS . 9.3 t-20 -52.16 141.5 18.57 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 125.016 1.326 . . . . 0.0 111.579 174.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.2 p -67.26 -17.14 64.67 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.109 1.364 . . . . 0.0 113.205 -176.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 32.0 p -61.91 -11.43 13.06 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 117.542 -1.218 . . . . 0.0 113.858 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.252 21.7 ptt180 -100.69 -37.99 8.5 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.032 1.287 . . . . 0.0 111.567 169.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.8 p -98.43 -54.34 3.07 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.757 1.617 . . . . 0.0 114.891 -169.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -66.58 -23.18 66.16 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.137 -0.977 . . . . 0.0 108.652 170.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.473 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.9 tpt -67.56 -44.05 79.19 Favored 'General case' 0 C--O 1.224 -0.251 0 O-C-N 120.791 -1.193 . . . . 0.0 109.978 168.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.14 -39.8 87.6 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -58.61 -44.55 89.95 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.377 1.071 . . . . 0.0 110.623 169.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.53 -39.35 61.09 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 120.594 1.543 . . . . 0.0 112.092 -174.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -66.45 -36.78 83.63 Favored 'General case' 0 C--O 1.223 -0.315 0 O-C-N 121.489 -1.007 . . . . 0.0 108.958 170.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.68 -39.92 66.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.978 1.263 . . . . 0.0 110.899 -174.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -66.3 -27.18 67.72 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 120.664 1.575 . . . . 0.0 111.36 175.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 m -75.43 -50.91 14.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.982 1.713 . . . . 0.0 110.477 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.9 mt -89.48 -27.66 20.19 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.007 1.323 . . . . 0.0 112.485 -169.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.28 12.45 63.49 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 127.064 2.269 . . . . 0.0 111.904 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.52 123.43 17.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.14 1.376 . . . . 0.0 110.012 -171.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.95 8.49 86.77 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.465 -0.631 . . . . 0.0 113.636 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -124.7 -41.18 2.15 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.18 1.392 . . . . 0.0 109.201 -175.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.7 pp -140.44 156.06 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.731 1.213 . . . . 0.0 109.437 176.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.95 154.66 17.17 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 173.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 t -140.55 146.14 24.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-N 119.116 0.871 . . . . 0.0 111.585 -168.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.43 158.24 39.68 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.588 1.155 . . . . 0.0 110.418 -176.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.4 p -133.26 156.08 48.21 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.039 1.29 . . . . 0.0 110.906 176.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.415 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 8.1 p -146.78 145.79 30.05 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.05 0.841 . . . . 0.0 109.759 176.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.7 129.6 0.16 Allowed Glycine 0 CA--C 1.532 1.118 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 -169.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.8 tp -151.1 52.99 0.85 Allowed 'General case' 0 CA--C 1.533 0.291 0 O-C-N 120.718 -1.46 . . . . 0.0 109.445 -169.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 59.72 -80.27 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.696 2.398 . . . . 0.0 111.049 -169.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 p -169.66 26.56 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.723 2.009 . . . . 0.0 110.893 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.9 m -139.53 164.05 30.92 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.577 1.151 . . . . 0.0 110.327 -169.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -74.68 -25.33 59.1 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 118.96 -0.543 . . . . 0.0 111.756 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -171.4 171.49 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 127.09 2.156 . . . . 0.0 106.843 177.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.454 ' CD2' HD22 ' A' ' 11' ' ' ASN . 82.3 t60 -139.99 112.69 7.51 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -172.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -64.34 -30.19 63.26 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.352 2.701 . . . . 0.0 112.751 -169.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.7 m -64.98 -37.5 87.87 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.98 -44.12 90.37 Favored 'General case' 0 C--N 1.346 0.426 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.87 -49.25 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.12 -42.16 98.03 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.523 0.601 . . . . 0.0 110.808 -177.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.9 mmt -63.44 -24.5 67.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.802 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.473 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -94.92 -31.68 13.56 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -176.63 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -60.56 -34.1 73.67 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.603 1.161 . . . . 0.0 110.054 169.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -63.8 -9.59 15.55 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.419 1.488 . . . . 0.0 112.39 173.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.73 14.32 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 125.949 1.7 . . . . 0.0 111.329 172.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.81 37.94 88.95 Favored Glycine 0 CA--C 1.532 1.121 0 O-C-N 121.452 -0.78 . . . . 0.0 112.982 175.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.4 mt -120.16 152.75 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 125.706 1.602 . . . . 0.0 106.95 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -127.79 124.47 37.72 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -176.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.9 pt -129.12 12.91 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 124.246 1.018 . . . . 0.0 111.232 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.95 -31.31 50.87 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.9 1.68 . . . . 0.0 113.577 -178.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.37 -9.69 73.48 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -83.19 159.27 22.04 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.256 1.022 . . . . 0.0 111.528 -173.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -146.77 158.67 43.96 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 128.373 2.669 . . . . 0.0 105.71 169.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.5 m -147.98 167.75 24.09 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -142.5 162.19 45.97 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -169.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.58 164.25 36.16 Favored 'Trans proline' 0 C--N 1.348 0.504 0 CA-C-N 122.686 1.995 . . . . 0.0 113.163 -169.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.5 tt -57.11 -35.87 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.364 1.465 . . . . 0.0 111.118 -173.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.95 -18.42 62.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.298 0.639 . . . . 0.0 112.699 -169.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -82.18 -16.37 49.95 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.482 170.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' ' 35' ' ' CYS . 46.4 m-85 -96.35 168.84 10.33 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.272 1.029 . . . . 0.0 110.842 -177.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.08 93.57 2.41 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 -169.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.45 ' HB3' ' CD2' ' A' ' 90' ' ' TRP . . . -52.97 -25.03 10.7 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 177.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.87 -21.95 13.12 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.123 0.42 . . . . 0.0 111.275 173.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -99.52 6.72 45.79 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.513 1.525 . . . . 0.0 113.248 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -136.77 113.58 10.36 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 120.284 1.402 . . . . 0.0 108.932 178.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.5 -17.37 59.53 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -169.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.7 t -144.22 122.03 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 -171.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.0 m -129.64 131.36 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 O-C-N 120.845 -1.159 . . . . 0.0 108.763 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.9 mm -126.19 96.72 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 102.977 -2.971 . . . . 0.0 102.977 -170.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.5 t -70.81 166.16 21.6 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -147.38 49.44 1.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 173.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 38.5 m -115.68 10.87 15.59 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.739 1.216 . . . . 0.0 110.786 -170.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.62 21.48 16.53 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 118.486 0.585 . . . . 0.0 112.563 173.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 4.3 t 47.4 41.15 12.16 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.049 1.74 . . . . 0.0 111.771 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -162.51 36.31 0.35 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-O 119.601 -0.555 . . . . 0.0 112.452 -170.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.9 t -117.83 137.4 51.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 173.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -82.72 69.07 9.43 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.131 0.972 . . . . 0.0 109.947 -171.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 18.4 mt -59.57 144.81 84.16 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -52.97 154.99 11.95 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.764 2.309 . . . . 0.0 111.846 170.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.65 -19.48 53.88 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 121.649 1.566 . . . . 0.0 114.362 -170.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.08 -25.95 68.33 Favored 'General case' 0 C--O 1.226 -0.162 0 O-C-N 120.938 -1.101 . . . . 0.0 111.224 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.45 ' CD2' ' HB3' ' A' ' 70' ' ' ALA . 72.3 m95 -68.57 -5.31 19.05 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.271 -0.893 . . . . 0.0 112.554 174.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.8 t -108.07 -28.5 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 119.67 1.123 . . . . 0.0 111.184 -174.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.1 p -77.07 -19.05 57.58 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.87 0.868 . . . . 0.0 113.123 -169.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -49.99 159.55 0.41 Allowed 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 129.2 3.0 . . . . 0.0 113.964 174.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -63.34 -38.83 92.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.674 1.59 . . . . 0.0 109.118 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.5 mm -125.71 138.89 53.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 169.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -139.3 112.19 7.93 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 102.641 -3.096 . . . . 0.0 102.641 167.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -134.68 171.0 14.97 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 174.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -139.49 116.0 10.64 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 170.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -93.74 68.74 3.97 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -36.99 -50.05 0.86 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.856 1.663 . . . . 0.0 110.108 169.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . 0.254 0.5 OUTLIER 38.04 -158.39 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 129.936 3.294 . . . . 0.0 112.734 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -60.4 166.6 2.96 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 122.35 1.071 . . . . 0.0 109.181 169.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -133.17 70.45 77.86 Favored Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 126.362 1.865 . . . . 0.0 109.952 -168.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -77.21 49.74 2.93 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.498 3.465 . . . . 0.0 114.738 -169.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -62.69 102.43 0.34 Allowed 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.981 -1.074 . . . . 0.0 109.424 169.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.55 26.34 66.45 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 123.967 0.794 . . . . 0.0 114.203 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -63.93 167.48 6.16 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -176.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.1 m -67.22 154.07 42.15 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 113.228 -1.806 . . . . 0.0 109.219 169.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 25.7 mt -59.03 -34.88 72.41 Favored 'General case' 0 C--O 1.222 -0.366 0 O-C-N 122.08 -0.387 . . . . 0.0 111.519 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -61.11 -39.79 91.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.339 0.518 . . . . 0.0 110.615 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.96 -40.3 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-O 116.75 -1.595 . . . . 0.0 108.998 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -51.63 -47.23 63.77 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 121.207 1.821 . . . . 0.0 111.033 170.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -59.17 -43.96 92.15 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 118.626 0.648 . . . . 0.0 110.441 177.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 86.7 m -69.27 -42.05 76.05 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -174.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 67.5 t -65.02 -48.68 83.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -174.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -47.21 -51.58 18.2 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.957 1.303 . . . . 0.0 110.69 170.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.81 -43.85 97.06 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 119.764 1.165 . . . . 0.0 112.409 -177.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -66.69 -33.96 76.8 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.838 1.319 . . . . 0.0 111.42 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.4 t -62.94 -41.1 91.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.47 -37.56 81.42 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 120.245 1.384 . . . . 0.0 111.166 -177.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -70.17 -40.19 74.85 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 118.865 -0.588 . . . . 0.0 110.733 175.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -60.76 -46.28 91.08 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.515 1.052 . . . . 0.0 110.078 175.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 69.8 t -57.19 -51.42 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 124.224 1.01 . . . . 0.0 109.451 176.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -67.02 -33.0 74.59 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 119.473 -0.299 . . . . 0.0 111.347 -175.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -61.59 -49.26 77.34 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 123.41 0.684 . . . . 0.0 110.679 172.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -46.14 87.34 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 122.93 0.492 . . . . 0.0 110.219 177.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.1 mt -59.36 -41.0 82.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 124.691 1.196 . . . . 0.0 109.813 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.08 -27.59 67.11 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.068 0.849 . . . . 0.0 111.933 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -75.88 -39.73 55.85 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.776 -0.578 . . . . 0.0 111.786 176.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.1 pt -102.89 -33.14 3.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 -168.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 C--O 1.254 1.3 0 C-N-CA 124.755 1.222 . . . . 0.0 111.679 -171.426 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 tpt . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 118.273 -0.87 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.452 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -50.72 116.14 1.81 Allowed 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 120.285 1.402 . . . . 0.0 110.135 -173.123 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.5 mtpt -91.86 142.29 27.72 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 119.263 0.938 . . . . 0.0 108.693 -170.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.67 154.32 13.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 170.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -138.81 131.95 29.81 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -113.65 132.35 55.8 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.4 t -123.19 112.02 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 120.802 1.637 . . . . 0.0 110.164 -169.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.79 170.78 12.86 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 122.76 1.267 . . . . 0.0 112.835 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.0 mmtp -148.47 148.67 30.53 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 130.971 3.708 . . . . 0.0 101.706 168.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.484 ' CG ' ' H ' ' A' ' 11' ' ' ASN . 26.1 ttm-85 57.51 -160.51 0.24 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.743 1.156 . . . . 0.0 107.908 -168.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.484 ' H ' ' CG ' ' A' ' 10' ' ' ARG . 20.2 t-20 -55.77 133.96 51.32 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.221 0.919 . . . . 0.0 112.308 -169.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.4 m -48.06 -24.96 1.24 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 130.286 3.434 . . . . 0.0 115.125 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.0 m -50.2 -49.41 52.72 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 125.713 1.605 . . . . 0.0 114.107 -169.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.27 34.0 ptt180 -70.02 -42.12 73.4 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 118.23 -0.89 . . . . 0.0 113.21 -168.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 87.9 p -78.38 -39.4 39.29 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 120.528 1.513 . . . . 0.0 110.114 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -70.76 -27.68 64.12 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.628 -0.67 . . . . 0.0 110.003 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.471 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.1 tpt -66.72 -41.76 87.44 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 121.149 -0.97 . . . . 0.0 109.51 169.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.57 -38.46 84.65 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -61.33 -42.55 98.87 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.902 169.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.54 -44.88 88.97 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 120.643 1.565 . . . . 0.0 111.798 -175.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -64.98 -40.83 95.56 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 117.937 0.868 . . . . 0.0 108.836 173.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.19 -37.31 72.14 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 119.622 1.101 . . . . 0.0 111.286 -173.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -69.56 -24.77 63.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 120.567 1.53 . . . . 0.0 111.891 177.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.3 m -78.06 -49.98 12.95 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.345 2.258 . . . . 0.0 110.328 175.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.6 mt -88.01 -27.98 21.69 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.732 1.213 . . . . 0.0 112.355 -169.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.34 12.32 58.47 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 127.251 2.358 . . . . 0.0 111.96 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.06 122.83 15.97 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.264 1.426 . . . . 0.0 109.511 -170.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.94 8.41 87.84 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 119.536 -0.591 . . . . 0.0 113.764 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -124.85 -41.94 2.08 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.998 1.319 . . . . 0.0 108.832 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.8 pp -140.99 162.08 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.979 1.312 . . . . 0.0 109.124 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.84 155.53 18.54 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -143.9 139.4 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 118.622 0.646 . . . . 0.0 111.2 -168.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.5 m -150.09 165.85 31.53 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.232 1.413 . . . . 0.0 108.271 177.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.1 p -139.21 169.67 17.35 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.684 -1.26 . . . . 0.0 110.552 171.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.6 p -160.69 -178.31 6.77 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.103 0.961 . . . . 0.0 109.349 176.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.34 34.57 57.51 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 mt -76.03 57.0 1.04 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.368 1.067 . . . . 0.0 110.895 -174.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 53.28 8.03 0.1 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 128.157 2.583 . . . . 0.0 115.495 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.5 m 58.85 26.75 15.23 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.075 0.95 . . . . 0.0 110.922 -168.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 38.0 m -135.26 10.58 3.52 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.321 1.849 . . . . 0.0 111.957 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? 59.34 -158.51 0.31 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.596 1.159 . . . . 0.0 110.45 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.3 m -67.1 172.38 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.208 1.003 . . . . 0.0 111.886 -172.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.413 ' CG ' HD22 ' A' ' 11' ' ' ASN . 82.5 t60 -141.08 119.65 8.1 Favored Pre-proline 0 N--CA 1.451 -0.397 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -176.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -66.68 -26.69 45.73 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.534 2.823 . . . . 0.0 113.116 -169.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.8 m -61.85 -35.37 78.08 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.973 0.806 . . . . 0.0 109.464 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.3 -43.71 90.25 Favored 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.09 -47.24 90.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 118.566 -0.731 . . . . 0.0 109.041 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.5 99.25 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 118.759 0.709 . . . . 0.0 110.919 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.2 mmt -61.41 -24.94 66.87 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 123.615 0.766 . . . . 0.0 111.936 176.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.471 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.4 OUTLIER -95.45 -26.96 15.63 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 119.052 0.842 . . . . 0.0 108.965 -179.371 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.29 -29.05 70.44 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.996 0.919 . . . . 0.0 110.149 170.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -56.7 -26.23 56.23 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.24 0.616 . . . . 0.0 111.517 169.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.89 -15.95 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 126.744 2.018 . . . . 0.0 109.874 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.65 29.49 52.11 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.153 0.882 . . . . 0.0 111.099 -169.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.0 mt -109.4 156.91 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.259 1.423 . . . . 0.0 107.884 177.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.63 132.65 51.19 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 126.31 1.844 . . . . 0.0 107.669 -173.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.3 pt -140.71 4.48 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.628 1.171 . . . . 0.0 111.883 175.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.83 144.89 55.12 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.712 1.205 . . . . 0.0 110.262 176.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.82 3.68 4.84 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 117.926 -1.485 . . . . 0.0 114.67 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -56.62 -58.42 8.16 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-N 119.589 1.694 . . . . 0.0 112.745 -172.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.8 165.49 27.32 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.317 -167.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.3 m -163.13 19.7 0.08 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -173.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -141.89 154.0 64.9 Favored Pre-proline 0 N--CA 1.476 0.831 0 CA-C-N 120.803 1.638 . . . . 0.0 113.135 -169.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.13 -177.5 3.54 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 125.241 3.961 . . . . 0.0 113.373 174.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.9 tt -77.21 -33.15 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 126.015 1.726 . . . . 0.0 113.756 -173.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -68.92 -27.75 66.05 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -168.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.54 -7.48 57.56 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 117.579 -1.2 . . . . 0.0 112.776 171.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -102.93 166.13 10.63 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.692 1.587 . . . . 0.0 111.894 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.43 88.53 2.21 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 125.383 1.473 . . . . 0.0 108.884 -169.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -52.02 -27.75 14.66 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.028 0.931 . . . . 0.0 113.009 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -50.48 -32.51 18.29 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.346 1.058 . . . . 0.0 112.312 174.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -72.1 -20.83 61.58 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -101.68 175.03 5.69 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.104 2.562 . . . . 0.0 109.211 -175.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -117.06 -18.54 10.04 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 117.608 -1.187 . . . . 0.0 113.064 174.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.437 ' CG1' ' HB ' ' A' ' 95' ' ' ILE . 22.3 t -138.06 133.08 43.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 121.478 1.945 . . . . 0.0 108.672 -178.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.9 t -117.65 138.42 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 49.2 mm -131.54 92.12 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 103.004 -2.961 . . . . 0.0 103.004 172.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.7 t -69.63 164.58 23.04 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 169.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.8 mp -139.24 32.0 2.13 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.7 1.6 . . . . 0.0 106.892 173.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 87.7 m -74.39 -3.06 28.19 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.383 1.073 . . . . 0.0 111.908 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.48 34.36 6.09 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 119.585 1.084 . . . . 0.0 110.864 176.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . 0.25 30.3 p 38.91 45.14 0.93 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.003 2.521 . . . . 0.0 113.809 -178.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -142.88 36.55 1.6 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.404 1.478 . . . . 0.0 111.037 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.14 161.94 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 127.202 2.201 . . . . 0.0 108.949 -177.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -134.98 85.65 2.19 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 174.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.402 ' CD2' ' H ' ' A' ' 86' ' ' LEU . 1.3 mm? -62.08 153.85 72.13 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.708 -171.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.41 157.36 18.54 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.002 1.801 . . . . 0.0 112.272 174.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -52.13 -36.92 68.16 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.772 2.315 . . . . 0.0 116.152 -170.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -67.06 -23.79 65.91 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 120.982 -1.074 . . . . 0.0 112.288 -175.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -75.86 -11.65 60.01 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.745 1.218 . . . . 0.0 112.622 177.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.76 -16.67 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 120.032 1.287 . . . . 0.0 112.314 -177.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.6 p -76.72 -13.46 60.03 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.282 0.946 . . . . 0.0 112.342 177.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -41.67 154.17 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 129.982 3.313 . . . . 0.0 111.793 169.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -60.68 -36.91 79.93 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.096 1.758 . . . . 0.0 109.729 172.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.437 ' HB ' ' CG1' ' A' ' 75' ' ' VAL . 29.1 mm -130.18 136.35 58.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 170.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -133.69 123.03 24.27 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 102.92 -2.993 . . . . 0.0 102.92 166.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.46 167.04 23.43 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 173.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -130.51 102.24 6.07 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 169.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -76.86 80.81 3.44 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.898 1.679 . . . . 0.0 108.807 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.77 22.4 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.263 2.625 . . . . 0.0 115.234 175.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.72 164.91 13.6 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.062 -1.024 . . . . 0.0 111.219 -169.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -51.71 146.86 7.29 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -168.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -80.89 110.29 16.87 Favored Pre-proline 0 C--N 1.321 -0.669 0 C-N-CA 127.72 2.408 . . . . 0.0 109.531 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -84.16 -7.14 10.17 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.882 2.388 . . . . 0.0 112.378 176.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.6 t70 19.8 -101.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 128.758 2.823 . . . . 0.0 113.508 -176.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.81 39.76 1.74 Allowed Glycine 0 CA--C 1.533 1.191 0 C-N-CA 127.138 2.304 . . . . 0.0 108.059 169.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -70.03 -179.51 1.93 Allowed 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.987 1.715 . . . . 0.0 112.397 -173.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.2 p -60.27 154.47 19.94 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 113.142 -1.844 . . . . 0.0 109.04 169.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 27.6 mt -57.35 -29.74 64.25 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 122.799 0.44 . . . . 0.0 110.406 176.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -61.4 -41.08 96.56 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 118.527 -0.749 . . . . 0.0 110.948 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.5 t -72.17 -40.19 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 117.705 -1.14 . . . . 0.0 109.59 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -51.35 -51.31 55.62 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.934 1.243 . . . . 0.0 111.425 169.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 80.2 mtt180 -59.65 -44.27 93.6 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.847 0.749 . . . . 0.0 110.99 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 95.8 m -67.03 -45.93 75.98 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -175.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.1 t -64.95 -48.89 82.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -172.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -43.97 -53.58 6.1 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 125.374 1.47 . . . . 0.0 111.262 169.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.82 -40.41 95.57 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 120.104 1.32 . . . . 0.0 112.526 -177.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -66.05 -37.22 85.28 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 120.819 -1.4 . . . . 0.0 110.261 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.9 t -63.41 -43.7 98.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 CA-C-O 117.997 -1.002 . . . . 0.0 108.439 173.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.52 -40.22 82.31 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.716 1.598 . . . . 0.0 110.842 -175.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -71.26 -44.46 65.22 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 125.382 1.473 . . . . 0.0 109.084 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -66.24 -41.87 89.41 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 120.011 1.278 . . . . 0.0 111.582 177.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.7 t -53.98 -50.13 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 173.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -66.67 -34.4 77.79 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -176.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -61.68 -48.28 81.54 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 118.46 0.573 . . . . 0.0 110.394 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.58 -45.92 90.46 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 123.049 0.54 . . . . 0.0 109.829 177.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 12.4 mt -58.43 -42.2 83.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.735 1.214 . . . . 0.0 110.195 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.13 -28.38 67.83 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.296 0.498 . . . . 0.0 112.085 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -75.79 -43.54 45.81 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.418 0.554 . . . . 0.0 111.873 174.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 pt -91.92 -37.53 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -169.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.6 m . . . . . 0 C--O 1.255 1.348 0 CA-C-N 120.266 1.393 . . . . 0.0 110.352 179.36 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 tpt . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 118.524 -0.75 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.436 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -61.54 119.7 9.12 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 121.128 1.785 . . . . 0.0 108.035 -176.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 37.1 mtpt -92.25 137.97 31.92 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -170.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 t -122.06 153.77 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 58.9 tpp -138.44 145.12 40.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -129.42 121.82 28.12 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 t -118.5 113.35 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 119.644 1.111 . . . . 0.0 109.252 -169.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.96 167.42 18.92 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 123.32 1.533 . . . . 0.0 113.476 178.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -152.94 141.03 20.37 Favored 'General case' 0 C--O 1.238 0.479 2 N-CA-C 100.032 -4.062 . . . . 0.0 100.032 168.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 62.16 -179.36 0.13 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 120.331 1.423 . . . . 0.0 108.644 -167.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.505 HD22 ' CD2' ' A' ' 43' ' ' HIS . 28.8 t-20 -41.52 123.0 2.07 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 125.131 1.372 . . . . 0.0 112.129 -169.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.3 m -45.78 -26.71 0.7 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 127.868 2.467 . . . . 0.0 115.108 -176.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.5 t -39.78 -54.08 2.15 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 125.557 1.543 . . . . 0.0 112.859 -178.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.289 33.5 ptt180 -65.84 -44.35 85.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 117.784 -1.103 . . . . 0.0 113.454 -168.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 97.5 p -77.3 -41.67 39.79 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 121.094 1.77 . . . . 0.0 110.304 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -70.06 -34.91 73.81 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -172.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.46 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 3.4 tpt -63.72 -41.76 98.03 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 123.496 0.718 . . . . 0.0 110.363 170.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.58 -37.66 82.06 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.494 -177.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -62.51 -42.73 99.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 117.94 -1.028 . . . . 0.0 111.204 170.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.58 -45.23 93.62 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 120.746 1.612 . . . . 0.0 111.284 -175.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -66.77 -40.49 88.22 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.203 172.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.96 78.44 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 120.295 1.407 . . . . 0.0 111.6 -176.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -81.91 -13.82 57.01 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 120.46 1.482 . . . . 0.0 113.11 176.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.6 m -79.95 -52.01 8.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.698 1.199 . . . . 0.0 108.533 169.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.1 mt -84.44 -27.44 27.54 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.899 1.28 . . . . 0.0 111.859 -169.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.87 12.66 57.73 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.675 2.084 . . . . 0.0 111.889 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.53 121.98 12.91 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.585 1.154 . . . . 0.0 109.861 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.38 9.41 86.84 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 119.853 -0.415 . . . . 0.0 113.559 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -123.2 -32.56 3.42 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.849 1.66 . . . . 0.0 109.012 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.4 pt -142.64 174.57 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 125.305 1.442 . . . . 0.0 109.785 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.56 145.27 43.48 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 169.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 t -134.13 143.88 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 118.542 0.61 . . . . 0.0 111.279 -168.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.76 156.18 42.0 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.934 1.294 . . . . 0.0 109.74 -173.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.3 p -139.65 155.34 47.46 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 120.364 1.438 . . . . 0.0 111.069 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.2 p -160.11 -178.54 7.06 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.93 0.892 . . . . 0.0 110.313 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.43 33.32 72.42 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.0 mp -61.2 128.21 35.28 Favored 'General case' 0 C--N 1.344 0.338 0 N-CA-C 102.272 -3.232 . . . . 0.0 102.272 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -70.15 80.4 0.51 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-O 123.184 1.468 . . . . 0.0 113.415 -169.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.0 m 50.74 30.99 5.42 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 127.924 2.49 . . . . 0.0 112.758 174.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.0 m -149.87 167.01 27.81 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.517 1.527 . . . . 0.0 108.81 -170.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -78.48 -174.18 3.69 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 169.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.2 m -55.57 162.74 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 124.564 1.146 . . . . 0.0 112.06 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.505 ' CD2' HD22 ' A' ' 11' ' ' ASN . 81.5 t60 -119.74 110.07 37.29 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.623 -169.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -59.88 -29.1 88.68 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.07 2.513 . . . . 0.0 113.67 -169.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.33 -37.49 80.78 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.475 1.034 . . . . 0.0 110.847 175.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.21 -45.82 72.29 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.5 -45.81 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.5 -43.74 93.27 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.373 0.533 . . . . 0.0 111.438 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.3 mmt -65.86 -19.64 65.95 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 118.969 -0.539 . . . . 0.0 112.1 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.46 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 2.0 mmt -98.63 -28.65 13.45 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.93 -33.67 75.84 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.557 1.143 . . . . 0.0 109.547 169.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -58.51 -15.17 10.01 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.792 1.637 . . . . 0.0 112.067 172.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.0 m -132.45 14.3 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 C-N-CA 126.439 1.896 . . . . 0.0 111.753 177.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.51 43.54 76.9 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-O 118.944 -0.92 . . . . 0.0 114.31 174.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.1 mt -124.25 151.61 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.133 1.373 . . . . 0.0 107.872 171.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -113.81 129.86 56.53 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.293 1.437 . . . . 0.0 109.073 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.1 pt -129.76 14.12 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 125.568 1.547 . . . . 0.0 111.017 171.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.54 -28.1 31.24 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.372 1.469 . . . . 0.0 113.107 175.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.05 -9.5 86.74 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 118.372 0.533 . . . . 0.0 112.902 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -71.79 157.99 36.9 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.63 1.572 . . . . 0.0 109.614 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.48 165.15 31.15 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.54 144.84 49.43 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.682 1.993 . . . . 0.0 112.005 -172.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.65 139.41 1.67 Allowed Pre-proline 0 C--O 1.237 0.409 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 169.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -79.39 158.64 25.94 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.271 1.981 . . . . 0.0 110.845 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.6 tt -57.92 -37.2 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 124.707 1.203 . . . . 0.0 110.641 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -69.76 -21.87 63.4 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.357 0.663 . . . . 0.0 112.344 -174.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -22.2 60.94 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.28 0.491 . . . . 0.0 111.069 171.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -94.01 168.95 10.62 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 122.072 0.939 . . . . 0.0 110.646 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.39 93.41 2.43 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 125.451 1.5 . . . . 0.0 107.516 -175.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.426 ' HB1' ' CD2' ' A' ' 90' ' ' TRP . . . -50.0 -24.31 2.54 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 124.306 1.042 . . . . 0.0 113.392 175.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -50.81 -28.99 10.52 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.136 0.574 . . . . 0.0 111.318 173.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -91.92 -9.34 43.48 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.403 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 12.8 m-85 -120.2 112.93 19.69 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 120.595 1.543 . . . . 0.0 109.332 -173.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -65.54 -14.48 61.16 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -169.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.0 t -143.85 118.19 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 -171.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.3 m -128.19 134.2 65.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 O-C-N 120.875 -1.14 . . . . 0.0 108.718 -174.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.4 mm -127.5 97.14 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 104.203 -2.518 . . . . 0.0 104.203 -169.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.0 t -72.81 166.29 23.21 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 169.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.8 mp -144.27 40.19 1.33 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 173.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 60.9 m -100.04 12.0 37.96 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.334 1.054 . . . . 0.0 111.358 -172.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.7 23.53 28.04 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.512 -0.605 . . . . 0.0 111.862 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.405 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 4.0 t 45.65 45.7 11.1 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.857 1.663 . . . . 0.0 111.945 -177.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -153.53 35.9 0.75 Allowed Glycine 0 C--N 1.341 0.821 0 C-N-CA 123.405 0.526 . . . . 0.0 111.928 -171.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 78.5 t -122.43 133.16 69.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 125.039 1.335 . . . . 0.0 107.737 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -78.42 72.42 4.95 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 172.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.3 mt -57.73 145.98 68.15 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -55.1 155.24 19.65 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.046 1.831 . . . . 0.0 112.432 176.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -54.18 -29.28 55.61 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.549 2.166 . . . . 0.0 115.94 -173.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -66.25 -27.06 67.66 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 120.986 -1.071 . . . . 0.0 111.159 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.426 ' CD2' ' HB1' ' A' ' 70' ' ' ALA . 71.0 m95 -71.47 -3.63 22.12 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 117.91 -1.043 . . . . 0.0 113.165 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.0 m -120.71 -7.17 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 120.575 1.534 . . . . 0.0 113.471 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.8 p -87.28 -16.25 35.7 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.448 1.022 . . . . 0.0 112.632 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -54.02 163.33 0.79 Allowed 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 129.153 2.981 . . . . 0.0 113.605 175.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -64.89 -41.72 95.37 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.673 1.189 . . . . 0.0 108.708 176.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.7 mm -121.64 140.48 45.53 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 CA-C-O 121.58 0.705 . . . . 0.0 110.097 169.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -140.71 114.3 8.8 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 100.946 -3.724 . . . . 0.0 100.946 166.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -135.9 170.28 16.24 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 170.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.405 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.2 t70 -137.31 106.24 5.95 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 172.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.474 ' C ' ' H ' ' A' ' 101' ' ' LEU . 48.7 m0 -85.13 70.48 10.89 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -48.03 7.91 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.208 1 C-N-CA 131.836 4.054 . . . . 0.0 115.324 169.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.474 ' H ' ' C ' ' A' ' 99' ' ' TRP . 3.8 mm? -61.48 126.39 27.17 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 126.798 2.039 . . . . 0.0 111.338 -168.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 51.01 -160.04 0.09 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.826 2.051 . . . . 0.0 113.765 169.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -165.48 70.76 1.32 Allowed Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 128.101 2.561 . . . . 0.0 108.061 -172.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.95 -4.8 16.01 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 122.526 2.15 . . . . 0.0 114.215 -169.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -56.61 -34.19 66.99 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -173.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.35 40.65 1.94 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.651 1.119 . . . . 0.0 112.737 -174.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -116.13 -157.62 0.66 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.085 0.954 . . . . 0.0 111.89 -175.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.9 m -131.11 173.56 10.9 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 128.662 2.785 . . . . 0.0 107.542 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 35.4 mt -54.7 -36.06 64.3 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.962 0.905 . . . . 0.0 110.785 -172.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -60.13 -40.0 88.22 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 123.031 0.532 . . . . 0.0 110.269 -175.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.61 -37.82 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.091 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -53.68 -42.73 68.27 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.948 1.249 . . . . 0.0 111.255 170.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -63.44 -43.76 96.5 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 119.607 1.094 . . . . 0.0 111.141 174.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.1 m -71.91 -43.39 65.42 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -171.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 57.9 t -64.48 -47.19 90.33 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -173.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.3 ttp180 -45.08 -50.38 11.06 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 125.475 1.51 . . . . 0.0 111.026 169.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.69 -43.4 96.34 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 119.576 1.08 . . . . 0.0 112.696 177.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -75.91 -31.68 59.27 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 120.956 -1.32 . . . . 0.0 110.652 -175.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.2 -37.75 80.27 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 170.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -57.8 -47.79 81.57 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 120.595 1.543 . . . . 0.0 110.876 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -62.05 -38.25 88.03 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.021 0.826 . . . . 0.0 109.011 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -68.13 -47.18 68.81 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.404 0.681 . . . . 0.0 110.878 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.6 t -56.49 -52.51 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.87 1.268 . . . . 0.0 108.738 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -68.66 -33.37 73.87 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -171.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -62.16 -49.43 75.87 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 123.099 0.56 . . . . 0.0 110.852 171.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.87 -46.14 78.33 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 122.978 0.511 . . . . 0.0 109.876 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.7 mt -58.85 -43.84 89.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 124.807 1.243 . . . . 0.0 110.687 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.71 -29.06 67.85 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 118.782 0.719 . . . . 0.0 111.726 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -74.71 -40.64 61.2 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 118.538 0.608 . . . . 0.0 112.032 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.9 pt -100.62 -42.38 9.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 116.976 2.213 . . . . 0.0 116.976 -168.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.254 1.307 0 CA-C-N 119.195 0.907 . . . . 0.0 110.304 -171.909 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 tpt . . . . . 0 N--CA 1.499 1.977 0 CA-C-O 117.706 -1.14 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.454 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -54.96 118.02 3.93 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 121.337 1.881 . . . . 0.0 110.377 -169.69 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -86.19 135.47 33.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -170.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.0 t -125.36 153.71 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 61.4 tpp -140.59 131.91 26.69 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -176.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -116.17 107.27 14.68 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.9 t -94.39 144.31 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -169.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.4 t -128.0 -177.76 4.26 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.38 1.072 . . . . 0.0 110.185 172.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -152.4 -45.93 0.1 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.63 1.572 . . . . 0.0 108.688 176.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -167.7 0.17 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.187 0.995 . . . . 0.0 109.017 169.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.473 HD22 ' CD2' ' A' ' 43' ' ' HIS . 26.6 t-20 -47.94 139.58 7.69 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.698 0.799 . . . . 0.0 109.614 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -55.22 -22.9 19.63 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.504 1.522 . . . . 0.0 114.396 -169.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.9 m -42.2 -67.5 0.26 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 127.21 2.204 . . . . 0.0 114.318 -172.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.272 34.9 ptt180 -56.19 -47.67 77.87 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.451 1.478 . . . . 0.0 114.715 -167.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.43 -29.98 21.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 119.005 0.82 . . . . 0.0 111.315 -171.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -70.09 -27.01 64.26 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.112 -0.992 . . . . 0.0 110.023 170.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.473 ' SD ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -69.03 -42.25 76.6 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 120.574 -1.329 . . . . 0.0 109.789 169.439 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.08 -40.21 84.54 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -59.65 -39.09 83.26 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.42 169.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.19 -43.08 56.77 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 120.715 1.598 . . . . 0.0 112.587 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.473 ' CD2' ' SD ' ' A' ' 17' ' ' MET . 10.6 m-85 -64.68 -37.52 87.88 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 119.075 1.438 . . . . 0.0 108.989 170.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.45 -39.17 68.0 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 119.497 1.044 . . . . 0.0 111.118 -173.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -65.27 -33.79 76.81 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 120.371 1.441 . . . . 0.0 110.915 174.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.8 m -69.06 -50.98 43.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.285 1.834 . . . . 0.0 110.232 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.0 mt -90.06 -25.83 20.58 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.55 1.14 . . . . 0.0 112.129 -169.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.23 14.84 58.15 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 126.748 2.118 . . . . 0.0 111.903 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.66 120.82 10.77 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.908 1.283 . . . . 0.0 110.091 -171.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.11 8.53 86.93 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-O 119.811 -0.439 . . . . 0.0 113.511 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -123.1 -28.45 4.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.413 1.485 . . . . 0.0 109.583 -176.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.6 pt -143.35 175.87 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 125.832 1.653 . . . . 0.0 109.386 176.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.56 145.12 46.66 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 103.868 -2.641 . . . . 0.0 103.868 168.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 t -132.17 144.04 38.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 123.851 0.86 . . . . 0.0 111.316 -167.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.75 161.97 41.18 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.799 1.24 . . . . 0.0 109.723 -173.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.9 t -142.18 154.76 45.09 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.688 1.586 . . . . 0.0 109.524 172.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.6 p -157.11 171.03 21.18 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 118.509 0.595 . . . . 0.0 112.312 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.18 47.36 90.28 Favored Glycine 0 N--CA 1.472 1.091 0 N-CA-C 107.786 -2.126 . . . . 0.0 107.786 -169.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.92 56.89 3.25 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.114 1.766 . . . . 0.0 109.097 -168.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 60.98 -67.43 0.05 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 129.759 3.224 . . . . 0.0 111.381 -168.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.3 m -155.0 40.93 0.44 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.385 2.274 . . . . 0.0 107.995 -175.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.3 m 58.36 48.66 12.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.489 1.116 . . . . 0.0 113.129 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.79 142.75 22.2 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.503 -0.748 . . . . 0.0 111.725 171.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.4 m -71.47 177.81 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 124.668 1.187 . . . . 0.0 110.528 175.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.473 ' CD2' HD22 ' A' ' 11' ' ' ASN . 20.9 t-80 -139.75 119.52 9.09 Favored Pre-proline 0 N--CA 1.451 -0.403 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -176.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -67.11 -27.28 42.06 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.057 2.505 . . . . 0.0 112.555 -169.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.7 m -62.43 -35.48 79.38 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.967 0.803 . . . . 0.0 109.53 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.23 -43.03 92.77 Favored 'General case' 0 C--O 1.221 -0.447 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.57 -47.84 89.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 118.206 -0.902 . . . . 0.0 109.382 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.35 -42.69 99.1 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 119.633 1.106 . . . . 0.0 110.878 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.0 mmt -64.32 -18.2 64.39 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.765 0.826 . . . . 0.0 112.112 176.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 3.9 mmt -95.02 -28.03 15.33 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 119.387 0.994 . . . . 0.0 110.992 173.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -63.6 -30.01 71.18 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 123.62 0.768 . . . . 0.0 109.694 172.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -57.96 -21.13 42.73 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.535 1.134 . . . . 0.0 113.101 170.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.4 p -121.44 9.03 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 125.229 1.412 . . . . 0.0 110.386 -177.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.32 36.88 85.5 Favored Glycine 0 CA--C 1.531 1.072 0 O-C-N 121.148 -0.97 . . . . 0.0 111.808 177.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 35.3 mt -121.83 157.93 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 126.2 1.8 . . . . 0.0 106.153 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -140.33 145.08 36.73 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 172.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 27.6 pt -138.55 7.7 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 126.354 1.862 . . . . 0.0 111.023 -174.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.3 t -64.28 145.67 55.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.612 -0.68 . . . . 0.0 109.289 172.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.63 3.52 5.75 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 117.802 -1.555 . . . . 0.0 114.552 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -54.6 -58.7 6.49 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-N 119.776 1.788 . . . . 0.0 111.481 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.77 154.03 32.16 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 125.57 1.548 . . . . 0.0 106.986 -169.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.0 m -163.43 68.03 0.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 102.428 -3.175 . . . . 0.0 102.428 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -142.46 141.44 20.82 Favored Pre-proline 0 C--O 1.236 0.347 0 CA-C-O 119.152 -0.451 . . . . 0.0 112.195 -167.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -82.66 159.99 16.58 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.522 2.815 . . . . 0.0 111.268 173.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.63 -36.87 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 124.463 1.105 . . . . 0.0 111.778 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -70.46 -19.96 62.92 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.277 0.631 . . . . 0.0 112.16 -173.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.25 -23.9 62.98 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 118.763 -0.637 . . . . 0.0 111.6 170.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -99.82 169.71 9.04 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 122.128 0.966 . . . . 0.0 111.093 -174.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -142.59 90.69 2.25 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 -170.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.442 ' HB3' ' CD2' ' A' ' 90' ' ' TRP . . . -54.26 -22.79 12.67 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.4 -21.07 5.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 122.943 0.497 . . . . 0.0 111.301 171.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -111.31 17.09 20.54 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.881 2.072 . . . . 0.0 112.346 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -132.82 107.57 8.43 Favored 'General case' 0 C--N 1.345 0.407 0 O-C-N 120.685 -1.259 . . . . 0.0 107.787 170.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -58.94 -18.86 37.45 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -169.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.5 t -143.07 123.43 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -170.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 t -118.06 134.45 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.8 mm -131.98 87.69 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.1 t -68.31 165.8 17.84 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.988 -1.07 . . . . 0.0 108.653 169.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -144.5 53.03 1.25 Allowed 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 170.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.3 m -113.53 15.73 18.93 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.11 0.964 . . . . 0.0 110.583 -176.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.68 24.7 29.73 Favored Glycine 0 C--N 1.339 0.723 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 172.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 6.7 t 44.54 42.44 5.62 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.311 1.844 . . . . 0.0 112.327 -176.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -151.66 37.88 0.82 Allowed Glycine 0 C--N 1.339 0.72 0 C-N-CA 123.53 0.586 . . . . 0.0 112.012 -171.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.5 t -120.24 141.67 39.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 C-N-CA 124.753 1.221 . . . . 0.0 108.612 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -82.03 55.95 2.97 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.588 1.155 . . . . 0.0 110.159 -178.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.4 mt -57.15 133.64 80.73 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.59 154.6 19.6 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.666 2.244 . . . . 0.0 112.758 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -55.0 -27.98 57.33 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.619 2.213 . . . . 0.0 116.208 -172.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -65.45 -25.36 67.48 Favored 'General case' 0 C--O 1.226 -0.147 0 O-C-N 121.284 -0.885 . . . . 0.0 111.288 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.442 ' CD2' ' HB3' ' A' ' 70' ' ' ALA . 61.7 m95 -67.93 -8.66 38.76 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.251 -0.906 . . . . 0.0 112.813 175.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.3 t -107.78 -30.54 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.022 1.329 . . . . 0.0 111.122 -170.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.7 p -74.65 -16.77 60.76 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.37 1.068 . . . . 0.0 113.688 -169.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -50.56 160.76 0.38 Allowed 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 130.213 3.405 . . . . 0.0 114.308 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -60.11 -39.41 86.08 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.414 1.486 . . . . 0.0 108.591 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.2 mm -126.32 137.07 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 169.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -137.49 113.09 9.48 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 102.156 -3.276 . . . . 0.0 102.156 166.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -140.75 166.66 24.15 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -139.67 110.56 6.83 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 169.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -83.04 81.98 8.44 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.33 25.6 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 127.337 2.255 . . . . 0.0 114.564 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.57 175.64 2.77 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.696 -1.253 . . . . 0.0 110.372 -172.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.79 160.46 2.62 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 123.238 1.494 . . . . 0.0 114.542 -170.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -103.91 108.08 58.73 Favored Pre-proline 0 C--N 1.322 -0.608 0 C-N-CA 127.01 2.124 . . . . 0.0 108.717 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -80.85 -6.65 13.32 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.609 2.206 . . . . 0.0 112.014 177.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.7 t0 22.9 -99.33 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 128.389 2.676 . . . . 0.0 113.336 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.64 39.91 1.66 Allowed Glycine 0 CA--C 1.531 1.084 0 C-N-CA 127.119 2.295 . . . . 0.0 108.7 169.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -70.38 -178.07 1.63 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.397 1.879 . . . . 0.0 112.635 -175.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.3 m -61.3 153.67 25.88 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 113.376 -1.738 . . . . 0.0 108.731 171.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.7 mt -56.68 -29.73 62.66 Favored 'General case' 0 C--O 1.221 -0.396 0 C-N-CA 122.954 0.502 . . . . 0.0 110.82 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -61.24 -39.68 91.21 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.058 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.5 t -73.72 -40.02 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.257 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -51.13 -51.45 53.4 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.738 1.154 . . . . 0.0 111.326 169.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -59.05 -45.18 91.41 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.441 0.696 . . . . 0.0 110.958 178.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.1 m -67.58 -45.71 74.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -173.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.3 t -66.02 -48.24 82.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -171.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -44.1 -56.83 3.76 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.783 1.233 . . . . 0.0 110.575 169.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.94 -41.76 99.82 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 119.968 1.258 . . . . 0.0 111.948 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -63.75 -41.73 97.97 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.516 -0.99 . . . . 0.0 110.263 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.35 -39.07 82.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -41.45 83.41 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 120.013 1.279 . . . . 0.0 110.642 -175.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.69 -40.41 80.07 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.633 0.373 . . . . 0.0 110.063 177.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -64.49 -47.11 80.15 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.618 0.644 . . . . 0.0 110.292 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.1 t -56.05 -51.38 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 124.049 0.939 . . . . 0.0 108.469 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -66.01 -32.36 73.79 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 119.353 -0.356 . . . . 0.0 111.5 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -62.51 -48.07 81.16 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 118.612 0.642 . . . . 0.0 111.013 173.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -42.98 91.55 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 123.247 0.619 . . . . 0.0 110.624 176.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.0 mt -62.26 -43.09 97.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 123.102 0.561 . . . . 0.0 110.116 175.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.35 -31.68 71.57 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.311 0.959 . . . . 0.0 112.039 -175.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -81.37 -35.08 31.26 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 117.763 -1.113 . . . . 0.0 112.978 175.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 pt -96.52 -43.66 12.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 115.421 1.638 . . . . 0.0 115.421 -173.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.2 m . . . . . 0 C--O 1.256 1.444 0 C-N-CA 124.636 1.174 . . . . 0.0 111.586 -171.165 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mmm . . . . . 0 N--CA 1.502 2.131 0 CA-C-O 119.257 -0.402 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.482 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -59.31 137.74 57.87 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 169.463 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -112.19 142.06 45.13 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 -169.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.5 t -122.86 155.29 28.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -174.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 57.0 tpp -136.68 134.25 37.05 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -115.74 112.07 21.49 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 t -96.32 136.72 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -169.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.3 m -109.72 149.95 29.02 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.258 1.023 . . . . 0.0 112.237 -169.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.7 mmtt -150.07 146.09 26.74 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.372 1.869 . . . . 0.0 106.054 169.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.511 ' CG ' ' H ' ' A' ' 11' ' ' ASN . 27.0 ttm180 57.01 -172.44 0.08 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.544 1.138 . . . . 0.0 109.307 -168.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.511 ' H ' ' CG ' ' A' ' 10' ' ' ARG . 37.0 t-20 -49.95 105.36 0.09 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.418 1.487 . . . . 0.0 107.857 -177.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 m -62.06 0.15 0.44 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 117.137 2.273 . . . . 0.0 117.137 -167.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.1 m -38.22 -50.57 1.43 Allowed 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 126.36 1.864 . . . . 0.0 111.923 173.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -65.23 -43.25 92.03 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.243 0.545 . . . . 0.0 111.329 -171.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.1 p -88.45 -37.75 15.57 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 124.422 1.089 . . . . 0.0 111.1 -170.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -72.13 -32.08 66.61 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.552 -0.717 . . . . 0.0 109.545 174.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.415 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.5 tpt -62.09 -39.22 91.72 Favored 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 121.158 -0.964 . . . . 0.0 109.685 169.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.07 92.1 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -62.94 -39.16 93.76 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.204 170.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.77 -43.07 68.5 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 120.852 1.66 . . . . 0.0 111.275 -174.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -63.53 -40.4 96.94 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 170.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.29 -40.27 81.84 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 119.58 1.082 . . . . 0.0 111.464 -176.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.4 pttp -70.84 -22.72 62.28 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 120.455 1.48 . . . . 0.0 112.373 176.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.9 m -77.79 -52.13 9.4 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.763 1.625 . . . . 0.0 110.23 175.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 71.1 mt -85.33 -26.49 26.51 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.017 1.327 . . . . 0.0 111.606 -169.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.63 15.27 55.97 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 126.74 2.114 . . . . 0.0 111.707 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.91 121.94 12.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.668 1.187 . . . . 0.0 109.936 -175.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.04 8.05 87.46 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 119.752 -0.471 . . . . 0.0 113.385 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -122.6 -32.25 3.61 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 125.234 1.414 . . . . 0.0 109.36 -177.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.6 pt -141.55 163.92 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 125.018 1.327 . . . . 0.0 110.54 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.74 144.18 31.43 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 168.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.27 135.12 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.472 0.709 . . . . 0.0 110.512 -168.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.7 m -147.31 161.4 41.04 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.776 1.231 . . . . 0.0 109.501 -178.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.5 p -128.09 161.67 28.67 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.726 1.21 . . . . 0.0 109.491 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.5 p -152.31 147.56 26.48 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 121.328 -0.858 . . . . 0.0 111.709 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.82 140.26 1.78 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 105.154 -3.178 . . . . 0.0 105.154 -168.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -162.74 118.39 1.84 Allowed 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 104.343 -2.466 . . . . 0.0 104.343 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.01 116.59 2.65 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 122.111 0.958 . . . . 0.0 110.043 -170.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.4 m 52.94 31.53 11.05 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.387 1.475 . . . . 0.0 113.157 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.5 m 64.67 3.68 2.06 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.674 2.39 . . . . 0.0 115.601 169.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.8 148.54 50.45 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 120.273 1.397 . . . . 0.0 110.121 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.6 m -68.66 177.84 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 124.539 1.135 . . . . 0.0 111.287 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.466 ' CD2' HD22 ' A' ' 11' ' ' ASN . 82.9 t60 -134.15 116.23 13.22 Favored Pre-proline 0 N--CA 1.446 -0.671 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 -175.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -64.75 -24.26 62.05 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 123.714 2.942 . . . . 0.0 112.7 -169.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.0 m -61.27 -36.64 80.61 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.106 0.867 . . . . 0.0 109.731 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.15 -45.1 82.17 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -56.37 -49.24 77.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.49 -42.93 99.53 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.41 0.55 . . . . 0.0 111.024 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.6 mmt -61.51 -23.99 66.3 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 124.251 1.021 . . . . 0.0 113.337 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.415 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 4.3 mmt -101.98 -24.11 14.03 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.084 0.856 . . . . 0.0 108.958 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -64.94 -34.75 79.15 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 118.952 0.796 . . . . 0.0 109.435 171.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -72.6 7.1 2.04 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 173.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.3 t -119.29 -39.56 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 127.23 2.212 . . . . 0.0 110.023 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.94 24.14 2.58 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.375 1.464 . . . . 0.0 112.884 -176.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.7 mt -124.42 161.6 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 125.879 1.671 . . . . 0.0 107.222 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -108.19 -61.5 1.58 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -169.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . 0.421 28.7 pt 56.17 1.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 118.245 2.683 . . . . 0.0 118.245 -177.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.76 147.93 43.03 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 120.899 1.681 . . . . 0.0 109.39 169.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.69 1.42 11.45 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 118.248 -1.307 . . . . 0.0 114.777 176.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -48.47 -65.32 0.59 Allowed 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.258 1.529 . . . . 0.0 113.23 -177.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.9 166.15 25.74 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 123.672 0.608 . . . . 0.0 112.548 -168.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.9 p -169.56 22.81 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.91 0.884 . . . . 0.0 112.565 -171.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -139.47 150.36 63.46 Favored Pre-proline 0 N--CA 1.475 0.821 0 CA-C-N 119.895 1.225 . . . . 0.0 112.193 -169.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -84.25 162.54 13.23 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 124.095 3.196 . . . . 0.0 112.909 -170.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.1 tt -57.43 -36.4 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.99 1.716 . . . . 0.0 111.269 -176.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -73.86 -16.37 61.13 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -170.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.16 -17.07 44.19 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 118.691 -0.671 . . . . 0.0 111.793 170.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -88.79 170.47 10.73 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.195 0.907 . . . . 0.0 110.721 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.7 89.91 2.24 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.451 1.501 . . . . 0.0 107.921 -177.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.44 ' HB3' ' CD2' ' A' ' 90' ' ' TRP . . . -52.39 -23.16 5.52 Favored 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 176.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -50.86 -30.2 13.85 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.349 0.66 . . . . 0.0 111.398 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -91.71 4.18 53.35 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -131.83 114.8 15.14 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 120.437 1.471 . . . . 0.0 109.454 -177.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -69.78 -6.91 35.33 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -169.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.7 t -145.02 123.31 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -171.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.0 t -118.51 127.39 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.8 mm -121.45 94.3 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 171.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.2 p -73.95 167.52 21.32 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 118.252 -1.379 . . . . 0.0 107.747 168.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mp -143.02 41.82 1.53 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 173.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 59.1 m -101.03 -5.49 25.71 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.523 1.529 . . . . 0.0 112.188 -168.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.15 15.64 7.09 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-N 119.543 1.065 . . . . 0.0 113.985 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 6.0 t 45.5 56.06 6.07 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.77 1.628 . . . . 0.0 111.172 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -175.52 -26.18 0.03 OUTLIER Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.479 -172.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 78.5 t -56.6 121.21 4.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 169.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -65.41 136.45 56.5 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 173.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.5 mt -123.71 144.34 44.27 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 176.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.25 156.72 9.96 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.6 2.2 . . . . 0.0 112.997 176.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -53.91 -30.39 58.08 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.824 2.349 . . . . 0.0 116.399 -170.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -67.04 -26.0 66.54 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.377 -0.827 . . . . 0.0 111.328 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.44 ' CD2' ' HB3' ' A' ' 70' ' ' ALA . 66.2 m95 -69.67 -13.25 62.21 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 120.87 -1.144 . . . . 0.0 113.388 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.96 -9.35 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 119.721 1.146 . . . . 0.0 112.957 -169.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.1 p -85.79 -10.26 55.76 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.253 1.021 . . . . 0.0 112.714 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -60.46 167.94 2.35 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 128.974 2.91 . . . . 0.0 113.18 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.88 -40.96 87.95 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.651 1.181 . . . . 0.0 108.951 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 26.7 mm -119.93 139.27 47.79 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 CA-C-O 121.163 0.506 . . . . 0.0 109.717 170.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -144.66 106.5 4.29 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 102.16 -3.274 . . . . 0.0 102.16 166.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -132.84 168.21 18.81 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 175.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -139.67 111.66 7.45 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 171.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -92.13 65.65 4.76 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -33.19 -52.07 0.35 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.52 1.928 . . . . 0.0 111.773 177.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 40.1 -170.56 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 129.851 3.261 . . . . 0.0 114.371 -175.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.56 175.61 1.02 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 122.79 1.281 . . . . 0.0 111.887 170.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -127.28 103.83 22.63 Favored Pre-proline 0 C--N 1.321 -0.657 0 C-N-CA 128.232 2.613 . . . . 0.0 107.418 -170.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.3 -4.2 14.49 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.648 2.232 . . . . 0.0 112.602 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.3 t0 20.13 -95.06 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.784 2.834 . . . . 0.0 113.791 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.67 40.39 1.55 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 127.141 2.305 . . . . 0.0 109.151 169.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -75.16 179.01 5.31 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.722 1.609 . . . . 0.0 113.098 -170.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.3 p -62.35 157.38 19.99 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 113.148 -1.842 . . . . 0.0 109.634 171.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 21.7 mt -57.68 -30.42 65.44 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.602 176.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.34 -41.3 98.46 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 118.695 -0.669 . . . . 0.0 111.099 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.2 t -71.78 -40.81 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 117.705 -1.141 . . . . 0.0 109.238 178.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -50.7 -51.42 49.74 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.909 1.232 . . . . 0.0 111.725 169.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -59.05 -45.52 90.57 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.025 0.829 . . . . 0.0 110.931 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.7 m -68.09 -43.01 79.5 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -174.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.9 t -64.83 -49.75 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -175.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -48.08 -56.12 8.55 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.963 1.305 . . . . 0.0 111.017 173.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.09 -41.73 99.72 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 119.111 0.869 . . . . 0.0 111.519 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -66.78 -37.77 85.24 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.205 -1.173 . . . . 0.0 110.532 -178.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.4 t -62.87 -42.71 97.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 173.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -35.95 75.59 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 119.819 1.191 . . . . 0.0 111.352 -174.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -69.01 -43.08 75.52 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.512 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -64.18 -41.66 97.02 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.923 1.238 . . . . 0.0 110.559 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.7 t -54.23 -54.35 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 173.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -64.93 -32.65 74.47 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 122.012 -0.43 . . . . 0.0 111.599 -174.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -62.34 -48.25 80.65 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 123.368 0.667 . . . . 0.0 111.363 171.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -48.35 75.09 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 118.56 0.618 . . . . 0.0 109.562 175.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.7 mt -58.09 -42.19 82.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 123.804 0.842 . . . . 0.0 109.287 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.93 -31.43 71.75 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.797 0.726 . . . . 0.0 111.74 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -72.3 -42.77 65.1 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.554 173.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.2 pt -103.28 -46.2 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 118.607 2.817 . . . . 0.0 118.607 -168.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.5 m . . . . . 0 C--O 1.253 1.247 0 C-N-CA 124.06 0.944 . . . . 0.0 111.883 -169.177 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.9 mmm . . . . . 0 N--CA 1.501 2.084 0 N-CA-C 111.483 0.179 . . . . 0.0 111.483 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.635 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -58.44 132.57 54.11 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 172.337 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.506 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 53.1 mtpt -99.05 138.85 35.56 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -172.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.674 HG13 HG12 ' A' ' 75' ' ' VAL . 11.1 t -134.11 153.66 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 123.005 0.522 . . . . 0.0 109.716 -171.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.4 tpp -139.53 147.95 41.93 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.627 0.771 . . . . 0.0 109.792 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -132.1 112.21 12.13 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.46 1.504 . . . . 0.0 107.611 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 4.1 t -97.1 137.42 24.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -172.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 m -120.08 146.59 45.78 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -169.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -150.75 164.71 35.52 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.465 1.906 . . . . 0.0 108.602 174.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.468 ' HD3' ' H ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER 54.75 -146.1 0.58 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.668 1.587 . . . . 0.0 108.589 -169.538 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.468 ' H ' ' HD3' ' A' ' 10' ' ' ARG . 55.3 t-20 -65.55 99.37 0.43 Allowed 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 173.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.7 m -64.36 -4.01 3.45 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.441 ' HA ' ' HG2' ' A' ' 16' ' ' GLN . 68.4 m -48.0 -38.65 17.53 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 119.309 0.959 . . . . 0.0 113.062 169.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -62.91 -41.08 99.32 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 120.051 1.296 . . . . 0.0 111.909 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.41 -37.07 12.78 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.766 0.826 . . . . 0.0 109.613 -169.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.509 HE22 HG12 ' A' ' 42' ' ' VAL . 11.6 pt20 -66.84 -31.15 71.58 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.102 -0.998 . . . . 0.0 110.127 169.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.438 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.9 tpt -62.88 -37.44 86.9 Favored 'General case' 0 CA--C 1.51 -0.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.448 171.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.99 90.5 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -64.84 -38.04 89.64 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.153 169.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.9 -42.32 96.99 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 120.931 1.696 . . . . 0.0 111.811 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -66.73 -37.44 84.68 Favored 'General case' 0 C--O 1.222 -0.356 0 O-C-N 121.861 -0.788 . . . . 0.0 109.296 170.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.05 -35.19 69.25 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 119.539 1.063 . . . . 0.0 111.652 -175.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -66.93 -34.39 77.66 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 121.382 1.901 . . . . 0.0 111.425 171.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.2 m -69.39 -50.61 44.4 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.509 1.524 . . . . 0.0 110.343 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.0 mt -91.83 -25.55 18.93 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.079 1.352 . . . . 0.0 111.905 -169.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.97 8.72 76.09 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 126.675 2.083 . . . . 0.0 112.195 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.51 121.88 13.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.393 1.077 . . . . 0.0 110.064 -170.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.91 9.93 85.12 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 119.975 -0.347 . . . . 0.0 113.477 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -122.18 -36.8 2.91 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 125.947 1.699 . . . . 0.0 109.192 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.9 pt -138.44 162.96 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.873 1.269 . . . . 0.0 108.987 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.44 132.78 53.81 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 169.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.41 140.65 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 119.745 1.157 . . . . 0.0 113.308 -168.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.4 m -142.58 166.94 23.3 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.51 1.524 . . . . 0.0 109.903 -169.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.8 p -136.69 158.83 43.54 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.721 1.208 . . . . 0.0 110.069 176.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.479 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 27.5 p -151.81 158.66 43.58 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 122.83 0.452 . . . . 0.0 110.479 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.112 0 N-CA-C 106.857 -2.497 . . . . 0.0 106.857 -168.104 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.509 HG12 HE22 ' A' ' 16' ' ' GLN . 19.5 m . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -128.73 111.11 18.89 Favored Pre-proline 0 C--O 1.233 0.194 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -171.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -51.54 -30.44 35.82 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.855 3.037 . . . . 0.0 114.913 -174.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -60.42 -39.13 86.32 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.995 0.816 . . . . 0.0 110.964 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.72 -44.85 76.65 Favored 'General case' 0 CA--C 1.513 -0.444 0 O-C-N 121.448 -0.782 . . . . 0.0 109.062 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.02 -44.39 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.45 -43.91 96.37 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.507 0.594 . . . . 0.0 111.525 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.8 mmt -65.67 -18.74 65.55 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 118.879 -0.582 . . . . 0.0 112.3 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.438 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.8 OUTLIER -96.4 -31.64 12.75 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -178.138 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -63.08 -33.4 75.36 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.166 1.386 . . . . 0.0 110.003 169.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -58.49 -15.97 13.29 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.114 1.766 . . . . 0.0 111.845 172.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.4 m -130.62 12.84 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 126.156 1.783 . . . . 0.0 111.683 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.4 42.84 80.86 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 121.173 -0.955 . . . . 0.0 113.772 175.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.3 mt -124.69 155.27 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.81 1.644 . . . . 0.0 107.73 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -123.84 125.55 44.87 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.826 1.25 . . . . 0.0 108.296 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.9 pt -128.53 9.99 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.51 1.124 . . . . 0.0 112.339 173.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.65 -30.47 41.28 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.521 1.528 . . . . 0.0 111.935 174.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.43 -12.87 73.61 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 118.097 0.408 . . . . 0.0 112.679 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -76.86 153.0 35.22 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.773 1.229 . . . . 0.0 109.654 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.7 p -150.47 168.74 23.29 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.4 m -64.19 138.56 58.5 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.851 1.661 . . . . 0.0 111.393 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -163.1 123.25 1.42 Allowed Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 169.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -75.83 150.55 34.84 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.573 2.182 . . . . 0.0 113.315 -168.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.7 tt -55.96 -35.62 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.702 1.601 . . . . 0.0 111.395 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -68.75 -21.58 64.36 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.204 0.601 . . . . 0.0 112.177 -174.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.2 -10.55 57.62 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.336 0.654 . . . . 0.0 111.999 173.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.479 ' CE2' ' HB3' ' A' ' 35' ' ' CYS . 67.0 m-85 -92.69 168.49 11.18 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.908 0.861 . . . . 0.0 110.418 176.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -145.79 89.86 1.94 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 -171.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.489 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -51.47 -24.73 5.39 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -20.64 8.73 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.02 0.528 . . . . 0.0 111.528 173.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -107.02 13.76 27.17 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.383 1.873 . . . . 0.0 112.374 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.506 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 38.6 m-85 -135.24 108.85 7.95 Favored 'General case' 0 CA--C 1.516 -0.332 0 O-C-N 120.805 -1.184 . . . . 0.0 108.578 172.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.77 -16.05 36.27 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -170.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.674 HG12 HG13 ' A' ' 4' ' ' VAL . 11.9 t -144.85 121.31 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 -170.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.66 132.13 64.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 O-C-N 120.521 -1.362 . . . . 0.0 108.85 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.0 mm -125.68 96.93 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 -171.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.438 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 36.6 t -72.31 164.68 25.89 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 169.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mp -142.69 38.04 1.48 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 170.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.607 ' HB3' HG21 ' A' ' 84' ' ' VAL . 76.9 m -96.2 4.4 52.45 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.566 1.147 . . . . 0.0 111.291 -169.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.77 20.9 17.66 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 111.329 -0.709 . . . . 0.0 111.329 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.464 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 5.2 t 46.33 39.94 7.06 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.104 1.762 . . . . 0.0 112.314 -176.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -150.23 33.46 1.02 Allowed Glycine 0 C--N 1.339 0.7 0 C-N-CA 123.754 0.692 . . . . 0.0 111.795 -172.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.607 HG21 ' HB3' ' A' ' 80' ' ' CYS . 93.9 t -121.85 136.58 58.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 125.183 1.393 . . . . 0.0 107.652 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -82.35 67.59 8.44 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.182 0.993 . . . . 0.0 109.836 -172.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.8 mt -58.6 142.3 83.2 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -53.14 154.06 14.76 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.758 2.306 . . . . 0.0 111.63 171.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.19 -19.15 56.83 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 121.646 1.564 . . . . 0.0 114.403 -170.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.81 -26.95 68.86 Favored 'General case' 0 C--O 1.225 -0.233 0 O-C-N 121.205 -0.934 . . . . 0.0 110.983 175.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.489 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 71.8 m95 -68.08 -4.82 14.78 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.089 -1.007 . . . . 0.0 112.651 174.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -108.61 -28.96 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 120.04 1.291 . . . . 0.0 111.025 -174.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.5 p -76.91 -16.58 59.34 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.574 0.954 . . . . 0.0 113.574 -169.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -52.88 161.04 0.83 Allowed 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 129.354 3.062 . . . . 0.0 113.949 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -62.17 -38.96 91.03 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.084 1.354 . . . . 0.0 108.754 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.529 ' HB ' HG13 ' A' ' 75' ' ' VAL . 33.5 mm -126.17 138.01 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 169.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -139.67 112.26 7.84 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 101.359 -3.571 . . . . 0.0 101.359 167.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -135.16 167.78 20.36 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 9.7 t70 -139.33 104.69 5.04 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 171.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -83.73 77.99 9.78 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -54.54 41.79 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 131.6 3.96 . . . . 0.0 113.796 171.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.63 -176.6 3.33 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.961 1.304 . . . . 0.0 112.637 -168.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -51.43 169.09 0.06 Allowed 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 127.477 2.311 . . . . 0.0 112.529 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -127.21 107.92 21.55 Favored Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 125.975 1.71 . . . . 0.0 108.558 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -82.31 -2.1 10.99 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.044 1.83 . . . . 0.0 112.985 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.3 t0 20.06 -91.85 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 128.869 2.868 . . . . 0.0 114.408 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.95 42.11 1.36 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 126.015 1.769 . . . . 0.0 110.532 172.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -78.31 -176.8 4.86 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.26 1.424 . . . . 0.0 113.297 -171.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.7 p -64.15 162.79 13.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 113.859 -1.519 . . . . 0.0 110.269 173.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.1 mt -55.68 -33.91 64.57 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 122.819 0.448 . . . . 0.0 110.542 175.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -62.64 -38.11 88.98 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.774 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.3 t -73.98 -45.1 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 119.515 1.052 . . . . 0.0 108.777 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -52.01 -38.0 55.32 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.765 1.166 . . . . 0.0 112.832 172.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -68.99 -46.3 68.41 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 119.778 1.172 . . . . 0.0 112.188 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.5 m -71.69 -42.46 67.38 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 119.342 -0.361 . . . . 0.0 110.357 -169.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.8 t -67.82 -44.52 85.45 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -173.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -47.16 -53.27 13.41 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 124.853 1.261 . . . . 0.0 110.386 169.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.86 -45.39 96.29 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 119.325 0.966 . . . . 0.0 111.538 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -66.29 -36.9 84.15 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 121.683 -0.892 . . . . 0.0 111.418 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.8 t -62.66 -43.31 98.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 174.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -36.13 78.32 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 119.781 1.173 . . . . 0.0 111.56 -174.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -68.14 -42.34 80.27 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.432 -0.794 . . . . 0.0 110.131 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -63.07 -43.57 98.2 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.748 1.158 . . . . 0.0 110.431 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 75.9 t -54.81 -52.55 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 123.607 0.763 . . . . 0.0 109.582 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -66.77 -32.65 74.08 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 121.862 -0.524 . . . . 0.0 111.503 -175.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -62.3 -48.34 80.32 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 123.239 0.616 . . . . 0.0 111.22 171.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.93 -46.6 78.45 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.361 0.528 . . . . 0.0 110.13 176.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.4 mt -58.38 -43.64 86.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 124.34 1.056 . . . . 0.0 109.779 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.88 -29.81 69.78 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.3 0.955 . . . . 0.0 111.894 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -72.13 -39.61 68.7 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.573 0.624 . . . . 0.0 111.509 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.9 pt -103.35 -48.71 10.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 116.703 2.112 . . . . 0.0 116.703 -168.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 40.6 m . . . . . 0 C--O 1.252 1.232 0 C-N-CA 124.308 1.043 . . . . 0.0 110.653 -170.264 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 tpt . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 118.518 -0.753 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.488 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -60.32 118.4 6.38 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 120.98 1.718 . . . . 0.0 108.541 -173.508 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.416 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 39.0 mtpt -90.58 134.24 34.52 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -169.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.809 HG13 HG12 ' A' ' 75' ' ' VAL . 12.0 t -116.01 155.32 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.07 140.54 43.86 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -125.63 120.37 30.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 177.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.1 t -118.72 112.49 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 118.736 0.698 . . . . 0.0 110.404 -168.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.6 171.79 13.67 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.801 1.286 . . . . 0.0 113.616 -174.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -152.36 130.99 12.3 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 100.779 -3.785 . . . . 0.0 100.779 168.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.421 ' CG ' ' H ' ' A' ' 11' ' ' ASN . 27.2 ttm180 63.47 176.53 0.16 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.755 1.161 . . . . 0.0 109.955 -169.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.421 ' H ' ' CG ' ' A' ' 10' ' ' ARG . 33.6 t-20 -40.57 137.2 1.17 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.138 2.175 . . . . 0.0 113.652 -169.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.9 m -52.41 -20.4 2.8 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 129.856 3.262 . . . . 0.0 115.417 -171.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.9 m -59.44 -5.34 0.77 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.946 2.098 . . . . 0.0 114.802 -171.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.291 31.5 ptt180 -111.41 -61.3 1.72 Allowed 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 116.801 -1.571 . . . . 0.0 111.079 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.562 ' CB ' HD13 ' A' ' 79' ' ' LEU . 59.7 p -74.97 -44.6 47.44 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 122.688 2.495 . . . . 0.0 111.316 -175.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.29 2.0 mt-30 -75.65 -24.75 56.41 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -172.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.463 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.2 tpt -65.79 -41.89 91.39 Favored 'General case' 0 C--O 1.222 -0.363 0 O-C-N 121.003 -1.061 . . . . 0.0 108.19 167.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.54 -36.77 79.26 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.745 -0.597 . . . . 0.0 109.602 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -63.25 -39.1 93.64 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 118.378 -0.82 . . . . 0.0 110.823 169.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.38 -45.15 94.15 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 120.5 1.5 . . . . 0.0 111.115 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -65.55 -38.29 89.18 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 173.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.441 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -72.45 -37.63 68.5 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 119.758 1.163 . . . . 0.0 110.929 -173.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.401 ' HA ' HG21 ' A' ' 32' ' ' VAL . 61.7 pttt -71.08 -19.73 62.44 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 120.214 1.37 . . . . 0.0 112.065 174.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.3 m -82.02 -51.05 8.42 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.845 1.658 . . . . 0.0 109.56 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.2 mt -89.42 -25.73 21.36 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.334 1.454 . . . . 0.0 112.176 -169.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.76 13.75 56.32 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.885 2.183 . . . . 0.0 111.846 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.28 122.02 14.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.675 1.19 . . . . 0.0 109.723 -173.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.12 8.44 87.84 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.66 -0.522 . . . . 0.0 113.626 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -123.22 -31.69 3.54 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.506 1.522 . . . . 0.0 109.001 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.7 pt -141.37 173.37 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 125.457 1.503 . . . . 0.0 109.598 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.42 144.08 43.88 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 103.879 -2.638 . . . . 0.0 103.879 168.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 22' ' ' ALA . 1.7 t -133.33 139.94 48.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 123.279 0.631 . . . . 0.0 110.283 -168.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.14 158.59 44.16 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.836 1.254 . . . . 0.0 109.254 -173.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 63.8 p -155.46 165.99 34.9 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 120.016 1.28 . . . . 0.0 113.257 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.3 p -154.61 166.45 33.32 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.164 1.386 . . . . 0.0 109.197 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.652 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.02 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 C--O 1.235 0.33 0 CA-C-O 121.816 0.817 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -113.12 106.6 54.77 Favored Pre-proline 0 N--CA 1.446 -0.665 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -170.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -63.87 -29.25 67.55 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.264 2.643 . . . . 0.0 111.83 -169.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.2 m -64.51 -37.41 87.45 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.743 0.701 . . . . 0.0 109.213 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.24 -44.43 83.78 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.26 -46.58 85.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 CA-C-O 118.632 -0.699 . . . . 0.0 109.135 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.41 -43.96 97.56 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.859 0.754 . . . . 0.0 111.101 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.0 mmt -60.05 -26.16 65.91 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 118.76 -0.638 . . . . 0.0 111.6 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.463 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -94.09 -27.0 16.5 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -177.132 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -64.34 -30.74 71.78 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.93 1.292 . . . . 0.0 110.067 169.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.43 -21.75 38.8 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.297 0.639 . . . . 0.0 112.002 171.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.0 m -123.61 9.53 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 125.75 1.62 . . . . 0.0 111.138 -177.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.81 40.94 74.84 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.372 0.987 . . . . 0.0 113.007 174.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.7 mt -122.94 152.39 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.542 1.537 . . . . 0.0 108.077 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -118.55 122.13 41.9 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.924 1.29 . . . . 0.0 108.677 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 43.8 pt -127.02 12.91 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 124.271 1.028 . . . . 0.0 111.481 169.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.58 -25.0 45.18 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.23 1.812 . . . . 0.0 112.459 172.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.6 -8.06 85.93 Favored Glycine 0 CA--C 1.537 1.423 0 CA-C-N 118.603 0.638 . . . . 0.0 112.946 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -76.56 166.77 22.93 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.776 1.23 . . . . 0.0 111.557 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.6 p -144.86 -177.95 5.78 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.813 1.645 . . . . 0.0 109.949 174.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.98 173.32 6.41 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.206 1.002 . . . . 0.0 109.615 170.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.28 146.37 7.15 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 169.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.64 141.94 97.96 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.706 2.271 . . . . 0.0 111.834 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.5 tt -59.93 -37.73 73.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 123.491 0.716 . . . . 0.0 110.718 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -73.04 -18.38 61.34 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.416 0.686 . . . . 0.0 112.336 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.05 -25.58 61.85 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 118.939 -0.553 . . . . 0.0 111.274 170.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -79.11 170.51 16.56 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 122.191 0.996 . . . . 0.0 111.318 -172.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.44 68.75 1.39 Allowed 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 125.827 1.651 . . . . 0.0 106.891 -177.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.457 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -51.3 -24.21 4.36 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 124.524 1.129 . . . . 0.0 113.749 -178.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -44.1 -41.27 5.48 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.005 0.922 . . . . 0.0 110.794 172.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.37 -14.74 58.08 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.746 1.218 . . . . 0.0 113.842 -175.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.416 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 11.4 m-85 -105.72 112.73 25.92 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 119.64 1.109 . . . . 0.0 108.405 -173.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -65.51 -12.14 49.99 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -168.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.809 HG12 HG13 ' A' ' 4' ' ' VAL . 27.3 t -146.56 124.31 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 -171.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.1 t -123.13 130.76 74.18 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.2 mm -124.42 92.65 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 173.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.9 t -76.85 166.85 22.79 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 169.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.562 HD13 ' CB ' ' A' ' 15' ' ' SER . 5.5 mp -140.76 32.18 1.82 Allowed 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.185 -1.572 . . . . 0.0 108.025 174.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 92.5 m -76.99 -3.71 40.36 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.203 1.001 . . . . 0.0 111.707 -177.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.19 35.49 3.63 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 119.572 1.078 . . . . 0.0 111.084 172.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 32.0 p 35.88 45.03 0.26 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 128.02 2.528 . . . . 0.0 114.216 -175.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.73 47.4 0.48 Allowed Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -173.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.2 p -125.72 159.11 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 126.102 1.761 . . . . 0.0 109.786 -171.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -118.09 56.35 0.86 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.785 1.234 . . . . 0.0 108.745 -174.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.6 mt -59.33 143.9 84.59 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.36 151.49 22.98 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.198 1.932 . . . . 0.0 111.95 171.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -55.86 -27.57 63.42 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.194 1.93 . . . . 0.0 115.541 -173.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.41 -21.14 66.21 Favored 'General case' 0 N--CA 1.456 -0.175 0 O-C-N 121.009 -1.057 . . . . 0.0 112.361 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.457 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 73.4 m95 -73.65 -17.89 61.1 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 117.952 -1.023 . . . . 0.0 112.659 175.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.8 m -110.77 -13.54 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 120.064 1.302 . . . . 0.0 113.461 -169.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.4 p -83.26 -8.11 59.5 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.367 1.067 . . . . 0.0 113.255 -173.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -64.96 173.04 2.52 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 130.054 3.341 . . . . 0.0 113.569 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -67.45 -41.47 84.64 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.532 ' HB ' HG13 ' A' ' 75' ' ' VAL . 16.8 mm -120.25 136.9 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 169.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -143.45 111.82 6.31 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 103.03 -2.952 . . . . 0.0 103.03 166.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -136.63 164.64 27.74 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -132.59 102.17 5.6 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 169.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.3 m0 -76.94 89.06 3.5 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.417 ' H ' ' CD ' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -62.6 33.99 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 128.508 2.723 . . . . 0.0 113.827 173.625 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.26 178.39 1.94 Allowed 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.086 -1.009 . . . . 0.0 112.832 -169.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.486 ' HB2' HG22 ' A' ' 115' ' ' VAL . 44.8 mt-10 -52.51 164.91 0.29 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 126.26 1.824 . . . . 0.0 112.525 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -120.9 102.74 43.86 Favored Pre-proline 0 C--N 1.325 -0.478 0 C-N-CA 127.278 2.231 . . . . 0.0 108.163 -175.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -82.13 -1.93 10.99 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.769 2.313 . . . . 0.0 112.592 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.4 t0 26.42 -99.04 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 128.372 2.669 . . . . 0.0 113.533 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.86 38.99 1.74 Allowed Glycine 0 CA--C 1.532 1.151 0 C-N-CA 127.278 2.371 . . . . 0.0 109.285 169.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -70.18 -176.99 1.28 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.413 1.885 . . . . 0.0 112.937 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.9 m -63.6 156.66 25.99 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.235 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.1 mt -56.35 -31.16 63.49 Favored 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 123.129 0.572 . . . . 0.0 110.933 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.62 -41.15 97.06 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 118.528 0.604 . . . . 0.0 110.768 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 40.1 t -72.85 -42.12 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 117.284 -1.341 . . . . 0.0 109.061 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -48.42 -49.47 34.96 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 120.318 1.417 . . . . 0.0 111.379 169.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -60.16 -44.11 95.26 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.976 0.807 . . . . 0.0 111.055 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 87.3 m -68.95 -43.83 74.23 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 118.885 -0.579 . . . . 0.0 109.486 -173.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.486 HG22 ' HB2' ' A' ' 102' ' ' GLU . 42.0 t -68.43 -46.71 80.03 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -174.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -45.45 -55.74 5.79 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.864 1.266 . . . . 0.0 110.97 169.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.71 -43.03 98.41 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 119.321 0.964 . . . . 0.0 111.525 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -63.27 -37.44 87.26 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.381 1.09 . . . . 0.0 111.394 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 37.4 t -62.96 -41.41 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 118.067 -0.968 . . . . 0.0 109.033 173.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.14 -37.56 74.89 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 120.009 1.277 . . . . 0.0 111.029 -177.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -68.88 -43.3 75.57 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.208 0.603 . . . . 0.0 110.585 177.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -68.17 -42.43 80.02 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.415 1.007 . . . . 0.0 110.392 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.1 t -53.54 -53.54 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 124.007 0.923 . . . . 0.0 108.988 171.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.77 -33.01 74.98 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.954 -0.466 . . . . 0.0 111.815 -175.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -62.62 -47.98 81.41 Favored 'General case' 0 C--O 1.227 -0.084 0 C-N-CA 122.934 0.494 . . . . 0.0 111.284 171.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.86 -47.24 77.65 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.11 0.564 . . . . 0.0 109.552 176.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.2 mt -58.25 -42.91 84.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 124.292 1.037 . . . . 0.0 110.147 176.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.43 -29.45 69.01 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.609 0.64 . . . . 0.0 111.864 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -74.12 -40.43 62.67 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 118.594 0.633 . . . . 0.0 111.814 175.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.3 pt -101.55 -42.4 9.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 117.251 2.315 . . . . 0.0 117.251 -168.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 C--O 1.254 1.335 0 CA-C-N 119.05 0.841 . . . . 0.0 110.394 -171.967 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.1 mmm . . . . . 0 N--CA 1.5 2.054 0 CA-C-O 119.972 -0.061 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.627 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -58.97 136.33 57.89 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 171.172 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 26.8 mtpt -109.18 145.89 35.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 119.638 1.108 . . . . 0.0 108.357 -171.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.748 HG13 HG12 ' A' ' 75' ' ' VAL . 6.2 t -127.21 153.9 36.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 123.693 0.797 . . . . 0.0 108.896 -174.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 59.6 tpp -135.87 138.47 42.51 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -124.56 106.69 10.34 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.0 t -84.39 122.48 38.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -172.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 86.5 m -68.77 156.78 37.7 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.282 2.233 . . . . 0.0 111.279 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -144.32 -125.17 0.08 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 169.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.59 115.24 1.27 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.078 1.351 . . . . 0.0 112.009 -169.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.9 t30 45.59 26.86 0.36 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.897 2.079 . . . . 0.0 113.973 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.2 m 56.94 -22.34 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 119.106 3.002 . . . . 0.0 119.106 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 85.2 m -48.78 -55.72 10.72 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 125.69 1.596 . . . . 0.0 113.348 -168.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -58.77 -47.03 86.09 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.334 0.97 . . . . 0.0 112.329 -169.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.535 ' HB3' HD13 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -87.77 -31.81 19.44 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.709 -0.619 . . . . 0.0 111.138 -170.954 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -65.62 -36.47 83.81 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 172.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.456 ' SD ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -63.09 -39.75 95.63 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 120.703 -1.248 . . . . 0.0 110.109 172.451 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.39 -36.1 75.16 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.757 -0.589 . . . . 0.0 110.698 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -64.69 -38.84 92.35 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.802 -0.618 . . . . 0.0 111.104 169.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.92 -43.9 92.84 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 120.491 1.496 . . . . 0.0 110.86 -178.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.456 ' CD2' ' SD ' ' A' ' 17' ' ' MET . 5.0 m-85 -64.81 -40.52 95.35 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 118.68 1.24 . . . . 0.0 109.428 171.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.484 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -69.88 -37.11 75.94 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 119.661 1.119 . . . . 0.0 111.104 -173.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -74.1 -25.14 59.62 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 120.142 1.337 . . . . 0.0 111.922 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 m -72.36 -50.8 23.97 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.173 1.389 . . . . 0.0 110.166 173.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.0 mt -87.86 -26.66 22.67 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 124.617 1.167 . . . . 0.0 112.647 -169.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.55 14.01 59.4 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 126.45 1.976 . . . . 0.0 111.602 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.23 125.18 22.8 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.227 1.411 . . . . 0.0 109.41 -172.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.68 8.42 87.2 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-O 119.732 -0.482 . . . . 0.0 113.647 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -125.47 -44.32 1.85 Allowed 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 125.161 1.385 . . . . 0.0 108.69 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.56 HG22 ' HB2' ' A' ' 2' ' ' LYS . 2.7 pp -140.25 150.27 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.463 1.105 . . . . 0.0 109.782 177.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.71 152.28 20.27 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.484 HG11 ' HB3' ' A' ' 22' ' ' ALA . 2.0 t -142.5 137.57 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 118.393 0.542 . . . . 0.0 111.061 -168.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.7 m -143.21 165.51 27.24 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.19 1.396 . . . . 0.0 109.524 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.9 p -141.48 156.27 45.76 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.929 1.292 . . . . 0.0 108.698 175.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 29.6 p -159.73 173.39 16.11 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.001 0.818 . . . . 0.0 112.201 -173.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.75 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 177.52 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -137.22 117.08 10.45 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -172.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -69.24 -25.98 30.49 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.537 2.825 . . . . 0.0 113.179 -169.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.0 m -62.19 -36.21 81.21 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.177 0.899 . . . . 0.0 109.153 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.98 -41.89 90.58 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -58.59 -49.89 80.89 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 CA-C-O 118.312 -0.852 . . . . 0.0 108.874 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.5 -43.81 96.65 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 119.362 0.983 . . . . 0.0 110.916 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.7 mmt -64.51 -17.12 63.59 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.867 0.867 . . . . 0.0 112.723 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 3.4 mmt -97.99 -26.95 14.46 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 119.457 1.026 . . . . 0.0 110.656 173.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -65.0 -27.66 68.98 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.976 0.91 . . . . 0.0 110.164 172.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -56.37 -25.3 49.04 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.187 0.995 . . . . 0.0 112.603 169.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.1 m -127.24 14.56 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.468 1.507 . . . . 0.0 111.211 -171.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.1 39.11 84.06 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.941 0.782 . . . . 0.0 112.717 174.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.3 mt -126.99 156.65 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -136.85 143.35 43.03 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.39 1.076 . . . . 0.0 109.033 175.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.7 pt -140.59 15.83 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 126.778 2.031 . . . . 0.0 111.288 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.6 p -69.87 -40.91 75.43 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 120.767 -1.208 . . . . 0.0 112.414 173.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.18 8.05 41.28 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 123.819 0.723 . . . . 0.0 113.075 -177.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -73.96 -176.54 2.53 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.561 1.145 . . . . 0.0 112.132 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -69.3 170.27 10.62 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.533 1.933 . . . . 0.0 112.758 -170.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.4 m -159.16 57.18 0.41 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 104.042 -2.577 . . . . 0.0 104.042 171.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -143.38 147.96 42.15 Favored Pre-proline 0 C--N 1.345 0.389 0 C-N-CA 123.166 0.586 . . . . 0.0 110.351 -167.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -82.82 159.5 16.13 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.397 2.732 . . . . 0.0 112.438 -174.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.2 tt -58.75 -34.77 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.056 1.342 . . . . 0.0 111.371 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -69.16 -22.52 63.92 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.19 0.596 . . . . 0.0 112.309 -174.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -13.85 59.54 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 119.103 -0.475 . . . . 0.0 111.741 172.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -98.98 172.18 7.57 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.212 1.005 . . . . 0.0 110.789 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.71 99.06 3.06 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 125.21 1.404 . . . . 0.0 107.774 -178.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -49.83 -23.53 1.93 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 171.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -51.36 -25.69 6.45 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.885 0.874 . . . . 0.0 111.524 173.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -107.1 15.28 25.38 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.72 1.208 . . . . 0.0 113.491 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.45 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 24.6 m-85 -134.88 111.07 9.58 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 120.243 1.383 . . . . 0.0 109.16 173.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.29 -17.28 52.86 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 124.643 1.177 . . . . 0.0 113.422 -169.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.748 HG12 HG13 ' A' ' 4' ' ' VAL . 12.6 t -143.09 130.44 18.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 -170.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.3 t -135.96 131.84 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 -169.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.446 HD11 HD12 ' A' ' 126' ' ' LEU . 18.3 mm -133.83 100.62 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 103.031 -2.951 . . . . 0.0 103.031 -172.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.408 ' C ' ' H ' ' A' ' 80' ' ' CYS . 6.3 m -111.29 85.56 2.15 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 121.853 -0.529 . . . . 0.0 111.034 -168.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.535 HD13 ' HB3' ' A' ' 15' ' ' SER . 3.9 mp -73.12 25.51 0.06 Allowed 'General case' 0 C--N 1.343 0.291 0 C-N-CA 127.969 2.508 . . . . 0.0 110.547 -174.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.58 ' HB3' HG21 ' A' ' 84' ' ' VAL . 4.4 m -64.12 1.02 0.78 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.89 2.076 . . . . 0.0 111.411 170.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.22 26.4 28.48 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 118.742 0.701 . . . . 0.0 111.658 174.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 49.91 20.09 0.53 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.761 2.025 . . . . 0.0 114.771 -175.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -109.46 24.53 20.0 Favored Glycine 0 C--N 1.338 0.658 0 C-N-CA 124.43 1.014 . . . . 0.0 111.213 -176.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.58 HG21 ' HB3' ' A' ' 80' ' ' CYS . 20.1 t -132.29 121.43 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -174.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.32 -40.45 85.96 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.806 0.842 . . . . 0.0 110.893 -177.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.1 mt 64.48 152.63 0.12 Allowed Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 127.921 2.488 . . . . 0.0 112.64 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.04 151.45 50.1 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 121.926 1.75 . . . . 0.0 110.219 169.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.4 -19.61 55.31 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.634 1.556 . . . . 0.0 114.436 -169.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -64.52 -26.51 68.45 Favored 'General case' 0 C--O 1.224 -0.246 0 O-C-N 121.019 -1.051 . . . . 0.0 110.879 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.471 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 62.3 m95 -67.63 -8.61 36.09 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.197 -0.939 . . . . 0.0 112.622 175.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.4 t -108.68 -30.09 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.968 1.307 . . . . 0.0 111.105 -171.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.5 p -75.37 -17.25 60.27 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.21 1.004 . . . . 0.0 113.483 -169.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -51.67 160.68 0.61 Allowed 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 129.403 3.081 . . . . 0.0 114.033 176.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -62.47 -38.9 91.63 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.608 1.563 . . . . 0.0 108.762 177.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.547 ' HB ' HG13 ' A' ' 75' ' ' VAL . 30.5 mm -125.02 135.44 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 169.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -136.57 104.88 5.7 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 101.758 -3.423 . . . . 0.0 101.758 166.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -128.27 177.57 6.85 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 125.62 1.568 . . . . 0.0 106.901 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.24 -56.9 1.42 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -174.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 24.1 m0 56.02 65.7 1.38 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.072 0.949 . . . . 0.0 110.662 -169.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -56.39 46.28 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 130.274 3.429 . . . . 0.0 113.54 169.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.81 -177.65 2.03 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.615 -1.303 . . . . 0.0 113.422 -168.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.448 ' HB2' HG22 ' A' ' 115' ' ' VAL . 41.1 mt-10 -55.88 168.86 0.41 Allowed 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 127.253 2.221 . . . . 0.0 112.323 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -115.04 102.99 54.95 Favored Pre-proline 0 C--N 1.323 -0.566 0 C-N-CA 126.272 1.829 . . . . 0.0 109.243 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -83.75 -4.37 10.66 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.577 2.185 . . . . 0.0 112.814 175.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.7 t0 25.18 -101.27 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 128.246 2.618 . . . . 0.0 113.025 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -136.88 42.3 1.33 Allowed Glycine 0 CA--C 1.533 1.16 0 C-N-CA 128.188 2.804 . . . . 0.0 107.11 169.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -68.91 -174.48 0.6 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.619 1.968 . . . . 0.0 112.069 -174.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.5 p -57.39 152.84 13.58 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.962 -1.472 . . . . 0.0 108.433 169.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.1 mt -59.14 -30.37 68.1 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.625 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -61.41 -41.25 96.86 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 119.001 -0.523 . . . . 0.0 110.791 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.17 -42.28 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 117.647 -1.168 . . . . 0.0 109.305 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -50.35 -49.4 54.19 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.276 1.398 . . . . 0.0 111.765 171.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -59.05 -44.18 91.76 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.694 0.679 . . . . 0.0 111.36 176.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 91.7 m -68.48 -45.6 71.97 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -173.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.448 HG22 ' HB2' ' A' ' 102' ' ' GLU . 58.6 t -67.41 -47.59 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -173.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -43.43 -54.5 4.72 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.93 1.292 . . . . 0.0 110.665 169.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.87 -43.43 98.93 Favored Glycine 0 CA--C 1.522 0.503 0 CA-C-N 119.844 1.202 . . . . 0.0 112.065 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -67.91 -34.38 76.51 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 120.797 -1.413 . . . . 0.0 111.398 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.59 -42.23 93.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 170.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -43.52 85.35 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.995 1.27 . . . . 0.0 110.258 -174.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -66.44 -43.78 84.68 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 119.1 -0.476 . . . . 0.0 110.038 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -64.97 -42.42 94.6 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.136 0.88 . . . . 0.0 110.944 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 52.9 t -56.66 -52.29 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -64.95 -32.89 74.83 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 121.846 -0.534 . . . . 0.0 111.667 -175.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -62.84 -46.66 86.9 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 123.58 0.752 . . . . 0.0 111.15 172.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.446 HD12 HD11 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -57.84 -46.68 84.42 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 122.807 0.443 . . . . 0.0 110.101 175.641 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.5 mt -58.75 -41.8 83.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 123.918 0.887 . . . . 0.0 110.233 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.31 -28.87 68.47 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.216 0.916 . . . . 0.0 111.637 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -75.2 -40.73 58.99 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.538 0.608 . . . . 0.0 111.85 176.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.4 pt -101.85 -35.89 4.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 116.496 2.035 . . . . 0.0 116.496 -168.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 C--O 1.255 1.365 0 C-N-CA 124.438 1.095 . . . . 0.0 111.608 -170.269 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 tpt . . . . . 0 N--CA 1.5 2.034 0 CA-C-O 118.594 -0.717 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.517 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -60.79 120.54 10.32 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 120.895 1.679 . . . . 0.0 108.39 -174.86 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.408 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 31.9 mtpt -93.37 134.64 35.38 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -170.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.787 HG13 HG12 ' A' ' 75' ' ' VAL . 14.6 t -116.6 154.81 18.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 53.6 tpp -136.03 136.17 40.05 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -118.53 106.63 12.85 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.45 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 4.7 t -91.06 119.43 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -170.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.9 m -91.61 162.33 14.56 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.947 0.499 . . . . 0.0 111.52 -173.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -160.13 151.42 19.48 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.535 1.934 . . . . 0.0 106.258 169.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.447 ' HD3' ' H ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER 59.46 -165.16 0.2 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.484 1.113 . . . . 0.0 109.527 -169.788 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.541 HD21 ' CG ' ' A' ' 43' ' ' HIS . 51.9 t-20 -61.5 109.02 1.06 Allowed 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.3 m -61.41 2.53 0.15 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 -168.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 35.4 m -44.51 -47.62 10.11 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 120.099 1.318 . . . . 0.0 111.854 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -63.66 -39.46 94.4 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 118.992 0.815 . . . . 0.0 112.654 -175.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.27 -40.4 10.0 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.989 1.316 . . . . 0.0 111.298 -169.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.442 HE22 HG12 ' A' ' 42' ' ' VAL . 5.7 pt20 -65.67 -34.58 78.54 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.551 -0.718 . . . . 0.0 109.908 170.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.446 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.3 tpt -62.9 -39.87 95.85 Favored 'General case' 0 CA--C 1.512 -0.506 0 O-C-N 121.238 -0.914 . . . . 0.0 110.135 171.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.88 -39.22 84.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -64.28 -39.28 93.6 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.302 170.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.21 -45.59 85.55 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 120.726 1.603 . . . . 0.0 111.333 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -63.88 -39.63 94.63 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.459 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -68.59 -39.34 80.98 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 119.868 1.213 . . . . 0.0 110.99 -175.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -70.36 -26.47 63.74 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 120.532 1.514 . . . . 0.0 112.096 175.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 m -73.01 -51.04 19.73 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.369 1.467 . . . . 0.0 110.741 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.9 mt -88.82 -27.18 21.26 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.351 1.46 . . . . 0.0 112.307 -169.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.89 13.33 59.14 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 126.445 1.974 . . . . 0.0 111.682 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.52 122.81 14.97 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.039 1.335 . . . . 0.0 109.76 -174.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.31 9.13 86.99 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 119.887 -0.396 . . . . 0.0 113.649 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -123.88 -32.11 3.32 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.407 1.483 . . . . 0.0 109.275 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.8 pt -142.75 174.75 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 125.443 1.497 . . . . 0.0 109.439 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.87 146.07 43.16 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 168.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.459 HG11 ' HB3' ' A' ' 22' ' ' ALA . 1.8 t -135.58 142.12 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 123.168 0.587 . . . . 0.0 110.878 -168.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.03 159.63 44.42 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.92 0.888 . . . . 0.0 110.559 -176.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.0 p -133.83 156.26 48.37 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.873 1.269 . . . . 0.0 109.272 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.403 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 24.4 p -151.64 167.27 28.68 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.469 0.707 . . . . 0.0 111.234 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.958 0 C-N-CA 123.501 0.572 . . . . 0.0 112.913 173.284 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.442 HG12 HE22 ' A' ' 16' ' ' GLN . 17.9 m . . . . . 0 CA--C 1.531 0.23 0 CA-C-O 121.192 0.52 . . . . 0.0 111.416 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.541 ' CG ' HD21 ' A' ' 11' ' ' ASN . 13.5 t-80 -132.96 98.88 15.5 Favored Pre-proline 0 CA--C 1.53 0.2 0 C-N-CA 123.311 0.645 . . . . 0.0 109.672 -169.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -42.28 -33.18 2.37 Favored 'Trans proline' 0 CA--C 1.534 0.499 1 C-N-CA 125.846 4.364 . . . . 0.0 116.377 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.4 m -64.0 -39.29 93.79 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.792 1.178 . . . . 0.0 110.798 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.55 -43.48 80.6 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 121.133 -0.979 . . . . 0.0 109.218 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.88 -44.3 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.27 -43.23 99.22 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.429 0.559 . . . . 0.0 111.701 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.4 mmt -65.44 -21.61 66.67 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.166 0.439 . . . . 0.0 111.893 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.446 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.4 OUTLIER -93.4 -33.65 13.76 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -177.245 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -61.76 -34.13 75.3 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.954 1.302 . . . . 0.0 109.941 169.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.54 -8.31 4.17 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.601 1.961 . . . . 0.0 112.347 172.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.2 p -134.56 12.44 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 125.484 1.513 . . . . 0.0 110.91 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.81 36.87 66.15 Favored Glycine 0 CA--C 1.534 1.268 0 O-C-N 120.841 -1.162 . . . . 0.0 113.599 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.5 mt -120.46 154.71 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.319 1.448 . . . . 0.0 108.639 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.8 126.8 53.1 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.882 1.673 . . . . 0.0 109.571 -177.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.6 pt -134.59 8.19 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 125.501 1.52 . . . . 0.0 110.59 168.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.42 -37.41 68.64 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.404 1.882 . . . . 0.0 111.567 177.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.27 -6.81 89.04 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 123.471 0.558 . . . . 0.0 113.32 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -72.48 156.31 39.18 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.939 1.296 . . . . 0.0 109.874 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -150.97 164.98 35.1 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.5 m -68.08 141.28 56.19 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 126.999 2.119 . . . . 0.0 112.131 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -162.38 127.67 2.17 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 169.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.88 152.17 28.36 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.648 2.232 . . . . 0.0 113.38 -169.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.5 tt -59.3 -37.12 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.478 1.511 . . . . 0.0 111.366 -173.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -70.92 -19.67 62.56 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.126 0.57 . . . . 0.0 112.11 -173.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -15.68 54.54 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 118.762 -0.637 . . . . 0.0 111.85 173.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.403 ' CE2' ' HB3' ' A' ' 35' ' ' CYS . 62.6 m-85 -84.03 168.49 15.88 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.225 1.012 . . . . 0.0 110.804 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -140.16 86.17 2.06 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 102.634 -3.098 . . . . 0.0 102.634 -178.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.493 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -54.37 -23.23 14.76 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.58 -27.55 17.31 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.279 0.632 . . . . 0.0 111.184 172.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -84.48 -7.6 59.23 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.25 1.02 . . . . 0.0 113.16 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 26.0 m-85 -126.09 113.74 17.48 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 120.132 1.333 . . . . 0.0 108.912 -171.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -66.1 -12.21 54.09 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -168.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.787 HG12 HG13 ' A' ' 4' ' ' VAL . 22.9 t -145.25 123.24 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -170.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.3 t -118.74 129.63 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.2 mm -120.55 96.87 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 169.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.45 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 61.7 p -74.43 160.45 30.96 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 169.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -138.39 42.07 2.21 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 170.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.7 m -80.69 11.03 4.11 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.43 1.492 . . . . 0.0 111.177 -172.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.81 26.95 70.02 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 -174.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 2.0 t 52.78 -176.26 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.631 1.972 . . . . 0.0 111.314 -169.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.04 -33.79 1.07 Allowed Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.009 1.29 . . . . 0.0 114.677 172.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.5 t -57.61 119.32 2.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 125.198 1.399 . . . . 0.0 107.522 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -73.78 146.79 44.0 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 171.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.3 mt -127.09 153.41 76.62 Favored Pre-proline 0 C--O 1.237 0.439 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -53.08 151.94 19.88 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.26 1.973 . . . . 0.0 111.079 170.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -65.93 -19.8 58.07 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.574 1.516 . . . . 0.0 114.302 -169.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.58 -27.0 68.65 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.135 -0.978 . . . . 0.0 110.917 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.493 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 70.8 m95 -67.01 -12.47 59.97 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.046 -1.034 . . . . 0.0 112.819 175.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.8 t -104.74 -29.63 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.79 1.236 . . . . 0.0 111.127 -170.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.4 p -75.01 -13.38 60.5 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.365 1.066 . . . . 0.0 113.775 -169.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -55.78 163.6 1.36 Allowed 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 129.562 3.145 . . . . 0.0 113.761 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.62 -41.42 96.19 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.676 1.19 . . . . 0.0 108.373 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.557 ' HB ' HG13 ' A' ' 75' ' ' VAL . 20.0 mm -119.92 136.02 58.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 169.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -142.42 109.52 5.55 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 103.96 -2.607 . . . . 0.0 103.96 165.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -137.28 166.3 24.1 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 125.852 1.661 . . . . 0.0 106.765 178.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -133.07 130.16 38.98 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 169.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -111.31 83.12 1.71 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.512 ' H ' ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -66.81 46.49 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.481 2.312 . . . . 0.0 112.856 178.142 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.73 169.67 15.17 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.21 -0.931 . . . . 0.0 111.154 -173.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -46.93 142.57 3.39 Favored 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 126.03 1.732 . . . . 0.0 112.221 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -87.58 111.58 42.77 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.915 1.286 . . . . 0.0 108.759 176.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -83.38 -7.44 10.83 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.489 2.126 . . . . 0.0 112.416 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.4 t0 23.88 -96.96 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 128.233 2.613 . . . . 0.0 113.961 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.57 44.1 1.22 Allowed Glycine 0 CA--C 1.533 1.205 0 C-N-CA 126.944 2.211 . . . . 0.0 110.607 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -70.44 -175.39 1.02 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.847 1.659 . . . . 0.0 113.274 -175.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.2 p -69.08 162.38 27.05 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.44 169.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 22.8 mt -55.84 -37.0 68.14 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.942 0.497 . . . . 0.0 111.026 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.47 -37.32 77.9 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 123.262 0.625 . . . . 0.0 110.39 -174.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.4 t -74.2 -41.68 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -55.94 -34.74 65.93 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.451 1.023 . . . . 0.0 112.138 171.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.8 mtp85 -73.0 -44.87 60.51 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 119.705 1.139 . . . . 0.0 111.606 173.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 91.3 m -75.46 -38.21 59.82 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.372 0.669 . . . . 0.0 112.021 -169.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 87.4 t -71.49 -45.2 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -176.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -43.51 -53.02 5.81 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 125.886 1.675 . . . . 0.0 111.236 169.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.53 -40.18 97.44 Favored Glycine 0 N--CA 1.467 0.721 0 CA-C-N 119.785 1.175 . . . . 0.0 111.96 -175.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -65.17 -38.65 91.21 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 121.492 -1.005 . . . . 0.0 110.359 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.18 -40.44 89.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 175.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -36.89 76.04 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.454 1.025 . . . . 0.0 111.292 -177.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -69.85 -42.93 72.91 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 118.743 -0.646 . . . . 0.0 110.448 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -63.47 -43.18 98.09 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.88 1.218 . . . . 0.0 110.388 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 63.9 t -54.98 -53.66 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 123.475 0.71 . . . . 0.0 109.627 173.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -64.77 -32.77 74.61 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 122.151 -0.343 . . . . 0.0 111.419 -175.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -62.8 -47.73 82.19 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 123.363 0.665 . . . . 0.0 111.208 172.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.92 -47.75 76.95 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.454 0.57 . . . . 0.0 109.589 175.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -57.89 -42.49 82.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 124.452 1.101 . . . . 0.0 110.091 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.07 -28.94 68.22 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.885 0.766 . . . . 0.0 111.94 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -75.49 -40.56 57.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.614 0.643 . . . . 0.0 111.759 175.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 pt -101.33 -42.45 9.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -168.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 C--O 1.253 1.287 0 CA-C-N 119.089 0.859 . . . . 0.0 110.237 -173.423 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 tpt . . . . . 0 N--CA 1.497 1.918 0 CA-C-O 117.957 -1.02 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.546 ' HB2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -48.75 121.87 5.08 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 120.597 1.544 . . . . 0.0 109.863 -174.044 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -97.8 135.83 39.0 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -169.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.808 HG13 HG12 ' A' ' 75' ' ' VAL . 11.8 t -113.52 156.52 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 59.2 tpp -135.67 137.49 41.87 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.448 ' HE2' HG13 ' A' ' 32' ' ' VAL . 97.3 m-85 -119.78 117.07 27.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 177.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.437 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 8.5 t -99.55 132.39 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -169.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.8 t -111.79 131.22 55.47 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.962 0.887 . . . . 0.0 112.892 -169.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -140.15 150.93 44.84 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 129.08 2.952 . . . . 0.0 103.503 169.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 58.0 -170.8 0.11 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.799 0.84 . . . . 0.0 109.79 -168.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.421 HD21 ' CD2' ' A' ' 43' ' ' HIS . 15.1 t-20 -58.0 130.03 44.69 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -168.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.9 m -35.0 -35.41 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.997 1.719 . . . . 0.0 115.636 169.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.1 p -61.41 -9.6 5.82 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -99.96 -52.97 3.28 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 120.369 1.44 . . . . 0.0 110.823 171.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 p -94.21 -51.26 4.9 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 120.703 -1.248 . . . . 0.0 113.736 -168.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.32 -21.64 63.83 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 118.069 -1.452 . . . . 0.0 110.031 173.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.468 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 0.8 OUTLIER -63.39 -39.57 94.88 Favored 'General case' 0 CA--C 1.512 -0.498 0 O-C-N 120.899 -1.126 . . . . 0.0 109.056 168.364 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.9 -37.91 74.86 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 118.753 -0.641 . . . . 0.0 109.866 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -61.44 -40.07 93.12 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.942 169.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.33 -42.9 93.76 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 120.242 1.383 . . . . 0.0 111.454 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -67.23 -39.01 86.15 Favored 'General case' 0 CA--C 1.518 -0.274 0 O-C-N 121.554 -0.968 . . . . 0.0 108.705 173.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.06 -40.28 71.73 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 119.525 1.057 . . . . 0.0 110.433 -173.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -72.03 -15.5 62.03 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.449 1.022 . . . . 0.0 112.327 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 m -85.08 -50.54 7.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.798 1.639 . . . . 0.0 109.469 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.6 mt -88.85 -26.21 21.76 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.515 1.126 . . . . 0.0 112.7 -169.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.91 13.87 57.5 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 126.161 1.839 . . . . 0.0 112.076 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.01 125.16 23.05 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.635 1.174 . . . . 0.0 108.825 -174.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.2 7.79 88.21 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.711 -0.494 . . . . 0.0 113.795 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt -125.64 -42.78 1.91 Allowed 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 125.731 1.612 . . . . 0.0 108.988 -176.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.546 HG22 ' HB2' ' A' ' 2' ' ' LYS . 2.7 pp -143.29 152.04 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 124.642 1.177 . . . . 0.0 109.301 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.12 152.2 21.24 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 172.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.448 HG13 ' HE2' ' A' ' 6' ' ' PHE . 2.6 t -139.33 139.86 38.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 121.819 -0.551 . . . . 0.0 110.157 -168.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.98 159.23 43.82 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.337 1.055 . . . . 0.0 109.135 -172.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.2 t -146.88 156.08 42.81 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 119.376 0.989 . . . . 0.0 110.251 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.3 p -147.37 153.61 39.87 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.842 0.857 . . . . 0.0 109.707 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.709 0 N-CA-C 106.542 -2.623 . . . . 0.0 106.542 -169.334 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.236 0.345 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.421 ' CD2' HD21 ' A' ' 11' ' ' ASN . 80.0 t60 -132.98 108.47 12.71 Favored Pre-proline 0 C--O 1.234 0.251 0 C-N-CA 123.187 0.595 . . . . 0.0 109.414 -169.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -64.37 -30.38 62.92 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.157 2.571 . . . . 0.0 112.234 -168.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.5 m -65.73 -36.53 83.85 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 119.296 0.953 . . . . 0.0 109.246 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.411 ' HB1' HD11 ' A' ' 57' ' ' ILE . . . -65.97 -44.6 84.46 Favored 'General case' 0 C--N 1.346 0.424 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -58.05 -48.8 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.96 96.26 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.713 0.688 . . . . 0.0 110.906 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.6 mmt -58.66 -25.89 63.24 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.873 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.468 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.5 OUTLIER -95.87 -26.33 15.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 119.178 0.899 . . . . 0.0 108.932 -177.579 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -64.74 -29.64 70.63 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.546 1.138 . . . . 0.0 110.445 169.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -57.63 -22.82 47.8 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.386 0.674 . . . . 0.0 112.186 171.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.9 m -124.09 11.59 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 125.708 1.603 . . . . 0.0 111.279 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.41 40.92 86.63 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.0 0.81 . . . . 0.0 113.012 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.7 mt -124.87 154.29 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.542 1.537 . . . . 0.0 107.758 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -122.6 126.37 47.55 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.013 1.325 . . . . 0.0 109.014 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.411 HD11 ' HB1' ' A' ' 46' ' ' ALA . 35.8 pt -129.47 16.38 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 125.14 1.376 . . . . 0.0 111.268 170.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.51 -24.89 45.56 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.762 1.625 . . . . 0.0 112.226 169.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.27 -13.13 81.63 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 118.136 0.426 . . . . 0.0 112.399 174.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -73.12 163.09 28.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.697 1.199 . . . . 0.0 110.545 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.7 p -148.3 168.06 23.56 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.727 1.211 . . . . 0.0 110.791 170.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.35 143.88 51.81 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.714 1.206 . . . . 0.0 109.801 174.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -161.04 127.93 2.56 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 117.225 -1.369 . . . . 0.0 107.751 173.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -65.52 152.33 82.17 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.136 2.557 . . . . 0.0 114.468 -172.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.1 tt -62.05 -41.13 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 124.438 1.095 . . . . 0.0 111.083 174.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -70.42 -20.82 62.89 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.085 0.554 . . . . 0.0 111.891 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.98 -19.04 60.78 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.548 0.739 . . . . 0.0 111.642 171.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -92.54 169.8 10.25 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.912 0.863 . . . . 0.0 110.954 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -140.94 88.58 2.19 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 -173.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.496 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -53.95 -24.15 15.53 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -28.58 16.06 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.355 0.662 . . . . 0.0 111.372 173.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -82.3 -13.71 56.53 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.311 1.044 . . . . 0.0 113.302 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -121.64 113.63 20.02 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 120.081 1.309 . . . . 0.0 109.383 -169.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.4 -16.03 52.43 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -169.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.808 HG12 HG13 ' A' ' 4' ' ' VAL . 14.3 t -144.8 127.13 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -170.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.7 t -121.26 127.39 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.2 mm -119.72 95.05 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 169.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.437 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 31.2 t -74.45 165.96 24.31 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 168.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.88 26.14 2.29 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.61 -1.306 . . . . 0.0 109.128 171.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.576 ' HB3' HG21 ' A' ' 84' ' ' VAL . 57.0 m -83.52 -1.32 53.43 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.167 -0.958 . . . . 0.0 112.476 -170.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.96 23.89 6.86 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 123.783 0.706 . . . . 0.0 111.73 175.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.453 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 3.2 t 44.32 45.16 7.18 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.148 1.779 . . . . 0.0 112.336 -174.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -155.6 35.82 0.63 Allowed Glycine 0 C--N 1.339 0.743 0 CA-C-O 119.735 -0.481 . . . . 0.0 112.319 -171.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.576 HG21 ' HB3' ' A' ' 80' ' ' CYS . 86.6 t -122.87 141.91 41.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 125.058 1.343 . . . . 0.0 108.6 178.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -81.95 60.09 4.63 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.37 1.068 . . . . 0.0 109.966 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 68.4 mt -56.63 134.35 77.89 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -54.57 155.36 17.22 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.552 2.168 . . . . 0.0 112.568 178.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -54.9 -28.82 60.71 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.76 2.306 . . . . 0.0 116.099 -171.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -66.53 -24.36 66.37 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.153 -0.967 . . . . 0.0 111.607 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.496 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 66.9 m95 -70.97 -13.93 62.18 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 117.892 -1.051 . . . . 0.0 113.14 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.9 m -113.52 -10.93 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 120.107 1.321 . . . . 0.0 113.165 -171.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.4 p -84.05 -16.41 43.93 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.615 0.766 . . . . 0.0 112.739 -175.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -50.45 161.86 0.28 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 130.017 3.327 . . . . 0.0 114.377 174.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -62.36 -39.32 92.79 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.454 1.502 . . . . 0.0 108.801 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.594 ' HB ' HG13 ' A' ' 75' ' ' VAL . 23.4 mm -122.85 136.83 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 169.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -141.14 111.89 7.07 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 100.926 -3.731 . . . . 0.0 100.926 166.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.92 164.32 28.22 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 174.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.8 t70 -134.56 100.31 4.6 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 170.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -77.2 78.32 3.73 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -55.62 33.43 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.953 1 C-N-CA 131.745 4.018 . . . . 0.0 113.761 170.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.93 172.15 5.85 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.083 1.353 . . . . 0.0 111.717 -169.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.52 ' HB2' HG22 ' A' ' 115' ' ' VAL . 38.4 mt-10 -49.88 155.52 0.87 Allowed 'General case' 0 C--O 1.231 0.088 0 C-N-CA 125.354 1.462 . . . . 0.0 112.632 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -107.24 110.58 63.31 Favored Pre-proline 0 N--CA 1.448 -0.538 0 C-N-CA 126.556 1.942 . . . . 0.0 109.062 175.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -95.31 1.03 2.49 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 124.068 3.179 . . . . 0.0 112.631 175.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -51.37 -37.09 46.32 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -168.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -109.38 25.05 18.96 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.48 -1.178 . . . . 0.0 112.677 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.469 ' NE2' HG11 ' A' ' 111' ' ' VAL . 28.9 mt-30 -122.34 174.65 6.87 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 118.999 1.4 . . . . 0.0 113.95 -169.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.1 m -73.14 166.79 22.46 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 112.947 -1.933 . . . . 0.0 110.144 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.6 mt -55.51 -31.61 62.2 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 123.189 0.596 . . . . 0.0 110.951 175.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -62.28 -41.16 98.25 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 118.298 0.499 . . . . 0.0 110.567 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.469 HG11 ' NE2' ' A' ' 107' ' ' GLN . 17.2 t -76.48 -39.82 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 117.322 -1.323 . . . . 0.0 108.784 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -47.23 -48.57 24.25 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 120.264 1.393 . . . . 0.0 110.949 168.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -61.21 -46.1 91.82 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.261 0.937 . . . . 0.0 111.184 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.5 m -68.21 -37.37 80.81 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 122.865 0.466 . . . . 0.0 110.16 -171.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.52 HG22 ' HB2' ' A' ' 102' ' ' GLU . 40.3 t -75.93 -44.01 38.8 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -177.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -45.59 -51.09 12.53 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 124.795 1.238 . . . . 0.0 111.193 170.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.18 -42.97 97.75 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 119.506 1.048 . . . . 0.0 112.19 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -65.61 -35.56 81.17 Favored 'General case' 0 CA--C 1.52 -0.192 0 O-C-N 120.942 -1.328 . . . . 0.0 110.832 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.2 -42.63 97.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 173.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.15 -39.65 83.09 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.422 1.465 . . . . 0.0 111.369 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.7 -44.62 73.59 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.393 1.477 . . . . 0.0 109.743 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -66.89 -41.34 87.36 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.574 -0.704 . . . . 0.0 112.039 177.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 38.9 t -54.77 -53.02 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -64.08 -32.74 74.41 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 122.043 -0.411 . . . . 0.0 111.647 -175.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -63.13 -46.09 88.88 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 121.612 -0.68 . . . . 0.0 111.392 172.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.11 -47.58 82.82 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 175.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -58.02 -41.37 80.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 123.896 0.878 . . . . 0.0 109.825 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.26 -27.39 68.42 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.868 0.758 . . . . 0.0 112.093 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -76.82 -41.21 45.22 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 118.616 -0.706 . . . . 0.0 112.315 174.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.8 pt -101.13 -35.11 4.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 -168.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 28.2 m . . . . . 0 C--O 1.256 1.401 0 CA-C-N 119.304 0.956 . . . . 0.0 111.497 -177.107 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 tpt . . . . . 0 N--CA 1.499 2.011 0 CA-C-O 118.53 -0.747 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.477 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -60.94 119.28 7.95 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 120.842 1.655 . . . . 0.0 108.679 -174.566 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -90.37 138.08 31.83 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -172.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.7 t -116.37 153.74 17.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 O-C-N 124.25 0.969 . . . . 0.0 108.386 174.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.25 142.09 50.94 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 175.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -121.5 103.92 9.28 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.544 -1.651 . . . . 0.0 106.544 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 6.1 t -89.32 134.52 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -169.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 82.4 m -91.84 169.15 10.92 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -169.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -147.52 -160.45 1.17 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 128.159 2.584 . . . . 0.0 105.476 168.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.8 ttm105 -46.38 141.46 3.53 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.916 1.235 . . . . 0.0 111.504 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.541 HD21 ' CD2' ' A' ' 43' ' ' HIS . 9.0 t-20 44.34 67.62 0.66 Allowed 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 127.964 2.506 . . . . 0.0 109.694 -172.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 p -51.4 -20.61 1.85 Allowed 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 126.522 1.929 . . . . 0.0 114.71 -171.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 77.1 m -61.0 -17.64 53.26 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 116.734 -1.603 . . . . 0.0 113.658 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -65.45 -37.14 86.01 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 122.978 2.626 . . . . 0.0 111.334 169.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.473 ' HB3' HD13 ' A' ' 79' ' ' LEU . 0.4 OUTLIER -86.63 -39.91 15.64 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.409 -0.807 . . . . 0.0 108.901 -174.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -66.89 -25.28 66.31 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 120.902 -1.124 . . . . 0.0 110.875 169.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.437 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.8 tpt -67.03 -37.89 84.94 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 119.884 -1.76 . . . . 0.0 109.153 169.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.58 89.73 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.429 ' HG3' HG12 ' A' ' 32' ' ' VAL . 60.4 tt0 -61.87 -40.19 94.5 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.49 -0.766 . . . . 0.0 110.533 169.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.31 -35.65 63.59 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 120.894 1.679 . . . . 0.0 112.676 -175.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -71.87 -37.81 70.13 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 118.329 1.065 . . . . 0.0 108.724 169.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.472 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -71.53 -39.27 70.84 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 120.567 -1.333 . . . . 0.0 111.275 -174.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.432 ' HA ' HG21 ' A' ' 32' ' ' VAL . 52.8 pttt -63.45 -23.95 67.62 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.054 1.297 . . . . 0.0 111.979 174.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 m -84.94 -50.42 7.51 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.146 2.178 . . . . 0.0 109.581 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.6 mt -88.45 -25.12 22.79 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.377 1.471 . . . . 0.0 112.022 -169.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -106.5 15.75 41.74 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 126.715 2.102 . . . . 0.0 111.73 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.35 123.09 16.79 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.595 1.158 . . . . 0.0 109.442 -175.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.24 8.38 87.5 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 123.07 0.367 . . . . 0.0 113.786 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.2 mmtt -120.66 -34.82 3.5 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 126.117 1.767 . . . . 0.0 109.278 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.5 pt -142.38 172.77 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 124.912 1.285 . . . . 0.0 109.307 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.8 145.98 39.65 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 168.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.472 HG11 ' HB3' ' A' ' 22' ' ' ALA . 2.1 t -134.57 141.26 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 123.163 0.585 . . . . 0.0 110.782 -168.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.01 160.51 42.06 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.129 0.972 . . . . 0.0 109.826 -173.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.5 p -135.51 168.14 19.78 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.124 1.329 . . . . 0.0 109.443 169.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.3 p -153.61 157.01 39.01 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.6 -0.687 . . . . 0.0 112.005 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.815 0 C-N-CA 125.693 1.616 . . . . 0.0 110.626 173.869 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 121.292 0.568 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.541 ' CD2' HD21 ' A' ' 11' ' ' ASN . 77.4 t60 -123.25 110.8 30.59 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 124.312 1.045 . . . . 0.0 110.147 -169.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.48 -25.03 41.8 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.389 2.726 . . . . 0.0 115.113 -169.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -59.73 -37.63 79.48 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 120.538 1.517 . . . . 0.0 110.775 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.41 -44.51 71.25 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.13 -44.19 78.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 CA-C-O 118.616 -0.707 . . . . 0.0 109.137 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.05 -42.77 81.15 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.689 0.677 . . . . 0.0 110.974 177.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.415 ' HG3' ' HB3' ' A' ' 112' ' ' PHE . 30.4 mmt -66.78 -22.47 66.03 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.779 -0.629 . . . . 0.0 112.311 178.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.437 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 1.8 mmt -90.18 -36.32 14.86 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -65.38 -34.86 79.31 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.368 1.067 . . . . 0.0 110.267 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.26 1.0 OUTLIER -76.31 5.21 7.38 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.3 0.64 . . . . 0.0 112.289 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.0 m -129.07 -23.02 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.831 1.252 . . . . 0.0 112.707 169.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.72 31.11 0.91 Allowed Glycine 0 CA--C 1.532 1.125 0 CA-C-N 119.739 1.154 . . . . 0.0 114.422 170.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.0 mt -130.13 161.62 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.534 1.534 . . . . 0.0 107.112 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -140.36 146.81 38.9 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 169.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.6 pt -138.37 5.71 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.486 1.914 . . . . 0.0 110.618 -176.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.6 p -64.04 145.12 56.45 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.172 -0.955 . . . . 0.0 110.138 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.2 6.02 18.2 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 118.253 -1.304 . . . . 0.0 113.811 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -57.14 -44.76 83.71 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 119.521 1.66 . . . . 0.0 113.205 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -149.53 162.24 40.54 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 124.232 0.958 . . . . 0.0 110.626 -168.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.3 p -170.5 27.4 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.702 0.801 . . . . 0.0 111.994 -170.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -139.33 147.08 51.41 Favored Pre-proline 0 N--CA 1.475 0.809 0 O-C-N 120.604 -1.31 . . . . 0.0 111.614 -169.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -83.08 161.67 15.59 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.872 3.048 . . . . 0.0 112.558 -174.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.7 tt -59.76 -37.24 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.666 1.186 . . . . 0.0 111.545 -177.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -70.5 -20.69 62.82 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.275 0.63 . . . . 0.0 112.134 -173.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -19.05 59.26 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 118.872 -0.585 . . . . 0.0 111.338 171.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -97.72 167.32 11.02 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.934 0.874 . . . . 0.0 110.637 -176.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -141.46 89.61 2.23 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 -172.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.473 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -50.94 -30.66 15.45 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.53 -29.56 10.92 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.134 0.974 . . . . 0.0 112.459 174.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -71.53 -18.58 62.26 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -107.64 171.03 7.62 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 128.398 2.679 . . . . 0.0 108.707 -172.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -111.42 -22.6 11.22 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-O 117.792 -1.099 . . . . 0.0 113.274 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.706 HG13 ' HB ' ' A' ' 95' ' ' ILE . 37.7 t -137.4 133.92 46.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 121.544 1.975 . . . . 0.0 108.585 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.0 t -116.5 129.89 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 173.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.3 mm -122.89 96.82 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 101.76 -3.422 . . . . 0.0 101.76 169.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.415 ' HA ' ' HB ' ' A' ' 7' ' ' VAL 0.254 22.0 p -74.32 166.39 23.55 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 117.649 -1.62 . . . . 0.0 108.257 169.552 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.473 HD13 ' HB3' ' A' ' 15' ' ' SER . 5.4 mp -136.36 37.86 2.71 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 170.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 63.8 m -95.91 7.59 45.93 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.869 2.067 . . . . 0.0 110.932 -169.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.85 31.78 6.83 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 119.246 -0.752 . . . . 0.0 112.221 172.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 31.5 p 40.26 37.85 0.47 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.644 2.378 . . . . 0.0 116.041 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.86 24.46 0.49 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 123.896 0.76 . . . . 0.0 112.566 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 p -78.21 143.75 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 124.615 1.166 . . . . 0.0 108.897 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -92.96 58.85 3.05 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.476 1.11 . . . . 0.0 109.239 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.8 mt -61.29 147.47 87.14 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -175.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -56.41 157.58 17.95 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.895 2.397 . . . . 0.0 111.89 170.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.3 -25.34 64.37 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 121.853 1.702 . . . . 0.0 114.875 -169.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.47 -24.68 67.22 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.49 -1.382 . . . . 0.0 111.636 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.473 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 72.1 m95 -72.65 -9.26 58.4 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 117.855 -1.069 . . . . 0.0 112.686 175.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.8 m -117.49 -16.06 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 119.926 1.239 . . . . 0.0 113.166 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.9 p -76.06 -11.18 59.9 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.15 0.886 . . . . 0.0 112.352 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.407 ' HG2' ' H ' ' A' ' 93' ' ' GLN . 69.8 mm-40 -43.38 156.1 0.06 Allowed 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 130.618 3.567 . . . . 0.0 111.826 169.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -62.12 -36.18 80.97 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.725 1.61 . . . . 0.0 109.731 171.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.706 ' HB ' HG13 ' A' ' 75' ' ' VAL . 24.4 mm -131.98 137.0 55.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -135.46 112.62 10.43 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 102.07 -3.307 . . . . 0.0 102.07 166.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -136.31 168.42 19.46 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -141.94 118.68 11.08 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 170.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.45 ' CD2' ' HB3' ' A' ' 122' ' ' ARG . 49.5 m0 -95.52 79.59 3.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.31 18.74 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 129.022 2.929 . . . . 0.0 116.411 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -61.76 128.8 37.97 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 120.615 -1.303 . . . . 0.0 113.857 -168.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 46.94 -157.74 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 128.403 2.681 . . . . 0.0 114.161 169.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -163.51 74.47 1.84 Allowed Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 127.871 2.468 . . . . 0.0 108.054 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.5 -13.35 32.72 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.365 2.71 . . . . 0.0 115.834 -169.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.0 t70 26.17 -92.37 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.001 2.52 . . . . 0.0 114.045 172.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.89 45.23 1.01 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 126.888 2.185 . . . . 0.0 109.771 171.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -66.45 175.04 2.41 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.712 2.005 . . . . 0.0 114.133 -172.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.0 m -66.21 152.05 45.69 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 113.217 -1.811 . . . . 0.0 109.657 169.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.3 mt -57.18 -35.24 69.34 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.262 0.625 . . . . 0.0 111.077 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -61.3 -36.35 79.85 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 122.862 0.465 . . . . 0.0 110.794 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 23.3 t -74.83 -40.75 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-O 117.849 -1.072 . . . . 0.0 108.76 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.415 ' HB3' ' HG3' ' A' ' 49' ' ' MET . 57.3 m-85 -54.84 -42.55 72.11 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 120.432 1.469 . . . . 0.0 110.748 172.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 59.0 mtt85 -62.21 -46.01 90.81 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.227 0.921 . . . . 0.0 111.743 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.4 m -69.89 -43.64 71.37 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -172.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.8 t -65.9 -45.67 90.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -173.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -47.55 -53.77 13.55 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.997 1.319 . . . . 0.0 110.566 169.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.78 -42.15 99.71 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 119.328 0.967 . . . . 0.0 111.998 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -64.88 -39.71 93.97 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 121.425 -1.044 . . . . 0.0 110.607 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 45.0 t -62.82 -42.34 95.98 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -36.64 78.89 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 120.128 1.331 . . . . 0.0 111.475 -174.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -68.57 -42.69 77.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.691 -0.671 . . . . 0.0 109.869 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.45 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 10.4 mpt_? -63.41 -42.36 98.76 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 119.831 1.196 . . . . 0.0 110.412 177.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 56.7 t -54.7 -52.93 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 123.469 0.708 . . . . 0.0 109.114 174.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -66.29 -32.85 74.51 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 122.046 -0.409 . . . . 0.0 111.461 -175.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -62.16 -47.87 82.62 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 123.906 0.883 . . . . 0.0 110.966 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -48.03 80.51 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 176.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -57.39 -42.16 79.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 124.447 1.099 . . . . 0.0 109.769 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.68 -27.88 68.19 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.714 0.688 . . . . 0.0 112.154 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -77.01 -41.86 40.97 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.491 0.587 . . . . 0.0 111.951 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.8 pt -99.33 -40.02 8.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 -168.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 40.4 m . . . . . 0 C--O 1.255 1.366 0 CA-C-N 119.005 0.821 . . . . 0.0 110.891 -174.351 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 tpt . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 117.513 -1.232 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.716 ' HG2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -55.98 123.57 14.78 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 121.566 1.985 . . . . 0.0 109.996 -172.054 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -93.47 142.13 27.68 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -169.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.769 HG13 HG12 ' A' ' 75' ' ' VAL . 9.1 t -121.57 153.91 25.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.289 0.993 . . . . 0.0 108.56 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 59.9 tpp -136.32 135.05 38.56 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -117.22 109.88 17.43 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.446 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 10.2 t -96.98 141.74 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -169.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.9 t -125.81 156.7 39.12 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.335 0.97 . . . . 0.0 111.316 173.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp -140.11 34.67 1.92 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.664 1.586 . . . . 0.0 109.197 172.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -156.43 171.6 19.98 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 128.006 2.522 . . . . 0.0 105.156 -170.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.417 HD21 ' CE1' ' A' ' 43' ' ' HIS . 62.5 t-20 -42.2 125.41 3.06 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 169.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.0 p -41.52 -29.46 0.17 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 117.277 2.325 . . . . 0.0 117.277 -169.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.7 m -34.16 -62.16 0.33 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 127.367 2.267 . . . . 0.0 115.148 -169.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -64.6 -52.0 59.79 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.056 0.844 . . . . 0.0 112.529 -168.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -81.67 -34.09 30.92 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 121.514 -0.741 . . . . 0.0 111.417 -172.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.27 -30.76 65.14 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.454 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.7 tpt -64.88 -40.88 95.8 Favored 'General case' 0 CA--C 1.514 -0.419 0 O-C-N 121.018 -1.051 . . . . 0.0 109.094 168.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.67 -36.79 79.59 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -62.03 -42.96 99.73 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.83 -0.605 . . . . 0.0 111.313 169.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.14 -45.61 91.0 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-N 119.936 1.244 . . . . 0.0 110.907 -176.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -63.09 -39.98 96.31 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 117.934 0.867 . . . . 0.0 109.364 172.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.28 -35.82 76.43 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 119.58 1.082 . . . . 0.0 111.561 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -81.93 -13.91 56.85 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 120.311 1.414 . . . . 0.0 113.244 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.9 m -78.18 -50.69 11.47 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.229 1.412 . . . . 0.0 109.397 169.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.3 mt -89.56 -27.4 20.28 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.16 1.384 . . . . 0.0 112.423 -169.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.78 14.63 57.47 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 126.661 2.077 . . . . 0.0 111.685 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.34 120.45 9.32 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.579 1.151 . . . . 0.0 110.054 -172.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.58 9.5 86.13 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 119.81 -0.439 . . . . 0.0 113.467 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -123.27 -24.87 4.56 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 125.159 1.384 . . . . 0.0 109.701 -177.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.716 HG22 ' HG2' ' A' ' 2' ' ' LYS . 13.1 pt -144.29 172.0 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 125.962 1.705 . . . . 0.0 110.42 175.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.31 144.71 38.62 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 103.836 -2.653 . . . . 0.0 103.836 168.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 t -135.59 140.42 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 123.47 0.708 . . . . 0.0 110.743 -168.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.6 160.63 42.49 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.127 0.971 . . . . 0.0 109.939 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.5 p -139.02 163.64 31.85 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.288 1.404 . . . . 0.0 111.221 174.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.7 p -149.64 160.49 43.46 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.151 0.58 . . . . 0.0 111.339 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.696 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 -177.608 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.417 ' CE1' HD21 ' A' ' 11' ' ' ASN . 70.6 t60 -121.28 111.28 33.71 Favored Pre-proline 0 N--CA 1.454 -0.268 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -169.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -66.08 -27.11 49.92 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.385 2.724 . . . . 0.0 112.343 -169.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.9 m -63.32 -37.11 85.99 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.64 0.655 . . . . 0.0 109.249 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.39 -44.15 88.43 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.08 -49.66 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.22 -42.86 99.34 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.487 0.585 . . . . 0.0 111.119 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.6 mmt -61.89 -24.75 67.14 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.353 -0.832 . . . . 0.0 111.967 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.454 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.6 OUTLIER -94.4 -27.61 15.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 119.151 0.887 . . . . 0.0 108.688 -179.194 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.59 -30.42 71.53 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.371 1.068 . . . . 0.0 110.408 170.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -56.84 -23.19 42.26 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.457 0.703 . . . . 0.0 112.098 171.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.8 m -123.64 12.01 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 125.445 1.498 . . . . 0.0 111.142 -175.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.36 39.65 87.46 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 123.815 0.722 . . . . 0.0 112.759 174.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.6 mt -122.98 154.56 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.428 1.491 . . . . 0.0 107.19 175.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -127.84 128.11 44.65 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 124.552 1.141 . . . . 0.0 108.795 -177.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 46.3 pt -134.64 15.31 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 126.661 1.984 . . . . 0.0 109.752 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.65 160.16 27.66 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 167.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.17 -15.86 2.34 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 118.958 -0.912 . . . . 0.0 112.456 -174.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -61.58 147.46 45.55 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.757 1.279 . . . . 0.0 107.903 169.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.06 169.64 17.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -169.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.3 m -73.06 145.11 46.8 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.663 1.585 . . . . 0.0 111.937 -170.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -166.32 123.8 1.03 Allowed Pre-proline 0 C--O 1.237 0.442 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 169.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -76.87 161.12 33.54 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.115 1.876 . . . . 0.0 111.454 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.8 tt -56.17 -37.79 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.217 1.007 . . . . 0.0 111.142 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -68.86 -21.27 64.28 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.586 0.754 . . . . 0.0 112.16 -176.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.79 -22.43 63.33 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.637 -0.697 . . . . 0.0 111.203 171.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -107.45 165.9 11.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.578 1.18 . . . . 0.0 112.018 -172.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.86 89.8 2.28 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 102.658 -3.09 . . . . 0.0 102.658 -170.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.481 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -49.4 -32.14 11.01 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.275 0.63 . . . . 0.0 112.283 -177.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.08 -28.29 10.18 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.26 1.024 . . . . 0.0 112.868 174.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.04 -23.2 61.34 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.366 0.666 . . . . 0.0 112.208 176.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -104.12 178.89 4.43 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.618 2.767 . . . . 0.0 108.659 -175.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -123.57 -17.4 6.47 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 118.601 -0.714 . . . . 0.0 112.579 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.769 HG12 HG13 ' A' ' 4' ' ' VAL . 17.5 t -143.72 124.25 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -169.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.6 t -117.41 130.09 72.86 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.782 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.425 HG21 ' CE3' ' A' ' 99' ' ' TRP . 33.0 mm -119.35 92.44 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 103.026 -2.953 . . . . 0.0 103.026 169.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.446 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 16.9 t -72.42 161.38 30.9 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 169.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.6 mp -141.32 46.87 1.71 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 169.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 72.2 m -89.76 2.06 55.34 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.992 0.917 . . . . 0.0 110.682 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.12 42.69 5.22 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 172.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.2 p 37.75 44.72 0.59 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.321 2.248 . . . . 0.0 114.638 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -157.56 47.89 0.45 Allowed Glycine 0 C--N 1.34 0.757 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -172.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.9 p -128.09 161.92 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.873 1.669 . . . . 0.0 109.99 -172.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -123.21 45.31 2.45 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.177 2.191 . . . . 0.0 109.445 -170.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.8 mt -54.42 140.98 54.82 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.2 1.0 . . . . 0.0 109.245 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -53.88 153.39 20.13 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.596 2.197 . . . . 0.0 112.554 173.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -55.53 -26.82 56.43 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.515 2.143 . . . . 0.0 116.006 -173.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -64.75 -25.09 67.78 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.915 -1.116 . . . . 0.0 111.865 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.481 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 70.0 m95 -71.43 -9.19 57.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.661 1.184 . . . . 0.0 112.323 173.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.27 -29.8 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.663 1.585 . . . . 0.0 110.294 -173.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.0 p -75.25 -9.63 58.73 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.758 0.823 . . . . 0.0 112.738 -175.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -45.21 155.67 0.12 Allowed 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 129.916 3.287 . . . . 0.0 111.722 169.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -62.19 -39.23 92.0 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.803 1.641 . . . . 0.0 109.561 170.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.61 ' HB ' HG13 ' A' ' 75' ' ' VAL . 21.8 mm -122.56 134.64 65.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 169.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -137.92 111.78 8.33 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 103.892 -2.633 . . . . 0.0 103.892 166.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -137.39 165.72 25.54 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -133.41 105.04 6.71 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.441 1.096 . . . . 0.0 108.157 171.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.425 ' CE3' HG21 ' A' ' 77' ' ' ILE . 46.1 m0 -79.35 72.82 5.98 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.181 1.392 . . . . 0.0 108.613 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -51.94 34.05 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.952 1 C-N-CA 132.43 4.292 . . . . 0.0 116.015 169.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.87 -175.0 1.6 Allowed 'General case' 0 CA--C 1.544 0.742 0 O-C-N 120.958 -1.088 . . . . 0.0 110.162 -174.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.456 ' HB2' HG22 ' A' ' 115' ' ' VAL . 1.5 mp0 -42.21 164.51 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 127.735 2.414 . . . . 0.0 113.213 176.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -126.58 63.17 52.24 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 125.779 1.632 . . . . 0.0 112.802 -168.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -79.94 69.06 8.1 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 124.164 3.243 . . . . 0.0 112.549 -169.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.35 -38.56 89.99 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.799 -1.188 . . . . 0.0 112.404 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -162.8 42.56 0.35 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.259 1.409 . . . . 0.0 110.763 -176.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -71.88 171.58 11.47 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -169.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.3 m -69.25 154.2 42.43 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 113.103 -1.862 . . . . 0.0 108.194 168.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 24.6 mt -59.17 -32.48 69.94 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.911 -0.493 . . . . 0.0 111.438 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -62.81 -39.75 95.24 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 118.611 0.642 . . . . 0.0 111.005 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.621 ' O ' HG23 ' A' ' 115' ' ' VAL . 98.7 t -72.02 -42.13 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 116.37 -1.776 . . . . 0.0 108.526 177.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -50.38 -49.13 55.21 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 121.086 1.766 . . . . 0.0 111.1 172.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -58.67 -44.33 90.17 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.371 0.532 . . . . 0.0 110.762 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 88.0 m -66.15 -44.6 83.66 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 118.642 -0.694 . . . . 0.0 109.432 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 111' ' ' VAL . 17.3 t -67.36 -49.16 74.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -172.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -44.29 -56.36 4.22 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.332 1.453 . . . . 0.0 111.269 170.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.81 -42.77 96.9 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 119.231 0.923 . . . . 0.0 111.416 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -62.2 -39.35 92.45 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.503 -0.998 . . . . 0.0 111.409 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.0 t -62.72 -41.52 92.68 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 CA-C-O 117.842 -1.075 . . . . 0.0 108.212 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -38.3 75.9 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 120.208 1.367 . . . . 0.0 111.048 -177.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -69.79 -43.76 71.47 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.988 -0.529 . . . . 0.0 110.219 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -66.36 -42.9 87.35 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.381 0.991 . . . . 0.0 110.357 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.8 t -52.72 -54.53 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 123.833 0.853 . . . . 0.0 108.983 172.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -65.1 -32.54 74.29 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 122.121 -0.362 . . . . 0.0 111.301 -174.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -62.41 -47.74 82.8 Favored 'General case' 0 C--O 1.225 -0.188 0 O-C-N 121.806 -0.559 . . . . 0.0 111.185 172.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.63 -47.57 79.41 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 176.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.2 mt -57.97 -42.71 83.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 123.895 0.878 . . . . 0.0 109.697 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.3 -32.0 71.85 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.961 0.801 . . . . 0.0 111.957 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -72.36 -42.25 65.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.611 173.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.3 pt -103.93 -44.7 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 118.942 2.941 . . . . 0.0 118.942 -168.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 71.8 m . . . . . 0 C--O 1.252 1.228 0 CA-C-N 119.733 1.152 . . . . 0.0 111.561 -169.336 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 tpt . . . . . 0 N--CA 1.498 1.942 0 CA-C-O 118.724 -0.655 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -64.31 128.13 34.47 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.892 1.678 . . . . 0.0 108.891 -174.853 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -94.24 145.8 24.47 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -170.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.753 HG13 HG12 ' A' ' 75' ' ' VAL . 12.2 t -124.28 153.52 30.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 O-C-N 124.495 1.122 . . . . 0.0 108.142 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 56.5 tpp -134.59 146.24 49.42 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 175.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -127.0 106.53 9.34 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.454 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 4.0 t -93.47 136.52 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -169.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.5 m -108.55 171.62 7.31 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.133 0.573 . . . . 0.0 110.748 -174.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -149.69 -52.36 0.15 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.451 0.7 . . . . 0.0 109.395 169.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.44 ' CG ' ' H ' ' A' ' 11' ' ' ASN . 30.9 ttm180 -103.92 -176.44 3.08 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.387 1.075 . . . . 0.0 108.293 169.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.483 HD21 ' CD2' ' A' ' 43' ' ' HIS . 27.4 t-20 -36.07 125.24 0.75 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 127.821 2.448 . . . . 0.0 113.65 -169.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.78 -19.56 6.65 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 129.243 3.017 . . . . 0.0 113.818 -173.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 p -58.17 -12.41 3.52 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 177.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -101.54 -43.91 5.75 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 120.597 1.544 . . . . 0.0 111.509 169.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.0 p -93.23 -52.88 4.34 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.964 1.306 . . . . 0.0 113.542 -168.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -65.87 -28.03 68.66 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.667 -1.271 . . . . 0.0 110.068 169.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.464 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.7 tpt -62.47 -39.81 94.61 Favored 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 121.267 -0.896 . . . . 0.0 110.741 169.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.03 -37.52 80.02 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 118.834 -0.603 . . . . 0.0 109.678 178.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -62.22 -41.29 98.25 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 118.721 -0.657 . . . . 0.0 110.915 169.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.87 -43.02 84.83 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 120.255 1.388 . . . . 0.0 111.686 -175.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -65.31 -37.53 87.41 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 121.742 -0.858 . . . . 0.0 108.733 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.66 -38.0 67.76 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 119.752 1.16 . . . . 0.0 111.358 -174.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.418 ' HA ' HG21 ' A' ' 32' ' ' VAL . 54.6 pttt -68.42 -26.75 65.69 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.869 1.213 . . . . 0.0 111.627 175.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.0 m -77.21 -52.32 9.44 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.967 1.707 . . . . 0.0 110.235 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.1 mt -88.2 -26.44 22.38 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.008 1.323 . . . . 0.0 111.695 -169.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.13 13.77 58.63 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 126.431 1.967 . . . . 0.0 111.673 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.6 119.5 7.68 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.414 1.086 . . . . 0.0 109.548 -174.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.07 8.3 87.93 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 119.754 -0.47 . . . . 0.0 113.564 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.4 ' O ' ' HE2' ' A' ' 2' ' ' LYS . 75.6 mmtt -123.51 -26.22 4.25 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 125.568 1.547 . . . . 0.0 109.977 -177.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.512 HG21 HD12 ' A' ' 130' ' ' ILE . 9.1 pt -145.92 170.58 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 125.058 1.343 . . . . 0.0 109.589 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.12 145.82 35.08 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 167.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.457 HG22 HD12 ' A' ' 30' ' ' ILE . 1.7 t -136.43 140.24 43.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 119.05 0.841 . . . . 0.0 111.263 -167.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 m -150.7 160.78 43.61 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 124.209 1.003 . . . . 0.0 110.682 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 64.6 p -133.2 161.86 33.3 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.057 1.299 . . . . 0.0 109.746 169.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.8 p -154.39 169.8 22.87 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.063 0.459 . . . . 0.0 111.879 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.44 0 C-N-CA 125.471 1.51 . . . . 0.0 111.846 -174.008 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 t . . . . . 0 CA--C 1.531 0.246 0 CA-C-O 122.115 0.96 . . . . 0.0 112.285 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.483 ' CD2' HD21 ' A' ' 11' ' ' ASN . 85.9 t60 -127.74 114.62 20.79 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 125.76 1.624 . . . . 0.0 108.321 -172.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -68.35 -27.04 34.62 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 124.021 3.147 . . . . 0.0 113.241 -169.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.0 m -62.65 -34.37 76.94 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.134 0.879 . . . . 0.0 109.206 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.12 -45.97 86.23 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.48 -46.7 92.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.128 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.96 -43.57 98.57 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 119.091 0.86 . . . . 0.0 111.077 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.4 mmt -59.74 -25.45 64.86 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.204 0.602 . . . . 0.0 111.986 175.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.464 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -93.09 -29.32 15.84 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -176.88 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -63.25 -31.47 72.63 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.328 1.451 . . . . 0.0 110.212 171.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -56.83 -20.81 24.79 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.794 0.838 . . . . 0.0 112.516 171.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.8 p -126.25 14.15 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 125.191 1.397 . . . . 0.0 110.253 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.8 33.76 66.32 Favored Glycine 0 CA--C 1.531 1.069 0 O-C-N 121.053 -1.029 . . . . 0.0 112.842 173.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.8 mt -121.01 159.04 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 126.08 1.752 . . . . 0.0 106.944 176.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -140.09 146.99 39.62 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.2 pt -135.15 8.77 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 126.262 1.825 . . . . 0.0 111.183 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.5 t -70.73 161.31 31.07 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 168.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.7 -25.53 1.43 Allowed Glycine 0 CA--C 1.533 1.199 0 CA-C-O 119.029 -0.873 . . . . 0.0 111.942 -173.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -76.85 137.95 39.5 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 103.397 -2.816 . . . . 0.0 103.397 168.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -146.84 165.19 30.45 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -168.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.1 m -68.0 141.37 56.27 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.961 2.105 . . . . 0.0 111.01 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -164.56 132.19 2.5 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.66 147.61 35.78 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.887 2.392 . . . . 0.0 113.753 -168.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.5 tt -60.48 -34.25 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.087 1.355 . . . . 0.0 111.238 -171.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.28 -13.17 61.44 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.211 0.604 . . . . 0.0 112.541 -171.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -91.58 -10.29 41.09 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.027 0.931 . . . . 0.0 112.173 171.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -84.0 171.07 13.3 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 122.015 0.912 . . . . 0.0 111.161 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.77 83.2 1.52 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.787 1.635 . . . . 0.0 107.638 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.41 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -49.1 -30.96 7.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -50.65 -32.6 19.61 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.143 0.977 . . . . 0.0 112.627 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -71.11 -24.85 62.37 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -94.36 177.28 6.0 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 127.402 2.281 . . . . 0.0 109.064 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -116.14 -19.23 10.36 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 118.257 -0.878 . . . . 0.0 112.585 173.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.753 HG12 HG13 ' A' ' 4' ' ' VAL . 8.2 t -143.2 132.41 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 120.685 1.584 . . . . 0.0 106.939 -169.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.8 m -132.99 130.15 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.43 HG21 ' CE3' ' A' ' 99' ' ' TRP . 28.0 mm -116.96 99.96 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 102.749 -3.056 . . . . 0.0 102.749 176.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.454 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 30.3 t -72.85 161.38 30.79 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 169.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.2 mp -140.1 34.29 1.92 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 169.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.541 ' HB3' HG21 ' A' ' 84' ' ' VAL . 85.5 m -74.01 -5.79 43.5 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.388 1.075 . . . . 0.0 111.6 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.33 27.32 18.41 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -173.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.501 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 3.1 t 53.96 -173.13 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.287 1.835 . . . . 0.0 111.095 -169.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.93 -34.4 1.25 Allowed Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.414 1.483 . . . . 0.0 114.818 173.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.541 HG21 ' HB3' ' A' ' 80' ' ' CYS . 78.2 t -58.67 126.07 15.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 118.502 1.151 . . . . 0.0 108.679 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -82.04 73.31 9.09 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.455 1.102 . . . . 0.0 110.317 -169.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.2 mt -58.9 143.01 84.16 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 118.28 -0.867 . . . . 0.0 108.871 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.1 156.59 9.76 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.208 2.605 . . . . 0.0 112.458 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.57 -20.46 65.67 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.72 1.613 . . . . 0.0 115.172 -169.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.83 -24.8 66.2 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 120.576 -1.328 . . . . 0.0 112.067 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.41 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 71.7 m95 -70.33 -8.9 54.1 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.215 1.006 . . . . 0.0 111.884 171.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.2 t -105.83 -30.56 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 119.831 1.196 . . . . 0.0 110.517 -174.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.8 p -73.8 -14.48 61.11 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.114 0.966 . . . . 0.0 112.911 -174.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.418 ' HG2' ' H ' ' A' ' 93' ' ' GLN . 79.2 mm-40 -44.25 154.19 0.12 Allowed 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 129.835 3.254 . . . . 0.0 112.075 169.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -63.01 -38.72 92.32 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.735 1.614 . . . . 0.0 109.45 169.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.498 ' HB ' HG13 ' A' ' 75' ' ' VAL . 2.5 mt -126.95 131.11 71.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 174.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -137.95 109.84 7.18 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 101.126 -3.657 . . . . 0.0 101.126 166.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.86 165.99 23.72 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.501 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 11.1 t70 -130.62 103.91 6.9 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 169.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.43 ' CE3' HG21 ' A' ' 77' ' ' ILE . 53.0 m0 -76.35 73.12 3.13 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 174.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -58.99 42.9 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.87 1 C-N-CA 131.865 4.066 . . . . 0.0 111.755 169.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.36 -172.69 1.2 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.714 1.206 . . . . 0.0 112.128 -168.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.486 ' HB2' HG22 ' A' ' 115' ' ' VAL . 39.0 mt-10 -50.96 161.64 0.35 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.344 1.458 . . . . 0.0 111.745 172.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -117.42 101.22 52.83 Favored Pre-proline 0 C--N 1.323 -0.557 0 C-N-CA 126.313 1.845 . . . . 0.0 108.766 -176.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -79.08 -4.5 13.91 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.071 2.514 . . . . 0.0 113.064 175.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.8 t70 23.26 -96.6 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 128.536 2.735 . . . . 0.0 114.238 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.84 38.31 1.83 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 127.105 2.288 . . . . 0.0 109.51 169.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -71.67 -178.0 2.09 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.238 1.815 . . . . 0.0 112.775 -174.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.0 m -62.55 155.2 26.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 113.52 -1.673 . . . . 0.0 109.047 172.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 27.0 mt -56.43 -30.82 63.3 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 123.09 0.556 . . . . 0.0 110.805 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.35 -40.04 92.81 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 118.636 0.653 . . . . 0.0 110.811 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.4 t -72.32 -44.02 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 117.361 -1.304 . . . . 0.0 108.781 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -48.01 -48.71 32.58 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 120.181 1.355 . . . . 0.0 111.383 170.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -60.64 -45.13 95.23 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.948 0.795 . . . . 0.0 111.364 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.7 m -68.58 -44.32 74.66 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -173.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.486 HG22 ' HB2' ' A' ' 102' ' ' GLU . 19.7 t -67.68 -43.47 86.65 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -174.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -47.37 -56.4 6.98 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 124.638 1.175 . . . . 0.0 110.825 171.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.66 -42.49 99.68 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 119.546 1.066 . . . . 0.0 111.869 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -63.7 -38.74 92.26 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 121.317 -1.108 . . . . 0.0 111.803 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.5 t -62.52 -41.42 91.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -37.29 76.75 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 119.805 1.184 . . . . 0.0 111.184 -175.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -70.11 -41.05 74.5 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 118.695 -0.669 . . . . 0.0 110.722 176.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -64.4 -43.74 93.46 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.948 1.249 . . . . 0.0 110.214 177.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.497 HG12 HD12 ' A' ' 127' ' ' ILE . 66.7 t -54.38 -52.02 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 123.782 0.833 . . . . 0.0 109.536 173.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -66.29 -34.46 78.04 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 118.057 0.39 . . . . 0.0 111.634 -175.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -61.74 -48.91 78.58 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.313 0.645 . . . . 0.0 110.897 172.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.42 HD23 HG13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -58.5 -45.06 89.53 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 122.882 0.473 . . . . 0.0 109.937 176.888 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.497 HD12 HG12 ' A' ' 123' ' ' VAL . 6.6 mt -58.38 -42.71 84.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 123.489 0.715 . . . . 0.0 109.576 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.04 -28.11 68.61 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -68.19 -53.53 24.26 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.022 0.828 . . . . 0.0 110.431 172.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.512 HD12 HG21 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -84.33 -40.5 15.48 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 -169.372 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--O 1.255 1.345 0 CA-C-N 119.554 1.07 . . . . 0.0 112.486 -169.638 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.5 2.03 0 CA-C-O 117.491 -1.242 . . . . 0.0 109.208 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.705 ' HG2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -56.44 123.54 15.07 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 121.509 1.959 . . . . 0.0 109.812 -172.758 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -92.47 142.05 27.84 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -170.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.707 HG13 HG12 ' A' ' 75' ' ' VAL . 10.5 t -123.66 152.21 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 O-C-N 124.381 1.051 . . . . 0.0 108.385 -177.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 53.8 tpp -137.29 143.94 42.4 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -126.23 119.56 27.77 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.8 t -103.86 131.14 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -169.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.8 t -123.56 -174.76 3.04 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.624 1.57 . . . . 0.0 110.314 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -158.59 -63.63 0.08 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 169.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.3 ttm105 -70.66 135.15 48.15 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 122.333 0.253 . . . . 0.0 111.272 -175.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 65.4 t30 42.91 25.74 0.06 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.72 2.808 . . . . 0.0 115.877 168.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.4 m 29.45 64.87 0.13 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.177 2.191 . . . . 0.0 114.395 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 p -139.38 -71.88 0.39 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 116.593 -1.67 . . . . 0.0 115.129 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.262 20.0 ptt180 -44.18 -45.68 8.48 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 122.355 2.343 . . . . 0.0 116.035 -168.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.445 ' HB3' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -93.04 -30.69 15.17 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.486 -0.759 . . . . 0.0 111.215 -174.08 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -62.11 -37.14 83.97 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.857 -1.152 . . . . 0.0 108.677 169.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.423 ' SD ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -64.25 -39.49 94.06 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 121.146 -0.971 . . . . 0.0 110.681 172.203 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.56 -34.5 74.26 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 118.633 -0.699 . . . . 0.0 110.326 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -64.24 -40.78 96.72 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-N 118.979 0.809 . . . . 0.0 110.172 169.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.29 -43.55 98.92 Favored Glycine 0 C--N 1.339 0.697 0 CA-C-N 120.009 1.277 . . . . 0.0 111.33 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.423 ' CD2' ' SD ' ' A' ' 17' ' ' MET . 7.2 m-85 -68.24 -38.31 81.69 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 118.571 1.186 . . . . 0.0 109.847 172.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.83 -37.11 70.36 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 119.642 1.11 . . . . 0.0 111.171 -172.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.438 ' HA ' HG21 ' A' ' 32' ' ' VAL . 42.4 pttt -71.34 -27.14 63.16 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 119.868 1.213 . . . . 0.0 111.867 174.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 m -72.58 -50.8 22.98 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.184 1.794 . . . . 0.0 110.331 175.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.1 mt -88.76 -28.36 20.54 Favored 'General case' 0 CA--C 1.53 0.212 0 C-N-CA 124.74 1.216 . . . . 0.0 112.056 -169.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.59 15.14 60.17 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.878 2.18 . . . . 0.0 111.423 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.56 120.11 8.81 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.706 1.203 . . . . 0.0 110.012 -173.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.65 9.05 87.12 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.692 -0.504 . . . . 0.0 113.48 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -123.1 -24.02 4.81 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.348 1.459 . . . . 0.0 110.026 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.705 HG22 ' HG2' ' A' ' 2' ' ' LYS . 12.9 pt -146.08 171.85 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 125.972 1.709 . . . . 0.0 110.124 177.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.82 143.81 42.15 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 168.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.484 HG22 HD12 ' A' ' 30' ' ' ILE . 1.6 t -137.34 138.14 45.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 118.907 0.776 . . . . 0.0 111.178 -168.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.4 m -144.86 166.42 25.31 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.203 1.401 . . . . 0.0 109.841 178.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.5 p -136.37 161.78 34.87 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.594 -1.316 . . . . 0.0 108.899 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.4 p -159.07 176.27 12.47 Favored 'General case' 0 C--O 1.233 0.226 0 O-C-N 121.556 -0.715 . . . . 0.0 109.491 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.6 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -176.433 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.445 -0.703 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -149.55 116.17 3.62 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -65.35 -29.35 54.39 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.018 2.479 . . . . 0.0 112.176 -169.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.6 m -64.21 -37.5 87.69 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.91 -42.25 90.42 Favored 'General case' 0 C--O 1.219 -0.536 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.73 -48.4 86.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 118.457 -0.783 . . . . 0.0 109.286 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.98 -42.74 98.93 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.228 0.922 . . . . 0.0 110.992 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 24.6 mmt -64.87 -21.24 66.77 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.962 0.905 . . . . 0.0 112.102 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.1 mmt -91.49 -29.16 17.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 119.305 0.957 . . . . 0.0 110.175 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.24 -29.38 70.16 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.897 0.879 . . . . 0.0 110.491 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -56.39 -25.58 50.34 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.047 0.939 . . . . 0.0 112.489 170.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.5 m -121.95 12.74 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.987 1.315 . . . . 0.0 111.056 -173.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.2 37.4 81.25 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.361 -0.688 . . . . 0.0 112.385 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.6 mt -121.87 153.74 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -129.92 127.63 40.52 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 37.3 pt -132.02 9.73 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 C-N-CA 123.303 0.641 . . . . 0.0 111.931 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.16 -32.18 61.22 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.355 1.462 . . . . 0.0 112.456 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.06 3.83 69.33 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.551 -0.583 . . . . 0.0 112.841 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -76.1 -175.42 3.1 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.225 1.01 . . . . 0.0 111.847 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.43 171.14 1.14 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.013 2.525 . . . . 0.0 114.999 -169.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.2 m -144.74 21.55 1.63 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.426 1.49 . . . . 0.0 111.699 -169.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -139.59 160.13 62.63 Favored Pre-proline 0 N--CA 1.471 0.578 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -168.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.7 165.58 24.61 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 124.724 3.616 . . . . 0.0 112.454 175.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.4 tt -59.93 -34.55 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.384 1.474 . . . . 0.0 111.971 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -68.89 -21.56 64.23 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -169.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.49 -16.44 56.04 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.161 172.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -89.67 171.3 9.76 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.237 0.926 . . . . 0.0 110.706 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.24 88.57 1.73 Allowed 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.236 1.414 . . . . 0.0 108.912 -173.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.456 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -49.86 -29.71 8.59 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.805 0.842 . . . . 0.0 113.168 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -48.76 -33.98 11.35 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.282 1.033 . . . . 0.0 112.034 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -73.51 -23.11 59.98 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -99.43 -177.66 3.66 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 127.547 2.339 . . . . 0.0 109.796 -174.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -123.19 -20.52 5.67 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.707 HG12 HG13 ' A' ' 4' ' ' VAL . 17.1 t -142.86 130.09 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 -169.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.8 m -135.27 135.76 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 O-C-N 120.825 -1.172 . . . . 0.0 108.368 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.1 mm -130.37 100.27 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 -172.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 77.4 p -80.83 159.91 24.96 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 119.042 -1.063 . . . . 0.0 109.461 173.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.445 HD13 ' HB3' ' A' ' 15' ' ' SER . 3.4 mp -137.39 53.54 1.86 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 103.009 -2.96 . . . . 0.0 103.009 169.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 60.1 m -107.9 18.86 20.79 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.623 1.969 . . . . 0.0 108.774 -176.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.46 21.86 76.24 Favored Glycine 0 C--N 1.344 0.972 0 CA-C-O 118.785 -1.008 . . . . 0.0 112.548 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.4 p 53.52 -8.7 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.504 3.122 . . . . 0.0 117.418 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.97 -27.94 73.47 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 119.248 0.931 . . . . 0.0 112.005 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.0 t -65.99 113.63 2.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -76.19 105.59 7.32 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 104.154 -2.536 . . . . 0.0 104.154 168.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.5 mt -72.9 154.61 90.95 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.26 158.29 12.44 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.906 2.404 . . . . 0.0 112.487 173.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.84 -24.02 68.41 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 121.727 1.618 . . . . 0.0 115.717 -169.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -67.99 -24.3 65.12 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 120.705 -1.247 . . . . 0.0 111.835 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.456 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 65.6 m95 -72.6 -7.57 50.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.318 1.047 . . . . 0.0 111.756 172.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.2 t -105.34 -30.52 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 120.213 1.37 . . . . 0.0 110.309 -174.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.9 p -74.19 -13.11 60.75 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.242 1.017 . . . . 0.0 112.88 -175.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -45.29 154.64 0.16 Allowed 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 129.898 3.279 . . . . 0.0 112.468 169.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -64.33 -39.03 93.08 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.203 1.801 . . . . 0.0 109.347 170.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.575 ' HB ' HG13 ' A' ' 75' ' ' VAL . 31.1 mm -127.44 135.65 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 171.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -137.67 104.27 5.26 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 100.773 -3.788 . . . . 0.0 100.773 166.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -127.25 169.93 12.99 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 174.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' A' ' 78' ' ' SER . 8.3 t70 -142.44 137.12 30.13 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 169.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.421 ' CD2' ' HB3' ' A' ' 122' ' ' ARG . 54.0 m0 -107.19 6.29 28.57 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -172.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 42.88 -70.78 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 131.282 3.833 . . . . 0.0 112.678 -172.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.413 ' CD1' ' H ' ' A' ' 102' ' ' GLU 0.26 0.3 OUTLIER 52.69 -174.41 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.507 1 C-N-CA 132.977 4.511 . . . . 0.0 114.891 177.012 . . . . . . . . 5 4 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.44 ' HB2' HG22 ' A' ' 115' ' ' VAL . 27.0 mt-10 -62.19 172.28 1.51 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.065 1.746 . . . . 0.0 109.867 -175.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -129.15 72.23 81.99 Favored Pre-proline 0 C--N 1.323 -0.556 0 C-N-CA 125.135 1.374 . . . . 0.0 111.249 -168.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.6 68.25 5.43 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 124.481 3.454 . . . . 0.0 113.489 -172.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -64.68 -33.01 74.95 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.348 1.059 . . . . 0.0 112.902 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 154.46 92.35 0.09 OUTLIER Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.933 1.73 . . . . 0.0 109.209 -175.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.85 -167.94 1.8 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.458 1.503 . . . . 0.0 111.451 -169.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.2 p -70.89 157.92 37.32 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 113.424 -1.717 . . . . 0.0 108.162 168.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.1 mt -61.07 -31.63 71.29 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 121.842 -0.536 . . . . 0.0 111.292 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -58.58 -38.61 78.26 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.279 0.632 . . . . 0.0 111.088 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.667 ' O ' HG23 ' A' ' 115' ' ' VAL . 42.9 t -72.93 -43.6 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 117.172 -1.394 . . . . 0.0 108.594 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -52.78 -46.73 67.73 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.757 1.617 . . . . 0.0 111.591 171.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -58.86 -43.68 90.88 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.758 0.708 . . . . 0.0 111.04 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.0 m -68.13 -44.23 76.55 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -175.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 111' ' ' VAL . 60.1 t -62.5 -52.82 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -173.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -42.25 -58.99 1.96 Allowed 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 126.1 1.76 . . . . 0.0 110.974 169.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.46 -43.23 99.6 Favored Glycine 0 CA--C 1.524 0.607 0 CA-C-N 119.796 1.18 . . . . 0.0 111.632 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -63.93 -38.87 92.69 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 120.616 -1.52 . . . . 0.0 111.563 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.5 t -60.28 -40.48 83.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 118.374 -0.822 . . . . 0.0 108.835 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -42.58 76.62 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.623 1.101 . . . . 0.0 110.425 -177.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -65.86 -43.34 88.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 119.426 -0.321 . . . . 0.0 110.385 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.421 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 5.5 mpt_? -70.55 -41.2 72.8 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.919 0.782 . . . . 0.0 109.844 -176.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 64.8 t -53.37 -52.92 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 123.31 0.644 . . . . 0.0 109.486 172.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.99 -33.1 75.23 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 122.212 -0.305 . . . . 0.0 111.491 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -61.81 -47.54 84.65 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.078 0.551 . . . . 0.0 111.135 172.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -46.93 84.39 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 118.259 0.482 . . . . 0.0 110.089 176.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -57.81 -42.22 81.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 123.473 0.709 . . . . 0.0 109.557 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.03 -30.26 70.84 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 118.909 0.777 . . . . 0.0 111.798 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -72.89 -44.23 61.53 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 118.346 -0.835 . . . . 0.0 111.623 172.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 21.3 pt -101.96 -43.85 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 118.465 2.765 . . . . 0.0 118.465 -168.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.0 m . . . . . 0 C--O 1.254 1.317 0 CA-C-O 116.692 -1.623 . . . . 0.0 111.536 -169.236 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.498 1.958 0 CA-C-O 118.91 -0.566 . . . . 0.0 109.848 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -64.65 128.58 36.39 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.565 1.53 . . . . 0.0 107.967 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -94.89 143.06 26.77 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -173.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.778 HG13 HG12 ' A' ' 75' ' ' VAL . 11.3 t -121.78 153.23 25.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 O-C-N 124.457 1.098 . . . . 0.0 108.631 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.4 mmt -129.13 138.78 52.0 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -119.7 100.09 7.05 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 170.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.43 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 2.7 t -84.64 116.78 28.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -168.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.9 m -82.75 167.5 18.11 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.848 0.833 . . . . 0.0 112.339 -171.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.0 mtpp -159.02 170.88 21.09 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 127.57 2.348 . . . . 0.0 105.6 169.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.02 -143.66 0.73 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.081 0.952 . . . . 0.0 108.49 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -72.67 1.78 7.72 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.405 -0.809 . . . . 0.0 112.426 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.3 m 65.57 -1.49 1.0 Allowed 'General case' 0 C--N 1.348 0.526 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 169.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 p -59.02 -45.94 89.46 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 119.953 1.251 . . . . 0.0 111.613 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -58.38 -35.34 71.84 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 119.406 1.003 . . . . 0.0 113.039 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.79 -40.49 10.17 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.565 1.146 . . . . 0.0 110.942 -169.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -64.53 -35.05 79.71 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.511 0.724 . . . . 0.0 110.01 169.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.459 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.6 tpt -63.05 -39.77 95.73 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 121.394 -0.816 . . . . 0.0 110.983 169.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.48 -36.98 79.58 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 118.439 -0.791 . . . . 0.0 109.647 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -63.11 -42.5 99.56 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.938 0.79 . . . . 0.0 110.373 169.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.24 -42.14 99.72 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 120.385 1.448 . . . . 0.0 112.226 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -69.26 -41.18 77.25 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 117.983 0.891 . . . . 0.0 109.322 172.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.439 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -71.63 -35.44 70.43 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 119.747 1.158 . . . . 0.0 111.565 -172.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.426 ' HA ' HG21 ' A' ' 32' ' ' VAL . 45.2 pttt -72.58 -21.89 61.07 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.809 1.186 . . . . 0.0 112.177 175.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 m -80.68 -50.63 9.66 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.352 1.861 . . . . 0.0 109.693 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.1 mt -88.55 -26.96 21.7 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.13 1.372 . . . . 0.0 111.599 -169.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.05 17.71 47.81 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 127.121 2.296 . . . . 0.0 111.525 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.74 121.56 12.57 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.628 1.171 . . . . 0.0 109.739 -172.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.38 9.29 85.91 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 119.869 -0.406 . . . . 0.0 113.54 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.406 ' O ' ' HE2' ' A' ' 2' ' ' LYS . 31.3 mmtp -124.44 -28.51 3.62 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 125.868 1.667 . . . . 0.0 110.532 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.439 HD12 HG22 ' A' ' 32' ' ' VAL . 6.2 pt -141.55 162.32 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 124.308 1.043 . . . . 0.0 109.222 173.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.25 144.43 29.28 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 103.339 -2.838 . . . . 0.0 103.339 167.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.439 HG11 ' HB3' ' A' ' 22' ' ' ALA . 2.0 t -133.43 142.06 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 118.821 0.737 . . . . 0.0 111.275 -167.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.31 148.96 28.8 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.936 0.894 . . . . 0.0 110.202 -175.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.7 p -131.75 117.01 18.02 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 175.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.1 m -141.93 165.46 27.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 119.186 0.903 . . . . 0.0 111.044 -169.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.79 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -169.775 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 m . . . . . 0 C--O 1.234 0.253 0 CA-C-O 122.055 0.931 . . . . 0.0 111.4 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -133.45 120.78 15.99 Favored Pre-proline 0 N--CA 1.448 -0.562 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -176.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -66.69 -26.16 46.05 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.559 2.839 . . . . 0.0 112.321 -169.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.6 m -61.01 -37.05 81.18 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.004 0.82 . . . . 0.0 109.154 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.18 -44.12 84.94 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.499 HG12 ' HB3' ' A' ' 58' ' ' SER . 1.8 mp -58.3 -48.08 85.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 CA-C-O 118.278 -0.868 . . . . 0.0 108.874 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.92 98.3 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.293 0.951 . . . . 0.0 111.182 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.5 mmt -60.66 -25.22 66.18 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.395 1.078 . . . . 0.0 112.974 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.459 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -95.39 -33.1 12.63 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -178.074 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -61.77 -37.23 83.55 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.305 1.042 . . . . 0.0 110.158 174.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -71.64 0.37 8.86 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.7 m -130.14 13.87 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 125.983 1.713 . . . . 0.0 111.435 169.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.26 33.56 48.68 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 121.134 -0.979 . . . . 0.0 114.159 171.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.7 mt -125.41 160.79 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.994 1.718 . . . . 0.0 107.367 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -139.98 140.52 36.32 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.221 1.008 . . . . 0.0 108.928 175.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.8 pt -138.27 11.96 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 126.633 1.973 . . . . 0.0 110.001 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.499 ' HB3' HG12 ' A' ' 47' ' ' ILE . 63.9 p -62.27 145.01 54.86 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.945 0.793 . . . . 0.0 110.669 175.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.23 8.21 6.23 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 117.094 -1.948 . . . . 0.0 114.659 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -50.08 -61.03 2.39 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-N 120.067 1.933 . . . . 0.0 113.08 -172.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -159.01 159.33 34.65 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.461 1.104 . . . . 0.0 108.794 -169.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.5 m -163.04 43.96 0.12 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.862 1.665 . . . . 0.0 107.699 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -134.8 149.68 71.31 Favored Pre-proline 0 N--CA 1.47 0.563 0 O-C-N 121.493 -0.754 . . . . 0.0 111.847 -168.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -83.12 158.33 15.29 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 124.144 3.229 . . . . 0.0 112.282 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.4 tt -62.98 -35.64 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 125.235 1.414 . . . . 0.0 112.198 -175.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -70.0 -20.55 63.28 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.611 0.364 . . . . 0.0 111.917 -171.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.51 -13.98 59.57 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 118.853 -0.594 . . . . 0.0 112.236 172.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -101.2 168.79 9.34 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.26 1.024 . . . . 0.0 110.853 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.73 91.67 2.33 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 -170.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.494 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -50.96 -31.94 19.44 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.52 -28.46 13.66 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.379 1.072 . . . . 0.0 112.177 176.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -70.88 -20.85 62.47 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.204 0.601 . . . . 0.0 112.368 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -106.9 175.13 5.6 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 128.624 2.77 . . . . 0.0 108.292 -174.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -118.64 -17.09 9.35 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.778 HG12 HG13 ' A' ' 4' ' ' VAL . 6.3 t -142.19 129.01 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -169.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.6 t -124.44 128.4 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.418 HG21 ' CE3' ' A' ' 99' ' ' TRP . 38.7 mm -121.68 96.63 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 102.119 -3.289 . . . . 0.0 102.119 169.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.43 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 20.4 p -72.66 164.11 27.01 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 118.019 -1.472 . . . . 0.0 107.884 169.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.6 mp -135.66 36.29 2.9 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 172.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.551 ' HB3' HG21 ' A' ' 84' ' ' VAL . 35.5 m -90.92 5.65 47.77 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.76 1.624 . . . . 0.0 110.761 -172.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.55 22.29 26.89 Favored Glycine 0 C--N 1.339 0.725 0 CA-C-O 119.565 -0.575 . . . . 0.0 111.955 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.429 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 5.4 t 46.88 40.68 9.49 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.941 1.696 . . . . 0.0 112.344 -177.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -149.79 35.33 1.02 Allowed Glycine 0 C--N 1.34 0.759 0 C-N-CA 123.793 0.711 . . . . 0.0 111.661 -171.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.551 HG21 ' HB3' ' A' ' 80' ' ' CYS . 73.2 t -121.18 130.09 75.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 124.965 1.306 . . . . 0.0 107.948 177.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -78.93 70.58 5.29 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 173.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.28 145.46 81.31 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-O 118.488 -0.768 . . . . 0.0 109.1 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -54.07 157.07 11.55 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.973 2.448 . . . . 0.0 111.924 172.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.3 -24.42 65.03 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 121.866 1.71 . . . . 0.0 114.949 -169.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -64.71 -23.68 67.33 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 120.63 -1.293 . . . . 0.0 111.974 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.494 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 77.4 m95 -73.42 -11.34 60.44 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.649 1.18 . . . . 0.0 112.866 176.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.2 m -118.53 -14.84 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 119.715 1.143 . . . . 0.0 112.822 -176.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.1 p -77.56 -11.12 59.82 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.968 0.804 . . . . 0.0 112.061 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -47.15 156.29 0.24 Allowed 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 129.675 3.19 . . . . 0.0 111.138 169.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -64.04 -38.43 91.03 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.828 1.651 . . . . 0.0 109.872 171.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.516 ' HB ' HG13 ' A' ' 75' ' ' VAL . 2.1 mt -122.35 133.98 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 173.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -142.96 111.64 6.35 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 103.555 -2.757 . . . . 0.0 103.555 167.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -138.99 170.6 15.69 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 173.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.8 t70 -136.62 108.35 7.03 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 169.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.418 ' CE3' HG21 ' A' ' 77' ' ' ILE . 49.2 m0 -81.85 70.57 8.78 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -49.49 13.86 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 131.488 3.915 . . . . 0.0 115.916 170.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -60.02 124.69 20.98 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 126.075 1.75 . . . . 0.0 112.622 -168.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 48.08 -161.44 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.344 2.258 . . . . 0.0 114.915 169.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -156.48 77.95 4.18 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 128.371 2.668 . . . . 0.0 107.448 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.71 -15.03 15.48 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.495 2.13 . . . . 0.0 112.99 -172.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.3 t0 27.56 -101.7 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.565 2.346 . . . . 0.0 113.092 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.51 43.43 1.28 Allowed Glycine 0 CA--C 1.532 1.129 0 C-N-CA 126.734 2.111 . . . . 0.0 109.431 171.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -67.5 -176.73 0.64 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.881 1.672 . . . . 0.0 112.614 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.5 m -59.54 154.12 18.12 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.884 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.4 mt -56.67 -30.33 63.28 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 122.957 0.503 . . . . 0.0 111.038 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.93 -40.66 96.24 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 118.677 -0.678 . . . . 0.0 110.926 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 42.0 t -72.81 -41.35 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 117.803 -1.094 . . . . 0.0 108.867 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -49.37 -51.68 33.27 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.717 1.144 . . . . 0.0 110.921 169.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -59.45 -45.14 92.42 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.799 0.727 . . . . 0.0 111.37 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 94.5 m -69.78 -45.76 67.27 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -171.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.6 t -69.6 -42.16 80.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 -172.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.9 ttp180 -48.09 -53.63 15.9 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 124.853 1.261 . . . . 0.0 110.612 169.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.86 -40.58 99.42 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 119.296 0.953 . . . . 0.0 112.042 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -65.37 -38.51 90.27 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.321 -1.105 . . . . 0.0 111.066 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 48.5 t -62.69 -41.65 93.1 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -38.33 84.59 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 119.779 1.172 . . . . 0.0 111.661 -173.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -68.82 -42.77 76.77 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 119.101 -0.475 . . . . 0.0 109.762 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.2 mtt180 -65.93 -40.3 91.29 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.187 0.903 . . . . 0.0 111.156 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.456 HG12 HD12 ' A' ' 127' ' ' ILE . 47.4 t -54.82 -51.7 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 172.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -64.84 -33.55 76.26 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 122.099 -0.375 . . . . 0.0 111.822 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -65.08 -46.06 82.67 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 123.002 0.521 . . . . 0.0 111.269 174.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.433 HD23 HG13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -59.49 -45.63 91.14 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.717 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.456 HD12 HG12 ' A' ' 123' ' ' VAL . 6.7 mt -58.47 -39.94 76.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.32 -26.65 68.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.924 0.784 . . . . 0.0 112.488 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -72.52 -46.32 55.15 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 119.163 0.892 . . . . 0.0 111.783 173.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.8 pt -103.67 -33.89 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 117.75 2.5 . . . . 0.0 117.75 -168.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 C--O 1.255 1.392 0 CA-C-N 119.529 1.059 . . . . 0.0 111.066 -174.747 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.927 0 CA-C-O 118.868 -0.587 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.449 ' HE2' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -66.11 137.63 57.18 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.641 1.564 . . . . 0.0 107.59 175.328 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -105.99 140.93 38.23 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -171.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.699 HG13 HG12 ' A' ' 75' ' ' VAL . 12.8 t -118.31 151.73 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.5 tpp -137.94 141.55 40.55 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 177.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -116.54 150.29 38.2 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 172.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.499 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 6.6 t -134.18 137.77 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 120.491 1.496 . . . . 0.0 107.118 -170.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 t -126.47 156.39 40.76 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.522 0.729 . . . . 0.0 110.601 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -135.84 33.02 2.94 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.176 1.39 . . . . 0.0 109.474 170.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.57 -178.77 6.74 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 127.95 2.5 . . . . 0.0 106.186 -175.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -48.51 124.06 7.6 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 170.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.0 m -33.7 -30.06 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 129.592 3.157 . . . . 0.0 117.711 -174.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.3 m -38.87 -61.0 0.78 Allowed 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 126.714 2.006 . . . . 0.0 114.69 -169.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.259 39.4 ptt180 -63.17 -46.37 87.47 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.229 1.377 . . . . 0.0 113.161 -169.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.63 -28.53 19.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 118.776 0.716 . . . . 0.0 111.368 -172.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.461 ' HG3' HE21 ' A' ' 60' ' ' GLN . 39.0 tt0 -74.0 -27.95 61.21 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 120.828 -1.17 . . . . 0.0 110.605 171.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.461 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.8 tpt -64.49 -40.67 96.09 Favored 'General case' 0 CA--C 1.51 -0.586 0 O-C-N 120.844 -1.16 . . . . 0.0 108.37 169.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.48 -38.26 83.71 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -61.26 -39.96 92.29 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 118.63 -0.7 . . . . 0.0 111.156 169.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.07 -44.91 86.69 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 120.448 1.476 . . . . 0.0 112.392 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -65.32 -39.98 93.14 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.43 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -72.06 -37.09 69.72 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 118.951 0.796 . . . . 0.0 111.221 -173.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.42 ' HA ' HG21 ' A' ' 32' ' ' VAL . 46.5 pttt -68.97 -28.61 66.78 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.076 1.307 . . . . 0.0 111.74 174.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.8 m -74.76 -51.73 13.38 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.845 1.658 . . . . 0.0 110.35 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.4 mt -88.22 -26.51 22.33 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.727 1.211 . . . . 0.0 112.057 -169.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.65 17.21 50.5 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.796 2.141 . . . . 0.0 111.454 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.35 120.8 9.98 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.909 1.284 . . . . 0.0 109.954 -172.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.53 11.42 84.38 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 119.505 -0.608 . . . . 0.0 113.439 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.449 ' O ' ' HE2' ' A' ' 2' ' ' LYS . 74.6 mmtt -127.11 -26.95 3.04 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 125.346 1.459 . . . . 0.0 110.535 -176.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.5 HD12 HG22 ' A' ' 32' ' ' VAL . 6.6 pt -141.37 161.09 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 124.531 1.132 . . . . 0.0 108.66 172.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.6 144.55 27.78 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 167.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.5 HG22 HD12 ' A' ' 30' ' ' ILE . 2.1 t -135.42 142.56 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 118.93 0.786 . . . . 0.0 111.333 -168.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.26 159.5 40.08 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.097 -174.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.4 p -136.88 162.65 32.67 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 121.433 1.924 . . . . 0.0 110.106 169.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.3 p -151.22 165.39 34.08 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.761 1.164 . . . . 0.0 111.262 -177.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.34 0 N-CA-C 105.51 -3.036 . . . . 0.0 105.51 -172.895 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.7 t . . . . . 0 C--O 1.234 0.244 0 CA-C-O 121.957 0.884 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -127.07 115.37 21.89 Favored Pre-proline 0 N--CA 1.448 -0.53 0 C-N-CA 125.332 1.453 . . . . 0.0 107.683 -173.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -69.16 -24.96 31.82 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.429 2.753 . . . . 0.0 113.257 -168.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.5 m -62.75 -39.49 94.29 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-N 119.94 1.245 . . . . 0.0 108.415 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.72 98.78 Favored 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.14 -48.92 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 118.297 -0.858 . . . . 0.0 109.544 177.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.75 -43.64 85.56 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 119.08 0.855 . . . . 0.0 110.627 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -20.21 65.17 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.483 0.713 . . . . 0.0 110.635 -175.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.461 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -96.38 -28.43 14.47 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.355 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.25 -29.23 70.6 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.755 1.222 . . . . 0.0 110.376 170.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -56.6 -23.18 39.0 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.855 0.862 . . . . 0.0 112.301 170.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.0 m -126.71 13.7 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 125.963 1.705 . . . . 0.0 111.166 -175.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.58 37.93 78.2 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 119.16 -0.8 . . . . 0.0 113.209 174.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.4 mt -125.76 154.61 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.708 1.603 . . . . 0.0 107.403 176.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -126.8 143.92 51.12 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.702 1.601 . . . . 0.0 108.639 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.3 pt -138.07 9.06 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 125.551 1.54 . . . . 0.0 110.915 174.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.47 151.39 45.17 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.624 1.17 . . . . 0.0 107.944 168.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.04 -3.24 14.24 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.585 -1.119 . . . . 0.0 113.474 -175.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.461 HE21 ' HG3' ' A' ' 16' ' ' GLN . 26.4 mt-30 -69.46 -175.96 0.91 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.498 1.649 . . . . 0.0 109.956 169.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.4 p -50.46 164.54 0.12 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.887 2.475 . . . . 0.0 114.766 -173.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.0 p -156.91 39.99 0.32 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.306 1.842 . . . . 0.0 109.769 177.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -141.03 150.01 57.72 Favored Pre-proline 0 CA--C 1.542 0.67 0 O-C-N 121.354 -0.841 . . . . 0.0 111.683 -169.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.38 165.53 23.16 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.892 3.061 . . . . 0.0 112.518 -174.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.5 tt -57.8 -39.32 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 125.073 1.349 . . . . 0.0 110.843 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.92 -18.13 61.43 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -170.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.23 -22.23 58.06 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 118.858 -0.591 . . . . 0.0 111.446 169.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -92.14 168.38 11.4 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.875 0.845 . . . . 0.0 110.64 -178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -142.34 94.6 2.68 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 103.336 -2.839 . . . . 0.0 103.336 -174.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.481 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -55.31 -28.01 50.77 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -176.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.36 -28.35 19.11 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.995 0.918 . . . . 0.0 112.415 175.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -70.74 -22.63 62.39 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.16 0.436 . . . . 0.0 112.086 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -106.07 -178.7 3.72 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 129.352 3.061 . . . . 0.0 108.286 -174.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -131.74 -2.44 3.74 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 171.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.699 HG12 HG13 ' A' ' 4' ' ' VAL . 23.8 t -141.71 126.92 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 -177.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.8 m -131.28 135.45 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 O-C-N 120.868 -1.145 . . . . 0.0 108.246 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.7 mm -134.61 80.69 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -169.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.499 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 17.8 t -68.41 164.51 20.8 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.818 177.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -140.75 55.46 1.58 Allowed 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 169.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 81.8 m -106.12 8.9 32.39 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.854 1.262 . . . . 0.0 109.705 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.7 31.5 10.14 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-O 119.209 -0.773 . . . . 0.0 111.639 169.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.415 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 8.8 p 46.59 -10.1 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 130.391 3.476 . . . . 0.0 119.244 -174.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.82 -13.87 82.65 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 120.133 1.333 . . . . 0.0 113.065 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 p -58.9 151.07 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 122.817 1.294 . . . . 0.0 109.202 172.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -124.39 81.28 1.92 Allowed 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 103.741 -2.689 . . . . 0.0 103.741 178.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.8 mt -62.65 150.09 87.38 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.28 158.69 11.67 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.659 2.239 . . . . 0.0 113.316 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.01 -36.3 53.55 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.964 2.443 . . . . 0.0 116.716 -169.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.2 pm0 -67.34 -25.82 66.19 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.323 -0.861 . . . . 0.0 112.133 -176.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.481 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 58.3 m95 -70.44 -9.73 57.23 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.93 1.292 . . . . 0.0 112.088 174.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.2 t -96.62 -29.59 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 119.225 0.921 . . . . 0.0 109.438 175.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.7 p -86.2 56.71 4.11 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.68 1.192 . . . . 0.0 110.502 -174.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -130.47 156.32 44.97 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 128.762 2.825 . . . . 0.0 107.96 -169.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -65.71 -39.23 91.0 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 125.752 1.621 . . . . 0.0 109.005 169.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.551 ' HB ' HG13 ' A' ' 75' ' ' VAL . 25.9 mm -128.7 137.17 58.02 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-O 121.113 0.482 . . . . 0.0 110.294 170.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -135.14 110.03 8.74 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 100.833 -3.765 . . . . 0.0 100.833 166.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.91 165.04 24.79 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 176.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.8 t70 -139.52 105.45 5.18 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 170.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -77.52 87.25 3.85 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 125.223 1.409 . . . . 0.0 107.475 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -65.75 23.07 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 126.613 1.965 . . . . 0.0 114.045 -175.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.16 176.39 0.6 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.628 1.971 . . . . 0.0 111.763 -170.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -54.3 162.44 1.07 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 123.444 1.593 . . . . 0.0 113.582 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -117.68 105.97 46.97 Favored Pre-proline 0 C--N 1.316 -0.866 0 C-N-CA 126.376 1.87 . . . . 0.0 108.396 -170.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.76 16.84 1.23 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.475 2.117 . . . . 0.0 112.181 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -24.84 85.02 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 129.584 3.154 . . . . 0.0 115.441 174.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 44.8 32.03 2.91 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 124.633 1.111 . . . . 0.0 113.959 -174.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -79.72 -179.7 7.05 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 122.492 1.139 . . . . 0.0 112.813 -169.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.1 p -61.07 160.04 10.72 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 113.55 -1.659 . . . . 0.0 109.602 172.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.6 mt -58.03 -30.27 66.0 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 122.667 0.387 . . . . 0.0 110.597 175.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -64.24 -40.0 95.11 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 118.532 -0.746 . . . . 0.0 111.157 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.0 t -72.61 -40.15 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 118.923 -1.111 . . . . 0.0 109.513 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -50.27 -50.68 49.5 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 119.45 1.023 . . . . 0.0 110.524 169.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -60.91 -44.99 96.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.549 0.739 . . . . 0.0 111.31 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.5 m -69.5 -45.59 68.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -172.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 49.3 t -65.75 -46.84 87.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -171.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -42.74 -56.47 3.17 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 125.061 1.344 . . . . 0.0 111.041 169.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.84 -40.93 98.89 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 119.79 1.177 . . . . 0.0 111.908 -175.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -67.55 -38.24 83.86 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 121.298 -1.119 . . . . 0.0 110.941 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.3 t -61.34 -43.0 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 172.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -39.31 87.19 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 119.923 1.238 . . . . 0.0 111.827 -172.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -68.99 -42.03 77.03 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.749 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.7 mtt180 -65.61 -41.7 92.42 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.282 0.946 . . . . 0.0 111.197 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.463 HG12 HD12 ' A' ' 127' ' ' ILE . 47.2 t -54.83 -51.58 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -65.94 -33.73 76.5 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 122.134 -0.354 . . . . 0.0 111.826 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -63.33 -48.71 76.88 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 123.1 0.56 . . . . 0.0 110.345 174.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.404 HD23 HG13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -58.85 -45.7 89.48 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 109.614 -0.514 . . . . 0.0 109.614 177.368 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.463 HD12 HG12 ' A' ' 123' ' ' VAL . 9.3 mt -57.48 -43.01 82.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 123.599 0.759 . . . . 0.0 109.537 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.16 -26.64 68.62 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -71.17 -51.93 22.06 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.57 0.623 . . . . 0.0 110.446 173.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.427 HD12 HG21 ' A' ' 30' ' ' ILE . 1.3 pt -87.65 -46.1 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 -169.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 63.0 m . . . . . 0 C--O 1.254 1.334 0 CA-C-N 119.057 0.844 . . . . 0.0 110.678 -170.233 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 tpt . . . . . 0 N--CA 1.5 2.049 0 CA-C-O 118.33 -0.843 . . . . 0.0 109.659 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.464 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -57.75 118.62 5.48 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 120.727 1.603 . . . . 0.0 110.074 -169.835 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -87.89 137.61 32.18 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -171.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.786 HG13 HG12 ' A' ' 75' ' ' VAL . 11.2 t -117.9 154.05 19.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 124.398 1.079 . . . . 0.0 108.364 174.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 40.9 tpp -137.63 139.68 40.44 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -120.18 114.61 22.2 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.416 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 8.3 t -101.68 138.81 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 119.621 1.1 . . . . 0.0 108.361 -169.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -125.11 164.77 19.51 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 122.009 0.909 . . . . 0.0 111.808 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -150.27 156.0 40.75 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 129.648 3.179 . . . . 0.0 103.842 169.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 58.1 -153.66 0.37 Allowed 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -169.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.475 HD21 ' CD2' ' A' ' 43' ' ' HIS . 29.5 t-20 -59.13 123.63 17.28 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.317 0.647 . . . . 0.0 110.114 -169.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.2 m -49.84 -27.93 5.76 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.675 1.99 . . . . 0.0 113.98 -178.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 26.3 p -48.55 -48.01 38.89 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 117.954 -1.022 . . . . 0.0 112.98 -169.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -60.3 -45.99 91.43 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.987 1.267 . . . . 0.0 112.721 -170.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.485 ' HB3' HD13 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -93.8 -28.27 15.99 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.077 0.853 . . . . 0.0 111.595 -174.205 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -68.87 -33.0 73.07 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.045 -1.034 . . . . 0.0 109.769 171.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.474 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.7 tpt -65.68 -40.15 92.08 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 121.18 -0.95 . . . . 0.0 109.63 169.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.93 -40.67 89.72 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -60.52 -42.45 96.46 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.7 169.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.45 -45.21 80.33 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 120.598 1.545 . . . . 0.0 111.514 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -63.4 -40.34 96.94 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.504 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -71.34 -36.13 71.42 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 119.313 0.961 . . . . 0.0 111.517 -174.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -73.32 -22.91 60.22 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 120.757 1.617 . . . . 0.0 111.921 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 m -77.02 -50.85 12.2 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.818 1.647 . . . . 0.0 110.285 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.1 mt -86.32 -27.39 24.34 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.882 1.273 . . . . 0.0 112.039 -169.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.07 13.0 55.88 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 126.918 2.199 . . . . 0.0 111.523 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.98 121.85 12.23 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.041 1.336 . . . . 0.0 109.861 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.81 8.82 87.22 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-O 119.769 -0.462 . . . . 0.0 113.462 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -124.01 -31.5 3.37 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.42 1.488 . . . . 0.0 109.068 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.7 pt -142.74 176.46 3.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 125.527 1.531 . . . . 0.0 109.508 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -118.25 149.06 41.76 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 168.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.504 HG11 ' HB3' ' A' ' 22' ' ' ALA . 1.9 t -137.82 143.24 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 123.172 0.589 . . . . 0.0 111.412 -167.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.9 m -150.77 161.44 42.65 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.943 1.297 . . . . 0.0 109.745 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.468 ' H ' HG21 ' A' ' 61' ' ' THR . 61.8 p -130.24 163.33 26.97 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.907 1.23 . . . . 0.0 110.241 169.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.6 p -155.45 168.26 27.68 Favored 'General case' 0 N--CA 1.463 0.193 0 O-C-N 121.112 -0.992 . . . . 0.0 110.806 178.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.861 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -177.65 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 CA--C 1.532 0.279 0 CA-C-O 122.066 0.936 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.475 ' CD2' HD21 ' A' ' 11' ' ' ASN . 86.5 t60 -125.7 116.53 24.62 Favored Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -175.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -66.48 -26.09 47.73 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.657 2.905 . . . . 0.0 112.692 -169.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.7 m -60.63 -36.16 77.95 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.15 0.886 . . . . 0.0 109.122 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.427 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . . . -65.38 -45.13 85.27 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -58.69 -47.41 88.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.73 -43.16 98.24 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.923 0.783 . . . . 0.0 111.032 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.4 mmt -61.81 -22.51 65.53 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.367 1.067 . . . . 0.0 112.866 177.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.474 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.3 OUTLIER -99.53 -31.34 11.67 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -177.806 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -63.94 -35.92 82.25 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.437 -0.79 . . . . 0.0 109.786 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.62 6.82 3.47 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.186 0.595 . . . . 0.0 112.542 175.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.6 t -113.32 -43.03 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 126.355 1.862 . . . . 0.0 108.71 169.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.73 26.86 1.86 Allowed Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.088 1.328 . . . . 0.0 111.894 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.5 mt -123.62 158.92 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 125.952 1.701 . . . . 0.0 106.939 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -137.91 125.94 22.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -176.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.6 pt -133.76 5.42 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.326 0 C-N-CA 124.392 1.077 . . . . 0.0 111.404 -171.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.16 143.91 56.32 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.764 1.225 . . . . 0.0 109.376 174.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.06 4.57 11.82 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 117.591 -1.672 . . . . 0.0 113.894 -177.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -53.55 -57.43 10.75 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-N 120.044 1.922 . . . . 0.0 111.785 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.468 HG21 ' H ' ' A' ' 34' ' ' SER . 2.9 p -151.43 162.39 41.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.032 -167.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.1 m -167.13 42.47 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.089 1.755 . . . . 0.0 109.192 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -137.63 150.04 66.88 Favored Pre-proline 0 N--CA 1.475 0.802 0 O-C-N 120.885 -1.135 . . . . 0.0 112.629 -169.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -83.72 162.89 14.27 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 124.213 3.275 . . . . 0.0 112.342 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.2 tt -59.21 -37.69 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.253 1.421 . . . . 0.0 111.351 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.68 -22.71 62.45 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 122.969 0.507 . . . . 0.0 111.93 -171.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -21.19 60.09 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 118.653 -0.689 . . . . 0.0 111.548 172.11 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -92.34 167.88 11.69 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.865 0.84 . . . . 0.0 111.272 -174.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.44 82.18 1.77 Allowed 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.648 1.579 . . . . 0.0 108.288 -170.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.477 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -52.31 -27.91 17.1 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.811 1.244 . . . . 0.0 113.712 -175.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -54.25 -33.75 59.21 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.459 0.475 . . . . 0.0 111.048 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -71.32 -15.73 62.41 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -106.78 160.77 15.24 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.546 1.938 . . . . 0.0 109.541 -173.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -101.35 -18.76 15.91 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 118.931 -0.557 . . . . 0.0 111.977 -177.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.786 HG12 HG13 ' A' ' 4' ' ' VAL . 30.8 t -147.77 129.85 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 120.716 1.598 . . . . 0.0 106.949 -170.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -125.65 135.08 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.2 mm -133.65 85.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 -177.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.416 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 12.0 t -69.28 160.17 31.73 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.175 -0.953 . . . . 0.0 108.503 171.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.485 HD13 ' HB3' ' A' ' 15' ' ' SER . 6.6 mp -129.46 21.41 5.61 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 169.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.6 m -69.27 -8.88 50.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.29 1.036 . . . . 0.0 112.237 -175.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 108.11 23.22 6.81 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 119.15 0.887 . . . . 0.0 111.742 174.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.502 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 2.0 t 55.24 173.63 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.176 2.191 . . . . 0.0 112.685 -169.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.03 16.66 33.65 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.851 1.215 . . . . 0.0 114.423 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.421 HG12 ' H ' ' A' ' 84' ' ' VAL . 1.7 p -72.32 136.42 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 125.155 1.382 . . . . 0.0 108.021 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -79.1 61.52 3.27 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.527 1.131 . . . . 0.0 108.547 173.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.1 mt -59.52 148.31 74.45 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 172.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -54.98 155.38 18.69 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.166 1.911 . . . . 0.0 111.919 174.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.81 -1.19 8.1 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.003 2.469 . . . . 0.0 115.853 -169.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -84.62 -24.93 28.89 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.788 1.176 . . . . 0.0 112.155 169.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.477 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 24.7 m95 -77.21 24.31 0.18 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.642 1.177 . . . . 0.0 112.164 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.0 m -127.92 -2.74 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 125.489 1.516 . . . . 0.0 112.779 169.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.8 p -84.37 -12.32 54.72 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 120.773 1.624 . . . . 0.0 113.516 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.437 ' H ' ' CD ' ' A' ' 93' ' ' GLN . 19.4 mp0 -62.16 160.78 12.19 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 129.808 3.243 . . . . 0.0 110.892 -176.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -64.62 -41.97 95.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.796 1.639 . . . . 0.0 109.137 169.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.55 ' HB ' HG13 ' A' ' 75' ' ' VAL . 33.1 mm -119.15 135.69 58.73 Favored 'Isoleucine or valine' 0 C--N 1.341 0.199 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 170.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -135.45 110.95 9.14 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 100.977 -3.712 . . . . 0.0 100.977 166.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.11 164.67 26.82 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.0 t70 -137.1 99.97 4.15 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 122.118 0.961 . . . . 0.0 108.542 172.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -75.4 73.45 2.46 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.344 1.458 . . . . 0.0 107.811 174.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -54.92 44.3 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 131.278 3.831 . . . . 0.0 114.402 172.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -77.85 -174.15 3.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.337 1.455 . . . . 0.0 111.223 -169.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -50.27 160.94 0.33 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.611 1.565 . . . . 0.0 111.28 176.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -130.1 85.0 58.59 Favored Pre-proline 0 C--N 1.322 -0.59 0 C-N-CA 126.719 2.008 . . . . 0.0 108.364 -169.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.64 67.33 8.43 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 124.9 3.734 . . . . 0.0 111.472 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -64.1 81.05 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.483 1.913 . . . . 0.0 110.874 173.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 59.22 37.42 91.77 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.775 0.702 . . . . 0.0 112.441 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -64.96 170.06 4.69 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -170.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.8 m -68.13 151.89 46.33 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 113.301 -1.772 . . . . 0.0 108.293 168.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.3 mt -57.56 -32.96 67.64 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.91 -0.494 . . . . 0.0 111.808 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.07 -38.63 86.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.533 0.606 . . . . 0.0 111.182 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.595 ' O ' HG23 ' A' ' 115' ' ' VAL . 57.8 t -75.18 -40.58 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 116.456 -1.735 . . . . 0.0 108.88 178.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -50.47 -48.49 56.67 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 121.141 1.792 . . . . 0.0 110.636 170.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -58.84 -43.18 90.66 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.535 0.607 . . . . 0.0 110.81 176.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.8 m -69.22 -43.6 73.77 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -174.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 111' ' ' VAL . 25.8 t -66.28 -46.53 86.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -173.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -47.79 -56.16 8.03 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.016 1.326 . . . . 0.0 110.89 170.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.99 -40.65 99.56 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 119.795 1.179 . . . . 0.0 111.68 -175.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -64.64 -40.11 94.88 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.321 -1.105 . . . . 0.0 111.428 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.0 t -61.08 -42.09 91.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 174.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.06 -37.95 78.26 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 119.904 1.229 . . . . 0.0 111.448 -175.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -70.0 -42.3 73.22 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.136 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -64.24 -42.83 96.35 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 119.252 0.933 . . . . 0.0 110.14 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.5 t -54.36 -53.71 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 123.901 0.88 . . . . 0.0 109.385 173.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -65.31 -33.09 75.16 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 122.283 -0.261 . . . . 0.0 111.541 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -62.15 -49.17 76.9 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.03 0.532 . . . . 0.0 110.787 173.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.42 -46.05 83.93 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.987 0.515 . . . . 0.0 110.046 177.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.3 mt -57.92 -44.0 85.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 124.395 1.078 . . . . 0.0 110.272 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.07 -28.23 67.63 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.98 0.809 . . . . 0.0 112.151 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -75.95 -44.71 38.68 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.379 0.536 . . . . 0.0 111.605 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.9 pt -94.37 -42.36 12.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -169.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 C--O 1.252 1.232 0 CA-C-N 119.168 0.895 . . . . 0.0 109.929 -172.808 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.0 mmm . . . . . 0 N--CA 1.502 2.142 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.765 ' HG2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -57.54 134.9 56.51 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.503 1.047 . . . . 0.0 108.891 169.871 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 53.9 mtpt -101.07 140.97 34.63 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.758 1.223 . . . . 0.0 107.757 -169.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.684 HG13 HG12 ' A' ' 75' ' ' VAL . 14.9 t -129.02 152.18 36.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -175.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 58.6 tpp -137.73 145.29 42.32 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -121.81 150.2 42.23 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 171.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 6.2 t -132.46 134.73 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 120.333 -1.479 . . . . 0.0 108.219 -171.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -131.98 100.09 4.95 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.258 0.935 . . . . 0.0 111.626 -170.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -79.17 -30.76 43.69 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -129.88 141.53 50.8 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 176.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 29.06 101.78 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 129.972 3.309 . . . . 0.0 113.619 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.4 m -33.28 -33.64 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.212 0 C-N-CA 128.671 2.788 . . . . 0.0 115.327 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.4 t -36.52 -64.16 0.35 Allowed 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 125.884 1.673 . . . . 0.0 114.067 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.298 36.1 ptt180 -60.15 -43.66 95.59 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 120.333 1.424 . . . . 0.0 114.127 -168.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.604 ' HB3' HD13 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -95.22 -29.0 14.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 119.374 0.988 . . . . 0.0 112.092 -172.707 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -72.09 -25.45 61.76 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.79 -1.194 . . . . 0.0 109.924 169.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.47 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.0 tpt -68.97 -42.77 76.15 Favored 'General case' 0 CA--C 1.512 -0.514 0 O-C-N 120.812 -1.18 . . . . 0.0 108.508 168.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.95 -39.41 81.59 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -60.43 -41.41 93.92 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.19 1.396 . . . . 0.0 111.4 169.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.74 -40.36 58.53 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 120.651 1.569 . . . . 0.0 112.895 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -69.96 -38.04 76.0 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 118.527 1.164 . . . . 0.0 109.279 172.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.51 -40.88 66.49 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 120.434 1.47 . . . . 0.0 111.145 -175.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -61.35 -32.27 72.16 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.325 1.42 . . . . 0.0 110.842 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 m -75.39 -51.13 13.85 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.262 2.225 . . . . 0.0 111.131 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.1 mt -88.19 -26.22 22.52 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.494 1.118 . . . . 0.0 111.631 -169.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.69 12.71 62.79 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 126.542 2.02 . . . . 0.0 111.248 177.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.16 121.34 10.47 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.549 1.139 . . . . 0.0 110.241 -173.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.03 9.24 86.87 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 119.864 -0.409 . . . . 0.0 113.325 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -123.82 -31.73 3.39 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 125.222 1.409 . . . . 0.0 109.511 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.765 HG22 ' HG2' ' A' ' 2' ' ' LYS . 19.0 pt -142.6 168.39 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.539 1.536 . . . . 0.0 109.954 178.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.35 139.48 46.71 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 168.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.3 t -127.54 146.11 33.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 125.279 1.432 . . . . 0.0 111.207 -170.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.33 160.39 43.76 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.052 1.741 . . . . 0.0 109.725 -174.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -132.99 165.49 24.6 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.334 1.424 . . . . 0.0 109.227 170.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.1 p -158.78 168.8 25.88 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.796 -0.565 . . . . 0.0 111.299 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.406 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 -175.65 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 CA--C 1.535 0.384 0 CA-C-O 121.87 0.843 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -133.07 117.67 14.9 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -174.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -66.03 -30.18 47.95 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.319 2.679 . . . . 0.0 112.432 -169.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.0 m -61.89 -37.04 83.12 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 177.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.45 -44.52 86.98 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.98 -47.8 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.32 -43.04 99.54 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-N 118.938 0.79 . . . . 0.0 111.141 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.7 mmt -61.94 -23.75 66.56 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.553 -0.736 . . . . 0.0 111.828 177.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.47 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.3 OUTLIER -94.98 -27.93 15.4 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.705 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.55 -29.4 70.43 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.808 1.243 . . . . 0.0 110.693 171.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -56.2 -24.71 43.58 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.641 0.776 . . . . 0.0 112.487 170.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -126.23 16.3 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.712 0 C-N-CA 125.527 1.531 . . . . 0.0 111.087 -172.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.79 35.69 66.21 Favored Glycine 0 CA--C 1.529 0.952 0 O-C-N 121.516 -0.74 . . . . 0.0 113.395 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.9 mt -125.1 155.85 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -134.42 144.69 48.31 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 170.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.6 pt -137.56 11.17 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 126.513 1.925 . . . . 0.0 110.477 -175.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.2 t -65.69 151.44 46.56 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.529 -0.732 . . . . 0.0 109.496 170.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.98 -0.02 1.31 Allowed Glycine 0 CA--C 1.534 1.223 0 CA-C-O 117.691 -1.616 . . . . 0.0 115.084 -177.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -57.78 -55.47 34.4 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 120.162 1.981 . . . . 0.0 112.633 -171.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.98 161.22 42.76 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.802 -168.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.8 p -170.48 27.02 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.228 0.611 . . . . 0.0 112.288 -171.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -140.48 151.28 63.43 Favored Pre-proline 0 N--CA 1.476 0.847 0 O-C-N 120.818 -1.177 . . . . 0.0 112.828 -169.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.35 160.78 29.04 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 124.062 3.175 . . . . 0.0 112.791 -173.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.2 tt -59.17 -36.78 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.141 1.376 . . . . 0.0 111.671 -176.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -70.45 -22.23 62.72 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.042 0.537 . . . . 0.0 112.27 -172.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.61 -17.61 59.08 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 119.033 -0.508 . . . . 0.0 111.711 171.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -95.89 173.53 7.4 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.146 0.978 . . . . 0.0 110.129 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.83 101.7 3.21 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 125.137 1.375 . . . . 0.0 108.193 -177.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.47 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -49.45 -24.94 2.25 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.801 0.84 . . . . 0.0 113.156 171.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -51.4 -21.53 2.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.044 0.938 . . . . 0.0 112.218 172.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -115.66 17.05 16.37 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.617 1.167 . . . . 0.0 114.009 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.45 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 29.4 m-85 -133.04 112.47 11.83 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 119.968 1.258 . . . . 0.0 108.414 170.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -62.99 -14.62 50.06 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -169.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.684 HG12 HG13 ' A' ' 4' ' ' VAL . 7.9 t -145.31 123.05 4.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.455 -2.424 . . . . 0.0 104.455 -169.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.86 133.34 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 O-C-N 121.085 -1.009 . . . . 0.0 108.406 -174.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.8 mm -130.17 92.45 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -168.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.48 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 28.8 t -70.08 161.54 29.95 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.549 175.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.604 HD13 ' HB3' ' A' ' 15' ' ' SER . 5.7 mp -142.2 52.9 1.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 169.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 59.9 m -114.4 18.35 16.93 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.616 1.566 . . . . 0.0 109.577 -174.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.72 25.3 46.67 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-O 119.356 -0.691 . . . . 0.0 111.999 172.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.422 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 5.7 t 44.37 39.6 3.21 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.947 1.699 . . . . 0.0 112.595 -176.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.85 45.07 0.51 Allowed Glycine 0 C--N 1.34 0.797 0 C-N-CA 123.586 0.612 . . . . 0.0 111.86 -169.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.0 p -124.13 -0.8 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -173.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.8 t30 47.16 60.71 3.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.689 1.596 . . . . 0.0 109.433 175.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.2 mt -56.46 148.09 46.04 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.143 -175.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -55.27 156.01 18.16 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.701 2.267 . . . . 0.0 113.11 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -54.89 -30.11 66.92 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.756 2.304 . . . . 0.0 116.734 -170.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -65.88 -25.03 66.99 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 121.009 -1.057 . . . . 0.0 111.478 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.47 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 72.3 m95 -73.35 -4.46 33.51 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 117.669 -1.158 . . . . 0.0 113.133 178.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.4 m -118.58 -5.48 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 120.757 1.617 . . . . 0.0 113.41 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.3 p -88.73 -17.99 28.75 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.761 0.824 . . . . 0.0 112.416 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -52.59 161.82 0.65 Allowed 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 129.37 3.068 . . . . 0.0 113.906 175.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -64.35 -39.45 93.9 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.493 1.517 . . . . 0.0 108.901 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.508 ' HB ' HG13 ' A' ' 75' ' ' VAL . 33.2 mm -124.95 138.54 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 169.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -137.84 113.89 9.97 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 100.284 -3.969 . . . . 0.0 100.284 167.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -136.09 171.05 15.04 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 172.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.422 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.0 t70 -140.1 122.77 16.33 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 169.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -101.36 77.2 1.76 Allowed 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.4 ' CD ' ' H ' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -56.24 16.8 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 129.638 3.175 . . . . 0.0 115.06 179.21 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -61.22 126.28 26.77 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.673 1.589 . . . . 0.0 111.343 -168.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 52.11 -155.44 0.17 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.3 1.44 . . . . 0.0 112.564 169.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -163.7 57.37 0.61 Allowed Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 127.509 2.324 . . . . 0.0 109.842 -173.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -79.2 59.02 7.22 Favored 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 122.752 2.301 . . . . 0.0 112.251 -169.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -51.46 -46.87 63.22 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.078 -1.014 . . . . 0.0 110.726 176.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -173.23 44.38 0.16 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.714 1.626 . . . . 0.0 110.323 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -68.54 176.42 2.92 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 122.543 1.163 . . . . 0.0 112.633 -177.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.2 m -57.83 152.51 15.69 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 113.956 -1.475 . . . . 0.0 109.857 171.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.3 mt -57.58 -31.59 66.32 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 122.727 0.411 . . . . 0.0 111.228 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.72 -39.64 92.22 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 118.427 0.558 . . . . 0.0 110.968 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 66.1 t -70.53 -45.54 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 117.304 -1.332 . . . . 0.0 108.507 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -48.95 -47.95 43.4 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 120.401 1.455 . . . . 0.0 110.93 172.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -59.81 -45.78 91.29 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.539 0.736 . . . . 0.0 111.303 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 94.2 m -68.36 -45.76 71.95 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -174.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.9 t -65.03 -47.58 87.4 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -173.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -44.65 -55.05 5.56 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 125.225 1.41 . . . . 0.0 110.89 169.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.44 -40.85 99.28 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 119.43 1.014 . . . . 0.0 111.737 -177.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -64.93 -38.46 91.03 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 121.376 -1.073 . . . . 0.0 110.86 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.0 t -62.72 -42.19 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -38.72 84.03 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 120.152 1.342 . . . . 0.0 111.535 -174.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -69.11 -41.31 77.58 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 119.087 -0.482 . . . . 0.0 109.825 177.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -67.24 -38.94 86.0 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 119.299 0.954 . . . . 0.0 111.135 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.8 t -53.85 -54.97 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 169.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -64.86 -32.46 74.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 121.99 -0.444 . . . . 0.0 111.895 -174.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -63.66 -47.41 81.41 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.405 0.682 . . . . 0.0 110.713 172.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -46.6 83.52 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 122.9 0.48 . . . . 0.0 110.062 176.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.0 mt -58.23 -43.18 85.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 124.292 1.037 . . . . 0.0 109.606 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.65 -30.22 70.58 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.101 0.864 . . . . 0.0 111.694 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -72.18 -42.6 65.69 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.635 172.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.1 pt -103.73 -44.8 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 118.902 2.927 . . . . 0.0 118.902 -168.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.3 m . . . . . 0 C--O 1.254 1.299 0 CA-C-O 116.582 -1.675 . . . . 0.0 111.838 -169.084 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 tpt . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.501 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -61.63 121.47 12.85 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 121.227 1.83 . . . . 0.0 108.43 -177.149 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.44 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 34.2 mtpt -92.88 134.4 35.12 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -169.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.876 HG13 HG12 ' A' ' 75' ' ' VAL . 19.1 t -120.7 154.33 24.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -174.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 63.2 tpp -139.15 144.84 38.79 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -126.78 125.97 42.62 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 174.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.4 t -118.07 130.68 72.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -169.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 t -118.16 161.01 20.58 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.574 1.149 . . . . 0.0 111.207 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -141.97 34.54 1.56 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.101 1.36 . . . . 0.0 109.483 172.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.1 mmt-85 -141.9 168.13 20.5 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.235 1.414 . . . . 0.0 109.247 -175.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -46.05 121.8 3.48 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.317 1.447 . . . . 0.0 108.458 170.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.5 m -40.44 98.04 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.317 2.247 . . . . 0.0 114.098 -169.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.5 t -158.35 -84.85 0.04 OUTLIER 'General case' 0 C--N 1.343 0.317 0 CA-C-O 118.369 -0.824 . . . . 0.0 112.457 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.347 35.9 ptt180 -45.76 -52.6 10.82 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -167.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.452 ' HB3' HD13 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -84.62 -27.02 27.47 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.413 1.006 . . . . 0.0 112.047 -174.206 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -65.98 -40.72 91.45 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.119 -0.988 . . . . 0.0 109.304 171.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.447 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.1 tpt -62.9 -40.66 98.26 Favored 'General case' 0 CA--C 1.512 -0.489 0 O-C-N 121.735 -0.603 . . . . 0.0 109.821 171.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.34 -36.88 79.0 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 118.969 -0.539 . . . . 0.0 110.017 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -65.95 -39.91 90.85 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.504 170.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.49 -44.98 95.86 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 120.332 1.424 . . . . 0.0 111.055 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -65.49 -41.54 93.14 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 118.022 0.911 . . . . 0.0 109.067 173.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.04 -35.25 74.14 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 119.824 1.193 . . . . 0.0 111.741 -173.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -79.6 -15.83 56.95 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.184 1.356 . . . . 0.0 112.886 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.9 m -79.65 -50.91 9.94 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.896 1.678 . . . . 0.0 109.239 171.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.4 mt -88.48 -28.02 21.11 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.101 1.361 . . . . 0.0 112.384 -169.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.71 12.24 61.1 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.484 1.993 . . . . 0.0 111.751 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.52 121.52 12.34 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.939 1.295 . . . . 0.0 109.762 -172.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.86 11.05 85.79 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 119.755 -0.469 . . . . 0.0 113.538 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -124.9 -29.22 3.39 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.511 1.524 . . . . 0.0 109.153 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.2 pt -143.82 173.03 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.696 1.598 . . . . 0.0 109.677 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.69 144.59 44.24 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 103.836 -2.653 . . . . 0.0 103.836 168.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -133.78 148.64 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 118.536 0.607 . . . . 0.0 111.688 -167.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.95 158.33 44.09 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.342 1.457 . . . . 0.0 110.299 -174.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.4 p -131.17 153.23 49.64 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.633 1.573 . . . . 0.0 109.365 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.2 t -145.9 149.04 33.5 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -174.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.525 0 N-CA-C 107.086 -2.406 . . . . 0.0 107.086 -175.764 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.2 m . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 121.724 0.773 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -132.9 117.89 15.18 Favored Pre-proline 0 N--CA 1.453 -0.309 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -173.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -63.33 -27.53 71.63 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.327 2.685 . . . . 0.0 113.721 -169.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.4 m -61.56 -41.25 97.1 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.231 0.923 . . . . 0.0 109.474 171.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.79 -42.71 97.67 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 120.091 1.314 . . . . 0.0 108.958 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -56.33 -49.55 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 118.728 -0.654 . . . . 0.0 109.346 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.79 -41.32 90.89 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-N 118.723 0.692 . . . . 0.0 111.014 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.446 ' HG3' ' HB3' ' A' ' 112' ' ' PHE . 32.7 mmt -65.34 -22.29 66.8 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 123.457 0.703 . . . . 0.0 112.032 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.447 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 1.5 mmt -98.06 -28.41 13.78 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -62.6 -32.43 73.43 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.448 1.099 . . . . 0.0 110.258 170.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -59.24 -16.2 19.81 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.768 1.627 . . . . 0.0 112.292 172.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.3 m -129.07 15.02 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 125.953 1.701 . . . . 0.0 111.37 177.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.79 38.95 86.03 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 119.064 -0.853 . . . . 0.0 113.675 173.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.9 mt -121.13 152.52 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -118.73 126.59 52.22 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 124.865 1.266 . . . . 0.0 108.002 176.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.9 pt -128.23 17.87 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 124.064 0.946 . . . . 0.0 111.746 171.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.3 -33.07 59.07 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.671 1.188 . . . . 0.0 112.157 173.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.22 -3.47 81.93 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 123.302 0.477 . . . . 0.0 112.873 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -67.15 153.0 44.72 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.165 0.986 . . . . 0.0 111.185 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.0 p -147.1 157.76 43.72 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.97 1.708 . . . . 0.0 107.601 169.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.2 m -154.47 173.48 16.21 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.166 1.386 . . . . 0.0 108.41 -169.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -154.8 167.55 13.76 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-O 117.778 -1.106 . . . . 0.0 108.186 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.06 165.25 21.83 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.286 1.991 . . . . 0.0 112.853 -171.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.6 tt -63.78 -34.4 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 123.716 0.806 . . . . 0.0 110.622 -170.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.49 -19.04 61.62 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.757 0.823 . . . . 0.0 112.608 -174.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.85 -24.67 58.63 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.091 0.556 . . . . 0.0 110.945 169.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -95.79 169.77 9.78 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 122.199 0.999 . . . . 0.0 111.245 -169.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.16 97.13 2.73 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.876 1.671 . . . . 0.0 107.183 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.457 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -50.45 -23.07 2.19 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.039 0.936 . . . . 0.0 113.501 173.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -50.65 -22.92 2.27 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.802 0.841 . . . . 0.0 111.908 171.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -114.27 16.16 17.99 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.087 1.355 . . . . 0.0 113.226 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.44 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 23.5 m-85 -134.12 112.92 11.53 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 120.526 -1.359 . . . . 0.0 109.598 170.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -67.67 -8.99 39.42 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -169.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.876 HG12 HG13 ' A' ' 4' ' ' VAL . 18.2 t -146.65 119.64 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 -171.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.4 m -133.85 130.97 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 O-C-N 120.409 -1.432 . . . . 0.0 107.962 -174.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.3 mm -126.11 102.16 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 -173.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.7 p -78.03 157.54 29.57 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 171.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.452 HD13 ' HB3' ' A' ' 15' ' ' SER . 6.0 mp -133.43 44.38 2.8 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 169.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 69.0 m -93.16 10.51 31.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.81 1.644 . . . . 0.0 110.227 -174.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.41 29.39 33.27 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 170.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 4.9 t 39.33 43.66 0.97 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.705 2.002 . . . . 0.0 112.83 -171.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -144.18 44.13 0.94 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.688 1.137 . . . . 0.0 110.449 -171.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.2 p -134.99 165.06 32.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.38 1.872 . . . . 0.0 109.19 -173.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -129.58 71.54 1.44 Allowed 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 38.8 mt -60.77 149.45 79.8 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.63 153.75 17.87 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.511 2.141 . . . . 0.0 111.611 169.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.33 -18.67 55.67 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.787 1.658 . . . . 0.0 114.79 -169.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.05 -25.69 68.22 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 120.904 -1.122 . . . . 0.0 111.22 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.457 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 68.2 m95 -70.48 -11.12 60.71 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 117.224 -1.37 . . . . 0.0 113.235 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.6 m -110.36 -8.54 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 121.204 1.82 . . . . 0.0 113.285 -175.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.6 p -90.99 -11.2 39.64 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.892 0.877 . . . . 0.0 112.953 -174.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -61.67 167.27 3.64 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 128.763 2.825 . . . . 0.0 112.681 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -68.19 -38.71 82.27 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.217 1.007 . . . . 0.0 108.539 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.479 ' CG2' HG13 ' A' ' 75' ' ' VAL . 3.5 mt -119.91 135.47 60.11 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 CA-C-O 121.488 0.661 . . . . 0.0 109.632 169.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -148.39 114.84 5.93 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 166.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -143.73 167.51 22.1 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 173.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -126.08 124.56 40.88 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 169.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -100.53 77.4 1.91 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -177.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.46 ' H ' ' CD ' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -62.51 33.51 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 128.962 2.905 . . . . 0.0 114.19 178.461 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.58 -177.8 1.62 Allowed 'General case' 0 CA--C 1.535 0.394 0 O-C-N 120.789 -1.194 . . . . 0.0 110.67 -171.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -55.1 161.84 1.57 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 123.814 1.769 . . . . 0.0 113.356 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -115.19 103.06 54.74 Favored Pre-proline 0 C--N 1.318 -0.766 0 C-N-CA 128.853 2.861 . . . . 0.0 107.85 -169.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -82.04 18.58 1.37 Allowed 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.761 2.307 . . . . 0.0 112.477 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -39.61 96.35 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.539 1.935 . . . . 0.0 113.974 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 42.51 31.98 1.15 Allowed Glycine 0 CA--C 1.541 1.663 0 C-N-CA 125.095 1.331 . . . . 0.0 114.172 -172.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -76.85 177.51 7.61 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 122.496 1.141 . . . . 0.0 113.404 -169.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 p -59.88 154.65 18.13 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.731 -1.577 . . . . 0.0 109.355 170.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.8 mt -58.73 -29.49 66.75 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.797 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.62 -40.82 97.86 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 118.676 -0.678 . . . . 0.0 111.044 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.4 t -71.23 -39.96 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 119.469 1.031 . . . . 0.0 109.082 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.446 ' HB3' ' HG3' ' A' ' 49' ' ' MET . 29.7 m-85 -52.08 -51.33 58.4 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.527 1.058 . . . . 0.0 111.624 169.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -59.16 -45.23 91.51 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.935 0.789 . . . . 0.0 110.584 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.3 m -69.4 -45.19 69.83 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -173.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.5 t -65.31 -47.95 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -172.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.3 ttp180 -45.53 -53.34 9.12 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 124.732 1.213 . . . . 0.0 110.949 171.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.29 -42.25 97.89 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 119.334 0.97 . . . . 0.0 111.91 -177.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -64.99 -37.3 87.2 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.213 -1.169 . . . . 0.0 110.765 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.7 t -63.14 -42.74 97.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -39.25 83.47 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.201 1.364 . . . . 0.0 111.364 -173.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.27 -42.53 75.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 119.205 -0.426 . . . . 0.0 110.322 177.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -68.03 -39.46 83.1 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.401 1.0 . . . . 0.0 111.469 178.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.3 t -54.97 -52.97 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 171.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.37 -32.91 74.71 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.744 -0.597 . . . . 0.0 111.923 -176.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -63.44 -48.43 77.8 Favored 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 121.615 -0.678 . . . . 0.0 110.719 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -46.57 77.37 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 123.429 0.692 . . . . 0.0 109.659 177.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.1 mt -58.72 -44.3 89.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 124.432 1.093 . . . . 0.0 109.584 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.24 -29.31 68.69 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.876 0.762 . . . . 0.0 111.927 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -74.27 -42.32 59.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.478 0.581 . . . . 0.0 111.533 175.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 pt -98.85 -44.12 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 -168.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 C--O 1.255 1.343 0 CA-C-N 118.997 0.817 . . . . 0.0 110.223 -170.842 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.2 mmm . . . . . 0 N--CA 1.501 2.112 0 CA-C-O 119.937 -0.078 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.493 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -58.5 129.59 42.77 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 173.267 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -91.49 133.45 35.49 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.709 HG13 HG12 ' A' ' 75' ' ' VAL . 13.8 t -112.34 154.08 13.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 51.4 tpp -136.11 145.59 46.07 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -125.35 119.37 28.18 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 175.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.1 t -103.06 126.81 57.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -171.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 m -112.5 156.92 21.79 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.627 0.771 . . . . 0.0 110.628 -172.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -150.44 153.49 36.03 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 169.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.564 ' HG2' ' H ' ' A' ' 11' ' ' ASN . 53.5 ttm-85 58.61 -169.31 0.13 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.456 1.102 . . . . 0.0 108.472 -168.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.564 ' H ' ' HG2' ' A' ' 10' ' ' ARG . 50.9 t-20 -47.29 105.99 0.08 Allowed 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 124.008 0.923 . . . . 0.0 108.671 174.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.0 m -77.34 7.5 5.22 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.379 1.072 . . . . 0.0 112.378 -170.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.4 p -44.33 -56.75 3.95 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 124.309 1.044 . . . . 0.0 110.135 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 25.7 ptt85 -52.49 -44.66 65.78 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.795 1.238 . . . . 0.0 113.57 -177.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.6 -32.58 13.36 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.338 -0.851 . . . . 0.0 112.406 -168.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -71.48 -30.24 65.74 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.719 -1.238 . . . . 0.0 109.106 169.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.466 ' SD ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -64.05 -37.79 88.73 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 120.784 -1.198 . . . . 0.0 109.364 168.995 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.8 -36.77 75.01 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 119.077 -0.487 . . . . 0.0 110.008 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -63.15 -40.0 96.31 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.891 169.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.71 -44.4 92.48 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 120.609 1.549 . . . . 0.0 111.797 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.466 ' CD2' ' SD ' ' A' ' 17' ' ' MET . 5.4 m-85 -62.39 -40.93 98.07 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 118.562 1.181 . . . . 0.0 109.382 170.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.435 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -70.06 -36.19 74.8 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.574 1.079 . . . . 0.0 110.632 -173.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -73.84 -18.35 60.95 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 120.359 1.436 . . . . 0.0 112.584 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 m -82.84 -50.94 8.1 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.745 1.618 . . . . 0.0 109.473 176.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.8 mt -88.07 -26.52 22.5 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.301 1.44 . . . . 0.0 111.672 -169.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.96 11.73 60.65 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.574 2.035 . . . . 0.0 112.218 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.65 124.54 21.27 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.819 1.247 . . . . 0.0 109.179 -171.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.61 8.81 87.45 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 119.47 -0.628 . . . . 0.0 113.806 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -127.52 -31.06 2.53 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.566 1.546 . . . . 0.0 108.56 -177.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.47 HD12 HG22 ' A' ' 32' ' ' VAL . 12.1 pt -143.74 165.87 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 125.767 1.627 . . . . 0.0 110.22 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.58 146.62 35.78 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 103.469 -2.789 . . . . 0.0 103.469 168.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.47 HG22 HD12 ' A' ' 30' ' ' ILE . 1.8 t -134.76 146.25 31.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-N 118.922 0.783 . . . . 0.0 111.488 -168.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.8 162.64 40.7 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.656 1.582 . . . . 0.0 109.545 -174.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.5 p -136.58 165.43 25.89 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 120.395 -1.441 . . . . 0.0 110.215 173.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.3 p -149.78 150.75 32.49 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 123.515 0.726 . . . . 0.0 109.745 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.484 0 N-CA-C 106.861 -2.496 . . . . 0.0 106.861 -170.793 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.7 t . . . . . 0 CA--C 1.535 0.389 0 CA-C-O 121.483 0.658 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -129.67 110.97 17.5 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.722 1.209 . . . . 0.0 108.984 -169.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.3 -30.44 54.08 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.956 3.104 . . . . 0.0 114.701 -168.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.0 m -59.52 -36.61 76.43 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.661 1.119 . . . . 0.0 109.743 175.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.13 -43.8 90.74 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.47 -44.11 92.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.52 -41.93 98.06 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.169 0.895 . . . . 0.0 111.664 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 39.1 mmt -63.77 -29.77 70.94 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 118.943 -0.551 . . . . 0.0 111.682 178.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -85.27 -32.5 22.53 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.92 -33.77 76.05 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.275 1.03 . . . . 0.0 109.994 174.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -62.35 -12.54 21.75 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.72 1.208 . . . . 0.0 112.119 173.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.1 m -127.66 13.51 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 125.937 1.695 . . . . 0.0 111.863 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.48 35.61 59.52 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 121.003 -1.06 . . . . 0.0 114.563 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.3 mt -122.35 156.23 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 171.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -131.57 140.82 49.55 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.723 1.209 . . . . 0.0 108.479 171.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 27.6 pt -133.7 17.4 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.55 1.54 . . . . 0.0 111.146 -175.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.3 p -78.64 -28.64 45.54 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.574 1.15 . . . . 0.0 112.664 171.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.6 -8.12 66.5 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 123.136 0.398 . . . . 0.0 112.234 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -85.84 146.57 26.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.478 1.111 . . . . 0.0 108.335 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.4 p -143.16 154.52 43.98 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 169.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.99 166.03 32.83 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -169.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -147.61 162.67 31.02 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.185 1.794 . . . . 0.0 106.762 -171.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.84 160.14 48.66 Favored 'Trans proline' 0 C--N 1.347 0.488 0 CA-C-N 123.052 2.126 . . . . 0.0 112.728 -170.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.9 tt -57.06 -32.73 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.736 1.214 . . . . 0.0 111.95 -175.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -68.73 -22.66 64.31 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.59 0.756 . . . . 0.0 112.145 -173.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -13.34 59.89 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 118.808 -0.615 . . . . 0.0 112.177 171.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -110.76 172.59 6.78 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 122.274 1.035 . . . . 0.0 112.211 -170.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.77 103.23 2.91 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 126.78 2.032 . . . . 0.0 107.065 -172.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.444 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -54.87 -24.43 23.25 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 123.757 0.823 . . . . 0.0 112.988 177.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -50.64 -32.42 18.98 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.04 0.936 . . . . 0.0 111.585 172.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -86.6 12.0 11.55 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -136.0 177.68 7.65 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.064 2.146 . . . . 0.0 108.557 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -120.45 -21.88 6.67 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.709 HG12 HG13 ' A' ' 4' ' ' VAL . 20.2 t -142.21 128.34 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 -170.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.58 129.74 61.9 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 O-C-N 120.666 -1.271 . . . . 0.0 108.221 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.1 mm -117.9 134.54 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 176.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.4 t -115.06 156.76 24.57 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 175.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.5 mp -134.06 36.38 3.25 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 173.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 60.2 m -96.7 14.0 26.48 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.395 1.478 . . . . 0.0 110.025 -176.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.94 15.45 81.16 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-O 119.361 -0.689 . . . . 0.0 112.447 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 3.9 t 60.35 -20.07 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.234 2.614 . . . . 0.0 115.632 -178.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.13 -26.76 73.95 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 119.457 1.026 . . . . 0.0 112.829 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.8 t -63.21 116.59 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 174.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -66.14 138.17 57.54 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 172.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.4 mt -120.99 141.15 32.13 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.57 157.65 6.94 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.645 2.897 . . . . 0.0 113.163 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.7 -22.4 69.85 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 121.889 1.726 . . . . 0.0 115.222 -169.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -65.73 -24.02 66.88 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 120.188 -1.57 . . . . 0.0 111.746 176.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.444 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 70.7 m95 -70.0 -7.93 44.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 117.344 -1.312 . . . . 0.0 112.487 175.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.5 m -115.32 -12.25 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 121.273 1.851 . . . . 0.0 113.481 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.8 p -81.83 -13.3 57.84 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.158 0.89 . . . . 0.0 112.23 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -44.29 155.22 0.09 Allowed 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 130.979 3.712 . . . . 0.0 113.009 169.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -62.38 -38.33 89.19 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.673 1.989 . . . . 0.0 108.771 169.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.673 ' HB ' HG13 ' A' ' 75' ' ' VAL . 33.6 mm -130.44 138.11 54.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 C-N-CA 123.055 0.542 . . . . 0.0 109.847 171.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -135.42 117.49 15.38 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 100.707 -3.812 . . . . 0.0 100.707 166.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.65 165.75 26.77 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 175.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -141.85 132.75 25.87 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 169.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.4 ' CE3' ' HB3' ' A' ' 122' ' ' ARG . 54.1 m0 -102.35 2.22 36.5 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -172.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 47.19 -68.78 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 131.086 3.754 . . . . 0.0 111.833 -169.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . 0.258 0.8 OUTLIER 45.29 -172.73 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.238 1 C-N-CA 133.294 4.638 . . . . 0.0 114.369 -174.429 . . . . . . . . 4 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -64.83 174.89 1.67 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.356 1.462 . . . . 0.0 113.34 -169.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -132.63 66.62 77.06 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 126.483 1.913 . . . . 0.0 109.75 -169.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -79.21 61.8 8.28 Favored 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 124.276 3.317 . . . . 0.0 111.294 -169.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -55.68 -42.6 75.37 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.026 -1.046 . . . . 0.0 112.521 -175.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -163.69 42.68 0.32 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.0 1.762 . . . . 0.0 109.753 -177.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -69.37 171.5 8.53 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -169.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.5 p -64.8 158.74 24.12 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.001 169.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 27.8 mt -60.24 -32.81 71.49 Favored 'General case' 0 C--O 1.22 -0.449 0 O-C-N 122.007 -0.433 . . . . 0.0 110.295 172.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.19 -43.93 90.04 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 118.484 0.584 . . . . 0.0 110.958 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 63.2 t -68.09 -43.79 84.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 119.156 -1.018 . . . . 0.0 108.47 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -48.41 -48.44 37.11 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.674 1.124 . . . . 0.0 111.739 173.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -62.94 -48.19 79.97 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.622 0.769 . . . . 0.0 111.016 176.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.1 m -65.48 -45.61 82.97 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -171.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.5 t -59.32 -42.73 88.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 124.095 0.958 . . . . 0.0 108.764 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -52.57 -51.67 58.67 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 118.444 0.566 . . . . 0.0 110.249 173.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.38 -38.42 95.8 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 119.544 1.066 . . . . 0.0 112.143 -177.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -63.79 -40.36 96.48 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 120.851 -1.382 . . . . 0.0 110.511 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.9 t -62.04 -39.2 82.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 118.443 -0.789 . . . . 0.0 109.147 173.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -39.49 76.27 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.495 1.043 . . . . 0.0 110.881 -176.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -70.44 -42.26 71.78 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 119.043 -0.504 . . . . 0.0 110.565 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.4 ' HB3' ' CE3' ' A' ' 99' ' ' TRP . 9.4 mpt_? -65.44 -42.0 92.9 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.427 1.012 . . . . 0.0 110.559 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.2 t -55.16 -52.69 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 123.322 0.649 . . . . 0.0 109.728 173.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -63.5 -32.65 74.17 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 122.049 -0.407 . . . . 0.0 111.609 -175.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -62.56 -45.9 90.82 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.375 0.67 . . . . 0.0 111.991 172.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -47.4 81.91 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 174.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -58.74 -43.05 87.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.46 -35.32 78.94 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.526 0.603 . . . . 0.0 111.823 -176.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -77.44 -37.49 51.46 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 117.664 -1.16 . . . . 0.0 112.435 174.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.8 pt -93.32 -41.97 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -171.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 C--O 1.252 1.226 0 CA-C-N 119.19 0.904 . . . . 0.0 110.055 -171.513 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 tpt . . . . . 0 N--CA 1.499 1.977 0 CA-C-O 117.623 -1.18 . . . . 0.0 109.607 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.559 ' HB2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -47.52 118.19 2.12 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 120.708 1.595 . . . . 0.0 110.188 -171.948 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 33.5 mtpt -93.51 134.22 36.01 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -169.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.775 HG13 HG12 ' A' ' 75' ' ' VAL . 10.1 t -112.87 153.54 14.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 58.2 tpp -136.6 143.58 43.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -127.58 106.75 9.38 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.452 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 4.2 t -94.7 141.93 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.298 1.039 . . . . 0.0 108.249 -172.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.66 162.81 30.41 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.74 1.155 . . . . 0.0 113.598 175.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -142.36 30.0 1.58 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.378 1.871 . . . . 0.0 109.111 169.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -155.57 -174.76 5.1 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.807 2.043 . . . . 0.0 106.956 -170.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.473 HD21 ' CD2' ' A' ' 43' ' ' HIS . 9.3 t-20 -52.16 141.5 18.57 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 125.016 1.326 . . . . 0.0 111.579 174.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.2 p -67.26 -17.14 64.67 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.109 1.364 . . . . 0.0 113.205 -176.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 32.0 p -61.91 -11.43 13.06 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 117.542 -1.218 . . . . 0.0 113.858 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.252 21.7 ptt180 -100.69 -37.99 8.5 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.032 1.287 . . . . 0.0 111.567 169.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.8 p -98.43 -54.34 3.07 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.757 1.617 . . . . 0.0 114.891 -169.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -66.58 -23.18 66.16 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.137 -0.977 . . . . 0.0 108.652 170.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.473 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.9 tpt -67.56 -44.05 79.19 Favored 'General case' 0 C--O 1.224 -0.251 0 O-C-N 120.791 -1.193 . . . . 0.0 109.978 168.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.14 -39.8 87.6 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.507 ' HG2' HG12 ' A' ' 32' ' ' VAL . 12.0 tm-20 -58.61 -44.55 89.95 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.377 1.071 . . . . 0.0 110.623 169.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.53 -39.35 61.09 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 120.594 1.543 . . . . 0.0 112.092 -174.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -66.45 -36.78 83.63 Favored 'General case' 0 C--O 1.223 -0.315 0 O-C-N 121.489 -1.007 . . . . 0.0 108.958 170.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.485 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -72.68 -39.92 66.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.978 1.263 . . . . 0.0 110.899 -174.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -66.3 -27.18 67.72 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 120.664 1.575 . . . . 0.0 111.36 175.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 m -75.43 -50.91 14.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.982 1.713 . . . . 0.0 110.477 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.9 mt -89.48 -27.66 20.19 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.007 1.323 . . . . 0.0 112.485 -169.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.28 12.45 63.49 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 127.064 2.269 . . . . 0.0 111.904 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.52 123.43 17.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.14 1.376 . . . . 0.0 110.012 -171.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.95 8.49 86.77 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.465 -0.631 . . . . 0.0 113.636 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -124.7 -41.18 2.15 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.18 1.392 . . . . 0.0 109.201 -175.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.559 HG22 ' HB2' ' A' ' 2' ' ' LYS . 2.7 pp -140.44 156.06 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.731 1.213 . . . . 0.0 109.437 176.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.95 154.66 17.17 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 173.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.507 HG12 ' HG2' ' A' ' 19' ' ' GLU . 2.1 t -140.55 146.14 24.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-N 119.116 0.871 . . . . 0.0 111.585 -168.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.43 158.24 39.68 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.588 1.155 . . . . 0.0 110.418 -176.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.4 p -133.26 156.08 48.21 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.039 1.29 . . . . 0.0 110.906 176.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.457 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 8.1 p -146.78 145.79 30.05 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.05 0.841 . . . . 0.0 109.759 176.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.118 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 -169.034 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.348 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.473 ' CD2' HD21 ' A' ' 11' ' ' ASN . 82.3 t60 -139.99 112.69 7.51 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -172.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -64.34 -30.19 63.26 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.352 2.701 . . . . 0.0 112.751 -169.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.7 m -64.98 -37.5 87.87 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.98 -44.12 90.37 Favored 'General case' 0 C--N 1.346 0.426 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.87 -49.25 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.12 -42.16 98.03 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.523 0.601 . . . . 0.0 110.808 -177.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.9 mmt -63.44 -24.5 67.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.802 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.473 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -94.92 -31.68 13.56 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -176.63 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -60.56 -34.1 73.67 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.603 1.161 . . . . 0.0 110.054 169.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -63.8 -9.59 15.55 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.419 1.488 . . . . 0.0 112.39 173.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.73 14.32 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 125.949 1.7 . . . . 0.0 111.329 172.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.81 37.94 88.95 Favored Glycine 0 CA--C 1.532 1.121 0 O-C-N 121.452 -0.78 . . . . 0.0 112.982 175.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.4 mt -120.16 152.75 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 125.706 1.602 . . . . 0.0 106.95 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -127.79 124.47 37.72 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -176.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.9 pt -129.12 12.91 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 124.246 1.018 . . . . 0.0 111.232 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.95 -31.31 50.87 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.9 1.68 . . . . 0.0 113.577 -178.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.37 -9.69 73.48 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -83.19 159.27 22.04 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.256 1.022 . . . . 0.0 111.528 -173.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -146.77 158.67 43.96 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 128.373 2.669 . . . . 0.0 105.71 169.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.5 m -147.98 167.75 24.09 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -142.5 162.19 45.97 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -169.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.58 164.25 36.16 Favored 'Trans proline' 0 C--N 1.348 0.504 0 CA-C-N 122.686 1.995 . . . . 0.0 113.163 -169.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.5 tt -57.11 -35.87 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.364 1.465 . . . . 0.0 111.118 -173.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.95 -18.42 62.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.298 0.639 . . . . 0.0 112.699 -169.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -82.18 -16.37 49.95 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.482 170.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 35' ' ' CYS . 46.4 m-85 -96.35 168.84 10.33 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.272 1.029 . . . . 0.0 110.842 -177.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.08 93.57 2.41 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 -169.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.508 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -52.97 -25.03 10.7 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 177.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.87 -21.95 13.12 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.123 0.42 . . . . 0.0 111.275 173.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -99.52 6.72 45.79 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.513 1.525 . . . . 0.0 113.248 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.443 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 22.7 m-85 -136.77 113.58 10.36 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 120.284 1.402 . . . . 0.0 108.932 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.5 -17.37 59.53 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -169.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.775 HG12 HG13 ' A' ' 4' ' ' VAL . 9.7 t -144.22 122.03 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 -171.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.0 m -129.64 131.36 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 O-C-N 120.845 -1.159 . . . . 0.0 108.763 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.9 mm -126.19 96.72 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 102.977 -2.971 . . . . 0.0 102.977 -170.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.452 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 33.5 t -70.81 166.16 21.6 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -147.38 49.44 1.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 173.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.525 ' HB3' HG21 ' A' ' 84' ' ' VAL . 38.5 m -115.68 10.87 15.59 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.739 1.216 . . . . 0.0 110.786 -170.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.62 21.48 16.53 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 118.486 0.585 . . . . 0.0 112.563 173.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 4.3 t 47.4 41.15 12.16 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.049 1.74 . . . . 0.0 111.771 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -162.51 36.31 0.35 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-O 119.601 -0.555 . . . . 0.0 112.452 -170.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.525 HG21 ' HB3' ' A' ' 80' ' ' CYS . 57.9 t -117.83 137.4 51.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 173.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -82.72 69.07 9.43 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.131 0.972 . . . . 0.0 109.947 -171.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 18.4 mt -59.57 144.81 84.16 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -52.97 154.99 11.95 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.764 2.309 . . . . 0.0 111.846 170.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.65 -19.48 53.88 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 121.649 1.566 . . . . 0.0 114.362 -170.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.08 -25.95 68.33 Favored 'General case' 0 C--O 1.226 -0.162 0 O-C-N 120.938 -1.101 . . . . 0.0 111.224 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.508 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 72.3 m95 -68.57 -5.31 19.05 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.271 -0.893 . . . . 0.0 112.554 174.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.8 t -108.07 -28.5 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 119.67 1.123 . . . . 0.0 111.184 -174.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.1 p -77.07 -19.05 57.58 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.87 0.868 . . . . 0.0 113.123 -169.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -49.99 159.55 0.41 Allowed 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 129.2 3.0 . . . . 0.0 113.964 174.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -63.34 -38.83 92.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.674 1.59 . . . . 0.0 109.118 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.582 ' HB ' HG13 ' A' ' 75' ' ' VAL . 36.5 mm -125.71 138.89 53.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 169.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -139.3 112.19 7.93 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 102.641 -3.096 . . . . 0.0 102.641 167.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -134.68 171.0 14.97 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 174.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -139.49 116.0 10.64 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 170.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -93.74 68.74 3.97 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -36.99 -50.05 0.86 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.856 1.663 . . . . 0.0 110.108 169.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . 0.254 0.5 OUTLIER 38.04 -158.39 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 129.936 3.294 . . . . 0.0 112.734 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -60.4 166.6 2.96 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 122.35 1.071 . . . . 0.0 109.181 169.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -133.17 70.45 77.86 Favored Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 126.362 1.865 . . . . 0.0 109.952 -168.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -77.21 49.74 2.93 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.498 3.465 . . . . 0.0 114.738 -169.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -62.69 102.43 0.34 Allowed 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.981 -1.074 . . . . 0.0 109.424 169.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.55 26.34 66.45 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 123.967 0.794 . . . . 0.0 114.203 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -63.93 167.48 6.16 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -176.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.1 m -67.22 154.07 42.15 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 113.228 -1.806 . . . . 0.0 109.219 169.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 25.7 mt -59.03 -34.88 72.41 Favored 'General case' 0 C--O 1.222 -0.366 0 O-C-N 122.08 -0.387 . . . . 0.0 111.519 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -61.11 -39.79 91.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.339 0.518 . . . . 0.0 110.615 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.656 ' O ' HG23 ' A' ' 115' ' ' VAL . 61.9 t -72.96 -40.3 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-O 116.75 -1.595 . . . . 0.0 108.998 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -51.63 -47.23 63.77 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 121.207 1.821 . . . . 0.0 111.033 170.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -59.17 -43.96 92.15 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 118.626 0.648 . . . . 0.0 110.441 177.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 86.7 m -69.27 -42.05 76.05 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -174.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 111' ' ' VAL . 67.5 t -65.02 -48.68 83.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -174.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -47.21 -51.58 18.2 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.957 1.303 . . . . 0.0 110.69 170.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.81 -43.85 97.06 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 119.764 1.165 . . . . 0.0 112.409 -177.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -66.69 -33.96 76.8 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.838 1.319 . . . . 0.0 111.42 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.4 t -62.94 -41.1 91.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.47 -37.56 81.42 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 120.245 1.384 . . . . 0.0 111.166 -177.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -70.17 -40.19 74.85 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 118.865 -0.588 . . . . 0.0 110.733 175.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -60.76 -46.28 91.08 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.515 1.052 . . . . 0.0 110.078 175.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.48 HG12 HD12 ' A' ' 127' ' ' ILE . 69.8 t -57.19 -51.42 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 124.224 1.01 . . . . 0.0 109.451 176.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -67.02 -33.0 74.59 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 119.473 -0.299 . . . . 0.0 111.347 -175.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -61.59 -49.26 77.34 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 123.41 0.684 . . . . 0.0 110.679 172.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.415 HD23 HG13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -58.51 -46.14 87.34 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 122.93 0.492 . . . . 0.0 110.219 177.594 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.48 HD12 HG12 ' A' ' 123' ' ' VAL . 10.1 mt -59.36 -41.0 82.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 124.691 1.196 . . . . 0.0 109.813 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.08 -27.59 67.11 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.068 0.849 . . . . 0.0 111.933 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -75.88 -39.73 55.85 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.776 -0.578 . . . . 0.0 111.786 176.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.1 pt -102.89 -33.14 3.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 -168.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 C--O 1.254 1.3 0 C-N-CA 124.755 1.222 . . . . 0.0 111.679 -171.426 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 tpt . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 118.273 -0.87 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.522 ' HB2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -50.72 116.14 1.81 Allowed 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 120.285 1.402 . . . . 0.0 110.135 -173.123 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.5 mtpt -91.86 142.29 27.72 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 119.263 0.938 . . . . 0.0 108.693 -170.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.439 HG11 ' CZ ' ' A' ' 6' ' ' PHE . 21.3 t -111.67 154.32 13.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 170.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -138.81 131.95 29.81 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.439 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 86.2 m-85 -113.65 132.35 55.8 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.4 t -123.19 112.02 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 120.802 1.637 . . . . 0.0 110.164 -169.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.79 170.78 12.86 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 122.76 1.267 . . . . 0.0 112.835 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.0 mmtp -148.47 148.67 30.53 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 130.971 3.708 . . . . 0.0 101.706 168.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.433 ' HG2' ' H ' ' A' ' 11' ' ' ASN . 26.1 ttm-85 57.51 -160.51 0.24 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.743 1.156 . . . . 0.0 107.908 -168.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.433 ' H ' ' HG2' ' A' ' 10' ' ' ARG . 20.2 t-20 -55.77 133.96 51.32 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.221 0.919 . . . . 0.0 112.308 -169.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.4 m -48.06 -24.96 1.24 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 130.286 3.434 . . . . 0.0 115.125 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.0 m -50.2 -49.41 52.72 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 125.713 1.605 . . . . 0.0 114.107 -169.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.27 34.0 ptt180 -70.02 -42.12 73.4 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 118.23 -0.89 . . . . 0.0 113.21 -168.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 87.9 p -78.38 -39.4 39.29 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 120.528 1.513 . . . . 0.0 110.114 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -70.76 -27.68 64.12 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.628 -0.67 . . . . 0.0 110.003 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.471 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.1 tpt -66.72 -41.76 87.44 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 121.149 -0.97 . . . . 0.0 109.51 169.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.57 -38.46 84.65 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -61.33 -42.55 98.87 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.902 169.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.54 -44.88 88.97 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 120.643 1.565 . . . . 0.0 111.798 -175.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -64.98 -40.83 95.56 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 117.937 0.868 . . . . 0.0 108.836 173.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.517 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -71.19 -37.31 72.14 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 119.622 1.101 . . . . 0.0 111.286 -173.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -69.56 -24.77 63.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 120.567 1.53 . . . . 0.0 111.891 177.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.3 m -78.06 -49.98 12.95 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.345 2.258 . . . . 0.0 110.328 175.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.6 mt -88.01 -27.98 21.69 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.732 1.213 . . . . 0.0 112.355 -169.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.34 12.32 58.47 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 127.251 2.358 . . . . 0.0 111.96 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.06 122.83 15.97 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.264 1.426 . . . . 0.0 109.511 -170.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.94 8.41 87.84 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 119.536 -0.591 . . . . 0.0 113.764 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -124.85 -41.94 2.08 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.998 1.319 . . . . 0.0 108.832 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.522 HG22 ' HB2' ' A' ' 2' ' ' LYS . 2.8 pp -140.99 162.08 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.979 1.312 . . . . 0.0 109.124 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.84 155.53 18.54 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.517 HG11 ' HB3' ' A' ' 22' ' ' ALA . 2.4 t -143.9 139.4 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 118.622 0.646 . . . . 0.0 111.2 -168.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.5 m -150.09 165.85 31.53 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.232 1.413 . . . . 0.0 108.271 177.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.419 ' H ' HG21 ' A' ' 61' ' ' THR . 66.1 p -139.21 169.67 17.35 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.684 -1.26 . . . . 0.0 110.552 171.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.6 p -160.69 -178.31 6.77 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.103 0.961 . . . . 0.0 109.349 176.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.571 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -178.573 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.234 0.286 0 CA-C-O 121.769 0.795 . . . . 0.0 111.886 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.414 ' CG ' HD21 ' A' ' 11' ' ' ASN . 82.5 t60 -141.08 119.65 8.1 Favored Pre-proline 0 N--CA 1.451 -0.397 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -176.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -66.68 -26.69 45.73 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.534 2.823 . . . . 0.0 113.116 -169.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.8 m -61.85 -35.37 78.08 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.973 0.806 . . . . 0.0 109.464 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.3 -43.71 90.25 Favored 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.09 -47.24 90.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 118.566 -0.731 . . . . 0.0 109.041 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.5 99.25 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 118.759 0.709 . . . . 0.0 110.919 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.2 mmt -61.41 -24.94 66.87 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 123.615 0.766 . . . . 0.0 111.936 176.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.471 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.4 OUTLIER -95.45 -26.96 15.63 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 119.052 0.842 . . . . 0.0 108.965 -179.371 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.29 -29.05 70.44 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.996 0.919 . . . . 0.0 110.149 170.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -56.7 -26.23 56.23 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.24 0.616 . . . . 0.0 111.517 169.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.89 -15.95 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 126.744 2.018 . . . . 0.0 109.874 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.65 29.49 52.11 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.153 0.882 . . . . 0.0 111.099 -169.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.0 mt -109.4 156.91 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.259 1.423 . . . . 0.0 107.884 177.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.63 132.65 51.19 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 126.31 1.844 . . . . 0.0 107.669 -173.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.3 pt -140.71 4.48 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.628 1.171 . . . . 0.0 111.883 175.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.83 144.89 55.12 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.712 1.205 . . . . 0.0 110.262 176.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.82 3.68 4.84 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 117.926 -1.485 . . . . 0.0 114.67 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -56.62 -58.42 8.16 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-N 119.589 1.694 . . . . 0.0 112.745 -172.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.419 HG21 ' H ' ' A' ' 34' ' ' SER . 1.0 OUTLIER -141.8 165.49 27.32 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.317 -167.344 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.3 m -163.13 19.7 0.08 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -173.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -141.89 154.0 64.9 Favored Pre-proline 0 N--CA 1.476 0.831 0 CA-C-N 120.803 1.638 . . . . 0.0 113.135 -169.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.13 -177.5 3.54 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 125.241 3.961 . . . . 0.0 113.373 174.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.9 tt -77.21 -33.15 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 126.015 1.726 . . . . 0.0 113.756 -173.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -68.92 -27.75 66.05 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -168.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.54 -7.48 57.56 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 117.579 -1.2 . . . . 0.0 112.776 171.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -102.93 166.13 10.63 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.692 1.587 . . . . 0.0 111.894 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.43 88.53 2.21 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 125.383 1.473 . . . . 0.0 108.884 -169.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.43 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -52.02 -27.75 14.66 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.028 0.931 . . . . 0.0 113.009 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -50.48 -32.51 18.29 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.346 1.058 . . . . 0.0 112.312 174.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -72.1 -20.83 61.58 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -101.68 175.03 5.69 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.104 2.562 . . . . 0.0 109.211 -175.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -117.06 -18.54 10.04 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 117.608 -1.187 . . . . 0.0 113.064 174.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.663 HG13 ' HB ' ' A' ' 95' ' ' ILE . 22.3 t -138.06 133.08 43.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 121.478 1.945 . . . . 0.0 108.672 -178.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.9 t -117.65 138.42 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 6' ' ' PHE . 49.2 mm -131.54 92.12 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 103.004 -2.961 . . . . 0.0 103.004 172.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.7 t -69.63 164.58 23.04 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 169.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.8 mp -139.24 32.0 2.13 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.7 1.6 . . . . 0.0 106.892 173.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 87.7 m -74.39 -3.06 28.19 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.383 1.073 . . . . 0.0 111.908 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.48 34.36 6.09 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 119.585 1.084 . . . . 0.0 110.864 176.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . 0.25 30.3 p 38.91 45.14 0.93 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.003 2.521 . . . . 0.0 113.809 -178.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -142.88 36.55 1.6 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.404 1.478 . . . . 0.0 111.037 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.14 161.94 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 127.202 2.201 . . . . 0.0 108.949 -177.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -134.98 85.65 2.19 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 174.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.5 HD22 ' H ' ' A' ' 86' ' ' LEU . 1.3 mm? -62.08 153.85 72.13 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.708 -171.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.41 157.36 18.54 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.002 1.801 . . . . 0.0 112.272 174.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -52.13 -36.92 68.16 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.772 2.315 . . . . 0.0 116.152 -170.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -67.06 -23.79 65.91 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 120.982 -1.074 . . . . 0.0 112.288 -175.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.43 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 63.8 m95 -75.86 -11.65 60.01 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.745 1.218 . . . . 0.0 112.622 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.76 -16.67 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 120.032 1.287 . . . . 0.0 112.314 -177.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.6 p -76.72 -13.46 60.03 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.282 0.946 . . . . 0.0 112.342 177.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -41.67 154.17 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 129.982 3.313 . . . . 0.0 111.793 169.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -60.68 -36.91 79.93 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.096 1.758 . . . . 0.0 109.729 172.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.663 ' HB ' HG13 ' A' ' 75' ' ' VAL . 29.1 mm -130.18 136.35 58.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 170.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -133.69 123.03 24.27 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 102.92 -2.993 . . . . 0.0 102.92 166.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.46 167.04 23.43 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 173.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -130.51 102.24 6.07 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 169.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -76.86 80.81 3.44 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.898 1.679 . . . . 0.0 108.807 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.77 22.4 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.263 2.625 . . . . 0.0 115.234 175.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.72 164.91 13.6 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.062 -1.024 . . . . 0.0 111.219 -169.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -51.71 146.86 7.29 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -168.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -80.89 110.29 16.87 Favored Pre-proline 0 C--N 1.321 -0.669 0 C-N-CA 127.72 2.408 . . . . 0.0 109.531 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -84.16 -7.14 10.17 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.882 2.388 . . . . 0.0 112.378 176.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.6 t70 19.8 -101.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 128.758 2.823 . . . . 0.0 113.508 -176.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.81 39.76 1.74 Allowed Glycine 0 CA--C 1.533 1.191 0 C-N-CA 127.138 2.304 . . . . 0.0 108.059 169.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -70.03 -179.51 1.93 Allowed 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.987 1.715 . . . . 0.0 112.397 -173.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.2 p -60.27 154.47 19.94 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 113.142 -1.844 . . . . 0.0 109.04 169.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 27.6 mt -57.35 -29.74 64.25 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 122.799 0.44 . . . . 0.0 110.406 176.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -61.4 -41.08 96.56 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 118.527 -0.749 . . . . 0.0 110.948 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.5 t -72.17 -40.19 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 117.705 -1.14 . . . . 0.0 109.59 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -51.35 -51.31 55.62 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.934 1.243 . . . . 0.0 111.425 169.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 80.2 mtt180 -59.65 -44.27 93.6 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.847 0.749 . . . . 0.0 110.99 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 95.8 m -67.03 -45.93 75.98 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -175.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.1 t -64.95 -48.89 82.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -172.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -43.97 -53.58 6.1 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 125.374 1.47 . . . . 0.0 111.262 169.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.82 -40.41 95.57 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 120.104 1.32 . . . . 0.0 112.526 -177.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -66.05 -37.22 85.28 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 120.819 -1.4 . . . . 0.0 110.261 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.9 t -63.41 -43.7 98.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 CA-C-O 117.997 -1.002 . . . . 0.0 108.439 173.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.52 -40.22 82.31 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.716 1.598 . . . . 0.0 110.842 -175.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -71.26 -44.46 65.22 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 125.382 1.473 . . . . 0.0 109.084 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -66.24 -41.87 89.41 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 120.011 1.278 . . . . 0.0 111.582 177.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.504 HG12 HD12 ' A' ' 127' ' ' ILE . 48.7 t -53.98 -50.13 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 173.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -66.67 -34.4 77.79 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -176.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -61.68 -48.28 81.54 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 118.46 0.573 . . . . 0.0 110.394 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.416 HD11 HG11 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -59.58 -45.92 90.46 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 123.049 0.54 . . . . 0.0 109.829 177.875 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.504 HD12 HG12 ' A' ' 123' ' ' VAL . 12.4 mt -58.43 -42.2 83.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.735 1.214 . . . . 0.0 110.195 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.13 -28.38 67.83 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.296 0.498 . . . . 0.0 112.085 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -75.79 -43.54 45.81 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.418 0.554 . . . . 0.0 111.873 174.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 pt -91.92 -37.53 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -169.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.6 m . . . . . 0 C--O 1.255 1.348 0 CA-C-N 120.266 1.393 . . . . 0.0 110.352 179.36 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 tpt . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 118.524 -0.75 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.489 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -61.54 119.7 9.12 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 121.128 1.785 . . . . 0.0 108.035 -176.921 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 37.1 mtpt -92.25 137.97 31.92 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -170.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.747 HG13 HG12 ' A' ' 75' ' ' VAL . 14.5 t -122.06 153.77 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 58.9 tpp -138.44 145.12 40.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -129.42 121.82 28.12 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 t -118.5 113.35 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 119.644 1.111 . . . . 0.0 109.252 -169.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.96 167.42 18.92 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 123.32 1.533 . . . . 0.0 113.476 178.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -152.94 141.03 20.37 Favored 'General case' 0 C--O 1.238 0.479 2 N-CA-C 100.032 -4.062 . . . . 0.0 100.032 168.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 62.16 -179.36 0.13 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 120.331 1.423 . . . . 0.0 108.644 -167.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.502 HD21 ' CD2' ' A' ' 43' ' ' HIS . 28.8 t-20 -41.52 123.0 2.07 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 125.131 1.372 . . . . 0.0 112.129 -169.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.3 m -45.78 -26.71 0.7 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 127.868 2.467 . . . . 0.0 115.108 -176.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.5 t -39.78 -54.08 2.15 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 125.557 1.543 . . . . 0.0 112.859 -178.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.289 33.5 ptt180 -65.84 -44.35 85.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 117.784 -1.103 . . . . 0.0 113.454 -168.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 97.5 p -77.3 -41.67 39.79 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 121.094 1.77 . . . . 0.0 110.304 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -70.06 -34.91 73.81 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -172.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.46 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 3.4 tpt -63.72 -41.76 98.03 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 123.496 0.718 . . . . 0.0 110.363 170.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.58 -37.66 82.06 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.494 -177.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -62.51 -42.73 99.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 117.94 -1.028 . . . . 0.0 111.204 170.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.58 -45.23 93.62 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 120.746 1.612 . . . . 0.0 111.284 -175.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -66.77 -40.49 88.22 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.203 172.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.96 78.44 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 120.295 1.407 . . . . 0.0 111.6 -176.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -81.91 -13.82 57.01 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 120.46 1.482 . . . . 0.0 113.11 176.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.6 m -79.95 -52.01 8.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.698 1.199 . . . . 0.0 108.533 169.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.1 mt -84.44 -27.44 27.54 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.899 1.28 . . . . 0.0 111.859 -169.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.87 12.66 57.73 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.675 2.084 . . . . 0.0 111.889 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.53 121.98 12.91 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.585 1.154 . . . . 0.0 109.861 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.38 9.41 86.84 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 119.853 -0.415 . . . . 0.0 113.559 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -123.2 -32.56 3.42 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.849 1.66 . . . . 0.0 109.012 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.4 pt -142.64 174.57 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 125.305 1.442 . . . . 0.0 109.785 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.56 145.27 43.48 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 169.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 t -134.13 143.88 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 118.542 0.61 . . . . 0.0 111.279 -168.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.76 156.18 42.0 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.934 1.294 . . . . 0.0 109.74 -173.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.3 p -139.65 155.34 47.46 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 120.364 1.438 . . . . 0.0 111.069 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.2 p -160.11 -178.54 7.06 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.93 0.892 . . . . 0.0 110.313 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.879 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.01 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 C--O 1.235 0.307 0 CA-C-O 122.067 0.937 . . . . 0.0 112.06 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.502 ' CD2' HD21 ' A' ' 11' ' ' ASN . 81.5 t60 -119.74 110.07 37.29 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.623 -169.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -59.88 -29.1 88.68 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.07 2.513 . . . . 0.0 113.67 -169.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.33 -37.49 80.78 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.475 1.034 . . . . 0.0 110.847 175.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.21 -45.82 72.29 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.5 -45.81 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.5 -43.74 93.27 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.373 0.533 . . . . 0.0 111.438 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.3 mmt -65.86 -19.64 65.95 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 118.969 -0.539 . . . . 0.0 112.1 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.46 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 2.0 mmt -98.63 -28.65 13.45 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.93 -33.67 75.84 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.557 1.143 . . . . 0.0 109.547 169.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -58.51 -15.17 10.01 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.792 1.637 . . . . 0.0 112.067 172.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.0 m -132.45 14.3 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 C-N-CA 126.439 1.896 . . . . 0.0 111.753 177.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.51 43.54 76.9 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-O 118.944 -0.92 . . . . 0.0 114.31 174.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.1 mt -124.25 151.61 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.133 1.373 . . . . 0.0 107.872 171.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -113.81 129.86 56.53 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.293 1.437 . . . . 0.0 109.073 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 57' ' ' ILE . 30.1 pt -129.76 14.12 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 125.568 1.547 . . . . 0.0 111.017 171.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.54 -28.1 31.24 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.372 1.469 . . . . 0.0 113.107 175.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.05 -9.5 86.74 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 118.372 0.533 . . . . 0.0 112.902 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -71.79 157.99 36.9 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.63 1.572 . . . . 0.0 109.614 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.48 165.15 31.15 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.54 144.84 49.43 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.682 1.993 . . . . 0.0 112.005 -172.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.65 139.41 1.67 Allowed Pre-proline 0 C--O 1.237 0.409 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 169.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -79.39 158.64 25.94 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.271 1.981 . . . . 0.0 110.845 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.6 tt -57.92 -37.2 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 124.707 1.203 . . . . 0.0 110.641 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -69.76 -21.87 63.4 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.357 0.663 . . . . 0.0 112.344 -174.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -22.2 60.94 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.28 0.491 . . . . 0.0 111.069 171.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -94.01 168.95 10.62 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 122.072 0.939 . . . . 0.0 110.646 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.39 93.41 2.43 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 125.451 1.5 . . . . 0.0 107.516 -175.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.478 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -50.0 -24.31 2.54 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 124.306 1.042 . . . . 0.0 113.392 175.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -50.81 -28.99 10.52 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.136 0.574 . . . . 0.0 111.318 173.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -91.92 -9.34 43.48 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.454 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 12.8 m-85 -120.2 112.93 19.69 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 120.595 1.543 . . . . 0.0 109.332 -173.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -65.54 -14.48 61.16 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -169.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.747 HG12 HG13 ' A' ' 4' ' ' VAL . 13.0 t -143.85 118.19 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 -171.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.3 m -128.19 134.2 65.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 O-C-N 120.875 -1.14 . . . . 0.0 108.718 -174.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.4 mm -127.5 97.14 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 104.203 -2.518 . . . . 0.0 104.203 -169.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.0 t -72.81 166.29 23.21 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 169.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.8 mp -144.27 40.19 1.33 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 173.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.499 ' HB3' HG21 ' A' ' 84' ' ' VAL . 60.9 m -100.04 12.0 37.96 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.334 1.054 . . . . 0.0 111.358 -172.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.7 23.53 28.04 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.512 -0.605 . . . . 0.0 111.862 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.44 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 4.0 t 45.65 45.7 11.1 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.857 1.663 . . . . 0.0 111.945 -177.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -153.53 35.9 0.75 Allowed Glycine 0 C--N 1.341 0.821 0 C-N-CA 123.405 0.526 . . . . 0.0 111.928 -171.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.499 HG21 ' HB3' ' A' ' 80' ' ' CYS . 78.5 t -122.43 133.16 69.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 125.039 1.335 . . . . 0.0 107.737 177.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -78.42 72.42 4.95 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 172.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.3 mt -57.73 145.98 68.15 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -55.1 155.24 19.65 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.046 1.831 . . . . 0.0 112.432 176.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -54.18 -29.28 55.61 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.549 2.166 . . . . 0.0 115.94 -173.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -66.25 -27.06 67.66 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 120.986 -1.071 . . . . 0.0 111.159 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.478 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 71.0 m95 -71.47 -3.63 22.12 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 117.91 -1.043 . . . . 0.0 113.165 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.0 m -120.71 -7.17 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 120.575 1.534 . . . . 0.0 113.471 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.8 p -87.28 -16.25 35.7 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.448 1.022 . . . . 0.0 112.632 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -54.02 163.33 0.79 Allowed 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 129.153 2.981 . . . . 0.0 113.605 175.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -64.89 -41.72 95.37 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.673 1.189 . . . . 0.0 108.708 176.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.497 ' HB ' HG13 ' A' ' 75' ' ' VAL . 32.7 mm -121.64 140.48 45.53 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 CA-C-O 121.58 0.705 . . . . 0.0 110.097 169.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -140.71 114.3 8.8 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 100.946 -3.724 . . . . 0.0 100.946 166.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -135.9 170.28 16.24 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 170.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.44 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.2 t70 -137.31 106.24 5.95 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 172.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.429 ' C ' ' H ' ' A' ' 101' ' ' LEU . 48.7 m0 -85.13 70.48 10.89 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -48.03 7.91 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.208 1 C-N-CA 131.836 4.054 . . . . 0.0 115.324 169.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.429 ' H ' ' C ' ' A' ' 99' ' ' TRP . 3.8 mm? -61.48 126.39 27.17 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 126.798 2.039 . . . . 0.0 111.338 -168.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 51.01 -160.04 0.09 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.826 2.051 . . . . 0.0 113.765 169.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -165.48 70.76 1.32 Allowed Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 128.101 2.561 . . . . 0.0 108.061 -172.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.95 -4.8 16.01 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 122.526 2.15 . . . . 0.0 114.215 -169.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -56.61 -34.19 66.99 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -173.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.35 40.65 1.94 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.651 1.119 . . . . 0.0 112.737 -174.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.415 ' HB3' ' H ' ' A' ' 108' ' ' SER . 16.5 mm-40 -116.13 -157.62 0.66 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.085 0.954 . . . . 0.0 111.89 -175.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.415 ' H ' ' HB3' ' A' ' 107' ' ' GLN . 9.9 m -131.11 173.56 10.9 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 128.662 2.785 . . . . 0.0 107.542 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 35.4 mt -54.7 -36.06 64.3 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.962 0.905 . . . . 0.0 110.785 -172.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -60.13 -40.0 88.22 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 123.031 0.532 . . . . 0.0 110.269 -175.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.61 -37.82 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.091 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -53.68 -42.73 68.27 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.948 1.249 . . . . 0.0 111.255 170.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -63.44 -43.76 96.5 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 119.607 1.094 . . . . 0.0 111.141 174.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.1 m -71.91 -43.39 65.42 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -171.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 57.9 t -64.48 -47.19 90.33 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -173.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.3 ttp180 -45.08 -50.38 11.06 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 125.475 1.51 . . . . 0.0 111.026 169.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.69 -43.4 96.34 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 119.576 1.08 . . . . 0.0 112.696 177.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -75.91 -31.68 59.27 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 120.956 -1.32 . . . . 0.0 110.652 -175.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.2 -37.75 80.27 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 170.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.415 ' HE2' ' HB3' ' A' ' 120' ' ' LYS . 5.7 mtpt -57.8 -47.79 81.57 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 120.595 1.543 . . . . 0.0 110.876 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -62.05 -38.25 88.03 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.021 0.826 . . . . 0.0 109.011 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -68.13 -47.18 68.81 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.404 0.681 . . . . 0.0 110.878 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.6 t -56.49 -52.51 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.87 1.268 . . . . 0.0 108.738 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -68.66 -33.37 73.87 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -171.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -62.16 -49.43 75.87 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 123.099 0.56 . . . . 0.0 110.852 171.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.87 -46.14 78.33 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 122.978 0.511 . . . . 0.0 109.876 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.7 mt -58.85 -43.84 89.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 124.807 1.243 . . . . 0.0 110.687 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.71 -29.06 67.85 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 118.782 0.719 . . . . 0.0 111.726 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -74.71 -40.64 61.2 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 118.538 0.608 . . . . 0.0 112.032 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.9 pt -100.62 -42.38 9.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 116.976 2.213 . . . . 0.0 116.976 -168.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.254 1.307 0 CA-C-N 119.195 0.907 . . . . 0.0 110.304 -171.909 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 tpt . . . . . 0 N--CA 1.499 1.977 0 CA-C-O 117.706 -1.14 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.512 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -54.96 118.02 3.93 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 121.337 1.881 . . . . 0.0 110.377 -169.69 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.495 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 56.2 mtpt -86.19 135.47 33.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -170.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.75 HG13 HG12 ' A' ' 75' ' ' VAL . 9.0 t -125.36 153.71 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 61.4 tpp -140.59 131.91 26.69 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -176.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.409 ' HE1' HG13 ' A' ' 32' ' ' VAL . 92.5 m-85 -116.17 107.27 14.68 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.452 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 3.9 t -94.39 144.31 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -169.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.4 t -128.0 -177.76 4.26 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.38 1.072 . . . . 0.0 110.185 172.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -152.4 -45.93 0.1 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.63 1.572 . . . . 0.0 108.688 176.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -167.7 0.17 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.187 0.995 . . . . 0.0 109.017 169.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.484 HD21 ' CD2' ' A' ' 43' ' ' HIS . 26.6 t-20 -47.94 139.58 7.69 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.698 0.799 . . . . 0.0 109.614 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -55.22 -22.9 19.63 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.504 1.522 . . . . 0.0 114.396 -169.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.9 m -42.2 -67.5 0.26 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 127.21 2.204 . . . . 0.0 114.318 -172.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.272 34.9 ptt180 -56.19 -47.67 77.87 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.451 1.478 . . . . 0.0 114.715 -167.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.43 -29.98 21.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 119.005 0.82 . . . . 0.0 111.315 -171.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -70.09 -27.01 64.26 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.112 -0.992 . . . . 0.0 110.023 170.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.473 ' SD ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -69.03 -42.25 76.6 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 120.574 -1.329 . . . . 0.0 109.789 169.439 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.08 -40.21 84.54 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -59.65 -39.09 83.26 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.42 169.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.19 -43.08 56.77 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 120.715 1.598 . . . . 0.0 112.587 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.473 ' CD2' ' SD ' ' A' ' 17' ' ' MET . 10.6 m-85 -64.68 -37.52 87.88 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 119.075 1.438 . . . . 0.0 108.989 170.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.526 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -72.45 -39.17 68.0 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 119.497 1.044 . . . . 0.0 111.118 -173.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -65.27 -33.79 76.81 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 120.371 1.441 . . . . 0.0 110.915 174.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.8 m -69.06 -50.98 43.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.285 1.834 . . . . 0.0 110.232 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.0 mt -90.06 -25.83 20.58 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.55 1.14 . . . . 0.0 112.129 -169.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.23 14.84 58.15 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 126.748 2.118 . . . . 0.0 111.903 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.66 120.82 10.77 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.908 1.283 . . . . 0.0 110.091 -171.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.11 8.53 86.93 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-O 119.811 -0.439 . . . . 0.0 113.511 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -123.1 -28.45 4.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.413 1.485 . . . . 0.0 109.583 -176.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.6 pt -143.35 175.87 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 125.832 1.653 . . . . 0.0 109.386 176.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.56 145.12 46.66 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 103.868 -2.641 . . . . 0.0 103.868 168.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.526 HG11 ' HB3' ' A' ' 22' ' ' ALA . 2.1 t -132.17 144.04 38.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 123.851 0.86 . . . . 0.0 111.316 -167.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.75 161.97 41.18 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.799 1.24 . . . . 0.0 109.723 -173.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.428 ' H ' HG21 ' A' ' 61' ' ' THR . 22.9 t -142.18 154.76 45.09 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.688 1.586 . . . . 0.0 109.524 172.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.6 p -157.11 171.03 21.18 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 118.509 0.595 . . . . 0.0 112.312 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.091 0 N-CA-C 107.786 -2.126 . . . . 0.0 107.786 -169.985 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.235 0.33 0 CA-C-O 121.248 0.547 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.484 ' CD2' HD21 ' A' ' 11' ' ' ASN . 20.9 t-80 -139.75 119.52 9.09 Favored Pre-proline 0 N--CA 1.451 -0.403 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -176.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -67.11 -27.28 42.06 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.057 2.505 . . . . 0.0 112.555 -169.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.7 m -62.43 -35.48 79.38 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.967 0.803 . . . . 0.0 109.53 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.23 -43.03 92.77 Favored 'General case' 0 C--O 1.221 -0.447 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.57 -47.84 89.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 118.206 -0.902 . . . . 0.0 109.382 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.35 -42.69 99.1 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 119.633 1.106 . . . . 0.0 110.878 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.0 mmt -64.32 -18.2 64.39 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.765 0.826 . . . . 0.0 112.112 176.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 3.9 mmt -95.02 -28.03 15.33 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 119.387 0.994 . . . . 0.0 110.992 173.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -63.6 -30.01 71.18 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 123.62 0.768 . . . . 0.0 109.694 172.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -57.96 -21.13 42.73 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.535 1.134 . . . . 0.0 113.101 170.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.4 p -121.44 9.03 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 125.229 1.412 . . . . 0.0 110.386 -177.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.32 36.88 85.5 Favored Glycine 0 CA--C 1.531 1.072 0 O-C-N 121.148 -0.97 . . . . 0.0 111.808 177.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 35.3 mt -121.83 157.93 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 126.2 1.8 . . . . 0.0 106.153 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -140.33 145.08 36.73 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 172.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 27.6 pt -138.55 7.7 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 126.354 1.862 . . . . 0.0 111.023 -174.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.3 t -64.28 145.67 55.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.612 -0.68 . . . . 0.0 109.289 172.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.63 3.52 5.75 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 117.802 -1.555 . . . . 0.0 114.552 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -54.6 -58.7 6.49 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-N 119.776 1.788 . . . . 0.0 111.481 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.428 HG21 ' H ' ' A' ' 34' ' ' SER . 1.0 OUTLIER -154.77 154.03 32.16 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 125.57 1.548 . . . . 0.0 106.986 -169.331 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.0 m -163.43 68.03 0.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 102.428 -3.175 . . . . 0.0 102.428 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -142.46 141.44 20.82 Favored Pre-proline 0 C--O 1.236 0.347 0 CA-C-O 119.152 -0.451 . . . . 0.0 112.195 -167.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -82.66 159.99 16.58 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.522 2.815 . . . . 0.0 111.268 173.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.63 -36.87 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 124.463 1.105 . . . . 0.0 111.778 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -70.46 -19.96 62.92 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.277 0.631 . . . . 0.0 112.16 -173.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.25 -23.9 62.98 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 118.763 -0.637 . . . . 0.0 111.6 170.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -99.82 169.71 9.04 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 122.128 0.966 . . . . 0.0 111.093 -174.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -142.59 90.69 2.25 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 -170.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.508 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -54.26 -22.79 12.67 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.4 -21.07 5.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 122.943 0.497 . . . . 0.0 111.301 171.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -111.31 17.09 20.54 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.881 2.072 . . . . 0.0 112.346 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.495 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 28.4 m-85 -132.82 107.57 8.43 Favored 'General case' 0 C--N 1.345 0.407 0 O-C-N 120.685 -1.259 . . . . 0.0 107.787 170.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -58.94 -18.86 37.45 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -169.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.75 HG12 HG13 ' A' ' 4' ' ' VAL . 10.5 t -143.07 123.43 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -170.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 t -118.06 134.45 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.8 mm -131.98 87.69 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.452 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 29.1 t -68.31 165.8 17.84 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.988 -1.07 . . . . 0.0 108.653 169.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -144.5 53.03 1.25 Allowed 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 170.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.527 ' HB3' HG21 ' A' ' 84' ' ' VAL . 43.3 m -113.53 15.73 18.93 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.11 0.964 . . . . 0.0 110.583 -176.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.68 24.7 29.73 Favored Glycine 0 C--N 1.339 0.723 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 172.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.412 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 6.7 t 44.54 42.44 5.62 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.311 1.844 . . . . 0.0 112.327 -176.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -151.66 37.88 0.82 Allowed Glycine 0 C--N 1.339 0.72 0 C-N-CA 123.53 0.586 . . . . 0.0 112.012 -171.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.527 HG21 ' HB3' ' A' ' 80' ' ' CYS . 94.5 t -120.24 141.67 39.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 C-N-CA 124.753 1.221 . . . . 0.0 108.612 178.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -82.03 55.95 2.97 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.588 1.155 . . . . 0.0 110.159 -178.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.4 mt -57.15 133.64 80.73 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.59 154.6 19.6 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.666 2.244 . . . . 0.0 112.758 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -55.0 -27.98 57.33 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.619 2.213 . . . . 0.0 116.208 -172.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -65.45 -25.36 67.48 Favored 'General case' 0 C--O 1.226 -0.147 0 O-C-N 121.284 -0.885 . . . . 0.0 111.288 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.508 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 61.7 m95 -67.93 -8.66 38.76 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.251 -0.906 . . . . 0.0 112.813 175.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.3 t -107.78 -30.54 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.022 1.329 . . . . 0.0 111.122 -170.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.7 p -74.65 -16.77 60.76 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.37 1.068 . . . . 0.0 113.688 -169.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -50.56 160.76 0.38 Allowed 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 130.213 3.405 . . . . 0.0 114.308 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -60.11 -39.41 86.08 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.414 1.486 . . . . 0.0 108.591 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.612 ' HB ' HG13 ' A' ' 75' ' ' VAL . 36.2 mm -126.32 137.07 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 169.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -137.49 113.09 9.48 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 102.156 -3.276 . . . . 0.0 102.156 166.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -140.75 166.66 24.15 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 9.5 t70 -139.67 110.56 6.83 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 169.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -83.04 81.98 8.44 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.401 ' H ' ' CD ' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -61.33 25.6 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 127.337 2.255 . . . . 0.0 114.564 178.355 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.57 175.64 2.77 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.696 -1.253 . . . . 0.0 110.372 -172.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.79 160.46 2.62 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 123.238 1.494 . . . . 0.0 114.542 -170.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -103.91 108.08 58.73 Favored Pre-proline 0 C--N 1.322 -0.608 0 C-N-CA 127.01 2.124 . . . . 0.0 108.717 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -80.85 -6.65 13.32 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.609 2.206 . . . . 0.0 112.014 177.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.7 t0 22.9 -99.33 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 128.389 2.676 . . . . 0.0 113.336 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.64 39.91 1.66 Allowed Glycine 0 CA--C 1.531 1.084 0 C-N-CA 127.119 2.295 . . . . 0.0 108.7 169.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -70.38 -178.07 1.63 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.397 1.879 . . . . 0.0 112.635 -175.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.3 m -61.3 153.67 25.88 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 113.376 -1.738 . . . . 0.0 108.731 171.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.7 mt -56.68 -29.73 62.66 Favored 'General case' 0 C--O 1.221 -0.396 0 C-N-CA 122.954 0.502 . . . . 0.0 110.82 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -61.24 -39.68 91.21 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.058 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.5 t -73.72 -40.02 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.257 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -51.13 -51.45 53.4 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.738 1.154 . . . . 0.0 111.326 169.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -59.05 -45.18 91.41 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.441 0.696 . . . . 0.0 110.958 178.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.1 m -67.58 -45.71 74.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -173.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.3 t -66.02 -48.24 82.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -171.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -44.1 -56.83 3.76 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.783 1.233 . . . . 0.0 110.575 169.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.94 -41.76 99.82 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 119.968 1.258 . . . . 0.0 111.948 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -63.75 -41.73 97.97 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.516 -0.99 . . . . 0.0 110.263 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.35 -39.07 82.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -41.45 83.41 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 120.013 1.279 . . . . 0.0 110.642 -175.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.69 -40.41 80.07 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.633 0.373 . . . . 0.0 110.063 177.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -64.49 -47.11 80.15 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.618 0.644 . . . . 0.0 110.292 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.1 t -56.05 -51.38 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 124.049 0.939 . . . . 0.0 108.469 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -66.01 -32.36 73.79 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 119.353 -0.356 . . . . 0.0 111.5 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -62.51 -48.07 81.16 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 118.612 0.642 . . . . 0.0 111.013 173.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -42.98 91.55 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 123.247 0.619 . . . . 0.0 110.624 176.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.0 mt -62.26 -43.09 97.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 123.102 0.561 . . . . 0.0 110.116 175.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.35 -31.68 71.57 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.311 0.959 . . . . 0.0 112.039 -175.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.478 ' HE2' HD11 ' A' ' 95' ' ' ILE . 14.1 ptmt -81.37 -35.08 31.26 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 117.763 -1.113 . . . . 0.0 112.978 175.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 pt -96.52 -43.66 12.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 115.421 1.638 . . . . 0.0 115.421 -173.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.2 m . . . . . 0 C--O 1.256 1.444 0 C-N-CA 124.636 1.174 . . . . 0.0 111.586 -171.165 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mmm . . . . . 0 N--CA 1.502 2.131 0 CA-C-O 119.257 -0.402 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.727 ' HG2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -59.31 137.74 57.87 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 169.463 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.43 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 25.0 mtpt -112.19 142.06 45.13 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 -169.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.753 HG13 HG12 ' A' ' 75' ' ' VAL . 11.5 t -122.86 155.29 28.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -174.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 57.0 tpp -136.68 134.25 37.05 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -115.74 112.07 21.49 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.448 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 3.4 t -96.32 136.72 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -169.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.3 m -109.72 149.95 29.02 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.258 1.023 . . . . 0.0 112.237 -169.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.7 mmtt -150.07 146.09 26.74 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.372 1.869 . . . . 0.0 106.054 169.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.468 ' CG ' ' H ' ' A' ' 11' ' ' ASN . 27.0 ttm180 57.01 -172.44 0.08 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.544 1.138 . . . . 0.0 109.307 -168.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.468 ' H ' ' CG ' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -49.95 105.36 0.09 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.418 1.487 . . . . 0.0 107.857 -177.887 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 m -62.06 0.15 0.44 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 117.137 2.273 . . . . 0.0 117.137 -167.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.1 m -38.22 -50.57 1.43 Allowed 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 126.36 1.864 . . . . 0.0 111.923 173.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -65.23 -43.25 92.03 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.243 0.545 . . . . 0.0 111.329 -171.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.1 p -88.45 -37.75 15.57 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 124.422 1.089 . . . . 0.0 111.1 -170.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -72.13 -32.08 66.61 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.552 -0.717 . . . . 0.0 109.545 174.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.415 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.5 tpt -62.09 -39.22 91.72 Favored 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 121.158 -0.964 . . . . 0.0 109.685 169.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.07 92.1 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -62.94 -39.16 93.76 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.204 170.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.77 -43.07 68.5 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 120.852 1.66 . . . . 0.0 111.275 -174.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -63.53 -40.4 96.94 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 170.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.29 -40.27 81.84 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 119.58 1.082 . . . . 0.0 111.464 -176.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.479 ' HA ' HG21 ' A' ' 32' ' ' VAL . 13.4 pttp -70.84 -22.72 62.28 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 120.455 1.48 . . . . 0.0 112.373 176.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.9 m -77.79 -52.13 9.4 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.763 1.625 . . . . 0.0 110.23 175.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 71.1 mt -85.33 -26.49 26.51 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.017 1.327 . . . . 0.0 111.606 -169.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.63 15.27 55.97 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 126.74 2.114 . . . . 0.0 111.707 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.91 121.94 12.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.668 1.187 . . . . 0.0 109.936 -175.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.04 8.05 87.46 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 119.752 -0.471 . . . . 0.0 113.385 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -122.6 -32.25 3.61 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 125.234 1.414 . . . . 0.0 109.36 -177.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.727 HG22 ' HG2' ' A' ' 2' ' ' LYS . 12.6 pt -141.55 163.92 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 125.018 1.327 . . . . 0.0 110.54 177.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.74 144.18 31.43 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 168.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.479 HG21 ' HA ' ' A' ' 23' ' ' LYS . 2.2 t -136.27 135.12 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.472 0.709 . . . . 0.0 110.512 -168.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.7 m -147.31 161.4 41.04 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.776 1.231 . . . . 0.0 109.501 -178.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.5 p -128.09 161.67 28.67 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.726 1.21 . . . . 0.0 109.491 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.5 p -152.31 147.56 26.48 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 121.328 -0.858 . . . . 0.0 111.709 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.621 0 N-CA-C 105.154 -3.178 . . . . 0.0 105.154 -168.328 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.6 m . . . . . 0 C--O 1.234 0.238 0 CA-C-O 121.981 0.896 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -134.15 116.23 13.22 Favored Pre-proline 0 N--CA 1.446 -0.671 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 -175.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -64.75 -24.26 62.05 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 123.714 2.942 . . . . 0.0 112.7 -169.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.0 m -61.27 -36.64 80.61 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.106 0.867 . . . . 0.0 109.731 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.15 -45.1 82.17 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -56.37 -49.24 77.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.49 -42.93 99.53 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.41 0.55 . . . . 0.0 111.024 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.6 mmt -61.51 -23.99 66.3 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 124.251 1.021 . . . . 0.0 113.337 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.415 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 4.3 mmt -101.98 -24.11 14.03 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.084 0.856 . . . . 0.0 108.958 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -64.94 -34.75 79.15 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 118.952 0.796 . . . . 0.0 109.435 171.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -72.6 7.1 2.04 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 173.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.3 t -119.29 -39.56 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 127.23 2.212 . . . . 0.0 110.023 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.94 24.14 2.58 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.375 1.464 . . . . 0.0 112.884 -176.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.7 mt -124.42 161.6 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 125.879 1.671 . . . . 0.0 107.222 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -108.19 -61.5 1.58 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -169.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . 0.421 28.7 pt 56.17 1.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 118.245 2.683 . . . . 0.0 118.245 -177.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.76 147.93 43.03 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 120.899 1.681 . . . . 0.0 109.39 169.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.69 1.42 11.45 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 118.248 -1.307 . . . . 0.0 114.777 176.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -48.47 -65.32 0.59 Allowed 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.258 1.529 . . . . 0.0 113.23 -177.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.9 166.15 25.74 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 123.672 0.608 . . . . 0.0 112.548 -168.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.9 p -169.56 22.81 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.91 0.884 . . . . 0.0 112.565 -171.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -139.47 150.36 63.46 Favored Pre-proline 0 N--CA 1.475 0.821 0 CA-C-N 119.895 1.225 . . . . 0.0 112.193 -169.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -84.25 162.54 13.23 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 124.095 3.196 . . . . 0.0 112.909 -170.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.1 tt -57.43 -36.4 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.99 1.716 . . . . 0.0 111.269 -176.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -73.86 -16.37 61.13 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -170.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.16 -17.07 44.19 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 118.691 -0.671 . . . . 0.0 111.793 170.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -88.79 170.47 10.73 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.195 0.907 . . . . 0.0 110.721 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.7 89.91 2.24 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.451 1.501 . . . . 0.0 107.921 -177.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.496 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -52.39 -23.16 5.52 Favored 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 176.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -50.86 -30.2 13.85 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.349 0.66 . . . . 0.0 111.398 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -91.71 4.18 53.35 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.43 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 22.2 m-85 -131.83 114.8 15.14 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 120.437 1.471 . . . . 0.0 109.454 -177.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -69.78 -6.91 35.33 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -169.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.753 HG12 HG13 ' A' ' 4' ' ' VAL . 24.7 t -145.02 123.31 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -171.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.0 t -118.51 127.39 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.8 mm -121.45 94.3 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 171.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.448 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 18.2 p -73.95 167.52 21.32 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 118.252 -1.379 . . . . 0.0 107.747 168.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mp -143.02 41.82 1.53 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 173.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.419 ' HB3' HG21 ' A' ' 84' ' ' VAL . 59.1 m -101.03 -5.49 25.71 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.523 1.529 . . . . 0.0 112.188 -168.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.15 15.64 7.09 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-N 119.543 1.065 . . . . 0.0 113.985 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 6.0 t 45.5 56.06 6.07 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.77 1.628 . . . . 0.0 111.172 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -175.52 -26.18 0.03 OUTLIER Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.479 -172.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.419 HG21 ' HB3' ' A' ' 80' ' ' CYS . 78.5 t -56.6 121.21 4.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 169.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -65.41 136.45 56.5 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 173.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.5 mt -123.71 144.34 44.27 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 176.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.25 156.72 9.96 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.6 2.2 . . . . 0.0 112.997 176.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -53.91 -30.39 58.08 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.824 2.349 . . . . 0.0 116.399 -170.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -67.04 -26.0 66.54 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.377 -0.827 . . . . 0.0 111.328 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.496 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 66.2 m95 -69.67 -13.25 62.21 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 120.87 -1.144 . . . . 0.0 113.388 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.96 -9.35 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 119.721 1.146 . . . . 0.0 112.957 -169.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.1 p -85.79 -10.26 55.76 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.253 1.021 . . . . 0.0 112.714 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -60.46 167.94 2.35 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 128.974 2.91 . . . . 0.0 113.18 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.88 -40.96 87.95 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.651 1.181 . . . . 0.0 108.951 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.535 ' HB ' HG13 ' A' ' 75' ' ' VAL . 26.7 mm -119.93 139.27 47.79 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 CA-C-O 121.163 0.506 . . . . 0.0 109.717 170.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -144.66 106.5 4.29 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 102.16 -3.274 . . . . 0.0 102.16 166.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -132.84 168.21 18.81 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 175.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -139.67 111.66 7.45 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 171.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.451 ' CD2' ' HB3' ' A' ' 122' ' ' ARG . 45.5 m0 -92.13 65.65 4.76 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -33.19 -52.07 0.35 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.52 1.928 . . . . 0.0 111.773 177.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 40.1 -170.56 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 129.851 3.261 . . . . 0.0 114.371 -175.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.56 175.61 1.02 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 122.79 1.281 . . . . 0.0 111.887 170.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -127.28 103.83 22.63 Favored Pre-proline 0 C--N 1.321 -0.657 0 C-N-CA 128.232 2.613 . . . . 0.0 107.418 -170.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.3 -4.2 14.49 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.648 2.232 . . . . 0.0 112.602 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.3 t0 20.13 -95.06 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.784 2.834 . . . . 0.0 113.791 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.67 40.39 1.55 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 127.141 2.305 . . . . 0.0 109.151 169.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -75.16 179.01 5.31 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.722 1.609 . . . . 0.0 113.098 -170.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.3 p -62.35 157.38 19.99 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 113.148 -1.842 . . . . 0.0 109.634 171.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 21.7 mt -57.68 -30.42 65.44 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.602 176.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.34 -41.3 98.46 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 118.695 -0.669 . . . . 0.0 111.099 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.2 t -71.78 -40.81 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 117.705 -1.141 . . . . 0.0 109.238 178.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -50.7 -51.42 49.74 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.909 1.232 . . . . 0.0 111.725 169.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -59.05 -45.52 90.57 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.025 0.829 . . . . 0.0 110.931 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.7 m -68.09 -43.01 79.5 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -174.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.9 t -64.83 -49.75 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -175.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -48.08 -56.12 8.55 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.963 1.305 . . . . 0.0 111.017 173.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.09 -41.73 99.72 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 119.111 0.869 . . . . 0.0 111.519 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -66.78 -37.77 85.24 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.205 -1.173 . . . . 0.0 110.532 -178.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.4 t -62.87 -42.71 97.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 173.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -35.95 75.59 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 119.819 1.191 . . . . 0.0 111.352 -174.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -69.01 -43.08 75.52 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.512 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.451 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 10.4 mpt_? -64.18 -41.66 97.02 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.923 1.238 . . . . 0.0 110.559 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.7 t -54.23 -54.35 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 173.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -64.93 -32.65 74.47 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 122.012 -0.43 . . . . 0.0 111.599 -174.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -62.34 -48.25 80.65 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 123.368 0.667 . . . . 0.0 111.363 171.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -48.35 75.09 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 118.56 0.618 . . . . 0.0 109.562 175.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.7 mt -58.09 -42.19 82.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 123.804 0.842 . . . . 0.0 109.287 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.93 -31.43 71.75 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.797 0.726 . . . . 0.0 111.74 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -72.3 -42.77 65.1 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.554 173.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.2 pt -103.28 -46.2 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 118.607 2.817 . . . . 0.0 118.607 -168.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.5 m . . . . . 0 C--O 1.253 1.247 0 C-N-CA 124.06 0.944 . . . . 0.0 111.883 -169.177 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.9 mmm . . . . . 0 N--CA 1.501 2.084 0 N-CA-C 111.483 0.179 . . . . 0.0 111.483 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.635 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -58.44 132.57 54.11 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 172.337 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.506 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 53.1 mtpt -99.05 138.85 35.56 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -172.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.674 HG13 HG12 ' A' ' 75' ' ' VAL . 11.1 t -134.11 153.66 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 123.005 0.522 . . . . 0.0 109.716 -171.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.4 tpp -139.53 147.95 41.93 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.627 0.771 . . . . 0.0 109.792 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -132.1 112.21 12.13 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.46 1.504 . . . . 0.0 107.611 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 4.1 t -97.1 137.42 24.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -172.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 m -120.08 146.59 45.78 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -169.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -150.75 164.71 35.52 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.465 1.906 . . . . 0.0 108.602 174.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.468 ' HD3' ' H ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER 54.75 -146.1 0.58 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.668 1.587 . . . . 0.0 108.589 -169.538 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.468 ' H ' ' HD3' ' A' ' 10' ' ' ARG . 55.3 t-20 -65.55 99.37 0.43 Allowed 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 173.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.7 m -64.36 -4.01 3.45 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.441 ' HA ' ' HG2' ' A' ' 16' ' ' GLN . 68.4 m -48.0 -38.65 17.53 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 119.309 0.959 . . . . 0.0 113.062 169.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -62.91 -41.08 99.32 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 120.051 1.296 . . . . 0.0 111.909 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.41 -37.07 12.78 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.766 0.826 . . . . 0.0 109.613 -169.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.509 HE22 HG12 ' A' ' 42' ' ' VAL . 11.6 pt20 -66.84 -31.15 71.58 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.102 -0.998 . . . . 0.0 110.127 169.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.438 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.9 tpt -62.88 -37.44 86.9 Favored 'General case' 0 CA--C 1.51 -0.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.448 171.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.99 90.5 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -64.84 -38.04 89.64 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.153 169.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.9 -42.32 96.99 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 120.931 1.696 . . . . 0.0 111.811 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -66.73 -37.44 84.68 Favored 'General case' 0 C--O 1.222 -0.356 0 O-C-N 121.861 -0.788 . . . . 0.0 109.296 170.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.05 -35.19 69.25 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 119.539 1.063 . . . . 0.0 111.652 -175.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -66.93 -34.39 77.66 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 121.382 1.901 . . . . 0.0 111.425 171.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.2 m -69.39 -50.61 44.4 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.509 1.524 . . . . 0.0 110.343 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.0 mt -91.83 -25.55 18.93 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.079 1.352 . . . . 0.0 111.905 -169.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.97 8.72 76.09 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 126.675 2.083 . . . . 0.0 112.195 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.51 121.88 13.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.393 1.077 . . . . 0.0 110.064 -170.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.91 9.93 85.12 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 119.975 -0.347 . . . . 0.0 113.477 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -122.18 -36.8 2.91 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 125.947 1.699 . . . . 0.0 109.192 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.9 pt -138.44 162.96 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.873 1.269 . . . . 0.0 108.987 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.44 132.78 53.81 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 169.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.41 140.65 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 119.745 1.157 . . . . 0.0 113.308 -168.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.4 m -142.58 166.94 23.3 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.51 1.524 . . . . 0.0 109.903 -169.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.8 p -136.69 158.83 43.54 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.721 1.208 . . . . 0.0 110.069 176.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.479 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 27.5 p -151.81 158.66 43.58 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 122.83 0.452 . . . . 0.0 110.479 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.03 144.59 1.07 Allowed Glycine 0 CA--C 1.532 1.112 0 N-CA-C 106.857 -2.497 . . . . 0.0 106.857 -168.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.8 tp -163.04 61.29 0.19 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 102.751 -3.055 . . . . 0.0 102.751 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -60.8 -15.44 29.88 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.953 1.301 . . . . 0.0 113.828 -168.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 p -78.04 8.48 4.72 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.247 1.019 . . . . 0.0 113.586 173.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.6 m 59.68 -13.22 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 129.782 3.233 . . . . 0.0 115.425 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.22 170.49 22.37 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.858 2.463 . . . . 0.0 106.602 176.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.509 HG12 HE22 ' A' ' 16' ' ' GLN . 19.5 m -73.36 173.37 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 169.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -128.73 111.11 18.89 Favored Pre-proline 0 C--O 1.233 0.194 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -171.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -51.54 -30.44 35.82 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.855 3.037 . . . . 0.0 114.913 -174.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -60.42 -39.13 86.32 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.995 0.816 . . . . 0.0 110.964 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.72 -44.85 76.65 Favored 'General case' 0 CA--C 1.513 -0.444 0 O-C-N 121.448 -0.782 . . . . 0.0 109.062 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.02 -44.39 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.45 -43.91 96.37 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.507 0.594 . . . . 0.0 111.525 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.8 mmt -65.67 -18.74 65.55 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 118.879 -0.582 . . . . 0.0 112.3 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.438 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.8 OUTLIER -96.4 -31.64 12.75 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -178.138 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -63.08 -33.4 75.36 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.166 1.386 . . . . 0.0 110.003 169.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -58.49 -15.97 13.29 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.114 1.766 . . . . 0.0 111.845 172.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.4 m -130.62 12.84 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 126.156 1.783 . . . . 0.0 111.683 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.4 42.84 80.86 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 121.173 -0.955 . . . . 0.0 113.772 175.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.3 mt -124.69 155.27 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.81 1.644 . . . . 0.0 107.73 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -123.84 125.55 44.87 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.826 1.25 . . . . 0.0 108.296 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.9 pt -128.53 9.99 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.51 1.124 . . . . 0.0 112.339 173.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.65 -30.47 41.28 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.521 1.528 . . . . 0.0 111.935 174.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.43 -12.87 73.61 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 118.097 0.408 . . . . 0.0 112.679 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -76.86 153.0 35.22 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.773 1.229 . . . . 0.0 109.654 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.7 p -150.47 168.74 23.29 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.4 m -64.19 138.56 58.5 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.851 1.661 . . . . 0.0 111.393 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -163.1 123.25 1.42 Allowed Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 169.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -75.83 150.55 34.84 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.573 2.182 . . . . 0.0 113.315 -168.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.7 tt -55.96 -35.62 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.702 1.601 . . . . 0.0 111.395 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -68.75 -21.58 64.36 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.204 0.601 . . . . 0.0 112.177 -174.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.2 -10.55 57.62 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.336 0.654 . . . . 0.0 111.999 173.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.479 ' CE2' ' HB3' ' A' ' 35' ' ' CYS . 67.0 m-85 -92.69 168.49 11.18 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.908 0.861 . . . . 0.0 110.418 176.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -145.79 89.86 1.94 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 -171.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.489 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -51.47 -24.73 5.39 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -20.64 8.73 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.02 0.528 . . . . 0.0 111.528 173.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -107.02 13.76 27.17 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.383 1.873 . . . . 0.0 112.374 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.506 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 38.6 m-85 -135.24 108.85 7.95 Favored 'General case' 0 CA--C 1.516 -0.332 0 O-C-N 120.805 -1.184 . . . . 0.0 108.578 172.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.77 -16.05 36.27 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -170.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.674 HG12 HG13 ' A' ' 4' ' ' VAL . 11.9 t -144.85 121.31 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 -170.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.66 132.13 64.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 O-C-N 120.521 -1.362 . . . . 0.0 108.85 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.0 mm -125.68 96.93 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 -171.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.438 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 36.6 t -72.31 164.68 25.89 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 169.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mp -142.69 38.04 1.48 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 170.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.607 ' HB3' HG21 ' A' ' 84' ' ' VAL . 76.9 m -96.2 4.4 52.45 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.566 1.147 . . . . 0.0 111.291 -169.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.77 20.9 17.66 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 111.329 -0.709 . . . . 0.0 111.329 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.464 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 5.2 t 46.33 39.94 7.06 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.104 1.762 . . . . 0.0 112.314 -176.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -150.23 33.46 1.02 Allowed Glycine 0 C--N 1.339 0.7 0 C-N-CA 123.754 0.692 . . . . 0.0 111.795 -172.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.607 HG21 ' HB3' ' A' ' 80' ' ' CYS . 93.9 t -121.85 136.58 58.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 125.183 1.393 . . . . 0.0 107.652 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -82.35 67.59 8.44 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.182 0.993 . . . . 0.0 109.836 -172.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.8 mt -58.6 142.3 83.2 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -53.14 154.06 14.76 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.758 2.306 . . . . 0.0 111.63 171.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.19 -19.15 56.83 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 121.646 1.564 . . . . 0.0 114.403 -170.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.81 -26.95 68.86 Favored 'General case' 0 C--O 1.225 -0.233 0 O-C-N 121.205 -0.934 . . . . 0.0 110.983 175.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.489 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 71.8 m95 -68.08 -4.82 14.78 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.089 -1.007 . . . . 0.0 112.651 174.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -108.61 -28.96 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 120.04 1.291 . . . . 0.0 111.025 -174.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.5 p -76.91 -16.58 59.34 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.574 0.954 . . . . 0.0 113.574 -169.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -52.88 161.04 0.83 Allowed 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 129.354 3.062 . . . . 0.0 113.949 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -62.17 -38.96 91.03 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.084 1.354 . . . . 0.0 108.754 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.529 ' HB ' HG13 ' A' ' 75' ' ' VAL . 33.5 mm -126.17 138.01 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 169.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -139.67 112.26 7.84 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 101.359 -3.571 . . . . 0.0 101.359 167.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -135.16 167.78 20.36 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 9.7 t70 -139.33 104.69 5.04 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 171.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -83.73 77.99 9.78 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -54.54 41.79 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 131.6 3.96 . . . . 0.0 113.796 171.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.63 -176.6 3.33 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.961 1.304 . . . . 0.0 112.637 -168.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -51.43 169.09 0.06 Allowed 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 127.477 2.311 . . . . 0.0 112.529 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -127.21 107.92 21.55 Favored Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 125.975 1.71 . . . . 0.0 108.558 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -82.31 -2.1 10.99 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.044 1.83 . . . . 0.0 112.985 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.3 t0 20.06 -91.85 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 128.869 2.868 . . . . 0.0 114.408 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.95 42.11 1.36 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 126.015 1.769 . . . . 0.0 110.532 172.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -78.31 -176.8 4.86 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.26 1.424 . . . . 0.0 113.297 -171.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.7 p -64.15 162.79 13.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 113.859 -1.519 . . . . 0.0 110.269 173.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.1 mt -55.68 -33.91 64.57 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 122.819 0.448 . . . . 0.0 110.542 175.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -62.64 -38.11 88.98 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.774 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.3 t -73.98 -45.1 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 119.515 1.052 . . . . 0.0 108.777 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -52.01 -38.0 55.32 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.765 1.166 . . . . 0.0 112.832 172.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -68.99 -46.3 68.41 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 119.778 1.172 . . . . 0.0 112.188 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.5 m -71.69 -42.46 67.38 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 119.342 -0.361 . . . . 0.0 110.357 -169.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.8 t -67.82 -44.52 85.45 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -173.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -47.16 -53.27 13.41 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 124.853 1.261 . . . . 0.0 110.386 169.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.86 -45.39 96.29 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 119.325 0.966 . . . . 0.0 111.538 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -66.29 -36.9 84.15 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 121.683 -0.892 . . . . 0.0 111.418 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.8 t -62.66 -43.31 98.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 174.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -36.13 78.32 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 119.781 1.173 . . . . 0.0 111.56 -174.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -68.14 -42.34 80.27 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.432 -0.794 . . . . 0.0 110.131 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -63.07 -43.57 98.2 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.748 1.158 . . . . 0.0 110.431 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 75.9 t -54.81 -52.55 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 123.607 0.763 . . . . 0.0 109.582 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -66.77 -32.65 74.08 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 121.862 -0.524 . . . . 0.0 111.503 -175.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -62.3 -48.34 80.32 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 123.239 0.616 . . . . 0.0 111.22 171.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.93 -46.6 78.45 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.361 0.528 . . . . 0.0 110.13 176.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.4 mt -58.38 -43.64 86.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 124.34 1.056 . . . . 0.0 109.779 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.88 -29.81 69.78 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.3 0.955 . . . . 0.0 111.894 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -72.13 -39.61 68.7 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.573 0.624 . . . . 0.0 111.509 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.9 pt -103.35 -48.71 10.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 116.703 2.112 . . . . 0.0 116.703 -168.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 40.6 m . . . . . 0 C--O 1.252 1.232 0 C-N-CA 124.308 1.043 . . . . 0.0 110.653 -170.264 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 tpt . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 118.518 -0.753 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.488 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -60.32 118.4 6.38 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 120.98 1.718 . . . . 0.0 108.541 -173.508 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.416 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 39.0 mtpt -90.58 134.24 34.52 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -169.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.809 HG13 HG12 ' A' ' 75' ' ' VAL . 12.0 t -116.01 155.32 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.07 140.54 43.86 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -125.63 120.37 30.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 177.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.1 t -118.72 112.49 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 118.736 0.698 . . . . 0.0 110.404 -168.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.6 171.79 13.67 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.801 1.286 . . . . 0.0 113.616 -174.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -152.36 130.99 12.3 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 100.779 -3.785 . . . . 0.0 100.779 168.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.421 ' CG ' ' H ' ' A' ' 11' ' ' ASN . 27.2 ttm180 63.47 176.53 0.16 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.755 1.161 . . . . 0.0 109.955 -169.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.421 ' H ' ' CG ' ' A' ' 10' ' ' ARG . 33.6 t-20 -40.57 137.2 1.17 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.138 2.175 . . . . 0.0 113.652 -169.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.9 m -52.41 -20.4 2.8 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 129.856 3.262 . . . . 0.0 115.417 -171.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.9 m -59.44 -5.34 0.77 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.946 2.098 . . . . 0.0 114.802 -171.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.291 31.5 ptt180 -111.41 -61.3 1.72 Allowed 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 116.801 -1.571 . . . . 0.0 111.079 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.562 ' CB ' HD13 ' A' ' 79' ' ' LEU . 59.7 p -74.97 -44.6 47.44 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 122.688 2.495 . . . . 0.0 111.316 -175.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.29 2.0 mt-30 -75.65 -24.75 56.41 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -172.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.463 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.2 tpt -65.79 -41.89 91.39 Favored 'General case' 0 C--O 1.222 -0.363 0 O-C-N 121.003 -1.061 . . . . 0.0 108.19 167.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.54 -36.77 79.26 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.745 -0.597 . . . . 0.0 109.602 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -63.25 -39.1 93.64 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 118.378 -0.82 . . . . 0.0 110.823 169.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.38 -45.15 94.15 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 120.5 1.5 . . . . 0.0 111.115 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -65.55 -38.29 89.18 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 173.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.441 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -72.45 -37.63 68.5 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 119.758 1.163 . . . . 0.0 110.929 -173.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.401 ' HA ' HG21 ' A' ' 32' ' ' VAL . 61.7 pttt -71.08 -19.73 62.44 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 120.214 1.37 . . . . 0.0 112.065 174.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.3 m -82.02 -51.05 8.42 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.845 1.658 . . . . 0.0 109.56 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.2 mt -89.42 -25.73 21.36 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.334 1.454 . . . . 0.0 112.176 -169.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.76 13.75 56.32 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.885 2.183 . . . . 0.0 111.846 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.28 122.02 14.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.675 1.19 . . . . 0.0 109.723 -173.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.12 8.44 87.84 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.66 -0.522 . . . . 0.0 113.626 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -123.22 -31.69 3.54 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.506 1.522 . . . . 0.0 109.001 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.7 pt -141.37 173.37 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 125.457 1.503 . . . . 0.0 109.598 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.42 144.08 43.88 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 103.879 -2.638 . . . . 0.0 103.879 168.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 22' ' ' ALA . 1.7 t -133.33 139.94 48.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 123.279 0.631 . . . . 0.0 110.283 -168.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.14 158.59 44.16 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.836 1.254 . . . . 0.0 109.254 -173.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 63.8 p -155.46 165.99 34.9 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 120.016 1.28 . . . . 0.0 113.257 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.3 p -154.61 166.45 33.32 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.164 1.386 . . . . 0.0 109.197 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.31 53.92 1.79 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.3 tp -88.51 68.69 8.82 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 102.029 -3.322 . . . . 0.0 102.029 -176.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.17 -1.12 0.64 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.86 1.264 . . . . 0.0 111.813 -169.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.5 p -88.38 7.1 34.17 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.407 1.483 . . . . 0.0 112.82 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.6 m 62.08 -29.33 0.07 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 130.063 3.345 . . . . 0.0 114.746 -175.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -132.75 -178.13 4.81 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 128.145 2.578 . . . . 0.0 104.776 169.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.8 m -61.71 158.67 2.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 O-C-N 120.623 -1.298 . . . . 0.0 109.454 171.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -113.12 106.6 54.77 Favored Pre-proline 0 N--CA 1.446 -0.665 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -170.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -63.87 -29.25 67.55 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.264 2.643 . . . . 0.0 111.83 -169.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.2 m -64.51 -37.41 87.45 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.743 0.701 . . . . 0.0 109.213 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.24 -44.43 83.78 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.26 -46.58 85.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 CA-C-O 118.632 -0.699 . . . . 0.0 109.135 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.41 -43.96 97.56 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.859 0.754 . . . . 0.0 111.101 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.0 mmt -60.05 -26.16 65.91 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 118.76 -0.638 . . . . 0.0 111.6 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.463 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -94.09 -27.0 16.5 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -177.132 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -64.34 -30.74 71.78 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.93 1.292 . . . . 0.0 110.067 169.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.43 -21.75 38.8 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.297 0.639 . . . . 0.0 112.002 171.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.0 m -123.61 9.53 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 125.75 1.62 . . . . 0.0 111.138 -177.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.81 40.94 74.84 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.372 0.987 . . . . 0.0 113.007 174.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.7 mt -122.94 152.39 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.542 1.537 . . . . 0.0 108.077 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -118.55 122.13 41.9 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.924 1.29 . . . . 0.0 108.677 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 43.8 pt -127.02 12.91 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 124.271 1.028 . . . . 0.0 111.481 169.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.58 -25.0 45.18 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.23 1.812 . . . . 0.0 112.459 172.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.6 -8.06 85.93 Favored Glycine 0 CA--C 1.537 1.423 0 CA-C-N 118.603 0.638 . . . . 0.0 112.946 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -76.56 166.77 22.93 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.776 1.23 . . . . 0.0 111.557 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.6 p -144.86 -177.95 5.78 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.813 1.645 . . . . 0.0 109.949 174.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.98 173.32 6.41 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.206 1.002 . . . . 0.0 109.615 170.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.28 146.37 7.15 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 169.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.64 141.94 97.96 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.706 2.271 . . . . 0.0 111.834 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.5 tt -59.93 -37.73 73.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 123.491 0.716 . . . . 0.0 110.718 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -73.04 -18.38 61.34 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.416 0.686 . . . . 0.0 112.336 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.05 -25.58 61.85 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 118.939 -0.553 . . . . 0.0 111.274 170.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -79.11 170.51 16.56 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 122.191 0.996 . . . . 0.0 111.318 -172.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.44 68.75 1.39 Allowed 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 125.827 1.651 . . . . 0.0 106.891 -177.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.457 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -51.3 -24.21 4.36 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 124.524 1.129 . . . . 0.0 113.749 -178.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -44.1 -41.27 5.48 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.005 0.922 . . . . 0.0 110.794 172.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.37 -14.74 58.08 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.746 1.218 . . . . 0.0 113.842 -175.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.416 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 11.4 m-85 -105.72 112.73 25.92 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 119.64 1.109 . . . . 0.0 108.405 -173.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -65.51 -12.14 49.99 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -168.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.809 HG12 HG13 ' A' ' 4' ' ' VAL . 27.3 t -146.56 124.31 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 -171.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.1 t -123.13 130.76 74.18 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.2 mm -124.42 92.65 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 173.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.9 t -76.85 166.85 22.79 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 169.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.562 HD13 ' CB ' ' A' ' 15' ' ' SER . 5.5 mp -140.76 32.18 1.82 Allowed 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.185 -1.572 . . . . 0.0 108.025 174.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 92.5 m -76.99 -3.71 40.36 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.203 1.001 . . . . 0.0 111.707 -177.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.19 35.49 3.63 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 119.572 1.078 . . . . 0.0 111.084 172.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 32.0 p 35.88 45.03 0.26 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 128.02 2.528 . . . . 0.0 114.216 -175.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.73 47.4 0.48 Allowed Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -173.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.2 p -125.72 159.11 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 126.102 1.761 . . . . 0.0 109.786 -171.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -118.09 56.35 0.86 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.785 1.234 . . . . 0.0 108.745 -174.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.6 mt -59.33 143.9 84.59 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.36 151.49 22.98 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.198 1.932 . . . . 0.0 111.95 171.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -55.86 -27.57 63.42 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.194 1.93 . . . . 0.0 115.541 -173.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.41 -21.14 66.21 Favored 'General case' 0 N--CA 1.456 -0.175 0 O-C-N 121.009 -1.057 . . . . 0.0 112.361 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.457 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 73.4 m95 -73.65 -17.89 61.1 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 117.952 -1.023 . . . . 0.0 112.659 175.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.8 m -110.77 -13.54 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 120.064 1.302 . . . . 0.0 113.461 -169.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.4 p -83.26 -8.11 59.5 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.367 1.067 . . . . 0.0 113.255 -173.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -64.96 173.04 2.52 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 130.054 3.341 . . . . 0.0 113.569 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -67.45 -41.47 84.64 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.532 ' HB ' HG13 ' A' ' 75' ' ' VAL . 16.8 mm -120.25 136.9 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 169.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -143.45 111.82 6.31 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 103.03 -2.952 . . . . 0.0 103.03 166.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -136.63 164.64 27.74 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -132.59 102.17 5.6 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 169.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.3 m0 -76.94 89.06 3.5 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.417 ' H ' ' CD ' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -62.6 33.99 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 128.508 2.723 . . . . 0.0 113.827 173.625 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.26 178.39 1.94 Allowed 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.086 -1.009 . . . . 0.0 112.832 -169.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.486 ' HB2' HG22 ' A' ' 115' ' ' VAL . 44.8 mt-10 -52.51 164.91 0.29 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 126.26 1.824 . . . . 0.0 112.525 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -120.9 102.74 43.86 Favored Pre-proline 0 C--N 1.325 -0.478 0 C-N-CA 127.278 2.231 . . . . 0.0 108.163 -175.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -82.13 -1.93 10.99 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.769 2.313 . . . . 0.0 112.592 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.4 t0 26.42 -99.04 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 128.372 2.669 . . . . 0.0 113.533 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.86 38.99 1.74 Allowed Glycine 0 CA--C 1.532 1.151 0 C-N-CA 127.278 2.371 . . . . 0.0 109.285 169.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -70.18 -176.99 1.28 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.413 1.885 . . . . 0.0 112.937 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.9 m -63.6 156.66 25.99 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.235 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.1 mt -56.35 -31.16 63.49 Favored 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 123.129 0.572 . . . . 0.0 110.933 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.62 -41.15 97.06 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 118.528 0.604 . . . . 0.0 110.768 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 40.1 t -72.85 -42.12 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 117.284 -1.341 . . . . 0.0 109.061 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -48.42 -49.47 34.96 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 120.318 1.417 . . . . 0.0 111.379 169.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -60.16 -44.11 95.26 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.976 0.807 . . . . 0.0 111.055 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 87.3 m -68.95 -43.83 74.23 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 118.885 -0.579 . . . . 0.0 109.486 -173.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.486 HG22 ' HB2' ' A' ' 102' ' ' GLU . 42.0 t -68.43 -46.71 80.03 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -174.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -45.45 -55.74 5.79 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.864 1.266 . . . . 0.0 110.97 169.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.71 -43.03 98.41 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 119.321 0.964 . . . . 0.0 111.525 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -63.27 -37.44 87.26 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.381 1.09 . . . . 0.0 111.394 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 37.4 t -62.96 -41.41 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 118.067 -0.968 . . . . 0.0 109.033 173.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.14 -37.56 74.89 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 120.009 1.277 . . . . 0.0 111.029 -177.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -68.88 -43.3 75.57 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.208 0.603 . . . . 0.0 110.585 177.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -68.17 -42.43 80.02 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.415 1.007 . . . . 0.0 110.392 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.1 t -53.54 -53.54 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 124.007 0.923 . . . . 0.0 108.988 171.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.77 -33.01 74.98 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.954 -0.466 . . . . 0.0 111.815 -175.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -62.62 -47.98 81.41 Favored 'General case' 0 C--O 1.227 -0.084 0 C-N-CA 122.934 0.494 . . . . 0.0 111.284 171.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.86 -47.24 77.65 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.11 0.564 . . . . 0.0 109.552 176.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.2 mt -58.25 -42.91 84.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 124.292 1.037 . . . . 0.0 110.147 176.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.43 -29.45 69.01 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.609 0.64 . . . . 0.0 111.864 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -74.12 -40.43 62.67 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 118.594 0.633 . . . . 0.0 111.814 175.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.3 pt -101.55 -42.4 9.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 117.251 2.315 . . . . 0.0 117.251 -168.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 C--O 1.254 1.335 0 CA-C-N 119.05 0.841 . . . . 0.0 110.394 -171.967 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.1 mmm . . . . . 0 N--CA 1.5 2.054 0 CA-C-O 119.972 -0.061 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.627 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -58.97 136.33 57.89 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 171.172 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 26.8 mtpt -109.18 145.89 35.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 119.638 1.108 . . . . 0.0 108.357 -171.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.748 HG13 HG12 ' A' ' 75' ' ' VAL . 6.2 t -127.21 153.9 36.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 123.693 0.797 . . . . 0.0 108.896 -174.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 59.6 tpp -135.87 138.47 42.51 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -124.56 106.69 10.34 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.0 t -84.39 122.48 38.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -172.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 86.5 m -68.77 156.78 37.7 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.282 2.233 . . . . 0.0 111.279 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -144.32 -125.17 0.08 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 169.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.59 115.24 1.27 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.078 1.351 . . . . 0.0 112.009 -169.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.9 t30 45.59 26.86 0.36 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.897 2.079 . . . . 0.0 113.973 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.2 m 56.94 -22.34 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 119.106 3.002 . . . . 0.0 119.106 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 85.2 m -48.78 -55.72 10.72 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 125.69 1.596 . . . . 0.0 113.348 -168.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -58.77 -47.03 86.09 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.334 0.97 . . . . 0.0 112.329 -169.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.535 ' HB3' HD13 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -87.77 -31.81 19.44 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.709 -0.619 . . . . 0.0 111.138 -170.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -65.62 -36.47 83.81 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 172.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.456 ' SD ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -63.09 -39.75 95.63 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 120.703 -1.248 . . . . 0.0 110.109 172.451 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.39 -36.1 75.16 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.757 -0.589 . . . . 0.0 110.698 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -64.69 -38.84 92.35 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.802 -0.618 . . . . 0.0 111.104 169.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.92 -43.9 92.84 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 120.491 1.496 . . . . 0.0 110.86 -178.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.456 ' CD2' ' SD ' ' A' ' 17' ' ' MET . 5.0 m-85 -64.81 -40.52 95.35 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 118.68 1.24 . . . . 0.0 109.428 171.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.484 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -69.88 -37.11 75.94 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 119.661 1.119 . . . . 0.0 111.104 -173.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -74.1 -25.14 59.62 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 120.142 1.337 . . . . 0.0 111.922 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 m -72.36 -50.8 23.97 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.173 1.389 . . . . 0.0 110.166 173.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.0 mt -87.86 -26.66 22.67 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 124.617 1.167 . . . . 0.0 112.647 -169.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.55 14.01 59.4 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 126.45 1.976 . . . . 0.0 111.602 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.23 125.18 22.8 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.227 1.411 . . . . 0.0 109.41 -172.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.68 8.42 87.2 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-O 119.732 -0.482 . . . . 0.0 113.647 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -125.47 -44.32 1.85 Allowed 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 125.161 1.385 . . . . 0.0 108.69 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.56 HG22 ' HB2' ' A' ' 2' ' ' LYS . 2.7 pp -140.25 150.27 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.463 1.105 . . . . 0.0 109.782 177.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.71 152.28 20.27 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.484 HG11 ' HB3' ' A' ' 22' ' ' ALA . 2.0 t -142.5 137.57 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 118.393 0.542 . . . . 0.0 111.061 -168.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.7 m -143.21 165.51 27.24 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.19 1.396 . . . . 0.0 109.524 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.9 p -141.48 156.27 45.76 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.929 1.292 . . . . 0.0 108.698 175.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 29.6 p -159.73 173.39 16.11 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.001 0.818 . . . . 0.0 112.201 -173.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.51 34.92 63.14 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.2 mp -61.76 122.54 15.61 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -75.46 3.14 9.8 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 169.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 p -145.24 67.47 1.23 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -175.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.8 m -64.93 60.62 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.847 2.459 . . . . 0.0 111.427 173.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.402 ' H ' ' H ' ' A' ' 42' ' ' VAL . 0.3 OUTLIER -160.96 -20.15 0.05 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 129.277 3.031 . . . . 0.0 110.517 -178.055 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.402 ' H ' ' H ' ' A' ' 41' ' ' ARG . 0.5 OUTLIER 72.88 171.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 127.245 2.218 . . . . 0.0 109.123 -172.615 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -137.22 117.08 10.45 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -172.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -69.24 -25.98 30.49 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.537 2.825 . . . . 0.0 113.179 -169.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.0 m -62.19 -36.21 81.21 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.177 0.899 . . . . 0.0 109.153 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.98 -41.89 90.58 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -58.59 -49.89 80.89 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 CA-C-O 118.312 -0.852 . . . . 0.0 108.874 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.5 -43.81 96.65 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 119.362 0.983 . . . . 0.0 110.916 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.7 mmt -64.51 -17.12 63.59 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.867 0.867 . . . . 0.0 112.723 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 3.4 mmt -97.99 -26.95 14.46 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 119.457 1.026 . . . . 0.0 110.656 173.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -65.0 -27.66 68.98 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.976 0.91 . . . . 0.0 110.164 172.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -56.37 -25.3 49.04 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.187 0.995 . . . . 0.0 112.603 169.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.1 m -127.24 14.56 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.468 1.507 . . . . 0.0 111.211 -171.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.1 39.11 84.06 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.941 0.782 . . . . 0.0 112.717 174.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.3 mt -126.99 156.65 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -136.85 143.35 43.03 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.39 1.076 . . . . 0.0 109.033 175.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.7 pt -140.59 15.83 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 126.778 2.031 . . . . 0.0 111.288 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.6 p -69.87 -40.91 75.43 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 120.767 -1.208 . . . . 0.0 112.414 173.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.18 8.05 41.28 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 123.819 0.723 . . . . 0.0 113.075 -177.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -73.96 -176.54 2.53 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.561 1.145 . . . . 0.0 112.132 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -69.3 170.27 10.62 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.533 1.933 . . . . 0.0 112.758 -170.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.4 m -159.16 57.18 0.41 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 104.042 -2.577 . . . . 0.0 104.042 171.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -143.38 147.96 42.15 Favored Pre-proline 0 C--N 1.345 0.389 0 C-N-CA 123.166 0.586 . . . . 0.0 110.351 -167.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -82.82 159.5 16.13 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.397 2.732 . . . . 0.0 112.438 -174.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.2 tt -58.75 -34.77 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.056 1.342 . . . . 0.0 111.371 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -69.16 -22.52 63.92 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.19 0.596 . . . . 0.0 112.309 -174.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -13.85 59.54 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 119.103 -0.475 . . . . 0.0 111.741 172.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -98.98 172.18 7.57 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.212 1.005 . . . . 0.0 110.789 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.71 99.06 3.06 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 125.21 1.404 . . . . 0.0 107.774 -178.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -49.83 -23.53 1.93 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 171.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -51.36 -25.69 6.45 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.885 0.874 . . . . 0.0 111.524 173.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -107.1 15.28 25.38 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.72 1.208 . . . . 0.0 113.491 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.45 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 24.6 m-85 -134.88 111.07 9.58 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 120.243 1.383 . . . . 0.0 109.16 173.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.29 -17.28 52.86 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 124.643 1.177 . . . . 0.0 113.422 -169.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.748 HG12 HG13 ' A' ' 4' ' ' VAL . 12.6 t -143.09 130.44 18.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 -170.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.3 t -135.96 131.84 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 -169.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.446 HD11 HD12 ' A' ' 126' ' ' LEU . 18.3 mm -133.83 100.62 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 103.031 -2.951 . . . . 0.0 103.031 -172.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.408 ' C ' ' H ' ' A' ' 80' ' ' CYS . 6.3 m -111.29 85.56 2.15 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 121.853 -0.529 . . . . 0.0 111.034 -168.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.535 HD13 ' HB3' ' A' ' 15' ' ' SER . 3.9 mp -73.12 25.51 0.06 Allowed 'General case' 0 C--N 1.343 0.291 0 C-N-CA 127.969 2.508 . . . . 0.0 110.547 -174.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.58 ' HB3' HG21 ' A' ' 84' ' ' VAL . 4.4 m -64.12 1.02 0.78 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.89 2.076 . . . . 0.0 111.411 170.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.22 26.4 28.48 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 118.742 0.701 . . . . 0.0 111.658 174.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 49.91 20.09 0.53 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.761 2.025 . . . . 0.0 114.771 -175.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -109.46 24.53 20.0 Favored Glycine 0 C--N 1.338 0.658 0 C-N-CA 124.43 1.014 . . . . 0.0 111.213 -176.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.58 HG21 ' HB3' ' A' ' 80' ' ' CYS . 20.1 t -132.29 121.43 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -174.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.32 -40.45 85.96 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.806 0.842 . . . . 0.0 110.893 -177.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.1 mt 64.48 152.63 0.12 Allowed Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 127.921 2.488 . . . . 0.0 112.64 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.04 151.45 50.1 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 121.926 1.75 . . . . 0.0 110.219 169.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.4 -19.61 55.31 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.634 1.556 . . . . 0.0 114.436 -169.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -64.52 -26.51 68.45 Favored 'General case' 0 C--O 1.224 -0.246 0 O-C-N 121.019 -1.051 . . . . 0.0 110.879 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.471 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 62.3 m95 -67.63 -8.61 36.09 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.197 -0.939 . . . . 0.0 112.622 175.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.4 t -108.68 -30.09 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.968 1.307 . . . . 0.0 111.105 -171.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.5 p -75.37 -17.25 60.27 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.21 1.004 . . . . 0.0 113.483 -169.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -51.67 160.68 0.61 Allowed 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 129.403 3.081 . . . . 0.0 114.033 176.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -62.47 -38.9 91.63 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.608 1.563 . . . . 0.0 108.762 177.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.547 ' HB ' HG13 ' A' ' 75' ' ' VAL . 30.5 mm -125.02 135.44 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 169.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -136.57 104.88 5.7 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 101.758 -3.423 . . . . 0.0 101.758 166.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -128.27 177.57 6.85 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 125.62 1.568 . . . . 0.0 106.901 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.24 -56.9 1.42 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -174.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 24.1 m0 56.02 65.7 1.38 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.072 0.949 . . . . 0.0 110.662 -169.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -56.39 46.28 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 130.274 3.429 . . . . 0.0 113.54 169.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.81 -177.65 2.03 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.615 -1.303 . . . . 0.0 113.422 -168.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.448 ' HB2' HG22 ' A' ' 115' ' ' VAL . 41.1 mt-10 -55.88 168.86 0.41 Allowed 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 127.253 2.221 . . . . 0.0 112.323 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -115.04 102.99 54.95 Favored Pre-proline 0 C--N 1.323 -0.566 0 C-N-CA 126.272 1.829 . . . . 0.0 109.243 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -83.75 -4.37 10.66 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.577 2.185 . . . . 0.0 112.814 175.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.7 t0 25.18 -101.27 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 128.246 2.618 . . . . 0.0 113.025 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -136.88 42.3 1.33 Allowed Glycine 0 CA--C 1.533 1.16 0 C-N-CA 128.188 2.804 . . . . 0.0 107.11 169.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -68.91 -174.48 0.6 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.619 1.968 . . . . 0.0 112.069 -174.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.5 p -57.39 152.84 13.58 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.962 -1.472 . . . . 0.0 108.433 169.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.1 mt -59.14 -30.37 68.1 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.625 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -61.41 -41.25 96.86 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 119.001 -0.523 . . . . 0.0 110.791 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.17 -42.28 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 117.647 -1.168 . . . . 0.0 109.305 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -50.35 -49.4 54.19 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.276 1.398 . . . . 0.0 111.765 171.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -59.05 -44.18 91.76 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.694 0.679 . . . . 0.0 111.36 176.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 91.7 m -68.48 -45.6 71.97 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -173.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.448 HG22 ' HB2' ' A' ' 102' ' ' GLU . 58.6 t -67.41 -47.59 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -173.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -43.43 -54.5 4.72 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.93 1.292 . . . . 0.0 110.665 169.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.87 -43.43 98.93 Favored Glycine 0 CA--C 1.522 0.503 0 CA-C-N 119.844 1.202 . . . . 0.0 112.065 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -67.91 -34.38 76.51 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 120.797 -1.413 . . . . 0.0 111.398 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.59 -42.23 93.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 170.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -43.52 85.35 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.995 1.27 . . . . 0.0 110.258 -174.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -66.44 -43.78 84.68 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 119.1 -0.476 . . . . 0.0 110.038 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -64.97 -42.42 94.6 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.136 0.88 . . . . 0.0 110.944 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 52.9 t -56.66 -52.29 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -64.95 -32.89 74.83 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 121.846 -0.534 . . . . 0.0 111.667 -175.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -62.84 -46.66 86.9 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 123.58 0.752 . . . . 0.0 111.15 172.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.446 HD12 HD11 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -57.84 -46.68 84.42 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 122.807 0.443 . . . . 0.0 110.101 175.641 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.5 mt -58.75 -41.8 83.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 123.918 0.887 . . . . 0.0 110.233 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.31 -28.87 68.47 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.216 0.916 . . . . 0.0 111.637 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -75.2 -40.73 58.99 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.538 0.608 . . . . 0.0 111.85 176.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.4 pt -101.85 -35.89 4.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 116.496 2.035 . . . . 0.0 116.496 -168.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 C--O 1.255 1.365 0 C-N-CA 124.438 1.095 . . . . 0.0 111.608 -170.269 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 tpt . . . . . 0 N--CA 1.5 2.034 0 CA-C-O 118.594 -0.717 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.517 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -60.79 120.54 10.32 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 120.895 1.679 . . . . 0.0 108.39 -174.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.408 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 31.9 mtpt -93.37 134.64 35.38 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -170.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.787 HG13 HG12 ' A' ' 75' ' ' VAL . 14.6 t -116.6 154.81 18.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 53.6 tpp -136.03 136.17 40.05 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -118.53 106.63 12.85 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.45 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 4.7 t -91.06 119.43 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -170.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.9 m -91.61 162.33 14.56 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.947 0.499 . . . . 0.0 111.52 -173.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -160.13 151.42 19.48 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.535 1.934 . . . . 0.0 106.258 169.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.447 ' HD3' ' H ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER 59.46 -165.16 0.2 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.484 1.113 . . . . 0.0 109.527 -169.788 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.541 HD21 ' CG ' ' A' ' 43' ' ' HIS . 51.9 t-20 -61.5 109.02 1.06 Allowed 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.3 m -61.41 2.53 0.15 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 -168.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 35.4 m -44.51 -47.62 10.11 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 120.099 1.318 . . . . 0.0 111.854 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -63.66 -39.46 94.4 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 118.992 0.815 . . . . 0.0 112.654 -175.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.27 -40.4 10.0 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.989 1.316 . . . . 0.0 111.298 -169.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.442 HE22 HG12 ' A' ' 42' ' ' VAL . 5.7 pt20 -65.67 -34.58 78.54 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.551 -0.718 . . . . 0.0 109.908 170.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.446 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.3 tpt -62.9 -39.87 95.85 Favored 'General case' 0 CA--C 1.512 -0.506 0 O-C-N 121.238 -0.914 . . . . 0.0 110.135 171.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.88 -39.22 84.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -64.28 -39.28 93.6 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.302 170.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.21 -45.59 85.55 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 120.726 1.603 . . . . 0.0 111.333 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -63.88 -39.63 94.63 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.459 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -68.59 -39.34 80.98 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 119.868 1.213 . . . . 0.0 110.99 -175.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -70.36 -26.47 63.74 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 120.532 1.514 . . . . 0.0 112.096 175.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 m -73.01 -51.04 19.73 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.369 1.467 . . . . 0.0 110.741 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.9 mt -88.82 -27.18 21.26 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.351 1.46 . . . . 0.0 112.307 -169.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.89 13.33 59.14 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 126.445 1.974 . . . . 0.0 111.682 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.52 122.81 14.97 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.039 1.335 . . . . 0.0 109.76 -174.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.31 9.13 86.99 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 119.887 -0.396 . . . . 0.0 113.649 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -123.88 -32.11 3.32 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.407 1.483 . . . . 0.0 109.275 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.8 pt -142.75 174.75 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 125.443 1.497 . . . . 0.0 109.439 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.87 146.07 43.16 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 168.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.459 HG11 ' HB3' ' A' ' 22' ' ' ALA . 1.8 t -135.58 142.12 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 123.168 0.587 . . . . 0.0 110.878 -168.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.03 159.63 44.42 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.92 0.888 . . . . 0.0 110.559 -176.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.0 p -133.83 156.26 48.37 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.873 1.269 . . . . 0.0 109.272 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.403 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 24.4 p -151.64 167.27 28.68 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.469 0.707 . . . . 0.0 111.234 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.44 38.4 86.77 Favored Glycine 0 N--CA 1.47 0.958 0 C-N-CA 123.501 0.572 . . . . 0.0 112.913 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 tp -69.74 58.56 0.14 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.735 2.014 . . . . 0.0 113.087 -169.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 53.0 7.51 0.08 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.142 2.177 . . . . 0.0 114.852 -170.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.9 m 56.57 33.66 23.08 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.462 1.105 . . . . 0.0 111.127 -169.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.6 m -132.4 -115.23 0.22 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.272 1.429 . . . . 0.0 108.93 -176.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -155.57 176.3 12.78 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.88 1.272 . . . . 0.0 109.354 -177.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.442 HG12 HE22 ' A' ' 16' ' ' GLN . 17.9 m -67.14 174.87 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.634 1.174 . . . . 0.0 111.416 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.541 ' CG ' HD21 ' A' ' 11' ' ' ASN . 13.5 t-80 -132.96 98.88 15.5 Favored Pre-proline 0 CA--C 1.53 0.2 0 C-N-CA 123.311 0.645 . . . . 0.0 109.672 -169.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -42.28 -33.18 2.37 Favored 'Trans proline' 0 CA--C 1.534 0.499 1 C-N-CA 125.846 4.364 . . . . 0.0 116.377 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.4 m -64.0 -39.29 93.79 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.792 1.178 . . . . 0.0 110.798 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.55 -43.48 80.6 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 121.133 -0.979 . . . . 0.0 109.218 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.88 -44.3 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.27 -43.23 99.22 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.429 0.559 . . . . 0.0 111.701 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.4 mmt -65.44 -21.61 66.67 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.166 0.439 . . . . 0.0 111.893 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.446 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.4 OUTLIER -93.4 -33.65 13.76 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -177.245 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -61.76 -34.13 75.3 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.954 1.302 . . . . 0.0 109.941 169.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.54 -8.31 4.17 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.601 1.961 . . . . 0.0 112.347 172.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.2 p -134.56 12.44 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 125.484 1.513 . . . . 0.0 110.91 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.81 36.87 66.15 Favored Glycine 0 CA--C 1.534 1.268 0 O-C-N 120.841 -1.162 . . . . 0.0 113.599 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.5 mt -120.46 154.71 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.319 1.448 . . . . 0.0 108.639 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.8 126.8 53.1 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.882 1.673 . . . . 0.0 109.571 -177.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.6 pt -134.59 8.19 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 125.501 1.52 . . . . 0.0 110.59 168.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.42 -37.41 68.64 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.404 1.882 . . . . 0.0 111.567 177.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.27 -6.81 89.04 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 123.471 0.558 . . . . 0.0 113.32 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -72.48 156.31 39.18 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.939 1.296 . . . . 0.0 109.874 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -150.97 164.98 35.1 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.5 m -68.08 141.28 56.19 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 126.999 2.119 . . . . 0.0 112.131 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -162.38 127.67 2.17 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 169.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.88 152.17 28.36 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.648 2.232 . . . . 0.0 113.38 -169.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.5 tt -59.3 -37.12 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.478 1.511 . . . . 0.0 111.366 -173.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -70.92 -19.67 62.56 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.126 0.57 . . . . 0.0 112.11 -173.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -15.68 54.54 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 118.762 -0.637 . . . . 0.0 111.85 173.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.403 ' CE2' ' HB3' ' A' ' 35' ' ' CYS . 62.6 m-85 -84.03 168.49 15.88 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.225 1.012 . . . . 0.0 110.804 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -140.16 86.17 2.06 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 102.634 -3.098 . . . . 0.0 102.634 -178.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.493 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -54.37 -23.23 14.76 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.58 -27.55 17.31 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.279 0.632 . . . . 0.0 111.184 172.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -84.48 -7.6 59.23 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.25 1.02 . . . . 0.0 113.16 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 26.0 m-85 -126.09 113.74 17.48 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 120.132 1.333 . . . . 0.0 108.912 -171.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -66.1 -12.21 54.09 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -168.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.787 HG12 HG13 ' A' ' 4' ' ' VAL . 22.9 t -145.25 123.24 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -170.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.3 t -118.74 129.63 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.2 mm -120.55 96.87 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 169.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.45 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 61.7 p -74.43 160.45 30.96 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 169.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -138.39 42.07 2.21 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 170.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.7 m -80.69 11.03 4.11 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.43 1.492 . . . . 0.0 111.177 -172.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.81 26.95 70.02 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 -174.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 2.0 t 52.78 -176.26 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.631 1.972 . . . . 0.0 111.314 -169.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.04 -33.79 1.07 Allowed Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.009 1.29 . . . . 0.0 114.677 172.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.5 t -57.61 119.32 2.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 125.198 1.399 . . . . 0.0 107.522 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -73.78 146.79 44.0 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 171.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.3 mt -127.09 153.41 76.62 Favored Pre-proline 0 C--O 1.237 0.439 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -53.08 151.94 19.88 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.26 1.973 . . . . 0.0 111.079 170.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -65.93 -19.8 58.07 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.574 1.516 . . . . 0.0 114.302 -169.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.58 -27.0 68.65 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.135 -0.978 . . . . 0.0 110.917 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.493 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 70.8 m95 -67.01 -12.47 59.97 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.046 -1.034 . . . . 0.0 112.819 175.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.8 t -104.74 -29.63 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.79 1.236 . . . . 0.0 111.127 -170.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.4 p -75.01 -13.38 60.5 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.365 1.066 . . . . 0.0 113.775 -169.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -55.78 163.6 1.36 Allowed 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 129.562 3.145 . . . . 0.0 113.761 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.62 -41.42 96.19 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.676 1.19 . . . . 0.0 108.373 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.557 ' HB ' HG13 ' A' ' 75' ' ' VAL . 20.0 mm -119.92 136.02 58.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 169.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -142.42 109.52 5.55 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 103.96 -2.607 . . . . 0.0 103.96 165.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -137.28 166.3 24.1 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 125.852 1.661 . . . . 0.0 106.765 178.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -133.07 130.16 38.98 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 169.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -111.31 83.12 1.71 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.512 ' H ' ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -66.81 46.49 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.481 2.312 . . . . 0.0 112.856 178.142 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.73 169.67 15.17 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.21 -0.931 . . . . 0.0 111.154 -173.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -46.93 142.57 3.39 Favored 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 126.03 1.732 . . . . 0.0 112.221 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -87.58 111.58 42.77 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.915 1.286 . . . . 0.0 108.759 176.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -83.38 -7.44 10.83 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.489 2.126 . . . . 0.0 112.416 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.4 t0 23.88 -96.96 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 128.233 2.613 . . . . 0.0 113.961 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.57 44.1 1.22 Allowed Glycine 0 CA--C 1.533 1.205 0 C-N-CA 126.944 2.211 . . . . 0.0 110.607 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -70.44 -175.39 1.02 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.847 1.659 . . . . 0.0 113.274 -175.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.2 p -69.08 162.38 27.05 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.44 169.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 22.8 mt -55.84 -37.0 68.14 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.942 0.497 . . . . 0.0 111.026 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.47 -37.32 77.9 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 123.262 0.625 . . . . 0.0 110.39 -174.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.4 t -74.2 -41.68 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -55.94 -34.74 65.93 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.451 1.023 . . . . 0.0 112.138 171.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.8 mtp85 -73.0 -44.87 60.51 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 119.705 1.139 . . . . 0.0 111.606 173.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 91.3 m -75.46 -38.21 59.82 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.372 0.669 . . . . 0.0 112.021 -169.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 87.4 t -71.49 -45.2 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -176.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -43.51 -53.02 5.81 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 125.886 1.675 . . . . 0.0 111.236 169.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.53 -40.18 97.44 Favored Glycine 0 N--CA 1.467 0.721 0 CA-C-N 119.785 1.175 . . . . 0.0 111.96 -175.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -65.17 -38.65 91.21 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 121.492 -1.005 . . . . 0.0 110.359 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.18 -40.44 89.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 175.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -36.89 76.04 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.454 1.025 . . . . 0.0 111.292 -177.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -69.85 -42.93 72.91 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 118.743 -0.646 . . . . 0.0 110.448 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -63.47 -43.18 98.09 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.88 1.218 . . . . 0.0 110.388 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 63.9 t -54.98 -53.66 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 123.475 0.71 . . . . 0.0 109.627 173.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -64.77 -32.77 74.61 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 122.151 -0.343 . . . . 0.0 111.419 -175.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -62.8 -47.73 82.19 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 123.363 0.665 . . . . 0.0 111.208 172.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.92 -47.75 76.95 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.454 0.57 . . . . 0.0 109.589 175.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -57.89 -42.49 82.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 124.452 1.101 . . . . 0.0 110.091 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.07 -28.94 68.22 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.885 0.766 . . . . 0.0 111.94 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -75.49 -40.56 57.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.614 0.643 . . . . 0.0 111.759 175.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 pt -101.33 -42.45 9.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -168.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 C--O 1.253 1.287 0 CA-C-N 119.089 0.859 . . . . 0.0 110.237 -173.423 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 tpt . . . . . 0 N--CA 1.497 1.918 0 CA-C-O 117.957 -1.02 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.546 ' HB2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -48.75 121.87 5.08 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 120.597 1.544 . . . . 0.0 109.863 -174.044 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -97.8 135.83 39.0 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -169.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.808 HG13 HG12 ' A' ' 75' ' ' VAL . 11.8 t -113.52 156.52 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 59.2 tpp -135.67 137.49 41.87 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.448 ' HE2' HG13 ' A' ' 32' ' ' VAL . 97.3 m-85 -119.78 117.07 27.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 177.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.437 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 8.5 t -99.55 132.39 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -169.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.8 t -111.79 131.22 55.47 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.962 0.887 . . . . 0.0 112.892 -169.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -140.15 150.93 44.84 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 129.08 2.952 . . . . 0.0 103.503 169.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 58.0 -170.8 0.11 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.799 0.84 . . . . 0.0 109.79 -168.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.421 HD21 ' CD2' ' A' ' 43' ' ' HIS . 15.1 t-20 -58.0 130.03 44.69 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -168.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.9 m -35.0 -35.41 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.997 1.719 . . . . 0.0 115.636 169.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.1 p -61.41 -9.6 5.82 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -99.96 -52.97 3.28 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 120.369 1.44 . . . . 0.0 110.823 171.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 p -94.21 -51.26 4.9 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 120.703 -1.248 . . . . 0.0 113.736 -168.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.32 -21.64 63.83 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 118.069 -1.452 . . . . 0.0 110.031 173.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.468 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 0.8 OUTLIER -63.39 -39.57 94.88 Favored 'General case' 0 CA--C 1.512 -0.498 0 O-C-N 120.899 -1.126 . . . . 0.0 109.056 168.364 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.9 -37.91 74.86 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 118.753 -0.641 . . . . 0.0 109.866 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -61.44 -40.07 93.12 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.942 169.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.33 -42.9 93.76 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 120.242 1.383 . . . . 0.0 111.454 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -67.23 -39.01 86.15 Favored 'General case' 0 CA--C 1.518 -0.274 0 O-C-N 121.554 -0.968 . . . . 0.0 108.705 173.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.06 -40.28 71.73 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 119.525 1.057 . . . . 0.0 110.433 -173.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -72.03 -15.5 62.03 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.449 1.022 . . . . 0.0 112.327 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 m -85.08 -50.54 7.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.798 1.639 . . . . 0.0 109.469 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.6 mt -88.85 -26.21 21.76 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.515 1.126 . . . . 0.0 112.7 -169.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.91 13.87 57.5 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 126.161 1.839 . . . . 0.0 112.076 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.01 125.16 23.05 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.635 1.174 . . . . 0.0 108.825 -174.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.2 7.79 88.21 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.711 -0.494 . . . . 0.0 113.795 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt -125.64 -42.78 1.91 Allowed 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 125.731 1.612 . . . . 0.0 108.988 -176.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.546 HG22 ' HB2' ' A' ' 2' ' ' LYS . 2.7 pp -143.29 152.04 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 124.642 1.177 . . . . 0.0 109.301 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.12 152.2 21.24 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 172.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.448 HG13 ' HE2' ' A' ' 6' ' ' PHE . 2.6 t -139.33 139.86 38.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 121.819 -0.551 . . . . 0.0 110.157 -168.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.98 159.23 43.82 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.337 1.055 . . . . 0.0 109.135 -172.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.2 t -146.88 156.08 42.81 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 119.376 0.989 . . . . 0.0 110.251 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.3 p -147.37 153.61 39.87 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.842 0.857 . . . . 0.0 109.707 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.82 -119.4 5.75 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 106.542 -2.623 . . . . 0.0 106.542 -169.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.6 tp 83.59 62.77 0.01 OUTLIER 'General case' 0 C--N 1.346 0.447 0 C-N-CA 127.449 2.299 . . . . 0.0 105.234 -177.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -67.63 -18.25 64.9 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.82 -171.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.8 m -83.79 38.87 0.66 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.469 1.108 . . . . 0.0 112.197 -175.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.5 m 67.82 -169.76 0.19 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.253 1.821 . . . . 0.0 110.712 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -57.65 -25.43 60.17 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -169.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -169.72 159.38 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 126.971 2.108 . . . . 0.0 107.254 169.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.421 ' CD2' HD21 ' A' ' 11' ' ' ASN . 80.0 t60 -132.98 108.47 12.71 Favored Pre-proline 0 C--O 1.234 0.251 0 C-N-CA 123.187 0.595 . . . . 0.0 109.414 -169.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -64.37 -30.38 62.92 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.157 2.571 . . . . 0.0 112.234 -168.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.5 m -65.73 -36.53 83.85 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 119.296 0.953 . . . . 0.0 109.246 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.411 ' HB1' HD11 ' A' ' 57' ' ' ILE . . . -65.97 -44.6 84.46 Favored 'General case' 0 C--N 1.346 0.424 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -58.05 -48.8 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.96 96.26 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.713 0.688 . . . . 0.0 110.906 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.6 mmt -58.66 -25.89 63.24 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.873 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.468 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.5 OUTLIER -95.87 -26.33 15.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 119.178 0.899 . . . . 0.0 108.932 -177.579 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -64.74 -29.64 70.63 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.546 1.138 . . . . 0.0 110.445 169.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -57.63 -22.82 47.8 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.386 0.674 . . . . 0.0 112.186 171.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.9 m -124.09 11.59 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 125.708 1.603 . . . . 0.0 111.279 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.41 40.92 86.63 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.0 0.81 . . . . 0.0 113.012 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.7 mt -124.87 154.29 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.542 1.537 . . . . 0.0 107.758 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -122.6 126.37 47.55 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.013 1.325 . . . . 0.0 109.014 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.411 HD11 ' HB1' ' A' ' 46' ' ' ALA . 35.8 pt -129.47 16.38 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 125.14 1.376 . . . . 0.0 111.268 170.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.51 -24.89 45.56 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.762 1.625 . . . . 0.0 112.226 169.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.27 -13.13 81.63 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 118.136 0.426 . . . . 0.0 112.399 174.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -73.12 163.09 28.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.697 1.199 . . . . 0.0 110.545 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.7 p -148.3 168.06 23.56 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.727 1.211 . . . . 0.0 110.791 170.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.35 143.88 51.81 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.714 1.206 . . . . 0.0 109.801 174.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -161.04 127.93 2.56 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 117.225 -1.369 . . . . 0.0 107.751 173.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -65.52 152.33 82.17 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.136 2.557 . . . . 0.0 114.468 -172.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.1 tt -62.05 -41.13 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 124.438 1.095 . . . . 0.0 111.083 174.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -70.42 -20.82 62.89 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.085 0.554 . . . . 0.0 111.891 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.98 -19.04 60.78 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.548 0.739 . . . . 0.0 111.642 171.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -92.54 169.8 10.25 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.912 0.863 . . . . 0.0 110.954 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -140.94 88.58 2.19 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 -173.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.496 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -53.95 -24.15 15.53 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -28.58 16.06 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.355 0.662 . . . . 0.0 111.372 173.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -82.3 -13.71 56.53 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.311 1.044 . . . . 0.0 113.302 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -121.64 113.63 20.02 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 120.081 1.309 . . . . 0.0 109.383 -169.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.4 -16.03 52.43 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -169.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.808 HG12 HG13 ' A' ' 4' ' ' VAL . 14.3 t -144.8 127.13 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -170.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.7 t -121.26 127.39 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.2 mm -119.72 95.05 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 169.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.437 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 31.2 t -74.45 165.96 24.31 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 168.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.88 26.14 2.29 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.61 -1.306 . . . . 0.0 109.128 171.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.576 ' HB3' HG21 ' A' ' 84' ' ' VAL . 57.0 m -83.52 -1.32 53.43 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.167 -0.958 . . . . 0.0 112.476 -170.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.96 23.89 6.86 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 123.783 0.706 . . . . 0.0 111.73 175.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.453 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 3.2 t 44.32 45.16 7.18 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.148 1.779 . . . . 0.0 112.336 -174.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -155.6 35.82 0.63 Allowed Glycine 0 C--N 1.339 0.743 0 CA-C-O 119.735 -0.481 . . . . 0.0 112.319 -171.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.576 HG21 ' HB3' ' A' ' 80' ' ' CYS . 86.6 t -122.87 141.91 41.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 125.058 1.343 . . . . 0.0 108.6 178.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -81.95 60.09 4.63 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.37 1.068 . . . . 0.0 109.966 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 68.4 mt -56.63 134.35 77.89 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -54.57 155.36 17.22 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.552 2.168 . . . . 0.0 112.568 178.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -54.9 -28.82 60.71 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.76 2.306 . . . . 0.0 116.099 -171.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -66.53 -24.36 66.37 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.153 -0.967 . . . . 0.0 111.607 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.496 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 66.9 m95 -70.97 -13.93 62.18 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 117.892 -1.051 . . . . 0.0 113.14 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.9 m -113.52 -10.93 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 120.107 1.321 . . . . 0.0 113.165 -171.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.4 p -84.05 -16.41 43.93 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.615 0.766 . . . . 0.0 112.739 -175.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -50.45 161.86 0.28 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 130.017 3.327 . . . . 0.0 114.377 174.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -62.36 -39.32 92.79 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.454 1.502 . . . . 0.0 108.801 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.594 ' HB ' HG13 ' A' ' 75' ' ' VAL . 23.4 mm -122.85 136.83 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 169.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -141.14 111.89 7.07 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 100.926 -3.731 . . . . 0.0 100.926 166.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.92 164.32 28.22 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 174.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.8 t70 -134.56 100.31 4.6 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 170.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -77.2 78.32 3.73 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -55.62 33.43 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.953 1 C-N-CA 131.745 4.018 . . . . 0.0 113.761 170.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.93 172.15 5.85 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.083 1.353 . . . . 0.0 111.717 -169.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.52 ' HB2' HG22 ' A' ' 115' ' ' VAL . 38.4 mt-10 -49.88 155.52 0.87 Allowed 'General case' 0 C--O 1.231 0.088 0 C-N-CA 125.354 1.462 . . . . 0.0 112.632 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -107.24 110.58 63.31 Favored Pre-proline 0 N--CA 1.448 -0.538 0 C-N-CA 126.556 1.942 . . . . 0.0 109.062 175.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -95.31 1.03 2.49 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 124.068 3.179 . . . . 0.0 112.631 175.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -51.37 -37.09 46.32 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -168.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -109.38 25.05 18.96 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.48 -1.178 . . . . 0.0 112.677 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.469 ' NE2' HG11 ' A' ' 111' ' ' VAL . 28.9 mt-30 -122.34 174.65 6.87 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 118.999 1.4 . . . . 0.0 113.95 -169.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.1 m -73.14 166.79 22.46 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 112.947 -1.933 . . . . 0.0 110.144 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.6 mt -55.51 -31.61 62.2 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 123.189 0.596 . . . . 0.0 110.951 175.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -62.28 -41.16 98.25 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 118.298 0.499 . . . . 0.0 110.567 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.469 HG11 ' NE2' ' A' ' 107' ' ' GLN . 17.2 t -76.48 -39.82 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 117.322 -1.323 . . . . 0.0 108.784 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -47.23 -48.57 24.25 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 120.264 1.393 . . . . 0.0 110.949 168.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -61.21 -46.1 91.82 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.261 0.937 . . . . 0.0 111.184 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.5 m -68.21 -37.37 80.81 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 122.865 0.466 . . . . 0.0 110.16 -171.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.52 HG22 ' HB2' ' A' ' 102' ' ' GLU . 40.3 t -75.93 -44.01 38.8 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -177.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -45.59 -51.09 12.53 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 124.795 1.238 . . . . 0.0 111.193 170.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.18 -42.97 97.75 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 119.506 1.048 . . . . 0.0 112.19 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -65.61 -35.56 81.17 Favored 'General case' 0 CA--C 1.52 -0.192 0 O-C-N 120.942 -1.328 . . . . 0.0 110.832 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.2 -42.63 97.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 173.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.15 -39.65 83.09 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.422 1.465 . . . . 0.0 111.369 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.7 -44.62 73.59 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.393 1.477 . . . . 0.0 109.743 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -66.89 -41.34 87.36 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.574 -0.704 . . . . 0.0 112.039 177.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 38.9 t -54.77 -53.02 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -64.08 -32.74 74.41 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 122.043 -0.411 . . . . 0.0 111.647 -175.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -63.13 -46.09 88.88 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 121.612 -0.68 . . . . 0.0 111.392 172.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.11 -47.58 82.82 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 175.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -58.02 -41.37 80.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 123.896 0.878 . . . . 0.0 109.825 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.26 -27.39 68.42 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.868 0.758 . . . . 0.0 112.093 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -76.82 -41.21 45.22 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 118.616 -0.706 . . . . 0.0 112.315 174.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.8 pt -101.13 -35.11 4.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 -168.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 28.2 m . . . . . 0 C--O 1.256 1.401 0 CA-C-N 119.304 0.956 . . . . 0.0 111.497 -177.107 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 tpt . . . . . 0 N--CA 1.499 2.011 0 CA-C-O 118.53 -0.747 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.477 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -60.94 119.28 7.95 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 120.842 1.655 . . . . 0.0 108.679 -174.566 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -90.37 138.08 31.83 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -172.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.7 t -116.37 153.74 17.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 O-C-N 124.25 0.969 . . . . 0.0 108.386 174.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.25 142.09 50.94 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 175.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -121.5 103.92 9.28 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.544 -1.651 . . . . 0.0 106.544 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 6.1 t -89.32 134.52 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -169.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 82.4 m -91.84 169.15 10.92 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -169.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -147.52 -160.45 1.17 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 128.159 2.584 . . . . 0.0 105.476 168.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.8 ttm105 -46.38 141.46 3.53 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.916 1.235 . . . . 0.0 111.504 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.541 HD21 ' CD2' ' A' ' 43' ' ' HIS . 9.0 t-20 44.34 67.62 0.66 Allowed 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 127.964 2.506 . . . . 0.0 109.694 -172.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 p -51.4 -20.61 1.85 Allowed 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 126.522 1.929 . . . . 0.0 114.71 -171.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 77.1 m -61.0 -17.64 53.26 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 116.734 -1.603 . . . . 0.0 113.658 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -65.45 -37.14 86.01 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 122.978 2.626 . . . . 0.0 111.334 169.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.473 ' HB3' HD13 ' A' ' 79' ' ' LEU . 0.4 OUTLIER -86.63 -39.91 15.64 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.409 -0.807 . . . . 0.0 108.901 -174.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -66.89 -25.28 66.31 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 120.902 -1.124 . . . . 0.0 110.875 169.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.437 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.8 tpt -67.03 -37.89 84.94 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 119.884 -1.76 . . . . 0.0 109.153 169.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.58 89.73 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.429 ' HG3' HG12 ' A' ' 32' ' ' VAL . 60.4 tt0 -61.87 -40.19 94.5 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.49 -0.766 . . . . 0.0 110.533 169.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.31 -35.65 63.59 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 120.894 1.679 . . . . 0.0 112.676 -175.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -71.87 -37.81 70.13 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 118.329 1.065 . . . . 0.0 108.724 169.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.472 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -71.53 -39.27 70.84 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 120.567 -1.333 . . . . 0.0 111.275 -174.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.432 ' HA ' HG21 ' A' ' 32' ' ' VAL . 52.8 pttt -63.45 -23.95 67.62 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.054 1.297 . . . . 0.0 111.979 174.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 m -84.94 -50.42 7.51 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.146 2.178 . . . . 0.0 109.581 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.6 mt -88.45 -25.12 22.79 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.377 1.471 . . . . 0.0 112.022 -169.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -106.5 15.75 41.74 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 126.715 2.102 . . . . 0.0 111.73 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.35 123.09 16.79 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.595 1.158 . . . . 0.0 109.442 -175.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.24 8.38 87.5 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 123.07 0.367 . . . . 0.0 113.786 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.2 mmtt -120.66 -34.82 3.5 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 126.117 1.767 . . . . 0.0 109.278 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.5 pt -142.38 172.77 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 124.912 1.285 . . . . 0.0 109.307 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.8 145.98 39.65 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 168.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.472 HG11 ' HB3' ' A' ' 22' ' ' ALA . 2.1 t -134.57 141.26 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 123.163 0.585 . . . . 0.0 110.782 -168.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.01 160.51 42.06 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.129 0.972 . . . . 0.0 109.826 -173.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.5 p -135.51 168.14 19.78 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.124 1.329 . . . . 0.0 109.443 169.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.3 p -153.61 157.01 39.01 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.6 -0.687 . . . . 0.0 112.005 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.63 -54.14 0.57 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.693 1.616 . . . . 0.0 110.626 173.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 43.83 33.8 0.79 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.703 2.001 . . . . 0.0 114.882 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 55.51 11.53 0.63 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.207 1.403 . . . . 0.0 114.235 -174.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 26.4 m 57.65 33.0 22.69 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.836 1.254 . . . . 0.0 111.727 -169.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.8 m -138.21 178.13 7.36 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.454 1.902 . . . . 0.0 109.738 -176.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -72.34 166.8 21.79 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.467 -0.771 . . . . 0.0 109.946 170.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 p -62.58 167.05 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.24 1.416 . . . . 0.0 110.341 175.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.541 ' CD2' HD21 ' A' ' 11' ' ' ASN . 77.4 t60 -123.25 110.8 30.59 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 124.312 1.045 . . . . 0.0 110.147 -169.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.48 -25.03 41.8 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.389 2.726 . . . . 0.0 115.113 -169.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -59.73 -37.63 79.48 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 120.538 1.517 . . . . 0.0 110.775 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.41 -44.51 71.25 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.13 -44.19 78.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 CA-C-O 118.616 -0.707 . . . . 0.0 109.137 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.05 -42.77 81.15 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.689 0.677 . . . . 0.0 110.974 177.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.415 ' HG3' ' HB3' ' A' ' 112' ' ' PHE . 30.4 mmt -66.78 -22.47 66.03 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.779 -0.629 . . . . 0.0 112.311 178.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.437 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 1.8 mmt -90.18 -36.32 14.86 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -65.38 -34.86 79.31 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.368 1.067 . . . . 0.0 110.267 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.26 1.0 OUTLIER -76.31 5.21 7.38 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.3 0.64 . . . . 0.0 112.289 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.0 m -129.07 -23.02 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.831 1.252 . . . . 0.0 112.707 169.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.72 31.11 0.91 Allowed Glycine 0 CA--C 1.532 1.125 0 CA-C-N 119.739 1.154 . . . . 0.0 114.422 170.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.0 mt -130.13 161.62 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.534 1.534 . . . . 0.0 107.112 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -140.36 146.81 38.9 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 169.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.6 pt -138.37 5.71 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.486 1.914 . . . . 0.0 110.618 -176.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.6 p -64.04 145.12 56.45 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.172 -0.955 . . . . 0.0 110.138 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.2 6.02 18.2 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 118.253 -1.304 . . . . 0.0 113.811 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -57.14 -44.76 83.71 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 119.521 1.66 . . . . 0.0 113.205 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -149.53 162.24 40.54 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 124.232 0.958 . . . . 0.0 110.626 -168.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.3 p -170.5 27.4 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.702 0.801 . . . . 0.0 111.994 -170.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -139.33 147.08 51.41 Favored Pre-proline 0 N--CA 1.475 0.809 0 O-C-N 120.604 -1.31 . . . . 0.0 111.614 -169.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -83.08 161.67 15.59 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.872 3.048 . . . . 0.0 112.558 -174.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.7 tt -59.76 -37.24 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.666 1.186 . . . . 0.0 111.545 -177.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -70.5 -20.69 62.82 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.275 0.63 . . . . 0.0 112.134 -173.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -19.05 59.26 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 118.872 -0.585 . . . . 0.0 111.338 171.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -97.72 167.32 11.02 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.934 0.874 . . . . 0.0 110.637 -176.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -141.46 89.61 2.23 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 -172.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.473 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -50.94 -30.66 15.45 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.53 -29.56 10.92 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.134 0.974 . . . . 0.0 112.459 174.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -71.53 -18.58 62.26 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -107.64 171.03 7.62 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 128.398 2.679 . . . . 0.0 108.707 -172.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -111.42 -22.6 11.22 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-O 117.792 -1.099 . . . . 0.0 113.274 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.706 HG13 ' HB ' ' A' ' 95' ' ' ILE . 37.7 t -137.4 133.92 46.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 121.544 1.975 . . . . 0.0 108.585 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.0 t -116.5 129.89 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 173.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.3 mm -122.89 96.82 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 101.76 -3.422 . . . . 0.0 101.76 169.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.415 ' HA ' ' HB ' ' A' ' 7' ' ' VAL 0.254 22.0 p -74.32 166.39 23.55 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 117.649 -1.62 . . . . 0.0 108.257 169.552 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.473 HD13 ' HB3' ' A' ' 15' ' ' SER . 5.4 mp -136.36 37.86 2.71 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 170.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 63.8 m -95.91 7.59 45.93 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.869 2.067 . . . . 0.0 110.932 -169.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.85 31.78 6.83 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 119.246 -0.752 . . . . 0.0 112.221 172.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 31.5 p 40.26 37.85 0.47 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.644 2.378 . . . . 0.0 116.041 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.86 24.46 0.49 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 123.896 0.76 . . . . 0.0 112.566 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 p -78.21 143.75 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 124.615 1.166 . . . . 0.0 108.897 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -92.96 58.85 3.05 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.476 1.11 . . . . 0.0 109.239 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.8 mt -61.29 147.47 87.14 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -175.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -56.41 157.58 17.95 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.895 2.397 . . . . 0.0 111.89 170.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.3 -25.34 64.37 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 121.853 1.702 . . . . 0.0 114.875 -169.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.47 -24.68 67.22 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.49 -1.382 . . . . 0.0 111.636 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.473 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 72.1 m95 -72.65 -9.26 58.4 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 117.855 -1.069 . . . . 0.0 112.686 175.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.8 m -117.49 -16.06 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 119.926 1.239 . . . . 0.0 113.166 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.9 p -76.06 -11.18 59.9 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.15 0.886 . . . . 0.0 112.352 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.407 ' HG2' ' H ' ' A' ' 93' ' ' GLN . 69.8 mm-40 -43.38 156.1 0.06 Allowed 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 130.618 3.567 . . . . 0.0 111.826 169.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -62.12 -36.18 80.97 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.725 1.61 . . . . 0.0 109.731 171.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.706 ' HB ' HG13 ' A' ' 75' ' ' VAL . 24.4 mm -131.98 137.0 55.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -135.46 112.62 10.43 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 102.07 -3.307 . . . . 0.0 102.07 166.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -136.31 168.42 19.46 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -141.94 118.68 11.08 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 170.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.45 ' CD2' ' HB3' ' A' ' 122' ' ' ARG . 49.5 m0 -95.52 79.59 3.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.31 18.74 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 129.022 2.929 . . . . 0.0 116.411 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -61.76 128.8 37.97 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 120.615 -1.303 . . . . 0.0 113.857 -168.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 46.94 -157.74 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 128.403 2.681 . . . . 0.0 114.161 169.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -163.51 74.47 1.84 Allowed Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 127.871 2.468 . . . . 0.0 108.054 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.5 -13.35 32.72 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.365 2.71 . . . . 0.0 115.834 -169.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.0 t70 26.17 -92.37 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.001 2.52 . . . . 0.0 114.045 172.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.89 45.23 1.01 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 126.888 2.185 . . . . 0.0 109.771 171.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -66.45 175.04 2.41 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.712 2.005 . . . . 0.0 114.133 -172.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.0 m -66.21 152.05 45.69 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 113.217 -1.811 . . . . 0.0 109.657 169.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.3 mt -57.18 -35.24 69.34 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.262 0.625 . . . . 0.0 111.077 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -61.3 -36.35 79.85 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 122.862 0.465 . . . . 0.0 110.794 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 23.3 t -74.83 -40.75 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-O 117.849 -1.072 . . . . 0.0 108.76 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.415 ' HB3' ' HG3' ' A' ' 49' ' ' MET . 57.3 m-85 -54.84 -42.55 72.11 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 120.432 1.469 . . . . 0.0 110.748 172.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 59.0 mtt85 -62.21 -46.01 90.81 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.227 0.921 . . . . 0.0 111.743 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.4 m -69.89 -43.64 71.37 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -172.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.8 t -65.9 -45.67 90.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -173.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -47.55 -53.77 13.55 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.997 1.319 . . . . 0.0 110.566 169.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.78 -42.15 99.71 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 119.328 0.967 . . . . 0.0 111.998 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -64.88 -39.71 93.97 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 121.425 -1.044 . . . . 0.0 110.607 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 45.0 t -62.82 -42.34 95.98 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -36.64 78.89 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 120.128 1.331 . . . . 0.0 111.475 -174.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -68.57 -42.69 77.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.691 -0.671 . . . . 0.0 109.869 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.45 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 10.4 mpt_? -63.41 -42.36 98.76 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 119.831 1.196 . . . . 0.0 110.412 177.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 56.7 t -54.7 -52.93 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 123.469 0.708 . . . . 0.0 109.114 174.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -66.29 -32.85 74.51 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 122.046 -0.409 . . . . 0.0 111.461 -175.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -62.16 -47.87 82.62 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 123.906 0.883 . . . . 0.0 110.966 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -48.03 80.51 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 176.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -57.39 -42.16 79.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 124.447 1.099 . . . . 0.0 109.769 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.68 -27.88 68.19 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.714 0.688 . . . . 0.0 112.154 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -77.01 -41.86 40.97 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.491 0.587 . . . . 0.0 111.951 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.8 pt -99.33 -40.02 8.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 -168.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 40.4 m . . . . . 0 C--O 1.255 1.366 0 CA-C-N 119.005 0.821 . . . . 0.0 110.891 -174.351 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 tpt . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 117.513 -1.232 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.716 ' HG2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -55.98 123.57 14.78 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 121.566 1.985 . . . . 0.0 109.996 -172.054 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -93.47 142.13 27.68 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -169.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.769 HG13 HG12 ' A' ' 75' ' ' VAL . 9.1 t -121.57 153.91 25.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.289 0.993 . . . . 0.0 108.56 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 59.9 tpp -136.32 135.05 38.56 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -117.22 109.88 17.43 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.446 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 10.2 t -96.98 141.74 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -169.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.9 t -125.81 156.7 39.12 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.335 0.97 . . . . 0.0 111.316 173.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp -140.11 34.67 1.92 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.664 1.586 . . . . 0.0 109.197 172.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -156.43 171.6 19.98 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 128.006 2.522 . . . . 0.0 105.156 -170.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.417 HD21 ' CE1' ' A' ' 43' ' ' HIS . 62.5 t-20 -42.2 125.41 3.06 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 169.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.0 p -41.52 -29.46 0.17 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 117.277 2.325 . . . . 0.0 117.277 -169.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.7 m -34.16 -62.16 0.33 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 127.367 2.267 . . . . 0.0 115.148 -169.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -64.6 -52.0 59.79 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.056 0.844 . . . . 0.0 112.529 -168.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -81.67 -34.09 30.92 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 121.514 -0.741 . . . . 0.0 111.417 -172.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.27 -30.76 65.14 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.454 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.7 tpt -64.88 -40.88 95.8 Favored 'General case' 0 CA--C 1.514 -0.419 0 O-C-N 121.018 -1.051 . . . . 0.0 109.094 168.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.67 -36.79 79.59 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -62.03 -42.96 99.73 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.83 -0.605 . . . . 0.0 111.313 169.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.14 -45.61 91.0 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-N 119.936 1.244 . . . . 0.0 110.907 -176.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -63.09 -39.98 96.31 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 117.934 0.867 . . . . 0.0 109.364 172.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.28 -35.82 76.43 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 119.58 1.082 . . . . 0.0 111.561 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -81.93 -13.91 56.85 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 120.311 1.414 . . . . 0.0 113.244 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.9 m -78.18 -50.69 11.47 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.229 1.412 . . . . 0.0 109.397 169.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.3 mt -89.56 -27.4 20.28 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.16 1.384 . . . . 0.0 112.423 -169.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.78 14.63 57.47 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 126.661 2.077 . . . . 0.0 111.685 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.34 120.45 9.32 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.579 1.151 . . . . 0.0 110.054 -172.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.58 9.5 86.13 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 119.81 -0.439 . . . . 0.0 113.467 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -123.27 -24.87 4.56 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 125.159 1.384 . . . . 0.0 109.701 -177.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.716 HG22 ' HG2' ' A' ' 2' ' ' LYS . 13.1 pt -144.29 172.0 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 125.962 1.705 . . . . 0.0 110.42 175.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.31 144.71 38.62 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 103.836 -2.653 . . . . 0.0 103.836 168.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 t -135.59 140.42 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 123.47 0.708 . . . . 0.0 110.743 -168.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.6 160.63 42.49 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.127 0.971 . . . . 0.0 109.939 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.5 p -139.02 163.64 31.85 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.288 1.404 . . . . 0.0 111.221 174.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.7 p -149.64 160.49 43.46 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.151 0.58 . . . . 0.0 111.339 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.24 -87.16 0.43 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 54.65 50.97 14.73 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 125.264 1.425 . . . . 0.0 109.829 -175.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -61.69 -13.06 19.5 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.85 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 p -71.3 6.41 1.74 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 172.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.4 m 63.05 -20.62 0.05 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 129.641 3.176 . . . . 0.0 115.141 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.91 178.63 10.14 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.548 2.339 . . . . 0.0 106.601 174.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.27 159.16 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.417 ' CE1' HD21 ' A' ' 11' ' ' ASN . 70.6 t60 -121.28 111.28 33.71 Favored Pre-proline 0 N--CA 1.454 -0.268 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -169.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -66.08 -27.11 49.92 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.385 2.724 . . . . 0.0 112.343 -169.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.9 m -63.32 -37.11 85.99 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.64 0.655 . . . . 0.0 109.249 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.39 -44.15 88.43 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.08 -49.66 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.22 -42.86 99.34 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.487 0.585 . . . . 0.0 111.119 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.6 mmt -61.89 -24.75 67.14 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.353 -0.832 . . . . 0.0 111.967 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.454 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.6 OUTLIER -94.4 -27.61 15.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 119.151 0.887 . . . . 0.0 108.688 -179.194 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.59 -30.42 71.53 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.371 1.068 . . . . 0.0 110.408 170.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -56.84 -23.19 42.26 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.457 0.703 . . . . 0.0 112.098 171.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.8 m -123.64 12.01 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 125.445 1.498 . . . . 0.0 111.142 -175.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.36 39.65 87.46 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 123.815 0.722 . . . . 0.0 112.759 174.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.6 mt -122.98 154.56 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.428 1.491 . . . . 0.0 107.19 175.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -127.84 128.11 44.65 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 124.552 1.141 . . . . 0.0 108.795 -177.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 46.3 pt -134.64 15.31 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 126.661 1.984 . . . . 0.0 109.752 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.65 160.16 27.66 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 167.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.17 -15.86 2.34 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 118.958 -0.912 . . . . 0.0 112.456 -174.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -61.58 147.46 45.55 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.757 1.279 . . . . 0.0 107.903 169.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.06 169.64 17.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -169.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.3 m -73.06 145.11 46.8 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.663 1.585 . . . . 0.0 111.937 -170.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -166.32 123.8 1.03 Allowed Pre-proline 0 C--O 1.237 0.442 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 169.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -76.87 161.12 33.54 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.115 1.876 . . . . 0.0 111.454 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.8 tt -56.17 -37.79 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.217 1.007 . . . . 0.0 111.142 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -68.86 -21.27 64.28 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.586 0.754 . . . . 0.0 112.16 -176.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.79 -22.43 63.33 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.637 -0.697 . . . . 0.0 111.203 171.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -107.45 165.9 11.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.578 1.18 . . . . 0.0 112.018 -172.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.86 89.8 2.28 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 102.658 -3.09 . . . . 0.0 102.658 -170.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.481 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -49.4 -32.14 11.01 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.275 0.63 . . . . 0.0 112.283 -177.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.08 -28.29 10.18 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.26 1.024 . . . . 0.0 112.868 174.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.04 -23.2 61.34 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.366 0.666 . . . . 0.0 112.208 176.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -104.12 178.89 4.43 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.618 2.767 . . . . 0.0 108.659 -175.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -123.57 -17.4 6.47 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 118.601 -0.714 . . . . 0.0 112.579 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.769 HG12 HG13 ' A' ' 4' ' ' VAL . 17.5 t -143.72 124.25 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -169.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.6 t -117.41 130.09 72.86 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.782 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.425 HG21 ' CE3' ' A' ' 99' ' ' TRP . 33.0 mm -119.35 92.44 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 103.026 -2.953 . . . . 0.0 103.026 169.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.446 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 16.9 t -72.42 161.38 30.9 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 169.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.6 mp -141.32 46.87 1.71 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 169.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 72.2 m -89.76 2.06 55.34 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.992 0.917 . . . . 0.0 110.682 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.12 42.69 5.22 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 172.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.2 p 37.75 44.72 0.59 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.321 2.248 . . . . 0.0 114.638 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -157.56 47.89 0.45 Allowed Glycine 0 C--N 1.34 0.757 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -172.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.9 p -128.09 161.92 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.873 1.669 . . . . 0.0 109.99 -172.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -123.21 45.31 2.45 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.177 2.191 . . . . 0.0 109.445 -170.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.8 mt -54.42 140.98 54.82 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.2 1.0 . . . . 0.0 109.245 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -53.88 153.39 20.13 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.596 2.197 . . . . 0.0 112.554 173.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -55.53 -26.82 56.43 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.515 2.143 . . . . 0.0 116.006 -173.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -64.75 -25.09 67.78 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.915 -1.116 . . . . 0.0 111.865 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.481 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 70.0 m95 -71.43 -9.19 57.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.661 1.184 . . . . 0.0 112.323 173.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.27 -29.8 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.663 1.585 . . . . 0.0 110.294 -173.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.0 p -75.25 -9.63 58.73 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.758 0.823 . . . . 0.0 112.738 -175.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -45.21 155.67 0.12 Allowed 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 129.916 3.287 . . . . 0.0 111.722 169.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -62.19 -39.23 92.0 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.803 1.641 . . . . 0.0 109.561 170.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.61 ' HB ' HG13 ' A' ' 75' ' ' VAL . 21.8 mm -122.56 134.64 65.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 169.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -137.92 111.78 8.33 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 103.892 -2.633 . . . . 0.0 103.892 166.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -137.39 165.72 25.54 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -133.41 105.04 6.71 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.441 1.096 . . . . 0.0 108.157 171.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.425 ' CE3' HG21 ' A' ' 77' ' ' ILE . 46.1 m0 -79.35 72.82 5.98 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.181 1.392 . . . . 0.0 108.613 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -51.94 34.05 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.952 1 C-N-CA 132.43 4.292 . . . . 0.0 116.015 169.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.87 -175.0 1.6 Allowed 'General case' 0 CA--C 1.544 0.742 0 O-C-N 120.958 -1.088 . . . . 0.0 110.162 -174.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.456 ' HB2' HG22 ' A' ' 115' ' ' VAL . 1.5 mp0 -42.21 164.51 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 127.735 2.414 . . . . 0.0 113.213 176.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -126.58 63.17 52.24 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 125.779 1.632 . . . . 0.0 112.802 -168.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -79.94 69.06 8.1 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 124.164 3.243 . . . . 0.0 112.549 -169.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.35 -38.56 89.99 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.799 -1.188 . . . . 0.0 112.404 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -162.8 42.56 0.35 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.259 1.409 . . . . 0.0 110.763 -176.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -71.88 171.58 11.47 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -169.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.3 m -69.25 154.2 42.43 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 113.103 -1.862 . . . . 0.0 108.194 168.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 24.6 mt -59.17 -32.48 69.94 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.911 -0.493 . . . . 0.0 111.438 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -62.81 -39.75 95.24 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 118.611 0.642 . . . . 0.0 111.005 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.621 ' O ' HG23 ' A' ' 115' ' ' VAL . 98.7 t -72.02 -42.13 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 116.37 -1.776 . . . . 0.0 108.526 177.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -50.38 -49.13 55.21 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 121.086 1.766 . . . . 0.0 111.1 172.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -58.67 -44.33 90.17 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.371 0.532 . . . . 0.0 110.762 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 88.0 m -66.15 -44.6 83.66 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 118.642 -0.694 . . . . 0.0 109.432 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 111' ' ' VAL . 17.3 t -67.36 -49.16 74.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -172.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -44.29 -56.36 4.22 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.332 1.453 . . . . 0.0 111.269 170.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.81 -42.77 96.9 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 119.231 0.923 . . . . 0.0 111.416 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -62.2 -39.35 92.45 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.503 -0.998 . . . . 0.0 111.409 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.0 t -62.72 -41.52 92.68 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 CA-C-O 117.842 -1.075 . . . . 0.0 108.212 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -38.3 75.9 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 120.208 1.367 . . . . 0.0 111.048 -177.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -69.79 -43.76 71.47 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.988 -0.529 . . . . 0.0 110.219 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -66.36 -42.9 87.35 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.381 0.991 . . . . 0.0 110.357 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.8 t -52.72 -54.53 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 123.833 0.853 . . . . 0.0 108.983 172.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -65.1 -32.54 74.29 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 122.121 -0.362 . . . . 0.0 111.301 -174.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -62.41 -47.74 82.8 Favored 'General case' 0 C--O 1.225 -0.188 0 O-C-N 121.806 -0.559 . . . . 0.0 111.185 172.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.63 -47.57 79.41 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 176.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.2 mt -57.97 -42.71 83.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 123.895 0.878 . . . . 0.0 109.697 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.3 -32.0 71.85 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.961 0.801 . . . . 0.0 111.957 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -72.36 -42.25 65.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.611 173.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.3 pt -103.93 -44.7 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 118.942 2.941 . . . . 0.0 118.942 -168.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 71.8 m . . . . . 0 C--O 1.252 1.228 0 CA-C-N 119.733 1.152 . . . . 0.0 111.561 -169.336 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 tpt . . . . . 0 N--CA 1.498 1.942 0 CA-C-O 118.724 -0.655 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -64.31 128.13 34.47 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.892 1.678 . . . . 0.0 108.891 -174.853 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -94.24 145.8 24.47 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -170.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.753 HG13 HG12 ' A' ' 75' ' ' VAL . 12.2 t -124.28 153.52 30.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 O-C-N 124.495 1.122 . . . . 0.0 108.142 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 56.5 tpp -134.59 146.24 49.42 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 175.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -127.0 106.53 9.34 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.454 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 4.0 t -93.47 136.52 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -169.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.5 m -108.55 171.62 7.31 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.133 0.573 . . . . 0.0 110.748 -174.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -149.69 -52.36 0.15 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.451 0.7 . . . . 0.0 109.395 169.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.44 ' CG ' ' H ' ' A' ' 11' ' ' ASN . 30.9 ttm180 -103.92 -176.44 3.08 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.387 1.075 . . . . 0.0 108.293 169.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.483 HD21 ' CD2' ' A' ' 43' ' ' HIS . 27.4 t-20 -36.07 125.24 0.75 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 127.821 2.448 . . . . 0.0 113.65 -169.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.78 -19.56 6.65 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 129.243 3.017 . . . . 0.0 113.818 -173.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 p -58.17 -12.41 3.52 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 177.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -101.54 -43.91 5.75 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 120.597 1.544 . . . . 0.0 111.509 169.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.0 p -93.23 -52.88 4.34 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.964 1.306 . . . . 0.0 113.542 -168.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -65.87 -28.03 68.66 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.667 -1.271 . . . . 0.0 110.068 169.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.464 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.7 tpt -62.47 -39.81 94.61 Favored 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 121.267 -0.896 . . . . 0.0 110.741 169.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.03 -37.52 80.02 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 118.834 -0.603 . . . . 0.0 109.678 178.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -62.22 -41.29 98.25 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 118.721 -0.657 . . . . 0.0 110.915 169.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.87 -43.02 84.83 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 120.255 1.388 . . . . 0.0 111.686 -175.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -65.31 -37.53 87.41 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 121.742 -0.858 . . . . 0.0 108.733 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.66 -38.0 67.76 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 119.752 1.16 . . . . 0.0 111.358 -174.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.418 ' HA ' HG21 ' A' ' 32' ' ' VAL . 54.6 pttt -68.42 -26.75 65.69 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.869 1.213 . . . . 0.0 111.627 175.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.0 m -77.21 -52.32 9.44 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.967 1.707 . . . . 0.0 110.235 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.1 mt -88.2 -26.44 22.38 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.008 1.323 . . . . 0.0 111.695 -169.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.13 13.77 58.63 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 126.431 1.967 . . . . 0.0 111.673 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.6 119.5 7.68 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.414 1.086 . . . . 0.0 109.548 -174.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.07 8.3 87.93 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 119.754 -0.47 . . . . 0.0 113.564 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.4 ' O ' ' HE2' ' A' ' 2' ' ' LYS . 75.6 mmtt -123.51 -26.22 4.25 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 125.568 1.547 . . . . 0.0 109.977 -177.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.512 HG21 HD12 ' A' ' 130' ' ' ILE . 9.1 pt -145.92 170.58 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 125.058 1.343 . . . . 0.0 109.589 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.12 145.82 35.08 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 167.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.457 HG22 HD12 ' A' ' 30' ' ' ILE . 1.7 t -136.43 140.24 43.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 119.05 0.841 . . . . 0.0 111.263 -167.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 m -150.7 160.78 43.61 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 124.209 1.003 . . . . 0.0 110.682 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 64.6 p -133.2 161.86 33.3 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.057 1.299 . . . . 0.0 109.746 169.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.8 p -154.39 169.8 22.87 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.063 0.459 . . . . 0.0 111.879 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.95 -51.43 2.76 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 125.471 1.51 . . . . 0.0 111.846 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 mp 50.47 -156.25 0.11 Allowed 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -168.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -73.07 11.89 0.63 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.079 1.352 . . . . 0.0 112.472 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.9 m 63.17 24.71 14.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.017 1.327 . . . . 0.0 110.714 -168.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 55.9 m -145.8 168.28 21.15 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 129.307 3.043 . . . . 0.0 106.013 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -70.53 178.79 2.8 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.34 0.656 . . . . 0.0 111.56 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 t -44.89 151.91 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 127.564 2.345 . . . . 0.0 112.285 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.483 ' CD2' HD21 ' A' ' 11' ' ' ASN . 85.9 t60 -127.74 114.62 20.79 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 125.76 1.624 . . . . 0.0 108.321 -172.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -68.35 -27.04 34.62 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 124.021 3.147 . . . . 0.0 113.241 -169.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.0 m -62.65 -34.37 76.94 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.134 0.879 . . . . 0.0 109.206 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.12 -45.97 86.23 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.48 -46.7 92.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.128 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.96 -43.57 98.57 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 119.091 0.86 . . . . 0.0 111.077 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.4 mmt -59.74 -25.45 64.86 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.204 0.602 . . . . 0.0 111.986 175.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.464 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -93.09 -29.32 15.84 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -176.88 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -63.25 -31.47 72.63 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.328 1.451 . . . . 0.0 110.212 171.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -56.83 -20.81 24.79 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.794 0.838 . . . . 0.0 112.516 171.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.8 p -126.25 14.15 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 125.191 1.397 . . . . 0.0 110.253 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.8 33.76 66.32 Favored Glycine 0 CA--C 1.531 1.069 0 O-C-N 121.053 -1.029 . . . . 0.0 112.842 173.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.8 mt -121.01 159.04 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 126.08 1.752 . . . . 0.0 106.944 176.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -140.09 146.99 39.62 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.2 pt -135.15 8.77 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 126.262 1.825 . . . . 0.0 111.183 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.5 t -70.73 161.31 31.07 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 168.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.7 -25.53 1.43 Allowed Glycine 0 CA--C 1.533 1.199 0 CA-C-O 119.029 -0.873 . . . . 0.0 111.942 -173.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -76.85 137.95 39.5 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 103.397 -2.816 . . . . 0.0 103.397 168.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -146.84 165.19 30.45 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -168.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.1 m -68.0 141.37 56.27 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.961 2.105 . . . . 0.0 111.01 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -164.56 132.19 2.5 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.66 147.61 35.78 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.887 2.392 . . . . 0.0 113.753 -168.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.5 tt -60.48 -34.25 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.087 1.355 . . . . 0.0 111.238 -171.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.28 -13.17 61.44 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.211 0.604 . . . . 0.0 112.541 -171.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -91.58 -10.29 41.09 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.027 0.931 . . . . 0.0 112.173 171.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -84.0 171.07 13.3 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 122.015 0.912 . . . . 0.0 111.161 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.77 83.2 1.52 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.787 1.635 . . . . 0.0 107.638 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.41 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -49.1 -30.96 7.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -50.65 -32.6 19.61 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.143 0.977 . . . . 0.0 112.627 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -71.11 -24.85 62.37 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -94.36 177.28 6.0 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 127.402 2.281 . . . . 0.0 109.064 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -116.14 -19.23 10.36 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 118.257 -0.878 . . . . 0.0 112.585 173.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.753 HG12 HG13 ' A' ' 4' ' ' VAL . 8.2 t -143.2 132.41 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 120.685 1.584 . . . . 0.0 106.939 -169.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.8 m -132.99 130.15 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.43 HG21 ' CE3' ' A' ' 99' ' ' TRP . 28.0 mm -116.96 99.96 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 102.749 -3.056 . . . . 0.0 102.749 176.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.454 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 30.3 t -72.85 161.38 30.79 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 169.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.2 mp -140.1 34.29 1.92 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 169.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.541 ' HB3' HG21 ' A' ' 84' ' ' VAL . 85.5 m -74.01 -5.79 43.5 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.388 1.075 . . . . 0.0 111.6 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.33 27.32 18.41 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -173.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.501 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 3.1 t 53.96 -173.13 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.287 1.835 . . . . 0.0 111.095 -169.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.93 -34.4 1.25 Allowed Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.414 1.483 . . . . 0.0 114.818 173.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.541 HG21 ' HB3' ' A' ' 80' ' ' CYS . 78.2 t -58.67 126.07 15.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 118.502 1.151 . . . . 0.0 108.679 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -82.04 73.31 9.09 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.455 1.102 . . . . 0.0 110.317 -169.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.2 mt -58.9 143.01 84.16 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 118.28 -0.867 . . . . 0.0 108.871 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.1 156.59 9.76 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.208 2.605 . . . . 0.0 112.458 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.57 -20.46 65.67 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.72 1.613 . . . . 0.0 115.172 -169.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.83 -24.8 66.2 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 120.576 -1.328 . . . . 0.0 112.067 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.41 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 71.7 m95 -70.33 -8.9 54.1 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.215 1.006 . . . . 0.0 111.884 171.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.2 t -105.83 -30.56 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 119.831 1.196 . . . . 0.0 110.517 -174.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.8 p -73.8 -14.48 61.11 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.114 0.966 . . . . 0.0 112.911 -174.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.418 ' HG2' ' H ' ' A' ' 93' ' ' GLN . 79.2 mm-40 -44.25 154.19 0.12 Allowed 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 129.835 3.254 . . . . 0.0 112.075 169.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -63.01 -38.72 92.32 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.735 1.614 . . . . 0.0 109.45 169.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.498 ' HB ' HG13 ' A' ' 75' ' ' VAL . 2.5 mt -126.95 131.11 71.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 174.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -137.95 109.84 7.18 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 101.126 -3.657 . . . . 0.0 101.126 166.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.86 165.99 23.72 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.501 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 11.1 t70 -130.62 103.91 6.9 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 169.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.43 ' CE3' HG21 ' A' ' 77' ' ' ILE . 53.0 m0 -76.35 73.12 3.13 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 174.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -58.99 42.9 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.87 1 C-N-CA 131.865 4.066 . . . . 0.0 111.755 169.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.36 -172.69 1.2 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.714 1.206 . . . . 0.0 112.128 -168.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.486 ' HB2' HG22 ' A' ' 115' ' ' VAL . 39.0 mt-10 -50.96 161.64 0.35 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.344 1.458 . . . . 0.0 111.745 172.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -117.42 101.22 52.83 Favored Pre-proline 0 C--N 1.323 -0.557 0 C-N-CA 126.313 1.845 . . . . 0.0 108.766 -176.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -79.08 -4.5 13.91 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.071 2.514 . . . . 0.0 113.064 175.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.8 t70 23.26 -96.6 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 128.536 2.735 . . . . 0.0 114.238 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.84 38.31 1.83 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 127.105 2.288 . . . . 0.0 109.51 169.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -71.67 -178.0 2.09 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.238 1.815 . . . . 0.0 112.775 -174.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.0 m -62.55 155.2 26.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 113.52 -1.673 . . . . 0.0 109.047 172.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 27.0 mt -56.43 -30.82 63.3 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 123.09 0.556 . . . . 0.0 110.805 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.35 -40.04 92.81 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 118.636 0.653 . . . . 0.0 110.811 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.4 t -72.32 -44.02 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 117.361 -1.304 . . . . 0.0 108.781 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -48.01 -48.71 32.58 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 120.181 1.355 . . . . 0.0 111.383 170.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -60.64 -45.13 95.23 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.948 0.795 . . . . 0.0 111.364 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.7 m -68.58 -44.32 74.66 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -173.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.486 HG22 ' HB2' ' A' ' 102' ' ' GLU . 19.7 t -67.68 -43.47 86.65 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -174.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -47.37 -56.4 6.98 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 124.638 1.175 . . . . 0.0 110.825 171.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.66 -42.49 99.68 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 119.546 1.066 . . . . 0.0 111.869 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -63.7 -38.74 92.26 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 121.317 -1.108 . . . . 0.0 111.803 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.5 t -62.52 -41.42 91.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -37.29 76.75 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 119.805 1.184 . . . . 0.0 111.184 -175.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -70.11 -41.05 74.5 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 118.695 -0.669 . . . . 0.0 110.722 176.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -64.4 -43.74 93.46 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.948 1.249 . . . . 0.0 110.214 177.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.497 HG12 HD12 ' A' ' 127' ' ' ILE . 66.7 t -54.38 -52.02 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 123.782 0.833 . . . . 0.0 109.536 173.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -66.29 -34.46 78.04 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 118.057 0.39 . . . . 0.0 111.634 -175.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -61.74 -48.91 78.58 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.313 0.645 . . . . 0.0 110.897 172.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.42 HD23 HG13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -58.5 -45.06 89.53 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 122.882 0.473 . . . . 0.0 109.937 176.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.497 HD12 HG12 ' A' ' 123' ' ' VAL . 6.6 mt -58.38 -42.71 84.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 123.489 0.715 . . . . 0.0 109.576 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.04 -28.11 68.61 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -68.19 -53.53 24.26 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.022 0.828 . . . . 0.0 110.431 172.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.512 HD12 HG21 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -84.33 -40.5 15.48 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 -169.372 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--O 1.255 1.345 0 CA-C-N 119.554 1.07 . . . . 0.0 112.486 -169.638 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.5 2.03 0 CA-C-O 117.491 -1.242 . . . . 0.0 109.208 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.705 ' HG2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -56.44 123.54 15.07 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 121.509 1.959 . . . . 0.0 109.812 -172.758 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -92.47 142.05 27.84 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -170.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.707 HG13 HG12 ' A' ' 75' ' ' VAL . 10.5 t -123.66 152.21 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 O-C-N 124.381 1.051 . . . . 0.0 108.385 -177.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 53.8 tpp -137.29 143.94 42.4 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -126.23 119.56 27.77 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.8 t -103.86 131.14 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -169.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.8 t -123.56 -174.76 3.04 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.624 1.57 . . . . 0.0 110.314 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -158.59 -63.63 0.08 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 169.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.3 ttm105 -70.66 135.15 48.15 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 122.333 0.253 . . . . 0.0 111.272 -175.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 65.4 t30 42.91 25.74 0.06 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.72 2.808 . . . . 0.0 115.877 168.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.4 m 29.45 64.87 0.13 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.177 2.191 . . . . 0.0 114.395 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 p -139.38 -71.88 0.39 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 116.593 -1.67 . . . . 0.0 115.129 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.262 20.0 ptt180 -44.18 -45.68 8.48 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 122.355 2.343 . . . . 0.0 116.035 -168.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.445 ' HB3' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -93.04 -30.69 15.17 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.486 -0.759 . . . . 0.0 111.215 -174.08 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -62.11 -37.14 83.97 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.857 -1.152 . . . . 0.0 108.677 169.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.423 ' SD ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -64.25 -39.49 94.06 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 121.146 -0.971 . . . . 0.0 110.681 172.203 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.56 -34.5 74.26 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 118.633 -0.699 . . . . 0.0 110.326 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -64.24 -40.78 96.72 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-N 118.979 0.809 . . . . 0.0 110.172 169.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.29 -43.55 98.92 Favored Glycine 0 C--N 1.339 0.697 0 CA-C-N 120.009 1.277 . . . . 0.0 111.33 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.423 ' CD2' ' SD ' ' A' ' 17' ' ' MET . 7.2 m-85 -68.24 -38.31 81.69 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 118.571 1.186 . . . . 0.0 109.847 172.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.83 -37.11 70.36 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 119.642 1.11 . . . . 0.0 111.171 -172.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.438 ' HA ' HG21 ' A' ' 32' ' ' VAL . 42.4 pttt -71.34 -27.14 63.16 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 119.868 1.213 . . . . 0.0 111.867 174.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 m -72.58 -50.8 22.98 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.184 1.794 . . . . 0.0 110.331 175.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.1 mt -88.76 -28.36 20.54 Favored 'General case' 0 CA--C 1.53 0.212 0 C-N-CA 124.74 1.216 . . . . 0.0 112.056 -169.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.59 15.14 60.17 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.878 2.18 . . . . 0.0 111.423 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.56 120.11 8.81 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.706 1.203 . . . . 0.0 110.012 -173.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.65 9.05 87.12 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.692 -0.504 . . . . 0.0 113.48 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -123.1 -24.02 4.81 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.348 1.459 . . . . 0.0 110.026 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.705 HG22 ' HG2' ' A' ' 2' ' ' LYS . 12.9 pt -146.08 171.85 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 125.972 1.709 . . . . 0.0 110.124 177.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.82 143.81 42.15 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 168.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.484 HG22 HD12 ' A' ' 30' ' ' ILE . 1.6 t -137.34 138.14 45.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 118.907 0.776 . . . . 0.0 111.178 -168.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.4 m -144.86 166.42 25.31 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.203 1.401 . . . . 0.0 109.841 178.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.5 p -136.37 161.78 34.87 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.594 -1.316 . . . . 0.0 108.899 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.4 p -159.07 176.27 12.47 Favored 'General case' 0 C--O 1.233 0.226 0 O-C-N 121.556 -0.715 . . . . 0.0 109.491 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.2 38.78 38.65 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -176.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.88 139.89 58.76 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 103.052 -2.944 . . . . 0.0 103.052 168.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -54.6 -23.86 18.75 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.24 1.016 . . . . 0.0 112.893 -174.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 89.2 p 129.46 -28.08 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 1 C-N-CA 132.468 4.307 . . . . 0.0 110.817 -169.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.0 m -72.13 141.0 49.14 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 113.448 -1.705 . . . . 0.0 107.606 169.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -83.67 112.32 19.94 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 175.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 m 46.63 -166.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 127.47 2.308 . . . . 0.0 114.423 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -149.55 116.17 3.62 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -65.35 -29.35 54.39 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.018 2.479 . . . . 0.0 112.176 -169.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.6 m -64.21 -37.5 87.69 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.91 -42.25 90.42 Favored 'General case' 0 C--O 1.219 -0.536 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.73 -48.4 86.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 118.457 -0.783 . . . . 0.0 109.286 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.98 -42.74 98.93 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.228 0.922 . . . . 0.0 110.992 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 24.6 mmt -64.87 -21.24 66.77 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.962 0.905 . . . . 0.0 112.102 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.1 mmt -91.49 -29.16 17.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 119.305 0.957 . . . . 0.0 110.175 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.24 -29.38 70.16 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.897 0.879 . . . . 0.0 110.491 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -56.39 -25.58 50.34 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.047 0.939 . . . . 0.0 112.489 170.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.5 m -121.95 12.74 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.987 1.315 . . . . 0.0 111.056 -173.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.2 37.4 81.25 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.361 -0.688 . . . . 0.0 112.385 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.6 mt -121.87 153.74 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -129.92 127.63 40.52 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 37.3 pt -132.02 9.73 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 C-N-CA 123.303 0.641 . . . . 0.0 111.931 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.16 -32.18 61.22 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.355 1.462 . . . . 0.0 112.456 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.06 3.83 69.33 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.551 -0.583 . . . . 0.0 112.841 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -76.1 -175.42 3.1 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.225 1.01 . . . . 0.0 111.847 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.43 171.14 1.14 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.013 2.525 . . . . 0.0 114.999 -169.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.2 m -144.74 21.55 1.63 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.426 1.49 . . . . 0.0 111.699 -169.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -139.59 160.13 62.63 Favored Pre-proline 0 N--CA 1.471 0.578 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -168.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.7 165.58 24.61 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 124.724 3.616 . . . . 0.0 112.454 175.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.4 tt -59.93 -34.55 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.384 1.474 . . . . 0.0 111.971 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -68.89 -21.56 64.23 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -169.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.49 -16.44 56.04 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.161 172.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -89.67 171.3 9.76 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.237 0.926 . . . . 0.0 110.706 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.24 88.57 1.73 Allowed 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.236 1.414 . . . . 0.0 108.912 -173.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.456 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -49.86 -29.71 8.59 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.805 0.842 . . . . 0.0 113.168 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -48.76 -33.98 11.35 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.282 1.033 . . . . 0.0 112.034 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -73.51 -23.11 59.98 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -99.43 -177.66 3.66 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 127.547 2.339 . . . . 0.0 109.796 -174.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -123.19 -20.52 5.67 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.707 HG12 HG13 ' A' ' 4' ' ' VAL . 17.1 t -142.86 130.09 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 -169.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.8 m -135.27 135.76 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 O-C-N 120.825 -1.172 . . . . 0.0 108.368 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.1 mm -130.37 100.27 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 -172.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 77.4 p -80.83 159.91 24.96 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 119.042 -1.063 . . . . 0.0 109.461 173.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.445 HD13 ' HB3' ' A' ' 15' ' ' SER . 3.4 mp -137.39 53.54 1.86 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 103.009 -2.96 . . . . 0.0 103.009 169.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 60.1 m -107.9 18.86 20.79 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.623 1.969 . . . . 0.0 108.774 -176.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.46 21.86 76.24 Favored Glycine 0 C--N 1.344 0.972 0 CA-C-O 118.785 -1.008 . . . . 0.0 112.548 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.4 p 53.52 -8.7 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.504 3.122 . . . . 0.0 117.418 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.97 -27.94 73.47 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 119.248 0.931 . . . . 0.0 112.005 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.0 t -65.99 113.63 2.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -76.19 105.59 7.32 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 104.154 -2.536 . . . . 0.0 104.154 168.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.5 mt -72.9 154.61 90.95 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.26 158.29 12.44 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.906 2.404 . . . . 0.0 112.487 173.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.84 -24.02 68.41 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 121.727 1.618 . . . . 0.0 115.717 -169.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -67.99 -24.3 65.12 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 120.705 -1.247 . . . . 0.0 111.835 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.456 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 65.6 m95 -72.6 -7.57 50.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.318 1.047 . . . . 0.0 111.756 172.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.2 t -105.34 -30.52 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 120.213 1.37 . . . . 0.0 110.309 -174.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.9 p -74.19 -13.11 60.75 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.242 1.017 . . . . 0.0 112.88 -175.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -45.29 154.64 0.16 Allowed 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 129.898 3.279 . . . . 0.0 112.468 169.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -64.33 -39.03 93.08 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.203 1.801 . . . . 0.0 109.347 170.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.575 ' HB ' HG13 ' A' ' 75' ' ' VAL . 31.1 mm -127.44 135.65 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 171.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -137.67 104.27 5.26 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 100.773 -3.788 . . . . 0.0 100.773 166.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -127.25 169.93 12.99 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 174.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' A' ' 78' ' ' SER . 8.3 t70 -142.44 137.12 30.13 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 169.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.421 ' CD2' ' HB3' ' A' ' 122' ' ' ARG . 54.0 m0 -107.19 6.29 28.57 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -172.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 42.88 -70.78 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 131.282 3.833 . . . . 0.0 112.678 -172.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.413 ' CD1' ' H ' ' A' ' 102' ' ' GLU 0.26 0.3 OUTLIER 52.69 -174.41 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.507 1 C-N-CA 132.977 4.511 . . . . 0.0 114.891 177.012 . . . . . . . . 5 4 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.44 ' HB2' HG22 ' A' ' 115' ' ' VAL . 27.0 mt-10 -62.19 172.28 1.51 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.065 1.746 . . . . 0.0 109.867 -175.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -129.15 72.23 81.99 Favored Pre-proline 0 C--N 1.323 -0.556 0 C-N-CA 125.135 1.374 . . . . 0.0 111.249 -168.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.6 68.25 5.43 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 124.481 3.454 . . . . 0.0 113.489 -172.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -64.68 -33.01 74.95 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.348 1.059 . . . . 0.0 112.902 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 154.46 92.35 0.09 OUTLIER Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.933 1.73 . . . . 0.0 109.209 -175.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.85 -167.94 1.8 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.458 1.503 . . . . 0.0 111.451 -169.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.2 p -70.89 157.92 37.32 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 113.424 -1.717 . . . . 0.0 108.162 168.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.1 mt -61.07 -31.63 71.29 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 121.842 -0.536 . . . . 0.0 111.292 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -58.58 -38.61 78.26 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.279 0.632 . . . . 0.0 111.088 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.667 ' O ' HG23 ' A' ' 115' ' ' VAL . 42.9 t -72.93 -43.6 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 117.172 -1.394 . . . . 0.0 108.594 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -52.78 -46.73 67.73 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.757 1.617 . . . . 0.0 111.591 171.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -58.86 -43.68 90.88 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.758 0.708 . . . . 0.0 111.04 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.0 m -68.13 -44.23 76.55 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -175.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 111' ' ' VAL . 60.1 t -62.5 -52.82 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -173.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -42.25 -58.99 1.96 Allowed 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 126.1 1.76 . . . . 0.0 110.974 169.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.46 -43.23 99.6 Favored Glycine 0 CA--C 1.524 0.607 0 CA-C-N 119.796 1.18 . . . . 0.0 111.632 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -63.93 -38.87 92.69 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 120.616 -1.52 . . . . 0.0 111.563 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.5 t -60.28 -40.48 83.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 118.374 -0.822 . . . . 0.0 108.835 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -42.58 76.62 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.623 1.101 . . . . 0.0 110.425 -177.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -65.86 -43.34 88.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 119.426 -0.321 . . . . 0.0 110.385 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.421 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 5.5 mpt_? -70.55 -41.2 72.8 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.919 0.782 . . . . 0.0 109.844 -176.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 64.8 t -53.37 -52.92 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 123.31 0.644 . . . . 0.0 109.486 172.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.99 -33.1 75.23 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 122.212 -0.305 . . . . 0.0 111.491 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -61.81 -47.54 84.65 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.078 0.551 . . . . 0.0 111.135 172.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -46.93 84.39 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 118.259 0.482 . . . . 0.0 110.089 176.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -57.81 -42.22 81.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 123.473 0.709 . . . . 0.0 109.557 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.03 -30.26 70.84 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 118.909 0.777 . . . . 0.0 111.798 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -72.89 -44.23 61.53 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 118.346 -0.835 . . . . 0.0 111.623 172.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 21.3 pt -101.96 -43.85 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 118.465 2.765 . . . . 0.0 118.465 -168.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.0 m . . . . . 0 C--O 1.254 1.317 0 CA-C-O 116.692 -1.623 . . . . 0.0 111.536 -169.236 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.498 1.958 0 CA-C-O 118.91 -0.566 . . . . 0.0 109.848 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -64.65 128.58 36.39 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.565 1.53 . . . . 0.0 107.967 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -94.89 143.06 26.77 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -173.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.778 HG13 HG12 ' A' ' 75' ' ' VAL . 11.3 t -121.78 153.23 25.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 O-C-N 124.457 1.098 . . . . 0.0 108.631 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.4 mmt -129.13 138.78 52.0 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -119.7 100.09 7.05 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 170.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.43 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 2.7 t -84.64 116.78 28.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -168.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.9 m -82.75 167.5 18.11 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.848 0.833 . . . . 0.0 112.339 -171.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.0 mtpp -159.02 170.88 21.09 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 127.57 2.348 . . . . 0.0 105.6 169.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.02 -143.66 0.73 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.081 0.952 . . . . 0.0 108.49 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -72.67 1.78 7.72 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.405 -0.809 . . . . 0.0 112.426 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.3 m 65.57 -1.49 1.0 Allowed 'General case' 0 C--N 1.348 0.526 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 169.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 p -59.02 -45.94 89.46 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 119.953 1.251 . . . . 0.0 111.613 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -58.38 -35.34 71.84 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 119.406 1.003 . . . . 0.0 113.039 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.79 -40.49 10.17 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.565 1.146 . . . . 0.0 110.942 -169.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -64.53 -35.05 79.71 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.511 0.724 . . . . 0.0 110.01 169.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.459 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.6 tpt -63.05 -39.77 95.73 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 121.394 -0.816 . . . . 0.0 110.983 169.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.48 -36.98 79.58 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 118.439 -0.791 . . . . 0.0 109.647 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -63.11 -42.5 99.56 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.938 0.79 . . . . 0.0 110.373 169.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.24 -42.14 99.72 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 120.385 1.448 . . . . 0.0 112.226 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -69.26 -41.18 77.25 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 117.983 0.891 . . . . 0.0 109.322 172.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.439 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -71.63 -35.44 70.43 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 119.747 1.158 . . . . 0.0 111.565 -172.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.426 ' HA ' HG21 ' A' ' 32' ' ' VAL . 45.2 pttt -72.58 -21.89 61.07 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.809 1.186 . . . . 0.0 112.177 175.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 m -80.68 -50.63 9.66 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.352 1.861 . . . . 0.0 109.693 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.1 mt -88.55 -26.96 21.7 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.13 1.372 . . . . 0.0 111.599 -169.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.05 17.71 47.81 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 127.121 2.296 . . . . 0.0 111.525 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.74 121.56 12.57 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.628 1.171 . . . . 0.0 109.739 -172.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.38 9.29 85.91 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 119.869 -0.406 . . . . 0.0 113.54 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.406 ' O ' ' HE2' ' A' ' 2' ' ' LYS . 31.3 mmtp -124.44 -28.51 3.62 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 125.868 1.667 . . . . 0.0 110.532 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.439 HD12 HG22 ' A' ' 32' ' ' VAL . 6.2 pt -141.55 162.32 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 124.308 1.043 . . . . 0.0 109.222 173.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.25 144.43 29.28 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 103.339 -2.838 . . . . 0.0 103.339 167.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.439 HG11 ' HB3' ' A' ' 22' ' ' ALA . 2.0 t -133.43 142.06 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 118.821 0.737 . . . . 0.0 111.275 -167.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.31 148.96 28.8 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.936 0.894 . . . . 0.0 110.202 -175.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.7 p -131.75 117.01 18.02 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 175.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.1 m -141.93 165.46 27.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 119.186 0.903 . . . . 0.0 111.044 -169.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.33 33.73 27.85 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -169.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mp -67.05 120.17 13.22 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 101.359 -3.571 . . . . 0.0 101.359 169.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.95 86.91 0.36 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.532 1.06 . . . . 0.0 113.262 -168.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.5 m 48.81 34.1 4.99 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.743 2.017 . . . . 0.0 112.233 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.8 m -144.83 165.94 26.68 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.545 1.538 . . . . 0.0 108.985 -170.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -97.53 -174.99 3.06 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.085 0.954 . . . . 0.0 109.684 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 m -58.09 172.25 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 124.308 1.043 . . . . 0.0 111.4 172.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -133.45 120.78 15.99 Favored Pre-proline 0 N--CA 1.448 -0.562 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -176.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -66.69 -26.16 46.05 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.559 2.839 . . . . 0.0 112.321 -169.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.6 m -61.01 -37.05 81.18 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.004 0.82 . . . . 0.0 109.154 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.18 -44.12 84.94 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.499 HG12 ' HB3' ' A' ' 58' ' ' SER . 1.8 mp -58.3 -48.08 85.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 CA-C-O 118.278 -0.868 . . . . 0.0 108.874 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.92 98.3 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.293 0.951 . . . . 0.0 111.182 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.5 mmt -60.66 -25.22 66.18 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.395 1.078 . . . . 0.0 112.974 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.459 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -95.39 -33.1 12.63 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -178.074 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -61.77 -37.23 83.55 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.305 1.042 . . . . 0.0 110.158 174.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -71.64 0.37 8.86 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.7 m -130.14 13.87 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 125.983 1.713 . . . . 0.0 111.435 169.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.26 33.56 48.68 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 121.134 -0.979 . . . . 0.0 114.159 171.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.7 mt -125.41 160.79 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.994 1.718 . . . . 0.0 107.367 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -139.98 140.52 36.32 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.221 1.008 . . . . 0.0 108.928 175.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.8 pt -138.27 11.96 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 126.633 1.973 . . . . 0.0 110.001 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.499 ' HB3' HG12 ' A' ' 47' ' ' ILE . 63.9 p -62.27 145.01 54.86 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.945 0.793 . . . . 0.0 110.669 175.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.23 8.21 6.23 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 117.094 -1.948 . . . . 0.0 114.659 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -50.08 -61.03 2.39 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-N 120.067 1.933 . . . . 0.0 113.08 -172.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -159.01 159.33 34.65 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.461 1.104 . . . . 0.0 108.794 -169.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.5 m -163.04 43.96 0.12 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.862 1.665 . . . . 0.0 107.699 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -134.8 149.68 71.31 Favored Pre-proline 0 N--CA 1.47 0.563 0 O-C-N 121.493 -0.754 . . . . 0.0 111.847 -168.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -83.12 158.33 15.29 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 124.144 3.229 . . . . 0.0 112.282 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.4 tt -62.98 -35.64 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 125.235 1.414 . . . . 0.0 112.198 -175.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -70.0 -20.55 63.28 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.611 0.364 . . . . 0.0 111.917 -171.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.51 -13.98 59.57 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 118.853 -0.594 . . . . 0.0 112.236 172.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -101.2 168.79 9.34 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.26 1.024 . . . . 0.0 110.853 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.73 91.67 2.33 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 -170.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.494 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -50.96 -31.94 19.44 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.52 -28.46 13.66 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.379 1.072 . . . . 0.0 112.177 176.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -70.88 -20.85 62.47 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.204 0.601 . . . . 0.0 112.368 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -106.9 175.13 5.6 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 128.624 2.77 . . . . 0.0 108.292 -174.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -118.64 -17.09 9.35 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.778 HG12 HG13 ' A' ' 4' ' ' VAL . 6.3 t -142.19 129.01 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -169.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.6 t -124.44 128.4 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.418 HG21 ' CE3' ' A' ' 99' ' ' TRP . 38.7 mm -121.68 96.63 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 102.119 -3.289 . . . . 0.0 102.119 169.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.43 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 20.4 p -72.66 164.11 27.01 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 118.019 -1.472 . . . . 0.0 107.884 169.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.6 mp -135.66 36.29 2.9 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 172.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.551 ' HB3' HG21 ' A' ' 84' ' ' VAL . 35.5 m -90.92 5.65 47.77 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.76 1.624 . . . . 0.0 110.761 -172.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.55 22.29 26.89 Favored Glycine 0 C--N 1.339 0.725 0 CA-C-O 119.565 -0.575 . . . . 0.0 111.955 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.429 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 5.4 t 46.88 40.68 9.49 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.941 1.696 . . . . 0.0 112.344 -177.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -149.79 35.33 1.02 Allowed Glycine 0 C--N 1.34 0.759 0 C-N-CA 123.793 0.711 . . . . 0.0 111.661 -171.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.551 HG21 ' HB3' ' A' ' 80' ' ' CYS . 73.2 t -121.18 130.09 75.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 124.965 1.306 . . . . 0.0 107.948 177.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -78.93 70.58 5.29 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 173.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.28 145.46 81.31 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-O 118.488 -0.768 . . . . 0.0 109.1 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -54.07 157.07 11.55 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.973 2.448 . . . . 0.0 111.924 172.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.3 -24.42 65.03 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 121.866 1.71 . . . . 0.0 114.949 -169.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -64.71 -23.68 67.33 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 120.63 -1.293 . . . . 0.0 111.974 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.494 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 77.4 m95 -73.42 -11.34 60.44 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.649 1.18 . . . . 0.0 112.866 176.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.2 m -118.53 -14.84 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 119.715 1.143 . . . . 0.0 112.822 -176.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.1 p -77.56 -11.12 59.82 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.968 0.804 . . . . 0.0 112.061 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -47.15 156.29 0.24 Allowed 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 129.675 3.19 . . . . 0.0 111.138 169.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -64.04 -38.43 91.03 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.828 1.651 . . . . 0.0 109.872 171.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.516 ' HB ' HG13 ' A' ' 75' ' ' VAL . 2.1 mt -122.35 133.98 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 173.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -142.96 111.64 6.35 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 103.555 -2.757 . . . . 0.0 103.555 167.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -138.99 170.6 15.69 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 173.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.8 t70 -136.62 108.35 7.03 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 169.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.418 ' CE3' HG21 ' A' ' 77' ' ' ILE . 49.2 m0 -81.85 70.57 8.78 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -49.49 13.86 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 131.488 3.915 . . . . 0.0 115.916 170.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -60.02 124.69 20.98 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 126.075 1.75 . . . . 0.0 112.622 -168.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 48.08 -161.44 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.344 2.258 . . . . 0.0 114.915 169.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -156.48 77.95 4.18 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 128.371 2.668 . . . . 0.0 107.448 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.71 -15.03 15.48 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.495 2.13 . . . . 0.0 112.99 -172.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.3 t0 27.56 -101.7 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.565 2.346 . . . . 0.0 113.092 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.51 43.43 1.28 Allowed Glycine 0 CA--C 1.532 1.129 0 C-N-CA 126.734 2.111 . . . . 0.0 109.431 171.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -67.5 -176.73 0.64 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.881 1.672 . . . . 0.0 112.614 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.5 m -59.54 154.12 18.12 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.884 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.4 mt -56.67 -30.33 63.28 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 122.957 0.503 . . . . 0.0 111.038 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.93 -40.66 96.24 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 118.677 -0.678 . . . . 0.0 110.926 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 42.0 t -72.81 -41.35 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 117.803 -1.094 . . . . 0.0 108.867 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -49.37 -51.68 33.27 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.717 1.144 . . . . 0.0 110.921 169.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -59.45 -45.14 92.42 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.799 0.727 . . . . 0.0 111.37 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 94.5 m -69.78 -45.76 67.27 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -171.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.6 t -69.6 -42.16 80.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 -172.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.9 ttp180 -48.09 -53.63 15.9 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 124.853 1.261 . . . . 0.0 110.612 169.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.86 -40.58 99.42 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 119.296 0.953 . . . . 0.0 112.042 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -65.37 -38.51 90.27 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.321 -1.105 . . . . 0.0 111.066 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 48.5 t -62.69 -41.65 93.1 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -38.33 84.59 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 119.779 1.172 . . . . 0.0 111.661 -173.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -68.82 -42.77 76.77 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 119.101 -0.475 . . . . 0.0 109.762 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.2 mtt180 -65.93 -40.3 91.29 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.187 0.903 . . . . 0.0 111.156 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.456 HG12 HD12 ' A' ' 127' ' ' ILE . 47.4 t -54.82 -51.7 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 172.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -64.84 -33.55 76.26 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 122.099 -0.375 . . . . 0.0 111.822 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -65.08 -46.06 82.67 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 123.002 0.521 . . . . 0.0 111.269 174.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.433 HD23 HG13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -59.49 -45.63 91.14 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.717 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.456 HD12 HG12 ' A' ' 123' ' ' VAL . 6.7 mt -58.47 -39.94 76.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.32 -26.65 68.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.924 0.784 . . . . 0.0 112.488 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -72.52 -46.32 55.15 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 119.163 0.892 . . . . 0.0 111.783 173.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.8 pt -103.67 -33.89 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 117.75 2.5 . . . . 0.0 117.75 -168.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 C--O 1.255 1.392 0 CA-C-N 119.529 1.059 . . . . 0.0 111.066 -174.747 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.927 0 CA-C-O 118.868 -0.587 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.449 ' HE2' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -66.11 137.63 57.18 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.641 1.564 . . . . 0.0 107.59 175.328 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -105.99 140.93 38.23 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -171.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.699 HG13 HG12 ' A' ' 75' ' ' VAL . 12.8 t -118.31 151.73 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.5 tpp -137.94 141.55 40.55 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 177.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -116.54 150.29 38.2 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 172.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.499 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 6.6 t -134.18 137.77 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 120.491 1.496 . . . . 0.0 107.118 -170.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 t -126.47 156.39 40.76 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.522 0.729 . . . . 0.0 110.601 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -135.84 33.02 2.94 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.176 1.39 . . . . 0.0 109.474 170.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.57 -178.77 6.74 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 127.95 2.5 . . . . 0.0 106.186 -175.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -48.51 124.06 7.6 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 170.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.0 m -33.7 -30.06 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 129.592 3.157 . . . . 0.0 117.711 -174.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.3 m -38.87 -61.0 0.78 Allowed 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 126.714 2.006 . . . . 0.0 114.69 -169.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.259 39.4 ptt180 -63.17 -46.37 87.47 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.229 1.377 . . . . 0.0 113.161 -169.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.63 -28.53 19.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 118.776 0.716 . . . . 0.0 111.368 -172.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.461 ' HG3' HE21 ' A' ' 60' ' ' GLN . 39.0 tt0 -74.0 -27.95 61.21 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 120.828 -1.17 . . . . 0.0 110.605 171.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.461 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.8 tpt -64.49 -40.67 96.09 Favored 'General case' 0 CA--C 1.51 -0.586 0 O-C-N 120.844 -1.16 . . . . 0.0 108.37 169.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.48 -38.26 83.71 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -61.26 -39.96 92.29 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 118.63 -0.7 . . . . 0.0 111.156 169.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.07 -44.91 86.69 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 120.448 1.476 . . . . 0.0 112.392 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -65.32 -39.98 93.14 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.43 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -72.06 -37.09 69.72 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 118.951 0.796 . . . . 0.0 111.221 -173.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.42 ' HA ' HG21 ' A' ' 32' ' ' VAL . 46.5 pttt -68.97 -28.61 66.78 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.076 1.307 . . . . 0.0 111.74 174.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.8 m -74.76 -51.73 13.38 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.845 1.658 . . . . 0.0 110.35 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.4 mt -88.22 -26.51 22.33 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.727 1.211 . . . . 0.0 112.057 -169.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.65 17.21 50.5 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.796 2.141 . . . . 0.0 111.454 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.35 120.8 9.98 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.909 1.284 . . . . 0.0 109.954 -172.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.53 11.42 84.38 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 119.505 -0.608 . . . . 0.0 113.439 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.449 ' O ' ' HE2' ' A' ' 2' ' ' LYS . 74.6 mmtt -127.11 -26.95 3.04 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 125.346 1.459 . . . . 0.0 110.535 -176.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.5 HD12 HG22 ' A' ' 32' ' ' VAL . 6.6 pt -141.37 161.09 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 124.531 1.132 . . . . 0.0 108.66 172.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.6 144.55 27.78 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 167.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.5 HG22 HD12 ' A' ' 30' ' ' ILE . 2.1 t -135.42 142.56 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 118.93 0.786 . . . . 0.0 111.333 -168.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.26 159.5 40.08 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.097 -174.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.4 p -136.88 162.65 32.67 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 121.433 1.924 . . . . 0.0 110.106 169.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.3 p -151.22 165.39 34.08 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.761 1.164 . . . . 0.0 111.262 -177.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.83 -85.72 0.41 Allowed Glycine 0 C--N 1.332 0.34 0 N-CA-C 105.51 -3.036 . . . . 0.0 105.51 -172.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 51.9 59.11 4.78 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.376 1.07 . . . . 0.0 108.24 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -66.27 -14.41 61.93 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.282 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.6 p -81.52 19.94 0.95 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.753 0.787 . . . . 0.0 112.202 169.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.6 m 66.46 -38.81 0.32 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 130.857 3.663 . . . . 0.0 114.503 177.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -143.52 -178.97 6.15 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.836 1.654 . . . . 0.0 108.145 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.7 t -48.29 150.83 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 125.269 1.428 . . . . 0.0 110.317 169.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -127.07 115.37 21.89 Favored Pre-proline 0 N--CA 1.448 -0.53 0 C-N-CA 125.332 1.453 . . . . 0.0 107.683 -173.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -69.16 -24.96 31.82 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.429 2.753 . . . . 0.0 113.257 -168.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.5 m -62.75 -39.49 94.29 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-N 119.94 1.245 . . . . 0.0 108.415 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.72 98.78 Favored 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.14 -48.92 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 118.297 -0.858 . . . . 0.0 109.544 177.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.75 -43.64 85.56 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 119.08 0.855 . . . . 0.0 110.627 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -20.21 65.17 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.483 0.713 . . . . 0.0 110.635 -175.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.461 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -96.38 -28.43 14.47 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.355 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.25 -29.23 70.6 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.755 1.222 . . . . 0.0 110.376 170.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -56.6 -23.18 39.0 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.855 0.862 . . . . 0.0 112.301 170.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.0 m -126.71 13.7 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 125.963 1.705 . . . . 0.0 111.166 -175.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.58 37.93 78.2 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 119.16 -0.8 . . . . 0.0 113.209 174.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.4 mt -125.76 154.61 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.708 1.603 . . . . 0.0 107.403 176.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -126.8 143.92 51.12 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.702 1.601 . . . . 0.0 108.639 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.3 pt -138.07 9.06 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 125.551 1.54 . . . . 0.0 110.915 174.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.47 151.39 45.17 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.624 1.17 . . . . 0.0 107.944 168.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.04 -3.24 14.24 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.585 -1.119 . . . . 0.0 113.474 -175.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.461 HE21 ' HG3' ' A' ' 16' ' ' GLN . 26.4 mt-30 -69.46 -175.96 0.91 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.498 1.649 . . . . 0.0 109.956 169.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.4 p -50.46 164.54 0.12 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.887 2.475 . . . . 0.0 114.766 -173.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.0 p -156.91 39.99 0.32 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.306 1.842 . . . . 0.0 109.769 177.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -141.03 150.01 57.72 Favored Pre-proline 0 CA--C 1.542 0.67 0 O-C-N 121.354 -0.841 . . . . 0.0 111.683 -169.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.38 165.53 23.16 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.892 3.061 . . . . 0.0 112.518 -174.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.5 tt -57.8 -39.32 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 125.073 1.349 . . . . 0.0 110.843 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.92 -18.13 61.43 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -170.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.23 -22.23 58.06 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 118.858 -0.591 . . . . 0.0 111.446 169.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -92.14 168.38 11.4 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.875 0.845 . . . . 0.0 110.64 -178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -142.34 94.6 2.68 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 103.336 -2.839 . . . . 0.0 103.336 -174.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.481 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -55.31 -28.01 50.77 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -176.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.36 -28.35 19.11 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.995 0.918 . . . . 0.0 112.415 175.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -70.74 -22.63 62.39 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.16 0.436 . . . . 0.0 112.086 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -106.07 -178.7 3.72 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 129.352 3.061 . . . . 0.0 108.286 -174.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -131.74 -2.44 3.74 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 171.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.699 HG12 HG13 ' A' ' 4' ' ' VAL . 23.8 t -141.71 126.92 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 -177.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.8 m -131.28 135.45 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 O-C-N 120.868 -1.145 . . . . 0.0 108.246 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.7 mm -134.61 80.69 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -169.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.499 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 17.8 t -68.41 164.51 20.8 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.818 177.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -140.75 55.46 1.58 Allowed 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 169.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 81.8 m -106.12 8.9 32.39 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.854 1.262 . . . . 0.0 109.705 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.7 31.5 10.14 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-O 119.209 -0.773 . . . . 0.0 111.639 169.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.415 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 8.8 p 46.59 -10.1 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 130.391 3.476 . . . . 0.0 119.244 -174.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.82 -13.87 82.65 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 120.133 1.333 . . . . 0.0 113.065 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 p -58.9 151.07 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 122.817 1.294 . . . . 0.0 109.202 172.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -124.39 81.28 1.92 Allowed 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 103.741 -2.689 . . . . 0.0 103.741 178.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.8 mt -62.65 150.09 87.38 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.28 158.69 11.67 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.659 2.239 . . . . 0.0 113.316 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.01 -36.3 53.55 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.964 2.443 . . . . 0.0 116.716 -169.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.2 pm0 -67.34 -25.82 66.19 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.323 -0.861 . . . . 0.0 112.133 -176.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.481 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 58.3 m95 -70.44 -9.73 57.23 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.93 1.292 . . . . 0.0 112.088 174.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.2 t -96.62 -29.59 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 119.225 0.921 . . . . 0.0 109.438 175.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.7 p -86.2 56.71 4.11 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.68 1.192 . . . . 0.0 110.502 -174.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -130.47 156.32 44.97 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 128.762 2.825 . . . . 0.0 107.96 -169.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -65.71 -39.23 91.0 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 125.752 1.621 . . . . 0.0 109.005 169.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.551 ' HB ' HG13 ' A' ' 75' ' ' VAL . 25.9 mm -128.7 137.17 58.02 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-O 121.113 0.482 . . . . 0.0 110.294 170.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -135.14 110.03 8.74 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 100.833 -3.765 . . . . 0.0 100.833 166.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.91 165.04 24.79 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 176.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.8 t70 -139.52 105.45 5.18 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 170.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -77.52 87.25 3.85 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 125.223 1.409 . . . . 0.0 107.475 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -65.75 23.07 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 126.613 1.965 . . . . 0.0 114.045 -175.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.16 176.39 0.6 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.628 1.971 . . . . 0.0 111.763 -170.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -54.3 162.44 1.07 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 123.444 1.593 . . . . 0.0 113.582 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -117.68 105.97 46.97 Favored Pre-proline 0 C--N 1.316 -0.866 0 C-N-CA 126.376 1.87 . . . . 0.0 108.396 -170.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.76 16.84 1.23 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.475 2.117 . . . . 0.0 112.181 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -24.84 85.02 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 129.584 3.154 . . . . 0.0 115.441 174.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 44.8 32.03 2.91 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 124.633 1.111 . . . . 0.0 113.959 -174.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -79.72 -179.7 7.05 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 122.492 1.139 . . . . 0.0 112.813 -169.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.1 p -61.07 160.04 10.72 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 113.55 -1.659 . . . . 0.0 109.602 172.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.6 mt -58.03 -30.27 66.0 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 122.667 0.387 . . . . 0.0 110.597 175.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -64.24 -40.0 95.11 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 118.532 -0.746 . . . . 0.0 111.157 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.0 t -72.61 -40.15 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 118.923 -1.111 . . . . 0.0 109.513 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -50.27 -50.68 49.5 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 119.45 1.023 . . . . 0.0 110.524 169.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -60.91 -44.99 96.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.549 0.739 . . . . 0.0 111.31 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.5 m -69.5 -45.59 68.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -172.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 49.3 t -65.75 -46.84 87.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -171.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -42.74 -56.47 3.17 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 125.061 1.344 . . . . 0.0 111.041 169.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.84 -40.93 98.89 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 119.79 1.177 . . . . 0.0 111.908 -175.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -67.55 -38.24 83.86 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 121.298 -1.119 . . . . 0.0 110.941 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.3 t -61.34 -43.0 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 172.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -39.31 87.19 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 119.923 1.238 . . . . 0.0 111.827 -172.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -68.99 -42.03 77.03 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.749 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.7 mtt180 -65.61 -41.7 92.42 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.282 0.946 . . . . 0.0 111.197 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.463 HG12 HD12 ' A' ' 127' ' ' ILE . 47.2 t -54.83 -51.58 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -65.94 -33.73 76.5 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 122.134 -0.354 . . . . 0.0 111.826 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -63.33 -48.71 76.88 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 123.1 0.56 . . . . 0.0 110.345 174.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.404 HD23 HG13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -58.85 -45.7 89.48 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 109.614 -0.514 . . . . 0.0 109.614 177.368 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.463 HD12 HG12 ' A' ' 123' ' ' VAL . 9.3 mt -57.48 -43.01 82.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 123.599 0.759 . . . . 0.0 109.537 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.16 -26.64 68.62 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -71.17 -51.93 22.06 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.57 0.623 . . . . 0.0 110.446 173.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.427 HD12 HG21 ' A' ' 30' ' ' ILE . 1.3 pt -87.65 -46.1 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 -169.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 63.0 m . . . . . 0 C--O 1.254 1.334 0 CA-C-N 119.057 0.844 . . . . 0.0 110.678 -170.233 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 tpt . . . . . 0 N--CA 1.5 2.049 0 CA-C-O 118.33 -0.843 . . . . 0.0 109.659 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.464 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -57.75 118.62 5.48 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 120.727 1.603 . . . . 0.0 110.074 -169.835 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -87.89 137.61 32.18 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -171.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.786 HG13 HG12 ' A' ' 75' ' ' VAL . 11.2 t -117.9 154.05 19.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 124.398 1.079 . . . . 0.0 108.364 174.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 40.9 tpp -137.63 139.68 40.44 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -120.18 114.61 22.2 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.416 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 8.3 t -101.68 138.81 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 119.621 1.1 . . . . 0.0 108.361 -169.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -125.11 164.77 19.51 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 122.009 0.909 . . . . 0.0 111.808 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -150.27 156.0 40.75 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 129.648 3.179 . . . . 0.0 103.842 169.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 58.1 -153.66 0.37 Allowed 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -169.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.475 HD21 ' CD2' ' A' ' 43' ' ' HIS . 29.5 t-20 -59.13 123.63 17.28 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.317 0.647 . . . . 0.0 110.114 -169.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.2 m -49.84 -27.93 5.76 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.675 1.99 . . . . 0.0 113.98 -178.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 26.3 p -48.55 -48.01 38.89 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 117.954 -1.022 . . . . 0.0 112.98 -169.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -60.3 -45.99 91.43 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.987 1.267 . . . . 0.0 112.721 -170.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.485 ' HB3' HD13 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -93.8 -28.27 15.99 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.077 0.853 . . . . 0.0 111.595 -174.205 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -68.87 -33.0 73.07 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.045 -1.034 . . . . 0.0 109.769 171.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.474 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.7 tpt -65.68 -40.15 92.08 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 121.18 -0.95 . . . . 0.0 109.63 169.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.93 -40.67 89.72 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -60.52 -42.45 96.46 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.7 169.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.45 -45.21 80.33 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 120.598 1.545 . . . . 0.0 111.514 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -63.4 -40.34 96.94 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.504 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -71.34 -36.13 71.42 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 119.313 0.961 . . . . 0.0 111.517 -174.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -73.32 -22.91 60.22 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 120.757 1.617 . . . . 0.0 111.921 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 m -77.02 -50.85 12.2 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.818 1.647 . . . . 0.0 110.285 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.1 mt -86.32 -27.39 24.34 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.882 1.273 . . . . 0.0 112.039 -169.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.07 13.0 55.88 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 126.918 2.199 . . . . 0.0 111.523 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.98 121.85 12.23 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.041 1.336 . . . . 0.0 109.861 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.81 8.82 87.22 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-O 119.769 -0.462 . . . . 0.0 113.462 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -124.01 -31.5 3.37 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.42 1.488 . . . . 0.0 109.068 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.7 pt -142.74 176.46 3.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 125.527 1.531 . . . . 0.0 109.508 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -118.25 149.06 41.76 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 168.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.504 HG11 ' HB3' ' A' ' 22' ' ' ALA . 1.9 t -137.82 143.24 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 123.172 0.589 . . . . 0.0 111.412 -167.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.9 m -150.77 161.44 42.65 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.943 1.297 . . . . 0.0 109.745 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.468 ' H ' HG21 ' A' ' 61' ' ' THR . 61.8 p -130.24 163.33 26.97 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.907 1.23 . . . . 0.0 110.241 169.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.6 p -155.45 168.26 27.68 Favored 'General case' 0 N--CA 1.463 0.193 0 O-C-N 121.112 -0.992 . . . . 0.0 110.806 178.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.97 40.24 52.23 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mp -72.79 62.19 0.57 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.003 1.321 . . . . 0.0 109.851 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 52.11 27.09 4.27 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.797 1.639 . . . . 0.0 112.749 -175.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.7 m 55.7 31.06 16.67 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.214 1.406 . . . . 0.0 111.914 -175.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.6 m -144.25 -171.98 3.69 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.985 2.114 . . . . 0.0 109.509 -169.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.43 -179.25 3.36 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.346 0.593 . . . . 0.0 110.795 172.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.6 m -56.16 170.89 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.947 1.299 . . . . 0.0 111.517 169.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.475 ' CD2' HD21 ' A' ' 11' ' ' ASN . 86.5 t60 -125.7 116.53 24.62 Favored Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -175.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -66.48 -26.09 47.73 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.657 2.905 . . . . 0.0 112.692 -169.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.7 m -60.63 -36.16 77.95 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.15 0.886 . . . . 0.0 109.122 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.427 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . . . -65.38 -45.13 85.27 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -58.69 -47.41 88.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.73 -43.16 98.24 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.923 0.783 . . . . 0.0 111.032 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.4 mmt -61.81 -22.51 65.53 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.367 1.067 . . . . 0.0 112.866 177.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.474 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.3 OUTLIER -99.53 -31.34 11.67 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -177.806 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -63.94 -35.92 82.25 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.437 -0.79 . . . . 0.0 109.786 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.62 6.82 3.47 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.186 0.595 . . . . 0.0 112.542 175.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.6 t -113.32 -43.03 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 126.355 1.862 . . . . 0.0 108.71 169.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.73 26.86 1.86 Allowed Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.088 1.328 . . . . 0.0 111.894 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.5 mt -123.62 158.92 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 125.952 1.701 . . . . 0.0 106.939 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -137.91 125.94 22.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -176.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.6 pt -133.76 5.42 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.326 0 C-N-CA 124.392 1.077 . . . . 0.0 111.404 -171.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.16 143.91 56.32 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.764 1.225 . . . . 0.0 109.376 174.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.06 4.57 11.82 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 117.591 -1.672 . . . . 0.0 113.894 -177.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -53.55 -57.43 10.75 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-N 120.044 1.922 . . . . 0.0 111.785 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.468 HG21 ' H ' ' A' ' 34' ' ' SER . 2.9 p -151.43 162.39 41.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.032 -167.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.1 m -167.13 42.47 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.089 1.755 . . . . 0.0 109.192 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -137.63 150.04 66.88 Favored Pre-proline 0 N--CA 1.475 0.802 0 O-C-N 120.885 -1.135 . . . . 0.0 112.629 -169.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -83.72 162.89 14.27 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 124.213 3.275 . . . . 0.0 112.342 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.2 tt -59.21 -37.69 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.253 1.421 . . . . 0.0 111.351 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.68 -22.71 62.45 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 122.969 0.507 . . . . 0.0 111.93 -171.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -21.19 60.09 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 118.653 -0.689 . . . . 0.0 111.548 172.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -92.34 167.88 11.69 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.865 0.84 . . . . 0.0 111.272 -174.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.44 82.18 1.77 Allowed 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.648 1.579 . . . . 0.0 108.288 -170.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.477 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -52.31 -27.91 17.1 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.811 1.244 . . . . 0.0 113.712 -175.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -54.25 -33.75 59.21 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.459 0.475 . . . . 0.0 111.048 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -71.32 -15.73 62.41 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -106.78 160.77 15.24 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.546 1.938 . . . . 0.0 109.541 -173.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -101.35 -18.76 15.91 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 118.931 -0.557 . . . . 0.0 111.977 -177.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.786 HG12 HG13 ' A' ' 4' ' ' VAL . 30.8 t -147.77 129.85 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 120.716 1.598 . . . . 0.0 106.949 -170.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -125.65 135.08 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.2 mm -133.65 85.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 -177.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.416 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 12.0 t -69.28 160.17 31.73 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.175 -0.953 . . . . 0.0 108.503 171.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.485 HD13 ' HB3' ' A' ' 15' ' ' SER . 6.6 mp -129.46 21.41 5.61 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 169.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.6 m -69.27 -8.88 50.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.29 1.036 . . . . 0.0 112.237 -175.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 108.11 23.22 6.81 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 119.15 0.887 . . . . 0.0 111.742 174.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.502 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 2.0 t 55.24 173.63 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.176 2.191 . . . . 0.0 112.685 -169.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.03 16.66 33.65 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.851 1.215 . . . . 0.0 114.423 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.421 HG12 ' H ' ' A' ' 84' ' ' VAL . 1.7 p -72.32 136.42 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 125.155 1.382 . . . . 0.0 108.021 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -79.1 61.52 3.27 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.527 1.131 . . . . 0.0 108.547 173.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.1 mt -59.52 148.31 74.45 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 172.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -54.98 155.38 18.69 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.166 1.911 . . . . 0.0 111.919 174.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.81 -1.19 8.1 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.003 2.469 . . . . 0.0 115.853 -169.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -84.62 -24.93 28.89 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.788 1.176 . . . . 0.0 112.155 169.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.477 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 24.7 m95 -77.21 24.31 0.18 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.642 1.177 . . . . 0.0 112.164 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.0 m -127.92 -2.74 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 125.489 1.516 . . . . 0.0 112.779 169.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.8 p -84.37 -12.32 54.72 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 120.773 1.624 . . . . 0.0 113.516 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.437 ' H ' ' CD ' ' A' ' 93' ' ' GLN . 19.4 mp0 -62.16 160.78 12.19 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 129.808 3.243 . . . . 0.0 110.892 -176.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -64.62 -41.97 95.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.796 1.639 . . . . 0.0 109.137 169.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.55 ' HB ' HG13 ' A' ' 75' ' ' VAL . 33.1 mm -119.15 135.69 58.73 Favored 'Isoleucine or valine' 0 C--N 1.341 0.199 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 170.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -135.45 110.95 9.14 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 100.977 -3.712 . . . . 0.0 100.977 166.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.11 164.67 26.82 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.0 t70 -137.1 99.97 4.15 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 122.118 0.961 . . . . 0.0 108.542 172.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -75.4 73.45 2.46 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.344 1.458 . . . . 0.0 107.811 174.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -54.92 44.3 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 131.278 3.831 . . . . 0.0 114.402 172.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -77.85 -174.15 3.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.337 1.455 . . . . 0.0 111.223 -169.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -50.27 160.94 0.33 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.611 1.565 . . . . 0.0 111.28 176.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -130.1 85.0 58.59 Favored Pre-proline 0 C--N 1.322 -0.59 0 C-N-CA 126.719 2.008 . . . . 0.0 108.364 -169.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.64 67.33 8.43 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 124.9 3.734 . . . . 0.0 111.472 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -64.1 81.05 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.483 1.913 . . . . 0.0 110.874 173.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 59.22 37.42 91.77 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.775 0.702 . . . . 0.0 112.441 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -64.96 170.06 4.69 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -170.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.8 m -68.13 151.89 46.33 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 113.301 -1.772 . . . . 0.0 108.293 168.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.3 mt -57.56 -32.96 67.64 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.91 -0.494 . . . . 0.0 111.808 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.07 -38.63 86.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.533 0.606 . . . . 0.0 111.182 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.595 ' O ' HG23 ' A' ' 115' ' ' VAL . 57.8 t -75.18 -40.58 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 116.456 -1.735 . . . . 0.0 108.88 178.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -50.47 -48.49 56.67 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 121.141 1.792 . . . . 0.0 110.636 170.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -58.84 -43.18 90.66 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.535 0.607 . . . . 0.0 110.81 176.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.8 m -69.22 -43.6 73.77 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -174.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 111' ' ' VAL . 25.8 t -66.28 -46.53 86.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -173.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -47.79 -56.16 8.03 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.016 1.326 . . . . 0.0 110.89 170.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.99 -40.65 99.56 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 119.795 1.179 . . . . 0.0 111.68 -175.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -64.64 -40.11 94.88 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.321 -1.105 . . . . 0.0 111.428 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.0 t -61.08 -42.09 91.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 174.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.06 -37.95 78.26 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 119.904 1.229 . . . . 0.0 111.448 -175.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -70.0 -42.3 73.22 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.136 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -64.24 -42.83 96.35 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 119.252 0.933 . . . . 0.0 110.14 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.5 t -54.36 -53.71 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 123.901 0.88 . . . . 0.0 109.385 173.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -65.31 -33.09 75.16 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 122.283 -0.261 . . . . 0.0 111.541 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -62.15 -49.17 76.9 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.03 0.532 . . . . 0.0 110.787 173.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.42 -46.05 83.93 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.987 0.515 . . . . 0.0 110.046 177.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.3 mt -57.92 -44.0 85.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 124.395 1.078 . . . . 0.0 110.272 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.07 -28.23 67.63 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.98 0.809 . . . . 0.0 112.151 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -75.95 -44.71 38.68 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.379 0.536 . . . . 0.0 111.605 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.9 pt -94.37 -42.36 12.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -169.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 C--O 1.252 1.232 0 CA-C-N 119.168 0.895 . . . . 0.0 109.929 -172.808 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.0 mmm . . . . . 0 N--CA 1.502 2.142 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.765 ' HG2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -57.54 134.9 56.51 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.503 1.047 . . . . 0.0 108.891 169.871 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 53.9 mtpt -101.07 140.97 34.63 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.758 1.223 . . . . 0.0 107.757 -169.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.684 HG13 HG12 ' A' ' 75' ' ' VAL . 14.9 t -129.02 152.18 36.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -175.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 58.6 tpp -137.73 145.29 42.32 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -121.81 150.2 42.23 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 171.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 6.2 t -132.46 134.73 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 120.333 -1.479 . . . . 0.0 108.219 -171.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -131.98 100.09 4.95 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.258 0.935 . . . . 0.0 111.626 -170.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -79.17 -30.76 43.69 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -129.88 141.53 50.8 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 176.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 29.06 101.78 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 129.972 3.309 . . . . 0.0 113.619 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.4 m -33.28 -33.64 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.212 0 C-N-CA 128.671 2.788 . . . . 0.0 115.327 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.4 t -36.52 -64.16 0.35 Allowed 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 125.884 1.673 . . . . 0.0 114.067 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.298 36.1 ptt180 -60.15 -43.66 95.59 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 120.333 1.424 . . . . 0.0 114.127 -168.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.604 ' HB3' HD13 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -95.22 -29.0 14.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 119.374 0.988 . . . . 0.0 112.092 -172.707 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -72.09 -25.45 61.76 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.79 -1.194 . . . . 0.0 109.924 169.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.47 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.0 tpt -68.97 -42.77 76.15 Favored 'General case' 0 CA--C 1.512 -0.514 0 O-C-N 120.812 -1.18 . . . . 0.0 108.508 168.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.95 -39.41 81.59 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -60.43 -41.41 93.92 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.19 1.396 . . . . 0.0 111.4 169.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.74 -40.36 58.53 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 120.651 1.569 . . . . 0.0 112.895 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -69.96 -38.04 76.0 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 118.527 1.164 . . . . 0.0 109.279 172.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.51 -40.88 66.49 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 120.434 1.47 . . . . 0.0 111.145 -175.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -61.35 -32.27 72.16 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.325 1.42 . . . . 0.0 110.842 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 m -75.39 -51.13 13.85 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.262 2.225 . . . . 0.0 111.131 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.1 mt -88.19 -26.22 22.52 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.494 1.118 . . . . 0.0 111.631 -169.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.69 12.71 62.79 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 126.542 2.02 . . . . 0.0 111.248 177.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.16 121.34 10.47 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.549 1.139 . . . . 0.0 110.241 -173.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.03 9.24 86.87 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 119.864 -0.409 . . . . 0.0 113.325 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -123.82 -31.73 3.39 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 125.222 1.409 . . . . 0.0 109.511 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.765 HG22 ' HG2' ' A' ' 2' ' ' LYS . 19.0 pt -142.6 168.39 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.539 1.536 . . . . 0.0 109.954 178.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.35 139.48 46.71 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 168.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.3 t -127.54 146.11 33.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 125.279 1.432 . . . . 0.0 111.207 -170.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.33 160.39 43.76 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.052 1.741 . . . . 0.0 109.725 -174.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -132.99 165.49 24.6 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.334 1.424 . . . . 0.0 109.227 170.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.1 p -158.78 168.8 25.88 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.796 -0.565 . . . . 0.0 111.299 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.39 -73.79 2.55 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 -175.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.6 mp 44.83 41.7 5.38 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.622 1.169 . . . . 0.0 110.904 -176.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 59.76 16.41 5.54 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.587 1.155 . . . . 0.0 113.911 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.9 m 66.59 31.99 7.48 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.418 1.887 . . . . 0.0 111.473 -171.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.1 m -138.48 -168.9 2.48 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.519 2.328 . . . . 0.0 109.091 -175.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -97.99 -165.28 1.23 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.873 1.269 . . . . 0.0 109.092 -176.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 m -57.8 170.65 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.511 1.125 . . . . 0.0 111.486 171.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -133.07 117.67 14.9 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -174.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -66.03 -30.18 47.95 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.319 2.679 . . . . 0.0 112.432 -169.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.0 m -61.89 -37.04 83.12 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 177.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.45 -44.52 86.98 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.98 -47.8 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.32 -43.04 99.54 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-N 118.938 0.79 . . . . 0.0 111.141 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.7 mmt -61.94 -23.75 66.56 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.553 -0.736 . . . . 0.0 111.828 177.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.47 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.3 OUTLIER -94.98 -27.93 15.4 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.705 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.55 -29.4 70.43 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.808 1.243 . . . . 0.0 110.693 171.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -56.2 -24.71 43.58 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.641 0.776 . . . . 0.0 112.487 170.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -126.23 16.3 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.712 0 C-N-CA 125.527 1.531 . . . . 0.0 111.087 -172.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.79 35.69 66.21 Favored Glycine 0 CA--C 1.529 0.952 0 O-C-N 121.516 -0.74 . . . . 0.0 113.395 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.9 mt -125.1 155.85 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -134.42 144.69 48.31 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 170.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.6 pt -137.56 11.17 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 126.513 1.925 . . . . 0.0 110.477 -175.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.2 t -65.69 151.44 46.56 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.529 -0.732 . . . . 0.0 109.496 170.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.98 -0.02 1.31 Allowed Glycine 0 CA--C 1.534 1.223 0 CA-C-O 117.691 -1.616 . . . . 0.0 115.084 -177.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -57.78 -55.47 34.4 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 120.162 1.981 . . . . 0.0 112.633 -171.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.98 161.22 42.76 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.802 -168.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.8 p -170.48 27.02 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.228 0.611 . . . . 0.0 112.288 -171.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -140.48 151.28 63.43 Favored Pre-proline 0 N--CA 1.476 0.847 0 O-C-N 120.818 -1.177 . . . . 0.0 112.828 -169.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.35 160.78 29.04 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 124.062 3.175 . . . . 0.0 112.791 -173.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.2 tt -59.17 -36.78 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.141 1.376 . . . . 0.0 111.671 -176.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -70.45 -22.23 62.72 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.042 0.537 . . . . 0.0 112.27 -172.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.61 -17.61 59.08 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 119.033 -0.508 . . . . 0.0 111.711 171.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -95.89 173.53 7.4 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.146 0.978 . . . . 0.0 110.129 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.83 101.7 3.21 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 125.137 1.375 . . . . 0.0 108.193 -177.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.47 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -49.45 -24.94 2.25 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.801 0.84 . . . . 0.0 113.156 171.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -51.4 -21.53 2.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.044 0.938 . . . . 0.0 112.218 172.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -115.66 17.05 16.37 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.617 1.167 . . . . 0.0 114.009 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.45 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 29.4 m-85 -133.04 112.47 11.83 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 119.968 1.258 . . . . 0.0 108.414 170.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -62.99 -14.62 50.06 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -169.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.684 HG12 HG13 ' A' ' 4' ' ' VAL . 7.9 t -145.31 123.05 4.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.455 -2.424 . . . . 0.0 104.455 -169.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.86 133.34 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 O-C-N 121.085 -1.009 . . . . 0.0 108.406 -174.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.8 mm -130.17 92.45 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -168.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.48 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 28.8 t -70.08 161.54 29.95 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.549 175.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.604 HD13 ' HB3' ' A' ' 15' ' ' SER . 5.7 mp -142.2 52.9 1.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 169.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 59.9 m -114.4 18.35 16.93 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.616 1.566 . . . . 0.0 109.577 -174.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.72 25.3 46.67 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-O 119.356 -0.691 . . . . 0.0 111.999 172.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.422 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 5.7 t 44.37 39.6 3.21 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.947 1.699 . . . . 0.0 112.595 -176.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.85 45.07 0.51 Allowed Glycine 0 C--N 1.34 0.797 0 C-N-CA 123.586 0.612 . . . . 0.0 111.86 -169.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.0 p -124.13 -0.8 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -173.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.8 t30 47.16 60.71 3.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.689 1.596 . . . . 0.0 109.433 175.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.2 mt -56.46 148.09 46.04 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.143 -175.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -55.27 156.01 18.16 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.701 2.267 . . . . 0.0 113.11 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -54.89 -30.11 66.92 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.756 2.304 . . . . 0.0 116.734 -170.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -65.88 -25.03 66.99 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 121.009 -1.057 . . . . 0.0 111.478 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.47 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 72.3 m95 -73.35 -4.46 33.51 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 117.669 -1.158 . . . . 0.0 113.133 178.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.4 m -118.58 -5.48 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 120.757 1.617 . . . . 0.0 113.41 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.3 p -88.73 -17.99 28.75 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.761 0.824 . . . . 0.0 112.416 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -52.59 161.82 0.65 Allowed 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 129.37 3.068 . . . . 0.0 113.906 175.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -64.35 -39.45 93.9 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.493 1.517 . . . . 0.0 108.901 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.508 ' HB ' HG13 ' A' ' 75' ' ' VAL . 33.2 mm -124.95 138.54 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 169.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -137.84 113.89 9.97 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 100.284 -3.969 . . . . 0.0 100.284 167.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -136.09 171.05 15.04 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 172.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.422 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.0 t70 -140.1 122.77 16.33 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 169.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -101.36 77.2 1.76 Allowed 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.4 ' CD ' ' H ' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -56.24 16.8 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 129.638 3.175 . . . . 0.0 115.06 179.21 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -61.22 126.28 26.77 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.673 1.589 . . . . 0.0 111.343 -168.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 52.11 -155.44 0.17 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.3 1.44 . . . . 0.0 112.564 169.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -163.7 57.37 0.61 Allowed Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 127.509 2.324 . . . . 0.0 109.842 -173.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -79.2 59.02 7.22 Favored 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 122.752 2.301 . . . . 0.0 112.251 -169.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -51.46 -46.87 63.22 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.078 -1.014 . . . . 0.0 110.726 176.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -173.23 44.38 0.16 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.714 1.626 . . . . 0.0 110.323 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -68.54 176.42 2.92 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 122.543 1.163 . . . . 0.0 112.633 -177.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.2 m -57.83 152.51 15.69 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 113.956 -1.475 . . . . 0.0 109.857 171.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.3 mt -57.58 -31.59 66.32 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 122.727 0.411 . . . . 0.0 111.228 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.72 -39.64 92.22 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 118.427 0.558 . . . . 0.0 110.968 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 66.1 t -70.53 -45.54 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 117.304 -1.332 . . . . 0.0 108.507 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -48.95 -47.95 43.4 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 120.401 1.455 . . . . 0.0 110.93 172.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -59.81 -45.78 91.29 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.539 0.736 . . . . 0.0 111.303 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 94.2 m -68.36 -45.76 71.95 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -174.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.9 t -65.03 -47.58 87.4 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -173.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -44.65 -55.05 5.56 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 125.225 1.41 . . . . 0.0 110.89 169.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.44 -40.85 99.28 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 119.43 1.014 . . . . 0.0 111.737 -177.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -64.93 -38.46 91.03 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 121.376 -1.073 . . . . 0.0 110.86 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.0 t -62.72 -42.19 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -38.72 84.03 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 120.152 1.342 . . . . 0.0 111.535 -174.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -69.11 -41.31 77.58 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 119.087 -0.482 . . . . 0.0 109.825 177.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -67.24 -38.94 86.0 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 119.299 0.954 . . . . 0.0 111.135 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.8 t -53.85 -54.97 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 169.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -64.86 -32.46 74.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 121.99 -0.444 . . . . 0.0 111.895 -174.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -63.66 -47.41 81.41 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.405 0.682 . . . . 0.0 110.713 172.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -46.6 83.52 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 122.9 0.48 . . . . 0.0 110.062 176.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.0 mt -58.23 -43.18 85.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 124.292 1.037 . . . . 0.0 109.606 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.65 -30.22 70.58 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.101 0.864 . . . . 0.0 111.694 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -72.18 -42.6 65.69 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.635 172.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.1 pt -103.73 -44.8 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 118.902 2.927 . . . . 0.0 118.902 -168.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.3 m . . . . . 0 C--O 1.254 1.299 0 CA-C-O 116.582 -1.675 . . . . 0.0 111.838 -169.084 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 tpt . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.501 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -61.63 121.47 12.85 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 121.227 1.83 . . . . 0.0 108.43 -177.149 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.44 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 34.2 mtpt -92.88 134.4 35.12 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -169.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.876 HG13 HG12 ' A' ' 75' ' ' VAL . 19.1 t -120.7 154.33 24.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -174.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 63.2 tpp -139.15 144.84 38.79 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -126.78 125.97 42.62 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 174.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.4 t -118.07 130.68 72.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -169.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 t -118.16 161.01 20.58 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.574 1.149 . . . . 0.0 111.207 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -141.97 34.54 1.56 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.101 1.36 . . . . 0.0 109.483 172.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.1 mmt-85 -141.9 168.13 20.5 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.235 1.414 . . . . 0.0 109.247 -175.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -46.05 121.8 3.48 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.317 1.447 . . . . 0.0 108.458 170.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.5 m -40.44 98.04 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.317 2.247 . . . . 0.0 114.098 -169.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.5 t -158.35 -84.85 0.04 OUTLIER 'General case' 0 C--N 1.343 0.317 0 CA-C-O 118.369 -0.824 . . . . 0.0 112.457 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.347 35.9 ptt180 -45.76 -52.6 10.82 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -167.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.452 ' HB3' HD13 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -84.62 -27.02 27.47 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.413 1.006 . . . . 0.0 112.047 -174.206 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -65.98 -40.72 91.45 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.119 -0.988 . . . . 0.0 109.304 171.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.447 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.1 tpt -62.9 -40.66 98.26 Favored 'General case' 0 CA--C 1.512 -0.489 0 O-C-N 121.735 -0.603 . . . . 0.0 109.821 171.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.34 -36.88 79.0 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 118.969 -0.539 . . . . 0.0 110.017 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -65.95 -39.91 90.85 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.504 170.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.49 -44.98 95.86 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 120.332 1.424 . . . . 0.0 111.055 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -65.49 -41.54 93.14 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 118.022 0.911 . . . . 0.0 109.067 173.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.04 -35.25 74.14 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 119.824 1.193 . . . . 0.0 111.741 -173.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -79.6 -15.83 56.95 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.184 1.356 . . . . 0.0 112.886 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.9 m -79.65 -50.91 9.94 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.896 1.678 . . . . 0.0 109.239 171.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.4 mt -88.48 -28.02 21.11 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.101 1.361 . . . . 0.0 112.384 -169.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.71 12.24 61.1 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.484 1.993 . . . . 0.0 111.751 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.52 121.52 12.34 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.939 1.295 . . . . 0.0 109.762 -172.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.86 11.05 85.79 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 119.755 -0.469 . . . . 0.0 113.538 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -124.9 -29.22 3.39 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.511 1.524 . . . . 0.0 109.153 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.2 pt -143.82 173.03 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.696 1.598 . . . . 0.0 109.677 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.69 144.59 44.24 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 103.836 -2.653 . . . . 0.0 103.836 168.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -133.78 148.64 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 118.536 0.607 . . . . 0.0 111.688 -167.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.95 158.33 44.09 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.342 1.457 . . . . 0.0 110.299 -174.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.4 p -131.17 153.23 49.64 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.633 1.573 . . . . 0.0 109.365 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.2 t -145.9 149.04 33.5 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -174.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 113.36 -107.3 1.92 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 107.086 -2.406 . . . . 0.0 107.086 -175.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 62' ' ' SER . 5.3 tp 64.65 50.45 2.1 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -58.17 -23.99 57.4 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 124.767 1.227 . . . . 0.0 111.124 -173.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.7 m -78.65 15.85 0.96 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 m 59.45 -12.44 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 129.705 3.202 . . . . 0.0 115.137 -173.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.59 -173.69 4.41 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.206 2.203 . . . . 0.0 106.965 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.2 m -62.41 173.11 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.329 1.052 . . . . 0.0 111.091 172.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -132.9 117.89 15.18 Favored Pre-proline 0 N--CA 1.453 -0.309 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -173.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -63.33 -27.53 71.63 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.327 2.685 . . . . 0.0 113.721 -169.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.4 m -61.56 -41.25 97.1 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.231 0.923 . . . . 0.0 109.474 171.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.79 -42.71 97.67 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 120.091 1.314 . . . . 0.0 108.958 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -56.33 -49.55 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 118.728 -0.654 . . . . 0.0 109.346 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.79 -41.32 90.89 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-N 118.723 0.692 . . . . 0.0 111.014 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.446 ' HG3' ' HB3' ' A' ' 112' ' ' PHE . 32.7 mmt -65.34 -22.29 66.8 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 123.457 0.703 . . . . 0.0 112.032 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.447 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 1.5 mmt -98.06 -28.41 13.78 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -62.6 -32.43 73.43 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.448 1.099 . . . . 0.0 110.258 170.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -59.24 -16.2 19.81 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.768 1.627 . . . . 0.0 112.292 172.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.3 m -129.07 15.02 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 125.953 1.701 . . . . 0.0 111.37 177.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.79 38.95 86.03 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 119.064 -0.853 . . . . 0.0 113.675 173.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.9 mt -121.13 152.52 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -118.73 126.59 52.22 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 124.865 1.266 . . . . 0.0 108.002 176.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.9 pt -128.23 17.87 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 124.064 0.946 . . . . 0.0 111.746 171.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.3 -33.07 59.07 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.671 1.188 . . . . 0.0 112.157 173.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.22 -3.47 81.93 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 123.302 0.477 . . . . 0.0 112.873 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -67.15 153.0 44.72 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.165 0.986 . . . . 0.0 111.185 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.0 p -147.1 157.76 43.72 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.97 1.708 . . . . 0.0 107.601 169.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . 7.2 m -154.47 173.48 16.21 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.166 1.386 . . . . 0.0 108.41 -169.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -154.8 167.55 13.76 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-O 117.778 -1.106 . . . . 0.0 108.186 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.06 165.25 21.83 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.286 1.991 . . . . 0.0 112.853 -171.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.6 tt -63.78 -34.4 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 123.716 0.806 . . . . 0.0 110.622 -170.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.49 -19.04 61.62 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.757 0.823 . . . . 0.0 112.608 -174.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.85 -24.67 58.63 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.091 0.556 . . . . 0.0 110.945 169.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -95.79 169.77 9.78 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 122.199 0.999 . . . . 0.0 111.245 -169.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.16 97.13 2.73 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.876 1.671 . . . . 0.0 107.183 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.457 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -50.45 -23.07 2.19 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.039 0.936 . . . . 0.0 113.501 173.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -50.65 -22.92 2.27 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.802 0.841 . . . . 0.0 111.908 171.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -114.27 16.16 17.99 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.087 1.355 . . . . 0.0 113.226 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.44 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 23.5 m-85 -134.12 112.92 11.53 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 120.526 -1.359 . . . . 0.0 109.598 170.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -67.67 -8.99 39.42 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -169.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.876 HG12 HG13 ' A' ' 4' ' ' VAL . 18.2 t -146.65 119.64 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 -171.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.4 m -133.85 130.97 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 O-C-N 120.409 -1.432 . . . . 0.0 107.962 -174.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.3 mm -126.11 102.16 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 -173.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.7 p -78.03 157.54 29.57 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 171.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.452 HD13 ' HB3' ' A' ' 15' ' ' SER . 6.0 mp -133.43 44.38 2.8 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 169.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 69.0 m -93.16 10.51 31.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.81 1.644 . . . . 0.0 110.227 -174.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.41 29.39 33.27 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 170.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 4.9 t 39.33 43.66 0.97 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.705 2.002 . . . . 0.0 112.83 -171.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -144.18 44.13 0.94 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.688 1.137 . . . . 0.0 110.449 -171.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.2 p -134.99 165.06 32.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.38 1.872 . . . . 0.0 109.19 -173.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -129.58 71.54 1.44 Allowed 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 38.8 mt -60.77 149.45 79.8 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.63 153.75 17.87 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.511 2.141 . . . . 0.0 111.611 169.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.33 -18.67 55.67 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.787 1.658 . . . . 0.0 114.79 -169.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.05 -25.69 68.22 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 120.904 -1.122 . . . . 0.0 111.22 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.457 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 68.2 m95 -70.48 -11.12 60.71 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 117.224 -1.37 . . . . 0.0 113.235 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.6 m -110.36 -8.54 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 121.204 1.82 . . . . 0.0 113.285 -175.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.6 p -90.99 -11.2 39.64 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.892 0.877 . . . . 0.0 112.953 -174.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -61.67 167.27 3.64 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 128.763 2.825 . . . . 0.0 112.681 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -68.19 -38.71 82.27 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.217 1.007 . . . . 0.0 108.539 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.479 ' CG2' HG13 ' A' ' 75' ' ' VAL . 3.5 mt -119.91 135.47 60.11 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 CA-C-O 121.488 0.661 . . . . 0.0 109.632 169.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -148.39 114.84 5.93 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 166.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -143.73 167.51 22.1 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 173.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -126.08 124.56 40.88 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 169.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -100.53 77.4 1.91 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -177.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.46 ' H ' ' CD ' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -62.51 33.51 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 128.962 2.905 . . . . 0.0 114.19 178.461 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.58 -177.8 1.62 Allowed 'General case' 0 CA--C 1.535 0.394 0 O-C-N 120.789 -1.194 . . . . 0.0 110.67 -171.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -55.1 161.84 1.57 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 123.814 1.769 . . . . 0.0 113.356 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -115.19 103.06 54.74 Favored Pre-proline 0 C--N 1.318 -0.766 0 C-N-CA 128.853 2.861 . . . . 0.0 107.85 -169.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -82.04 18.58 1.37 Allowed 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.761 2.307 . . . . 0.0 112.477 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -39.61 96.35 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.539 1.935 . . . . 0.0 113.974 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 42.51 31.98 1.15 Allowed Glycine 0 CA--C 1.541 1.663 0 C-N-CA 125.095 1.331 . . . . 0.0 114.172 -172.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -76.85 177.51 7.61 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 122.496 1.141 . . . . 0.0 113.404 -169.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 p -59.88 154.65 18.13 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.731 -1.577 . . . . 0.0 109.355 170.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.8 mt -58.73 -29.49 66.75 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.797 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.62 -40.82 97.86 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 118.676 -0.678 . . . . 0.0 111.044 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.4 t -71.23 -39.96 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 119.469 1.031 . . . . 0.0 109.082 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.446 ' HB3' ' HG3' ' A' ' 49' ' ' MET . 29.7 m-85 -52.08 -51.33 58.4 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.527 1.058 . . . . 0.0 111.624 169.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -59.16 -45.23 91.51 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.935 0.789 . . . . 0.0 110.584 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.3 m -69.4 -45.19 69.83 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -173.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.5 t -65.31 -47.95 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -172.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.3 ttp180 -45.53 -53.34 9.12 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 124.732 1.213 . . . . 0.0 110.949 171.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.29 -42.25 97.89 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 119.334 0.97 . . . . 0.0 111.91 -177.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -64.99 -37.3 87.2 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.213 -1.169 . . . . 0.0 110.765 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.7 t -63.14 -42.74 97.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -39.25 83.47 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.201 1.364 . . . . 0.0 111.364 -173.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.27 -42.53 75.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 119.205 -0.426 . . . . 0.0 110.322 177.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -68.03 -39.46 83.1 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.401 1.0 . . . . 0.0 111.469 178.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.3 t -54.97 -52.97 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 171.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.37 -32.91 74.71 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.744 -0.597 . . . . 0.0 111.923 -176.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -63.44 -48.43 77.8 Favored 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 121.615 -0.678 . . . . 0.0 110.719 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -46.57 77.37 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 123.429 0.692 . . . . 0.0 109.659 177.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.1 mt -58.72 -44.3 89.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 124.432 1.093 . . . . 0.0 109.584 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.24 -29.31 68.69 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.876 0.762 . . . . 0.0 111.927 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -74.27 -42.32 59.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.478 0.581 . . . . 0.0 111.533 175.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 pt -98.85 -44.12 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 -168.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 C--O 1.255 1.343 0 CA-C-N 118.997 0.817 . . . . 0.0 110.223 -170.842 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.2 mmm . . . . . 0 N--CA 1.501 2.112 0 CA-C-O 119.937 -0.078 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.493 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -58.5 129.59 42.77 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 173.267 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -91.49 133.45 35.49 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.709 HG13 HG12 ' A' ' 75' ' ' VAL . 13.8 t -112.34 154.08 13.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 51.4 tpp -136.11 145.59 46.07 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -125.35 119.37 28.18 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 175.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.1 t -103.06 126.81 57.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -171.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 m -112.5 156.92 21.79 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.627 0.771 . . . . 0.0 110.628 -172.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -150.44 153.49 36.03 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 169.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.564 ' HG2' ' H ' ' A' ' 11' ' ' ASN . 53.5 ttm-85 58.61 -169.31 0.13 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.456 1.102 . . . . 0.0 108.472 -168.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.564 ' H ' ' HG2' ' A' ' 10' ' ' ARG . 50.9 t-20 -47.29 105.99 0.08 Allowed 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 124.008 0.923 . . . . 0.0 108.671 174.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.409 ' HB2' HD23 ' A' ' 37' ' ' LEU . 50.0 m -77.34 7.5 5.22 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.379 1.072 . . . . 0.0 112.378 -170.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.4 p -44.33 -56.75 3.95 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 124.309 1.044 . . . . 0.0 110.135 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 25.7 ptt85 -52.49 -44.66 65.78 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.795 1.238 . . . . 0.0 113.57 -177.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.6 -32.58 13.36 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.338 -0.851 . . . . 0.0 112.406 -168.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -71.48 -30.24 65.74 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.719 -1.238 . . . . 0.0 109.106 169.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.466 ' SD ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -64.05 -37.79 88.73 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 120.784 -1.198 . . . . 0.0 109.364 168.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.8 -36.77 75.01 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 119.077 -0.487 . . . . 0.0 110.008 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -63.15 -40.0 96.31 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.891 169.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.71 -44.4 92.48 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 120.609 1.549 . . . . 0.0 111.797 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.466 ' CD2' ' SD ' ' A' ' 17' ' ' MET . 5.4 m-85 -62.39 -40.93 98.07 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 118.562 1.181 . . . . 0.0 109.382 170.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.435 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -70.06 -36.19 74.8 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.574 1.079 . . . . 0.0 110.632 -173.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -73.84 -18.35 60.95 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 120.359 1.436 . . . . 0.0 112.584 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 m -82.84 -50.94 8.1 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.745 1.618 . . . . 0.0 109.473 176.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.8 mt -88.07 -26.52 22.5 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.301 1.44 . . . . 0.0 111.672 -169.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.96 11.73 60.65 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.574 2.035 . . . . 0.0 112.218 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.65 124.54 21.27 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.819 1.247 . . . . 0.0 109.179 -171.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.61 8.81 87.45 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 119.47 -0.628 . . . . 0.0 113.806 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -127.52 -31.06 2.53 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.566 1.546 . . . . 0.0 108.56 -177.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.47 HD12 HG22 ' A' ' 32' ' ' VAL . 12.1 pt -143.74 165.87 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 125.767 1.627 . . . . 0.0 110.22 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.58 146.62 35.78 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 103.469 -2.789 . . . . 0.0 103.469 168.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.47 HG22 HD12 ' A' ' 30' ' ' ILE . 1.8 t -134.76 146.25 31.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-N 118.922 0.783 . . . . 0.0 111.488 -168.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.8 162.64 40.7 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.656 1.582 . . . . 0.0 109.545 -174.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.5 p -136.58 165.43 25.89 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 120.395 -1.441 . . . . 0.0 110.215 173.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.3 p -149.78 150.75 32.49 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 123.515 0.726 . . . . 0.0 109.745 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.8 -99.08 0.83 Allowed Glycine 0 CA--C 1.522 0.484 0 N-CA-C 106.861 -2.496 . . . . 0.0 106.861 -170.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 37' ' ' LEU . 9.0 mt 53.12 48.18 22.84 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 122.008 0.909 . . . . 0.0 109.02 -172.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -67.16 -17.36 64.81 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.176 0.99 . . . . 0.0 111.032 -178.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.82 30.28 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 127.645 2.378 . . . . 0.0 113.237 172.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.4 m 57.13 65.18 1.43 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.258 1.823 . . . . 0.0 111.065 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 61.04 -153.54 0.37 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.334 1.054 . . . . 0.0 109.009 -173.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.7 t -54.41 147.23 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.648 1.179 . . . . 0.0 110.378 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -129.67 110.97 17.5 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.722 1.209 . . . . 0.0 108.984 -169.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.3 -30.44 54.08 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.956 3.104 . . . . 0.0 114.701 -168.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.0 m -59.52 -36.61 76.43 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.661 1.119 . . . . 0.0 109.743 175.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.13 -43.8 90.74 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.47 -44.11 92.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.52 -41.93 98.06 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.169 0.895 . . . . 0.0 111.664 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 39.1 mmt -63.77 -29.77 70.94 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 118.943 -0.551 . . . . 0.0 111.682 178.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -85.27 -32.5 22.53 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.92 -33.77 76.05 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.275 1.03 . . . . 0.0 109.994 174.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -62.35 -12.54 21.75 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.72 1.208 . . . . 0.0 112.119 173.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.1 m -127.66 13.51 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 125.937 1.695 . . . . 0.0 111.863 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.48 35.61 59.52 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 121.003 -1.06 . . . . 0.0 114.563 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.3 mt -122.35 156.23 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 171.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -131.57 140.82 49.55 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.723 1.209 . . . . 0.0 108.479 171.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 27.6 pt -133.7 17.4 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.55 1.54 . . . . 0.0 111.146 -175.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.3 p -78.64 -28.64 45.54 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.574 1.15 . . . . 0.0 112.664 171.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.6 -8.12 66.5 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 123.136 0.398 . . . . 0.0 112.234 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -85.84 146.57 26.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.478 1.111 . . . . 0.0 108.335 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.4 p -143.16 154.52 43.98 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 169.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.99 166.03 32.83 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -169.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -147.61 162.67 31.02 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.185 1.794 . . . . 0.0 106.762 -171.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.84 160.14 48.66 Favored 'Trans proline' 0 C--N 1.347 0.488 0 CA-C-N 123.052 2.126 . . . . 0.0 112.728 -170.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.9 tt -57.06 -32.73 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.736 1.214 . . . . 0.0 111.95 -175.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -68.73 -22.66 64.31 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.59 0.756 . . . . 0.0 112.145 -173.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -13.34 59.89 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 118.808 -0.615 . . . . 0.0 112.177 171.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -110.76 172.59 6.78 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 122.274 1.035 . . . . 0.0 112.211 -170.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.77 103.23 2.91 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 126.78 2.032 . . . . 0.0 107.065 -172.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.444 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -54.87 -24.43 23.25 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 123.757 0.823 . . . . 0.0 112.988 177.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -50.64 -32.42 18.98 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.04 0.936 . . . . 0.0 111.585 172.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -86.6 12.0 11.55 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -136.0 177.68 7.65 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.064 2.146 . . . . 0.0 108.557 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -120.45 -21.88 6.67 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.709 HG12 HG13 ' A' ' 4' ' ' VAL . 20.2 t -142.21 128.34 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 -170.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.58 129.74 61.9 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 O-C-N 120.666 -1.271 . . . . 0.0 108.221 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.1 mm -117.9 134.54 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 176.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.4 t -115.06 156.76 24.57 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 175.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.5 mp -134.06 36.38 3.25 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 173.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 60.2 m -96.7 14.0 26.48 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.395 1.478 . . . . 0.0 110.025 -176.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.94 15.45 81.16 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-O 119.361 -0.689 . . . . 0.0 112.447 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 3.9 t 60.35 -20.07 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.234 2.614 . . . . 0.0 115.632 -178.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.13 -26.76 73.95 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 119.457 1.026 . . . . 0.0 112.829 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.8 t -63.21 116.59 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 174.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -66.14 138.17 57.54 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 172.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.4 mt -120.99 141.15 32.13 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.57 157.65 6.94 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.645 2.897 . . . . 0.0 113.163 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.7 -22.4 69.85 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 121.889 1.726 . . . . 0.0 115.222 -169.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -65.73 -24.02 66.88 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 120.188 -1.57 . . . . 0.0 111.746 176.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.444 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 70.7 m95 -70.0 -7.93 44.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 117.344 -1.312 . . . . 0.0 112.487 175.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.5 m -115.32 -12.25 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 121.273 1.851 . . . . 0.0 113.481 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.8 p -81.83 -13.3 57.84 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.158 0.89 . . . . 0.0 112.23 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -44.29 155.22 0.09 Allowed 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 130.979 3.712 . . . . 0.0 113.009 169.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -62.38 -38.33 89.19 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.673 1.989 . . . . 0.0 108.771 169.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.673 ' HB ' HG13 ' A' ' 75' ' ' VAL . 33.6 mm -130.44 138.11 54.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 C-N-CA 123.055 0.542 . . . . 0.0 109.847 171.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -135.42 117.49 15.38 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 100.707 -3.812 . . . . 0.0 100.707 166.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.65 165.75 26.77 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 175.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -141.85 132.75 25.87 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 169.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.4 ' CE3' ' HB3' ' A' ' 122' ' ' ARG . 54.1 m0 -102.35 2.22 36.5 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -172.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 47.19 -68.78 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 131.086 3.754 . . . . 0.0 111.833 -169.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . 0.258 0.8 OUTLIER 45.29 -172.73 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.238 1 C-N-CA 133.294 4.638 . . . . 0.0 114.369 -174.429 . . . . . . . . 4 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -64.83 174.89 1.67 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.356 1.462 . . . . 0.0 113.34 -169.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -132.63 66.62 77.06 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 126.483 1.913 . . . . 0.0 109.75 -169.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -79.21 61.8 8.28 Favored 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 124.276 3.317 . . . . 0.0 111.294 -169.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -55.68 -42.6 75.37 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.026 -1.046 . . . . 0.0 112.521 -175.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -163.69 42.68 0.32 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.0 1.762 . . . . 0.0 109.753 -177.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -69.37 171.5 8.53 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -169.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.5 p -64.8 158.74 24.12 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.001 169.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 27.8 mt -60.24 -32.81 71.49 Favored 'General case' 0 C--O 1.22 -0.449 0 O-C-N 122.007 -0.433 . . . . 0.0 110.295 172.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.19 -43.93 90.04 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 118.484 0.584 . . . . 0.0 110.958 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 63.2 t -68.09 -43.79 84.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 119.156 -1.018 . . . . 0.0 108.47 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -48.41 -48.44 37.11 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.674 1.124 . . . . 0.0 111.739 173.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -62.94 -48.19 79.97 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.622 0.769 . . . . 0.0 111.016 176.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.1 m -65.48 -45.61 82.97 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -171.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.5 t -59.32 -42.73 88.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 124.095 0.958 . . . . 0.0 108.764 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -52.57 -51.67 58.67 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 118.444 0.566 . . . . 0.0 110.249 173.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.38 -38.42 95.8 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 119.544 1.066 . . . . 0.0 112.143 -177.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -63.79 -40.36 96.48 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 120.851 -1.382 . . . . 0.0 110.511 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.9 t -62.04 -39.2 82.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 118.443 -0.789 . . . . 0.0 109.147 173.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -39.49 76.27 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.495 1.043 . . . . 0.0 110.881 -176.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -70.44 -42.26 71.78 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 119.043 -0.504 . . . . 0.0 110.565 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.4 ' HB3' ' CE3' ' A' ' 99' ' ' TRP . 9.4 mpt_? -65.44 -42.0 92.9 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.427 1.012 . . . . 0.0 110.559 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.2 t -55.16 -52.69 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 123.322 0.649 . . . . 0.0 109.728 173.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -63.5 -32.65 74.17 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 122.049 -0.407 . . . . 0.0 111.609 -175.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -62.56 -45.9 90.82 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.375 0.67 . . . . 0.0 111.991 172.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -47.4 81.91 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 174.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -58.74 -43.05 87.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.46 -35.32 78.94 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.526 0.603 . . . . 0.0 111.823 -176.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -77.44 -37.49 51.46 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 117.664 -1.16 . . . . 0.0 112.435 174.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.8 pt -93.32 -41.97 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -171.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 C--O 1.252 1.226 0 CA-C-N 119.19 0.904 . . . . 0.0 110.055 -171.513 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 tpt . . . . . 0 N--CA 1.499 1.977 0 CA-C-O 117.623 -1.18 . . . . 0.0 109.607 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.559 ' HB2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -47.52 118.19 2.12 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 120.708 1.595 . . . . 0.0 110.188 -171.948 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 33.5 mtpt -93.51 134.22 36.01 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -169.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.775 HG13 HG12 ' A' ' 75' ' ' VAL . 10.1 t -112.87 153.54 14.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 58.2 tpp -136.6 143.58 43.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -127.58 106.75 9.38 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.452 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 4.2 t -94.7 141.93 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.298 1.039 . . . . 0.0 108.249 -172.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.66 162.81 30.41 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.74 1.155 . . . . 0.0 113.598 175.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -142.36 30.0 1.58 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.378 1.871 . . . . 0.0 109.111 169.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -155.57 -174.76 5.1 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.807 2.043 . . . . 0.0 106.956 -170.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.473 HD21 ' CD2' ' A' ' 43' ' ' HIS . 9.3 t-20 -52.16 141.5 18.57 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 125.016 1.326 . . . . 0.0 111.579 174.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.2 p -67.26 -17.14 64.67 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.109 1.364 . . . . 0.0 113.205 -176.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 32.0 p -61.91 -11.43 13.06 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 117.542 -1.218 . . . . 0.0 113.858 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.252 21.7 ptt180 -100.69 -37.99 8.5 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.032 1.287 . . . . 0.0 111.567 169.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.8 p -98.43 -54.34 3.07 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.757 1.617 . . . . 0.0 114.891 -169.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -66.58 -23.18 66.16 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.137 -0.977 . . . . 0.0 108.652 170.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.473 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.9 tpt -67.56 -44.05 79.19 Favored 'General case' 0 C--O 1.224 -0.251 0 O-C-N 120.791 -1.193 . . . . 0.0 109.978 168.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.14 -39.8 87.6 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.507 ' HG2' HG12 ' A' ' 32' ' ' VAL . 12.0 tm-20 -58.61 -44.55 89.95 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.377 1.071 . . . . 0.0 110.623 169.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.53 -39.35 61.09 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 120.594 1.543 . . . . 0.0 112.092 -174.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -66.45 -36.78 83.63 Favored 'General case' 0 C--O 1.223 -0.315 0 O-C-N 121.489 -1.007 . . . . 0.0 108.958 170.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.485 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -72.68 -39.92 66.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.978 1.263 . . . . 0.0 110.899 -174.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -66.3 -27.18 67.72 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 120.664 1.575 . . . . 0.0 111.36 175.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 m -75.43 -50.91 14.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.982 1.713 . . . . 0.0 110.477 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.9 mt -89.48 -27.66 20.19 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.007 1.323 . . . . 0.0 112.485 -169.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.28 12.45 63.49 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 127.064 2.269 . . . . 0.0 111.904 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.52 123.43 17.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.14 1.376 . . . . 0.0 110.012 -171.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.95 8.49 86.77 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.465 -0.631 . . . . 0.0 113.636 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -124.7 -41.18 2.15 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.18 1.392 . . . . 0.0 109.201 -175.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.559 HG22 ' HB2' ' A' ' 2' ' ' LYS . 2.7 pp -140.44 156.06 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.731 1.213 . . . . 0.0 109.437 176.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.95 154.66 17.17 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 173.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.507 HG12 ' HG2' ' A' ' 19' ' ' GLU . 2.1 t -140.55 146.14 24.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-N 119.116 0.871 . . . . 0.0 111.585 -168.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.43 158.24 39.68 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.588 1.155 . . . . 0.0 110.418 -176.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.4 p -133.26 156.08 48.21 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.039 1.29 . . . . 0.0 110.906 176.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.457 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 8.1 p -146.78 145.79 30.05 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.05 0.841 . . . . 0.0 109.759 176.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.7 129.6 0.16 Allowed Glycine 0 CA--C 1.532 1.118 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 -169.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.8 tp -151.1 52.99 0.85 Allowed 'General case' 0 CA--C 1.533 0.291 0 O-C-N 120.718 -1.46 . . . . 0.0 109.445 -169.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 59.72 -80.27 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.696 2.398 . . . . 0.0 111.049 -169.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 p -169.66 26.56 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.723 2.009 . . . . 0.0 110.893 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.9 m -139.53 164.05 30.92 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.577 1.151 . . . . 0.0 110.327 -169.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -74.68 -25.33 59.1 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 118.96 -0.543 . . . . 0.0 111.756 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -171.4 171.49 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 127.09 2.156 . . . . 0.0 106.843 177.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.473 ' CD2' HD21 ' A' ' 11' ' ' ASN . 82.3 t60 -139.99 112.69 7.51 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -172.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -64.34 -30.19 63.26 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.352 2.701 . . . . 0.0 112.751 -169.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.7 m -64.98 -37.5 87.87 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.98 -44.12 90.37 Favored 'General case' 0 C--N 1.346 0.426 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.87 -49.25 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.12 -42.16 98.03 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.523 0.601 . . . . 0.0 110.808 -177.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.9 mmt -63.44 -24.5 67.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.802 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.473 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -94.92 -31.68 13.56 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -176.63 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -60.56 -34.1 73.67 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.603 1.161 . . . . 0.0 110.054 169.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -63.8 -9.59 15.55 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.419 1.488 . . . . 0.0 112.39 173.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.73 14.32 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 125.949 1.7 . . . . 0.0 111.329 172.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.81 37.94 88.95 Favored Glycine 0 CA--C 1.532 1.121 0 O-C-N 121.452 -0.78 . . . . 0.0 112.982 175.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.4 mt -120.16 152.75 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 125.706 1.602 . . . . 0.0 106.95 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -127.79 124.47 37.72 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -176.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.9 pt -129.12 12.91 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 124.246 1.018 . . . . 0.0 111.232 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.95 -31.31 50.87 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.9 1.68 . . . . 0.0 113.577 -178.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.37 -9.69 73.48 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -83.19 159.27 22.04 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.256 1.022 . . . . 0.0 111.528 -173.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -146.77 158.67 43.96 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 128.373 2.669 . . . . 0.0 105.71 169.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.5 m -147.98 167.75 24.09 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -142.5 162.19 45.97 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -169.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.58 164.25 36.16 Favored 'Trans proline' 0 C--N 1.348 0.504 0 CA-C-N 122.686 1.995 . . . . 0.0 113.163 -169.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.5 tt -57.11 -35.87 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.364 1.465 . . . . 0.0 111.118 -173.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.95 -18.42 62.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.298 0.639 . . . . 0.0 112.699 -169.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -82.18 -16.37 49.95 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.482 170.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 35' ' ' CYS . 46.4 m-85 -96.35 168.84 10.33 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.272 1.029 . . . . 0.0 110.842 -177.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.08 93.57 2.41 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 -169.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.508 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -52.97 -25.03 10.7 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 177.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.87 -21.95 13.12 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.123 0.42 . . . . 0.0 111.275 173.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -99.52 6.72 45.79 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.513 1.525 . . . . 0.0 113.248 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.443 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 22.7 m-85 -136.77 113.58 10.36 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 120.284 1.402 . . . . 0.0 108.932 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.5 -17.37 59.53 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -169.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.775 HG12 HG13 ' A' ' 4' ' ' VAL . 9.7 t -144.22 122.03 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 -171.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.0 m -129.64 131.36 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 O-C-N 120.845 -1.159 . . . . 0.0 108.763 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.9 mm -126.19 96.72 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 102.977 -2.971 . . . . 0.0 102.977 -170.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.452 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 33.5 t -70.81 166.16 21.6 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -147.38 49.44 1.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 173.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.525 ' HB3' HG21 ' A' ' 84' ' ' VAL . 38.5 m -115.68 10.87 15.59 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.739 1.216 . . . . 0.0 110.786 -170.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.62 21.48 16.53 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 118.486 0.585 . . . . 0.0 112.563 173.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 4.3 t 47.4 41.15 12.16 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.049 1.74 . . . . 0.0 111.771 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -162.51 36.31 0.35 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-O 119.601 -0.555 . . . . 0.0 112.452 -170.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.525 HG21 ' HB3' ' A' ' 80' ' ' CYS . 57.9 t -117.83 137.4 51.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 173.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -82.72 69.07 9.43 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.131 0.972 . . . . 0.0 109.947 -171.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 18.4 mt -59.57 144.81 84.16 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -52.97 154.99 11.95 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.764 2.309 . . . . 0.0 111.846 170.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.65 -19.48 53.88 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 121.649 1.566 . . . . 0.0 114.362 -170.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.08 -25.95 68.33 Favored 'General case' 0 C--O 1.226 -0.162 0 O-C-N 120.938 -1.101 . . . . 0.0 111.224 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.508 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 72.3 m95 -68.57 -5.31 19.05 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.271 -0.893 . . . . 0.0 112.554 174.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.8 t -108.07 -28.5 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 119.67 1.123 . . . . 0.0 111.184 -174.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.1 p -77.07 -19.05 57.58 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.87 0.868 . . . . 0.0 113.123 -169.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -49.99 159.55 0.41 Allowed 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 129.2 3.0 . . . . 0.0 113.964 174.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -63.34 -38.83 92.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.674 1.59 . . . . 0.0 109.118 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.582 ' HB ' HG13 ' A' ' 75' ' ' VAL . 36.5 mm -125.71 138.89 53.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 169.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -139.3 112.19 7.93 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 102.641 -3.096 . . . . 0.0 102.641 167.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -134.68 171.0 14.97 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 174.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -139.49 116.0 10.64 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 170.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -93.74 68.74 3.97 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -36.99 -50.05 0.86 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.856 1.663 . . . . 0.0 110.108 169.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . 0.254 0.5 OUTLIER 38.04 -158.39 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 129.936 3.294 . . . . 0.0 112.734 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -60.4 166.6 2.96 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 122.35 1.071 . . . . 0.0 109.181 169.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -133.17 70.45 77.86 Favored Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 126.362 1.865 . . . . 0.0 109.952 -168.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -77.21 49.74 2.93 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.498 3.465 . . . . 0.0 114.738 -169.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -62.69 102.43 0.34 Allowed 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.981 -1.074 . . . . 0.0 109.424 169.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.55 26.34 66.45 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 123.967 0.794 . . . . 0.0 114.203 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -63.93 167.48 6.16 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -176.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.1 m -67.22 154.07 42.15 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 113.228 -1.806 . . . . 0.0 109.219 169.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 25.7 mt -59.03 -34.88 72.41 Favored 'General case' 0 C--O 1.222 -0.366 0 O-C-N 122.08 -0.387 . . . . 0.0 111.519 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -61.11 -39.79 91.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.339 0.518 . . . . 0.0 110.615 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.656 ' O ' HG23 ' A' ' 115' ' ' VAL . 61.9 t -72.96 -40.3 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-O 116.75 -1.595 . . . . 0.0 108.998 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -51.63 -47.23 63.77 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 121.207 1.821 . . . . 0.0 111.033 170.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -59.17 -43.96 92.15 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 118.626 0.648 . . . . 0.0 110.441 177.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 86.7 m -69.27 -42.05 76.05 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -174.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 111' ' ' VAL . 67.5 t -65.02 -48.68 83.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -174.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -47.21 -51.58 18.2 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.957 1.303 . . . . 0.0 110.69 170.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.81 -43.85 97.06 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 119.764 1.165 . . . . 0.0 112.409 -177.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -66.69 -33.96 76.8 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.838 1.319 . . . . 0.0 111.42 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.4 t -62.94 -41.1 91.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.47 -37.56 81.42 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 120.245 1.384 . . . . 0.0 111.166 -177.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -70.17 -40.19 74.85 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 118.865 -0.588 . . . . 0.0 110.733 175.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -60.76 -46.28 91.08 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.515 1.052 . . . . 0.0 110.078 175.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.48 HG12 HD12 ' A' ' 127' ' ' ILE . 69.8 t -57.19 -51.42 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 124.224 1.01 . . . . 0.0 109.451 176.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -67.02 -33.0 74.59 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 119.473 -0.299 . . . . 0.0 111.347 -175.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -61.59 -49.26 77.34 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 123.41 0.684 . . . . 0.0 110.679 172.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.415 HD23 HG13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -58.51 -46.14 87.34 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 122.93 0.492 . . . . 0.0 110.219 177.594 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.48 HD12 HG12 ' A' ' 123' ' ' VAL . 10.1 mt -59.36 -41.0 82.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 124.691 1.196 . . . . 0.0 109.813 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.08 -27.59 67.11 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.068 0.849 . . . . 0.0 111.933 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -75.88 -39.73 55.85 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.776 -0.578 . . . . 0.0 111.786 176.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.1 pt -102.89 -33.14 3.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 -168.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 C--O 1.254 1.3 0 C-N-CA 124.755 1.222 . . . . 0.0 111.679 -171.426 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 tpt . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 118.273 -0.87 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.522 ' HB2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -50.72 116.14 1.81 Allowed 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 120.285 1.402 . . . . 0.0 110.135 -173.123 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.5 mtpt -91.86 142.29 27.72 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 119.263 0.938 . . . . 0.0 108.693 -170.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.439 HG11 ' CZ ' ' A' ' 6' ' ' PHE . 21.3 t -111.67 154.32 13.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 170.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -138.81 131.95 29.81 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.439 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 86.2 m-85 -113.65 132.35 55.8 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.4 t -123.19 112.02 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 120.802 1.637 . . . . 0.0 110.164 -169.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.79 170.78 12.86 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 122.76 1.267 . . . . 0.0 112.835 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.0 mmtp -148.47 148.67 30.53 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 130.971 3.708 . . . . 0.0 101.706 168.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.433 ' HG2' ' H ' ' A' ' 11' ' ' ASN . 26.1 ttm-85 57.51 -160.51 0.24 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.743 1.156 . . . . 0.0 107.908 -168.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.433 ' H ' ' HG2' ' A' ' 10' ' ' ARG . 20.2 t-20 -55.77 133.96 51.32 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.221 0.919 . . . . 0.0 112.308 -169.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.4 m -48.06 -24.96 1.24 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 130.286 3.434 . . . . 0.0 115.125 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.0 m -50.2 -49.41 52.72 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 125.713 1.605 . . . . 0.0 114.107 -169.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.27 34.0 ptt180 -70.02 -42.12 73.4 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 118.23 -0.89 . . . . 0.0 113.21 -168.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 87.9 p -78.38 -39.4 39.29 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 120.528 1.513 . . . . 0.0 110.114 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -70.76 -27.68 64.12 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.628 -0.67 . . . . 0.0 110.003 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.471 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.1 tpt -66.72 -41.76 87.44 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 121.149 -0.97 . . . . 0.0 109.51 169.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.57 -38.46 84.65 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -61.33 -42.55 98.87 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.902 169.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.54 -44.88 88.97 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 120.643 1.565 . . . . 0.0 111.798 -175.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -64.98 -40.83 95.56 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 117.937 0.868 . . . . 0.0 108.836 173.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.517 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -71.19 -37.31 72.14 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 119.622 1.101 . . . . 0.0 111.286 -173.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -69.56 -24.77 63.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 120.567 1.53 . . . . 0.0 111.891 177.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.3 m -78.06 -49.98 12.95 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.345 2.258 . . . . 0.0 110.328 175.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.6 mt -88.01 -27.98 21.69 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.732 1.213 . . . . 0.0 112.355 -169.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.34 12.32 58.47 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 127.251 2.358 . . . . 0.0 111.96 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.06 122.83 15.97 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.264 1.426 . . . . 0.0 109.511 -170.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.94 8.41 87.84 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 119.536 -0.591 . . . . 0.0 113.764 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -124.85 -41.94 2.08 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.998 1.319 . . . . 0.0 108.832 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.522 HG22 ' HB2' ' A' ' 2' ' ' LYS . 2.8 pp -140.99 162.08 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.979 1.312 . . . . 0.0 109.124 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.84 155.53 18.54 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.517 HG11 ' HB3' ' A' ' 22' ' ' ALA . 2.4 t -143.9 139.4 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 118.622 0.646 . . . . 0.0 111.2 -168.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.5 m -150.09 165.85 31.53 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.232 1.413 . . . . 0.0 108.271 177.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.419 ' H ' HG21 ' A' ' 61' ' ' THR . 66.1 p -139.21 169.67 17.35 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.684 -1.26 . . . . 0.0 110.552 171.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.6 p -160.69 -178.31 6.77 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.103 0.961 . . . . 0.0 109.349 176.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.34 34.57 57.51 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 mt -76.03 57.0 1.04 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.368 1.067 . . . . 0.0 110.895 -174.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 53.28 8.03 0.1 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 128.157 2.583 . . . . 0.0 115.495 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.5 m 58.85 26.75 15.23 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.075 0.95 . . . . 0.0 110.922 -168.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 38.0 m -135.26 10.58 3.52 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.321 1.849 . . . . 0.0 111.957 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? 59.34 -158.51 0.31 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.596 1.159 . . . . 0.0 110.45 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.3 m -67.1 172.38 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.208 1.003 . . . . 0.0 111.886 -172.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.414 ' CG ' HD21 ' A' ' 11' ' ' ASN . 82.5 t60 -141.08 119.65 8.1 Favored Pre-proline 0 N--CA 1.451 -0.397 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -176.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -66.68 -26.69 45.73 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.534 2.823 . . . . 0.0 113.116 -169.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.8 m -61.85 -35.37 78.08 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.973 0.806 . . . . 0.0 109.464 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.3 -43.71 90.25 Favored 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.09 -47.24 90.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 118.566 -0.731 . . . . 0.0 109.041 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.5 99.25 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 118.759 0.709 . . . . 0.0 110.919 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.2 mmt -61.41 -24.94 66.87 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 123.615 0.766 . . . . 0.0 111.936 176.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.471 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.4 OUTLIER -95.45 -26.96 15.63 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 119.052 0.842 . . . . 0.0 108.965 -179.371 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.29 -29.05 70.44 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.996 0.919 . . . . 0.0 110.149 170.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -56.7 -26.23 56.23 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.24 0.616 . . . . 0.0 111.517 169.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.89 -15.95 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 126.744 2.018 . . . . 0.0 109.874 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.65 29.49 52.11 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.153 0.882 . . . . 0.0 111.099 -169.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.0 mt -109.4 156.91 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.259 1.423 . . . . 0.0 107.884 177.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.63 132.65 51.19 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 126.31 1.844 . . . . 0.0 107.669 -173.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.3 pt -140.71 4.48 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.628 1.171 . . . . 0.0 111.883 175.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.83 144.89 55.12 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.712 1.205 . . . . 0.0 110.262 176.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.82 3.68 4.84 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 117.926 -1.485 . . . . 0.0 114.67 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -56.62 -58.42 8.16 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-N 119.589 1.694 . . . . 0.0 112.745 -172.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.419 HG21 ' H ' ' A' ' 34' ' ' SER . 1.0 OUTLIER -141.8 165.49 27.32 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.317 -167.344 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.3 m -163.13 19.7 0.08 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -173.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -141.89 154.0 64.9 Favored Pre-proline 0 N--CA 1.476 0.831 0 CA-C-N 120.803 1.638 . . . . 0.0 113.135 -169.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.13 -177.5 3.54 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 125.241 3.961 . . . . 0.0 113.373 174.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.9 tt -77.21 -33.15 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 126.015 1.726 . . . . 0.0 113.756 -173.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -68.92 -27.75 66.05 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -168.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.54 -7.48 57.56 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 117.579 -1.2 . . . . 0.0 112.776 171.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -102.93 166.13 10.63 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.692 1.587 . . . . 0.0 111.894 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.43 88.53 2.21 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 125.383 1.473 . . . . 0.0 108.884 -169.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.43 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -52.02 -27.75 14.66 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.028 0.931 . . . . 0.0 113.009 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -50.48 -32.51 18.29 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.346 1.058 . . . . 0.0 112.312 174.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -72.1 -20.83 61.58 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -101.68 175.03 5.69 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.104 2.562 . . . . 0.0 109.211 -175.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -117.06 -18.54 10.04 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 117.608 -1.187 . . . . 0.0 113.064 174.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.663 HG13 ' HB ' ' A' ' 95' ' ' ILE . 22.3 t -138.06 133.08 43.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 121.478 1.945 . . . . 0.0 108.672 -178.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.9 t -117.65 138.42 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 6' ' ' PHE . 49.2 mm -131.54 92.12 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 103.004 -2.961 . . . . 0.0 103.004 172.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.7 t -69.63 164.58 23.04 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 169.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.8 mp -139.24 32.0 2.13 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.7 1.6 . . . . 0.0 106.892 173.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 87.7 m -74.39 -3.06 28.19 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.383 1.073 . . . . 0.0 111.908 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.48 34.36 6.09 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 119.585 1.084 . . . . 0.0 110.864 176.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . 0.25 30.3 p 38.91 45.14 0.93 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.003 2.521 . . . . 0.0 113.809 -178.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -142.88 36.55 1.6 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.404 1.478 . . . . 0.0 111.037 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.14 161.94 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 127.202 2.201 . . . . 0.0 108.949 -177.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -134.98 85.65 2.19 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 174.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.5 HD22 ' H ' ' A' ' 86' ' ' LEU . 1.3 mm? -62.08 153.85 72.13 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.708 -171.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.41 157.36 18.54 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.002 1.801 . . . . 0.0 112.272 174.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -52.13 -36.92 68.16 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.772 2.315 . . . . 0.0 116.152 -170.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -67.06 -23.79 65.91 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 120.982 -1.074 . . . . 0.0 112.288 -175.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.43 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 63.8 m95 -75.86 -11.65 60.01 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.745 1.218 . . . . 0.0 112.622 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.76 -16.67 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 120.032 1.287 . . . . 0.0 112.314 -177.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.6 p -76.72 -13.46 60.03 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.282 0.946 . . . . 0.0 112.342 177.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -41.67 154.17 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 129.982 3.313 . . . . 0.0 111.793 169.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -60.68 -36.91 79.93 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.096 1.758 . . . . 0.0 109.729 172.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.663 ' HB ' HG13 ' A' ' 75' ' ' VAL . 29.1 mm -130.18 136.35 58.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 170.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -133.69 123.03 24.27 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 102.92 -2.993 . . . . 0.0 102.92 166.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.46 167.04 23.43 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 173.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -130.51 102.24 6.07 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 169.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -76.86 80.81 3.44 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.898 1.679 . . . . 0.0 108.807 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.77 22.4 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.263 2.625 . . . . 0.0 115.234 175.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.72 164.91 13.6 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.062 -1.024 . . . . 0.0 111.219 -169.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -51.71 146.86 7.29 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -168.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -80.89 110.29 16.87 Favored Pre-proline 0 C--N 1.321 -0.669 0 C-N-CA 127.72 2.408 . . . . 0.0 109.531 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -84.16 -7.14 10.17 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.882 2.388 . . . . 0.0 112.378 176.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.6 t70 19.8 -101.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 128.758 2.823 . . . . 0.0 113.508 -176.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.81 39.76 1.74 Allowed Glycine 0 CA--C 1.533 1.191 0 C-N-CA 127.138 2.304 . . . . 0.0 108.059 169.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -70.03 -179.51 1.93 Allowed 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.987 1.715 . . . . 0.0 112.397 -173.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.2 p -60.27 154.47 19.94 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 113.142 -1.844 . . . . 0.0 109.04 169.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 27.6 mt -57.35 -29.74 64.25 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 122.799 0.44 . . . . 0.0 110.406 176.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -61.4 -41.08 96.56 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 118.527 -0.749 . . . . 0.0 110.948 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.5 t -72.17 -40.19 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 117.705 -1.14 . . . . 0.0 109.59 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -51.35 -51.31 55.62 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.934 1.243 . . . . 0.0 111.425 169.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 80.2 mtt180 -59.65 -44.27 93.6 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.847 0.749 . . . . 0.0 110.99 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 95.8 m -67.03 -45.93 75.98 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -175.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.1 t -64.95 -48.89 82.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -172.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -43.97 -53.58 6.1 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 125.374 1.47 . . . . 0.0 111.262 169.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.82 -40.41 95.57 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 120.104 1.32 . . . . 0.0 112.526 -177.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -66.05 -37.22 85.28 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 120.819 -1.4 . . . . 0.0 110.261 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.9 t -63.41 -43.7 98.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 CA-C-O 117.997 -1.002 . . . . 0.0 108.439 173.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.52 -40.22 82.31 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.716 1.598 . . . . 0.0 110.842 -175.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -71.26 -44.46 65.22 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 125.382 1.473 . . . . 0.0 109.084 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -66.24 -41.87 89.41 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 120.011 1.278 . . . . 0.0 111.582 177.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.504 HG12 HD12 ' A' ' 127' ' ' ILE . 48.7 t -53.98 -50.13 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 173.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -66.67 -34.4 77.79 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -176.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -61.68 -48.28 81.54 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 118.46 0.573 . . . . 0.0 110.394 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.416 HD11 HG11 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -59.58 -45.92 90.46 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 123.049 0.54 . . . . 0.0 109.829 177.875 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.504 HD12 HG12 ' A' ' 123' ' ' VAL . 12.4 mt -58.43 -42.2 83.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.735 1.214 . . . . 0.0 110.195 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.13 -28.38 67.83 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.296 0.498 . . . . 0.0 112.085 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -75.79 -43.54 45.81 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.418 0.554 . . . . 0.0 111.873 174.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 pt -91.92 -37.53 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -169.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.6 m . . . . . 0 C--O 1.255 1.348 0 CA-C-N 120.266 1.393 . . . . 0.0 110.352 179.36 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 tpt . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 118.524 -0.75 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.489 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -61.54 119.7 9.12 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 121.128 1.785 . . . . 0.0 108.035 -176.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 37.1 mtpt -92.25 137.97 31.92 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -170.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.747 HG13 HG12 ' A' ' 75' ' ' VAL . 14.5 t -122.06 153.77 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 58.9 tpp -138.44 145.12 40.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -129.42 121.82 28.12 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 t -118.5 113.35 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 119.644 1.111 . . . . 0.0 109.252 -169.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.96 167.42 18.92 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 123.32 1.533 . . . . 0.0 113.476 178.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -152.94 141.03 20.37 Favored 'General case' 0 C--O 1.238 0.479 2 N-CA-C 100.032 -4.062 . . . . 0.0 100.032 168.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 62.16 -179.36 0.13 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 120.331 1.423 . . . . 0.0 108.644 -167.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.502 HD21 ' CD2' ' A' ' 43' ' ' HIS . 28.8 t-20 -41.52 123.0 2.07 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 125.131 1.372 . . . . 0.0 112.129 -169.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.3 m -45.78 -26.71 0.7 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 127.868 2.467 . . . . 0.0 115.108 -176.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.5 t -39.78 -54.08 2.15 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 125.557 1.543 . . . . 0.0 112.859 -178.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.289 33.5 ptt180 -65.84 -44.35 85.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 117.784 -1.103 . . . . 0.0 113.454 -168.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 97.5 p -77.3 -41.67 39.79 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 121.094 1.77 . . . . 0.0 110.304 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -70.06 -34.91 73.81 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -172.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.46 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 3.4 tpt -63.72 -41.76 98.03 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 123.496 0.718 . . . . 0.0 110.363 170.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.58 -37.66 82.06 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.494 -177.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -62.51 -42.73 99.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 117.94 -1.028 . . . . 0.0 111.204 170.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.58 -45.23 93.62 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 120.746 1.612 . . . . 0.0 111.284 -175.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -66.77 -40.49 88.22 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.203 172.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.96 78.44 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 120.295 1.407 . . . . 0.0 111.6 -176.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -81.91 -13.82 57.01 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 120.46 1.482 . . . . 0.0 113.11 176.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.6 m -79.95 -52.01 8.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.698 1.199 . . . . 0.0 108.533 169.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.1 mt -84.44 -27.44 27.54 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.899 1.28 . . . . 0.0 111.859 -169.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.87 12.66 57.73 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.675 2.084 . . . . 0.0 111.889 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.53 121.98 12.91 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.585 1.154 . . . . 0.0 109.861 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.38 9.41 86.84 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 119.853 -0.415 . . . . 0.0 113.559 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -123.2 -32.56 3.42 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.849 1.66 . . . . 0.0 109.012 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.4 pt -142.64 174.57 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 125.305 1.442 . . . . 0.0 109.785 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.56 145.27 43.48 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 169.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 t -134.13 143.88 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 118.542 0.61 . . . . 0.0 111.279 -168.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.76 156.18 42.0 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.934 1.294 . . . . 0.0 109.74 -173.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.3 p -139.65 155.34 47.46 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 120.364 1.438 . . . . 0.0 111.069 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.2 p -160.11 -178.54 7.06 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.93 0.892 . . . . 0.0 110.313 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.43 33.32 72.42 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.0 mp -61.2 128.21 35.28 Favored 'General case' 0 C--N 1.344 0.338 0 N-CA-C 102.272 -3.232 . . . . 0.0 102.272 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -70.15 80.4 0.51 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-O 123.184 1.468 . . . . 0.0 113.415 -169.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.0 m 50.74 30.99 5.42 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 127.924 2.49 . . . . 0.0 112.758 174.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.0 m -149.87 167.01 27.81 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.517 1.527 . . . . 0.0 108.81 -170.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -78.48 -174.18 3.69 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 169.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.2 m -55.57 162.74 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 124.564 1.146 . . . . 0.0 112.06 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.502 ' CD2' HD21 ' A' ' 11' ' ' ASN . 81.5 t60 -119.74 110.07 37.29 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.623 -169.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -59.88 -29.1 88.68 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.07 2.513 . . . . 0.0 113.67 -169.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.33 -37.49 80.78 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.475 1.034 . . . . 0.0 110.847 175.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.21 -45.82 72.29 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.5 -45.81 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.5 -43.74 93.27 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.373 0.533 . . . . 0.0 111.438 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.3 mmt -65.86 -19.64 65.95 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 118.969 -0.539 . . . . 0.0 112.1 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.46 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 2.0 mmt -98.63 -28.65 13.45 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.93 -33.67 75.84 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.557 1.143 . . . . 0.0 109.547 169.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -58.51 -15.17 10.01 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.792 1.637 . . . . 0.0 112.067 172.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.0 m -132.45 14.3 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 C-N-CA 126.439 1.896 . . . . 0.0 111.753 177.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.51 43.54 76.9 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-O 118.944 -0.92 . . . . 0.0 114.31 174.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.1 mt -124.25 151.61 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.133 1.373 . . . . 0.0 107.872 171.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -113.81 129.86 56.53 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.293 1.437 . . . . 0.0 109.073 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 57' ' ' ILE . 30.1 pt -129.76 14.12 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 125.568 1.547 . . . . 0.0 111.017 171.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.54 -28.1 31.24 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.372 1.469 . . . . 0.0 113.107 175.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.05 -9.5 86.74 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 118.372 0.533 . . . . 0.0 112.902 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -71.79 157.99 36.9 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.63 1.572 . . . . 0.0 109.614 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.48 165.15 31.15 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.54 144.84 49.43 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.682 1.993 . . . . 0.0 112.005 -172.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.65 139.41 1.67 Allowed Pre-proline 0 C--O 1.237 0.409 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 169.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -79.39 158.64 25.94 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.271 1.981 . . . . 0.0 110.845 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.6 tt -57.92 -37.2 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 124.707 1.203 . . . . 0.0 110.641 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -69.76 -21.87 63.4 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.357 0.663 . . . . 0.0 112.344 -174.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -22.2 60.94 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.28 0.491 . . . . 0.0 111.069 171.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -94.01 168.95 10.62 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 122.072 0.939 . . . . 0.0 110.646 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.39 93.41 2.43 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 125.451 1.5 . . . . 0.0 107.516 -175.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.478 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -50.0 -24.31 2.54 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 124.306 1.042 . . . . 0.0 113.392 175.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -50.81 -28.99 10.52 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.136 0.574 . . . . 0.0 111.318 173.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -91.92 -9.34 43.48 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.454 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 12.8 m-85 -120.2 112.93 19.69 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 120.595 1.543 . . . . 0.0 109.332 -173.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -65.54 -14.48 61.16 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -169.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.747 HG12 HG13 ' A' ' 4' ' ' VAL . 13.0 t -143.85 118.19 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 -171.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.3 m -128.19 134.2 65.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 O-C-N 120.875 -1.14 . . . . 0.0 108.718 -174.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.4 mm -127.5 97.14 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 104.203 -2.518 . . . . 0.0 104.203 -169.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.0 t -72.81 166.29 23.21 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 169.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.8 mp -144.27 40.19 1.33 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 173.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.499 ' HB3' HG21 ' A' ' 84' ' ' VAL . 60.9 m -100.04 12.0 37.96 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.334 1.054 . . . . 0.0 111.358 -172.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.7 23.53 28.04 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.512 -0.605 . . . . 0.0 111.862 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.44 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 4.0 t 45.65 45.7 11.1 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.857 1.663 . . . . 0.0 111.945 -177.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -153.53 35.9 0.75 Allowed Glycine 0 C--N 1.341 0.821 0 C-N-CA 123.405 0.526 . . . . 0.0 111.928 -171.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.499 HG21 ' HB3' ' A' ' 80' ' ' CYS . 78.5 t -122.43 133.16 69.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 125.039 1.335 . . . . 0.0 107.737 177.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -78.42 72.42 4.95 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 172.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.3 mt -57.73 145.98 68.15 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -55.1 155.24 19.65 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.046 1.831 . . . . 0.0 112.432 176.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -54.18 -29.28 55.61 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.549 2.166 . . . . 0.0 115.94 -173.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -66.25 -27.06 67.66 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 120.986 -1.071 . . . . 0.0 111.159 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.478 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 71.0 m95 -71.47 -3.63 22.12 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 117.91 -1.043 . . . . 0.0 113.165 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.0 m -120.71 -7.17 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 120.575 1.534 . . . . 0.0 113.471 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.8 p -87.28 -16.25 35.7 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.448 1.022 . . . . 0.0 112.632 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -54.02 163.33 0.79 Allowed 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 129.153 2.981 . . . . 0.0 113.605 175.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -64.89 -41.72 95.37 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.673 1.189 . . . . 0.0 108.708 176.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.497 ' HB ' HG13 ' A' ' 75' ' ' VAL . 32.7 mm -121.64 140.48 45.53 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 CA-C-O 121.58 0.705 . . . . 0.0 110.097 169.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -140.71 114.3 8.8 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 100.946 -3.724 . . . . 0.0 100.946 166.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -135.9 170.28 16.24 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 170.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.44 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.2 t70 -137.31 106.24 5.95 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 172.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.429 ' C ' ' H ' ' A' ' 101' ' ' LEU . 48.7 m0 -85.13 70.48 10.89 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -48.03 7.91 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.208 1 C-N-CA 131.836 4.054 . . . . 0.0 115.324 169.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.429 ' H ' ' C ' ' A' ' 99' ' ' TRP . 3.8 mm? -61.48 126.39 27.17 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 126.798 2.039 . . . . 0.0 111.338 -168.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 51.01 -160.04 0.09 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.826 2.051 . . . . 0.0 113.765 169.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -165.48 70.76 1.32 Allowed Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 128.101 2.561 . . . . 0.0 108.061 -172.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.95 -4.8 16.01 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 122.526 2.15 . . . . 0.0 114.215 -169.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -56.61 -34.19 66.99 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -173.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.35 40.65 1.94 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.651 1.119 . . . . 0.0 112.737 -174.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.415 ' HB3' ' H ' ' A' ' 108' ' ' SER . 16.5 mm-40 -116.13 -157.62 0.66 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.085 0.954 . . . . 0.0 111.89 -175.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.415 ' H ' ' HB3' ' A' ' 107' ' ' GLN . 9.9 m -131.11 173.56 10.9 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 128.662 2.785 . . . . 0.0 107.542 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 35.4 mt -54.7 -36.06 64.3 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.962 0.905 . . . . 0.0 110.785 -172.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -60.13 -40.0 88.22 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 123.031 0.532 . . . . 0.0 110.269 -175.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.61 -37.82 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.091 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -53.68 -42.73 68.27 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.948 1.249 . . . . 0.0 111.255 170.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -63.44 -43.76 96.5 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 119.607 1.094 . . . . 0.0 111.141 174.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.1 m -71.91 -43.39 65.42 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -171.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 57.9 t -64.48 -47.19 90.33 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -173.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.3 ttp180 -45.08 -50.38 11.06 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 125.475 1.51 . . . . 0.0 111.026 169.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.69 -43.4 96.34 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 119.576 1.08 . . . . 0.0 112.696 177.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -75.91 -31.68 59.27 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 120.956 -1.32 . . . . 0.0 110.652 -175.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.2 -37.75 80.27 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 170.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.415 ' HE2' ' HB3' ' A' ' 120' ' ' LYS . 5.7 mtpt -57.8 -47.79 81.57 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 120.595 1.543 . . . . 0.0 110.876 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -62.05 -38.25 88.03 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.021 0.826 . . . . 0.0 109.011 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -68.13 -47.18 68.81 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.404 0.681 . . . . 0.0 110.878 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.6 t -56.49 -52.51 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.87 1.268 . . . . 0.0 108.738 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -68.66 -33.37 73.87 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -171.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -62.16 -49.43 75.87 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 123.099 0.56 . . . . 0.0 110.852 171.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.87 -46.14 78.33 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 122.978 0.511 . . . . 0.0 109.876 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.7 mt -58.85 -43.84 89.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 124.807 1.243 . . . . 0.0 110.687 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.71 -29.06 67.85 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 118.782 0.719 . . . . 0.0 111.726 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -74.71 -40.64 61.2 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 118.538 0.608 . . . . 0.0 112.032 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.9 pt -100.62 -42.38 9.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 116.976 2.213 . . . . 0.0 116.976 -168.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.254 1.307 0 CA-C-N 119.195 0.907 . . . . 0.0 110.304 -171.909 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 tpt . . . . . 0 N--CA 1.499 1.977 0 CA-C-O 117.706 -1.14 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.512 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -54.96 118.02 3.93 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 121.337 1.881 . . . . 0.0 110.377 -169.69 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.495 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 56.2 mtpt -86.19 135.47 33.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -170.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.75 HG13 HG12 ' A' ' 75' ' ' VAL . 9.0 t -125.36 153.71 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 61.4 tpp -140.59 131.91 26.69 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -176.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.409 ' HE1' HG13 ' A' ' 32' ' ' VAL . 92.5 m-85 -116.17 107.27 14.68 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.452 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 3.9 t -94.39 144.31 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -169.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.4 t -128.0 -177.76 4.26 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.38 1.072 . . . . 0.0 110.185 172.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -152.4 -45.93 0.1 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.63 1.572 . . . . 0.0 108.688 176.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -167.7 0.17 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.187 0.995 . . . . 0.0 109.017 169.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.484 HD21 ' CD2' ' A' ' 43' ' ' HIS . 26.6 t-20 -47.94 139.58 7.69 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.698 0.799 . . . . 0.0 109.614 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -55.22 -22.9 19.63 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.504 1.522 . . . . 0.0 114.396 -169.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.9 m -42.2 -67.5 0.26 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 127.21 2.204 . . . . 0.0 114.318 -172.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.272 34.9 ptt180 -56.19 -47.67 77.87 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.451 1.478 . . . . 0.0 114.715 -167.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.43 -29.98 21.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 119.005 0.82 . . . . 0.0 111.315 -171.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -70.09 -27.01 64.26 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.112 -0.992 . . . . 0.0 110.023 170.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.473 ' SD ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -69.03 -42.25 76.6 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 120.574 -1.329 . . . . 0.0 109.789 169.439 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.08 -40.21 84.54 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -59.65 -39.09 83.26 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.42 169.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.19 -43.08 56.77 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 120.715 1.598 . . . . 0.0 112.587 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.473 ' CD2' ' SD ' ' A' ' 17' ' ' MET . 10.6 m-85 -64.68 -37.52 87.88 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 119.075 1.438 . . . . 0.0 108.989 170.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.526 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -72.45 -39.17 68.0 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 119.497 1.044 . . . . 0.0 111.118 -173.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -65.27 -33.79 76.81 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 120.371 1.441 . . . . 0.0 110.915 174.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.8 m -69.06 -50.98 43.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.285 1.834 . . . . 0.0 110.232 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.0 mt -90.06 -25.83 20.58 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.55 1.14 . . . . 0.0 112.129 -169.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.23 14.84 58.15 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 126.748 2.118 . . . . 0.0 111.903 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.66 120.82 10.77 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.908 1.283 . . . . 0.0 110.091 -171.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.11 8.53 86.93 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-O 119.811 -0.439 . . . . 0.0 113.511 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -123.1 -28.45 4.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.413 1.485 . . . . 0.0 109.583 -176.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.6 pt -143.35 175.87 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 125.832 1.653 . . . . 0.0 109.386 176.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.56 145.12 46.66 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 103.868 -2.641 . . . . 0.0 103.868 168.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.526 HG11 ' HB3' ' A' ' 22' ' ' ALA . 2.1 t -132.17 144.04 38.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 123.851 0.86 . . . . 0.0 111.316 -167.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.75 161.97 41.18 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.799 1.24 . . . . 0.0 109.723 -173.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.428 ' H ' HG21 ' A' ' 61' ' ' THR . 22.9 t -142.18 154.76 45.09 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.688 1.586 . . . . 0.0 109.524 172.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.6 p -157.11 171.03 21.18 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 118.509 0.595 . . . . 0.0 112.312 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.18 47.36 90.28 Favored Glycine 0 N--CA 1.472 1.091 0 N-CA-C 107.786 -2.126 . . . . 0.0 107.786 -169.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.92 56.89 3.25 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.114 1.766 . . . . 0.0 109.097 -168.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 60.98 -67.43 0.05 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 129.759 3.224 . . . . 0.0 111.381 -168.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.3 m -155.0 40.93 0.44 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.385 2.274 . . . . 0.0 107.995 -175.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.3 m 58.36 48.66 12.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.489 1.116 . . . . 0.0 113.129 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.79 142.75 22.2 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.503 -0.748 . . . . 0.0 111.725 171.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.4 m -71.47 177.81 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 124.668 1.187 . . . . 0.0 110.528 175.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.484 ' CD2' HD21 ' A' ' 11' ' ' ASN . 20.9 t-80 -139.75 119.52 9.09 Favored Pre-proline 0 N--CA 1.451 -0.403 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -176.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -67.11 -27.28 42.06 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.057 2.505 . . . . 0.0 112.555 -169.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.7 m -62.43 -35.48 79.38 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.967 0.803 . . . . 0.0 109.53 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.23 -43.03 92.77 Favored 'General case' 0 C--O 1.221 -0.447 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.57 -47.84 89.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 118.206 -0.902 . . . . 0.0 109.382 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.35 -42.69 99.1 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 119.633 1.106 . . . . 0.0 110.878 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.0 mmt -64.32 -18.2 64.39 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.765 0.826 . . . . 0.0 112.112 176.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 3.9 mmt -95.02 -28.03 15.33 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 119.387 0.994 . . . . 0.0 110.992 173.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -63.6 -30.01 71.18 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 123.62 0.768 . . . . 0.0 109.694 172.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -57.96 -21.13 42.73 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.535 1.134 . . . . 0.0 113.101 170.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.4 p -121.44 9.03 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 125.229 1.412 . . . . 0.0 110.386 -177.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.32 36.88 85.5 Favored Glycine 0 CA--C 1.531 1.072 0 O-C-N 121.148 -0.97 . . . . 0.0 111.808 177.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 35.3 mt -121.83 157.93 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 126.2 1.8 . . . . 0.0 106.153 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -140.33 145.08 36.73 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 172.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 27.6 pt -138.55 7.7 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 126.354 1.862 . . . . 0.0 111.023 -174.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.3 t -64.28 145.67 55.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.612 -0.68 . . . . 0.0 109.289 172.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.63 3.52 5.75 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 117.802 -1.555 . . . . 0.0 114.552 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -54.6 -58.7 6.49 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-N 119.776 1.788 . . . . 0.0 111.481 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.428 HG21 ' H ' ' A' ' 34' ' ' SER . 1.0 OUTLIER -154.77 154.03 32.16 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 125.57 1.548 . . . . 0.0 106.986 -169.331 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.0 m -163.43 68.03 0.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 102.428 -3.175 . . . . 0.0 102.428 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -142.46 141.44 20.82 Favored Pre-proline 0 C--O 1.236 0.347 0 CA-C-O 119.152 -0.451 . . . . 0.0 112.195 -167.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -82.66 159.99 16.58 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.522 2.815 . . . . 0.0 111.268 173.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.63 -36.87 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 124.463 1.105 . . . . 0.0 111.778 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -70.46 -19.96 62.92 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.277 0.631 . . . . 0.0 112.16 -173.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.25 -23.9 62.98 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 118.763 -0.637 . . . . 0.0 111.6 170.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -99.82 169.71 9.04 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 122.128 0.966 . . . . 0.0 111.093 -174.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -142.59 90.69 2.25 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 -170.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.508 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -54.26 -22.79 12.67 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.4 -21.07 5.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 122.943 0.497 . . . . 0.0 111.301 171.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -111.31 17.09 20.54 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.881 2.072 . . . . 0.0 112.346 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.495 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 28.4 m-85 -132.82 107.57 8.43 Favored 'General case' 0 C--N 1.345 0.407 0 O-C-N 120.685 -1.259 . . . . 0.0 107.787 170.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -58.94 -18.86 37.45 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -169.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.75 HG12 HG13 ' A' ' 4' ' ' VAL . 10.5 t -143.07 123.43 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -170.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 t -118.06 134.45 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.8 mm -131.98 87.69 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.452 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 29.1 t -68.31 165.8 17.84 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.988 -1.07 . . . . 0.0 108.653 169.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -144.5 53.03 1.25 Allowed 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 170.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.527 ' HB3' HG21 ' A' ' 84' ' ' VAL . 43.3 m -113.53 15.73 18.93 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.11 0.964 . . . . 0.0 110.583 -176.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.68 24.7 29.73 Favored Glycine 0 C--N 1.339 0.723 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 172.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.412 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 6.7 t 44.54 42.44 5.62 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.311 1.844 . . . . 0.0 112.327 -176.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -151.66 37.88 0.82 Allowed Glycine 0 C--N 1.339 0.72 0 C-N-CA 123.53 0.586 . . . . 0.0 112.012 -171.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.527 HG21 ' HB3' ' A' ' 80' ' ' CYS . 94.5 t -120.24 141.67 39.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 C-N-CA 124.753 1.221 . . . . 0.0 108.612 178.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -82.03 55.95 2.97 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.588 1.155 . . . . 0.0 110.159 -178.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.4 mt -57.15 133.64 80.73 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.59 154.6 19.6 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.666 2.244 . . . . 0.0 112.758 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -55.0 -27.98 57.33 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.619 2.213 . . . . 0.0 116.208 -172.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -65.45 -25.36 67.48 Favored 'General case' 0 C--O 1.226 -0.147 0 O-C-N 121.284 -0.885 . . . . 0.0 111.288 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.508 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 61.7 m95 -67.93 -8.66 38.76 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.251 -0.906 . . . . 0.0 112.813 175.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.3 t -107.78 -30.54 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.022 1.329 . . . . 0.0 111.122 -170.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.7 p -74.65 -16.77 60.76 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.37 1.068 . . . . 0.0 113.688 -169.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -50.56 160.76 0.38 Allowed 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 130.213 3.405 . . . . 0.0 114.308 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -60.11 -39.41 86.08 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.414 1.486 . . . . 0.0 108.591 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.612 ' HB ' HG13 ' A' ' 75' ' ' VAL . 36.2 mm -126.32 137.07 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 169.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -137.49 113.09 9.48 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 102.156 -3.276 . . . . 0.0 102.156 166.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -140.75 166.66 24.15 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 9.5 t70 -139.67 110.56 6.83 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 169.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -83.04 81.98 8.44 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.401 ' H ' ' CD ' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -61.33 25.6 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 127.337 2.255 . . . . 0.0 114.564 178.355 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.57 175.64 2.77 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.696 -1.253 . . . . 0.0 110.372 -172.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.79 160.46 2.62 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 123.238 1.494 . . . . 0.0 114.542 -170.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -103.91 108.08 58.73 Favored Pre-proline 0 C--N 1.322 -0.608 0 C-N-CA 127.01 2.124 . . . . 0.0 108.717 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -80.85 -6.65 13.32 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.609 2.206 . . . . 0.0 112.014 177.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.7 t0 22.9 -99.33 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 128.389 2.676 . . . . 0.0 113.336 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.64 39.91 1.66 Allowed Glycine 0 CA--C 1.531 1.084 0 C-N-CA 127.119 2.295 . . . . 0.0 108.7 169.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -70.38 -178.07 1.63 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.397 1.879 . . . . 0.0 112.635 -175.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.3 m -61.3 153.67 25.88 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 113.376 -1.738 . . . . 0.0 108.731 171.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.7 mt -56.68 -29.73 62.66 Favored 'General case' 0 C--O 1.221 -0.396 0 C-N-CA 122.954 0.502 . . . . 0.0 110.82 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -61.24 -39.68 91.21 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.058 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.5 t -73.72 -40.02 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.257 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -51.13 -51.45 53.4 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.738 1.154 . . . . 0.0 111.326 169.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -59.05 -45.18 91.41 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.441 0.696 . . . . 0.0 110.958 178.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.1 m -67.58 -45.71 74.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -173.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.3 t -66.02 -48.24 82.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -171.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -44.1 -56.83 3.76 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.783 1.233 . . . . 0.0 110.575 169.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.94 -41.76 99.82 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 119.968 1.258 . . . . 0.0 111.948 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -63.75 -41.73 97.97 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.516 -0.99 . . . . 0.0 110.263 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.35 -39.07 82.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -41.45 83.41 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 120.013 1.279 . . . . 0.0 110.642 -175.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.69 -40.41 80.07 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.633 0.373 . . . . 0.0 110.063 177.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -64.49 -47.11 80.15 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.618 0.644 . . . . 0.0 110.292 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.1 t -56.05 -51.38 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 124.049 0.939 . . . . 0.0 108.469 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -66.01 -32.36 73.79 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 119.353 -0.356 . . . . 0.0 111.5 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -62.51 -48.07 81.16 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 118.612 0.642 . . . . 0.0 111.013 173.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -42.98 91.55 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 123.247 0.619 . . . . 0.0 110.624 176.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.0 mt -62.26 -43.09 97.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 123.102 0.561 . . . . 0.0 110.116 175.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.35 -31.68 71.57 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.311 0.959 . . . . 0.0 112.039 -175.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.478 ' HE2' HD11 ' A' ' 95' ' ' ILE . 14.1 ptmt -81.37 -35.08 31.26 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 117.763 -1.113 . . . . 0.0 112.978 175.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 pt -96.52 -43.66 12.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 115.421 1.638 . . . . 0.0 115.421 -173.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.2 m . . . . . 0 C--O 1.256 1.444 0 C-N-CA 124.636 1.174 . . . . 0.0 111.586 -171.165 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mmm . . . . . 0 N--CA 1.502 2.131 0 CA-C-O 119.257 -0.402 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.727 ' HG2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -59.31 137.74 57.87 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 169.463 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.43 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 25.0 mtpt -112.19 142.06 45.13 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 -169.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.753 HG13 HG12 ' A' ' 75' ' ' VAL . 11.5 t -122.86 155.29 28.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -174.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 57.0 tpp -136.68 134.25 37.05 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -115.74 112.07 21.49 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.448 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 3.4 t -96.32 136.72 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -169.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.3 m -109.72 149.95 29.02 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.258 1.023 . . . . 0.0 112.237 -169.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.7 mmtt -150.07 146.09 26.74 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.372 1.869 . . . . 0.0 106.054 169.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.468 ' CG ' ' H ' ' A' ' 11' ' ' ASN . 27.0 ttm180 57.01 -172.44 0.08 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.544 1.138 . . . . 0.0 109.307 -168.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.468 ' H ' ' CG ' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -49.95 105.36 0.09 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.418 1.487 . . . . 0.0 107.857 -177.887 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 m -62.06 0.15 0.44 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 117.137 2.273 . . . . 0.0 117.137 -167.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.1 m -38.22 -50.57 1.43 Allowed 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 126.36 1.864 . . . . 0.0 111.923 173.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -65.23 -43.25 92.03 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.243 0.545 . . . . 0.0 111.329 -171.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.1 p -88.45 -37.75 15.57 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 124.422 1.089 . . . . 0.0 111.1 -170.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -72.13 -32.08 66.61 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.552 -0.717 . . . . 0.0 109.545 174.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.415 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.5 tpt -62.09 -39.22 91.72 Favored 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 121.158 -0.964 . . . . 0.0 109.685 169.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.07 92.1 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -62.94 -39.16 93.76 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.204 170.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.77 -43.07 68.5 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 120.852 1.66 . . . . 0.0 111.275 -174.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -63.53 -40.4 96.94 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 170.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.29 -40.27 81.84 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 119.58 1.082 . . . . 0.0 111.464 -176.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.479 ' HA ' HG21 ' A' ' 32' ' ' VAL . 13.4 pttp -70.84 -22.72 62.28 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 120.455 1.48 . . . . 0.0 112.373 176.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.9 m -77.79 -52.13 9.4 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.763 1.625 . . . . 0.0 110.23 175.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 71.1 mt -85.33 -26.49 26.51 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.017 1.327 . . . . 0.0 111.606 -169.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.63 15.27 55.97 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 126.74 2.114 . . . . 0.0 111.707 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.91 121.94 12.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.668 1.187 . . . . 0.0 109.936 -175.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.04 8.05 87.46 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 119.752 -0.471 . . . . 0.0 113.385 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -122.6 -32.25 3.61 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 125.234 1.414 . . . . 0.0 109.36 -177.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.727 HG22 ' HG2' ' A' ' 2' ' ' LYS . 12.6 pt -141.55 163.92 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 125.018 1.327 . . . . 0.0 110.54 177.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.74 144.18 31.43 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 168.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.479 HG21 ' HA ' ' A' ' 23' ' ' LYS . 2.2 t -136.27 135.12 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.472 0.709 . . . . 0.0 110.512 -168.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.7 m -147.31 161.4 41.04 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.776 1.231 . . . . 0.0 109.501 -178.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.5 p -128.09 161.67 28.67 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.726 1.21 . . . . 0.0 109.491 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.5 p -152.31 147.56 26.48 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 121.328 -0.858 . . . . 0.0 111.709 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.82 140.26 1.78 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 105.154 -3.178 . . . . 0.0 105.154 -168.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -162.74 118.39 1.84 Allowed 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 104.343 -2.466 . . . . 0.0 104.343 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.01 116.59 2.65 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 122.111 0.958 . . . . 0.0 110.043 -170.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.4 m 52.94 31.53 11.05 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.387 1.475 . . . . 0.0 113.157 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.5 m 64.67 3.68 2.06 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.674 2.39 . . . . 0.0 115.601 169.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.8 148.54 50.45 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 120.273 1.397 . . . . 0.0 110.121 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.6 m -68.66 177.84 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 124.539 1.135 . . . . 0.0 111.287 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -134.15 116.23 13.22 Favored Pre-proline 0 N--CA 1.446 -0.671 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 -175.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -64.75 -24.26 62.05 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 123.714 2.942 . . . . 0.0 112.7 -169.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.0 m -61.27 -36.64 80.61 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.106 0.867 . . . . 0.0 109.731 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.15 -45.1 82.17 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -56.37 -49.24 77.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.49 -42.93 99.53 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.41 0.55 . . . . 0.0 111.024 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.6 mmt -61.51 -23.99 66.3 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 124.251 1.021 . . . . 0.0 113.337 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.415 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 4.3 mmt -101.98 -24.11 14.03 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.084 0.856 . . . . 0.0 108.958 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -64.94 -34.75 79.15 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 118.952 0.796 . . . . 0.0 109.435 171.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -72.6 7.1 2.04 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 173.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.3 t -119.29 -39.56 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 127.23 2.212 . . . . 0.0 110.023 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.94 24.14 2.58 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.375 1.464 . . . . 0.0 112.884 -176.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.7 mt -124.42 161.6 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 125.879 1.671 . . . . 0.0 107.222 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -108.19 -61.5 1.58 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -169.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . 0.421 28.7 pt 56.17 1.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 118.245 2.683 . . . . 0.0 118.245 -177.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.76 147.93 43.03 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 120.899 1.681 . . . . 0.0 109.39 169.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.69 1.42 11.45 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 118.248 -1.307 . . . . 0.0 114.777 176.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -48.47 -65.32 0.59 Allowed 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.258 1.529 . . . . 0.0 113.23 -177.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.9 166.15 25.74 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 123.672 0.608 . . . . 0.0 112.548 -168.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.9 p -169.56 22.81 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.91 0.884 . . . . 0.0 112.565 -171.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -139.47 150.36 63.46 Favored Pre-proline 0 N--CA 1.475 0.821 0 CA-C-N 119.895 1.225 . . . . 0.0 112.193 -169.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -84.25 162.54 13.23 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 124.095 3.196 . . . . 0.0 112.909 -170.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.1 tt -57.43 -36.4 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.99 1.716 . . . . 0.0 111.269 -176.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -73.86 -16.37 61.13 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -170.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.16 -17.07 44.19 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 118.691 -0.671 . . . . 0.0 111.793 170.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -88.79 170.47 10.73 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.195 0.907 . . . . 0.0 110.721 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.7 89.91 2.24 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.451 1.501 . . . . 0.0 107.921 -177.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.496 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -52.39 -23.16 5.52 Favored 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 176.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -50.86 -30.2 13.85 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.349 0.66 . . . . 0.0 111.398 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -91.71 4.18 53.35 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.43 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 22.2 m-85 -131.83 114.8 15.14 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 120.437 1.471 . . . . 0.0 109.454 -177.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -69.78 -6.91 35.33 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -169.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.753 HG12 HG13 ' A' ' 4' ' ' VAL . 24.7 t -145.02 123.31 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -171.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.0 t -118.51 127.39 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.8 mm -121.45 94.3 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 171.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.448 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 18.2 p -73.95 167.52 21.32 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 118.252 -1.379 . . . . 0.0 107.747 168.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mp -143.02 41.82 1.53 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 173.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.419 ' HB3' HG21 ' A' ' 84' ' ' VAL . 59.1 m -101.03 -5.49 25.71 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.523 1.529 . . . . 0.0 112.188 -168.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.15 15.64 7.09 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-N 119.543 1.065 . . . . 0.0 113.985 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 6.0 t 45.5 56.06 6.07 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.77 1.628 . . . . 0.0 111.172 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -175.52 -26.18 0.03 OUTLIER Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.479 -172.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.419 HG21 ' HB3' ' A' ' 80' ' ' CYS . 78.5 t -56.6 121.21 4.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 169.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -65.41 136.45 56.5 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 173.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.5 mt -123.71 144.34 44.27 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 176.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.25 156.72 9.96 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.6 2.2 . . . . 0.0 112.997 176.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -53.91 -30.39 58.08 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.824 2.349 . . . . 0.0 116.399 -170.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -67.04 -26.0 66.54 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.377 -0.827 . . . . 0.0 111.328 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.496 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 66.2 m95 -69.67 -13.25 62.21 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 120.87 -1.144 . . . . 0.0 113.388 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.96 -9.35 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 119.721 1.146 . . . . 0.0 112.957 -169.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.1 p -85.79 -10.26 55.76 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.253 1.021 . . . . 0.0 112.714 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -60.46 167.94 2.35 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 128.974 2.91 . . . . 0.0 113.18 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.88 -40.96 87.95 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.651 1.181 . . . . 0.0 108.951 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.535 ' HB ' HG13 ' A' ' 75' ' ' VAL . 26.7 mm -119.93 139.27 47.79 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 CA-C-O 121.163 0.506 . . . . 0.0 109.717 170.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -144.66 106.5 4.29 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 102.16 -3.274 . . . . 0.0 102.16 166.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -132.84 168.21 18.81 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 175.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -139.67 111.66 7.45 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 171.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.451 ' CD2' ' HB3' ' A' ' 122' ' ' ARG . 45.5 m0 -92.13 65.65 4.76 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -33.19 -52.07 0.35 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.52 1.928 . . . . 0.0 111.773 177.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 40.1 -170.56 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 129.851 3.261 . . . . 0.0 114.371 -175.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.56 175.61 1.02 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 122.79 1.281 . . . . 0.0 111.887 170.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -127.28 103.83 22.63 Favored Pre-proline 0 C--N 1.321 -0.657 0 C-N-CA 128.232 2.613 . . . . 0.0 107.418 -170.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.3 -4.2 14.49 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.648 2.232 . . . . 0.0 112.602 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.3 t0 20.13 -95.06 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.784 2.834 . . . . 0.0 113.791 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.67 40.39 1.55 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 127.141 2.305 . . . . 0.0 109.151 169.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -75.16 179.01 5.31 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.722 1.609 . . . . 0.0 113.098 -170.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.3 p -62.35 157.38 19.99 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 113.148 -1.842 . . . . 0.0 109.634 171.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 21.7 mt -57.68 -30.42 65.44 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.602 176.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.34 -41.3 98.46 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 118.695 -0.669 . . . . 0.0 111.099 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.2 t -71.78 -40.81 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 117.705 -1.141 . . . . 0.0 109.238 178.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -50.7 -51.42 49.74 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.909 1.232 . . . . 0.0 111.725 169.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -59.05 -45.52 90.57 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.025 0.829 . . . . 0.0 110.931 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.7 m -68.09 -43.01 79.5 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -174.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.9 t -64.83 -49.75 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -175.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -48.08 -56.12 8.55 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.963 1.305 . . . . 0.0 111.017 173.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.09 -41.73 99.72 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 119.111 0.869 . . . . 0.0 111.519 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -66.78 -37.77 85.24 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.205 -1.173 . . . . 0.0 110.532 -178.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.4 t -62.87 -42.71 97.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 173.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -35.95 75.59 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 119.819 1.191 . . . . 0.0 111.352 -174.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -69.01 -43.08 75.52 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.512 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.451 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 10.4 mpt_? -64.18 -41.66 97.02 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.923 1.238 . . . . 0.0 110.559 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.7 t -54.23 -54.35 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 173.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -64.93 -32.65 74.47 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 122.012 -0.43 . . . . 0.0 111.599 -174.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -62.34 -48.25 80.65 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 123.368 0.667 . . . . 0.0 111.363 171.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -48.35 75.09 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 118.56 0.618 . . . . 0.0 109.562 175.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.7 mt -58.09 -42.19 82.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 123.804 0.842 . . . . 0.0 109.287 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.93 -31.43 71.75 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.797 0.726 . . . . 0.0 111.74 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -72.3 -42.77 65.1 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.554 173.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.2 pt -103.28 -46.2 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 118.607 2.817 . . . . 0.0 118.607 -168.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.5 m . . . . . 0 C--O 1.253 1.247 0 C-N-CA 124.06 0.944 . . . . 0.0 111.883 -169.177 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.9 mmm . . . . . 0 N--CA 1.501 2.084 0 N-CA-C 111.483 0.179 . . . . 0.0 111.483 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.635 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -58.44 132.57 54.11 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 172.337 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.506 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 53.1 mtpt -99.05 138.85 35.56 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -172.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.674 HG13 HG12 ' A' ' 75' ' ' VAL . 11.1 t -134.11 153.66 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 123.005 0.522 . . . . 0.0 109.716 -171.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.4 tpp -139.53 147.95 41.93 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.627 0.771 . . . . 0.0 109.792 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -132.1 112.21 12.13 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.46 1.504 . . . . 0.0 107.611 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 4.1 t -97.1 137.42 24.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -172.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 m -120.08 146.59 45.78 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -169.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -150.75 164.71 35.52 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.465 1.906 . . . . 0.0 108.602 174.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.468 ' HD3' ' H ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER 54.75 -146.1 0.58 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.668 1.587 . . . . 0.0 108.589 -169.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.468 ' H ' ' HD3' ' A' ' 10' ' ' ARG . 55.3 t-20 -65.55 99.37 0.43 Allowed 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 173.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.7 m -64.36 -4.01 3.45 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.441 ' HA ' ' HG2' ' A' ' 16' ' ' GLN . 68.4 m -48.0 -38.65 17.53 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 119.309 0.959 . . . . 0.0 113.062 169.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -62.91 -41.08 99.32 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 120.051 1.296 . . . . 0.0 111.909 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.41 -37.07 12.78 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.766 0.826 . . . . 0.0 109.613 -169.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.509 HE22 HG12 ' A' ' 42' ' ' VAL . 11.6 pt20 -66.84 -31.15 71.58 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.102 -0.998 . . . . 0.0 110.127 169.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.438 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.9 tpt -62.88 -37.44 86.9 Favored 'General case' 0 CA--C 1.51 -0.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.448 171.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.99 90.5 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -64.84 -38.04 89.64 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.153 169.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.9 -42.32 96.99 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 120.931 1.696 . . . . 0.0 111.811 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -66.73 -37.44 84.68 Favored 'General case' 0 C--O 1.222 -0.356 0 O-C-N 121.861 -0.788 . . . . 0.0 109.296 170.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.05 -35.19 69.25 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 119.539 1.063 . . . . 0.0 111.652 -175.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -66.93 -34.39 77.66 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 121.382 1.901 . . . . 0.0 111.425 171.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.2 m -69.39 -50.61 44.4 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.509 1.524 . . . . 0.0 110.343 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.0 mt -91.83 -25.55 18.93 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.079 1.352 . . . . 0.0 111.905 -169.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.97 8.72 76.09 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 126.675 2.083 . . . . 0.0 112.195 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.51 121.88 13.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.393 1.077 . . . . 0.0 110.064 -170.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.91 9.93 85.12 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 119.975 -0.347 . . . . 0.0 113.477 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -122.18 -36.8 2.91 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 125.947 1.699 . . . . 0.0 109.192 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.9 pt -138.44 162.96 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.873 1.269 . . . . 0.0 108.987 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.44 132.78 53.81 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 169.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.41 140.65 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 119.745 1.157 . . . . 0.0 113.308 -168.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.4 m -142.58 166.94 23.3 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.51 1.524 . . . . 0.0 109.903 -169.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.8 p -136.69 158.83 43.54 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.721 1.208 . . . . 0.0 110.069 176.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.479 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 27.5 p -151.81 158.66 43.58 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 122.83 0.452 . . . . 0.0 110.479 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.112 0 N-CA-C 106.857 -2.497 . . . . 0.0 106.857 -168.104 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.509 HG12 HE22 ' A' ' 16' ' ' GLN . 19.5 m . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -128.73 111.11 18.89 Favored Pre-proline 0 C--O 1.233 0.194 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -171.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -51.54 -30.44 35.82 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.855 3.037 . . . . 0.0 114.913 -174.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -60.42 -39.13 86.32 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.995 0.816 . . . . 0.0 110.964 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.72 -44.85 76.65 Favored 'General case' 0 CA--C 1.513 -0.444 0 O-C-N 121.448 -0.782 . . . . 0.0 109.062 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.02 -44.39 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.45 -43.91 96.37 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.507 0.594 . . . . 0.0 111.525 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.8 mmt -65.67 -18.74 65.55 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 118.879 -0.582 . . . . 0.0 112.3 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.438 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.8 OUTLIER -96.4 -31.64 12.75 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -178.138 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -63.08 -33.4 75.36 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.166 1.386 . . . . 0.0 110.003 169.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -58.49 -15.97 13.29 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.114 1.766 . . . . 0.0 111.845 172.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.4 m -130.62 12.84 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 126.156 1.783 . . . . 0.0 111.683 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.4 42.84 80.86 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 121.173 -0.955 . . . . 0.0 113.772 175.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.3 mt -124.69 155.27 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.81 1.644 . . . . 0.0 107.73 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -123.84 125.55 44.87 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.826 1.25 . . . . 0.0 108.296 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.9 pt -128.53 9.99 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.51 1.124 . . . . 0.0 112.339 173.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.65 -30.47 41.28 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.521 1.528 . . . . 0.0 111.935 174.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.43 -12.87 73.61 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 118.097 0.408 . . . . 0.0 112.679 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -76.86 153.0 35.22 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.773 1.229 . . . . 0.0 109.654 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.7 p -150.47 168.74 23.29 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.4 m -64.19 138.56 58.5 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.851 1.661 . . . . 0.0 111.393 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -163.1 123.25 1.42 Allowed Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 169.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -75.83 150.55 34.84 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.573 2.182 . . . . 0.0 113.315 -168.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.7 tt -55.96 -35.62 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.702 1.601 . . . . 0.0 111.395 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -68.75 -21.58 64.36 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.204 0.601 . . . . 0.0 112.177 -174.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.2 -10.55 57.62 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.336 0.654 . . . . 0.0 111.999 173.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.479 ' CE2' ' HB3' ' A' ' 35' ' ' CYS . 67.0 m-85 -92.69 168.49 11.18 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.908 0.861 . . . . 0.0 110.418 176.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -145.79 89.86 1.94 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 -171.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.489 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -51.47 -24.73 5.39 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -20.64 8.73 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.02 0.528 . . . . 0.0 111.528 173.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -107.02 13.76 27.17 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.383 1.873 . . . . 0.0 112.374 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.506 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 38.6 m-85 -135.24 108.85 7.95 Favored 'General case' 0 CA--C 1.516 -0.332 0 O-C-N 120.805 -1.184 . . . . 0.0 108.578 172.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.77 -16.05 36.27 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -170.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.674 HG12 HG13 ' A' ' 4' ' ' VAL . 11.9 t -144.85 121.31 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 -170.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.66 132.13 64.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 O-C-N 120.521 -1.362 . . . . 0.0 108.85 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.0 mm -125.68 96.93 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 -171.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.438 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 36.6 t -72.31 164.68 25.89 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 169.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mp -142.69 38.04 1.48 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 170.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.607 ' HB3' HG21 ' A' ' 84' ' ' VAL . 76.9 m -96.2 4.4 52.45 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.566 1.147 . . . . 0.0 111.291 -169.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.77 20.9 17.66 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 111.329 -0.709 . . . . 0.0 111.329 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.464 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 5.2 t 46.33 39.94 7.06 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.104 1.762 . . . . 0.0 112.314 -176.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -150.23 33.46 1.02 Allowed Glycine 0 C--N 1.339 0.7 0 C-N-CA 123.754 0.692 . . . . 0.0 111.795 -172.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.607 HG21 ' HB3' ' A' ' 80' ' ' CYS . 93.9 t -121.85 136.58 58.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 125.183 1.393 . . . . 0.0 107.652 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -82.35 67.59 8.44 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.182 0.993 . . . . 0.0 109.836 -172.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.8 mt -58.6 142.3 83.2 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -53.14 154.06 14.76 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.758 2.306 . . . . 0.0 111.63 171.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.19 -19.15 56.83 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 121.646 1.564 . . . . 0.0 114.403 -170.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.81 -26.95 68.86 Favored 'General case' 0 C--O 1.225 -0.233 0 O-C-N 121.205 -0.934 . . . . 0.0 110.983 175.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.489 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 71.8 m95 -68.08 -4.82 14.78 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.089 -1.007 . . . . 0.0 112.651 174.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -108.61 -28.96 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 120.04 1.291 . . . . 0.0 111.025 -174.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.5 p -76.91 -16.58 59.34 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.574 0.954 . . . . 0.0 113.574 -169.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -52.88 161.04 0.83 Allowed 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 129.354 3.062 . . . . 0.0 113.949 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -62.17 -38.96 91.03 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.084 1.354 . . . . 0.0 108.754 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.529 ' HB ' HG13 ' A' ' 75' ' ' VAL . 33.5 mm -126.17 138.01 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 169.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -139.67 112.26 7.84 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 101.359 -3.571 . . . . 0.0 101.359 167.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -135.16 167.78 20.36 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 9.7 t70 -139.33 104.69 5.04 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 171.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -83.73 77.99 9.78 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -54.54 41.79 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 131.6 3.96 . . . . 0.0 113.796 171.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.63 -176.6 3.33 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.961 1.304 . . . . 0.0 112.637 -168.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -51.43 169.09 0.06 Allowed 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 127.477 2.311 . . . . 0.0 112.529 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -127.21 107.92 21.55 Favored Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 125.975 1.71 . . . . 0.0 108.558 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -82.31 -2.1 10.99 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.044 1.83 . . . . 0.0 112.985 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.3 t0 20.06 -91.85 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 128.869 2.868 . . . . 0.0 114.408 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.95 42.11 1.36 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 126.015 1.769 . . . . 0.0 110.532 172.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -78.31 -176.8 4.86 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.26 1.424 . . . . 0.0 113.297 -171.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.7 p -64.15 162.79 13.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 113.859 -1.519 . . . . 0.0 110.269 173.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.1 mt -55.68 -33.91 64.57 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 122.819 0.448 . . . . 0.0 110.542 175.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -62.64 -38.11 88.98 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.774 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.3 t -73.98 -45.1 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 119.515 1.052 . . . . 0.0 108.777 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -52.01 -38.0 55.32 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.765 1.166 . . . . 0.0 112.832 172.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -68.99 -46.3 68.41 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 119.778 1.172 . . . . 0.0 112.188 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.5 m -71.69 -42.46 67.38 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 119.342 -0.361 . . . . 0.0 110.357 -169.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.8 t -67.82 -44.52 85.45 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -173.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -47.16 -53.27 13.41 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 124.853 1.261 . . . . 0.0 110.386 169.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.86 -45.39 96.29 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 119.325 0.966 . . . . 0.0 111.538 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -66.29 -36.9 84.15 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 121.683 -0.892 . . . . 0.0 111.418 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.8 t -62.66 -43.31 98.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 174.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -36.13 78.32 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 119.781 1.173 . . . . 0.0 111.56 -174.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -68.14 -42.34 80.27 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.432 -0.794 . . . . 0.0 110.131 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -63.07 -43.57 98.2 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.748 1.158 . . . . 0.0 110.431 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 75.9 t -54.81 -52.55 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 123.607 0.763 . . . . 0.0 109.582 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -66.77 -32.65 74.08 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 121.862 -0.524 . . . . 0.0 111.503 -175.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -62.3 -48.34 80.32 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 123.239 0.616 . . . . 0.0 111.22 171.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.93 -46.6 78.45 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.361 0.528 . . . . 0.0 110.13 176.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.4 mt -58.38 -43.64 86.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 124.34 1.056 . . . . 0.0 109.779 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.88 -29.81 69.78 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.3 0.955 . . . . 0.0 111.894 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -72.13 -39.61 68.7 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.573 0.624 . . . . 0.0 111.509 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.9 pt -103.35 -48.71 10.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 116.703 2.112 . . . . 0.0 116.703 -168.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 40.6 m . . . . . 0 C--O 1.252 1.232 0 C-N-CA 124.308 1.043 . . . . 0.0 110.653 -170.264 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 tpt . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 118.518 -0.753 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.488 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -60.32 118.4 6.38 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 120.98 1.718 . . . . 0.0 108.541 -173.508 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.416 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 39.0 mtpt -90.58 134.24 34.52 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -169.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.809 HG13 HG12 ' A' ' 75' ' ' VAL . 12.0 t -116.01 155.32 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.07 140.54 43.86 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -125.63 120.37 30.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 177.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.1 t -118.72 112.49 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 118.736 0.698 . . . . 0.0 110.404 -168.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.6 171.79 13.67 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.801 1.286 . . . . 0.0 113.616 -174.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -152.36 130.99 12.3 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 100.779 -3.785 . . . . 0.0 100.779 168.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.421 ' CG ' ' H ' ' A' ' 11' ' ' ASN . 27.2 ttm180 63.47 176.53 0.16 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.755 1.161 . . . . 0.0 109.955 -169.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.421 ' H ' ' CG ' ' A' ' 10' ' ' ARG . 33.6 t-20 -40.57 137.2 1.17 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.138 2.175 . . . . 0.0 113.652 -169.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.9 m -52.41 -20.4 2.8 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 129.856 3.262 . . . . 0.0 115.417 -171.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.9 m -59.44 -5.34 0.77 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.946 2.098 . . . . 0.0 114.802 -171.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.291 31.5 ptt180 -111.41 -61.3 1.72 Allowed 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 116.801 -1.571 . . . . 0.0 111.079 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.562 ' CB ' HD13 ' A' ' 79' ' ' LEU . 59.7 p -74.97 -44.6 47.44 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 122.688 2.495 . . . . 0.0 111.316 -175.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.29 2.0 mt-30 -75.65 -24.75 56.41 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -172.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.463 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.2 tpt -65.79 -41.89 91.39 Favored 'General case' 0 C--O 1.222 -0.363 0 O-C-N 121.003 -1.061 . . . . 0.0 108.19 167.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.54 -36.77 79.26 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.745 -0.597 . . . . 0.0 109.602 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -63.25 -39.1 93.64 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 118.378 -0.82 . . . . 0.0 110.823 169.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.38 -45.15 94.15 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 120.5 1.5 . . . . 0.0 111.115 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -65.55 -38.29 89.18 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 173.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.441 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -72.45 -37.63 68.5 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 119.758 1.163 . . . . 0.0 110.929 -173.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.401 ' HA ' HG21 ' A' ' 32' ' ' VAL . 61.7 pttt -71.08 -19.73 62.44 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 120.214 1.37 . . . . 0.0 112.065 174.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.3 m -82.02 -51.05 8.42 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.845 1.658 . . . . 0.0 109.56 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.2 mt -89.42 -25.73 21.36 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.334 1.454 . . . . 0.0 112.176 -169.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.76 13.75 56.32 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.885 2.183 . . . . 0.0 111.846 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.28 122.02 14.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.675 1.19 . . . . 0.0 109.723 -173.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.12 8.44 87.84 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.66 -0.522 . . . . 0.0 113.626 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -123.22 -31.69 3.54 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.506 1.522 . . . . 0.0 109.001 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.7 pt -141.37 173.37 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 125.457 1.503 . . . . 0.0 109.598 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.42 144.08 43.88 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 103.879 -2.638 . . . . 0.0 103.879 168.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 22' ' ' ALA . 1.7 t -133.33 139.94 48.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 123.279 0.631 . . . . 0.0 110.283 -168.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.14 158.59 44.16 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.836 1.254 . . . . 0.0 109.254 -173.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 63.8 p -155.46 165.99 34.9 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 120.016 1.28 . . . . 0.0 113.257 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.3 p -154.61 166.45 33.32 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.164 1.386 . . . . 0.0 109.197 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.652 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.02 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 C--O 1.235 0.33 0 CA-C-O 121.816 0.817 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -113.12 106.6 54.77 Favored Pre-proline 0 N--CA 1.446 -0.665 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -170.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -63.87 -29.25 67.55 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.264 2.643 . . . . 0.0 111.83 -169.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.2 m -64.51 -37.41 87.45 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.743 0.701 . . . . 0.0 109.213 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.24 -44.43 83.78 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.26 -46.58 85.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 CA-C-O 118.632 -0.699 . . . . 0.0 109.135 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.41 -43.96 97.56 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.859 0.754 . . . . 0.0 111.101 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.0 mmt -60.05 -26.16 65.91 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 118.76 -0.638 . . . . 0.0 111.6 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.463 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -94.09 -27.0 16.5 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -177.132 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -64.34 -30.74 71.78 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.93 1.292 . . . . 0.0 110.067 169.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.43 -21.75 38.8 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.297 0.639 . . . . 0.0 112.002 171.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.0 m -123.61 9.53 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 125.75 1.62 . . . . 0.0 111.138 -177.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.81 40.94 74.84 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.372 0.987 . . . . 0.0 113.007 174.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.7 mt -122.94 152.39 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.542 1.537 . . . . 0.0 108.077 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -118.55 122.13 41.9 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.924 1.29 . . . . 0.0 108.677 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 43.8 pt -127.02 12.91 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 124.271 1.028 . . . . 0.0 111.481 169.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.58 -25.0 45.18 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.23 1.812 . . . . 0.0 112.459 172.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.6 -8.06 85.93 Favored Glycine 0 CA--C 1.537 1.423 0 CA-C-N 118.603 0.638 . . . . 0.0 112.946 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -76.56 166.77 22.93 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.776 1.23 . . . . 0.0 111.557 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.6 p -144.86 -177.95 5.78 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.813 1.645 . . . . 0.0 109.949 174.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.98 173.32 6.41 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.206 1.002 . . . . 0.0 109.615 170.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.28 146.37 7.15 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 169.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.64 141.94 97.96 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.706 2.271 . . . . 0.0 111.834 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.5 tt -59.93 -37.73 73.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 123.491 0.716 . . . . 0.0 110.718 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -73.04 -18.38 61.34 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.416 0.686 . . . . 0.0 112.336 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.05 -25.58 61.85 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 118.939 -0.553 . . . . 0.0 111.274 170.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -79.11 170.51 16.56 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 122.191 0.996 . . . . 0.0 111.318 -172.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.44 68.75 1.39 Allowed 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 125.827 1.651 . . . . 0.0 106.891 -177.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.457 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -51.3 -24.21 4.36 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 124.524 1.129 . . . . 0.0 113.749 -178.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -44.1 -41.27 5.48 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.005 0.922 . . . . 0.0 110.794 172.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.37 -14.74 58.08 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.746 1.218 . . . . 0.0 113.842 -175.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.416 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 11.4 m-85 -105.72 112.73 25.92 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 119.64 1.109 . . . . 0.0 108.405 -173.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -65.51 -12.14 49.99 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -168.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.809 HG12 HG13 ' A' ' 4' ' ' VAL . 27.3 t -146.56 124.31 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 -171.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.1 t -123.13 130.76 74.18 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.2 mm -124.42 92.65 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 173.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.9 t -76.85 166.85 22.79 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 169.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.562 HD13 ' CB ' ' A' ' 15' ' ' SER . 5.5 mp -140.76 32.18 1.82 Allowed 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.185 -1.572 . . . . 0.0 108.025 174.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 92.5 m -76.99 -3.71 40.36 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.203 1.001 . . . . 0.0 111.707 -177.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.19 35.49 3.63 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 119.572 1.078 . . . . 0.0 111.084 172.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 32.0 p 35.88 45.03 0.26 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 128.02 2.528 . . . . 0.0 114.216 -175.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.73 47.4 0.48 Allowed Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -173.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.2 p -125.72 159.11 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 126.102 1.761 . . . . 0.0 109.786 -171.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -118.09 56.35 0.86 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.785 1.234 . . . . 0.0 108.745 -174.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.6 mt -59.33 143.9 84.59 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.36 151.49 22.98 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.198 1.932 . . . . 0.0 111.95 171.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -55.86 -27.57 63.42 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.194 1.93 . . . . 0.0 115.541 -173.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.41 -21.14 66.21 Favored 'General case' 0 N--CA 1.456 -0.175 0 O-C-N 121.009 -1.057 . . . . 0.0 112.361 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.457 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 73.4 m95 -73.65 -17.89 61.1 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 117.952 -1.023 . . . . 0.0 112.659 175.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.8 m -110.77 -13.54 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 120.064 1.302 . . . . 0.0 113.461 -169.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.4 p -83.26 -8.11 59.5 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.367 1.067 . . . . 0.0 113.255 -173.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -64.96 173.04 2.52 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 130.054 3.341 . . . . 0.0 113.569 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -67.45 -41.47 84.64 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.532 ' HB ' HG13 ' A' ' 75' ' ' VAL . 16.8 mm -120.25 136.9 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 169.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -143.45 111.82 6.31 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 103.03 -2.952 . . . . 0.0 103.03 166.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -136.63 164.64 27.74 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -132.59 102.17 5.6 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 169.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.3 m0 -76.94 89.06 3.5 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.417 ' CD ' ' H ' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -62.6 33.99 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 128.508 2.723 . . . . 0.0 113.827 173.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.26 178.39 1.94 Allowed 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.086 -1.009 . . . . 0.0 112.832 -169.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.486 ' HB2' HG22 ' A' ' 115' ' ' VAL . 44.8 mt-10 -52.51 164.91 0.29 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 126.26 1.824 . . . . 0.0 112.525 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -120.9 102.74 43.86 Favored Pre-proline 0 C--N 1.325 -0.478 0 C-N-CA 127.278 2.231 . . . . 0.0 108.163 -175.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -82.13 -1.93 10.99 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.769 2.313 . . . . 0.0 112.592 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.4 t0 26.42 -99.04 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 128.372 2.669 . . . . 0.0 113.533 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.86 38.99 1.74 Allowed Glycine 0 CA--C 1.532 1.151 0 C-N-CA 127.278 2.371 . . . . 0.0 109.285 169.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -70.18 -176.99 1.28 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.413 1.885 . . . . 0.0 112.937 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.9 m -63.6 156.66 25.99 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.235 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.1 mt -56.35 -31.16 63.49 Favored 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 123.129 0.572 . . . . 0.0 110.933 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.62 -41.15 97.06 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 118.528 0.604 . . . . 0.0 110.768 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 40.1 t -72.85 -42.12 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 117.284 -1.341 . . . . 0.0 109.061 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -48.42 -49.47 34.96 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 120.318 1.417 . . . . 0.0 111.379 169.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -60.16 -44.11 95.26 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.976 0.807 . . . . 0.0 111.055 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 87.3 m -68.95 -43.83 74.23 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 118.885 -0.579 . . . . 0.0 109.486 -173.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.486 HG22 ' HB2' ' A' ' 102' ' ' GLU . 42.0 t -68.43 -46.71 80.03 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -174.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -45.45 -55.74 5.79 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.864 1.266 . . . . 0.0 110.97 169.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.71 -43.03 98.41 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 119.321 0.964 . . . . 0.0 111.525 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -63.27 -37.44 87.26 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.381 1.09 . . . . 0.0 111.394 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 37.4 t -62.96 -41.41 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 118.067 -0.968 . . . . 0.0 109.033 173.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.14 -37.56 74.89 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 120.009 1.277 . . . . 0.0 111.029 -177.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -68.88 -43.3 75.57 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.208 0.603 . . . . 0.0 110.585 177.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -68.17 -42.43 80.02 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.415 1.007 . . . . 0.0 110.392 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.1 t -53.54 -53.54 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 124.007 0.923 . . . . 0.0 108.988 171.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.77 -33.01 74.98 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.954 -0.466 . . . . 0.0 111.815 -175.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -62.62 -47.98 81.41 Favored 'General case' 0 C--O 1.227 -0.084 0 C-N-CA 122.934 0.494 . . . . 0.0 111.284 171.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.86 -47.24 77.65 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.11 0.564 . . . . 0.0 109.552 176.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.2 mt -58.25 -42.91 84.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 124.292 1.037 . . . . 0.0 110.147 176.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.43 -29.45 69.01 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.609 0.64 . . . . 0.0 111.864 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -74.12 -40.43 62.67 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 118.594 0.633 . . . . 0.0 111.814 175.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.3 pt -101.55 -42.4 9.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 117.251 2.315 . . . . 0.0 117.251 -168.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 C--O 1.254 1.335 0 CA-C-N 119.05 0.841 . . . . 0.0 110.394 -171.967 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.1 mmm . . . . . 0 N--CA 1.5 2.054 0 CA-C-O 119.972 -0.061 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.627 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -58.97 136.33 57.89 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 171.172 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 26.8 mtpt -109.18 145.89 35.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 119.638 1.108 . . . . 0.0 108.357 -171.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.748 HG13 HG12 ' A' ' 75' ' ' VAL . 6.2 t -127.21 153.9 36.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 123.693 0.797 . . . . 0.0 108.896 -174.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 59.6 tpp -135.87 138.47 42.51 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -124.56 106.69 10.34 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.0 t -84.39 122.48 38.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -172.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 86.5 m -68.77 156.78 37.7 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.282 2.233 . . . . 0.0 111.279 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -144.32 -125.17 0.08 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 169.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.59 115.24 1.27 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.078 1.351 . . . . 0.0 112.009 -169.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.9 t30 45.59 26.86 0.36 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.897 2.079 . . . . 0.0 113.973 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.2 m 56.94 -22.34 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 119.106 3.002 . . . . 0.0 119.106 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 85.2 m -48.78 -55.72 10.72 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 125.69 1.596 . . . . 0.0 113.348 -168.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -58.77 -47.03 86.09 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.334 0.97 . . . . 0.0 112.329 -169.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.535 ' HB3' HD13 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -87.77 -31.81 19.44 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.709 -0.619 . . . . 0.0 111.138 -170.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.496 HE22 ' CG2' ' A' ' 42' ' ' VAL . 4.8 pt20 -65.62 -36.47 83.81 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 172.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.456 ' SD ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -63.09 -39.75 95.63 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 120.703 -1.248 . . . . 0.0 110.109 172.451 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.39 -36.1 75.16 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.757 -0.589 . . . . 0.0 110.698 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -64.69 -38.84 92.35 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.802 -0.618 . . . . 0.0 111.104 169.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.92 -43.9 92.84 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 120.491 1.496 . . . . 0.0 110.86 -178.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.456 ' CD2' ' SD ' ' A' ' 17' ' ' MET . 5.0 m-85 -64.81 -40.52 95.35 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 118.68 1.24 . . . . 0.0 109.428 171.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.484 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -69.88 -37.11 75.94 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 119.661 1.119 . . . . 0.0 111.104 -173.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -74.1 -25.14 59.62 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 120.142 1.337 . . . . 0.0 111.922 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 m -72.36 -50.8 23.97 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.173 1.389 . . . . 0.0 110.166 173.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.0 mt -87.86 -26.66 22.67 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 124.617 1.167 . . . . 0.0 112.647 -169.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.55 14.01 59.4 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 126.45 1.976 . . . . 0.0 111.602 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.23 125.18 22.8 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.227 1.411 . . . . 0.0 109.41 -172.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.68 8.42 87.2 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-O 119.732 -0.482 . . . . 0.0 113.647 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -125.47 -44.32 1.85 Allowed 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 125.161 1.385 . . . . 0.0 108.69 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.56 HG22 ' HB2' ' A' ' 2' ' ' LYS . 2.7 pp -140.25 150.27 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.463 1.105 . . . . 0.0 109.782 177.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.71 152.28 20.27 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.484 HG11 ' HB3' ' A' ' 22' ' ' ALA . 2.0 t -142.5 137.57 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 118.393 0.542 . . . . 0.0 111.061 -168.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.7 m -143.21 165.51 27.24 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.19 1.396 . . . . 0.0 109.524 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.9 p -141.48 156.27 45.76 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.929 1.292 . . . . 0.0 108.698 175.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 29.6 p -159.73 173.39 16.11 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.001 0.818 . . . . 0.0 112.201 -173.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.75 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 177.52 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.496 ' CG2' HE22 ' A' ' 16' ' ' GLN . 0.5 OUTLIER . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -137.22 117.08 10.45 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -172.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -69.24 -25.98 30.49 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.537 2.825 . . . . 0.0 113.179 -169.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.0 m -62.19 -36.21 81.21 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.177 0.899 . . . . 0.0 109.153 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.98 -41.89 90.58 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -58.59 -49.89 80.89 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 CA-C-O 118.312 -0.852 . . . . 0.0 108.874 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.5 -43.81 96.65 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 119.362 0.983 . . . . 0.0 110.916 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.7 mmt -64.51 -17.12 63.59 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.867 0.867 . . . . 0.0 112.723 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 3.4 mmt -97.99 -26.95 14.46 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 119.457 1.026 . . . . 0.0 110.656 173.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -65.0 -27.66 68.98 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.976 0.91 . . . . 0.0 110.164 172.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -56.37 -25.3 49.04 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.187 0.995 . . . . 0.0 112.603 169.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.1 m -127.24 14.56 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.468 1.507 . . . . 0.0 111.211 -171.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.1 39.11 84.06 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.941 0.782 . . . . 0.0 112.717 174.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.3 mt -126.99 156.65 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -136.85 143.35 43.03 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.39 1.076 . . . . 0.0 109.033 175.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.7 pt -140.59 15.83 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 126.778 2.031 . . . . 0.0 111.288 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.6 p -69.87 -40.91 75.43 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 120.767 -1.208 . . . . 0.0 112.414 173.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.18 8.05 41.28 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 123.819 0.723 . . . . 0.0 113.075 -177.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -73.96 -176.54 2.53 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.561 1.145 . . . . 0.0 112.132 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -69.3 170.27 10.62 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.533 1.933 . . . . 0.0 112.758 -170.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.4 m -159.16 57.18 0.41 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 104.042 -2.577 . . . . 0.0 104.042 171.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -143.38 147.96 42.15 Favored Pre-proline 0 C--N 1.345 0.389 0 C-N-CA 123.166 0.586 . . . . 0.0 110.351 -167.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -82.82 159.5 16.13 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.397 2.732 . . . . 0.0 112.438 -174.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.2 tt -58.75 -34.77 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.056 1.342 . . . . 0.0 111.371 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -69.16 -22.52 63.92 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.19 0.596 . . . . 0.0 112.309 -174.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -13.85 59.54 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 119.103 -0.475 . . . . 0.0 111.741 172.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -98.98 172.18 7.57 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.212 1.005 . . . . 0.0 110.789 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.71 99.06 3.06 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 125.21 1.404 . . . . 0.0 107.774 -178.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -49.83 -23.53 1.93 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 171.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -51.36 -25.69 6.45 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.885 0.874 . . . . 0.0 111.524 173.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -107.1 15.28 25.38 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.72 1.208 . . . . 0.0 113.491 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.45 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 24.6 m-85 -134.88 111.07 9.58 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 120.243 1.383 . . . . 0.0 109.16 173.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.29 -17.28 52.86 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 124.643 1.177 . . . . 0.0 113.422 -169.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.748 HG12 HG13 ' A' ' 4' ' ' VAL . 12.6 t -143.09 130.44 18.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 -170.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.3 t -135.96 131.84 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 -169.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.446 HD11 HD12 ' A' ' 126' ' ' LEU . 18.3 mm -133.83 100.62 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 103.031 -2.951 . . . . 0.0 103.031 -172.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.408 ' C ' ' H ' ' A' ' 80' ' ' CYS . 6.3 m -111.29 85.56 2.15 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 121.853 -0.529 . . . . 0.0 111.034 -168.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.535 HD13 ' HB3' ' A' ' 15' ' ' SER . 3.9 mp -73.12 25.51 0.06 Allowed 'General case' 0 C--N 1.343 0.291 0 C-N-CA 127.969 2.508 . . . . 0.0 110.547 -174.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.58 ' HB3' HG21 ' A' ' 84' ' ' VAL . 4.4 m -64.12 1.02 0.78 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.89 2.076 . . . . 0.0 111.411 170.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.22 26.4 28.48 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 118.742 0.701 . . . . 0.0 111.658 174.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 49.91 20.09 0.53 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.761 2.025 . . . . 0.0 114.771 -175.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -109.46 24.53 20.0 Favored Glycine 0 C--N 1.338 0.658 0 C-N-CA 124.43 1.014 . . . . 0.0 111.213 -176.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.58 HG21 ' HB3' ' A' ' 80' ' ' CYS . 20.1 t -132.29 121.43 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -174.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.32 -40.45 85.96 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.806 0.842 . . . . 0.0 110.893 -177.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.1 mt 64.48 152.63 0.12 Allowed Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 127.921 2.488 . . . . 0.0 112.64 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.04 151.45 50.1 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 121.926 1.75 . . . . 0.0 110.219 169.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.4 -19.61 55.31 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.634 1.556 . . . . 0.0 114.436 -169.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -64.52 -26.51 68.45 Favored 'General case' 0 C--O 1.224 -0.246 0 O-C-N 121.019 -1.051 . . . . 0.0 110.879 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.471 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 62.3 m95 -67.63 -8.61 36.09 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.197 -0.939 . . . . 0.0 112.622 175.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.4 t -108.68 -30.09 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.968 1.307 . . . . 0.0 111.105 -171.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.5 p -75.37 -17.25 60.27 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.21 1.004 . . . . 0.0 113.483 -169.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -51.67 160.68 0.61 Allowed 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 129.403 3.081 . . . . 0.0 114.033 176.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -62.47 -38.9 91.63 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.608 1.563 . . . . 0.0 108.762 177.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.547 ' HB ' HG13 ' A' ' 75' ' ' VAL . 30.5 mm -125.02 135.44 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 169.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -136.57 104.88 5.7 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 101.758 -3.423 . . . . 0.0 101.758 166.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -128.27 177.57 6.85 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 125.62 1.568 . . . . 0.0 106.901 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.24 -56.9 1.42 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -174.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 24.1 m0 56.02 65.7 1.38 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.072 0.949 . . . . 0.0 110.662 -169.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -56.39 46.28 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 130.274 3.429 . . . . 0.0 113.54 169.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.81 -177.65 2.03 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.615 -1.303 . . . . 0.0 113.422 -168.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.448 ' HB2' HG22 ' A' ' 115' ' ' VAL . 41.1 mt-10 -55.88 168.86 0.41 Allowed 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 127.253 2.221 . . . . 0.0 112.323 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -115.04 102.99 54.95 Favored Pre-proline 0 C--N 1.323 -0.566 0 C-N-CA 126.272 1.829 . . . . 0.0 109.243 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -83.75 -4.37 10.66 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.577 2.185 . . . . 0.0 112.814 175.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.7 t0 25.18 -101.27 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 128.246 2.618 . . . . 0.0 113.025 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -136.88 42.3 1.33 Allowed Glycine 0 CA--C 1.533 1.16 0 C-N-CA 128.188 2.804 . . . . 0.0 107.11 169.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -68.91 -174.48 0.6 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.619 1.968 . . . . 0.0 112.069 -174.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.5 p -57.39 152.84 13.58 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.962 -1.472 . . . . 0.0 108.433 169.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.1 mt -59.14 -30.37 68.1 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.625 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -61.41 -41.25 96.86 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 119.001 -0.523 . . . . 0.0 110.791 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.17 -42.28 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 117.647 -1.168 . . . . 0.0 109.305 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -50.35 -49.4 54.19 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.276 1.398 . . . . 0.0 111.765 171.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -59.05 -44.18 91.76 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.694 0.679 . . . . 0.0 111.36 176.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 91.7 m -68.48 -45.6 71.97 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -173.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.448 HG22 ' HB2' ' A' ' 102' ' ' GLU . 58.6 t -67.41 -47.59 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -173.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -43.43 -54.5 4.72 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.93 1.292 . . . . 0.0 110.665 169.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.87 -43.43 98.93 Favored Glycine 0 CA--C 1.522 0.503 0 CA-C-N 119.844 1.202 . . . . 0.0 112.065 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -67.91 -34.38 76.51 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 120.797 -1.413 . . . . 0.0 111.398 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.59 -42.23 93.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 170.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -43.52 85.35 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.995 1.27 . . . . 0.0 110.258 -174.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -66.44 -43.78 84.68 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 119.1 -0.476 . . . . 0.0 110.038 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -64.97 -42.42 94.6 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.136 0.88 . . . . 0.0 110.944 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 52.9 t -56.66 -52.29 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -64.95 -32.89 74.83 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 121.846 -0.534 . . . . 0.0 111.667 -175.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -62.84 -46.66 86.9 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 123.58 0.752 . . . . 0.0 111.15 172.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.446 HD12 HD11 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -57.84 -46.68 84.42 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 122.807 0.443 . . . . 0.0 110.101 175.641 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.5 mt -58.75 -41.8 83.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 123.918 0.887 . . . . 0.0 110.233 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.31 -28.87 68.47 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.216 0.916 . . . . 0.0 111.637 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -75.2 -40.73 58.99 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.538 0.608 . . . . 0.0 111.85 176.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.4 pt -101.85 -35.89 4.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 116.496 2.035 . . . . 0.0 116.496 -168.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 C--O 1.255 1.365 0 C-N-CA 124.438 1.095 . . . . 0.0 111.608 -170.269 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 tpt . . . . . 0 N--CA 1.5 2.034 0 CA-C-O 118.594 -0.717 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.517 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -60.79 120.54 10.32 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 120.895 1.679 . . . . 0.0 108.39 -174.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.408 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 31.9 mtpt -93.37 134.64 35.38 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -170.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.787 HG13 HG12 ' A' ' 75' ' ' VAL . 14.6 t -116.6 154.81 18.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 53.6 tpp -136.03 136.17 40.05 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -118.53 106.63 12.85 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.45 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 4.7 t -91.06 119.43 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -170.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.9 m -91.61 162.33 14.56 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.947 0.499 . . . . 0.0 111.52 -173.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -160.13 151.42 19.48 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.535 1.934 . . . . 0.0 106.258 169.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.447 ' HD3' ' H ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER 59.46 -165.16 0.2 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.484 1.113 . . . . 0.0 109.527 -169.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.541 HD21 ' CG ' ' A' ' 43' ' ' HIS . 51.9 t-20 -61.5 109.02 1.06 Allowed 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.3 m -61.41 2.53 0.15 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 -168.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 35.4 m -44.51 -47.62 10.11 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 120.099 1.318 . . . . 0.0 111.854 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -63.66 -39.46 94.4 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 118.992 0.815 . . . . 0.0 112.654 -175.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.27 -40.4 10.0 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.989 1.316 . . . . 0.0 111.298 -169.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.442 HE22 HG12 ' A' ' 42' ' ' VAL . 5.7 pt20 -65.67 -34.58 78.54 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.551 -0.718 . . . . 0.0 109.908 170.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.446 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.3 tpt -62.9 -39.87 95.85 Favored 'General case' 0 CA--C 1.512 -0.506 0 O-C-N 121.238 -0.914 . . . . 0.0 110.135 171.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.88 -39.22 84.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -64.28 -39.28 93.6 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.302 170.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.21 -45.59 85.55 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 120.726 1.603 . . . . 0.0 111.333 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -63.88 -39.63 94.63 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.459 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -68.59 -39.34 80.98 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 119.868 1.213 . . . . 0.0 110.99 -175.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -70.36 -26.47 63.74 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 120.532 1.514 . . . . 0.0 112.096 175.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 m -73.01 -51.04 19.73 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.369 1.467 . . . . 0.0 110.741 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.9 mt -88.82 -27.18 21.26 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.351 1.46 . . . . 0.0 112.307 -169.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.89 13.33 59.14 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 126.445 1.974 . . . . 0.0 111.682 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.52 122.81 14.97 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.039 1.335 . . . . 0.0 109.76 -174.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.31 9.13 86.99 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 119.887 -0.396 . . . . 0.0 113.649 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -123.88 -32.11 3.32 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.407 1.483 . . . . 0.0 109.275 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.8 pt -142.75 174.75 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 125.443 1.497 . . . . 0.0 109.439 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.87 146.07 43.16 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 168.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.459 HG11 ' HB3' ' A' ' 22' ' ' ALA . 1.8 t -135.58 142.12 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 123.168 0.587 . . . . 0.0 110.878 -168.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.03 159.63 44.42 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.92 0.888 . . . . 0.0 110.559 -176.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.0 p -133.83 156.26 48.37 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.873 1.269 . . . . 0.0 109.272 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.403 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 24.4 p -151.64 167.27 28.68 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.469 0.707 . . . . 0.0 111.234 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.958 0 C-N-CA 123.501 0.572 . . . . 0.0 112.913 173.284 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.442 HG12 HE22 ' A' ' 16' ' ' GLN . 17.9 m . . . . . 0 CA--C 1.531 0.23 0 CA-C-O 121.192 0.52 . . . . 0.0 111.416 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.541 ' CG ' HD21 ' A' ' 11' ' ' ASN . 13.5 t-80 -132.96 98.88 15.5 Favored Pre-proline 0 CA--C 1.53 0.2 0 C-N-CA 123.311 0.645 . . . . 0.0 109.672 -169.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -42.28 -33.18 2.37 Favored 'Trans proline' 0 CA--C 1.534 0.499 1 C-N-CA 125.846 4.364 . . . . 0.0 116.377 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.4 m -64.0 -39.29 93.79 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.792 1.178 . . . . 0.0 110.798 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.55 -43.48 80.6 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 121.133 -0.979 . . . . 0.0 109.218 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.88 -44.3 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.27 -43.23 99.22 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.429 0.559 . . . . 0.0 111.701 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.4 mmt -65.44 -21.61 66.67 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.166 0.439 . . . . 0.0 111.893 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.446 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.4 OUTLIER -93.4 -33.65 13.76 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -177.245 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -61.76 -34.13 75.3 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.954 1.302 . . . . 0.0 109.941 169.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.54 -8.31 4.17 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.601 1.961 . . . . 0.0 112.347 172.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.2 p -134.56 12.44 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 125.484 1.513 . . . . 0.0 110.91 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.81 36.87 66.15 Favored Glycine 0 CA--C 1.534 1.268 0 O-C-N 120.841 -1.162 . . . . 0.0 113.599 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.5 mt -120.46 154.71 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.319 1.448 . . . . 0.0 108.639 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.8 126.8 53.1 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.882 1.673 . . . . 0.0 109.571 -177.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.6 pt -134.59 8.19 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 125.501 1.52 . . . . 0.0 110.59 168.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.42 -37.41 68.64 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.404 1.882 . . . . 0.0 111.567 177.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.27 -6.81 89.04 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 123.471 0.558 . . . . 0.0 113.32 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -72.48 156.31 39.18 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.939 1.296 . . . . 0.0 109.874 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -150.97 164.98 35.1 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.5 m -68.08 141.28 56.19 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 126.999 2.119 . . . . 0.0 112.131 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -162.38 127.67 2.17 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 169.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.88 152.17 28.36 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.648 2.232 . . . . 0.0 113.38 -169.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.5 tt -59.3 -37.12 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.478 1.511 . . . . 0.0 111.366 -173.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -70.92 -19.67 62.56 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.126 0.57 . . . . 0.0 112.11 -173.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -15.68 54.54 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 118.762 -0.637 . . . . 0.0 111.85 173.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.403 ' CE2' ' HB3' ' A' ' 35' ' ' CYS . 62.6 m-85 -84.03 168.49 15.88 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.225 1.012 . . . . 0.0 110.804 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -140.16 86.17 2.06 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 102.634 -3.098 . . . . 0.0 102.634 -178.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.493 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -54.37 -23.23 14.76 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.58 -27.55 17.31 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.279 0.632 . . . . 0.0 111.184 172.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -84.48 -7.6 59.23 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.25 1.02 . . . . 0.0 113.16 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 26.0 m-85 -126.09 113.74 17.48 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 120.132 1.333 . . . . 0.0 108.912 -171.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -66.1 -12.21 54.09 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -168.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.787 HG12 HG13 ' A' ' 4' ' ' VAL . 22.9 t -145.25 123.24 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -170.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.3 t -118.74 129.63 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.2 mm -120.55 96.87 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 169.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.45 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 61.7 p -74.43 160.45 30.96 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 169.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -138.39 42.07 2.21 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 170.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.7 m -80.69 11.03 4.11 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.43 1.492 . . . . 0.0 111.177 -172.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.81 26.95 70.02 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 -174.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 2.0 t 52.78 -176.26 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.631 1.972 . . . . 0.0 111.314 -169.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.04 -33.79 1.07 Allowed Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.009 1.29 . . . . 0.0 114.677 172.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.5 t -57.61 119.32 2.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 125.198 1.399 . . . . 0.0 107.522 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -73.78 146.79 44.0 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 171.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.3 mt -127.09 153.41 76.62 Favored Pre-proline 0 C--O 1.237 0.439 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -53.08 151.94 19.88 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.26 1.973 . . . . 0.0 111.079 170.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -65.93 -19.8 58.07 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.574 1.516 . . . . 0.0 114.302 -169.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.58 -27.0 68.65 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.135 -0.978 . . . . 0.0 110.917 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.493 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 70.8 m95 -67.01 -12.47 59.97 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.046 -1.034 . . . . 0.0 112.819 175.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.8 t -104.74 -29.63 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.79 1.236 . . . . 0.0 111.127 -170.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.4 p -75.01 -13.38 60.5 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.365 1.066 . . . . 0.0 113.775 -169.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -55.78 163.6 1.36 Allowed 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 129.562 3.145 . . . . 0.0 113.761 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.62 -41.42 96.19 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.676 1.19 . . . . 0.0 108.373 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.557 ' HB ' HG13 ' A' ' 75' ' ' VAL . 20.0 mm -119.92 136.02 58.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 169.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -142.42 109.52 5.55 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 103.96 -2.607 . . . . 0.0 103.96 165.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -137.28 166.3 24.1 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 125.852 1.661 . . . . 0.0 106.765 178.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -133.07 130.16 38.98 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 169.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -111.31 83.12 1.71 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.512 ' H ' ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -66.81 46.49 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.481 2.312 . . . . 0.0 112.856 178.142 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.73 169.67 15.17 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.21 -0.931 . . . . 0.0 111.154 -173.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -46.93 142.57 3.39 Favored 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 126.03 1.732 . . . . 0.0 112.221 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -87.58 111.58 42.77 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.915 1.286 . . . . 0.0 108.759 176.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -83.38 -7.44 10.83 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.489 2.126 . . . . 0.0 112.416 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.4 t0 23.88 -96.96 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 128.233 2.613 . . . . 0.0 113.961 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.57 44.1 1.22 Allowed Glycine 0 CA--C 1.533 1.205 0 C-N-CA 126.944 2.211 . . . . 0.0 110.607 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -70.44 -175.39 1.02 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.847 1.659 . . . . 0.0 113.274 -175.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.2 p -69.08 162.38 27.05 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.44 169.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 22.8 mt -55.84 -37.0 68.14 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.942 0.497 . . . . 0.0 111.026 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.47 -37.32 77.9 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 123.262 0.625 . . . . 0.0 110.39 -174.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.4 t -74.2 -41.68 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -55.94 -34.74 65.93 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.451 1.023 . . . . 0.0 112.138 171.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.8 mtp85 -73.0 -44.87 60.51 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 119.705 1.139 . . . . 0.0 111.606 173.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 91.3 m -75.46 -38.21 59.82 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.372 0.669 . . . . 0.0 112.021 -169.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 87.4 t -71.49 -45.2 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -176.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -43.51 -53.02 5.81 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 125.886 1.675 . . . . 0.0 111.236 169.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.53 -40.18 97.44 Favored Glycine 0 N--CA 1.467 0.721 0 CA-C-N 119.785 1.175 . . . . 0.0 111.96 -175.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -65.17 -38.65 91.21 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 121.492 -1.005 . . . . 0.0 110.359 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.18 -40.44 89.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 175.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -36.89 76.04 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.454 1.025 . . . . 0.0 111.292 -177.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -69.85 -42.93 72.91 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 118.743 -0.646 . . . . 0.0 110.448 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -63.47 -43.18 98.09 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.88 1.218 . . . . 0.0 110.388 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 63.9 t -54.98 -53.66 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 123.475 0.71 . . . . 0.0 109.627 173.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -64.77 -32.77 74.61 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 122.151 -0.343 . . . . 0.0 111.419 -175.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -62.8 -47.73 82.19 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 123.363 0.665 . . . . 0.0 111.208 172.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.92 -47.75 76.95 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.454 0.57 . . . . 0.0 109.589 175.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -57.89 -42.49 82.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 124.452 1.101 . . . . 0.0 110.091 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.07 -28.94 68.22 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.885 0.766 . . . . 0.0 111.94 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -75.49 -40.56 57.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.614 0.643 . . . . 0.0 111.759 175.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 pt -101.33 -42.45 9.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -168.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 C--O 1.253 1.287 0 CA-C-N 119.089 0.859 . . . . 0.0 110.237 -173.423 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 tpt . . . . . 0 N--CA 1.497 1.918 0 CA-C-O 117.957 -1.02 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.546 ' HB2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -48.75 121.87 5.08 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 120.597 1.544 . . . . 0.0 109.863 -174.044 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -97.8 135.83 39.0 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -169.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.808 HG13 HG12 ' A' ' 75' ' ' VAL . 11.8 t -113.52 156.52 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 59.2 tpp -135.67 137.49 41.87 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.448 ' HE2' HG13 ' A' ' 32' ' ' VAL . 97.3 m-85 -119.78 117.07 27.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 177.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.437 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 8.5 t -99.55 132.39 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -169.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.8 t -111.79 131.22 55.47 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.962 0.887 . . . . 0.0 112.892 -169.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -140.15 150.93 44.84 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 129.08 2.952 . . . . 0.0 103.503 169.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 58.0 -170.8 0.11 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.799 0.84 . . . . 0.0 109.79 -168.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.421 HD21 ' CD2' ' A' ' 43' ' ' HIS . 15.1 t-20 -58.0 130.03 44.69 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -168.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.9 m -35.0 -35.41 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.997 1.719 . . . . 0.0 115.636 169.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.1 p -61.41 -9.6 5.82 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -99.96 -52.97 3.28 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 120.369 1.44 . . . . 0.0 110.823 171.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 p -94.21 -51.26 4.9 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 120.703 -1.248 . . . . 0.0 113.736 -168.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.32 -21.64 63.83 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 118.069 -1.452 . . . . 0.0 110.031 173.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.468 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 0.8 OUTLIER -63.39 -39.57 94.88 Favored 'General case' 0 CA--C 1.512 -0.498 0 O-C-N 120.899 -1.126 . . . . 0.0 109.056 168.364 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.9 -37.91 74.86 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 118.753 -0.641 . . . . 0.0 109.866 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -61.44 -40.07 93.12 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.942 169.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.33 -42.9 93.76 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 120.242 1.383 . . . . 0.0 111.454 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -67.23 -39.01 86.15 Favored 'General case' 0 CA--C 1.518 -0.274 0 O-C-N 121.554 -0.968 . . . . 0.0 108.705 173.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.06 -40.28 71.73 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 119.525 1.057 . . . . 0.0 110.433 -173.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -72.03 -15.5 62.03 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.449 1.022 . . . . 0.0 112.327 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 m -85.08 -50.54 7.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.798 1.639 . . . . 0.0 109.469 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.6 mt -88.85 -26.21 21.76 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.515 1.126 . . . . 0.0 112.7 -169.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.91 13.87 57.5 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 126.161 1.839 . . . . 0.0 112.076 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.01 125.16 23.05 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.635 1.174 . . . . 0.0 108.825 -174.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.2 7.79 88.21 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.711 -0.494 . . . . 0.0 113.795 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt -125.64 -42.78 1.91 Allowed 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 125.731 1.612 . . . . 0.0 108.988 -176.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.546 HG22 ' HB2' ' A' ' 2' ' ' LYS . 2.7 pp -143.29 152.04 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 124.642 1.177 . . . . 0.0 109.301 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.12 152.2 21.24 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 172.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.448 HG13 ' HE2' ' A' ' 6' ' ' PHE . 2.6 t -139.33 139.86 38.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 121.819 -0.551 . . . . 0.0 110.157 -168.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.98 159.23 43.82 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.337 1.055 . . . . 0.0 109.135 -172.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.2 t -146.88 156.08 42.81 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 119.376 0.989 . . . . 0.0 110.251 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.3 p -147.37 153.61 39.87 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.842 0.857 . . . . 0.0 109.707 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.709 0 N-CA-C 106.542 -2.623 . . . . 0.0 106.542 -169.334 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.236 0.345 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.421 ' CD2' HD21 ' A' ' 11' ' ' ASN . 80.0 t60 -132.98 108.47 12.71 Favored Pre-proline 0 C--O 1.234 0.251 0 C-N-CA 123.187 0.595 . . . . 0.0 109.414 -169.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -64.37 -30.38 62.92 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.157 2.571 . . . . 0.0 112.234 -168.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.5 m -65.73 -36.53 83.85 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 119.296 0.953 . . . . 0.0 109.246 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.411 ' HB1' HD11 ' A' ' 57' ' ' ILE . . . -65.97 -44.6 84.46 Favored 'General case' 0 C--N 1.346 0.424 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -58.05 -48.8 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.96 96.26 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.713 0.688 . . . . 0.0 110.906 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.6 mmt -58.66 -25.89 63.24 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.873 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.468 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.5 OUTLIER -95.87 -26.33 15.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 119.178 0.899 . . . . 0.0 108.932 -177.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -64.74 -29.64 70.63 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.546 1.138 . . . . 0.0 110.445 169.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -57.63 -22.82 47.8 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.386 0.674 . . . . 0.0 112.186 171.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.9 m -124.09 11.59 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 125.708 1.603 . . . . 0.0 111.279 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.41 40.92 86.63 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.0 0.81 . . . . 0.0 113.012 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.7 mt -124.87 154.29 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.542 1.537 . . . . 0.0 107.758 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -122.6 126.37 47.55 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.013 1.325 . . . . 0.0 109.014 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.411 HD11 ' HB1' ' A' ' 46' ' ' ALA . 35.8 pt -129.47 16.38 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 125.14 1.376 . . . . 0.0 111.268 170.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.51 -24.89 45.56 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.762 1.625 . . . . 0.0 112.226 169.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.27 -13.13 81.63 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 118.136 0.426 . . . . 0.0 112.399 174.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -73.12 163.09 28.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.697 1.199 . . . . 0.0 110.545 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.7 p -148.3 168.06 23.56 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.727 1.211 . . . . 0.0 110.791 170.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.35 143.88 51.81 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.714 1.206 . . . . 0.0 109.801 174.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -161.04 127.93 2.56 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 117.225 -1.369 . . . . 0.0 107.751 173.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -65.52 152.33 82.17 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.136 2.557 . . . . 0.0 114.468 -172.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.1 tt -62.05 -41.13 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 124.438 1.095 . . . . 0.0 111.083 174.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -70.42 -20.82 62.89 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.085 0.554 . . . . 0.0 111.891 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.98 -19.04 60.78 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.548 0.739 . . . . 0.0 111.642 171.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -92.54 169.8 10.25 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.912 0.863 . . . . 0.0 110.954 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -140.94 88.58 2.19 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 -173.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.496 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -53.95 -24.15 15.53 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -28.58 16.06 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.355 0.662 . . . . 0.0 111.372 173.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -82.3 -13.71 56.53 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.311 1.044 . . . . 0.0 113.302 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -121.64 113.63 20.02 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 120.081 1.309 . . . . 0.0 109.383 -169.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.4 -16.03 52.43 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -169.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.808 HG12 HG13 ' A' ' 4' ' ' VAL . 14.3 t -144.8 127.13 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -170.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.7 t -121.26 127.39 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.2 mm -119.72 95.05 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 169.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.437 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 31.2 t -74.45 165.96 24.31 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 168.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.88 26.14 2.29 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.61 -1.306 . . . . 0.0 109.128 171.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.576 ' HB3' HG21 ' A' ' 84' ' ' VAL . 57.0 m -83.52 -1.32 53.43 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.167 -0.958 . . . . 0.0 112.476 -170.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.96 23.89 6.86 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 123.783 0.706 . . . . 0.0 111.73 175.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.453 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 3.2 t 44.32 45.16 7.18 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.148 1.779 . . . . 0.0 112.336 -174.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -155.6 35.82 0.63 Allowed Glycine 0 C--N 1.339 0.743 0 CA-C-O 119.735 -0.481 . . . . 0.0 112.319 -171.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.576 HG21 ' HB3' ' A' ' 80' ' ' CYS . 86.6 t -122.87 141.91 41.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 125.058 1.343 . . . . 0.0 108.6 178.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -81.95 60.09 4.63 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.37 1.068 . . . . 0.0 109.966 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 68.4 mt -56.63 134.35 77.89 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -54.57 155.36 17.22 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.552 2.168 . . . . 0.0 112.568 178.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -54.9 -28.82 60.71 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.76 2.306 . . . . 0.0 116.099 -171.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -66.53 -24.36 66.37 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.153 -0.967 . . . . 0.0 111.607 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.496 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 66.9 m95 -70.97 -13.93 62.18 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 117.892 -1.051 . . . . 0.0 113.14 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.9 m -113.52 -10.93 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 120.107 1.321 . . . . 0.0 113.165 -171.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.4 p -84.05 -16.41 43.93 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.615 0.766 . . . . 0.0 112.739 -175.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -50.45 161.86 0.28 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 130.017 3.327 . . . . 0.0 114.377 174.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -62.36 -39.32 92.79 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.454 1.502 . . . . 0.0 108.801 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.594 ' HB ' HG13 ' A' ' 75' ' ' VAL . 23.4 mm -122.85 136.83 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 169.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -141.14 111.89 7.07 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 100.926 -3.731 . . . . 0.0 100.926 166.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.92 164.32 28.22 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 174.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.8 t70 -134.56 100.31 4.6 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 170.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -77.2 78.32 3.73 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -55.62 33.43 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.953 1 C-N-CA 131.745 4.018 . . . . 0.0 113.761 170.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.93 172.15 5.85 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.083 1.353 . . . . 0.0 111.717 -169.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.52 ' HB2' HG22 ' A' ' 115' ' ' VAL . 38.4 mt-10 -49.88 155.52 0.87 Allowed 'General case' 0 C--O 1.231 0.088 0 C-N-CA 125.354 1.462 . . . . 0.0 112.632 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -107.24 110.58 63.31 Favored Pre-proline 0 N--CA 1.448 -0.538 0 C-N-CA 126.556 1.942 . . . . 0.0 109.062 175.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -95.31 1.03 2.49 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 124.068 3.179 . . . . 0.0 112.631 175.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -51.37 -37.09 46.32 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -168.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -109.38 25.05 18.96 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.48 -1.178 . . . . 0.0 112.677 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.469 ' NE2' HG11 ' A' ' 111' ' ' VAL . 28.9 mt-30 -122.34 174.65 6.87 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 118.999 1.4 . . . . 0.0 113.95 -169.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.1 m -73.14 166.79 22.46 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 112.947 -1.933 . . . . 0.0 110.144 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.6 mt -55.51 -31.61 62.2 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 123.189 0.596 . . . . 0.0 110.951 175.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -62.28 -41.16 98.25 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 118.298 0.499 . . . . 0.0 110.567 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.469 HG11 ' NE2' ' A' ' 107' ' ' GLN . 17.2 t -76.48 -39.82 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 117.322 -1.323 . . . . 0.0 108.784 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -47.23 -48.57 24.25 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 120.264 1.393 . . . . 0.0 110.949 168.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -61.21 -46.1 91.82 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.261 0.937 . . . . 0.0 111.184 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.5 m -68.21 -37.37 80.81 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 122.865 0.466 . . . . 0.0 110.16 -171.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.52 HG22 ' HB2' ' A' ' 102' ' ' GLU . 40.3 t -75.93 -44.01 38.8 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -177.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -45.59 -51.09 12.53 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 124.795 1.238 . . . . 0.0 111.193 170.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.18 -42.97 97.75 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 119.506 1.048 . . . . 0.0 112.19 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -65.61 -35.56 81.17 Favored 'General case' 0 CA--C 1.52 -0.192 0 O-C-N 120.942 -1.328 . . . . 0.0 110.832 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.2 -42.63 97.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 173.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.15 -39.65 83.09 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.422 1.465 . . . . 0.0 111.369 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.7 -44.62 73.59 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.393 1.477 . . . . 0.0 109.743 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -66.89 -41.34 87.36 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.574 -0.704 . . . . 0.0 112.039 177.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 38.9 t -54.77 -53.02 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -64.08 -32.74 74.41 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 122.043 -0.411 . . . . 0.0 111.647 -175.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -63.13 -46.09 88.88 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 121.612 -0.68 . . . . 0.0 111.392 172.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.11 -47.58 82.82 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 175.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -58.02 -41.37 80.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 123.896 0.878 . . . . 0.0 109.825 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.26 -27.39 68.42 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.868 0.758 . . . . 0.0 112.093 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -76.82 -41.21 45.22 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 118.616 -0.706 . . . . 0.0 112.315 174.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.8 pt -101.13 -35.11 4.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 -168.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 28.2 m . . . . . 0 C--O 1.256 1.401 0 CA-C-N 119.304 0.956 . . . . 0.0 111.497 -177.107 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 tpt . . . . . 0 N--CA 1.499 2.011 0 CA-C-O 118.53 -0.747 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.477 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -60.94 119.28 7.95 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 120.842 1.655 . . . . 0.0 108.679 -174.566 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -90.37 138.08 31.83 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -172.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.7 t -116.37 153.74 17.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 O-C-N 124.25 0.969 . . . . 0.0 108.386 174.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.25 142.09 50.94 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 175.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -121.5 103.92 9.28 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.544 -1.651 . . . . 0.0 106.544 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 6.1 t -89.32 134.52 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -169.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 82.4 m -91.84 169.15 10.92 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -169.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -147.52 -160.45 1.17 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 128.159 2.584 . . . . 0.0 105.476 168.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.8 ttm105 -46.38 141.46 3.53 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.916 1.235 . . . . 0.0 111.504 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.541 HD21 ' CD2' ' A' ' 43' ' ' HIS . 9.0 t-20 44.34 67.62 0.66 Allowed 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 127.964 2.506 . . . . 0.0 109.694 -172.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 p -51.4 -20.61 1.85 Allowed 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 126.522 1.929 . . . . 0.0 114.71 -171.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 77.1 m -61.0 -17.64 53.26 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 116.734 -1.603 . . . . 0.0 113.658 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -65.45 -37.14 86.01 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 122.978 2.626 . . . . 0.0 111.334 169.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.473 ' HB3' HD13 ' A' ' 79' ' ' LEU . 0.4 OUTLIER -86.63 -39.91 15.64 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.409 -0.807 . . . . 0.0 108.901 -174.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -66.89 -25.28 66.31 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 120.902 -1.124 . . . . 0.0 110.875 169.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.437 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.8 tpt -67.03 -37.89 84.94 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 119.884 -1.76 . . . . 0.0 109.153 169.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.58 89.73 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.429 ' HG3' HG12 ' A' ' 32' ' ' VAL . 60.4 tt0 -61.87 -40.19 94.5 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.49 -0.766 . . . . 0.0 110.533 169.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.31 -35.65 63.59 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 120.894 1.679 . . . . 0.0 112.676 -175.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -71.87 -37.81 70.13 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 118.329 1.065 . . . . 0.0 108.724 169.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.472 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -71.53 -39.27 70.84 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 120.567 -1.333 . . . . 0.0 111.275 -174.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.432 ' HA ' HG21 ' A' ' 32' ' ' VAL . 52.8 pttt -63.45 -23.95 67.62 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.054 1.297 . . . . 0.0 111.979 174.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 m -84.94 -50.42 7.51 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.146 2.178 . . . . 0.0 109.581 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.6 mt -88.45 -25.12 22.79 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.377 1.471 . . . . 0.0 112.022 -169.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -106.5 15.75 41.74 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 126.715 2.102 . . . . 0.0 111.73 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.35 123.09 16.79 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.595 1.158 . . . . 0.0 109.442 -175.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.24 8.38 87.5 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 123.07 0.367 . . . . 0.0 113.786 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.2 mmtt -120.66 -34.82 3.5 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 126.117 1.767 . . . . 0.0 109.278 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.5 pt -142.38 172.77 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 124.912 1.285 . . . . 0.0 109.307 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.8 145.98 39.65 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 168.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.472 HG11 ' HB3' ' A' ' 22' ' ' ALA . 2.1 t -134.57 141.26 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 123.163 0.585 . . . . 0.0 110.782 -168.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.01 160.51 42.06 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.129 0.972 . . . . 0.0 109.826 -173.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.5 p -135.51 168.14 19.78 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.124 1.329 . . . . 0.0 109.443 169.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.3 p -153.61 157.01 39.01 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.6 -0.687 . . . . 0.0 112.005 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.815 0 C-N-CA 125.693 1.616 . . . . 0.0 110.626 173.869 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 121.292 0.568 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.541 ' CD2' HD21 ' A' ' 11' ' ' ASN . 77.4 t60 -123.25 110.8 30.59 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 124.312 1.045 . . . . 0.0 110.147 -169.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.48 -25.03 41.8 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.389 2.726 . . . . 0.0 115.113 -169.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -59.73 -37.63 79.48 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 120.538 1.517 . . . . 0.0 110.775 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.41 -44.51 71.25 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.13 -44.19 78.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 CA-C-O 118.616 -0.707 . . . . 0.0 109.137 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.05 -42.77 81.15 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.689 0.677 . . . . 0.0 110.974 177.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.415 ' HG3' ' HB3' ' A' ' 112' ' ' PHE . 30.4 mmt -66.78 -22.47 66.03 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.779 -0.629 . . . . 0.0 112.311 178.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.437 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 1.8 mmt -90.18 -36.32 14.86 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -65.38 -34.86 79.31 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.368 1.067 . . . . 0.0 110.267 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.26 1.0 OUTLIER -76.31 5.21 7.38 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.3 0.64 . . . . 0.0 112.289 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.0 m -129.07 -23.02 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.831 1.252 . . . . 0.0 112.707 169.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.72 31.11 0.91 Allowed Glycine 0 CA--C 1.532 1.125 0 CA-C-N 119.739 1.154 . . . . 0.0 114.422 170.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.0 mt -130.13 161.62 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.534 1.534 . . . . 0.0 107.112 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -140.36 146.81 38.9 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 169.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.6 pt -138.37 5.71 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.486 1.914 . . . . 0.0 110.618 -176.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.6 p -64.04 145.12 56.45 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.172 -0.955 . . . . 0.0 110.138 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.2 6.02 18.2 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 118.253 -1.304 . . . . 0.0 113.811 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -57.14 -44.76 83.71 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 119.521 1.66 . . . . 0.0 113.205 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -149.53 162.24 40.54 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 124.232 0.958 . . . . 0.0 110.626 -168.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.3 p -170.5 27.4 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.702 0.801 . . . . 0.0 111.994 -170.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -139.33 147.08 51.41 Favored Pre-proline 0 N--CA 1.475 0.809 0 O-C-N 120.604 -1.31 . . . . 0.0 111.614 -169.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -83.08 161.67 15.59 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.872 3.048 . . . . 0.0 112.558 -174.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.7 tt -59.76 -37.24 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.666 1.186 . . . . 0.0 111.545 -177.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -70.5 -20.69 62.82 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.275 0.63 . . . . 0.0 112.134 -173.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -19.05 59.26 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 118.872 -0.585 . . . . 0.0 111.338 171.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -97.72 167.32 11.02 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.934 0.874 . . . . 0.0 110.637 -176.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -141.46 89.61 2.23 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 -172.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.473 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -50.94 -30.66 15.45 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.53 -29.56 10.92 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.134 0.974 . . . . 0.0 112.459 174.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -71.53 -18.58 62.26 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -107.64 171.03 7.62 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 128.398 2.679 . . . . 0.0 108.707 -172.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -111.42 -22.6 11.22 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-O 117.792 -1.099 . . . . 0.0 113.274 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.706 HG13 ' HB ' ' A' ' 95' ' ' ILE . 37.7 t -137.4 133.92 46.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 121.544 1.975 . . . . 0.0 108.585 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.0 t -116.5 129.89 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 173.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.3 mm -122.89 96.82 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 101.76 -3.422 . . . . 0.0 101.76 169.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.415 ' HA ' ' HB ' ' A' ' 7' ' ' VAL 0.254 22.0 p -74.32 166.39 23.55 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 117.649 -1.62 . . . . 0.0 108.257 169.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.473 HD13 ' HB3' ' A' ' 15' ' ' SER . 5.4 mp -136.36 37.86 2.71 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 170.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 63.8 m -95.91 7.59 45.93 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.869 2.067 . . . . 0.0 110.932 -169.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.85 31.78 6.83 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 119.246 -0.752 . . . . 0.0 112.221 172.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 31.5 p 40.26 37.85 0.47 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.644 2.378 . . . . 0.0 116.041 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.86 24.46 0.49 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 123.896 0.76 . . . . 0.0 112.566 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 p -78.21 143.75 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 124.615 1.166 . . . . 0.0 108.897 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -92.96 58.85 3.05 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.476 1.11 . . . . 0.0 109.239 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.8 mt -61.29 147.47 87.14 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -175.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -56.41 157.58 17.95 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.895 2.397 . . . . 0.0 111.89 170.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.3 -25.34 64.37 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 121.853 1.702 . . . . 0.0 114.875 -169.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.47 -24.68 67.22 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.49 -1.382 . . . . 0.0 111.636 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.473 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 72.1 m95 -72.65 -9.26 58.4 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 117.855 -1.069 . . . . 0.0 112.686 175.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.8 m -117.49 -16.06 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 119.926 1.239 . . . . 0.0 113.166 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.9 p -76.06 -11.18 59.9 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.15 0.886 . . . . 0.0 112.352 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.407 ' HG2' ' H ' ' A' ' 93' ' ' GLN . 69.8 mm-40 -43.38 156.1 0.06 Allowed 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 130.618 3.567 . . . . 0.0 111.826 169.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -62.12 -36.18 80.97 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.725 1.61 . . . . 0.0 109.731 171.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.706 ' HB ' HG13 ' A' ' 75' ' ' VAL . 24.4 mm -131.98 137.0 55.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -135.46 112.62 10.43 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 102.07 -3.307 . . . . 0.0 102.07 166.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -136.31 168.42 19.46 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -141.94 118.68 11.08 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 170.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.45 ' CD2' ' HB3' ' A' ' 122' ' ' ARG . 49.5 m0 -95.52 79.59 3.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.31 18.74 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 129.022 2.929 . . . . 0.0 116.411 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -61.76 128.8 37.97 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 120.615 -1.303 . . . . 0.0 113.857 -168.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 46.94 -157.74 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 128.403 2.681 . . . . 0.0 114.161 169.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -163.51 74.47 1.84 Allowed Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 127.871 2.468 . . . . 0.0 108.054 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.5 -13.35 32.72 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.365 2.71 . . . . 0.0 115.834 -169.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.0 t70 26.17 -92.37 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.001 2.52 . . . . 0.0 114.045 172.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.89 45.23 1.01 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 126.888 2.185 . . . . 0.0 109.771 171.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -66.45 175.04 2.41 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.712 2.005 . . . . 0.0 114.133 -172.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.0 m -66.21 152.05 45.69 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 113.217 -1.811 . . . . 0.0 109.657 169.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.3 mt -57.18 -35.24 69.34 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.262 0.625 . . . . 0.0 111.077 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -61.3 -36.35 79.85 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 122.862 0.465 . . . . 0.0 110.794 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 23.3 t -74.83 -40.75 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-O 117.849 -1.072 . . . . 0.0 108.76 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.415 ' HB3' ' HG3' ' A' ' 49' ' ' MET . 57.3 m-85 -54.84 -42.55 72.11 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 120.432 1.469 . . . . 0.0 110.748 172.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 59.0 mtt85 -62.21 -46.01 90.81 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.227 0.921 . . . . 0.0 111.743 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.4 m -69.89 -43.64 71.37 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -172.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.8 t -65.9 -45.67 90.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -173.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -47.55 -53.77 13.55 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.997 1.319 . . . . 0.0 110.566 169.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.78 -42.15 99.71 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 119.328 0.967 . . . . 0.0 111.998 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -64.88 -39.71 93.97 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 121.425 -1.044 . . . . 0.0 110.607 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 45.0 t -62.82 -42.34 95.98 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -36.64 78.89 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 120.128 1.331 . . . . 0.0 111.475 -174.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -68.57 -42.69 77.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.691 -0.671 . . . . 0.0 109.869 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.45 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 10.4 mpt_? -63.41 -42.36 98.76 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 119.831 1.196 . . . . 0.0 110.412 177.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 56.7 t -54.7 -52.93 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 123.469 0.708 . . . . 0.0 109.114 174.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -66.29 -32.85 74.51 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 122.046 -0.409 . . . . 0.0 111.461 -175.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -62.16 -47.87 82.62 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 123.906 0.883 . . . . 0.0 110.966 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -48.03 80.51 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 176.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -57.39 -42.16 79.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 124.447 1.099 . . . . 0.0 109.769 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.68 -27.88 68.19 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.714 0.688 . . . . 0.0 112.154 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -77.01 -41.86 40.97 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.491 0.587 . . . . 0.0 111.951 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.8 pt -99.33 -40.02 8.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 -168.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 40.4 m . . . . . 0 C--O 1.255 1.366 0 CA-C-N 119.005 0.821 . . . . 0.0 110.891 -174.351 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 tpt . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 117.513 -1.232 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.716 ' HG2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -55.98 123.57 14.78 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 121.566 1.985 . . . . 0.0 109.996 -172.054 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -93.47 142.13 27.68 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -169.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.769 HG13 HG12 ' A' ' 75' ' ' VAL . 9.1 t -121.57 153.91 25.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.289 0.993 . . . . 0.0 108.56 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 59.9 tpp -136.32 135.05 38.56 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -117.22 109.88 17.43 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.446 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 10.2 t -96.98 141.74 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -169.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.9 t -125.81 156.7 39.12 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.335 0.97 . . . . 0.0 111.316 173.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp -140.11 34.67 1.92 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.664 1.586 . . . . 0.0 109.197 172.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -156.43 171.6 19.98 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 128.006 2.522 . . . . 0.0 105.156 -170.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.417 HD21 ' CE1' ' A' ' 43' ' ' HIS . 62.5 t-20 -42.2 125.41 3.06 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 169.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.0 p -41.52 -29.46 0.17 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 117.277 2.325 . . . . 0.0 117.277 -169.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.7 m -34.16 -62.16 0.33 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 127.367 2.267 . . . . 0.0 115.148 -169.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -64.6 -52.0 59.79 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.056 0.844 . . . . 0.0 112.529 -168.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -81.67 -34.09 30.92 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 121.514 -0.741 . . . . 0.0 111.417 -172.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.27 -30.76 65.14 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.454 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.7 tpt -64.88 -40.88 95.8 Favored 'General case' 0 CA--C 1.514 -0.419 0 O-C-N 121.018 -1.051 . . . . 0.0 109.094 168.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.67 -36.79 79.59 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -62.03 -42.96 99.73 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.83 -0.605 . . . . 0.0 111.313 169.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.14 -45.61 91.0 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-N 119.936 1.244 . . . . 0.0 110.907 -176.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -63.09 -39.98 96.31 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 117.934 0.867 . . . . 0.0 109.364 172.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.28 -35.82 76.43 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 119.58 1.082 . . . . 0.0 111.561 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -81.93 -13.91 56.85 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 120.311 1.414 . . . . 0.0 113.244 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.9 m -78.18 -50.69 11.47 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.229 1.412 . . . . 0.0 109.397 169.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.3 mt -89.56 -27.4 20.28 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.16 1.384 . . . . 0.0 112.423 -169.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.78 14.63 57.47 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 126.661 2.077 . . . . 0.0 111.685 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.34 120.45 9.32 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.579 1.151 . . . . 0.0 110.054 -172.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.58 9.5 86.13 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 119.81 -0.439 . . . . 0.0 113.467 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -123.27 -24.87 4.56 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 125.159 1.384 . . . . 0.0 109.701 -177.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.716 HG22 ' HG2' ' A' ' 2' ' ' LYS . 13.1 pt -144.29 172.0 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 125.962 1.705 . . . . 0.0 110.42 175.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.31 144.71 38.62 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 103.836 -2.653 . . . . 0.0 103.836 168.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 t -135.59 140.42 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 123.47 0.708 . . . . 0.0 110.743 -168.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.6 160.63 42.49 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.127 0.971 . . . . 0.0 109.939 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.5 p -139.02 163.64 31.85 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.288 1.404 . . . . 0.0 111.221 174.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.7 p -149.64 160.49 43.46 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.151 0.58 . . . . 0.0 111.339 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.696 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 -177.608 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.417 ' CE1' HD21 ' A' ' 11' ' ' ASN . 70.6 t60 -121.28 111.28 33.71 Favored Pre-proline 0 N--CA 1.454 -0.268 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -169.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -66.08 -27.11 49.92 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.385 2.724 . . . . 0.0 112.343 -169.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.9 m -63.32 -37.11 85.99 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.64 0.655 . . . . 0.0 109.249 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.39 -44.15 88.43 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.08 -49.66 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.22 -42.86 99.34 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.487 0.585 . . . . 0.0 111.119 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.6 mmt -61.89 -24.75 67.14 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.353 -0.832 . . . . 0.0 111.967 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.454 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.6 OUTLIER -94.4 -27.61 15.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 119.151 0.887 . . . . 0.0 108.688 -179.194 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.59 -30.42 71.53 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.371 1.068 . . . . 0.0 110.408 170.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -56.84 -23.19 42.26 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.457 0.703 . . . . 0.0 112.098 171.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.8 m -123.64 12.01 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 125.445 1.498 . . . . 0.0 111.142 -175.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.36 39.65 87.46 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 123.815 0.722 . . . . 0.0 112.759 174.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.6 mt -122.98 154.56 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.428 1.491 . . . . 0.0 107.19 175.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -127.84 128.11 44.65 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 124.552 1.141 . . . . 0.0 108.795 -177.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 46.3 pt -134.64 15.31 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 126.661 1.984 . . . . 0.0 109.752 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.65 160.16 27.66 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 167.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.17 -15.86 2.34 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 118.958 -0.912 . . . . 0.0 112.456 -174.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -61.58 147.46 45.55 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.757 1.279 . . . . 0.0 107.903 169.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.06 169.64 17.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -169.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.3 m -73.06 145.11 46.8 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.663 1.585 . . . . 0.0 111.937 -170.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -166.32 123.8 1.03 Allowed Pre-proline 0 C--O 1.237 0.442 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 169.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -76.87 161.12 33.54 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.115 1.876 . . . . 0.0 111.454 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.8 tt -56.17 -37.79 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.217 1.007 . . . . 0.0 111.142 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -68.86 -21.27 64.28 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.586 0.754 . . . . 0.0 112.16 -176.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.79 -22.43 63.33 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.637 -0.697 . . . . 0.0 111.203 171.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -107.45 165.9 11.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.578 1.18 . . . . 0.0 112.018 -172.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.86 89.8 2.28 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 102.658 -3.09 . . . . 0.0 102.658 -170.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.481 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -49.4 -32.14 11.01 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.275 0.63 . . . . 0.0 112.283 -177.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.08 -28.29 10.18 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.26 1.024 . . . . 0.0 112.868 174.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.04 -23.2 61.34 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.366 0.666 . . . . 0.0 112.208 176.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -104.12 178.89 4.43 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.618 2.767 . . . . 0.0 108.659 -175.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -123.57 -17.4 6.47 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 118.601 -0.714 . . . . 0.0 112.579 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.769 HG12 HG13 ' A' ' 4' ' ' VAL . 17.5 t -143.72 124.25 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -169.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.6 t -117.41 130.09 72.86 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.782 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.425 HG21 ' CE3' ' A' ' 99' ' ' TRP . 33.0 mm -119.35 92.44 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 103.026 -2.953 . . . . 0.0 103.026 169.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.446 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 16.9 t -72.42 161.38 30.9 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 169.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.6 mp -141.32 46.87 1.71 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 169.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 72.2 m -89.76 2.06 55.34 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.992 0.917 . . . . 0.0 110.682 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.12 42.69 5.22 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 172.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.2 p 37.75 44.72 0.59 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.321 2.248 . . . . 0.0 114.638 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -157.56 47.89 0.45 Allowed Glycine 0 C--N 1.34 0.757 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -172.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.9 p -128.09 161.92 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.873 1.669 . . . . 0.0 109.99 -172.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -123.21 45.31 2.45 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.177 2.191 . . . . 0.0 109.445 -170.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.8 mt -54.42 140.98 54.82 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.2 1.0 . . . . 0.0 109.245 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -53.88 153.39 20.13 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.596 2.197 . . . . 0.0 112.554 173.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -55.53 -26.82 56.43 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.515 2.143 . . . . 0.0 116.006 -173.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -64.75 -25.09 67.78 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.915 -1.116 . . . . 0.0 111.865 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.481 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 70.0 m95 -71.43 -9.19 57.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.661 1.184 . . . . 0.0 112.323 173.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.27 -29.8 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.663 1.585 . . . . 0.0 110.294 -173.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.0 p -75.25 -9.63 58.73 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.758 0.823 . . . . 0.0 112.738 -175.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -45.21 155.67 0.12 Allowed 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 129.916 3.287 . . . . 0.0 111.722 169.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -62.19 -39.23 92.0 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.803 1.641 . . . . 0.0 109.561 170.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.61 ' HB ' HG13 ' A' ' 75' ' ' VAL . 21.8 mm -122.56 134.64 65.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 169.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -137.92 111.78 8.33 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 103.892 -2.633 . . . . 0.0 103.892 166.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -137.39 165.72 25.54 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -133.41 105.04 6.71 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.441 1.096 . . . . 0.0 108.157 171.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.425 ' CE3' HG21 ' A' ' 77' ' ' ILE . 46.1 m0 -79.35 72.82 5.98 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.181 1.392 . . . . 0.0 108.613 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -51.94 34.05 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.952 1 C-N-CA 132.43 4.292 . . . . 0.0 116.015 169.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.87 -175.0 1.6 Allowed 'General case' 0 CA--C 1.544 0.742 0 O-C-N 120.958 -1.088 . . . . 0.0 110.162 -174.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.456 ' HB2' HG22 ' A' ' 115' ' ' VAL . 1.5 mp0 -42.21 164.51 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 127.735 2.414 . . . . 0.0 113.213 176.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -126.58 63.17 52.24 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 125.779 1.632 . . . . 0.0 112.802 -168.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -79.94 69.06 8.1 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 124.164 3.243 . . . . 0.0 112.549 -169.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.35 -38.56 89.99 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.799 -1.188 . . . . 0.0 112.404 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -162.8 42.56 0.35 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.259 1.409 . . . . 0.0 110.763 -176.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -71.88 171.58 11.47 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -169.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.3 m -69.25 154.2 42.43 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 113.103 -1.862 . . . . 0.0 108.194 168.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 24.6 mt -59.17 -32.48 69.94 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.911 -0.493 . . . . 0.0 111.438 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -62.81 -39.75 95.24 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 118.611 0.642 . . . . 0.0 111.005 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.621 ' O ' HG23 ' A' ' 115' ' ' VAL . 98.7 t -72.02 -42.13 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 116.37 -1.776 . . . . 0.0 108.526 177.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -50.38 -49.13 55.21 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 121.086 1.766 . . . . 0.0 111.1 172.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -58.67 -44.33 90.17 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.371 0.532 . . . . 0.0 110.762 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 88.0 m -66.15 -44.6 83.66 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 118.642 -0.694 . . . . 0.0 109.432 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 111' ' ' VAL . 17.3 t -67.36 -49.16 74.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -172.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -44.29 -56.36 4.22 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.332 1.453 . . . . 0.0 111.269 170.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.81 -42.77 96.9 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 119.231 0.923 . . . . 0.0 111.416 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -62.2 -39.35 92.45 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.503 -0.998 . . . . 0.0 111.409 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.0 t -62.72 -41.52 92.68 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 CA-C-O 117.842 -1.075 . . . . 0.0 108.212 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -38.3 75.9 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 120.208 1.367 . . . . 0.0 111.048 -177.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -69.79 -43.76 71.47 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.988 -0.529 . . . . 0.0 110.219 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -66.36 -42.9 87.35 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.381 0.991 . . . . 0.0 110.357 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.8 t -52.72 -54.53 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 123.833 0.853 . . . . 0.0 108.983 172.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -65.1 -32.54 74.29 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 122.121 -0.362 . . . . 0.0 111.301 -174.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -62.41 -47.74 82.8 Favored 'General case' 0 C--O 1.225 -0.188 0 O-C-N 121.806 -0.559 . . . . 0.0 111.185 172.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.63 -47.57 79.41 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 176.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.2 mt -57.97 -42.71 83.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 123.895 0.878 . . . . 0.0 109.697 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.3 -32.0 71.85 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.961 0.801 . . . . 0.0 111.957 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -72.36 -42.25 65.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.611 173.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.3 pt -103.93 -44.7 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 118.942 2.941 . . . . 0.0 118.942 -168.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 71.8 m . . . . . 0 C--O 1.252 1.228 0 CA-C-N 119.733 1.152 . . . . 0.0 111.561 -169.336 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 tpt . . . . . 0 N--CA 1.498 1.942 0 CA-C-O 118.724 -0.655 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -64.31 128.13 34.47 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.892 1.678 . . . . 0.0 108.891 -174.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -94.24 145.8 24.47 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -170.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.753 HG13 HG12 ' A' ' 75' ' ' VAL . 12.2 t -124.28 153.52 30.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 O-C-N 124.495 1.122 . . . . 0.0 108.142 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 56.5 tpp -134.59 146.24 49.42 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 175.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -127.0 106.53 9.34 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.454 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 4.0 t -93.47 136.52 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -169.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.5 m -108.55 171.62 7.31 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.133 0.573 . . . . 0.0 110.748 -174.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -149.69 -52.36 0.15 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.451 0.7 . . . . 0.0 109.395 169.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.44 ' CG ' ' H ' ' A' ' 11' ' ' ASN . 30.9 ttm180 -103.92 -176.44 3.08 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.387 1.075 . . . . 0.0 108.293 169.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.483 HD21 ' CD2' ' A' ' 43' ' ' HIS . 27.4 t-20 -36.07 125.24 0.75 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 127.821 2.448 . . . . 0.0 113.65 -169.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.78 -19.56 6.65 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 129.243 3.017 . . . . 0.0 113.818 -173.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 p -58.17 -12.41 3.52 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 177.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -101.54 -43.91 5.75 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 120.597 1.544 . . . . 0.0 111.509 169.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.0 p -93.23 -52.88 4.34 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.964 1.306 . . . . 0.0 113.542 -168.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -65.87 -28.03 68.66 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.667 -1.271 . . . . 0.0 110.068 169.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.464 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.7 tpt -62.47 -39.81 94.61 Favored 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 121.267 -0.896 . . . . 0.0 110.741 169.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.03 -37.52 80.02 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 118.834 -0.603 . . . . 0.0 109.678 178.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -62.22 -41.29 98.25 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 118.721 -0.657 . . . . 0.0 110.915 169.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.87 -43.02 84.83 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 120.255 1.388 . . . . 0.0 111.686 -175.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -65.31 -37.53 87.41 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 121.742 -0.858 . . . . 0.0 108.733 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.66 -38.0 67.76 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 119.752 1.16 . . . . 0.0 111.358 -174.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.418 ' HA ' HG21 ' A' ' 32' ' ' VAL . 54.6 pttt -68.42 -26.75 65.69 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.869 1.213 . . . . 0.0 111.627 175.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.0 m -77.21 -52.32 9.44 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.967 1.707 . . . . 0.0 110.235 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.1 mt -88.2 -26.44 22.38 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.008 1.323 . . . . 0.0 111.695 -169.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.13 13.77 58.63 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 126.431 1.967 . . . . 0.0 111.673 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.6 119.5 7.68 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.414 1.086 . . . . 0.0 109.548 -174.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.07 8.3 87.93 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 119.754 -0.47 . . . . 0.0 113.564 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.4 ' O ' ' HE2' ' A' ' 2' ' ' LYS . 75.6 mmtt -123.51 -26.22 4.25 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 125.568 1.547 . . . . 0.0 109.977 -177.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.512 HG21 HD12 ' A' ' 130' ' ' ILE . 9.1 pt -145.92 170.58 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 125.058 1.343 . . . . 0.0 109.589 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.12 145.82 35.08 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 167.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.457 HG22 HD12 ' A' ' 30' ' ' ILE . 1.7 t -136.43 140.24 43.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 119.05 0.841 . . . . 0.0 111.263 -167.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 m -150.7 160.78 43.61 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 124.209 1.003 . . . . 0.0 110.682 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 64.6 p -133.2 161.86 33.3 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.057 1.299 . . . . 0.0 109.746 169.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.8 p -154.39 169.8 22.87 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.063 0.459 . . . . 0.0 111.879 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.44 0 C-N-CA 125.471 1.51 . . . . 0.0 111.846 -174.008 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 t . . . . . 0 CA--C 1.531 0.246 0 CA-C-O 122.115 0.96 . . . . 0.0 112.285 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.483 ' CD2' HD21 ' A' ' 11' ' ' ASN . 85.9 t60 -127.74 114.62 20.79 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 125.76 1.624 . . . . 0.0 108.321 -172.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -68.35 -27.04 34.62 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 124.021 3.147 . . . . 0.0 113.241 -169.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.0 m -62.65 -34.37 76.94 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.134 0.879 . . . . 0.0 109.206 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.12 -45.97 86.23 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.48 -46.7 92.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.128 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.96 -43.57 98.57 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 119.091 0.86 . . . . 0.0 111.077 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.4 mmt -59.74 -25.45 64.86 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.204 0.602 . . . . 0.0 111.986 175.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.464 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -93.09 -29.32 15.84 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -176.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -63.25 -31.47 72.63 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.328 1.451 . . . . 0.0 110.212 171.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -56.83 -20.81 24.79 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.794 0.838 . . . . 0.0 112.516 171.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.8 p -126.25 14.15 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 125.191 1.397 . . . . 0.0 110.253 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.8 33.76 66.32 Favored Glycine 0 CA--C 1.531 1.069 0 O-C-N 121.053 -1.029 . . . . 0.0 112.842 173.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.8 mt -121.01 159.04 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 126.08 1.752 . . . . 0.0 106.944 176.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -140.09 146.99 39.62 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.2 pt -135.15 8.77 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 126.262 1.825 . . . . 0.0 111.183 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.5 t -70.73 161.31 31.07 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 168.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.7 -25.53 1.43 Allowed Glycine 0 CA--C 1.533 1.199 0 CA-C-O 119.029 -0.873 . . . . 0.0 111.942 -173.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -76.85 137.95 39.5 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 103.397 -2.816 . . . . 0.0 103.397 168.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -146.84 165.19 30.45 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -168.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.1 m -68.0 141.37 56.27 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.961 2.105 . . . . 0.0 111.01 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -164.56 132.19 2.5 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.66 147.61 35.78 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.887 2.392 . . . . 0.0 113.753 -168.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.5 tt -60.48 -34.25 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.087 1.355 . . . . 0.0 111.238 -171.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.28 -13.17 61.44 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.211 0.604 . . . . 0.0 112.541 -171.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -91.58 -10.29 41.09 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.027 0.931 . . . . 0.0 112.173 171.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -84.0 171.07 13.3 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 122.015 0.912 . . . . 0.0 111.161 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.77 83.2 1.52 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.787 1.635 . . . . 0.0 107.638 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.41 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -49.1 -30.96 7.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -50.65 -32.6 19.61 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.143 0.977 . . . . 0.0 112.627 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -71.11 -24.85 62.37 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -94.36 177.28 6.0 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 127.402 2.281 . . . . 0.0 109.064 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -116.14 -19.23 10.36 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 118.257 -0.878 . . . . 0.0 112.585 173.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.753 HG12 HG13 ' A' ' 4' ' ' VAL . 8.2 t -143.2 132.41 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 120.685 1.584 . . . . 0.0 106.939 -169.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.8 m -132.99 130.15 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.43 HG21 ' CE3' ' A' ' 99' ' ' TRP . 28.0 mm -116.96 99.96 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 102.749 -3.056 . . . . 0.0 102.749 176.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.454 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 30.3 t -72.85 161.38 30.79 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 169.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.2 mp -140.1 34.29 1.92 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 169.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.541 ' HB3' HG21 ' A' ' 84' ' ' VAL . 85.5 m -74.01 -5.79 43.5 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.388 1.075 . . . . 0.0 111.6 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.33 27.32 18.41 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -173.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.501 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 3.1 t 53.96 -173.13 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.287 1.835 . . . . 0.0 111.095 -169.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.93 -34.4 1.25 Allowed Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.414 1.483 . . . . 0.0 114.818 173.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.541 HG21 ' HB3' ' A' ' 80' ' ' CYS . 78.2 t -58.67 126.07 15.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 118.502 1.151 . . . . 0.0 108.679 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -82.04 73.31 9.09 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.455 1.102 . . . . 0.0 110.317 -169.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.2 mt -58.9 143.01 84.16 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 118.28 -0.867 . . . . 0.0 108.871 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.1 156.59 9.76 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.208 2.605 . . . . 0.0 112.458 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.57 -20.46 65.67 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.72 1.613 . . . . 0.0 115.172 -169.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.83 -24.8 66.2 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 120.576 -1.328 . . . . 0.0 112.067 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.41 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 71.7 m95 -70.33 -8.9 54.1 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.215 1.006 . . . . 0.0 111.884 171.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.2 t -105.83 -30.56 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 119.831 1.196 . . . . 0.0 110.517 -174.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.8 p -73.8 -14.48 61.11 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.114 0.966 . . . . 0.0 112.911 -174.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.418 ' HG2' ' H ' ' A' ' 93' ' ' GLN . 79.2 mm-40 -44.25 154.19 0.12 Allowed 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 129.835 3.254 . . . . 0.0 112.075 169.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -63.01 -38.72 92.32 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.735 1.614 . . . . 0.0 109.45 169.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.498 ' HB ' HG13 ' A' ' 75' ' ' VAL . 2.5 mt -126.95 131.11 71.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 174.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -137.95 109.84 7.18 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 101.126 -3.657 . . . . 0.0 101.126 166.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.86 165.99 23.72 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.501 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 11.1 t70 -130.62 103.91 6.9 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 169.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.43 ' CE3' HG21 ' A' ' 77' ' ' ILE . 53.0 m0 -76.35 73.12 3.13 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 174.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -58.99 42.9 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.87 1 C-N-CA 131.865 4.066 . . . . 0.0 111.755 169.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.36 -172.69 1.2 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.714 1.206 . . . . 0.0 112.128 -168.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.486 ' HB2' HG22 ' A' ' 115' ' ' VAL . 39.0 mt-10 -50.96 161.64 0.35 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.344 1.458 . . . . 0.0 111.745 172.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -117.42 101.22 52.83 Favored Pre-proline 0 C--N 1.323 -0.557 0 C-N-CA 126.313 1.845 . . . . 0.0 108.766 -176.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -79.08 -4.5 13.91 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.071 2.514 . . . . 0.0 113.064 175.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.8 t70 23.26 -96.6 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 128.536 2.735 . . . . 0.0 114.238 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.84 38.31 1.83 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 127.105 2.288 . . . . 0.0 109.51 169.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -71.67 -178.0 2.09 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.238 1.815 . . . . 0.0 112.775 -174.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.0 m -62.55 155.2 26.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 113.52 -1.673 . . . . 0.0 109.047 172.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 27.0 mt -56.43 -30.82 63.3 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 123.09 0.556 . . . . 0.0 110.805 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.35 -40.04 92.81 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 118.636 0.653 . . . . 0.0 110.811 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.4 t -72.32 -44.02 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 117.361 -1.304 . . . . 0.0 108.781 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -48.01 -48.71 32.58 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 120.181 1.355 . . . . 0.0 111.383 170.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -60.64 -45.13 95.23 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.948 0.795 . . . . 0.0 111.364 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.7 m -68.58 -44.32 74.66 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -173.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.486 HG22 ' HB2' ' A' ' 102' ' ' GLU . 19.7 t -67.68 -43.47 86.65 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -174.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -47.37 -56.4 6.98 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 124.638 1.175 . . . . 0.0 110.825 171.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.66 -42.49 99.68 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 119.546 1.066 . . . . 0.0 111.869 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -63.7 -38.74 92.26 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 121.317 -1.108 . . . . 0.0 111.803 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.5 t -62.52 -41.42 91.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -37.29 76.75 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 119.805 1.184 . . . . 0.0 111.184 -175.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -70.11 -41.05 74.5 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 118.695 -0.669 . . . . 0.0 110.722 176.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -64.4 -43.74 93.46 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.948 1.249 . . . . 0.0 110.214 177.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.497 HG12 HD12 ' A' ' 127' ' ' ILE . 66.7 t -54.38 -52.02 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 123.782 0.833 . . . . 0.0 109.536 173.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -66.29 -34.46 78.04 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 118.057 0.39 . . . . 0.0 111.634 -175.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -61.74 -48.91 78.58 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.313 0.645 . . . . 0.0 110.897 172.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.42 HD23 HG13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -58.5 -45.06 89.53 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 122.882 0.473 . . . . 0.0 109.937 176.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.497 HD12 HG12 ' A' ' 123' ' ' VAL . 6.6 mt -58.38 -42.71 84.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 123.489 0.715 . . . . 0.0 109.576 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.04 -28.11 68.61 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -68.19 -53.53 24.26 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.022 0.828 . . . . 0.0 110.431 172.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.512 HD12 HG21 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -84.33 -40.5 15.48 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 -169.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--O 1.255 1.345 0 CA-C-N 119.554 1.07 . . . . 0.0 112.486 -169.638 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.5 2.03 0 CA-C-O 117.491 -1.242 . . . . 0.0 109.208 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.705 ' HG2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -56.44 123.54 15.07 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 121.509 1.959 . . . . 0.0 109.812 -172.758 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -92.47 142.05 27.84 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -170.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.707 HG13 HG12 ' A' ' 75' ' ' VAL . 10.5 t -123.66 152.21 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 O-C-N 124.381 1.051 . . . . 0.0 108.385 -177.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 53.8 tpp -137.29 143.94 42.4 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -126.23 119.56 27.77 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.8 t -103.86 131.14 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -169.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.8 t -123.56 -174.76 3.04 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.624 1.57 . . . . 0.0 110.314 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -158.59 -63.63 0.08 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 169.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.3 ttm105 -70.66 135.15 48.15 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 122.333 0.253 . . . . 0.0 111.272 -175.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 65.4 t30 42.91 25.74 0.06 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.72 2.808 . . . . 0.0 115.877 168.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.4 m 29.45 64.87 0.13 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.177 2.191 . . . . 0.0 114.395 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 p -139.38 -71.88 0.39 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 116.593 -1.67 . . . . 0.0 115.129 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.262 20.0 ptt180 -44.18 -45.68 8.48 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 122.355 2.343 . . . . 0.0 116.035 -168.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.445 ' HB3' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -93.04 -30.69 15.17 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.486 -0.759 . . . . 0.0 111.215 -174.08 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -62.11 -37.14 83.97 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.857 -1.152 . . . . 0.0 108.677 169.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.423 ' SD ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -64.25 -39.49 94.06 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 121.146 -0.971 . . . . 0.0 110.681 172.203 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.56 -34.5 74.26 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 118.633 -0.699 . . . . 0.0 110.326 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -64.24 -40.78 96.72 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-N 118.979 0.809 . . . . 0.0 110.172 169.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.29 -43.55 98.92 Favored Glycine 0 C--N 1.339 0.697 0 CA-C-N 120.009 1.277 . . . . 0.0 111.33 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.423 ' CD2' ' SD ' ' A' ' 17' ' ' MET . 7.2 m-85 -68.24 -38.31 81.69 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 118.571 1.186 . . . . 0.0 109.847 172.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.83 -37.11 70.36 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 119.642 1.11 . . . . 0.0 111.171 -172.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.438 ' HA ' HG21 ' A' ' 32' ' ' VAL . 42.4 pttt -71.34 -27.14 63.16 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 119.868 1.213 . . . . 0.0 111.867 174.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 m -72.58 -50.8 22.98 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.184 1.794 . . . . 0.0 110.331 175.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.1 mt -88.76 -28.36 20.54 Favored 'General case' 0 CA--C 1.53 0.212 0 C-N-CA 124.74 1.216 . . . . 0.0 112.056 -169.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.59 15.14 60.17 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.878 2.18 . . . . 0.0 111.423 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.56 120.11 8.81 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.706 1.203 . . . . 0.0 110.012 -173.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.65 9.05 87.12 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.692 -0.504 . . . . 0.0 113.48 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -123.1 -24.02 4.81 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.348 1.459 . . . . 0.0 110.026 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.705 HG22 ' HG2' ' A' ' 2' ' ' LYS . 12.9 pt -146.08 171.85 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 125.972 1.709 . . . . 0.0 110.124 177.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.82 143.81 42.15 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 168.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.484 HG22 HD12 ' A' ' 30' ' ' ILE . 1.6 t -137.34 138.14 45.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 118.907 0.776 . . . . 0.0 111.178 -168.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.4 m -144.86 166.42 25.31 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.203 1.401 . . . . 0.0 109.841 178.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.5 p -136.37 161.78 34.87 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.594 -1.316 . . . . 0.0 108.899 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.4 p -159.07 176.27 12.47 Favored 'General case' 0 C--O 1.233 0.226 0 O-C-N 121.556 -0.715 . . . . 0.0 109.491 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.6 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -176.433 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.445 -0.703 0 N-CA-C 114.423 1.268 . . . . 0.0 114.423 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -149.55 116.17 3.62 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -65.35 -29.35 54.39 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.018 2.479 . . . . 0.0 112.176 -169.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.6 m -64.21 -37.5 87.69 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.91 -42.25 90.42 Favored 'General case' 0 C--O 1.219 -0.536 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.73 -48.4 86.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 118.457 -0.783 . . . . 0.0 109.286 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.98 -42.74 98.93 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.228 0.922 . . . . 0.0 110.992 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 24.6 mmt -64.87 -21.24 66.77 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.962 0.905 . . . . 0.0 112.102 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.1 mmt -91.49 -29.16 17.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 119.305 0.957 . . . . 0.0 110.175 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.24 -29.38 70.16 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.897 0.879 . . . . 0.0 110.491 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -56.39 -25.58 50.34 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.047 0.939 . . . . 0.0 112.489 170.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.5 m -121.95 12.74 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.987 1.315 . . . . 0.0 111.056 -173.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.2 37.4 81.25 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.361 -0.688 . . . . 0.0 112.385 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.6 mt -121.87 153.74 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -129.92 127.63 40.52 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 37.3 pt -132.02 9.73 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 C-N-CA 123.303 0.641 . . . . 0.0 111.931 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.16 -32.18 61.22 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.355 1.462 . . . . 0.0 112.456 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.06 3.83 69.33 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.551 -0.583 . . . . 0.0 112.841 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -76.1 -175.42 3.1 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.225 1.01 . . . . 0.0 111.847 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.43 171.14 1.14 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.013 2.525 . . . . 0.0 114.999 -169.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.2 m -144.74 21.55 1.63 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.426 1.49 . . . . 0.0 111.699 -169.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -139.59 160.13 62.63 Favored Pre-proline 0 N--CA 1.471 0.578 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -168.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.7 165.58 24.61 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 124.724 3.616 . . . . 0.0 112.454 175.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.4 tt -59.93 -34.55 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.384 1.474 . . . . 0.0 111.971 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -68.89 -21.56 64.23 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -169.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.49 -16.44 56.04 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.161 172.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -89.67 171.3 9.76 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.237 0.926 . . . . 0.0 110.706 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.24 88.57 1.73 Allowed 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.236 1.414 . . . . 0.0 108.912 -173.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.456 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -49.86 -29.71 8.59 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.805 0.842 . . . . 0.0 113.168 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -48.76 -33.98 11.35 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.282 1.033 . . . . 0.0 112.034 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -73.51 -23.11 59.98 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -99.43 -177.66 3.66 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 127.547 2.339 . . . . 0.0 109.796 -174.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -123.19 -20.52 5.67 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.707 HG12 HG13 ' A' ' 4' ' ' VAL . 17.1 t -142.86 130.09 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 -169.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.8 m -135.27 135.76 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 O-C-N 120.825 -1.172 . . . . 0.0 108.368 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.1 mm -130.37 100.27 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 -172.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 77.4 p -80.83 159.91 24.96 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 119.042 -1.063 . . . . 0.0 109.461 173.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.445 HD13 ' HB3' ' A' ' 15' ' ' SER . 3.4 mp -137.39 53.54 1.86 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 103.009 -2.96 . . . . 0.0 103.009 169.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 60.1 m -107.9 18.86 20.79 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.623 1.969 . . . . 0.0 108.774 -176.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.46 21.86 76.24 Favored Glycine 0 C--N 1.344 0.972 0 CA-C-O 118.785 -1.008 . . . . 0.0 112.548 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.4 p 53.52 -8.7 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.504 3.122 . . . . 0.0 117.418 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.97 -27.94 73.47 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 119.248 0.931 . . . . 0.0 112.005 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.0 t -65.99 113.63 2.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -76.19 105.59 7.32 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 104.154 -2.536 . . . . 0.0 104.154 168.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.5 mt -72.9 154.61 90.95 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.26 158.29 12.44 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.906 2.404 . . . . 0.0 112.487 173.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.84 -24.02 68.41 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 121.727 1.618 . . . . 0.0 115.717 -169.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -67.99 -24.3 65.12 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 120.705 -1.247 . . . . 0.0 111.835 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.456 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 65.6 m95 -72.6 -7.57 50.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.318 1.047 . . . . 0.0 111.756 172.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.2 t -105.34 -30.52 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 120.213 1.37 . . . . 0.0 110.309 -174.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.9 p -74.19 -13.11 60.75 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.242 1.017 . . . . 0.0 112.88 -175.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -45.29 154.64 0.16 Allowed 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 129.898 3.279 . . . . 0.0 112.468 169.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -64.33 -39.03 93.08 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.203 1.801 . . . . 0.0 109.347 170.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.575 ' HB ' HG13 ' A' ' 75' ' ' VAL . 31.1 mm -127.44 135.65 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 171.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -137.67 104.27 5.26 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 100.773 -3.788 . . . . 0.0 100.773 166.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -127.25 169.93 12.99 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 174.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' A' ' 78' ' ' SER . 8.3 t70 -142.44 137.12 30.13 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 169.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.421 ' CD2' ' HB3' ' A' ' 122' ' ' ARG . 54.0 m0 -107.19 6.29 28.57 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -172.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 42.88 -70.78 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 131.282 3.833 . . . . 0.0 112.678 -172.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.413 ' CD1' ' H ' ' A' ' 102' ' ' GLU 0.26 0.3 OUTLIER 52.69 -174.41 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.507 1 C-N-CA 132.977 4.511 . . . . 0.0 114.891 177.012 . . . . . . . . 5 4 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.44 ' HB2' HG22 ' A' ' 115' ' ' VAL . 27.0 mt-10 -62.19 172.28 1.51 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.065 1.746 . . . . 0.0 109.867 -175.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -129.15 72.23 81.99 Favored Pre-proline 0 C--N 1.323 -0.556 0 C-N-CA 125.135 1.374 . . . . 0.0 111.249 -168.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.6 68.25 5.43 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 124.481 3.454 . . . . 0.0 113.489 -172.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -64.68 -33.01 74.95 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.348 1.059 . . . . 0.0 112.902 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 154.46 92.35 0.09 OUTLIER Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.933 1.73 . . . . 0.0 109.209 -175.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.85 -167.94 1.8 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.458 1.503 . . . . 0.0 111.451 -169.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.2 p -70.89 157.92 37.32 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 113.424 -1.717 . . . . 0.0 108.162 168.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.1 mt -61.07 -31.63 71.29 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 121.842 -0.536 . . . . 0.0 111.292 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -58.58 -38.61 78.26 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.279 0.632 . . . . 0.0 111.088 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.667 ' O ' HG23 ' A' ' 115' ' ' VAL . 42.9 t -72.93 -43.6 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 117.172 -1.394 . . . . 0.0 108.594 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -52.78 -46.73 67.73 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.757 1.617 . . . . 0.0 111.591 171.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -58.86 -43.68 90.88 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.758 0.708 . . . . 0.0 111.04 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.0 m -68.13 -44.23 76.55 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -175.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 111' ' ' VAL . 60.1 t -62.5 -52.82 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -173.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -42.25 -58.99 1.96 Allowed 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 126.1 1.76 . . . . 0.0 110.974 169.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.46 -43.23 99.6 Favored Glycine 0 CA--C 1.524 0.607 0 CA-C-N 119.796 1.18 . . . . 0.0 111.632 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -63.93 -38.87 92.69 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 120.616 -1.52 . . . . 0.0 111.563 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.5 t -60.28 -40.48 83.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 118.374 -0.822 . . . . 0.0 108.835 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -42.58 76.62 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.623 1.101 . . . . 0.0 110.425 -177.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -65.86 -43.34 88.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 119.426 -0.321 . . . . 0.0 110.385 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.421 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 5.5 mpt_? -70.55 -41.2 72.8 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.919 0.782 . . . . 0.0 109.844 -176.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 64.8 t -53.37 -52.92 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 123.31 0.644 . . . . 0.0 109.486 172.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.99 -33.1 75.23 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 122.212 -0.305 . . . . 0.0 111.491 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -61.81 -47.54 84.65 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.078 0.551 . . . . 0.0 111.135 172.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -46.93 84.39 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 118.259 0.482 . . . . 0.0 110.089 176.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -57.81 -42.22 81.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 123.473 0.709 . . . . 0.0 109.557 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.03 -30.26 70.84 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 118.909 0.777 . . . . 0.0 111.798 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -72.89 -44.23 61.53 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 118.346 -0.835 . . . . 0.0 111.623 172.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 21.3 pt -101.96 -43.85 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 118.465 2.765 . . . . 0.0 118.465 -168.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.0 m . . . . . 0 C--O 1.254 1.317 0 CA-C-O 116.692 -1.623 . . . . 0.0 111.536 -169.236 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.498 1.958 0 CA-C-O 118.91 -0.566 . . . . 0.0 109.848 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -64.65 128.58 36.39 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.565 1.53 . . . . 0.0 107.967 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -94.89 143.06 26.77 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -173.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.778 HG13 HG12 ' A' ' 75' ' ' VAL . 11.3 t -121.78 153.23 25.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 O-C-N 124.457 1.098 . . . . 0.0 108.631 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.4 mmt -129.13 138.78 52.0 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -119.7 100.09 7.05 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 170.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.43 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 2.7 t -84.64 116.78 28.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -168.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.9 m -82.75 167.5 18.11 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.848 0.833 . . . . 0.0 112.339 -171.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.0 mtpp -159.02 170.88 21.09 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 127.57 2.348 . . . . 0.0 105.6 169.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.02 -143.66 0.73 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.081 0.952 . . . . 0.0 108.49 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.427 HD21 ' CG ' ' A' ' 43' ' ' HIS . 60.6 t30 -72.67 1.78 7.72 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.405 -0.809 . . . . 0.0 112.426 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.3 m 65.57 -1.49 1.0 Allowed 'General case' 0 C--N 1.348 0.526 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 169.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 p -59.02 -45.94 89.46 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 119.953 1.251 . . . . 0.0 111.613 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -58.38 -35.34 71.84 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 119.406 1.003 . . . . 0.0 113.039 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.79 -40.49 10.17 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.565 1.146 . . . . 0.0 110.942 -169.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -64.53 -35.05 79.71 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.511 0.724 . . . . 0.0 110.01 169.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.459 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.6 tpt -63.05 -39.77 95.73 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 121.394 -0.816 . . . . 0.0 110.983 169.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.48 -36.98 79.58 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 118.439 -0.791 . . . . 0.0 109.647 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -63.11 -42.5 99.56 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.938 0.79 . . . . 0.0 110.373 169.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.24 -42.14 99.72 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 120.385 1.448 . . . . 0.0 112.226 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -69.26 -41.18 77.25 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 117.983 0.891 . . . . 0.0 109.322 172.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.439 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -71.63 -35.44 70.43 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 119.747 1.158 . . . . 0.0 111.565 -172.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.426 ' HA ' HG21 ' A' ' 32' ' ' VAL . 45.2 pttt -72.58 -21.89 61.07 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.809 1.186 . . . . 0.0 112.177 175.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 m -80.68 -50.63 9.66 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.352 1.861 . . . . 0.0 109.693 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.1 mt -88.55 -26.96 21.7 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.13 1.372 . . . . 0.0 111.599 -169.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.05 17.71 47.81 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 127.121 2.296 . . . . 0.0 111.525 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.74 121.56 12.57 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.628 1.171 . . . . 0.0 109.739 -172.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.38 9.29 85.91 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 119.869 -0.406 . . . . 0.0 113.54 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.406 ' O ' ' HE2' ' A' ' 2' ' ' LYS . 31.3 mmtp -124.44 -28.51 3.62 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 125.868 1.667 . . . . 0.0 110.532 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.439 HD12 HG22 ' A' ' 32' ' ' VAL . 6.2 pt -141.55 162.32 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 124.308 1.043 . . . . 0.0 109.222 173.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.25 144.43 29.28 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 103.339 -2.838 . . . . 0.0 103.339 167.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.439 HG11 ' HB3' ' A' ' 22' ' ' ALA . 2.0 t -133.43 142.06 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 118.821 0.737 . . . . 0.0 111.275 -167.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.31 148.96 28.8 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.936 0.894 . . . . 0.0 110.202 -175.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.7 p -131.75 117.01 18.02 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 175.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.1 m -141.93 165.46 27.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 119.186 0.903 . . . . 0.0 111.044 -169.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.79 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -169.775 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 m . . . . . 0 C--O 1.234 0.253 0 CA-C-O 122.055 0.931 . . . . 0.0 111.4 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.427 ' CG ' HD21 ' A' ' 11' ' ' ASN . 85.0 t60 -133.45 120.78 15.99 Favored Pre-proline 0 N--CA 1.448 -0.562 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -66.69 -26.16 46.05 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.559 2.839 . . . . 0.0 112.321 -169.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.6 m -61.01 -37.05 81.18 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.004 0.82 . . . . 0.0 109.154 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.18 -44.12 84.94 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.499 HG12 ' HB3' ' A' ' 58' ' ' SER . 1.8 mp -58.3 -48.08 85.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 CA-C-O 118.278 -0.868 . . . . 0.0 108.874 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.92 98.3 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.293 0.951 . . . . 0.0 111.182 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.5 mmt -60.66 -25.22 66.18 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.395 1.078 . . . . 0.0 112.974 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.459 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -95.39 -33.1 12.63 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -178.074 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -61.77 -37.23 83.55 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.305 1.042 . . . . 0.0 110.158 174.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -71.64 0.37 8.86 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.7 m -130.14 13.87 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 125.983 1.713 . . . . 0.0 111.435 169.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.26 33.56 48.68 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 121.134 -0.979 . . . . 0.0 114.159 171.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.7 mt -125.41 160.79 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.994 1.718 . . . . 0.0 107.367 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -139.98 140.52 36.32 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.221 1.008 . . . . 0.0 108.928 175.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.8 pt -138.27 11.96 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 126.633 1.973 . . . . 0.0 110.001 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.499 ' HB3' HG12 ' A' ' 47' ' ' ILE . 63.9 p -62.27 145.01 54.86 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.945 0.793 . . . . 0.0 110.669 175.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.23 8.21 6.23 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 117.094 -1.948 . . . . 0.0 114.659 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -50.08 -61.03 2.39 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-N 120.067 1.933 . . . . 0.0 113.08 -172.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -159.01 159.33 34.65 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.461 1.104 . . . . 0.0 108.794 -169.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.5 m -163.04 43.96 0.12 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.862 1.665 . . . . 0.0 107.699 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -134.8 149.68 71.31 Favored Pre-proline 0 N--CA 1.47 0.563 0 O-C-N 121.493 -0.754 . . . . 0.0 111.847 -168.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -83.12 158.33 15.29 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 124.144 3.229 . . . . 0.0 112.282 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.4 tt -62.98 -35.64 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 125.235 1.414 . . . . 0.0 112.198 -175.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -70.0 -20.55 63.28 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.611 0.364 . . . . 0.0 111.917 -171.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.51 -13.98 59.57 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 118.853 -0.594 . . . . 0.0 112.236 172.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -101.2 168.79 9.34 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.26 1.024 . . . . 0.0 110.853 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.73 91.67 2.33 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 -170.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.494 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -50.96 -31.94 19.44 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.52 -28.46 13.66 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.379 1.072 . . . . 0.0 112.177 176.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -70.88 -20.85 62.47 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.204 0.601 . . . . 0.0 112.368 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -106.9 175.13 5.6 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 128.624 2.77 . . . . 0.0 108.292 -174.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -118.64 -17.09 9.35 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.778 HG12 HG13 ' A' ' 4' ' ' VAL . 6.3 t -142.19 129.01 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -169.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.6 t -124.44 128.4 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.418 HG21 ' CE3' ' A' ' 99' ' ' TRP . 38.7 mm -121.68 96.63 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 102.119 -3.289 . . . . 0.0 102.119 169.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.43 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 20.4 p -72.66 164.11 27.01 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 118.019 -1.472 . . . . 0.0 107.884 169.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.6 mp -135.66 36.29 2.9 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 172.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.551 ' HB3' HG21 ' A' ' 84' ' ' VAL . 35.5 m -90.92 5.65 47.77 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.76 1.624 . . . . 0.0 110.761 -172.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.55 22.29 26.89 Favored Glycine 0 C--N 1.339 0.725 0 CA-C-O 119.565 -0.575 . . . . 0.0 111.955 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.429 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 5.4 t 46.88 40.68 9.49 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.941 1.696 . . . . 0.0 112.344 -177.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -149.79 35.33 1.02 Allowed Glycine 0 C--N 1.34 0.759 0 C-N-CA 123.793 0.711 . . . . 0.0 111.661 -171.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.551 HG21 ' HB3' ' A' ' 80' ' ' CYS . 73.2 t -121.18 130.09 75.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 124.965 1.306 . . . . 0.0 107.948 177.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -78.93 70.58 5.29 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 173.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.28 145.46 81.31 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-O 118.488 -0.768 . . . . 0.0 109.1 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -54.07 157.07 11.55 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.973 2.448 . . . . 0.0 111.924 172.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.3 -24.42 65.03 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 121.866 1.71 . . . . 0.0 114.949 -169.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -64.71 -23.68 67.33 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 120.63 -1.293 . . . . 0.0 111.974 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.494 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 77.4 m95 -73.42 -11.34 60.44 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.649 1.18 . . . . 0.0 112.866 176.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.2 m -118.53 -14.84 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 119.715 1.143 . . . . 0.0 112.822 -176.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.1 p -77.56 -11.12 59.82 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.968 0.804 . . . . 0.0 112.061 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -47.15 156.29 0.24 Allowed 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 129.675 3.19 . . . . 0.0 111.138 169.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -64.04 -38.43 91.03 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.828 1.651 . . . . 0.0 109.872 171.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.516 ' HB ' HG13 ' A' ' 75' ' ' VAL . 2.1 mt -122.35 133.98 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 173.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -142.96 111.64 6.35 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 103.555 -2.757 . . . . 0.0 103.555 167.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -138.99 170.6 15.69 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 173.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.8 t70 -136.62 108.35 7.03 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 169.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.418 ' CE3' HG21 ' A' ' 77' ' ' ILE . 49.2 m0 -81.85 70.57 8.78 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -49.49 13.86 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 131.488 3.915 . . . . 0.0 115.916 170.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -60.02 124.69 20.98 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 126.075 1.75 . . . . 0.0 112.622 -168.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 48.08 -161.44 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.344 2.258 . . . . 0.0 114.915 169.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -156.48 77.95 4.18 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 128.371 2.668 . . . . 0.0 107.448 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.71 -15.03 15.48 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.495 2.13 . . . . 0.0 112.99 -172.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.3 t0 27.56 -101.7 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.565 2.346 . . . . 0.0 113.092 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.51 43.43 1.28 Allowed Glycine 0 CA--C 1.532 1.129 0 C-N-CA 126.734 2.111 . . . . 0.0 109.431 171.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -67.5 -176.73 0.64 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.881 1.672 . . . . 0.0 112.614 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.5 m -59.54 154.12 18.12 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.884 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.4 mt -56.67 -30.33 63.28 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 122.957 0.503 . . . . 0.0 111.038 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.93 -40.66 96.24 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 118.677 -0.678 . . . . 0.0 110.926 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 42.0 t -72.81 -41.35 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 117.803 -1.094 . . . . 0.0 108.867 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -49.37 -51.68 33.27 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.717 1.144 . . . . 0.0 110.921 169.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -59.45 -45.14 92.42 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.799 0.727 . . . . 0.0 111.37 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 94.5 m -69.78 -45.76 67.27 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -171.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.6 t -69.6 -42.16 80.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 -172.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.9 ttp180 -48.09 -53.63 15.9 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 124.853 1.261 . . . . 0.0 110.612 169.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.86 -40.58 99.42 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 119.296 0.953 . . . . 0.0 112.042 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -65.37 -38.51 90.27 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.321 -1.105 . . . . 0.0 111.066 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 48.5 t -62.69 -41.65 93.1 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -38.33 84.59 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 119.779 1.172 . . . . 0.0 111.661 -173.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -68.82 -42.77 76.77 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 119.101 -0.475 . . . . 0.0 109.762 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.2 mtt180 -65.93 -40.3 91.29 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.187 0.903 . . . . 0.0 111.156 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.456 HG12 HD12 ' A' ' 127' ' ' ILE . 47.4 t -54.82 -51.7 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 172.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -64.84 -33.55 76.26 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 122.099 -0.375 . . . . 0.0 111.822 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -65.08 -46.06 82.67 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 123.002 0.521 . . . . 0.0 111.269 174.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.433 HD23 HG13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -59.49 -45.63 91.14 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.456 HD12 HG12 ' A' ' 123' ' ' VAL . 6.7 mt -58.47 -39.94 76.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.32 -26.65 68.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.924 0.784 . . . . 0.0 112.488 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -72.52 -46.32 55.15 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 119.163 0.892 . . . . 0.0 111.783 173.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.8 pt -103.67 -33.89 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 117.75 2.5 . . . . 0.0 117.75 -168.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 C--O 1.255 1.392 0 CA-C-N 119.529 1.059 . . . . 0.0 111.066 -174.747 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.927 0 CA-C-O 118.868 -0.587 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.449 ' HE2' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -66.11 137.63 57.18 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.641 1.564 . . . . 0.0 107.59 175.328 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -105.99 140.93 38.23 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -171.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.699 HG13 HG12 ' A' ' 75' ' ' VAL . 12.8 t -118.31 151.73 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.5 tpp -137.94 141.55 40.55 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 177.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -116.54 150.29 38.2 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 172.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.499 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 6.6 t -134.18 137.77 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 120.491 1.496 . . . . 0.0 107.118 -170.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 t -126.47 156.39 40.76 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.522 0.729 . . . . 0.0 110.601 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -135.84 33.02 2.94 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.176 1.39 . . . . 0.0 109.474 170.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.57 -178.77 6.74 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 127.95 2.5 . . . . 0.0 106.186 -175.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -48.51 124.06 7.6 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 170.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.0 m -33.7 -30.06 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 129.592 3.157 . . . . 0.0 117.711 -174.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.3 m -38.87 -61.0 0.78 Allowed 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 126.714 2.006 . . . . 0.0 114.69 -169.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.259 39.4 ptt180 -63.17 -46.37 87.47 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.229 1.377 . . . . 0.0 113.161 -169.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.63 -28.53 19.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 118.776 0.716 . . . . 0.0 111.368 -172.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.461 ' HG3' HE21 ' A' ' 60' ' ' GLN . 39.0 tt0 -74.0 -27.95 61.21 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 120.828 -1.17 . . . . 0.0 110.605 171.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.461 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.8 tpt -64.49 -40.67 96.09 Favored 'General case' 0 CA--C 1.51 -0.586 0 O-C-N 120.844 -1.16 . . . . 0.0 108.37 169.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.48 -38.26 83.71 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -61.26 -39.96 92.29 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 118.63 -0.7 . . . . 0.0 111.156 169.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.07 -44.91 86.69 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 120.448 1.476 . . . . 0.0 112.392 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -65.32 -39.98 93.14 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.43 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -72.06 -37.09 69.72 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 118.951 0.796 . . . . 0.0 111.221 -173.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.42 ' HA ' HG21 ' A' ' 32' ' ' VAL . 46.5 pttt -68.97 -28.61 66.78 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.076 1.307 . . . . 0.0 111.74 174.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.8 m -74.76 -51.73 13.38 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.845 1.658 . . . . 0.0 110.35 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.4 mt -88.22 -26.51 22.33 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.727 1.211 . . . . 0.0 112.057 -169.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.65 17.21 50.5 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.796 2.141 . . . . 0.0 111.454 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.35 120.8 9.98 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.909 1.284 . . . . 0.0 109.954 -172.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.53 11.42 84.38 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 119.505 -0.608 . . . . 0.0 113.439 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.449 ' O ' ' HE2' ' A' ' 2' ' ' LYS . 74.6 mmtt -127.11 -26.95 3.04 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 125.346 1.459 . . . . 0.0 110.535 -176.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.5 HD12 HG22 ' A' ' 32' ' ' VAL . 6.6 pt -141.37 161.09 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 124.531 1.132 . . . . 0.0 108.66 172.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.6 144.55 27.78 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 167.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.5 HG22 HD12 ' A' ' 30' ' ' ILE . 2.1 t -135.42 142.56 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 118.93 0.786 . . . . 0.0 111.333 -168.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.26 159.5 40.08 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.097 -174.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.4 p -136.88 162.65 32.67 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 121.433 1.924 . . . . 0.0 110.106 169.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.3 p -151.22 165.39 34.08 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.761 1.164 . . . . 0.0 111.262 -177.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.34 0 N-CA-C 105.51 -3.036 . . . . 0.0 105.51 -172.895 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.7 t . . . . . 0 C--O 1.234 0.244 0 CA-C-O 121.957 0.884 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -127.07 115.37 21.89 Favored Pre-proline 0 N--CA 1.448 -0.53 0 C-N-CA 125.332 1.453 . . . . 0.0 107.683 -173.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -69.16 -24.96 31.82 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.429 2.753 . . . . 0.0 113.257 -168.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.5 m -62.75 -39.49 94.29 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-N 119.94 1.245 . . . . 0.0 108.415 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.72 98.78 Favored 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.14 -48.92 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 118.297 -0.858 . . . . 0.0 109.544 177.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.75 -43.64 85.56 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 119.08 0.855 . . . . 0.0 110.627 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -20.21 65.17 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.483 0.713 . . . . 0.0 110.635 -175.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.461 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -96.38 -28.43 14.47 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.355 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.25 -29.23 70.6 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.755 1.222 . . . . 0.0 110.376 170.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -56.6 -23.18 39.0 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.855 0.862 . . . . 0.0 112.301 170.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.0 m -126.71 13.7 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 125.963 1.705 . . . . 0.0 111.166 -175.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.58 37.93 78.2 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 119.16 -0.8 . . . . 0.0 113.209 174.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.4 mt -125.76 154.61 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.708 1.603 . . . . 0.0 107.403 176.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -126.8 143.92 51.12 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.702 1.601 . . . . 0.0 108.639 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.3 pt -138.07 9.06 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 125.551 1.54 . . . . 0.0 110.915 174.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.47 151.39 45.17 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.624 1.17 . . . . 0.0 107.944 168.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.04 -3.24 14.24 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.585 -1.119 . . . . 0.0 113.474 -175.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.461 HE21 ' HG3' ' A' ' 16' ' ' GLN . 26.4 mt-30 -69.46 -175.96 0.91 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.498 1.649 . . . . 0.0 109.956 169.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.4 p -50.46 164.54 0.12 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.887 2.475 . . . . 0.0 114.766 -173.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.0 p -156.91 39.99 0.32 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.306 1.842 . . . . 0.0 109.769 177.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -141.03 150.01 57.72 Favored Pre-proline 0 CA--C 1.542 0.67 0 O-C-N 121.354 -0.841 . . . . 0.0 111.683 -169.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.38 165.53 23.16 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.892 3.061 . . . . 0.0 112.518 -174.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.5 tt -57.8 -39.32 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 125.073 1.349 . . . . 0.0 110.843 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.92 -18.13 61.43 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -170.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.23 -22.23 58.06 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 118.858 -0.591 . . . . 0.0 111.446 169.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -92.14 168.38 11.4 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.875 0.845 . . . . 0.0 110.64 -178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -142.34 94.6 2.68 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 103.336 -2.839 . . . . 0.0 103.336 -174.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.481 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -55.31 -28.01 50.77 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -176.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.36 -28.35 19.11 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.995 0.918 . . . . 0.0 112.415 175.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -70.74 -22.63 62.39 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.16 0.436 . . . . 0.0 112.086 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -106.07 -178.7 3.72 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 129.352 3.061 . . . . 0.0 108.286 -174.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -131.74 -2.44 3.74 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 171.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.699 HG12 HG13 ' A' ' 4' ' ' VAL . 23.8 t -141.71 126.92 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 -177.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.8 m -131.28 135.45 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 O-C-N 120.868 -1.145 . . . . 0.0 108.246 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.7 mm -134.61 80.69 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -169.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.499 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 17.8 t -68.41 164.51 20.8 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.818 177.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -140.75 55.46 1.58 Allowed 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 169.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 81.8 m -106.12 8.9 32.39 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.854 1.262 . . . . 0.0 109.705 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.7 31.5 10.14 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-O 119.209 -0.773 . . . . 0.0 111.639 169.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.415 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 8.8 p 46.59 -10.1 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 130.391 3.476 . . . . 0.0 119.244 -174.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.82 -13.87 82.65 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 120.133 1.333 . . . . 0.0 113.065 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 p -58.9 151.07 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 122.817 1.294 . . . . 0.0 109.202 172.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -124.39 81.28 1.92 Allowed 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 103.741 -2.689 . . . . 0.0 103.741 178.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.8 mt -62.65 150.09 87.38 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.28 158.69 11.67 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.659 2.239 . . . . 0.0 113.316 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.01 -36.3 53.55 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.964 2.443 . . . . 0.0 116.716 -169.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.2 pm0 -67.34 -25.82 66.19 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.323 -0.861 . . . . 0.0 112.133 -176.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.481 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 58.3 m95 -70.44 -9.73 57.23 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.93 1.292 . . . . 0.0 112.088 174.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.2 t -96.62 -29.59 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 119.225 0.921 . . . . 0.0 109.438 175.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.7 p -86.2 56.71 4.11 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.68 1.192 . . . . 0.0 110.502 -174.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -130.47 156.32 44.97 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 128.762 2.825 . . . . 0.0 107.96 -169.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -65.71 -39.23 91.0 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 125.752 1.621 . . . . 0.0 109.005 169.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.551 ' HB ' HG13 ' A' ' 75' ' ' VAL . 25.9 mm -128.7 137.17 58.02 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-O 121.113 0.482 . . . . 0.0 110.294 170.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -135.14 110.03 8.74 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 100.833 -3.765 . . . . 0.0 100.833 166.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.91 165.04 24.79 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 176.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.8 t70 -139.52 105.45 5.18 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 170.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -77.52 87.25 3.85 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 125.223 1.409 . . . . 0.0 107.475 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -65.75 23.07 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 126.613 1.965 . . . . 0.0 114.045 -175.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.16 176.39 0.6 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.628 1.971 . . . . 0.0 111.763 -170.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -54.3 162.44 1.07 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 123.444 1.593 . . . . 0.0 113.582 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -117.68 105.97 46.97 Favored Pre-proline 0 C--N 1.316 -0.866 0 C-N-CA 126.376 1.87 . . . . 0.0 108.396 -170.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.76 16.84 1.23 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.475 2.117 . . . . 0.0 112.181 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -24.84 85.02 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 129.584 3.154 . . . . 0.0 115.441 174.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 44.8 32.03 2.91 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 124.633 1.111 . . . . 0.0 113.959 -174.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -79.72 -179.7 7.05 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 122.492 1.139 . . . . 0.0 112.813 -169.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.1 p -61.07 160.04 10.72 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 113.55 -1.659 . . . . 0.0 109.602 172.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.6 mt -58.03 -30.27 66.0 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 122.667 0.387 . . . . 0.0 110.597 175.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -64.24 -40.0 95.11 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 118.532 -0.746 . . . . 0.0 111.157 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.0 t -72.61 -40.15 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 118.923 -1.111 . . . . 0.0 109.513 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -50.27 -50.68 49.5 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 119.45 1.023 . . . . 0.0 110.524 169.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -60.91 -44.99 96.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.549 0.739 . . . . 0.0 111.31 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.5 m -69.5 -45.59 68.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -172.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 49.3 t -65.75 -46.84 87.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -171.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -42.74 -56.47 3.17 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 125.061 1.344 . . . . 0.0 111.041 169.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.84 -40.93 98.89 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 119.79 1.177 . . . . 0.0 111.908 -175.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -67.55 -38.24 83.86 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 121.298 -1.119 . . . . 0.0 110.941 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.3 t -61.34 -43.0 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 172.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -39.31 87.19 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 119.923 1.238 . . . . 0.0 111.827 -172.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -68.99 -42.03 77.03 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.749 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.7 mtt180 -65.61 -41.7 92.42 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.282 0.946 . . . . 0.0 111.197 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.463 HG12 HD12 ' A' ' 127' ' ' ILE . 47.2 t -54.83 -51.58 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -65.94 -33.73 76.5 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 122.134 -0.354 . . . . 0.0 111.826 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -63.33 -48.71 76.88 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 123.1 0.56 . . . . 0.0 110.345 174.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.404 HD23 HG13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -58.85 -45.7 89.48 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 109.614 -0.514 . . . . 0.0 109.614 177.368 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.463 HD12 HG12 ' A' ' 123' ' ' VAL . 9.3 mt -57.48 -43.01 82.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 123.599 0.759 . . . . 0.0 109.537 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.16 -26.64 68.62 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -71.17 -51.93 22.06 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.57 0.623 . . . . 0.0 110.446 173.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.427 HD12 HG21 ' A' ' 30' ' ' ILE . 1.3 pt -87.65 -46.1 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 -169.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 63.0 m . . . . . 0 C--O 1.254 1.334 0 CA-C-N 119.057 0.844 . . . . 0.0 110.678 -170.233 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 tpt . . . . . 0 N--CA 1.5 2.049 0 CA-C-O 118.33 -0.843 . . . . 0.0 109.659 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.464 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -57.75 118.62 5.48 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 120.727 1.603 . . . . 0.0 110.074 -169.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -87.89 137.61 32.18 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -171.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.786 HG13 HG12 ' A' ' 75' ' ' VAL . 11.2 t -117.9 154.05 19.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 124.398 1.079 . . . . 0.0 108.364 174.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 40.9 tpp -137.63 139.68 40.44 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -120.18 114.61 22.2 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.416 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 8.3 t -101.68 138.81 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 119.621 1.1 . . . . 0.0 108.361 -169.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -125.11 164.77 19.51 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 122.009 0.909 . . . . 0.0 111.808 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -150.27 156.0 40.75 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 129.648 3.179 . . . . 0.0 103.842 169.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 58.1 -153.66 0.37 Allowed 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -169.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.475 HD21 ' CD2' ' A' ' 43' ' ' HIS . 29.5 t-20 -59.13 123.63 17.28 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.317 0.647 . . . . 0.0 110.114 -169.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.2 m -49.84 -27.93 5.76 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.675 1.99 . . . . 0.0 113.98 -178.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 26.3 p -48.55 -48.01 38.89 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 117.954 -1.022 . . . . 0.0 112.98 -169.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -60.3 -45.99 91.43 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.987 1.267 . . . . 0.0 112.721 -170.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.485 ' HB3' HD13 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -93.8 -28.27 15.99 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.077 0.853 . . . . 0.0 111.595 -174.205 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -68.87 -33.0 73.07 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.045 -1.034 . . . . 0.0 109.769 171.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.474 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.7 tpt -65.68 -40.15 92.08 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 121.18 -0.95 . . . . 0.0 109.63 169.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.93 -40.67 89.72 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -60.52 -42.45 96.46 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.7 169.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.45 -45.21 80.33 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 120.598 1.545 . . . . 0.0 111.514 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -63.4 -40.34 96.94 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.504 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -71.34 -36.13 71.42 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 119.313 0.961 . . . . 0.0 111.517 -174.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -73.32 -22.91 60.22 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 120.757 1.617 . . . . 0.0 111.921 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 m -77.02 -50.85 12.2 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.818 1.647 . . . . 0.0 110.285 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.1 mt -86.32 -27.39 24.34 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.882 1.273 . . . . 0.0 112.039 -169.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.07 13.0 55.88 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 126.918 2.199 . . . . 0.0 111.523 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.98 121.85 12.23 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.041 1.336 . . . . 0.0 109.861 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.81 8.82 87.22 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-O 119.769 -0.462 . . . . 0.0 113.462 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -124.01 -31.5 3.37 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.42 1.488 . . . . 0.0 109.068 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.7 pt -142.74 176.46 3.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 125.527 1.531 . . . . 0.0 109.508 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -118.25 149.06 41.76 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 168.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.504 HG11 ' HB3' ' A' ' 22' ' ' ALA . 1.9 t -137.82 143.24 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 123.172 0.589 . . . . 0.0 111.412 -167.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.9 m -150.77 161.44 42.65 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.943 1.297 . . . . 0.0 109.745 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.468 ' H ' HG21 ' A' ' 61' ' ' THR . 61.8 p -130.24 163.33 26.97 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.907 1.23 . . . . 0.0 110.241 169.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.6 p -155.45 168.26 27.68 Favored 'General case' 0 N--CA 1.463 0.193 0 O-C-N 121.112 -0.992 . . . . 0.0 110.806 178.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.861 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -177.65 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 CA--C 1.532 0.279 0 CA-C-O 122.066 0.936 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.475 ' CD2' HD21 ' A' ' 11' ' ' ASN . 86.5 t60 -125.7 116.53 24.62 Favored Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -175.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -66.48 -26.09 47.73 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.657 2.905 . . . . 0.0 112.692 -169.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.7 m -60.63 -36.16 77.95 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.15 0.886 . . . . 0.0 109.122 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.427 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . . . -65.38 -45.13 85.27 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -58.69 -47.41 88.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.73 -43.16 98.24 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.923 0.783 . . . . 0.0 111.032 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.4 mmt -61.81 -22.51 65.53 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.367 1.067 . . . . 0.0 112.866 177.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.474 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.3 OUTLIER -99.53 -31.34 11.67 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -177.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -63.94 -35.92 82.25 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.437 -0.79 . . . . 0.0 109.786 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.62 6.82 3.47 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.186 0.595 . . . . 0.0 112.542 175.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.6 t -113.32 -43.03 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 126.355 1.862 . . . . 0.0 108.71 169.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.73 26.86 1.86 Allowed Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.088 1.328 . . . . 0.0 111.894 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.5 mt -123.62 158.92 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 125.952 1.701 . . . . 0.0 106.939 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -137.91 125.94 22.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -176.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.6 pt -133.76 5.42 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.326 0 C-N-CA 124.392 1.077 . . . . 0.0 111.404 -171.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.16 143.91 56.32 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.764 1.225 . . . . 0.0 109.376 174.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.06 4.57 11.82 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 117.591 -1.672 . . . . 0.0 113.894 -177.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -53.55 -57.43 10.75 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-N 120.044 1.922 . . . . 0.0 111.785 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.468 HG21 ' H ' ' A' ' 34' ' ' SER . 2.9 p -151.43 162.39 41.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.032 -167.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.1 m -167.13 42.47 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.089 1.755 . . . . 0.0 109.192 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -137.63 150.04 66.88 Favored Pre-proline 0 N--CA 1.475 0.802 0 O-C-N 120.885 -1.135 . . . . 0.0 112.629 -169.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -83.72 162.89 14.27 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 124.213 3.275 . . . . 0.0 112.342 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.2 tt -59.21 -37.69 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.253 1.421 . . . . 0.0 111.351 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.68 -22.71 62.45 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 122.969 0.507 . . . . 0.0 111.93 -171.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -21.19 60.09 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 118.653 -0.689 . . . . 0.0 111.548 172.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -92.34 167.88 11.69 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.865 0.84 . . . . 0.0 111.272 -174.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.44 82.18 1.77 Allowed 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.648 1.579 . . . . 0.0 108.288 -170.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.477 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -52.31 -27.91 17.1 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.811 1.244 . . . . 0.0 113.712 -175.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -54.25 -33.75 59.21 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.459 0.475 . . . . 0.0 111.048 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -71.32 -15.73 62.41 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -106.78 160.77 15.24 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.546 1.938 . . . . 0.0 109.541 -173.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -101.35 -18.76 15.91 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 118.931 -0.557 . . . . 0.0 111.977 -177.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.786 HG12 HG13 ' A' ' 4' ' ' VAL . 30.8 t -147.77 129.85 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 120.716 1.598 . . . . 0.0 106.949 -170.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -125.65 135.08 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.2 mm -133.65 85.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 -177.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.416 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 12.0 t -69.28 160.17 31.73 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.175 -0.953 . . . . 0.0 108.503 171.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.485 HD13 ' HB3' ' A' ' 15' ' ' SER . 6.6 mp -129.46 21.41 5.61 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 169.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.6 m -69.27 -8.88 50.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.29 1.036 . . . . 0.0 112.237 -175.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 108.11 23.22 6.81 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 119.15 0.887 . . . . 0.0 111.742 174.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.502 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 2.0 t 55.24 173.63 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.176 2.191 . . . . 0.0 112.685 -169.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.03 16.66 33.65 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.851 1.215 . . . . 0.0 114.423 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.421 HG12 ' H ' ' A' ' 84' ' ' VAL . 1.7 p -72.32 136.42 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 125.155 1.382 . . . . 0.0 108.021 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -79.1 61.52 3.27 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.527 1.131 . . . . 0.0 108.547 173.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.1 mt -59.52 148.31 74.45 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 172.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -54.98 155.38 18.69 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.166 1.911 . . . . 0.0 111.919 174.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.81 -1.19 8.1 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.003 2.469 . . . . 0.0 115.853 -169.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -84.62 -24.93 28.89 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.788 1.176 . . . . 0.0 112.155 169.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.477 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 24.7 m95 -77.21 24.31 0.18 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.642 1.177 . . . . 0.0 112.164 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.0 m -127.92 -2.74 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 125.489 1.516 . . . . 0.0 112.779 169.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.8 p -84.37 -12.32 54.72 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 120.773 1.624 . . . . 0.0 113.516 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.437 ' H ' ' CD ' ' A' ' 93' ' ' GLN . 19.4 mp0 -62.16 160.78 12.19 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 129.808 3.243 . . . . 0.0 110.892 -176.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -64.62 -41.97 95.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.796 1.639 . . . . 0.0 109.137 169.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.55 ' HB ' HG13 ' A' ' 75' ' ' VAL . 33.1 mm -119.15 135.69 58.73 Favored 'Isoleucine or valine' 0 C--N 1.341 0.199 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 170.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -135.45 110.95 9.14 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 100.977 -3.712 . . . . 0.0 100.977 166.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.11 164.67 26.82 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.0 t70 -137.1 99.97 4.15 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 122.118 0.961 . . . . 0.0 108.542 172.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -75.4 73.45 2.46 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.344 1.458 . . . . 0.0 107.811 174.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -54.92 44.3 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 131.278 3.831 . . . . 0.0 114.402 172.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -77.85 -174.15 3.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.337 1.455 . . . . 0.0 111.223 -169.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -50.27 160.94 0.33 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.611 1.565 . . . . 0.0 111.28 176.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -130.1 85.0 58.59 Favored Pre-proline 0 C--N 1.322 -0.59 0 C-N-CA 126.719 2.008 . . . . 0.0 108.364 -169.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.64 67.33 8.43 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 124.9 3.734 . . . . 0.0 111.472 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -64.1 81.05 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.483 1.913 . . . . 0.0 110.874 173.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 59.22 37.42 91.77 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.775 0.702 . . . . 0.0 112.441 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -64.96 170.06 4.69 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -170.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.8 m -68.13 151.89 46.33 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 113.301 -1.772 . . . . 0.0 108.293 168.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.3 mt -57.56 -32.96 67.64 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.91 -0.494 . . . . 0.0 111.808 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.07 -38.63 86.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.533 0.606 . . . . 0.0 111.182 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.595 ' O ' HG23 ' A' ' 115' ' ' VAL . 57.8 t -75.18 -40.58 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 116.456 -1.735 . . . . 0.0 108.88 178.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -50.47 -48.49 56.67 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 121.141 1.792 . . . . 0.0 110.636 170.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -58.84 -43.18 90.66 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.535 0.607 . . . . 0.0 110.81 176.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.8 m -69.22 -43.6 73.77 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -174.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 111' ' ' VAL . 25.8 t -66.28 -46.53 86.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -173.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -47.79 -56.16 8.03 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.016 1.326 . . . . 0.0 110.89 170.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.99 -40.65 99.56 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 119.795 1.179 . . . . 0.0 111.68 -175.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -64.64 -40.11 94.88 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.321 -1.105 . . . . 0.0 111.428 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.0 t -61.08 -42.09 91.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 174.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.06 -37.95 78.26 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 119.904 1.229 . . . . 0.0 111.448 -175.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -70.0 -42.3 73.22 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.136 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -64.24 -42.83 96.35 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 119.252 0.933 . . . . 0.0 110.14 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.5 t -54.36 -53.71 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 123.901 0.88 . . . . 0.0 109.385 173.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -65.31 -33.09 75.16 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 122.283 -0.261 . . . . 0.0 111.541 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -62.15 -49.17 76.9 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.03 0.532 . . . . 0.0 110.787 173.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.42 -46.05 83.93 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.987 0.515 . . . . 0.0 110.046 177.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.3 mt -57.92 -44.0 85.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 124.395 1.078 . . . . 0.0 110.272 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.07 -28.23 67.63 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.98 0.809 . . . . 0.0 112.151 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -75.95 -44.71 38.68 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.379 0.536 . . . . 0.0 111.605 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.9 pt -94.37 -42.36 12.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -169.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 C--O 1.252 1.232 0 CA-C-N 119.168 0.895 . . . . 0.0 109.929 -172.808 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.0 mmm . . . . . 0 N--CA 1.502 2.142 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.765 ' HG2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -57.54 134.9 56.51 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.503 1.047 . . . . 0.0 108.891 169.871 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 53.9 mtpt -101.07 140.97 34.63 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.758 1.223 . . . . 0.0 107.757 -169.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.684 HG13 HG12 ' A' ' 75' ' ' VAL . 14.9 t -129.02 152.18 36.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -175.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 58.6 tpp -137.73 145.29 42.32 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -121.81 150.2 42.23 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 171.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 6.2 t -132.46 134.73 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 120.333 -1.479 . . . . 0.0 108.219 -171.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -131.98 100.09 4.95 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.258 0.935 . . . . 0.0 111.626 -170.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -79.17 -30.76 43.69 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -129.88 141.53 50.8 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 176.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 29.06 101.78 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 129.972 3.309 . . . . 0.0 113.619 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.4 m -33.28 -33.64 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.212 0 C-N-CA 128.671 2.788 . . . . 0.0 115.327 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.4 t -36.52 -64.16 0.35 Allowed 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 125.884 1.673 . . . . 0.0 114.067 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.298 36.1 ptt180 -60.15 -43.66 95.59 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 120.333 1.424 . . . . 0.0 114.127 -168.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.604 ' HB3' HD13 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -95.22 -29.0 14.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 119.374 0.988 . . . . 0.0 112.092 -172.707 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.643 HE22 HG12 ' A' ' 42' ' ' VAL . 50.0 tt0 -72.09 -25.45 61.76 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.79 -1.194 . . . . 0.0 109.924 169.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.47 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.0 tpt -68.97 -42.77 76.15 Favored 'General case' 0 CA--C 1.512 -0.514 0 O-C-N 120.812 -1.18 . . . . 0.0 108.508 168.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.95 -39.41 81.59 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -60.43 -41.41 93.92 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.19 1.396 . . . . 0.0 111.4 169.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.74 -40.36 58.53 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 120.651 1.569 . . . . 0.0 112.895 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -69.96 -38.04 76.0 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 118.527 1.164 . . . . 0.0 109.279 172.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.51 -40.88 66.49 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 120.434 1.47 . . . . 0.0 111.145 -175.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -61.35 -32.27 72.16 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.325 1.42 . . . . 0.0 110.842 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 m -75.39 -51.13 13.85 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.262 2.225 . . . . 0.0 111.131 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.1 mt -88.19 -26.22 22.52 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.494 1.118 . . . . 0.0 111.631 -169.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.69 12.71 62.79 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 126.542 2.02 . . . . 0.0 111.248 177.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.16 121.34 10.47 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.549 1.139 . . . . 0.0 110.241 -173.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.03 9.24 86.87 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 119.864 -0.409 . . . . 0.0 113.325 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -123.82 -31.73 3.39 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 125.222 1.409 . . . . 0.0 109.511 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.765 HG22 ' HG2' ' A' ' 2' ' ' LYS . 19.0 pt -142.6 168.39 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.539 1.536 . . . . 0.0 109.954 178.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.35 139.48 46.71 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 168.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.3 t -127.54 146.11 33.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 125.279 1.432 . . . . 0.0 111.207 -170.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.33 160.39 43.76 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.052 1.741 . . . . 0.0 109.725 -174.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -132.99 165.49 24.6 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.334 1.424 . . . . 0.0 109.227 170.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.1 p -158.78 168.8 25.88 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.796 -0.565 . . . . 0.0 111.299 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.406 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 -175.65 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.643 HG12 HE22 ' A' ' 16' ' ' GLN . 2.8 m . . . . . 0 CA--C 1.535 0.384 0 CA-C-O 121.87 0.843 . . . . 0.0 111.486 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -133.07 117.67 14.9 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -174.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -66.03 -30.18 47.95 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.319 2.679 . . . . 0.0 112.432 -169.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.0 m -61.89 -37.04 83.12 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 177.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.45 -44.52 86.98 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.98 -47.8 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.32 -43.04 99.54 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-N 118.938 0.79 . . . . 0.0 111.141 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.7 mmt -61.94 -23.75 66.56 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.553 -0.736 . . . . 0.0 111.828 177.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.47 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.3 OUTLIER -94.98 -27.93 15.4 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.705 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.55 -29.4 70.43 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.808 1.243 . . . . 0.0 110.693 171.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -56.2 -24.71 43.58 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.641 0.776 . . . . 0.0 112.487 170.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -126.23 16.3 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.712 0 C-N-CA 125.527 1.531 . . . . 0.0 111.087 -172.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.79 35.69 66.21 Favored Glycine 0 CA--C 1.529 0.952 0 O-C-N 121.516 -0.74 . . . . 0.0 113.395 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.9 mt -125.1 155.85 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -134.42 144.69 48.31 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 170.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.6 pt -137.56 11.17 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 126.513 1.925 . . . . 0.0 110.477 -175.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.2 t -65.69 151.44 46.56 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.529 -0.732 . . . . 0.0 109.496 170.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.98 -0.02 1.31 Allowed Glycine 0 CA--C 1.534 1.223 0 CA-C-O 117.691 -1.616 . . . . 0.0 115.084 -177.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -57.78 -55.47 34.4 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 120.162 1.981 . . . . 0.0 112.633 -171.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.98 161.22 42.76 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.802 -168.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.8 p -170.48 27.02 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.228 0.611 . . . . 0.0 112.288 -171.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -140.48 151.28 63.43 Favored Pre-proline 0 N--CA 1.476 0.847 0 O-C-N 120.818 -1.177 . . . . 0.0 112.828 -169.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.35 160.78 29.04 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 124.062 3.175 . . . . 0.0 112.791 -173.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.2 tt -59.17 -36.78 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.141 1.376 . . . . 0.0 111.671 -176.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -70.45 -22.23 62.72 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.042 0.537 . . . . 0.0 112.27 -172.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.61 -17.61 59.08 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 119.033 -0.508 . . . . 0.0 111.711 171.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -95.89 173.53 7.4 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.146 0.978 . . . . 0.0 110.129 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.83 101.7 3.21 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 125.137 1.375 . . . . 0.0 108.193 -177.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.47 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -49.45 -24.94 2.25 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.801 0.84 . . . . 0.0 113.156 171.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -51.4 -21.53 2.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.044 0.938 . . . . 0.0 112.218 172.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -115.66 17.05 16.37 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.617 1.167 . . . . 0.0 114.009 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.45 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 29.4 m-85 -133.04 112.47 11.83 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 119.968 1.258 . . . . 0.0 108.414 170.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -62.99 -14.62 50.06 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -169.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.684 HG12 HG13 ' A' ' 4' ' ' VAL . 7.9 t -145.31 123.05 4.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.455 -2.424 . . . . 0.0 104.455 -169.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.86 133.34 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 O-C-N 121.085 -1.009 . . . . 0.0 108.406 -174.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.8 mm -130.17 92.45 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -168.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.48 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 28.8 t -70.08 161.54 29.95 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.549 175.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.604 HD13 ' HB3' ' A' ' 15' ' ' SER . 5.7 mp -142.2 52.9 1.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 169.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 59.9 m -114.4 18.35 16.93 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.616 1.566 . . . . 0.0 109.577 -174.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.72 25.3 46.67 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-O 119.356 -0.691 . . . . 0.0 111.999 172.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.422 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 5.7 t 44.37 39.6 3.21 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.947 1.699 . . . . 0.0 112.595 -176.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.85 45.07 0.51 Allowed Glycine 0 C--N 1.34 0.797 0 C-N-CA 123.586 0.612 . . . . 0.0 111.86 -169.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.0 p -124.13 -0.8 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -173.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.8 t30 47.16 60.71 3.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.689 1.596 . . . . 0.0 109.433 175.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.2 mt -56.46 148.09 46.04 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.143 -175.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -55.27 156.01 18.16 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.701 2.267 . . . . 0.0 113.11 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -54.89 -30.11 66.92 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.756 2.304 . . . . 0.0 116.734 -170.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -65.88 -25.03 66.99 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 121.009 -1.057 . . . . 0.0 111.478 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.47 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 72.3 m95 -73.35 -4.46 33.51 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 117.669 -1.158 . . . . 0.0 113.133 178.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.4 m -118.58 -5.48 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 120.757 1.617 . . . . 0.0 113.41 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.3 p -88.73 -17.99 28.75 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.761 0.824 . . . . 0.0 112.416 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -52.59 161.82 0.65 Allowed 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 129.37 3.068 . . . . 0.0 113.906 175.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -64.35 -39.45 93.9 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.493 1.517 . . . . 0.0 108.901 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.508 ' HB ' HG13 ' A' ' 75' ' ' VAL . 33.2 mm -124.95 138.54 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 169.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -137.84 113.89 9.97 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 100.284 -3.969 . . . . 0.0 100.284 167.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -136.09 171.05 15.04 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 172.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.422 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.0 t70 -140.1 122.77 16.33 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 169.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -101.36 77.2 1.76 Allowed 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.4 ' CD ' ' H ' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -56.24 16.8 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 129.638 3.175 . . . . 0.0 115.06 179.21 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -61.22 126.28 26.77 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.673 1.589 . . . . 0.0 111.343 -168.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 52.11 -155.44 0.17 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.3 1.44 . . . . 0.0 112.564 169.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -163.7 57.37 0.61 Allowed Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 127.509 2.324 . . . . 0.0 109.842 -173.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -79.2 59.02 7.22 Favored 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 122.752 2.301 . . . . 0.0 112.251 -169.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -51.46 -46.87 63.22 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.078 -1.014 . . . . 0.0 110.726 176.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -173.23 44.38 0.16 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.714 1.626 . . . . 0.0 110.323 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -68.54 176.42 2.92 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 122.543 1.163 . . . . 0.0 112.633 -177.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.2 m -57.83 152.51 15.69 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 113.956 -1.475 . . . . 0.0 109.857 171.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.3 mt -57.58 -31.59 66.32 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 122.727 0.411 . . . . 0.0 111.228 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.72 -39.64 92.22 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 118.427 0.558 . . . . 0.0 110.968 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 66.1 t -70.53 -45.54 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 117.304 -1.332 . . . . 0.0 108.507 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -48.95 -47.95 43.4 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 120.401 1.455 . . . . 0.0 110.93 172.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -59.81 -45.78 91.29 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.539 0.736 . . . . 0.0 111.303 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 94.2 m -68.36 -45.76 71.95 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -174.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.9 t -65.03 -47.58 87.4 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -173.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -44.65 -55.05 5.56 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 125.225 1.41 . . . . 0.0 110.89 169.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.44 -40.85 99.28 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 119.43 1.014 . . . . 0.0 111.737 -177.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -64.93 -38.46 91.03 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 121.376 -1.073 . . . . 0.0 110.86 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.0 t -62.72 -42.19 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -38.72 84.03 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 120.152 1.342 . . . . 0.0 111.535 -174.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -69.11 -41.31 77.58 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 119.087 -0.482 . . . . 0.0 109.825 177.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -67.24 -38.94 86.0 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 119.299 0.954 . . . . 0.0 111.135 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.8 t -53.85 -54.97 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 169.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -64.86 -32.46 74.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 121.99 -0.444 . . . . 0.0 111.895 -174.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -63.66 -47.41 81.41 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.405 0.682 . . . . 0.0 110.713 172.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -46.6 83.52 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 122.9 0.48 . . . . 0.0 110.062 176.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.0 mt -58.23 -43.18 85.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 124.292 1.037 . . . . 0.0 109.606 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.65 -30.22 70.58 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.101 0.864 . . . . 0.0 111.694 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -72.18 -42.6 65.69 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.635 172.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.1 pt -103.73 -44.8 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 118.902 2.927 . . . . 0.0 118.902 -168.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.3 m . . . . . 0 C--O 1.254 1.299 0 CA-C-O 116.582 -1.675 . . . . 0.0 111.838 -169.084 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 tpt . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.501 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -61.63 121.47 12.85 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 121.227 1.83 . . . . 0.0 108.43 -177.149 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.44 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 34.2 mtpt -92.88 134.4 35.12 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -169.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.876 HG13 HG12 ' A' ' 75' ' ' VAL . 19.1 t -120.7 154.33 24.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -174.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 63.2 tpp -139.15 144.84 38.79 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -126.78 125.97 42.62 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 174.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.4 t -118.07 130.68 72.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -169.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 t -118.16 161.01 20.58 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.574 1.149 . . . . 0.0 111.207 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -141.97 34.54 1.56 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.101 1.36 . . . . 0.0 109.483 172.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.1 mmt-85 -141.9 168.13 20.5 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.235 1.414 . . . . 0.0 109.247 -175.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -46.05 121.8 3.48 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.317 1.447 . . . . 0.0 108.458 170.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.5 m -40.44 98.04 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.317 2.247 . . . . 0.0 114.098 -169.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.5 t -158.35 -84.85 0.04 OUTLIER 'General case' 0 C--N 1.343 0.317 0 CA-C-O 118.369 -0.824 . . . . 0.0 112.457 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.347 35.9 ptt180 -45.76 -52.6 10.82 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -167.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.452 ' HB3' HD13 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -84.62 -27.02 27.47 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.413 1.006 . . . . 0.0 112.047 -174.206 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -65.98 -40.72 91.45 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.119 -0.988 . . . . 0.0 109.304 171.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.447 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.1 tpt -62.9 -40.66 98.26 Favored 'General case' 0 CA--C 1.512 -0.489 0 O-C-N 121.735 -0.603 . . . . 0.0 109.821 171.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.34 -36.88 79.0 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 118.969 -0.539 . . . . 0.0 110.017 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -65.95 -39.91 90.85 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.504 170.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.49 -44.98 95.86 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 120.332 1.424 . . . . 0.0 111.055 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -65.49 -41.54 93.14 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 118.022 0.911 . . . . 0.0 109.067 173.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.04 -35.25 74.14 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 119.824 1.193 . . . . 0.0 111.741 -173.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -79.6 -15.83 56.95 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.184 1.356 . . . . 0.0 112.886 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.9 m -79.65 -50.91 9.94 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.896 1.678 . . . . 0.0 109.239 171.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.4 mt -88.48 -28.02 21.11 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.101 1.361 . . . . 0.0 112.384 -169.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.71 12.24 61.1 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.484 1.993 . . . . 0.0 111.751 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.52 121.52 12.34 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.939 1.295 . . . . 0.0 109.762 -172.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.86 11.05 85.79 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 119.755 -0.469 . . . . 0.0 113.538 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -124.9 -29.22 3.39 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.511 1.524 . . . . 0.0 109.153 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.2 pt -143.82 173.03 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.696 1.598 . . . . 0.0 109.677 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.69 144.59 44.24 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 103.836 -2.653 . . . . 0.0 103.836 168.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -133.78 148.64 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 118.536 0.607 . . . . 0.0 111.688 -167.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.95 158.33 44.09 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.342 1.457 . . . . 0.0 110.299 -174.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.4 p -131.17 153.23 49.64 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.633 1.573 . . . . 0.0 109.365 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.2 t -145.9 149.04 33.5 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -174.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.525 0 N-CA-C 107.086 -2.406 . . . . 0.0 107.086 -175.764 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.2 m . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 121.724 0.773 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -132.9 117.89 15.18 Favored Pre-proline 0 N--CA 1.453 -0.309 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -173.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -63.33 -27.53 71.63 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.327 2.685 . . . . 0.0 113.721 -169.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.4 m -61.56 -41.25 97.1 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.231 0.923 . . . . 0.0 109.474 171.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.79 -42.71 97.67 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 120.091 1.314 . . . . 0.0 108.958 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -56.33 -49.55 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 118.728 -0.654 . . . . 0.0 109.346 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.79 -41.32 90.89 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-N 118.723 0.692 . . . . 0.0 111.014 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.446 ' HG3' ' HB3' ' A' ' 112' ' ' PHE . 32.7 mmt -65.34 -22.29 66.8 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 123.457 0.703 . . . . 0.0 112.032 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.447 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 1.5 mmt -98.06 -28.41 13.78 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -62.6 -32.43 73.43 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.448 1.099 . . . . 0.0 110.258 170.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -59.24 -16.2 19.81 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.768 1.627 . . . . 0.0 112.292 172.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.3 m -129.07 15.02 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 125.953 1.701 . . . . 0.0 111.37 177.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.79 38.95 86.03 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 119.064 -0.853 . . . . 0.0 113.675 173.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.9 mt -121.13 152.52 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -118.73 126.59 52.22 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 124.865 1.266 . . . . 0.0 108.002 176.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.9 pt -128.23 17.87 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 124.064 0.946 . . . . 0.0 111.746 171.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.3 -33.07 59.07 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.671 1.188 . . . . 0.0 112.157 173.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.22 -3.47 81.93 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 123.302 0.477 . . . . 0.0 112.873 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -67.15 153.0 44.72 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.165 0.986 . . . . 0.0 111.185 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.0 p -147.1 157.76 43.72 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.97 1.708 . . . . 0.0 107.601 169.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.2 m -154.47 173.48 16.21 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.166 1.386 . . . . 0.0 108.41 -169.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -154.8 167.55 13.76 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-O 117.778 -1.106 . . . . 0.0 108.186 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.06 165.25 21.83 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.286 1.991 . . . . 0.0 112.853 -171.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.6 tt -63.78 -34.4 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 123.716 0.806 . . . . 0.0 110.622 -170.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.49 -19.04 61.62 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.757 0.823 . . . . 0.0 112.608 -174.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.85 -24.67 58.63 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.091 0.556 . . . . 0.0 110.945 169.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -95.79 169.77 9.78 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 122.199 0.999 . . . . 0.0 111.245 -169.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.16 97.13 2.73 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.876 1.671 . . . . 0.0 107.183 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.457 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -50.45 -23.07 2.19 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.039 0.936 . . . . 0.0 113.501 173.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -50.65 -22.92 2.27 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.802 0.841 . . . . 0.0 111.908 171.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -114.27 16.16 17.99 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.087 1.355 . . . . 0.0 113.226 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.44 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 23.5 m-85 -134.12 112.92 11.53 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 120.526 -1.359 . . . . 0.0 109.598 170.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -67.67 -8.99 39.42 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -169.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.876 HG12 HG13 ' A' ' 4' ' ' VAL . 18.2 t -146.65 119.64 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 -171.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.4 m -133.85 130.97 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 O-C-N 120.409 -1.432 . . . . 0.0 107.962 -174.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.3 mm -126.11 102.16 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 -173.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.7 p -78.03 157.54 29.57 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 171.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.452 HD13 ' HB3' ' A' ' 15' ' ' SER . 6.0 mp -133.43 44.38 2.8 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 169.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 69.0 m -93.16 10.51 31.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.81 1.644 . . . . 0.0 110.227 -174.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.41 29.39 33.27 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 170.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 4.9 t 39.33 43.66 0.97 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.705 2.002 . . . . 0.0 112.83 -171.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -144.18 44.13 0.94 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.688 1.137 . . . . 0.0 110.449 -171.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.2 p -134.99 165.06 32.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.38 1.872 . . . . 0.0 109.19 -173.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -129.58 71.54 1.44 Allowed 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 38.8 mt -60.77 149.45 79.8 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.63 153.75 17.87 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.511 2.141 . . . . 0.0 111.611 169.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.33 -18.67 55.67 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.787 1.658 . . . . 0.0 114.79 -169.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.05 -25.69 68.22 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 120.904 -1.122 . . . . 0.0 111.22 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.457 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 68.2 m95 -70.48 -11.12 60.71 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 117.224 -1.37 . . . . 0.0 113.235 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.6 m -110.36 -8.54 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 121.204 1.82 . . . . 0.0 113.285 -175.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.6 p -90.99 -11.2 39.64 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.892 0.877 . . . . 0.0 112.953 -174.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -61.67 167.27 3.64 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 128.763 2.825 . . . . 0.0 112.681 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -68.19 -38.71 82.27 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.217 1.007 . . . . 0.0 108.539 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.479 ' CG2' HG13 ' A' ' 75' ' ' VAL . 3.5 mt -119.91 135.47 60.11 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 CA-C-O 121.488 0.661 . . . . 0.0 109.632 169.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -148.39 114.84 5.93 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 166.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -143.73 167.51 22.1 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 173.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -126.08 124.56 40.88 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 169.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -100.53 77.4 1.91 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -177.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.46 ' CD ' ' H ' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -62.51 33.51 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 128.962 2.905 . . . . 0.0 114.19 178.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.58 -177.8 1.62 Allowed 'General case' 0 CA--C 1.535 0.394 0 O-C-N 120.789 -1.194 . . . . 0.0 110.67 -171.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -55.1 161.84 1.57 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 123.814 1.769 . . . . 0.0 113.356 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -115.19 103.06 54.74 Favored Pre-proline 0 C--N 1.318 -0.766 0 C-N-CA 128.853 2.861 . . . . 0.0 107.85 -169.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -82.04 18.58 1.37 Allowed 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.761 2.307 . . . . 0.0 112.477 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -39.61 96.35 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.539 1.935 . . . . 0.0 113.974 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 42.51 31.98 1.15 Allowed Glycine 0 CA--C 1.541 1.663 0 C-N-CA 125.095 1.331 . . . . 0.0 114.172 -172.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -76.85 177.51 7.61 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 122.496 1.141 . . . . 0.0 113.404 -169.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 p -59.88 154.65 18.13 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.731 -1.577 . . . . 0.0 109.355 170.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.8 mt -58.73 -29.49 66.75 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.797 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.62 -40.82 97.86 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 118.676 -0.678 . . . . 0.0 111.044 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.4 t -71.23 -39.96 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 119.469 1.031 . . . . 0.0 109.082 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.446 ' HB3' ' HG3' ' A' ' 49' ' ' MET . 29.7 m-85 -52.08 -51.33 58.4 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.527 1.058 . . . . 0.0 111.624 169.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -59.16 -45.23 91.51 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.935 0.789 . . . . 0.0 110.584 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.3 m -69.4 -45.19 69.83 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -173.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.5 t -65.31 -47.95 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -172.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.3 ttp180 -45.53 -53.34 9.12 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 124.732 1.213 . . . . 0.0 110.949 171.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.29 -42.25 97.89 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 119.334 0.97 . . . . 0.0 111.91 -177.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -64.99 -37.3 87.2 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.213 -1.169 . . . . 0.0 110.765 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.7 t -63.14 -42.74 97.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -39.25 83.47 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.201 1.364 . . . . 0.0 111.364 -173.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.27 -42.53 75.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 119.205 -0.426 . . . . 0.0 110.322 177.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -68.03 -39.46 83.1 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.401 1.0 . . . . 0.0 111.469 178.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.3 t -54.97 -52.97 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 171.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.37 -32.91 74.71 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.744 -0.597 . . . . 0.0 111.923 -176.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -63.44 -48.43 77.8 Favored 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 121.615 -0.678 . . . . 0.0 110.719 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -46.57 77.37 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 123.429 0.692 . . . . 0.0 109.659 177.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.1 mt -58.72 -44.3 89.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 124.432 1.093 . . . . 0.0 109.584 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.24 -29.31 68.69 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.876 0.762 . . . . 0.0 111.927 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -74.27 -42.32 59.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.478 0.581 . . . . 0.0 111.533 175.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 pt -98.85 -44.12 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 -168.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 C--O 1.255 1.343 0 CA-C-N 118.997 0.817 . . . . 0.0 110.223 -170.842 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.2 mmm . . . . . 0 N--CA 1.501 2.112 0 CA-C-O 119.937 -0.078 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.493 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -58.5 129.59 42.77 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 173.267 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -91.49 133.45 35.49 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.709 HG13 HG12 ' A' ' 75' ' ' VAL . 13.8 t -112.34 154.08 13.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 51.4 tpp -136.11 145.59 46.07 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -125.35 119.37 28.18 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 175.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.1 t -103.06 126.81 57.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -171.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 m -112.5 156.92 21.79 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.627 0.771 . . . . 0.0 110.628 -172.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -150.44 153.49 36.03 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 169.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.564 ' HG2' ' H ' ' A' ' 11' ' ' ASN . 53.5 ttm-85 58.61 -169.31 0.13 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.456 1.102 . . . . 0.0 108.472 -168.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.564 ' H ' ' HG2' ' A' ' 10' ' ' ARG . 50.9 t-20 -47.29 105.99 0.08 Allowed 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 124.008 0.923 . . . . 0.0 108.671 174.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.0 m -77.34 7.5 5.22 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.379 1.072 . . . . 0.0 112.378 -170.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.4 p -44.33 -56.75 3.95 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 124.309 1.044 . . . . 0.0 110.135 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 25.7 ptt85 -52.49 -44.66 65.78 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.795 1.238 . . . . 0.0 113.57 -177.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.6 -32.58 13.36 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.338 -0.851 . . . . 0.0 112.406 -168.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -71.48 -30.24 65.74 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.719 -1.238 . . . . 0.0 109.106 169.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.466 ' SD ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -64.05 -37.79 88.73 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 120.784 -1.198 . . . . 0.0 109.364 168.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.8 -36.77 75.01 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 119.077 -0.487 . . . . 0.0 110.008 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -63.15 -40.0 96.31 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.891 169.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.71 -44.4 92.48 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 120.609 1.549 . . . . 0.0 111.797 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.466 ' CD2' ' SD ' ' A' ' 17' ' ' MET . 5.4 m-85 -62.39 -40.93 98.07 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 118.562 1.181 . . . . 0.0 109.382 170.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.435 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -70.06 -36.19 74.8 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.574 1.079 . . . . 0.0 110.632 -173.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -73.84 -18.35 60.95 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 120.359 1.436 . . . . 0.0 112.584 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 m -82.84 -50.94 8.1 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.745 1.618 . . . . 0.0 109.473 176.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.8 mt -88.07 -26.52 22.5 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.301 1.44 . . . . 0.0 111.672 -169.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.96 11.73 60.65 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.574 2.035 . . . . 0.0 112.218 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.65 124.54 21.27 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.819 1.247 . . . . 0.0 109.179 -171.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.61 8.81 87.45 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 119.47 -0.628 . . . . 0.0 113.806 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -127.52 -31.06 2.53 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.566 1.546 . . . . 0.0 108.56 -177.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.47 HD12 HG22 ' A' ' 32' ' ' VAL . 12.1 pt -143.74 165.87 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 125.767 1.627 . . . . 0.0 110.22 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.58 146.62 35.78 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 103.469 -2.789 . . . . 0.0 103.469 168.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.47 HG22 HD12 ' A' ' 30' ' ' ILE . 1.8 t -134.76 146.25 31.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-N 118.922 0.783 . . . . 0.0 111.488 -168.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.8 162.64 40.7 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.656 1.582 . . . . 0.0 109.545 -174.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.5 p -136.58 165.43 25.89 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 120.395 -1.441 . . . . 0.0 110.215 173.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.3 p -149.78 150.75 32.49 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 123.515 0.726 . . . . 0.0 109.745 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.484 0 N-CA-C 106.861 -2.496 . . . . 0.0 106.861 -170.793 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.7 t . . . . . 0 CA--C 1.535 0.389 0 CA-C-O 121.483 0.658 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -129.67 110.97 17.5 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.722 1.209 . . . . 0.0 108.984 -169.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.3 -30.44 54.08 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.956 3.104 . . . . 0.0 114.701 -168.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.0 m -59.52 -36.61 76.43 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.661 1.119 . . . . 0.0 109.743 175.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.13 -43.8 90.74 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.47 -44.11 92.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.52 -41.93 98.06 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.169 0.895 . . . . 0.0 111.664 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 39.1 mmt -63.77 -29.77 70.94 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 118.943 -0.551 . . . . 0.0 111.682 178.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -85.27 -32.5 22.53 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.92 -33.77 76.05 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.275 1.03 . . . . 0.0 109.994 174.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -62.35 -12.54 21.75 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.72 1.208 . . . . 0.0 112.119 173.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.1 m -127.66 13.51 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 125.937 1.695 . . . . 0.0 111.863 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.48 35.61 59.52 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 121.003 -1.06 . . . . 0.0 114.563 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.3 mt -122.35 156.23 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 171.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -131.57 140.82 49.55 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.723 1.209 . . . . 0.0 108.479 171.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 27.6 pt -133.7 17.4 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.55 1.54 . . . . 0.0 111.146 -175.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.3 p -78.64 -28.64 45.54 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.574 1.15 . . . . 0.0 112.664 171.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.6 -8.12 66.5 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 123.136 0.398 . . . . 0.0 112.234 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -85.84 146.57 26.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.478 1.111 . . . . 0.0 108.335 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.4 p -143.16 154.52 43.98 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 169.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.99 166.03 32.83 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -169.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -147.61 162.67 31.02 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.185 1.794 . . . . 0.0 106.762 -171.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.84 160.14 48.66 Favored 'Trans proline' 0 C--N 1.347 0.488 0 CA-C-N 123.052 2.126 . . . . 0.0 112.728 -170.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.9 tt -57.06 -32.73 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.736 1.214 . . . . 0.0 111.95 -175.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -68.73 -22.66 64.31 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.59 0.756 . . . . 0.0 112.145 -173.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -13.34 59.89 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 118.808 -0.615 . . . . 0.0 112.177 171.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -110.76 172.59 6.78 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 122.274 1.035 . . . . 0.0 112.211 -170.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.77 103.23 2.91 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 126.78 2.032 . . . . 0.0 107.065 -172.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.444 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -54.87 -24.43 23.25 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 123.757 0.823 . . . . 0.0 112.988 177.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -50.64 -32.42 18.98 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.04 0.936 . . . . 0.0 111.585 172.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -86.6 12.0 11.55 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -136.0 177.68 7.65 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.064 2.146 . . . . 0.0 108.557 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -120.45 -21.88 6.67 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.709 HG12 HG13 ' A' ' 4' ' ' VAL . 20.2 t -142.21 128.34 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 -170.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.58 129.74 61.9 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 O-C-N 120.666 -1.271 . . . . 0.0 108.221 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.1 mm -117.9 134.54 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 176.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.4 t -115.06 156.76 24.57 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 175.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.5 mp -134.06 36.38 3.25 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 173.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 60.2 m -96.7 14.0 26.48 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.395 1.478 . . . . 0.0 110.025 -176.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.94 15.45 81.16 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-O 119.361 -0.689 . . . . 0.0 112.447 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 3.9 t 60.35 -20.07 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.234 2.614 . . . . 0.0 115.632 -178.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.13 -26.76 73.95 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 119.457 1.026 . . . . 0.0 112.829 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.8 t -63.21 116.59 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 174.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -66.14 138.17 57.54 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 172.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.4 mt -120.99 141.15 32.13 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.57 157.65 6.94 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.645 2.897 . . . . 0.0 113.163 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.7 -22.4 69.85 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 121.889 1.726 . . . . 0.0 115.222 -169.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -65.73 -24.02 66.88 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 120.188 -1.57 . . . . 0.0 111.746 176.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.444 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 70.7 m95 -70.0 -7.93 44.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 117.344 -1.312 . . . . 0.0 112.487 175.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.5 m -115.32 -12.25 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 121.273 1.851 . . . . 0.0 113.481 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.8 p -81.83 -13.3 57.84 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.158 0.89 . . . . 0.0 112.23 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -44.29 155.22 0.09 Allowed 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 130.979 3.712 . . . . 0.0 113.009 169.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -62.38 -38.33 89.19 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.673 1.989 . . . . 0.0 108.771 169.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.673 ' HB ' HG13 ' A' ' 75' ' ' VAL . 33.6 mm -130.44 138.11 54.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 C-N-CA 123.055 0.542 . . . . 0.0 109.847 171.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -135.42 117.49 15.38 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 100.707 -3.812 . . . . 0.0 100.707 166.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.65 165.75 26.77 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 175.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -141.85 132.75 25.87 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 169.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.4 ' CE3' ' HB3' ' A' ' 122' ' ' ARG . 54.1 m0 -102.35 2.22 36.5 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -172.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 47.19 -68.78 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 131.086 3.754 . . . . 0.0 111.833 -169.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . 0.258 0.8 OUTLIER 45.29 -172.73 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.238 1 C-N-CA 133.294 4.638 . . . . 0.0 114.369 -174.429 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -64.83 174.89 1.67 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.356 1.462 . . . . 0.0 113.34 -169.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -132.63 66.62 77.06 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 126.483 1.913 . . . . 0.0 109.75 -169.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -79.21 61.8 8.28 Favored 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 124.276 3.317 . . . . 0.0 111.294 -169.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -55.68 -42.6 75.37 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.026 -1.046 . . . . 0.0 112.521 -175.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -163.69 42.68 0.32 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.0 1.762 . . . . 0.0 109.753 -177.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -69.37 171.5 8.53 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -169.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.5 p -64.8 158.74 24.12 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.001 169.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 27.8 mt -60.24 -32.81 71.49 Favored 'General case' 0 C--O 1.22 -0.449 0 O-C-N 122.007 -0.433 . . . . 0.0 110.295 172.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.19 -43.93 90.04 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 118.484 0.584 . . . . 0.0 110.958 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 63.2 t -68.09 -43.79 84.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 119.156 -1.018 . . . . 0.0 108.47 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -48.41 -48.44 37.11 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.674 1.124 . . . . 0.0 111.739 173.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -62.94 -48.19 79.97 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.622 0.769 . . . . 0.0 111.016 176.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.1 m -65.48 -45.61 82.97 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -171.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.5 t -59.32 -42.73 88.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 124.095 0.958 . . . . 0.0 108.764 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -52.57 -51.67 58.67 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 118.444 0.566 . . . . 0.0 110.249 173.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.38 -38.42 95.8 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 119.544 1.066 . . . . 0.0 112.143 -177.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -63.79 -40.36 96.48 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 120.851 -1.382 . . . . 0.0 110.511 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.9 t -62.04 -39.2 82.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 118.443 -0.789 . . . . 0.0 109.147 173.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -39.49 76.27 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.495 1.043 . . . . 0.0 110.881 -176.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -70.44 -42.26 71.78 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 119.043 -0.504 . . . . 0.0 110.565 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.4 ' HB3' ' CE3' ' A' ' 99' ' ' TRP . 9.4 mpt_? -65.44 -42.0 92.9 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.427 1.012 . . . . 0.0 110.559 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.2 t -55.16 -52.69 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 123.322 0.649 . . . . 0.0 109.728 173.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -63.5 -32.65 74.17 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 122.049 -0.407 . . . . 0.0 111.609 -175.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -62.56 -45.9 90.82 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.375 0.67 . . . . 0.0 111.991 172.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -47.4 81.91 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 174.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -58.74 -43.05 87.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.46 -35.32 78.94 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.526 0.603 . . . . 0.0 111.823 -176.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -77.44 -37.49 51.46 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 117.664 -1.16 . . . . 0.0 112.435 174.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.8 pt -93.32 -41.97 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -171.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 C--O 1.252 1.226 0 CA-C-N 119.19 0.904 . . . . 0.0 110.055 -171.513 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 tpt . . . . . 0 N--CA 1.499 1.977 0 CA-C-O 117.623 -1.18 . . . . 0.0 109.607 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.559 ' HB2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -47.52 118.19 2.12 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 120.708 1.595 . . . . 0.0 110.188 -171.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 33.5 mtpt -93.51 134.22 36.01 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -169.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.775 HG13 HG12 ' A' ' 75' ' ' VAL . 10.1 t -112.87 153.54 14.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 58.2 tpp -136.6 143.58 43.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -127.58 106.75 9.38 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.452 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 4.2 t -94.7 141.93 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.298 1.039 . . . . 0.0 108.249 -172.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.66 162.81 30.41 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.74 1.155 . . . . 0.0 113.598 175.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -142.36 30.0 1.58 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.378 1.871 . . . . 0.0 109.111 169.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -155.57 -174.76 5.1 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.807 2.043 . . . . 0.0 106.956 -170.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.473 HD21 ' CD2' ' A' ' 43' ' ' HIS . 9.3 t-20 -52.16 141.5 18.57 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 125.016 1.326 . . . . 0.0 111.579 174.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.2 p -67.26 -17.14 64.67 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.109 1.364 . . . . 0.0 113.205 -176.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 32.0 p -61.91 -11.43 13.06 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 117.542 -1.218 . . . . 0.0 113.858 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.252 21.7 ptt180 -100.69 -37.99 8.5 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.032 1.287 . . . . 0.0 111.567 169.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.8 p -98.43 -54.34 3.07 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.757 1.617 . . . . 0.0 114.891 -169.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -66.58 -23.18 66.16 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.137 -0.977 . . . . 0.0 108.652 170.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.473 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.9 tpt -67.56 -44.05 79.19 Favored 'General case' 0 C--O 1.224 -0.251 0 O-C-N 120.791 -1.193 . . . . 0.0 109.978 168.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.14 -39.8 87.6 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.507 ' HG2' HG12 ' A' ' 32' ' ' VAL . 12.0 tm-20 -58.61 -44.55 89.95 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.377 1.071 . . . . 0.0 110.623 169.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.53 -39.35 61.09 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 120.594 1.543 . . . . 0.0 112.092 -174.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -66.45 -36.78 83.63 Favored 'General case' 0 C--O 1.223 -0.315 0 O-C-N 121.489 -1.007 . . . . 0.0 108.958 170.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.485 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -72.68 -39.92 66.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.978 1.263 . . . . 0.0 110.899 -174.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -66.3 -27.18 67.72 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 120.664 1.575 . . . . 0.0 111.36 175.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 m -75.43 -50.91 14.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.982 1.713 . . . . 0.0 110.477 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.9 mt -89.48 -27.66 20.19 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.007 1.323 . . . . 0.0 112.485 -169.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.28 12.45 63.49 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 127.064 2.269 . . . . 0.0 111.904 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.52 123.43 17.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.14 1.376 . . . . 0.0 110.012 -171.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.95 8.49 86.77 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.465 -0.631 . . . . 0.0 113.636 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -124.7 -41.18 2.15 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.18 1.392 . . . . 0.0 109.201 -175.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.559 HG22 ' HB2' ' A' ' 2' ' ' LYS . 2.7 pp -140.44 156.06 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.731 1.213 . . . . 0.0 109.437 176.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.95 154.66 17.17 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 173.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.507 HG12 ' HG2' ' A' ' 19' ' ' GLU . 2.1 t -140.55 146.14 24.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-N 119.116 0.871 . . . . 0.0 111.585 -168.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.43 158.24 39.68 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.588 1.155 . . . . 0.0 110.418 -176.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.4 p -133.26 156.08 48.21 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.039 1.29 . . . . 0.0 110.906 176.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.457 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 8.1 p -146.78 145.79 30.05 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.05 0.841 . . . . 0.0 109.759 176.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.118 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 -169.034 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.348 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.473 ' CD2' HD21 ' A' ' 11' ' ' ASN . 82.3 t60 -139.99 112.69 7.51 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -172.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -64.34 -30.19 63.26 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.352 2.701 . . . . 0.0 112.751 -169.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.7 m -64.98 -37.5 87.87 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.98 -44.12 90.37 Favored 'General case' 0 C--N 1.346 0.426 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.87 -49.25 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.12 -42.16 98.03 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.523 0.601 . . . . 0.0 110.808 -177.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.9 mmt -63.44 -24.5 67.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.802 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.473 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -94.92 -31.68 13.56 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -176.63 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -60.56 -34.1 73.67 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.603 1.161 . . . . 0.0 110.054 169.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -63.8 -9.59 15.55 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.419 1.488 . . . . 0.0 112.39 173.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.73 14.32 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 125.949 1.7 . . . . 0.0 111.329 172.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.81 37.94 88.95 Favored Glycine 0 CA--C 1.532 1.121 0 O-C-N 121.452 -0.78 . . . . 0.0 112.982 175.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.4 mt -120.16 152.75 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 125.706 1.602 . . . . 0.0 106.95 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -127.79 124.47 37.72 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -176.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.9 pt -129.12 12.91 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 124.246 1.018 . . . . 0.0 111.232 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.95 -31.31 50.87 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.9 1.68 . . . . 0.0 113.577 -178.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.37 -9.69 73.48 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -83.19 159.27 22.04 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.256 1.022 . . . . 0.0 111.528 -173.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -146.77 158.67 43.96 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 128.373 2.669 . . . . 0.0 105.71 169.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.5 m -147.98 167.75 24.09 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -142.5 162.19 45.97 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -169.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.58 164.25 36.16 Favored 'Trans proline' 0 C--N 1.348 0.504 0 CA-C-N 122.686 1.995 . . . . 0.0 113.163 -169.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.5 tt -57.11 -35.87 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.364 1.465 . . . . 0.0 111.118 -173.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.95 -18.42 62.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.298 0.639 . . . . 0.0 112.699 -169.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -82.18 -16.37 49.95 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.482 170.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 35' ' ' CYS . 46.4 m-85 -96.35 168.84 10.33 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.272 1.029 . . . . 0.0 110.842 -177.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.08 93.57 2.41 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 -169.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.508 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -52.97 -25.03 10.7 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 177.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.87 -21.95 13.12 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.123 0.42 . . . . 0.0 111.275 173.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -99.52 6.72 45.79 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.513 1.525 . . . . 0.0 113.248 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.443 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 22.7 m-85 -136.77 113.58 10.36 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 120.284 1.402 . . . . 0.0 108.932 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.5 -17.37 59.53 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -169.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.775 HG12 HG13 ' A' ' 4' ' ' VAL . 9.7 t -144.22 122.03 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 -171.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.0 m -129.64 131.36 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 O-C-N 120.845 -1.159 . . . . 0.0 108.763 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.9 mm -126.19 96.72 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 102.977 -2.971 . . . . 0.0 102.977 -170.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.452 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 33.5 t -70.81 166.16 21.6 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -147.38 49.44 1.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 173.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.525 ' HB3' HG21 ' A' ' 84' ' ' VAL . 38.5 m -115.68 10.87 15.59 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.739 1.216 . . . . 0.0 110.786 -170.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.62 21.48 16.53 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 118.486 0.585 . . . . 0.0 112.563 173.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 4.3 t 47.4 41.15 12.16 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.049 1.74 . . . . 0.0 111.771 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -162.51 36.31 0.35 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-O 119.601 -0.555 . . . . 0.0 112.452 -170.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.525 HG21 ' HB3' ' A' ' 80' ' ' CYS . 57.9 t -117.83 137.4 51.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 173.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -82.72 69.07 9.43 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.131 0.972 . . . . 0.0 109.947 -171.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 18.4 mt -59.57 144.81 84.16 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -52.97 154.99 11.95 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.764 2.309 . . . . 0.0 111.846 170.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.65 -19.48 53.88 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 121.649 1.566 . . . . 0.0 114.362 -170.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.08 -25.95 68.33 Favored 'General case' 0 C--O 1.226 -0.162 0 O-C-N 120.938 -1.101 . . . . 0.0 111.224 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.508 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 72.3 m95 -68.57 -5.31 19.05 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.271 -0.893 . . . . 0.0 112.554 174.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.8 t -108.07 -28.5 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 119.67 1.123 . . . . 0.0 111.184 -174.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.1 p -77.07 -19.05 57.58 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.87 0.868 . . . . 0.0 113.123 -169.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -49.99 159.55 0.41 Allowed 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 129.2 3.0 . . . . 0.0 113.964 174.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -63.34 -38.83 92.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.674 1.59 . . . . 0.0 109.118 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.582 ' HB ' HG13 ' A' ' 75' ' ' VAL . 36.5 mm -125.71 138.89 53.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 169.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -139.3 112.19 7.93 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 102.641 -3.096 . . . . 0.0 102.641 167.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -134.68 171.0 14.97 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 174.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -139.49 116.0 10.64 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 170.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -93.74 68.74 3.97 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -36.99 -50.05 0.86 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.856 1.663 . . . . 0.0 110.108 169.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . 0.254 0.5 OUTLIER 38.04 -158.39 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 129.936 3.294 . . . . 0.0 112.734 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -60.4 166.6 2.96 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 122.35 1.071 . . . . 0.0 109.181 169.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -133.17 70.45 77.86 Favored Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 126.362 1.865 . . . . 0.0 109.952 -168.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -77.21 49.74 2.93 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.498 3.465 . . . . 0.0 114.738 -169.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -62.69 102.43 0.34 Allowed 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.981 -1.074 . . . . 0.0 109.424 169.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.55 26.34 66.45 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 123.967 0.794 . . . . 0.0 114.203 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -63.93 167.48 6.16 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -176.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.1 m -67.22 154.07 42.15 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 113.228 -1.806 . . . . 0.0 109.219 169.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 25.7 mt -59.03 -34.88 72.41 Favored 'General case' 0 C--O 1.222 -0.366 0 O-C-N 122.08 -0.387 . . . . 0.0 111.519 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -61.11 -39.79 91.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.339 0.518 . . . . 0.0 110.615 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.656 ' O ' HG23 ' A' ' 115' ' ' VAL . 61.9 t -72.96 -40.3 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-O 116.75 -1.595 . . . . 0.0 108.998 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -51.63 -47.23 63.77 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 121.207 1.821 . . . . 0.0 111.033 170.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -59.17 -43.96 92.15 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 118.626 0.648 . . . . 0.0 110.441 177.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 86.7 m -69.27 -42.05 76.05 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -174.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 111' ' ' VAL . 67.5 t -65.02 -48.68 83.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -174.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -47.21 -51.58 18.2 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.957 1.303 . . . . 0.0 110.69 170.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.81 -43.85 97.06 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 119.764 1.165 . . . . 0.0 112.409 -177.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -66.69 -33.96 76.8 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.838 1.319 . . . . 0.0 111.42 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.4 t -62.94 -41.1 91.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.47 -37.56 81.42 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 120.245 1.384 . . . . 0.0 111.166 -177.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -70.17 -40.19 74.85 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 118.865 -0.588 . . . . 0.0 110.733 175.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -60.76 -46.28 91.08 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.515 1.052 . . . . 0.0 110.078 175.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.48 HG12 HD12 ' A' ' 127' ' ' ILE . 69.8 t -57.19 -51.42 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 124.224 1.01 . . . . 0.0 109.451 176.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -67.02 -33.0 74.59 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 119.473 -0.299 . . . . 0.0 111.347 -175.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -61.59 -49.26 77.34 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 123.41 0.684 . . . . 0.0 110.679 172.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.415 HD23 HG13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -58.51 -46.14 87.34 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 122.93 0.492 . . . . 0.0 110.219 177.594 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.48 HD12 HG12 ' A' ' 123' ' ' VAL . 10.1 mt -59.36 -41.0 82.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 124.691 1.196 . . . . 0.0 109.813 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.08 -27.59 67.11 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.068 0.849 . . . . 0.0 111.933 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -75.88 -39.73 55.85 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.776 -0.578 . . . . 0.0 111.786 176.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.1 pt -102.89 -33.14 3.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 -168.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 C--O 1.254 1.3 0 C-N-CA 124.755 1.222 . . . . 0.0 111.679 -171.426 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 tpt . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 118.273 -0.87 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.522 ' HB2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -50.72 116.14 1.81 Allowed 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 120.285 1.402 . . . . 0.0 110.135 -173.123 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.5 mtpt -91.86 142.29 27.72 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 119.263 0.938 . . . . 0.0 108.693 -170.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.439 HG11 ' CZ ' ' A' ' 6' ' ' PHE . 21.3 t -111.67 154.32 13.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 170.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -138.81 131.95 29.81 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.439 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 86.2 m-85 -113.65 132.35 55.8 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.4 t -123.19 112.02 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 120.802 1.637 . . . . 0.0 110.164 -169.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.79 170.78 12.86 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 122.76 1.267 . . . . 0.0 112.835 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.0 mmtp -148.47 148.67 30.53 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 130.971 3.708 . . . . 0.0 101.706 168.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.433 ' HG2' ' H ' ' A' ' 11' ' ' ASN . 26.1 ttm-85 57.51 -160.51 0.24 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.743 1.156 . . . . 0.0 107.908 -168.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.433 ' H ' ' HG2' ' A' ' 10' ' ' ARG . 20.2 t-20 -55.77 133.96 51.32 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.221 0.919 . . . . 0.0 112.308 -169.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.4 m -48.06 -24.96 1.24 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 130.286 3.434 . . . . 0.0 115.125 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.0 m -50.2 -49.41 52.72 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 125.713 1.605 . . . . 0.0 114.107 -169.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.27 34.0 ptt180 -70.02 -42.12 73.4 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 118.23 -0.89 . . . . 0.0 113.21 -168.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 87.9 p -78.38 -39.4 39.29 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 120.528 1.513 . . . . 0.0 110.114 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -70.76 -27.68 64.12 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.628 -0.67 . . . . 0.0 110.003 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.471 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.1 tpt -66.72 -41.76 87.44 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 121.149 -0.97 . . . . 0.0 109.51 169.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.57 -38.46 84.65 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -61.33 -42.55 98.87 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.902 169.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.54 -44.88 88.97 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 120.643 1.565 . . . . 0.0 111.798 -175.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -64.98 -40.83 95.56 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 117.937 0.868 . . . . 0.0 108.836 173.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.517 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -71.19 -37.31 72.14 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 119.622 1.101 . . . . 0.0 111.286 -173.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -69.56 -24.77 63.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 120.567 1.53 . . . . 0.0 111.891 177.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.3 m -78.06 -49.98 12.95 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.345 2.258 . . . . 0.0 110.328 175.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.6 mt -88.01 -27.98 21.69 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.732 1.213 . . . . 0.0 112.355 -169.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.34 12.32 58.47 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 127.251 2.358 . . . . 0.0 111.96 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.06 122.83 15.97 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.264 1.426 . . . . 0.0 109.511 -170.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.94 8.41 87.84 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 119.536 -0.591 . . . . 0.0 113.764 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -124.85 -41.94 2.08 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.998 1.319 . . . . 0.0 108.832 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.522 HG22 ' HB2' ' A' ' 2' ' ' LYS . 2.8 pp -140.99 162.08 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.979 1.312 . . . . 0.0 109.124 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.84 155.53 18.54 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.517 HG11 ' HB3' ' A' ' 22' ' ' ALA . 2.4 t -143.9 139.4 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 118.622 0.646 . . . . 0.0 111.2 -168.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.5 m -150.09 165.85 31.53 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.232 1.413 . . . . 0.0 108.271 177.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.419 ' H ' HG21 ' A' ' 61' ' ' THR . 66.1 p -139.21 169.67 17.35 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.684 -1.26 . . . . 0.0 110.552 171.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.6 p -160.69 -178.31 6.77 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.103 0.961 . . . . 0.0 109.349 176.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.571 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -178.573 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.234 0.286 0 CA-C-O 121.769 0.795 . . . . 0.0 111.886 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.414 ' CG ' HD21 ' A' ' 11' ' ' ASN . 82.5 t60 -141.08 119.65 8.1 Favored Pre-proline 0 N--CA 1.451 -0.397 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -176.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -66.68 -26.69 45.73 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.534 2.823 . . . . 0.0 113.116 -169.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.8 m -61.85 -35.37 78.08 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.973 0.806 . . . . 0.0 109.464 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.3 -43.71 90.25 Favored 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.09 -47.24 90.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 118.566 -0.731 . . . . 0.0 109.041 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.5 99.25 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 118.759 0.709 . . . . 0.0 110.919 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.2 mmt -61.41 -24.94 66.87 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 123.615 0.766 . . . . 0.0 111.936 176.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.471 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.4 OUTLIER -95.45 -26.96 15.63 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 119.052 0.842 . . . . 0.0 108.965 -179.371 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.29 -29.05 70.44 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.996 0.919 . . . . 0.0 110.149 170.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -56.7 -26.23 56.23 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.24 0.616 . . . . 0.0 111.517 169.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.89 -15.95 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 126.744 2.018 . . . . 0.0 109.874 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.65 29.49 52.11 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.153 0.882 . . . . 0.0 111.099 -169.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.0 mt -109.4 156.91 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.259 1.423 . . . . 0.0 107.884 177.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.63 132.65 51.19 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 126.31 1.844 . . . . 0.0 107.669 -173.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.3 pt -140.71 4.48 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.628 1.171 . . . . 0.0 111.883 175.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.83 144.89 55.12 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.712 1.205 . . . . 0.0 110.262 176.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.82 3.68 4.84 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 117.926 -1.485 . . . . 0.0 114.67 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -56.62 -58.42 8.16 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-N 119.589 1.694 . . . . 0.0 112.745 -172.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.419 HG21 ' H ' ' A' ' 34' ' ' SER . 1.0 OUTLIER -141.8 165.49 27.32 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.317 -167.344 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.3 m -163.13 19.7 0.08 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -173.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -141.89 154.0 64.9 Favored Pre-proline 0 N--CA 1.476 0.831 0 CA-C-N 120.803 1.638 . . . . 0.0 113.135 -169.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.13 -177.5 3.54 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 125.241 3.961 . . . . 0.0 113.373 174.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.9 tt -77.21 -33.15 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 126.015 1.726 . . . . 0.0 113.756 -173.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -68.92 -27.75 66.05 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -168.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.54 -7.48 57.56 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 117.579 -1.2 . . . . 0.0 112.776 171.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -102.93 166.13 10.63 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.692 1.587 . . . . 0.0 111.894 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.43 88.53 2.21 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 125.383 1.473 . . . . 0.0 108.884 -169.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.43 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -52.02 -27.75 14.66 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.028 0.931 . . . . 0.0 113.009 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -50.48 -32.51 18.29 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.346 1.058 . . . . 0.0 112.312 174.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -72.1 -20.83 61.58 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -101.68 175.03 5.69 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.104 2.562 . . . . 0.0 109.211 -175.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -117.06 -18.54 10.04 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 117.608 -1.187 . . . . 0.0 113.064 174.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.663 HG13 ' HB ' ' A' ' 95' ' ' ILE . 22.3 t -138.06 133.08 43.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 121.478 1.945 . . . . 0.0 108.672 -178.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.9 t -117.65 138.42 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 6' ' ' PHE . 49.2 mm -131.54 92.12 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 103.004 -2.961 . . . . 0.0 103.004 172.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.7 t -69.63 164.58 23.04 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 169.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.8 mp -139.24 32.0 2.13 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.7 1.6 . . . . 0.0 106.892 173.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 87.7 m -74.39 -3.06 28.19 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.383 1.073 . . . . 0.0 111.908 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.48 34.36 6.09 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 119.585 1.084 . . . . 0.0 110.864 176.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . 0.25 30.3 p 38.91 45.14 0.93 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.003 2.521 . . . . 0.0 113.809 -178.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -142.88 36.55 1.6 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.404 1.478 . . . . 0.0 111.037 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.14 161.94 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 127.202 2.201 . . . . 0.0 108.949 -177.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -134.98 85.65 2.19 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 174.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.5 HD22 ' H ' ' A' ' 86' ' ' LEU . 1.3 mm? -62.08 153.85 72.13 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.708 -171.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.41 157.36 18.54 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.002 1.801 . . . . 0.0 112.272 174.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -52.13 -36.92 68.16 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.772 2.315 . . . . 0.0 116.152 -170.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -67.06 -23.79 65.91 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 120.982 -1.074 . . . . 0.0 112.288 -175.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.43 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 63.8 m95 -75.86 -11.65 60.01 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.745 1.218 . . . . 0.0 112.622 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.76 -16.67 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 120.032 1.287 . . . . 0.0 112.314 -177.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.6 p -76.72 -13.46 60.03 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.282 0.946 . . . . 0.0 112.342 177.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -41.67 154.17 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 129.982 3.313 . . . . 0.0 111.793 169.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -60.68 -36.91 79.93 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.096 1.758 . . . . 0.0 109.729 172.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.663 ' HB ' HG13 ' A' ' 75' ' ' VAL . 29.1 mm -130.18 136.35 58.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 170.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -133.69 123.03 24.27 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 102.92 -2.993 . . . . 0.0 102.92 166.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.46 167.04 23.43 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 173.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -130.51 102.24 6.07 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 169.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -76.86 80.81 3.44 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.898 1.679 . . . . 0.0 108.807 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.77 22.4 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.263 2.625 . . . . 0.0 115.234 175.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.72 164.91 13.6 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.062 -1.024 . . . . 0.0 111.219 -169.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -51.71 146.86 7.29 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -168.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -80.89 110.29 16.87 Favored Pre-proline 0 C--N 1.321 -0.669 0 C-N-CA 127.72 2.408 . . . . 0.0 109.531 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -84.16 -7.14 10.17 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.882 2.388 . . . . 0.0 112.378 176.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.6 t70 19.8 -101.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 128.758 2.823 . . . . 0.0 113.508 -176.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.81 39.76 1.74 Allowed Glycine 0 CA--C 1.533 1.191 0 C-N-CA 127.138 2.304 . . . . 0.0 108.059 169.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -70.03 -179.51 1.93 Allowed 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.987 1.715 . . . . 0.0 112.397 -173.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.2 p -60.27 154.47 19.94 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 113.142 -1.844 . . . . 0.0 109.04 169.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 27.6 mt -57.35 -29.74 64.25 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 122.799 0.44 . . . . 0.0 110.406 176.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -61.4 -41.08 96.56 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 118.527 -0.749 . . . . 0.0 110.948 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.5 t -72.17 -40.19 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 117.705 -1.14 . . . . 0.0 109.59 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -51.35 -51.31 55.62 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.934 1.243 . . . . 0.0 111.425 169.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 80.2 mtt180 -59.65 -44.27 93.6 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.847 0.749 . . . . 0.0 110.99 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 95.8 m -67.03 -45.93 75.98 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -175.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.1 t -64.95 -48.89 82.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -172.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -43.97 -53.58 6.1 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 125.374 1.47 . . . . 0.0 111.262 169.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.82 -40.41 95.57 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 120.104 1.32 . . . . 0.0 112.526 -177.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -66.05 -37.22 85.28 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 120.819 -1.4 . . . . 0.0 110.261 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.9 t -63.41 -43.7 98.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 CA-C-O 117.997 -1.002 . . . . 0.0 108.439 173.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.52 -40.22 82.31 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.716 1.598 . . . . 0.0 110.842 -175.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -71.26 -44.46 65.22 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 125.382 1.473 . . . . 0.0 109.084 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -66.24 -41.87 89.41 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 120.011 1.278 . . . . 0.0 111.582 177.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.504 HG12 HD12 ' A' ' 127' ' ' ILE . 48.7 t -53.98 -50.13 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 173.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -66.67 -34.4 77.79 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -176.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -61.68 -48.28 81.54 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 118.46 0.573 . . . . 0.0 110.394 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.416 HD11 HG11 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -59.58 -45.92 90.46 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 123.049 0.54 . . . . 0.0 109.829 177.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.504 HD12 HG12 ' A' ' 123' ' ' VAL . 12.4 mt -58.43 -42.2 83.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.735 1.214 . . . . 0.0 110.195 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.13 -28.38 67.83 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.296 0.498 . . . . 0.0 112.085 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -75.79 -43.54 45.81 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.418 0.554 . . . . 0.0 111.873 174.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 pt -91.92 -37.53 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -169.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.6 m . . . . . 0 C--O 1.255 1.348 0 CA-C-N 120.266 1.393 . . . . 0.0 110.352 179.36 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 tpt . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 118.524 -0.75 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.489 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -61.54 119.7 9.12 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 121.128 1.785 . . . . 0.0 108.035 -176.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 37.1 mtpt -92.25 137.97 31.92 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -170.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.747 HG13 HG12 ' A' ' 75' ' ' VAL . 14.5 t -122.06 153.77 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 58.9 tpp -138.44 145.12 40.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -129.42 121.82 28.12 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 t -118.5 113.35 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 119.644 1.111 . . . . 0.0 109.252 -169.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.96 167.42 18.92 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 123.32 1.533 . . . . 0.0 113.476 178.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -152.94 141.03 20.37 Favored 'General case' 0 C--O 1.238 0.479 2 N-CA-C 100.032 -4.062 . . . . 0.0 100.032 168.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 62.16 -179.36 0.13 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 120.331 1.423 . . . . 0.0 108.644 -167.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.502 HD21 ' CD2' ' A' ' 43' ' ' HIS . 28.8 t-20 -41.52 123.0 2.07 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 125.131 1.372 . . . . 0.0 112.129 -169.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.3 m -45.78 -26.71 0.7 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 127.868 2.467 . . . . 0.0 115.108 -176.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.5 t -39.78 -54.08 2.15 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 125.557 1.543 . . . . 0.0 112.859 -178.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.289 33.5 ptt180 -65.84 -44.35 85.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 117.784 -1.103 . . . . 0.0 113.454 -168.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 97.5 p -77.3 -41.67 39.79 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 121.094 1.77 . . . . 0.0 110.304 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -70.06 -34.91 73.81 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -172.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.46 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 3.4 tpt -63.72 -41.76 98.03 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 123.496 0.718 . . . . 0.0 110.363 170.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.58 -37.66 82.06 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.494 -177.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -62.51 -42.73 99.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 117.94 -1.028 . . . . 0.0 111.204 170.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.58 -45.23 93.62 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 120.746 1.612 . . . . 0.0 111.284 -175.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -66.77 -40.49 88.22 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.203 172.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.96 78.44 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 120.295 1.407 . . . . 0.0 111.6 -176.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -81.91 -13.82 57.01 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 120.46 1.482 . . . . 0.0 113.11 176.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.6 m -79.95 -52.01 8.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.698 1.199 . . . . 0.0 108.533 169.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.1 mt -84.44 -27.44 27.54 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.899 1.28 . . . . 0.0 111.859 -169.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.87 12.66 57.73 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.675 2.084 . . . . 0.0 111.889 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.53 121.98 12.91 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.585 1.154 . . . . 0.0 109.861 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.38 9.41 86.84 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 119.853 -0.415 . . . . 0.0 113.559 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -123.2 -32.56 3.42 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.849 1.66 . . . . 0.0 109.012 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.4 pt -142.64 174.57 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 125.305 1.442 . . . . 0.0 109.785 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.56 145.27 43.48 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 169.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 t -134.13 143.88 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 118.542 0.61 . . . . 0.0 111.279 -168.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.76 156.18 42.0 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.934 1.294 . . . . 0.0 109.74 -173.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.3 p -139.65 155.34 47.46 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 120.364 1.438 . . . . 0.0 111.069 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.2 p -160.11 -178.54 7.06 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.93 0.892 . . . . 0.0 110.313 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.879 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.01 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 C--O 1.235 0.307 0 CA-C-O 122.067 0.937 . . . . 0.0 112.06 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.502 ' CD2' HD21 ' A' ' 11' ' ' ASN . 81.5 t60 -119.74 110.07 37.29 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.623 -169.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -59.88 -29.1 88.68 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.07 2.513 . . . . 0.0 113.67 -169.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.33 -37.49 80.78 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.475 1.034 . . . . 0.0 110.847 175.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.21 -45.82 72.29 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.5 -45.81 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.5 -43.74 93.27 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.373 0.533 . . . . 0.0 111.438 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.3 mmt -65.86 -19.64 65.95 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 118.969 -0.539 . . . . 0.0 112.1 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.46 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 2.0 mmt -98.63 -28.65 13.45 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.93 -33.67 75.84 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.557 1.143 . . . . 0.0 109.547 169.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -58.51 -15.17 10.01 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.792 1.637 . . . . 0.0 112.067 172.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.0 m -132.45 14.3 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 C-N-CA 126.439 1.896 . . . . 0.0 111.753 177.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.51 43.54 76.9 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-O 118.944 -0.92 . . . . 0.0 114.31 174.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.1 mt -124.25 151.61 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.133 1.373 . . . . 0.0 107.872 171.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -113.81 129.86 56.53 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.293 1.437 . . . . 0.0 109.073 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 57' ' ' ILE . 30.1 pt -129.76 14.12 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 125.568 1.547 . . . . 0.0 111.017 171.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.54 -28.1 31.24 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.372 1.469 . . . . 0.0 113.107 175.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.05 -9.5 86.74 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 118.372 0.533 . . . . 0.0 112.902 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -71.79 157.99 36.9 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.63 1.572 . . . . 0.0 109.614 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.48 165.15 31.15 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.54 144.84 49.43 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.682 1.993 . . . . 0.0 112.005 -172.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.65 139.41 1.67 Allowed Pre-proline 0 C--O 1.237 0.409 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 169.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -79.39 158.64 25.94 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.271 1.981 . . . . 0.0 110.845 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.6 tt -57.92 -37.2 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 124.707 1.203 . . . . 0.0 110.641 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -69.76 -21.87 63.4 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.357 0.663 . . . . 0.0 112.344 -174.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -22.2 60.94 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.28 0.491 . . . . 0.0 111.069 171.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -94.01 168.95 10.62 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 122.072 0.939 . . . . 0.0 110.646 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.39 93.41 2.43 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 125.451 1.5 . . . . 0.0 107.516 -175.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.478 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -50.0 -24.31 2.54 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 124.306 1.042 . . . . 0.0 113.392 175.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -50.81 -28.99 10.52 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.136 0.574 . . . . 0.0 111.318 173.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -91.92 -9.34 43.48 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.454 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 12.8 m-85 -120.2 112.93 19.69 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 120.595 1.543 . . . . 0.0 109.332 -173.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -65.54 -14.48 61.16 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -169.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.747 HG12 HG13 ' A' ' 4' ' ' VAL . 13.0 t -143.85 118.19 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 -171.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.3 m -128.19 134.2 65.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 O-C-N 120.875 -1.14 . . . . 0.0 108.718 -174.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.4 mm -127.5 97.14 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 104.203 -2.518 . . . . 0.0 104.203 -169.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.0 t -72.81 166.29 23.21 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 169.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.8 mp -144.27 40.19 1.33 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 173.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.499 ' HB3' HG21 ' A' ' 84' ' ' VAL . 60.9 m -100.04 12.0 37.96 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.334 1.054 . . . . 0.0 111.358 -172.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.7 23.53 28.04 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.512 -0.605 . . . . 0.0 111.862 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.44 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 4.0 t 45.65 45.7 11.1 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.857 1.663 . . . . 0.0 111.945 -177.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -153.53 35.9 0.75 Allowed Glycine 0 C--N 1.341 0.821 0 C-N-CA 123.405 0.526 . . . . 0.0 111.928 -171.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.499 HG21 ' HB3' ' A' ' 80' ' ' CYS . 78.5 t -122.43 133.16 69.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 125.039 1.335 . . . . 0.0 107.737 177.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -78.42 72.42 4.95 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 172.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.3 mt -57.73 145.98 68.15 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -55.1 155.24 19.65 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.046 1.831 . . . . 0.0 112.432 176.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -54.18 -29.28 55.61 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.549 2.166 . . . . 0.0 115.94 -173.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -66.25 -27.06 67.66 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 120.986 -1.071 . . . . 0.0 111.159 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.478 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 71.0 m95 -71.47 -3.63 22.12 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 117.91 -1.043 . . . . 0.0 113.165 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.0 m -120.71 -7.17 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 120.575 1.534 . . . . 0.0 113.471 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.8 p -87.28 -16.25 35.7 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.448 1.022 . . . . 0.0 112.632 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -54.02 163.33 0.79 Allowed 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 129.153 2.981 . . . . 0.0 113.605 175.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -64.89 -41.72 95.37 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.673 1.189 . . . . 0.0 108.708 176.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.497 ' HB ' HG13 ' A' ' 75' ' ' VAL . 32.7 mm -121.64 140.48 45.53 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 CA-C-O 121.58 0.705 . . . . 0.0 110.097 169.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -140.71 114.3 8.8 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 100.946 -3.724 . . . . 0.0 100.946 166.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -135.9 170.28 16.24 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 170.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.44 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.2 t70 -137.31 106.24 5.95 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 172.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.429 ' C ' ' H ' ' A' ' 101' ' ' LEU . 48.7 m0 -85.13 70.48 10.89 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -48.03 7.91 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.208 1 C-N-CA 131.836 4.054 . . . . 0.0 115.324 169.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.429 ' H ' ' C ' ' A' ' 99' ' ' TRP . 3.8 mm? -61.48 126.39 27.17 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 126.798 2.039 . . . . 0.0 111.338 -168.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 51.01 -160.04 0.09 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.826 2.051 . . . . 0.0 113.765 169.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -165.48 70.76 1.32 Allowed Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 128.101 2.561 . . . . 0.0 108.061 -172.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.95 -4.8 16.01 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 122.526 2.15 . . . . 0.0 114.215 -169.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -56.61 -34.19 66.99 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -173.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.35 40.65 1.94 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.651 1.119 . . . . 0.0 112.737 -174.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.415 ' HB3' ' H ' ' A' ' 108' ' ' SER . 16.5 mm-40 -116.13 -157.62 0.66 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.085 0.954 . . . . 0.0 111.89 -175.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.415 ' H ' ' HB3' ' A' ' 107' ' ' GLN . 9.9 m -131.11 173.56 10.9 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 128.662 2.785 . . . . 0.0 107.542 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 35.4 mt -54.7 -36.06 64.3 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.962 0.905 . . . . 0.0 110.785 -172.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -60.13 -40.0 88.22 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 123.031 0.532 . . . . 0.0 110.269 -175.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.61 -37.82 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.091 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -53.68 -42.73 68.27 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.948 1.249 . . . . 0.0 111.255 170.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -63.44 -43.76 96.5 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 119.607 1.094 . . . . 0.0 111.141 174.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.1 m -71.91 -43.39 65.42 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -171.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 57.9 t -64.48 -47.19 90.33 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -173.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.3 ttp180 -45.08 -50.38 11.06 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 125.475 1.51 . . . . 0.0 111.026 169.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.69 -43.4 96.34 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 119.576 1.08 . . . . 0.0 112.696 177.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -75.91 -31.68 59.27 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 120.956 -1.32 . . . . 0.0 110.652 -175.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.2 -37.75 80.27 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 170.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.415 ' HE2' ' HB3' ' A' ' 120' ' ' LYS . 5.7 mtpt -57.8 -47.79 81.57 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 120.595 1.543 . . . . 0.0 110.876 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -62.05 -38.25 88.03 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.021 0.826 . . . . 0.0 109.011 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -68.13 -47.18 68.81 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.404 0.681 . . . . 0.0 110.878 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.6 t -56.49 -52.51 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.87 1.268 . . . . 0.0 108.738 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -68.66 -33.37 73.87 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -171.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -62.16 -49.43 75.87 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 123.099 0.56 . . . . 0.0 110.852 171.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.87 -46.14 78.33 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 122.978 0.511 . . . . 0.0 109.876 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.7 mt -58.85 -43.84 89.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 124.807 1.243 . . . . 0.0 110.687 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.71 -29.06 67.85 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 118.782 0.719 . . . . 0.0 111.726 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -74.71 -40.64 61.2 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 118.538 0.608 . . . . 0.0 112.032 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.9 pt -100.62 -42.38 9.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 116.976 2.213 . . . . 0.0 116.976 -168.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.254 1.307 0 CA-C-N 119.195 0.907 . . . . 0.0 110.304 -171.909 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 tpt . . . . . 0 N--CA 1.499 1.977 0 CA-C-O 117.706 -1.14 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.512 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -54.96 118.02 3.93 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 121.337 1.881 . . . . 0.0 110.377 -169.69 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.495 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 56.2 mtpt -86.19 135.47 33.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -170.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.75 HG13 HG12 ' A' ' 75' ' ' VAL . 9.0 t -125.36 153.71 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 61.4 tpp -140.59 131.91 26.69 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -176.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.409 ' HE1' HG13 ' A' ' 32' ' ' VAL . 92.5 m-85 -116.17 107.27 14.68 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.452 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 3.9 t -94.39 144.31 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -169.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.4 t -128.0 -177.76 4.26 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.38 1.072 . . . . 0.0 110.185 172.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -152.4 -45.93 0.1 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.63 1.572 . . . . 0.0 108.688 176.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -167.7 0.17 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.187 0.995 . . . . 0.0 109.017 169.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.484 HD21 ' CD2' ' A' ' 43' ' ' HIS . 26.6 t-20 -47.94 139.58 7.69 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.698 0.799 . . . . 0.0 109.614 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -55.22 -22.9 19.63 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.504 1.522 . . . . 0.0 114.396 -169.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.9 m -42.2 -67.5 0.26 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 127.21 2.204 . . . . 0.0 114.318 -172.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.272 34.9 ptt180 -56.19 -47.67 77.87 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.451 1.478 . . . . 0.0 114.715 -167.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.43 -29.98 21.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 119.005 0.82 . . . . 0.0 111.315 -171.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -70.09 -27.01 64.26 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.112 -0.992 . . . . 0.0 110.023 170.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.473 ' SD ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -69.03 -42.25 76.6 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 120.574 -1.329 . . . . 0.0 109.789 169.439 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.08 -40.21 84.54 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -59.65 -39.09 83.26 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.42 169.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.19 -43.08 56.77 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 120.715 1.598 . . . . 0.0 112.587 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.473 ' CD2' ' SD ' ' A' ' 17' ' ' MET . 10.6 m-85 -64.68 -37.52 87.88 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 119.075 1.438 . . . . 0.0 108.989 170.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.526 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -72.45 -39.17 68.0 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 119.497 1.044 . . . . 0.0 111.118 -173.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -65.27 -33.79 76.81 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 120.371 1.441 . . . . 0.0 110.915 174.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.8 m -69.06 -50.98 43.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.285 1.834 . . . . 0.0 110.232 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.0 mt -90.06 -25.83 20.58 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.55 1.14 . . . . 0.0 112.129 -169.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.23 14.84 58.15 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 126.748 2.118 . . . . 0.0 111.903 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.66 120.82 10.77 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.908 1.283 . . . . 0.0 110.091 -171.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.11 8.53 86.93 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-O 119.811 -0.439 . . . . 0.0 113.511 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -123.1 -28.45 4.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.413 1.485 . . . . 0.0 109.583 -176.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.6 pt -143.35 175.87 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 125.832 1.653 . . . . 0.0 109.386 176.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.56 145.12 46.66 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 103.868 -2.641 . . . . 0.0 103.868 168.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.526 HG11 ' HB3' ' A' ' 22' ' ' ALA . 2.1 t -132.17 144.04 38.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 123.851 0.86 . . . . 0.0 111.316 -167.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.75 161.97 41.18 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.799 1.24 . . . . 0.0 109.723 -173.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.428 ' H ' HG21 ' A' ' 61' ' ' THR . 22.9 t -142.18 154.76 45.09 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.688 1.586 . . . . 0.0 109.524 172.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.6 p -157.11 171.03 21.18 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 118.509 0.595 . . . . 0.0 112.312 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.091 0 N-CA-C 107.786 -2.126 . . . . 0.0 107.786 -169.985 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.235 0.33 0 CA-C-O 121.248 0.547 . . . . 0.0 110.528 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.484 ' CD2' HD21 ' A' ' 11' ' ' ASN . 20.9 t-80 -139.75 119.52 9.09 Favored Pre-proline 0 N--CA 1.451 -0.403 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -176.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -67.11 -27.28 42.06 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.057 2.505 . . . . 0.0 112.555 -169.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.7 m -62.43 -35.48 79.38 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.967 0.803 . . . . 0.0 109.53 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.23 -43.03 92.77 Favored 'General case' 0 C--O 1.221 -0.447 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.57 -47.84 89.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 118.206 -0.902 . . . . 0.0 109.382 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.35 -42.69 99.1 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 119.633 1.106 . . . . 0.0 110.878 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.0 mmt -64.32 -18.2 64.39 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.765 0.826 . . . . 0.0 112.112 176.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 3.9 mmt -95.02 -28.03 15.33 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 119.387 0.994 . . . . 0.0 110.992 173.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -63.6 -30.01 71.18 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 123.62 0.768 . . . . 0.0 109.694 172.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -57.96 -21.13 42.73 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.535 1.134 . . . . 0.0 113.101 170.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.4 p -121.44 9.03 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 125.229 1.412 . . . . 0.0 110.386 -177.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.32 36.88 85.5 Favored Glycine 0 CA--C 1.531 1.072 0 O-C-N 121.148 -0.97 . . . . 0.0 111.808 177.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 35.3 mt -121.83 157.93 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 126.2 1.8 . . . . 0.0 106.153 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -140.33 145.08 36.73 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 172.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 27.6 pt -138.55 7.7 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 126.354 1.862 . . . . 0.0 111.023 -174.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.3 t -64.28 145.67 55.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.612 -0.68 . . . . 0.0 109.289 172.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.63 3.52 5.75 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 117.802 -1.555 . . . . 0.0 114.552 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -54.6 -58.7 6.49 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-N 119.776 1.788 . . . . 0.0 111.481 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.428 HG21 ' H ' ' A' ' 34' ' ' SER . 1.0 OUTLIER -154.77 154.03 32.16 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 125.57 1.548 . . . . 0.0 106.986 -169.331 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.0 m -163.43 68.03 0.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 102.428 -3.175 . . . . 0.0 102.428 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -142.46 141.44 20.82 Favored Pre-proline 0 C--O 1.236 0.347 0 CA-C-O 119.152 -0.451 . . . . 0.0 112.195 -167.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -82.66 159.99 16.58 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.522 2.815 . . . . 0.0 111.268 173.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.63 -36.87 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 124.463 1.105 . . . . 0.0 111.778 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -70.46 -19.96 62.92 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.277 0.631 . . . . 0.0 112.16 -173.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.25 -23.9 62.98 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 118.763 -0.637 . . . . 0.0 111.6 170.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -99.82 169.71 9.04 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 122.128 0.966 . . . . 0.0 111.093 -174.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -142.59 90.69 2.25 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 -170.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.508 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -54.26 -22.79 12.67 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.4 -21.07 5.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 122.943 0.497 . . . . 0.0 111.301 171.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -111.31 17.09 20.54 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.881 2.072 . . . . 0.0 112.346 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.495 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 28.4 m-85 -132.82 107.57 8.43 Favored 'General case' 0 C--N 1.345 0.407 0 O-C-N 120.685 -1.259 . . . . 0.0 107.787 170.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -58.94 -18.86 37.45 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -169.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.75 HG12 HG13 ' A' ' 4' ' ' VAL . 10.5 t -143.07 123.43 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -170.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 t -118.06 134.45 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.8 mm -131.98 87.69 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.452 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 29.1 t -68.31 165.8 17.84 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.988 -1.07 . . . . 0.0 108.653 169.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -144.5 53.03 1.25 Allowed 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 170.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.527 ' HB3' HG21 ' A' ' 84' ' ' VAL . 43.3 m -113.53 15.73 18.93 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.11 0.964 . . . . 0.0 110.583 -176.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.68 24.7 29.73 Favored Glycine 0 C--N 1.339 0.723 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 172.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.412 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 6.7 t 44.54 42.44 5.62 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.311 1.844 . . . . 0.0 112.327 -176.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -151.66 37.88 0.82 Allowed Glycine 0 C--N 1.339 0.72 0 C-N-CA 123.53 0.586 . . . . 0.0 112.012 -171.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.527 HG21 ' HB3' ' A' ' 80' ' ' CYS . 94.5 t -120.24 141.67 39.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 C-N-CA 124.753 1.221 . . . . 0.0 108.612 178.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -82.03 55.95 2.97 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.588 1.155 . . . . 0.0 110.159 -178.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.4 mt -57.15 133.64 80.73 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.59 154.6 19.6 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.666 2.244 . . . . 0.0 112.758 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -55.0 -27.98 57.33 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.619 2.213 . . . . 0.0 116.208 -172.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -65.45 -25.36 67.48 Favored 'General case' 0 C--O 1.226 -0.147 0 O-C-N 121.284 -0.885 . . . . 0.0 111.288 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.508 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 61.7 m95 -67.93 -8.66 38.76 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.251 -0.906 . . . . 0.0 112.813 175.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.3 t -107.78 -30.54 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.022 1.329 . . . . 0.0 111.122 -170.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.7 p -74.65 -16.77 60.76 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.37 1.068 . . . . 0.0 113.688 -169.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -50.56 160.76 0.38 Allowed 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 130.213 3.405 . . . . 0.0 114.308 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -60.11 -39.41 86.08 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.414 1.486 . . . . 0.0 108.591 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.612 ' HB ' HG13 ' A' ' 75' ' ' VAL . 36.2 mm -126.32 137.07 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 169.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -137.49 113.09 9.48 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 102.156 -3.276 . . . . 0.0 102.156 166.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -140.75 166.66 24.15 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 9.5 t70 -139.67 110.56 6.83 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 169.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -83.04 81.98 8.44 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.401 ' H ' ' CD ' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -61.33 25.6 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 127.337 2.255 . . . . 0.0 114.564 178.355 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.57 175.64 2.77 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.696 -1.253 . . . . 0.0 110.372 -172.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.79 160.46 2.62 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 123.238 1.494 . . . . 0.0 114.542 -170.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -103.91 108.08 58.73 Favored Pre-proline 0 C--N 1.322 -0.608 0 C-N-CA 127.01 2.124 . . . . 0.0 108.717 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -80.85 -6.65 13.32 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.609 2.206 . . . . 0.0 112.014 177.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.7 t0 22.9 -99.33 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 128.389 2.676 . . . . 0.0 113.336 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.64 39.91 1.66 Allowed Glycine 0 CA--C 1.531 1.084 0 C-N-CA 127.119 2.295 . . . . 0.0 108.7 169.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -70.38 -178.07 1.63 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.397 1.879 . . . . 0.0 112.635 -175.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.3 m -61.3 153.67 25.88 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 113.376 -1.738 . . . . 0.0 108.731 171.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.7 mt -56.68 -29.73 62.66 Favored 'General case' 0 C--O 1.221 -0.396 0 C-N-CA 122.954 0.502 . . . . 0.0 110.82 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -61.24 -39.68 91.21 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.058 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.5 t -73.72 -40.02 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.257 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -51.13 -51.45 53.4 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.738 1.154 . . . . 0.0 111.326 169.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -59.05 -45.18 91.41 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.441 0.696 . . . . 0.0 110.958 178.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.1 m -67.58 -45.71 74.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -173.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.3 t -66.02 -48.24 82.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -171.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -44.1 -56.83 3.76 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.783 1.233 . . . . 0.0 110.575 169.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.94 -41.76 99.82 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 119.968 1.258 . . . . 0.0 111.948 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -63.75 -41.73 97.97 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.516 -0.99 . . . . 0.0 110.263 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.35 -39.07 82.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -41.45 83.41 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 120.013 1.279 . . . . 0.0 110.642 -175.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.69 -40.41 80.07 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.633 0.373 . . . . 0.0 110.063 177.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -64.49 -47.11 80.15 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.618 0.644 . . . . 0.0 110.292 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.1 t -56.05 -51.38 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 124.049 0.939 . . . . 0.0 108.469 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -66.01 -32.36 73.79 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 119.353 -0.356 . . . . 0.0 111.5 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -62.51 -48.07 81.16 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 118.612 0.642 . . . . 0.0 111.013 173.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -42.98 91.55 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 123.247 0.619 . . . . 0.0 110.624 176.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.0 mt -62.26 -43.09 97.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 123.102 0.561 . . . . 0.0 110.116 175.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.35 -31.68 71.57 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.311 0.959 . . . . 0.0 112.039 -175.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.478 ' HE2' HD11 ' A' ' 95' ' ' ILE . 14.1 ptmt -81.37 -35.08 31.26 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 117.763 -1.113 . . . . 0.0 112.978 175.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 pt -96.52 -43.66 12.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 115.421 1.638 . . . . 0.0 115.421 -173.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.2 m . . . . . 0 C--O 1.256 1.444 0 C-N-CA 124.636 1.174 . . . . 0.0 111.586 -171.165 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mmm . . . . . 0 N--CA 1.502 2.131 0 CA-C-O 119.257 -0.402 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.727 ' HG2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -59.31 137.74 57.87 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 169.463 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.43 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 25.0 mtpt -112.19 142.06 45.13 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 -169.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.753 HG13 HG12 ' A' ' 75' ' ' VAL . 11.5 t -122.86 155.29 28.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -174.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 57.0 tpp -136.68 134.25 37.05 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -115.74 112.07 21.49 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.448 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 3.4 t -96.32 136.72 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -169.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.3 m -109.72 149.95 29.02 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.258 1.023 . . . . 0.0 112.237 -169.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.7 mmtt -150.07 146.09 26.74 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.372 1.869 . . . . 0.0 106.054 169.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.468 ' CG ' ' H ' ' A' ' 11' ' ' ASN . 27.0 ttm180 57.01 -172.44 0.08 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.544 1.138 . . . . 0.0 109.307 -168.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.475 HD21 ' CD2' ' A' ' 43' ' ' HIS . 37.0 t-20 -49.95 105.36 0.09 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.418 1.487 . . . . 0.0 107.857 -177.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 m -62.06 0.15 0.44 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 117.137 2.273 . . . . 0.0 117.137 -167.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.1 m -38.22 -50.57 1.43 Allowed 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 126.36 1.864 . . . . 0.0 111.923 173.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -65.23 -43.25 92.03 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.243 0.545 . . . . 0.0 111.329 -171.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.1 p -88.45 -37.75 15.57 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 124.422 1.089 . . . . 0.0 111.1 -170.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -72.13 -32.08 66.61 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.552 -0.717 . . . . 0.0 109.545 174.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.415 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.5 tpt -62.09 -39.22 91.72 Favored 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 121.158 -0.964 . . . . 0.0 109.685 169.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.07 92.1 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -62.94 -39.16 93.76 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.204 170.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.77 -43.07 68.5 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 120.852 1.66 . . . . 0.0 111.275 -174.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -63.53 -40.4 96.94 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 170.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.29 -40.27 81.84 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 119.58 1.082 . . . . 0.0 111.464 -176.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.479 ' HA ' HG21 ' A' ' 32' ' ' VAL . 13.4 pttp -70.84 -22.72 62.28 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 120.455 1.48 . . . . 0.0 112.373 176.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.9 m -77.79 -52.13 9.4 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.763 1.625 . . . . 0.0 110.23 175.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 71.1 mt -85.33 -26.49 26.51 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.017 1.327 . . . . 0.0 111.606 -169.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.63 15.27 55.97 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 126.74 2.114 . . . . 0.0 111.707 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.91 121.94 12.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.668 1.187 . . . . 0.0 109.936 -175.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.04 8.05 87.46 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 119.752 -0.471 . . . . 0.0 113.385 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -122.6 -32.25 3.61 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 125.234 1.414 . . . . 0.0 109.36 -177.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.727 HG22 ' HG2' ' A' ' 2' ' ' LYS . 12.6 pt -141.55 163.92 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 125.018 1.327 . . . . 0.0 110.54 177.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.74 144.18 31.43 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 168.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.479 HG21 ' HA ' ' A' ' 23' ' ' LYS . 2.2 t -136.27 135.12 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.472 0.709 . . . . 0.0 110.512 -168.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.7 m -147.31 161.4 41.04 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.776 1.231 . . . . 0.0 109.501 -178.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.5 p -128.09 161.67 28.67 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.726 1.21 . . . . 0.0 109.491 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.5 p -152.31 147.56 26.48 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 121.328 -0.858 . . . . 0.0 111.709 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.621 0 N-CA-C 105.154 -3.178 . . . . 0.0 105.154 -168.328 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.6 m . . . . . 0 C--O 1.234 0.238 0 CA-C-O 121.981 0.896 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.475 ' CD2' HD21 ' A' ' 11' ' ' ASN . 82.9 t60 -134.15 116.23 13.22 Favored Pre-proline 0 N--CA 1.446 -0.671 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 -175.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -64.75 -24.26 62.05 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 123.714 2.942 . . . . 0.0 112.7 -169.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.0 m -61.27 -36.64 80.61 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.106 0.867 . . . . 0.0 109.731 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.15 -45.1 82.17 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -56.37 -49.24 77.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.49 -42.93 99.53 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.41 0.55 . . . . 0.0 111.024 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.6 mmt -61.51 -23.99 66.3 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 124.251 1.021 . . . . 0.0 113.337 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.415 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 4.3 mmt -101.98 -24.11 14.03 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.084 0.856 . . . . 0.0 108.958 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -64.94 -34.75 79.15 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 118.952 0.796 . . . . 0.0 109.435 171.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -72.6 7.1 2.04 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 173.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.3 t -119.29 -39.56 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 127.23 2.212 . . . . 0.0 110.023 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.94 24.14 2.58 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.375 1.464 . . . . 0.0 112.884 -176.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.7 mt -124.42 161.6 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 125.879 1.671 . . . . 0.0 107.222 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -108.19 -61.5 1.58 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -169.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . 0.421 28.7 pt 56.17 1.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 118.245 2.683 . . . . 0.0 118.245 -177.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.76 147.93 43.03 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 120.899 1.681 . . . . 0.0 109.39 169.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.69 1.42 11.45 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 118.248 -1.307 . . . . 0.0 114.777 176.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -48.47 -65.32 0.59 Allowed 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.258 1.529 . . . . 0.0 113.23 -177.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.9 166.15 25.74 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 123.672 0.608 . . . . 0.0 112.548 -168.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.9 p -169.56 22.81 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.91 0.884 . . . . 0.0 112.565 -171.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -139.47 150.36 63.46 Favored Pre-proline 0 N--CA 1.475 0.821 0 CA-C-N 119.895 1.225 . . . . 0.0 112.193 -169.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -84.25 162.54 13.23 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 124.095 3.196 . . . . 0.0 112.909 -170.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.1 tt -57.43 -36.4 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.99 1.716 . . . . 0.0 111.269 -176.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -73.86 -16.37 61.13 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -170.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.16 -17.07 44.19 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 118.691 -0.671 . . . . 0.0 111.793 170.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -88.79 170.47 10.73 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.195 0.907 . . . . 0.0 110.721 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.7 89.91 2.24 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.451 1.501 . . . . 0.0 107.921 -177.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.496 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -52.39 -23.16 5.52 Favored 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 176.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -50.86 -30.2 13.85 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.349 0.66 . . . . 0.0 111.398 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -91.71 4.18 53.35 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.43 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 22.2 m-85 -131.83 114.8 15.14 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 120.437 1.471 . . . . 0.0 109.454 -177.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -69.78 -6.91 35.33 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -169.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.753 HG12 HG13 ' A' ' 4' ' ' VAL . 24.7 t -145.02 123.31 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -171.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.0 t -118.51 127.39 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.8 mm -121.45 94.3 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 171.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.448 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 18.2 p -73.95 167.52 21.32 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 118.252 -1.379 . . . . 0.0 107.747 168.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mp -143.02 41.82 1.53 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 173.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.419 ' HB3' HG21 ' A' ' 84' ' ' VAL . 59.1 m -101.03 -5.49 25.71 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.523 1.529 . . . . 0.0 112.188 -168.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.15 15.64 7.09 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-N 119.543 1.065 . . . . 0.0 113.985 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 6.0 t 45.5 56.06 6.07 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.77 1.628 . . . . 0.0 111.172 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -175.52 -26.18 0.03 OUTLIER Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.479 -172.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.419 HG21 ' HB3' ' A' ' 80' ' ' CYS . 78.5 t -56.6 121.21 4.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 169.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -65.41 136.45 56.5 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 173.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.5 mt -123.71 144.34 44.27 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 176.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.25 156.72 9.96 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.6 2.2 . . . . 0.0 112.997 176.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -53.91 -30.39 58.08 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.824 2.349 . . . . 0.0 116.399 -170.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -67.04 -26.0 66.54 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.377 -0.827 . . . . 0.0 111.328 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.496 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 66.2 m95 -69.67 -13.25 62.21 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 120.87 -1.144 . . . . 0.0 113.388 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.96 -9.35 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 119.721 1.146 . . . . 0.0 112.957 -169.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.1 p -85.79 -10.26 55.76 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.253 1.021 . . . . 0.0 112.714 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -60.46 167.94 2.35 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 128.974 2.91 . . . . 0.0 113.18 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.88 -40.96 87.95 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.651 1.181 . . . . 0.0 108.951 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.535 ' HB ' HG13 ' A' ' 75' ' ' VAL . 26.7 mm -119.93 139.27 47.79 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 CA-C-O 121.163 0.506 . . . . 0.0 109.717 170.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -144.66 106.5 4.29 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 102.16 -3.274 . . . . 0.0 102.16 166.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -132.84 168.21 18.81 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 175.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -139.67 111.66 7.45 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 171.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.451 ' CD2' ' HB3' ' A' ' 122' ' ' ARG . 45.5 m0 -92.13 65.65 4.76 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -33.19 -52.07 0.35 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.52 1.928 . . . . 0.0 111.773 177.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 40.1 -170.56 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 129.851 3.261 . . . . 0.0 114.371 -175.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.56 175.61 1.02 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 122.79 1.281 . . . . 0.0 111.887 170.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -127.28 103.83 22.63 Favored Pre-proline 0 C--N 1.321 -0.657 0 C-N-CA 128.232 2.613 . . . . 0.0 107.418 -170.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.3 -4.2 14.49 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.648 2.232 . . . . 0.0 112.602 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.3 t0 20.13 -95.06 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.784 2.834 . . . . 0.0 113.791 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.67 40.39 1.55 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 127.141 2.305 . . . . 0.0 109.151 169.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -75.16 179.01 5.31 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.722 1.609 . . . . 0.0 113.098 -170.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.3 p -62.35 157.38 19.99 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 113.148 -1.842 . . . . 0.0 109.634 171.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 21.7 mt -57.68 -30.42 65.44 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.602 176.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.34 -41.3 98.46 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 118.695 -0.669 . . . . 0.0 111.099 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.2 t -71.78 -40.81 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 117.705 -1.141 . . . . 0.0 109.238 178.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -50.7 -51.42 49.74 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.909 1.232 . . . . 0.0 111.725 169.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -59.05 -45.52 90.57 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.025 0.829 . . . . 0.0 110.931 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.7 m -68.09 -43.01 79.5 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -174.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.9 t -64.83 -49.75 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -175.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -48.08 -56.12 8.55 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.963 1.305 . . . . 0.0 111.017 173.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.09 -41.73 99.72 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 119.111 0.869 . . . . 0.0 111.519 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -66.78 -37.77 85.24 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.205 -1.173 . . . . 0.0 110.532 -178.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.4 t -62.87 -42.71 97.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 173.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -35.95 75.59 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 119.819 1.191 . . . . 0.0 111.352 -174.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -69.01 -43.08 75.52 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.512 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.451 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 10.4 mpt_? -64.18 -41.66 97.02 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.923 1.238 . . . . 0.0 110.559 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.7 t -54.23 -54.35 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 173.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -64.93 -32.65 74.47 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 122.012 -0.43 . . . . 0.0 111.599 -174.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -62.34 -48.25 80.65 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 123.368 0.667 . . . . 0.0 111.363 171.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -48.35 75.09 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 118.56 0.618 . . . . 0.0 109.562 175.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.7 mt -58.09 -42.19 82.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 123.804 0.842 . . . . 0.0 109.287 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.93 -31.43 71.75 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.797 0.726 . . . . 0.0 111.74 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -72.3 -42.77 65.1 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.554 173.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.2 pt -103.28 -46.2 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 118.607 2.817 . . . . 0.0 118.607 -168.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.5 m . . . . . 0 C--O 1.253 1.247 0 C-N-CA 124.06 0.944 . . . . 0.0 111.883 -169.177 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.9 mmm . . . . . 0 N--CA 1.501 2.084 0 N-CA-C 111.483 0.179 . . . . 0.0 111.483 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.635 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -58.44 132.57 54.11 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 172.337 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.506 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 53.1 mtpt -99.05 138.85 35.56 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -172.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.674 HG13 HG12 ' A' ' 75' ' ' VAL . 11.1 t -134.11 153.66 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 123.005 0.522 . . . . 0.0 109.716 -171.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 47.4 tpp -139.53 147.95 41.93 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.627 0.771 . . . . 0.0 109.792 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -132.1 112.21 12.13 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.46 1.504 . . . . 0.0 107.611 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 4.1 t -97.1 137.42 24.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -172.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 m -120.08 146.59 45.78 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -169.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -150.75 164.71 35.52 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.465 1.906 . . . . 0.0 108.602 174.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.468 ' HD3' ' H ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER 54.75 -146.1 0.58 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.668 1.587 . . . . 0.0 108.589 -169.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.468 ' H ' ' HD3' ' A' ' 10' ' ' ARG . 55.3 t-20 -65.55 99.37 0.43 Allowed 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 173.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.7 m -64.36 -4.01 3.45 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -173.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.441 ' HA ' ' HG2' ' A' ' 16' ' ' GLN . 68.4 m -48.0 -38.65 17.53 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 119.309 0.959 . . . . 0.0 113.062 169.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -62.91 -41.08 99.32 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 120.051 1.296 . . . . 0.0 111.909 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.41 -37.07 12.78 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 123.766 0.826 . . . . 0.0 109.613 -169.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.509 HE22 HG12 ' A' ' 42' ' ' VAL . 11.6 pt20 -66.84 -31.15 71.58 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.102 -0.998 . . . . 0.0 110.127 169.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.438 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.9 tpt -62.88 -37.44 86.9 Favored 'General case' 0 CA--C 1.51 -0.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.448 171.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.99 90.5 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -64.84 -38.04 89.64 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.153 169.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.9 -42.32 96.99 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 120.931 1.696 . . . . 0.0 111.811 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -66.73 -37.44 84.68 Favored 'General case' 0 C--O 1.222 -0.356 0 O-C-N 121.861 -0.788 . . . . 0.0 109.296 170.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.05 -35.19 69.25 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 119.539 1.063 . . . . 0.0 111.652 -175.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -66.93 -34.39 77.66 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 121.382 1.901 . . . . 0.0 111.425 171.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.2 m -69.39 -50.61 44.4 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.509 1.524 . . . . 0.0 110.343 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.0 mt -91.83 -25.55 18.93 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.079 1.352 . . . . 0.0 111.905 -169.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.97 8.72 76.09 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 126.675 2.083 . . . . 0.0 112.195 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.51 121.88 13.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.393 1.077 . . . . 0.0 110.064 -170.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.91 9.93 85.12 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 119.975 -0.347 . . . . 0.0 113.477 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.7 mmtt -122.18 -36.8 2.91 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 125.947 1.699 . . . . 0.0 109.192 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.9 pt -138.44 162.96 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.873 1.269 . . . . 0.0 108.987 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.44 132.78 53.81 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 169.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.41 140.65 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 119.745 1.157 . . . . 0.0 113.308 -168.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.4 m -142.58 166.94 23.3 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.51 1.524 . . . . 0.0 109.903 -169.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.8 p -136.69 158.83 43.54 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.721 1.208 . . . . 0.0 110.069 176.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.479 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 27.5 p -151.81 158.66 43.58 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 122.83 0.452 . . . . 0.0 110.479 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.03 144.59 1.07 Allowed Glycine 0 CA--C 1.532 1.112 0 N-CA-C 106.857 -2.497 . . . . 0.0 106.857 -168.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.8 tp -163.04 61.29 0.19 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 102.751 -3.055 . . . . 0.0 102.751 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -60.8 -15.44 29.88 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.953 1.301 . . . . 0.0 113.828 -168.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 p -78.04 8.48 4.72 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.247 1.019 . . . . 0.0 113.586 173.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.6 m 59.68 -13.22 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 129.782 3.233 . . . . 0.0 115.425 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.22 170.49 22.37 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.858 2.463 . . . . 0.0 106.602 176.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.509 HG12 HE22 ' A' ' 16' ' ' GLN . 19.5 m -73.36 173.37 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 169.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -128.73 111.11 18.89 Favored Pre-proline 0 C--O 1.233 0.194 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -171.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -51.54 -30.44 35.82 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.855 3.037 . . . . 0.0 114.913 -174.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -60.42 -39.13 86.32 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.995 0.816 . . . . 0.0 110.964 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.72 -44.85 76.65 Favored 'General case' 0 CA--C 1.513 -0.444 0 O-C-N 121.448 -0.782 . . . . 0.0 109.062 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.02 -44.39 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.45 -43.91 96.37 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.507 0.594 . . . . 0.0 111.525 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.8 mmt -65.67 -18.74 65.55 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 118.879 -0.582 . . . . 0.0 112.3 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.438 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.8 OUTLIER -96.4 -31.64 12.75 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -178.138 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -63.08 -33.4 75.36 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.166 1.386 . . . . 0.0 110.003 169.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -58.49 -15.97 13.29 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.114 1.766 . . . . 0.0 111.845 172.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.4 m -130.62 12.84 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 126.156 1.783 . . . . 0.0 111.683 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.4 42.84 80.86 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 121.173 -0.955 . . . . 0.0 113.772 175.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.3 mt -124.69 155.27 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.81 1.644 . . . . 0.0 107.73 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -123.84 125.55 44.87 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.826 1.25 . . . . 0.0 108.296 -178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 44.9 pt -128.53 9.99 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.51 1.124 . . . . 0.0 112.339 173.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.65 -30.47 41.28 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.521 1.528 . . . . 0.0 111.935 174.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.43 -12.87 73.61 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 118.097 0.408 . . . . 0.0 112.679 177.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -76.86 153.0 35.22 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.773 1.229 . . . . 0.0 109.654 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.7 p -150.47 168.74 23.29 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.4 m -64.19 138.56 58.5 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.851 1.661 . . . . 0.0 111.393 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -163.1 123.25 1.42 Allowed Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 104.874 -2.269 . . . . 0.0 104.874 169.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -75.83 150.55 34.84 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.573 2.182 . . . . 0.0 113.315 -168.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.7 tt -55.96 -35.62 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.702 1.601 . . . . 0.0 111.395 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -68.75 -21.58 64.36 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.204 0.601 . . . . 0.0 112.177 -174.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.2 -10.55 57.62 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.336 0.654 . . . . 0.0 111.999 173.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.479 ' CE2' ' HB3' ' A' ' 35' ' ' CYS . 67.0 m-85 -92.69 168.49 11.18 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.908 0.861 . . . . 0.0 110.418 176.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -145.79 89.86 1.94 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 -171.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.489 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -51.47 -24.73 5.39 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -20.64 8.73 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.02 0.528 . . . . 0.0 111.528 173.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -107.02 13.76 27.17 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.383 1.873 . . . . 0.0 112.374 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.506 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 38.6 m-85 -135.24 108.85 7.95 Favored 'General case' 0 CA--C 1.516 -0.332 0 O-C-N 120.805 -1.184 . . . . 0.0 108.578 172.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.77 -16.05 36.27 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -170.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.674 HG12 HG13 ' A' ' 4' ' ' VAL . 11.9 t -144.85 121.31 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 -170.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.66 132.13 64.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 O-C-N 120.521 -1.362 . . . . 0.0 108.85 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.0 mm -125.68 96.93 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 N-CA-C 104.683 -2.34 . . . . 0.0 104.683 -171.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.438 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 36.6 t -72.31 164.68 25.89 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 169.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mp -142.69 38.04 1.48 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 170.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.607 ' HB3' HG21 ' A' ' 84' ' ' VAL . 76.9 m -96.2 4.4 52.45 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.566 1.147 . . . . 0.0 111.291 -169.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.77 20.9 17.66 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 111.329 -0.709 . . . . 0.0 111.329 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.464 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 5.2 t 46.33 39.94 7.06 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.104 1.762 . . . . 0.0 112.314 -176.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -150.23 33.46 1.02 Allowed Glycine 0 C--N 1.339 0.7 0 C-N-CA 123.754 0.692 . . . . 0.0 111.795 -172.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.607 HG21 ' HB3' ' A' ' 80' ' ' CYS . 93.9 t -121.85 136.58 58.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 125.183 1.393 . . . . 0.0 107.652 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -82.35 67.59 8.44 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.182 0.993 . . . . 0.0 109.836 -172.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.8 mt -58.6 142.3 83.2 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -53.14 154.06 14.76 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.758 2.306 . . . . 0.0 111.63 171.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.19 -19.15 56.83 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 121.646 1.564 . . . . 0.0 114.403 -170.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.81 -26.95 68.86 Favored 'General case' 0 C--O 1.225 -0.233 0 O-C-N 121.205 -0.934 . . . . 0.0 110.983 175.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.489 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 71.8 m95 -68.08 -4.82 14.78 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.089 -1.007 . . . . 0.0 112.651 174.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -108.61 -28.96 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 120.04 1.291 . . . . 0.0 111.025 -174.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.5 p -76.91 -16.58 59.34 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.574 0.954 . . . . 0.0 113.574 -169.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -52.88 161.04 0.83 Allowed 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 129.354 3.062 . . . . 0.0 113.949 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -62.17 -38.96 91.03 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.084 1.354 . . . . 0.0 108.754 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.529 ' HB ' HG13 ' A' ' 75' ' ' VAL . 33.5 mm -126.17 138.01 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 169.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -139.67 112.26 7.84 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 101.359 -3.571 . . . . 0.0 101.359 167.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -135.16 167.78 20.36 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 9.7 t70 -139.33 104.69 5.04 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 171.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 43.1 m0 -83.73 77.99 9.78 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -54.54 41.79 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 131.6 3.96 . . . . 0.0 113.796 171.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.63 -176.6 3.33 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.961 1.304 . . . . 0.0 112.637 -168.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -51.43 169.09 0.06 Allowed 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 127.477 2.311 . . . . 0.0 112.529 175.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -127.21 107.92 21.55 Favored Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 125.975 1.71 . . . . 0.0 108.558 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -82.31 -2.1 10.99 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.044 1.83 . . . . 0.0 112.985 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.3 t0 20.06 -91.85 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 128.869 2.868 . . . . 0.0 114.408 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.95 42.11 1.36 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 126.015 1.769 . . . . 0.0 110.532 172.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -78.31 -176.8 4.86 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.26 1.424 . . . . 0.0 113.297 -171.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.7 p -64.15 162.79 13.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 113.859 -1.519 . . . . 0.0 110.269 173.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.1 mt -55.68 -33.91 64.57 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 122.819 0.448 . . . . 0.0 110.542 175.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -62.64 -38.11 88.98 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 118.391 -0.814 . . . . 0.0 110.774 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.3 t -73.98 -45.1 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 119.515 1.052 . . . . 0.0 108.777 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -52.01 -38.0 55.32 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.765 1.166 . . . . 0.0 112.832 172.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -68.99 -46.3 68.41 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 119.778 1.172 . . . . 0.0 112.188 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.5 m -71.69 -42.46 67.38 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 119.342 -0.361 . . . . 0.0 110.357 -169.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 63.8 t -67.82 -44.52 85.45 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -173.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -47.16 -53.27 13.41 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 124.853 1.261 . . . . 0.0 110.386 169.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.86 -45.39 96.29 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 119.325 0.966 . . . . 0.0 111.538 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -66.29 -36.9 84.15 Favored 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 121.683 -0.892 . . . . 0.0 111.418 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.8 t -62.66 -43.31 98.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 174.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -36.13 78.32 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 119.781 1.173 . . . . 0.0 111.56 -174.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -68.14 -42.34 80.27 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.432 -0.794 . . . . 0.0 110.131 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -63.07 -43.57 98.2 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.748 1.158 . . . . 0.0 110.431 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 75.9 t -54.81 -52.55 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 C-N-CA 123.607 0.763 . . . . 0.0 109.582 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -66.77 -32.65 74.08 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 121.862 -0.524 . . . . 0.0 111.503 -175.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -62.3 -48.34 80.32 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 123.239 0.616 . . . . 0.0 111.22 171.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.93 -46.6 78.45 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.361 0.528 . . . . 0.0 110.13 176.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.4 mt -58.38 -43.64 86.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 124.34 1.056 . . . . 0.0 109.779 175.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.88 -29.81 69.78 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.3 0.955 . . . . 0.0 111.894 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -72.13 -39.61 68.7 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.573 0.624 . . . . 0.0 111.509 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.9 pt -103.35 -48.71 10.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 116.703 2.112 . . . . 0.0 116.703 -168.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 40.6 m . . . . . 0 C--O 1.252 1.232 0 C-N-CA 124.308 1.043 . . . . 0.0 110.653 -170.264 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 tpt . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 118.518 -0.753 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.488 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -60.32 118.4 6.38 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-N 120.98 1.718 . . . . 0.0 108.541 -173.508 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.416 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 39.0 mtpt -90.58 134.24 34.52 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -169.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.809 HG13 HG12 ' A' ' 75' ' ' VAL . 12.0 t -116.01 155.32 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.07 140.54 43.86 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -125.63 120.37 30.57 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 177.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.1 t -118.72 112.49 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 118.736 0.698 . . . . 0.0 110.404 -168.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.6 171.79 13.67 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.801 1.286 . . . . 0.0 113.616 -174.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -152.36 130.99 12.3 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 100.779 -3.785 . . . . 0.0 100.779 168.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.421 ' CG ' ' H ' ' A' ' 11' ' ' ASN . 27.2 ttm180 63.47 176.53 0.16 Allowed 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.755 1.161 . . . . 0.0 109.955 -169.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.421 ' H ' ' CG ' ' A' ' 10' ' ' ARG . 33.6 t-20 -40.57 137.2 1.17 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.138 2.175 . . . . 0.0 113.652 -169.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.9 m -52.41 -20.4 2.8 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 129.856 3.262 . . . . 0.0 115.417 -171.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.9 m -59.44 -5.34 0.77 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.946 2.098 . . . . 0.0 114.802 -171.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.291 31.5 ptt180 -111.41 -61.3 1.72 Allowed 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 116.801 -1.571 . . . . 0.0 111.079 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.562 ' CB ' HD13 ' A' ' 79' ' ' LEU . 59.7 p -74.97 -44.6 47.44 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 122.688 2.495 . . . . 0.0 111.316 -175.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.29 2.0 mt-30 -75.65 -24.75 56.41 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -172.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.463 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.2 tpt -65.79 -41.89 91.39 Favored 'General case' 0 C--O 1.222 -0.363 0 O-C-N 121.003 -1.061 . . . . 0.0 108.19 167.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.54 -36.77 79.26 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 121.745 -0.597 . . . . 0.0 109.602 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -63.25 -39.1 93.64 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 118.378 -0.82 . . . . 0.0 110.823 169.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.38 -45.15 94.15 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 120.5 1.5 . . . . 0.0 111.115 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -65.55 -38.29 89.18 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 173.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.441 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -72.45 -37.63 68.5 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 119.758 1.163 . . . . 0.0 110.929 -173.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.401 ' HA ' HG21 ' A' ' 32' ' ' VAL . 61.7 pttt -71.08 -19.73 62.44 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 120.214 1.37 . . . . 0.0 112.065 174.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.3 m -82.02 -51.05 8.42 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.845 1.658 . . . . 0.0 109.56 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.2 mt -89.42 -25.73 21.36 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.334 1.454 . . . . 0.0 112.176 -169.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.76 13.75 56.32 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.885 2.183 . . . . 0.0 111.846 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.28 122.02 14.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.675 1.19 . . . . 0.0 109.723 -173.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.12 8.44 87.84 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.66 -0.522 . . . . 0.0 113.626 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -123.22 -31.69 3.54 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.506 1.522 . . . . 0.0 109.001 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.7 pt -141.37 173.37 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 125.457 1.503 . . . . 0.0 109.598 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -114.42 144.08 43.88 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 103.879 -2.638 . . . . 0.0 103.879 168.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 22' ' ' ALA . 1.7 t -133.33 139.94 48.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 123.279 0.631 . . . . 0.0 110.283 -168.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.14 158.59 44.16 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.836 1.254 . . . . 0.0 109.254 -173.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 63.8 p -155.46 165.99 34.9 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 120.016 1.28 . . . . 0.0 113.257 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.3 p -154.61 166.45 33.32 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.164 1.386 . . . . 0.0 109.197 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.31 53.92 1.79 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.3 tp -88.51 68.69 8.82 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 102.029 -3.322 . . . . 0.0 102.029 -176.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.17 -1.12 0.64 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.86 1.264 . . . . 0.0 111.813 -169.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.5 p -88.38 7.1 34.17 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.407 1.483 . . . . 0.0 112.82 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.6 m 62.08 -29.33 0.07 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 130.063 3.345 . . . . 0.0 114.746 -175.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -132.75 -178.13 4.81 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 128.145 2.578 . . . . 0.0 104.776 169.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.8 m -61.71 158.67 2.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 O-C-N 120.623 -1.298 . . . . 0.0 109.454 171.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -113.12 106.6 54.77 Favored Pre-proline 0 N--CA 1.446 -0.665 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -170.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -63.87 -29.25 67.55 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.264 2.643 . . . . 0.0 111.83 -169.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.2 m -64.51 -37.41 87.45 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.743 0.701 . . . . 0.0 109.213 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.24 -44.43 83.78 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.26 -46.58 85.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.232 0 CA-C-O 118.632 -0.699 . . . . 0.0 109.135 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.41 -43.96 97.56 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.859 0.754 . . . . 0.0 111.101 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.0 mmt -60.05 -26.16 65.91 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 118.76 -0.638 . . . . 0.0 111.6 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.463 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -94.09 -27.0 16.5 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -177.132 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -64.34 -30.74 71.78 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.93 1.292 . . . . 0.0 110.067 169.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.43 -21.75 38.8 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.297 0.639 . . . . 0.0 112.002 171.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.0 m -123.61 9.53 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 125.75 1.62 . . . . 0.0 111.138 -177.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.81 40.94 74.84 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.372 0.987 . . . . 0.0 113.007 174.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.7 mt -122.94 152.39 27.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.542 1.537 . . . . 0.0 108.077 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -118.55 122.13 41.9 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.924 1.29 . . . . 0.0 108.677 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 43.8 pt -127.02 12.91 3.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 124.271 1.028 . . . . 0.0 111.481 169.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.58 -25.0 45.18 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.23 1.812 . . . . 0.0 112.459 172.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -76.6 -8.06 85.93 Favored Glycine 0 CA--C 1.537 1.423 0 CA-C-N 118.603 0.638 . . . . 0.0 112.946 175.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -76.56 166.77 22.93 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.776 1.23 . . . . 0.0 111.557 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.6 p -144.86 -177.95 5.78 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.813 1.645 . . . . 0.0 109.949 174.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.98 173.32 6.41 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.206 1.002 . . . . 0.0 109.615 170.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.28 146.37 7.15 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 169.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.64 141.94 97.96 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.706 2.271 . . . . 0.0 111.834 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.5 tt -59.93 -37.73 73.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 123.491 0.716 . . . . 0.0 110.718 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -73.04 -18.38 61.34 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.416 0.686 . . . . 0.0 112.336 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.05 -25.58 61.85 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 118.939 -0.553 . . . . 0.0 111.274 170.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -79.11 170.51 16.56 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 122.191 0.996 . . . . 0.0 111.318 -172.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.44 68.75 1.39 Allowed 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 125.827 1.651 . . . . 0.0 106.891 -177.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.457 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -51.3 -24.21 4.36 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 124.524 1.129 . . . . 0.0 113.749 -178.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -44.1 -41.27 5.48 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.005 0.922 . . . . 0.0 110.794 172.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.37 -14.74 58.08 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.746 1.218 . . . . 0.0 113.842 -175.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.416 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 11.4 m-85 -105.72 112.73 25.92 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 119.64 1.109 . . . . 0.0 108.405 -173.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -65.51 -12.14 49.99 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -168.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.809 HG12 HG13 ' A' ' 4' ' ' VAL . 27.3 t -146.56 124.31 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 -171.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.1 t -123.13 130.76 74.18 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.2 mm -124.42 92.65 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 173.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.9 t -76.85 166.85 22.79 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 169.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.562 HD13 ' CB ' ' A' ' 15' ' ' SER . 5.5 mp -140.76 32.18 1.82 Allowed 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.185 -1.572 . . . . 0.0 108.025 174.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 92.5 m -76.99 -3.71 40.36 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.203 1.001 . . . . 0.0 111.707 -177.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.19 35.49 3.63 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 119.572 1.078 . . . . 0.0 111.084 172.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 32.0 p 35.88 45.03 0.26 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 128.02 2.528 . . . . 0.0 114.216 -175.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.73 47.4 0.48 Allowed Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -173.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.2 p -125.72 159.11 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 126.102 1.761 . . . . 0.0 109.786 -171.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -118.09 56.35 0.86 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.785 1.234 . . . . 0.0 108.745 -174.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.6 mt -59.33 143.9 84.59 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.36 151.49 22.98 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.198 1.932 . . . . 0.0 111.95 171.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -55.86 -27.57 63.42 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.194 1.93 . . . . 0.0 115.541 -173.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -66.41 -21.14 66.21 Favored 'General case' 0 N--CA 1.456 -0.175 0 O-C-N 121.009 -1.057 . . . . 0.0 112.361 -176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.457 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 73.4 m95 -73.65 -17.89 61.1 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 117.952 -1.023 . . . . 0.0 112.659 175.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.8 m -110.77 -13.54 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 120.064 1.302 . . . . 0.0 113.461 -169.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.4 p -83.26 -8.11 59.5 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.367 1.067 . . . . 0.0 113.255 -173.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -64.96 173.04 2.52 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 130.054 3.341 . . . . 0.0 113.569 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -67.45 -41.47 84.64 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.532 ' HB ' HG13 ' A' ' 75' ' ' VAL . 16.8 mm -120.25 136.9 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 169.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -143.45 111.82 6.31 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 103.03 -2.952 . . . . 0.0 103.03 166.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -136.63 164.64 27.74 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -132.59 102.17 5.6 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 169.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 54.3 m0 -76.94 89.06 3.5 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.417 ' CD ' ' H ' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -62.6 33.99 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 128.508 2.723 . . . . 0.0 113.827 173.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.26 178.39 1.94 Allowed 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.086 -1.009 . . . . 0.0 112.832 -169.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.486 ' HB2' HG22 ' A' ' 115' ' ' VAL . 44.8 mt-10 -52.51 164.91 0.29 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 126.26 1.824 . . . . 0.0 112.525 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -120.9 102.74 43.86 Favored Pre-proline 0 C--N 1.325 -0.478 0 C-N-CA 127.278 2.231 . . . . 0.0 108.163 -175.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -82.13 -1.93 10.99 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 122.769 2.313 . . . . 0.0 112.592 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.4 t0 26.42 -99.04 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 128.372 2.669 . . . . 0.0 113.533 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.86 38.99 1.74 Allowed Glycine 0 CA--C 1.532 1.151 0 C-N-CA 127.278 2.371 . . . . 0.0 109.285 169.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -70.18 -176.99 1.28 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.413 1.885 . . . . 0.0 112.937 -176.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.9 m -63.6 156.66 25.99 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.235 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.1 mt -56.35 -31.16 63.49 Favored 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 123.129 0.572 . . . . 0.0 110.933 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.62 -41.15 97.06 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 118.528 0.604 . . . . 0.0 110.768 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 40.1 t -72.85 -42.12 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 117.284 -1.341 . . . . 0.0 109.061 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -48.42 -49.47 34.96 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 120.318 1.417 . . . . 0.0 111.379 169.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -60.16 -44.11 95.26 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.976 0.807 . . . . 0.0 111.055 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 87.3 m -68.95 -43.83 74.23 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 118.885 -0.579 . . . . 0.0 109.486 -173.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.486 HG22 ' HB2' ' A' ' 102' ' ' GLU . 42.0 t -68.43 -46.71 80.03 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -174.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -45.45 -55.74 5.79 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.864 1.266 . . . . 0.0 110.97 169.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.71 -43.03 98.41 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 119.321 0.964 . . . . 0.0 111.525 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -63.27 -37.44 87.26 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.381 1.09 . . . . 0.0 111.394 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 37.4 t -62.96 -41.41 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 118.067 -0.968 . . . . 0.0 109.033 173.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.14 -37.56 74.89 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 120.009 1.277 . . . . 0.0 111.029 -177.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -68.88 -43.3 75.57 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.208 0.603 . . . . 0.0 110.585 177.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -68.17 -42.43 80.02 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.415 1.007 . . . . 0.0 110.392 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.1 t -53.54 -53.54 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 124.007 0.923 . . . . 0.0 108.988 171.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.77 -33.01 74.98 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.954 -0.466 . . . . 0.0 111.815 -175.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -62.62 -47.98 81.41 Favored 'General case' 0 C--O 1.227 -0.084 0 C-N-CA 122.934 0.494 . . . . 0.0 111.284 171.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.86 -47.24 77.65 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.11 0.564 . . . . 0.0 109.552 176.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.2 mt -58.25 -42.91 84.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 124.292 1.037 . . . . 0.0 110.147 176.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.43 -29.45 69.01 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.609 0.64 . . . . 0.0 111.864 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -74.12 -40.43 62.67 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 118.594 0.633 . . . . 0.0 111.814 175.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.3 pt -101.55 -42.4 9.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 117.251 2.315 . . . . 0.0 117.251 -168.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 C--O 1.254 1.335 0 CA-C-N 119.05 0.841 . . . . 0.0 110.394 -171.967 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.1 mmm . . . . . 0 N--CA 1.5 2.054 0 CA-C-O 119.972 -0.061 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.627 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -58.97 136.33 57.89 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 171.172 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 26.8 mtpt -109.18 145.89 35.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 119.638 1.108 . . . . 0.0 108.357 -171.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.748 HG13 HG12 ' A' ' 75' ' ' VAL . 6.2 t -127.21 153.9 36.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 123.693 0.797 . . . . 0.0 108.896 -174.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 59.6 tpp -135.87 138.47 42.51 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -124.56 106.69 10.34 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.0 t -84.39 122.48 38.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -172.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 86.5 m -68.77 156.78 37.7 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.282 2.233 . . . . 0.0 111.279 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -144.32 -125.17 0.08 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 169.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.59 115.24 1.27 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.078 1.351 . . . . 0.0 112.009 -169.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 66.9 t30 45.59 26.86 0.36 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.897 2.079 . . . . 0.0 113.973 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.2 m 56.94 -22.34 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 119.106 3.002 . . . . 0.0 119.106 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 85.2 m -48.78 -55.72 10.72 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 125.69 1.596 . . . . 0.0 113.348 -168.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -58.77 -47.03 86.09 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.334 0.97 . . . . 0.0 112.329 -169.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.535 ' HB3' HD13 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -87.77 -31.81 19.44 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.709 -0.619 . . . . 0.0 111.138 -170.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.496 HE22 ' CG2' ' A' ' 42' ' ' VAL . 4.8 pt20 -65.62 -36.47 83.81 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 172.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.456 ' SD ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -63.09 -39.75 95.63 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 120.703 -1.248 . . . . 0.0 110.109 172.451 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.39 -36.1 75.16 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.757 -0.589 . . . . 0.0 110.698 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -64.69 -38.84 92.35 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.802 -0.618 . . . . 0.0 111.104 169.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.92 -43.9 92.84 Favored Glycine 0 CA--C 1.523 0.578 0 CA-C-N 120.491 1.496 . . . . 0.0 110.86 -178.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.456 ' CD2' ' SD ' ' A' ' 17' ' ' MET . 5.0 m-85 -64.81 -40.52 95.35 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 118.68 1.24 . . . . 0.0 109.428 171.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.484 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -69.88 -37.11 75.94 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 119.661 1.119 . . . . 0.0 111.104 -173.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -74.1 -25.14 59.62 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 120.142 1.337 . . . . 0.0 111.922 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 m -72.36 -50.8 23.97 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.173 1.389 . . . . 0.0 110.166 173.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.0 mt -87.86 -26.66 22.67 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 124.617 1.167 . . . . 0.0 112.647 -169.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.55 14.01 59.4 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 126.45 1.976 . . . . 0.0 111.602 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.23 125.18 22.8 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.227 1.411 . . . . 0.0 109.41 -172.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.68 8.42 87.2 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-O 119.732 -0.482 . . . . 0.0 113.647 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -125.47 -44.32 1.85 Allowed 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 125.161 1.385 . . . . 0.0 108.69 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.56 HG22 ' HB2' ' A' ' 2' ' ' LYS . 2.7 pp -140.25 150.27 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.463 1.105 . . . . 0.0 109.782 177.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.71 152.28 20.27 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.484 HG11 ' HB3' ' A' ' 22' ' ' ALA . 2.0 t -142.5 137.57 28.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 118.393 0.542 . . . . 0.0 111.061 -168.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.7 m -143.21 165.51 27.24 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.19 1.396 . . . . 0.0 109.524 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.9 p -141.48 156.27 45.76 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.929 1.292 . . . . 0.0 108.698 175.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 29.6 p -159.73 173.39 16.11 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.001 0.818 . . . . 0.0 112.201 -173.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.51 34.92 63.14 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.2 mp -61.76 122.54 15.61 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -75.46 3.14 9.8 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 169.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 p -145.24 67.47 1.23 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -175.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.8 m -64.93 60.62 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.847 2.459 . . . . 0.0 111.427 173.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.402 ' H ' ' H ' ' A' ' 42' ' ' VAL . 0.3 OUTLIER -160.96 -20.15 0.05 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 129.277 3.031 . . . . 0.0 110.517 -178.055 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.496 ' CG2' HE22 ' A' ' 16' ' ' GLN . 0.5 OUTLIER 72.88 171.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 127.245 2.218 . . . . 0.0 109.123 -172.615 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -137.22 117.08 10.45 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -172.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -69.24 -25.98 30.49 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.537 2.825 . . . . 0.0 113.179 -169.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.0 m -62.19 -36.21 81.21 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.177 0.899 . . . . 0.0 109.153 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.98 -41.89 90.58 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -58.59 -49.89 80.89 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 CA-C-O 118.312 -0.852 . . . . 0.0 108.874 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.5 -43.81 96.65 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 119.362 0.983 . . . . 0.0 110.916 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.7 mmt -64.51 -17.12 63.59 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.867 0.867 . . . . 0.0 112.723 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 3.4 mmt -97.99 -26.95 14.46 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 119.457 1.026 . . . . 0.0 110.656 173.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -65.0 -27.66 68.98 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.976 0.91 . . . . 0.0 110.164 172.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -56.37 -25.3 49.04 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.187 0.995 . . . . 0.0 112.603 169.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.1 m -127.24 14.56 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.468 1.507 . . . . 0.0 111.211 -171.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.1 39.11 84.06 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.941 0.782 . . . . 0.0 112.717 174.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 28.3 mt -126.99 156.65 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -136.85 143.35 43.03 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.39 1.076 . . . . 0.0 109.033 175.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.7 pt -140.59 15.83 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 126.778 2.031 . . . . 0.0 111.288 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.6 p -69.87 -40.91 75.43 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 120.767 -1.208 . . . . 0.0 112.414 173.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.18 8.05 41.28 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 123.819 0.723 . . . . 0.0 113.075 -177.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -73.96 -176.54 2.53 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.561 1.145 . . . . 0.0 112.132 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -69.3 170.27 10.62 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.533 1.933 . . . . 0.0 112.758 -170.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.4 m -159.16 57.18 0.41 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 104.042 -2.577 . . . . 0.0 104.042 171.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -143.38 147.96 42.15 Favored Pre-proline 0 C--N 1.345 0.389 0 C-N-CA 123.166 0.586 . . . . 0.0 110.351 -167.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -82.82 159.5 16.13 Favored 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.397 2.732 . . . . 0.0 112.438 -174.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.2 tt -58.75 -34.77 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.056 1.342 . . . . 0.0 111.371 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -69.16 -22.52 63.92 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.19 0.596 . . . . 0.0 112.309 -174.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -13.85 59.54 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 119.103 -0.475 . . . . 0.0 111.741 172.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -98.98 172.18 7.57 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.212 1.005 . . . . 0.0 110.789 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.71 99.06 3.06 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 125.21 1.404 . . . . 0.0 107.774 -178.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -49.83 -23.53 1.93 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 171.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -51.36 -25.69 6.45 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.885 0.874 . . . . 0.0 111.524 173.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -107.1 15.28 25.38 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.72 1.208 . . . . 0.0 113.491 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.45 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 24.6 m-85 -134.88 111.07 9.58 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 120.243 1.383 . . . . 0.0 109.16 173.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.29 -17.28 52.86 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 124.643 1.177 . . . . 0.0 113.422 -169.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.748 HG12 HG13 ' A' ' 4' ' ' VAL . 12.6 t -143.09 130.44 18.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 -170.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.3 t -135.96 131.84 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 -169.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.446 HD11 HD12 ' A' ' 126' ' ' LEU . 18.3 mm -133.83 100.62 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 103.031 -2.951 . . . . 0.0 103.031 -172.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.408 ' C ' ' H ' ' A' ' 80' ' ' CYS . 6.3 m -111.29 85.56 2.15 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 121.853 -0.529 . . . . 0.0 111.034 -168.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.535 HD13 ' HB3' ' A' ' 15' ' ' SER . 3.9 mp -73.12 25.51 0.06 Allowed 'General case' 0 C--N 1.343 0.291 0 C-N-CA 127.969 2.508 . . . . 0.0 110.547 -174.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.58 ' HB3' HG21 ' A' ' 84' ' ' VAL . 4.4 m -64.12 1.02 0.78 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.89 2.076 . . . . 0.0 111.411 170.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.22 26.4 28.48 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 118.742 0.701 . . . . 0.0 111.658 174.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 49.91 20.09 0.53 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.761 2.025 . . . . 0.0 114.771 -175.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -109.46 24.53 20.0 Favored Glycine 0 C--N 1.338 0.658 0 C-N-CA 124.43 1.014 . . . . 0.0 111.213 -176.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.58 HG21 ' HB3' ' A' ' 80' ' ' CYS . 20.1 t -132.29 121.43 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -174.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.32 -40.45 85.96 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.806 0.842 . . . . 0.0 110.893 -177.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.1 mt 64.48 152.63 0.12 Allowed Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 127.921 2.488 . . . . 0.0 112.64 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.04 151.45 50.1 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 121.926 1.75 . . . . 0.0 110.219 169.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.4 -19.61 55.31 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.634 1.556 . . . . 0.0 114.436 -169.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -64.52 -26.51 68.45 Favored 'General case' 0 C--O 1.224 -0.246 0 O-C-N 121.019 -1.051 . . . . 0.0 110.879 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.471 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 62.3 m95 -67.63 -8.61 36.09 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.197 -0.939 . . . . 0.0 112.622 175.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.4 t -108.68 -30.09 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.968 1.307 . . . . 0.0 111.105 -171.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.5 p -75.37 -17.25 60.27 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.21 1.004 . . . . 0.0 113.483 -169.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -51.67 160.68 0.61 Allowed 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 129.403 3.081 . . . . 0.0 114.033 176.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -62.47 -38.9 91.63 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.608 1.563 . . . . 0.0 108.762 177.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.547 ' HB ' HG13 ' A' ' 75' ' ' VAL . 30.5 mm -125.02 135.44 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 169.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -136.57 104.88 5.7 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 101.758 -3.423 . . . . 0.0 101.758 166.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -128.27 177.57 6.85 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 125.62 1.568 . . . . 0.0 106.901 175.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -126.24 -56.9 1.42 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -174.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 24.1 m0 56.02 65.7 1.38 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.072 0.949 . . . . 0.0 110.662 -169.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -56.39 46.28 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 130.274 3.429 . . . . 0.0 113.54 169.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.81 -177.65 2.03 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.615 -1.303 . . . . 0.0 113.422 -168.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.448 ' HB2' HG22 ' A' ' 115' ' ' VAL . 41.1 mt-10 -55.88 168.86 0.41 Allowed 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 127.253 2.221 . . . . 0.0 112.323 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -115.04 102.99 54.95 Favored Pre-proline 0 C--N 1.323 -0.566 0 C-N-CA 126.272 1.829 . . . . 0.0 109.243 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -83.75 -4.37 10.66 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.577 2.185 . . . . 0.0 112.814 175.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.7 t0 25.18 -101.27 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 128.246 2.618 . . . . 0.0 113.025 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -136.88 42.3 1.33 Allowed Glycine 0 CA--C 1.533 1.16 0 C-N-CA 128.188 2.804 . . . . 0.0 107.11 169.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -68.91 -174.48 0.6 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.619 1.968 . . . . 0.0 112.069 -174.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.5 p -57.39 152.84 13.58 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 113.962 -1.472 . . . . 0.0 108.433 169.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 31.1 mt -59.14 -30.37 68.1 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.625 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -61.41 -41.25 96.86 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 119.001 -0.523 . . . . 0.0 110.791 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.17 -42.28 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 117.647 -1.168 . . . . 0.0 109.305 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -50.35 -49.4 54.19 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.276 1.398 . . . . 0.0 111.765 171.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -59.05 -44.18 91.76 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.694 0.679 . . . . 0.0 111.36 176.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 91.7 m -68.48 -45.6 71.97 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -173.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.448 HG22 ' HB2' ' A' ' 102' ' ' GLU . 58.6 t -67.41 -47.59 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -173.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -43.43 -54.5 4.72 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.93 1.292 . . . . 0.0 110.665 169.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.87 -43.43 98.93 Favored Glycine 0 CA--C 1.522 0.503 0 CA-C-N 119.844 1.202 . . . . 0.0 112.065 -176.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -67.91 -34.38 76.51 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 120.797 -1.413 . . . . 0.0 111.398 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.59 -42.23 93.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 170.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -43.52 85.35 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.995 1.27 . . . . 0.0 110.258 -174.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -66.44 -43.78 84.68 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 119.1 -0.476 . . . . 0.0 110.038 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -64.97 -42.42 94.6 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.136 0.88 . . . . 0.0 110.944 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 52.9 t -56.66 -52.29 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 174.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -64.95 -32.89 74.83 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 121.846 -0.534 . . . . 0.0 111.667 -175.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -62.84 -46.66 86.9 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 123.58 0.752 . . . . 0.0 111.15 172.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.446 HD12 HD11 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -57.84 -46.68 84.42 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 122.807 0.443 . . . . 0.0 110.101 175.641 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.5 mt -58.75 -41.8 83.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 123.918 0.887 . . . . 0.0 110.233 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.31 -28.87 68.47 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.216 0.916 . . . . 0.0 111.637 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -75.2 -40.73 58.99 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.538 0.608 . . . . 0.0 111.85 176.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.4 pt -101.85 -35.89 4.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 116.496 2.035 . . . . 0.0 116.496 -168.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 C--O 1.255 1.365 0 C-N-CA 124.438 1.095 . . . . 0.0 111.608 -170.269 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 tpt . . . . . 0 N--CA 1.5 2.034 0 CA-C-O 118.594 -0.717 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.517 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -60.79 120.54 10.32 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 120.895 1.679 . . . . 0.0 108.39 -174.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.408 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 31.9 mtpt -93.37 134.64 35.38 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -170.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.787 HG13 HG12 ' A' ' 75' ' ' VAL . 14.6 t -116.6 154.81 18.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 53.6 tpp -136.03 136.17 40.05 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -118.53 106.63 12.85 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.45 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 4.7 t -91.06 119.43 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -170.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.9 m -91.61 162.33 14.56 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.947 0.499 . . . . 0.0 111.52 -173.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -160.13 151.42 19.48 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.535 1.934 . . . . 0.0 106.258 169.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.447 ' HD3' ' H ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER 59.46 -165.16 0.2 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.484 1.113 . . . . 0.0 109.527 -169.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.541 HD21 ' CG ' ' A' ' 43' ' ' HIS . 51.9 t-20 -61.5 109.02 1.06 Allowed 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.3 m -61.41 2.53 0.15 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 116.546 2.054 . . . . 0.0 116.546 -168.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 35.4 m -44.51 -47.62 10.11 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 120.099 1.318 . . . . 0.0 111.854 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -63.66 -39.46 94.4 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 118.992 0.815 . . . . 0.0 112.654 -175.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.27 -40.4 10.0 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.989 1.316 . . . . 0.0 111.298 -169.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.442 HE22 HG12 ' A' ' 42' ' ' VAL . 5.7 pt20 -65.67 -34.58 78.54 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.551 -0.718 . . . . 0.0 109.908 170.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.446 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.3 tpt -62.9 -39.87 95.85 Favored 'General case' 0 CA--C 1.512 -0.506 0 O-C-N 121.238 -0.914 . . . . 0.0 110.135 171.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.88 -39.22 84.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -64.28 -39.28 93.6 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.302 170.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.21 -45.59 85.55 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 120.726 1.603 . . . . 0.0 111.333 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -63.88 -39.63 94.63 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.459 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -68.59 -39.34 80.98 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 119.868 1.213 . . . . 0.0 110.99 -175.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -70.36 -26.47 63.74 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 120.532 1.514 . . . . 0.0 112.096 175.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 m -73.01 -51.04 19.73 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.369 1.467 . . . . 0.0 110.741 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.9 mt -88.82 -27.18 21.26 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.351 1.46 . . . . 0.0 112.307 -169.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.89 13.33 59.14 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 126.445 1.974 . . . . 0.0 111.682 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.52 122.81 14.97 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.039 1.335 . . . . 0.0 109.76 -174.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.31 9.13 86.99 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 119.887 -0.396 . . . . 0.0 113.649 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -123.88 -32.11 3.32 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.407 1.483 . . . . 0.0 109.275 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.8 pt -142.75 174.75 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 125.443 1.497 . . . . 0.0 109.439 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.87 146.07 43.16 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 168.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.459 HG11 ' HB3' ' A' ' 22' ' ' ALA . 1.8 t -135.58 142.12 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 123.168 0.587 . . . . 0.0 110.878 -168.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.03 159.63 44.42 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.92 0.888 . . . . 0.0 110.559 -176.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.0 p -133.83 156.26 48.37 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.873 1.269 . . . . 0.0 109.272 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.403 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 24.4 p -151.64 167.27 28.68 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.469 0.707 . . . . 0.0 111.234 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.44 38.4 86.77 Favored Glycine 0 N--CA 1.47 0.958 0 C-N-CA 123.501 0.572 . . . . 0.0 112.913 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 tp -69.74 58.56 0.14 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.735 2.014 . . . . 0.0 113.087 -169.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 53.0 7.51 0.08 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.142 2.177 . . . . 0.0 114.852 -170.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.9 m 56.57 33.66 23.08 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.462 1.105 . . . . 0.0 111.127 -169.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.6 m -132.4 -115.23 0.22 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.272 1.429 . . . . 0.0 108.93 -176.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -155.57 176.3 12.78 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.88 1.272 . . . . 0.0 109.354 -177.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.442 HG12 HE22 ' A' ' 16' ' ' GLN . 17.9 m -67.14 174.87 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.634 1.174 . . . . 0.0 111.416 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.541 ' CG ' HD21 ' A' ' 11' ' ' ASN . 13.5 t-80 -132.96 98.88 15.5 Favored Pre-proline 0 CA--C 1.53 0.2 0 C-N-CA 123.311 0.645 . . . . 0.0 109.672 -169.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -42.28 -33.18 2.37 Favored 'Trans proline' 0 CA--C 1.534 0.499 1 C-N-CA 125.846 4.364 . . . . 0.0 116.377 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.4 m -64.0 -39.29 93.79 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.792 1.178 . . . . 0.0 110.798 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.55 -43.48 80.6 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 121.133 -0.979 . . . . 0.0 109.218 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.88 -44.3 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.27 -43.23 99.22 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.429 0.559 . . . . 0.0 111.701 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.4 mmt -65.44 -21.61 66.67 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.166 0.439 . . . . 0.0 111.893 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.446 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.4 OUTLIER -93.4 -33.65 13.76 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -177.245 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -61.76 -34.13 75.3 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.954 1.302 . . . . 0.0 109.941 169.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.54 -8.31 4.17 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.601 1.961 . . . . 0.0 112.347 172.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.2 p -134.56 12.44 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 125.484 1.513 . . . . 0.0 110.91 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.81 36.87 66.15 Favored Glycine 0 CA--C 1.534 1.268 0 O-C-N 120.841 -1.162 . . . . 0.0 113.599 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.5 mt -120.46 154.71 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.319 1.448 . . . . 0.0 108.639 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.8 126.8 53.1 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.882 1.673 . . . . 0.0 109.571 -177.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.6 pt -134.59 8.19 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 125.501 1.52 . . . . 0.0 110.59 168.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.42 -37.41 68.64 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.404 1.882 . . . . 0.0 111.567 177.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.27 -6.81 89.04 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 123.471 0.558 . . . . 0.0 113.32 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -72.48 156.31 39.18 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.939 1.296 . . . . 0.0 109.874 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -150.97 164.98 35.1 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.5 m -68.08 141.28 56.19 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 126.999 2.119 . . . . 0.0 112.131 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -162.38 127.67 2.17 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 169.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.88 152.17 28.36 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.648 2.232 . . . . 0.0 113.38 -169.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.5 tt -59.3 -37.12 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.478 1.511 . . . . 0.0 111.366 -173.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -70.92 -19.67 62.56 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.126 0.57 . . . . 0.0 112.11 -173.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -15.68 54.54 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 118.762 -0.637 . . . . 0.0 111.85 173.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.403 ' CE2' ' HB3' ' A' ' 35' ' ' CYS . 62.6 m-85 -84.03 168.49 15.88 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.225 1.012 . . . . 0.0 110.804 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -140.16 86.17 2.06 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 102.634 -3.098 . . . . 0.0 102.634 -178.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.493 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -54.37 -23.23 14.76 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.58 -27.55 17.31 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.279 0.632 . . . . 0.0 111.184 172.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -84.48 -7.6 59.23 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.25 1.02 . . . . 0.0 113.16 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 26.0 m-85 -126.09 113.74 17.48 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 120.132 1.333 . . . . 0.0 108.912 -171.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -66.1 -12.21 54.09 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -168.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.787 HG12 HG13 ' A' ' 4' ' ' VAL . 22.9 t -145.25 123.24 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -170.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.3 t -118.74 129.63 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.2 mm -120.55 96.87 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 169.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.45 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 61.7 p -74.43 160.45 30.96 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 169.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -138.39 42.07 2.21 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 170.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.7 m -80.69 11.03 4.11 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.43 1.492 . . . . 0.0 111.177 -172.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.81 26.95 70.02 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 -174.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 2.0 t 52.78 -176.26 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.631 1.972 . . . . 0.0 111.314 -169.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.04 -33.79 1.07 Allowed Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.009 1.29 . . . . 0.0 114.677 172.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.5 t -57.61 119.32 2.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 125.198 1.399 . . . . 0.0 107.522 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -73.78 146.79 44.0 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 171.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.3 mt -127.09 153.41 76.62 Favored Pre-proline 0 C--O 1.237 0.439 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -53.08 151.94 19.88 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.26 1.973 . . . . 0.0 111.079 170.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -65.93 -19.8 58.07 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.574 1.516 . . . . 0.0 114.302 -169.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.58 -27.0 68.65 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 121.135 -0.978 . . . . 0.0 110.917 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.493 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 70.8 m95 -67.01 -12.47 59.97 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.046 -1.034 . . . . 0.0 112.819 175.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 41.8 t -104.74 -29.63 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.79 1.236 . . . . 0.0 111.127 -170.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.4 p -75.01 -13.38 60.5 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.365 1.066 . . . . 0.0 113.775 -169.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -55.78 163.6 1.36 Allowed 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 129.562 3.145 . . . . 0.0 113.761 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -64.62 -41.42 96.19 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.676 1.19 . . . . 0.0 108.373 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.557 ' HB ' HG13 ' A' ' 75' ' ' VAL . 20.0 mm -119.92 136.02 58.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 169.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -142.42 109.52 5.55 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 103.96 -2.607 . . . . 0.0 103.96 165.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -137.28 166.3 24.1 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 125.852 1.661 . . . . 0.0 106.765 178.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -133.07 130.16 38.98 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 169.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -111.31 83.12 1.71 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.512 ' H ' ' NE2' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -66.81 46.49 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.481 2.312 . . . . 0.0 112.856 178.142 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.73 169.67 15.17 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.21 -0.931 . . . . 0.0 111.154 -173.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -46.93 142.57 3.39 Favored 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 126.03 1.732 . . . . 0.0 112.221 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -87.58 111.58 42.77 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.915 1.286 . . . . 0.0 108.759 176.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -83.38 -7.44 10.83 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.489 2.126 . . . . 0.0 112.416 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.4 t0 23.88 -96.96 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 128.233 2.613 . . . . 0.0 113.961 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.57 44.1 1.22 Allowed Glycine 0 CA--C 1.533 1.205 0 C-N-CA 126.944 2.211 . . . . 0.0 110.607 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -70.44 -175.39 1.02 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.847 1.659 . . . . 0.0 113.274 -175.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.2 p -69.08 162.38 27.05 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.44 169.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 22.8 mt -55.84 -37.0 68.14 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.942 0.497 . . . . 0.0 111.026 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.47 -37.32 77.9 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 123.262 0.625 . . . . 0.0 110.39 -174.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.4 t -74.2 -41.68 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -55.94 -34.74 65.93 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.451 1.023 . . . . 0.0 112.138 171.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 62.8 mtp85 -73.0 -44.87 60.51 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 119.705 1.139 . . . . 0.0 111.606 173.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 91.3 m -75.46 -38.21 59.82 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.372 0.669 . . . . 0.0 112.021 -169.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 87.4 t -71.49 -45.2 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -176.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -43.51 -53.02 5.81 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 125.886 1.675 . . . . 0.0 111.236 169.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.53 -40.18 97.44 Favored Glycine 0 N--CA 1.467 0.721 0 CA-C-N 119.785 1.175 . . . . 0.0 111.96 -175.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -65.17 -38.65 91.21 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 121.492 -1.005 . . . . 0.0 110.359 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.18 -40.44 89.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 175.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -36.89 76.04 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.454 1.025 . . . . 0.0 111.292 -177.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -69.85 -42.93 72.91 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 118.743 -0.646 . . . . 0.0 110.448 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -63.47 -43.18 98.09 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.88 1.218 . . . . 0.0 110.388 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 63.9 t -54.98 -53.66 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 123.475 0.71 . . . . 0.0 109.627 173.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -64.77 -32.77 74.61 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 122.151 -0.343 . . . . 0.0 111.419 -175.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -62.8 -47.73 82.19 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 123.363 0.665 . . . . 0.0 111.208 172.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.92 -47.75 76.95 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.454 0.57 . . . . 0.0 109.589 175.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -57.89 -42.49 82.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 124.452 1.101 . . . . 0.0 110.091 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.07 -28.94 68.22 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.885 0.766 . . . . 0.0 111.94 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -75.49 -40.56 57.08 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.614 0.643 . . . . 0.0 111.759 175.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 pt -101.33 -42.45 9.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -168.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 C--O 1.253 1.287 0 CA-C-N 119.089 0.859 . . . . 0.0 110.237 -173.423 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 tpt . . . . . 0 N--CA 1.497 1.918 0 CA-C-O 117.957 -1.02 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.546 ' HB2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -48.75 121.87 5.08 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 120.597 1.544 . . . . 0.0 109.863 -174.044 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -97.8 135.83 39.0 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -169.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.808 HG13 HG12 ' A' ' 75' ' ' VAL . 11.8 t -113.52 156.52 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 59.2 tpp -135.67 137.49 41.87 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.448 ' HE2' HG13 ' A' ' 32' ' ' VAL . 97.3 m-85 -119.78 117.07 27.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 177.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.437 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 8.5 t -99.55 132.39 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -169.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.8 t -111.79 131.22 55.47 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.962 0.887 . . . . 0.0 112.892 -169.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -140.15 150.93 44.84 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 129.08 2.952 . . . . 0.0 103.503 169.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 58.0 -170.8 0.11 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.799 0.84 . . . . 0.0 109.79 -168.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.421 HD21 ' CD2' ' A' ' 43' ' ' HIS . 15.1 t-20 -58.0 130.03 44.69 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -168.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.9 m -35.0 -35.41 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.997 1.719 . . . . 0.0 115.636 169.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.1 p -61.41 -9.6 5.82 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -99.96 -52.97 3.28 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 120.369 1.44 . . . . 0.0 110.823 171.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 p -94.21 -51.26 4.9 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 120.703 -1.248 . . . . 0.0 113.736 -168.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.32 -21.64 63.83 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 118.069 -1.452 . . . . 0.0 110.031 173.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.468 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 0.8 OUTLIER -63.39 -39.57 94.88 Favored 'General case' 0 CA--C 1.512 -0.498 0 O-C-N 120.899 -1.126 . . . . 0.0 109.056 168.364 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.9 -37.91 74.86 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 118.753 -0.641 . . . . 0.0 109.866 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -61.44 -40.07 93.12 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.942 169.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.33 -42.9 93.76 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 120.242 1.383 . . . . 0.0 111.454 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -67.23 -39.01 86.15 Favored 'General case' 0 CA--C 1.518 -0.274 0 O-C-N 121.554 -0.968 . . . . 0.0 108.705 173.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.06 -40.28 71.73 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-N 119.525 1.057 . . . . 0.0 110.433 -173.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -72.03 -15.5 62.03 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 119.449 1.022 . . . . 0.0 112.327 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 m -85.08 -50.54 7.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.798 1.639 . . . . 0.0 109.469 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.6 mt -88.85 -26.21 21.76 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.515 1.126 . . . . 0.0 112.7 -169.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.91 13.87 57.5 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 126.161 1.839 . . . . 0.0 112.076 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.01 125.16 23.05 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.635 1.174 . . . . 0.0 108.825 -174.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.2 7.79 88.21 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.711 -0.494 . . . . 0.0 113.795 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt -125.64 -42.78 1.91 Allowed 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 125.731 1.612 . . . . 0.0 108.988 -176.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.546 HG22 ' HB2' ' A' ' 2' ' ' LYS . 2.7 pp -143.29 152.04 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 124.642 1.177 . . . . 0.0 109.301 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.12 152.2 21.24 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 172.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.448 HG13 ' HE2' ' A' ' 6' ' ' PHE . 2.6 t -139.33 139.86 38.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 121.819 -0.551 . . . . 0.0 110.157 -168.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.98 159.23 43.82 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.337 1.055 . . . . 0.0 109.135 -172.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.2 t -146.88 156.08 42.81 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 119.376 0.989 . . . . 0.0 110.251 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.3 p -147.37 153.61 39.87 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.842 0.857 . . . . 0.0 109.707 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.82 -119.4 5.75 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 106.542 -2.623 . . . . 0.0 106.542 -169.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.6 tp 83.59 62.77 0.01 OUTLIER 'General case' 0 C--N 1.346 0.447 0 C-N-CA 127.449 2.299 . . . . 0.0 105.234 -177.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -67.63 -18.25 64.9 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.82 -171.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.8 m -83.79 38.87 0.66 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.469 1.108 . . . . 0.0 112.197 -175.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.5 m 67.82 -169.76 0.19 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.253 1.821 . . . . 0.0 110.712 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -57.65 -25.43 60.17 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -169.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -169.72 159.38 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.345 0 C-N-CA 126.971 2.108 . . . . 0.0 107.254 169.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.421 ' CD2' HD21 ' A' ' 11' ' ' ASN . 80.0 t60 -132.98 108.47 12.71 Favored Pre-proline 0 C--O 1.234 0.251 0 C-N-CA 123.187 0.595 . . . . 0.0 109.414 -169.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -64.37 -30.38 62.92 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.157 2.571 . . . . 0.0 112.234 -168.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.5 m -65.73 -36.53 83.85 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 119.296 0.953 . . . . 0.0 109.246 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.411 ' HB1' HD11 ' A' ' 57' ' ' ILE . . . -65.97 -44.6 84.46 Favored 'General case' 0 C--N 1.346 0.424 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -58.05 -48.8 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.96 96.26 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.713 0.688 . . . . 0.0 110.906 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.6 mmt -58.66 -25.89 63.24 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.873 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.468 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.5 OUTLIER -95.87 -26.33 15.66 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 119.178 0.899 . . . . 0.0 108.932 -177.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -64.74 -29.64 70.63 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.546 1.138 . . . . 0.0 110.445 169.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -57.63 -22.82 47.8 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.386 0.674 . . . . 0.0 112.186 171.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.9 m -124.09 11.59 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 125.708 1.603 . . . . 0.0 111.279 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.41 40.92 86.63 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.0 0.81 . . . . 0.0 113.012 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.7 mt -124.87 154.29 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.542 1.537 . . . . 0.0 107.758 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -122.6 126.37 47.55 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.013 1.325 . . . . 0.0 109.014 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.411 HD11 ' HB1' ' A' ' 46' ' ' ALA . 35.8 pt -129.47 16.38 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 125.14 1.376 . . . . 0.0 111.268 170.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.51 -24.89 45.56 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.762 1.625 . . . . 0.0 112.226 169.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.27 -13.13 81.63 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 118.136 0.426 . . . . 0.0 112.399 174.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -73.12 163.09 28.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.697 1.199 . . . . 0.0 110.545 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.7 p -148.3 168.06 23.56 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.727 1.211 . . . . 0.0 110.791 170.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.35 143.88 51.81 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.714 1.206 . . . . 0.0 109.801 174.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -161.04 127.93 2.56 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 117.225 -1.369 . . . . 0.0 107.751 173.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -65.52 152.33 82.17 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.136 2.557 . . . . 0.0 114.468 -172.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.1 tt -62.05 -41.13 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 124.438 1.095 . . . . 0.0 111.083 174.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -70.42 -20.82 62.89 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.085 0.554 . . . . 0.0 111.891 -175.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.98 -19.04 60.78 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.548 0.739 . . . . 0.0 111.642 171.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -92.54 169.8 10.25 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.912 0.863 . . . . 0.0 110.954 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -140.94 88.58 2.19 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 -173.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.496 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -53.95 -24.15 15.53 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -28.58 16.06 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.355 0.662 . . . . 0.0 111.372 173.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -82.3 -13.71 56.53 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.311 1.044 . . . . 0.0 113.302 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -121.64 113.63 20.02 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 120.081 1.309 . . . . 0.0 109.383 -169.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.4 -16.03 52.43 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -169.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.808 HG12 HG13 ' A' ' 4' ' ' VAL . 14.3 t -144.8 127.13 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 -170.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.7 t -121.26 127.39 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.2 mm -119.72 95.05 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 169.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.437 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 31.2 t -74.45 165.96 24.31 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 168.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.88 26.14 2.29 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.61 -1.306 . . . . 0.0 109.128 171.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.576 ' HB3' HG21 ' A' ' 84' ' ' VAL . 57.0 m -83.52 -1.32 53.43 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.167 -0.958 . . . . 0.0 112.476 -170.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.96 23.89 6.86 Favored Glycine 0 C--N 1.339 0.704 0 C-N-CA 123.783 0.706 . . . . 0.0 111.73 175.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.453 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 3.2 t 44.32 45.16 7.18 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.148 1.779 . . . . 0.0 112.336 -174.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -155.6 35.82 0.63 Allowed Glycine 0 C--N 1.339 0.743 0 CA-C-O 119.735 -0.481 . . . . 0.0 112.319 -171.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.576 HG21 ' HB3' ' A' ' 80' ' ' CYS . 86.6 t -122.87 141.91 41.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 125.058 1.343 . . . . 0.0 108.6 178.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -81.95 60.09 4.63 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.37 1.068 . . . . 0.0 109.966 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 68.4 mt -56.63 134.35 77.89 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -54.57 155.36 17.22 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.552 2.168 . . . . 0.0 112.568 178.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -54.9 -28.82 60.71 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.76 2.306 . . . . 0.0 116.099 -171.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -66.53 -24.36 66.37 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.153 -0.967 . . . . 0.0 111.607 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.496 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 66.9 m95 -70.97 -13.93 62.18 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 117.892 -1.051 . . . . 0.0 113.14 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.9 m -113.52 -10.93 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 120.107 1.321 . . . . 0.0 113.165 -171.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.4 p -84.05 -16.41 43.93 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.615 0.766 . . . . 0.0 112.739 -175.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -50.45 161.86 0.28 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 130.017 3.327 . . . . 0.0 114.377 174.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -62.36 -39.32 92.79 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.454 1.502 . . . . 0.0 108.801 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.594 ' HB ' HG13 ' A' ' 75' ' ' VAL . 23.4 mm -122.85 136.83 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 169.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -141.14 111.89 7.07 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 100.926 -3.731 . . . . 0.0 100.926 166.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.92 164.32 28.22 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 174.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.8 t70 -134.56 100.31 4.6 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 170.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -77.2 78.32 3.73 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -55.62 33.43 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.953 1 C-N-CA 131.745 4.018 . . . . 0.0 113.761 170.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.93 172.15 5.85 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.083 1.353 . . . . 0.0 111.717 -169.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.52 ' HB2' HG22 ' A' ' 115' ' ' VAL . 38.4 mt-10 -49.88 155.52 0.87 Allowed 'General case' 0 C--O 1.231 0.088 0 C-N-CA 125.354 1.462 . . . . 0.0 112.632 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -107.24 110.58 63.31 Favored Pre-proline 0 N--CA 1.448 -0.538 0 C-N-CA 126.556 1.942 . . . . 0.0 109.062 175.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -95.31 1.03 2.49 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 124.068 3.179 . . . . 0.0 112.631 175.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -51.37 -37.09 46.32 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -168.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -109.38 25.05 18.96 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.48 -1.178 . . . . 0.0 112.677 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.469 ' NE2' HG11 ' A' ' 111' ' ' VAL . 28.9 mt-30 -122.34 174.65 6.87 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 118.999 1.4 . . . . 0.0 113.95 -169.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.1 m -73.14 166.79 22.46 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 112.947 -1.933 . . . . 0.0 110.144 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.6 mt -55.51 -31.61 62.2 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 123.189 0.596 . . . . 0.0 110.951 175.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -62.28 -41.16 98.25 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 118.298 0.499 . . . . 0.0 110.567 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.469 HG11 ' NE2' ' A' ' 107' ' ' GLN . 17.2 t -76.48 -39.82 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 117.322 -1.323 . . . . 0.0 108.784 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -47.23 -48.57 24.25 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 120.264 1.393 . . . . 0.0 110.949 168.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -61.21 -46.1 91.82 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.261 0.937 . . . . 0.0 111.184 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.5 m -68.21 -37.37 80.81 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 122.865 0.466 . . . . 0.0 110.16 -171.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.52 HG22 ' HB2' ' A' ' 102' ' ' GLU . 40.3 t -75.93 -44.01 38.8 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -177.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -45.59 -51.09 12.53 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 124.795 1.238 . . . . 0.0 111.193 170.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.18 -42.97 97.75 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-N 119.506 1.048 . . . . 0.0 112.19 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -65.61 -35.56 81.17 Favored 'General case' 0 CA--C 1.52 -0.192 0 O-C-N 120.942 -1.328 . . . . 0.0 110.832 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.2 -42.63 97.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 173.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.15 -39.65 83.09 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.422 1.465 . . . . 0.0 111.369 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.7 -44.62 73.59 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.393 1.477 . . . . 0.0 109.743 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 15.2 mtt180 -66.89 -41.34 87.36 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.574 -0.704 . . . . 0.0 112.039 177.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 38.9 t -54.77 -53.02 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -64.08 -32.74 74.41 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 122.043 -0.411 . . . . 0.0 111.647 -175.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -63.13 -46.09 88.88 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 121.612 -0.68 . . . . 0.0 111.392 172.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.11 -47.58 82.82 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 175.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -58.02 -41.37 80.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 C-N-CA 123.896 0.878 . . . . 0.0 109.825 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.26 -27.39 68.42 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.868 0.758 . . . . 0.0 112.093 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -76.82 -41.21 45.22 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 118.616 -0.706 . . . . 0.0 112.315 174.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.8 pt -101.13 -35.11 4.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 -168.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 28.2 m . . . . . 0 C--O 1.256 1.401 0 CA-C-N 119.304 0.956 . . . . 0.0 111.497 -177.107 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 tpt . . . . . 0 N--CA 1.499 2.011 0 CA-C-O 118.53 -0.747 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.477 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -60.94 119.28 7.95 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 120.842 1.655 . . . . 0.0 108.679 -174.566 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -90.37 138.08 31.83 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -172.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.7 t -116.37 153.74 17.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 O-C-N 124.25 0.969 . . . . 0.0 108.386 174.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.25 142.09 50.94 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 175.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -121.5 103.92 9.28 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.544 -1.651 . . . . 0.0 106.544 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 6.1 t -89.32 134.52 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -169.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 82.4 m -91.84 169.15 10.92 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -169.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -147.52 -160.45 1.17 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 128.159 2.584 . . . . 0.0 105.476 168.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.8 ttm105 -46.38 141.46 3.53 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 119.916 1.235 . . . . 0.0 111.504 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.541 HD21 ' CD2' ' A' ' 43' ' ' HIS . 9.0 t-20 44.34 67.62 0.66 Allowed 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 127.964 2.506 . . . . 0.0 109.694 -172.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 p -51.4 -20.61 1.85 Allowed 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 126.522 1.929 . . . . 0.0 114.71 -171.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 77.1 m -61.0 -17.64 53.26 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 116.734 -1.603 . . . . 0.0 113.658 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -65.45 -37.14 86.01 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 122.978 2.626 . . . . 0.0 111.334 169.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.473 ' HB3' HD13 ' A' ' 79' ' ' LEU . 0.4 OUTLIER -86.63 -39.91 15.64 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.409 -0.807 . . . . 0.0 108.901 -174.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -66.89 -25.28 66.31 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 120.902 -1.124 . . . . 0.0 110.875 169.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.437 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.8 tpt -67.03 -37.89 84.94 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 119.884 -1.76 . . . . 0.0 109.153 169.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.58 89.73 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.429 ' HG3' HG12 ' A' ' 32' ' ' VAL . 60.4 tt0 -61.87 -40.19 94.5 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.49 -0.766 . . . . 0.0 110.533 169.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.31 -35.65 63.59 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 120.894 1.679 . . . . 0.0 112.676 -175.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -71.87 -37.81 70.13 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 118.329 1.065 . . . . 0.0 108.724 169.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.472 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -71.53 -39.27 70.84 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 120.567 -1.333 . . . . 0.0 111.275 -174.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.432 ' HA ' HG21 ' A' ' 32' ' ' VAL . 52.8 pttt -63.45 -23.95 67.62 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 120.054 1.297 . . . . 0.0 111.979 174.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 m -84.94 -50.42 7.51 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.146 2.178 . . . . 0.0 109.581 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.6 mt -88.45 -25.12 22.79 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.377 1.471 . . . . 0.0 112.022 -169.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -106.5 15.75 41.74 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 126.715 2.102 . . . . 0.0 111.73 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.35 123.09 16.79 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.595 1.158 . . . . 0.0 109.442 -175.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.24 8.38 87.5 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 123.07 0.367 . . . . 0.0 113.786 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.2 mmtt -120.66 -34.82 3.5 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 126.117 1.767 . . . . 0.0 109.278 -178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.5 pt -142.38 172.77 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 124.912 1.285 . . . . 0.0 109.307 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -112.8 145.98 39.65 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 168.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.472 HG11 ' HB3' ' A' ' 22' ' ' ALA . 2.1 t -134.57 141.26 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 123.163 0.585 . . . . 0.0 110.782 -168.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.01 160.51 42.06 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.129 0.972 . . . . 0.0 109.826 -173.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 71.5 p -135.51 168.14 19.78 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.124 1.329 . . . . 0.0 109.443 169.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.3 p -153.61 157.01 39.01 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.6 -0.687 . . . . 0.0 112.005 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.63 -54.14 0.57 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.693 1.616 . . . . 0.0 110.626 173.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 43.83 33.8 0.79 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.703 2.001 . . . . 0.0 114.882 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 55.51 11.53 0.63 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.207 1.403 . . . . 0.0 114.235 -174.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 26.4 m 57.65 33.0 22.69 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.836 1.254 . . . . 0.0 111.727 -169.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 66.8 m -138.21 178.13 7.36 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.454 1.902 . . . . 0.0 109.738 -176.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -72.34 166.8 21.79 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.467 -0.771 . . . . 0.0 109.946 170.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 p -62.58 167.05 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.24 1.416 . . . . 0.0 110.341 175.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.541 ' CD2' HD21 ' A' ' 11' ' ' ASN . 77.4 t60 -123.25 110.8 30.59 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 124.312 1.045 . . . . 0.0 110.147 -169.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.48 -25.03 41.8 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 123.389 2.726 . . . . 0.0 115.113 -169.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -59.73 -37.63 79.48 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 120.538 1.517 . . . . 0.0 110.775 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.41 -44.51 71.25 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.13 -44.19 78.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 CA-C-O 118.616 -0.707 . . . . 0.0 109.137 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.05 -42.77 81.15 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.689 0.677 . . . . 0.0 110.974 177.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.415 ' HG3' ' HB3' ' A' ' 112' ' ' PHE . 30.4 mmt -66.78 -22.47 66.03 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.779 -0.629 . . . . 0.0 112.311 178.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.437 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 1.8 mmt -90.18 -36.32 14.86 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -65.38 -34.86 79.31 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.368 1.067 . . . . 0.0 110.267 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.26 1.0 OUTLIER -76.31 5.21 7.38 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.3 0.64 . . . . 0.0 112.289 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.0 m -129.07 -23.02 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.831 1.252 . . . . 0.0 112.707 169.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.72 31.11 0.91 Allowed Glycine 0 CA--C 1.532 1.125 0 CA-C-N 119.739 1.154 . . . . 0.0 114.422 170.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 22.0 mt -130.13 161.62 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.534 1.534 . . . . 0.0 107.112 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -140.36 146.81 38.9 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 169.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.6 pt -138.37 5.71 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 126.486 1.914 . . . . 0.0 110.618 -176.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.6 p -64.04 145.12 56.45 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 121.172 -0.955 . . . . 0.0 110.138 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.2 6.02 18.2 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 118.253 -1.304 . . . . 0.0 113.811 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -57.14 -44.76 83.71 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-N 119.521 1.66 . . . . 0.0 113.205 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -149.53 162.24 40.54 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 124.232 0.958 . . . . 0.0 110.626 -168.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.3 p -170.5 27.4 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.702 0.801 . . . . 0.0 111.994 -170.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -139.33 147.08 51.41 Favored Pre-proline 0 N--CA 1.475 0.809 0 O-C-N 120.604 -1.31 . . . . 0.0 111.614 -169.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -83.08 161.67 15.59 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.872 3.048 . . . . 0.0 112.558 -174.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.7 tt -59.76 -37.24 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.666 1.186 . . . . 0.0 111.545 -177.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -70.5 -20.69 62.82 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.275 0.63 . . . . 0.0 112.134 -173.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -19.05 59.26 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 118.872 -0.585 . . . . 0.0 111.338 171.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -97.72 167.32 11.02 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.934 0.874 . . . . 0.0 110.637 -176.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -141.46 89.61 2.23 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 -172.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.473 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -50.94 -30.66 15.45 Favored 'General case' 0 C--N 1.343 0.312 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.53 -29.56 10.92 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.134 0.974 . . . . 0.0 112.459 174.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -71.53 -18.58 62.26 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -107.64 171.03 7.62 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 128.398 2.679 . . . . 0.0 108.707 -172.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -111.42 -22.6 11.22 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-O 117.792 -1.099 . . . . 0.0 113.274 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.706 HG13 ' HB ' ' A' ' 95' ' ' ILE . 37.7 t -137.4 133.92 46.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 121.544 1.975 . . . . 0.0 108.585 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.0 t -116.5 129.89 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 173.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.3 mm -122.89 96.82 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 101.76 -3.422 . . . . 0.0 101.76 169.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.415 ' HA ' ' HB ' ' A' ' 7' ' ' VAL 0.254 22.0 p -74.32 166.39 23.55 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 117.649 -1.62 . . . . 0.0 108.257 169.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.473 HD13 ' HB3' ' A' ' 15' ' ' SER . 5.4 mp -136.36 37.86 2.71 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 170.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 63.8 m -95.91 7.59 45.93 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.869 2.067 . . . . 0.0 110.932 -169.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.85 31.78 6.83 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 119.246 -0.752 . . . . 0.0 112.221 172.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 31.5 p 40.26 37.85 0.47 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.644 2.378 . . . . 0.0 116.041 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.86 24.46 0.49 Allowed Glycine 0 CA--C 1.53 1.02 0 C-N-CA 123.896 0.76 . . . . 0.0 112.566 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.7 p -78.21 143.75 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 124.615 1.166 . . . . 0.0 108.897 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -92.96 58.85 3.05 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.476 1.11 . . . . 0.0 109.239 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.8 mt -61.29 147.47 87.14 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -175.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -56.41 157.58 17.95 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.895 2.397 . . . . 0.0 111.89 170.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.3 -25.34 64.37 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 121.853 1.702 . . . . 0.0 114.875 -169.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.47 -24.68 67.22 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.49 -1.382 . . . . 0.0 111.636 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.473 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 72.1 m95 -72.65 -9.26 58.4 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 117.855 -1.069 . . . . 0.0 112.686 175.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.8 m -117.49 -16.06 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 119.926 1.239 . . . . 0.0 113.166 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.9 p -76.06 -11.18 59.9 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.15 0.886 . . . . 0.0 112.352 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.407 ' HG2' ' H ' ' A' ' 93' ' ' GLN . 69.8 mm-40 -43.38 156.1 0.06 Allowed 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 130.618 3.567 . . . . 0.0 111.826 169.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -62.12 -36.18 80.97 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.725 1.61 . . . . 0.0 109.731 171.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.706 ' HB ' HG13 ' A' ' 75' ' ' VAL . 24.4 mm -131.98 137.0 55.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -135.46 112.62 10.43 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 102.07 -3.307 . . . . 0.0 102.07 166.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -136.31 168.42 19.46 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -141.94 118.68 11.08 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 170.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.45 ' CD2' ' HB3' ' A' ' 122' ' ' ARG . 49.5 m0 -95.52 79.59 3.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.31 18.74 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 129.022 2.929 . . . . 0.0 116.411 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -61.76 128.8 37.97 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 120.615 -1.303 . . . . 0.0 113.857 -168.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 46.94 -157.74 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 128.403 2.681 . . . . 0.0 114.161 169.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -163.51 74.47 1.84 Allowed Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 127.871 2.468 . . . . 0.0 108.054 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.5 -13.35 32.72 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.365 2.71 . . . . 0.0 115.834 -169.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.0 t70 26.17 -92.37 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.001 2.52 . . . . 0.0 114.045 172.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.89 45.23 1.01 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 126.888 2.185 . . . . 0.0 109.771 171.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -66.45 175.04 2.41 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.712 2.005 . . . . 0.0 114.133 -172.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.0 m -66.21 152.05 45.69 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 113.217 -1.811 . . . . 0.0 109.657 169.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.3 mt -57.18 -35.24 69.34 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.262 0.625 . . . . 0.0 111.077 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -61.3 -36.35 79.85 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 122.862 0.465 . . . . 0.0 110.794 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 23.3 t -74.83 -40.75 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-O 117.849 -1.072 . . . . 0.0 108.76 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.415 ' HB3' ' HG3' ' A' ' 49' ' ' MET . 57.3 m-85 -54.84 -42.55 72.11 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 120.432 1.469 . . . . 0.0 110.748 172.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 59.0 mtt85 -62.21 -46.01 90.81 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.227 0.921 . . . . 0.0 111.743 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.4 m -69.89 -43.64 71.37 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -172.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 78.8 t -65.9 -45.67 90.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -173.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -47.55 -53.77 13.55 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.997 1.319 . . . . 0.0 110.566 169.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.78 -42.15 99.71 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 119.328 0.967 . . . . 0.0 111.998 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -64.88 -39.71 93.97 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 121.425 -1.044 . . . . 0.0 110.607 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 45.0 t -62.82 -42.34 95.98 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.53 -36.64 78.89 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 120.128 1.331 . . . . 0.0 111.475 -174.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -68.57 -42.69 77.95 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.691 -0.671 . . . . 0.0 109.869 176.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.45 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 10.4 mpt_? -63.41 -42.36 98.76 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 119.831 1.196 . . . . 0.0 110.412 177.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 56.7 t -54.7 -52.93 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 123.469 0.708 . . . . 0.0 109.114 174.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -66.29 -32.85 74.51 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 122.046 -0.409 . . . . 0.0 111.461 -175.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -62.16 -47.87 82.62 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 123.906 0.883 . . . . 0.0 110.966 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -48.03 80.51 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 176.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -57.39 -42.16 79.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 124.447 1.099 . . . . 0.0 109.769 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.68 -27.88 68.19 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.714 0.688 . . . . 0.0 112.154 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -77.01 -41.86 40.97 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.491 0.587 . . . . 0.0 111.951 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.8 pt -99.33 -40.02 8.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 -168.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 40.4 m . . . . . 0 C--O 1.255 1.366 0 CA-C-N 119.005 0.821 . . . . 0.0 110.891 -174.351 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 tpt . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 117.513 -1.232 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.716 ' HG2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -55.98 123.57 14.78 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 121.566 1.985 . . . . 0.0 109.996 -172.054 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -93.47 142.13 27.68 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -169.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.769 HG13 HG12 ' A' ' 75' ' ' VAL . 9.1 t -121.57 153.91 25.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.289 0.993 . . . . 0.0 108.56 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 59.9 tpp -136.32 135.05 38.56 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -117.22 109.88 17.43 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.446 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 10.2 t -96.98 141.74 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -169.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.9 t -125.81 156.7 39.12 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.335 0.97 . . . . 0.0 111.316 173.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp -140.11 34.67 1.92 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.664 1.586 . . . . 0.0 109.197 172.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.0 tpp180 -156.43 171.6 19.98 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 128.006 2.522 . . . . 0.0 105.156 -170.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.417 HD21 ' CE1' ' A' ' 43' ' ' HIS . 62.5 t-20 -42.2 125.41 3.06 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 169.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 85.0 p -41.52 -29.46 0.17 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 117.277 2.325 . . . . 0.0 117.277 -169.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.7 m -34.16 -62.16 0.33 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 127.367 2.267 . . . . 0.0 115.148 -169.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 -64.6 -52.0 59.79 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.056 0.844 . . . . 0.0 112.529 -168.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 m -81.67 -34.09 30.92 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 121.514 -0.741 . . . . 0.0 111.417 -172.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.27 -30.76 65.14 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.454 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.7 tpt -64.88 -40.88 95.8 Favored 'General case' 0 CA--C 1.514 -0.419 0 O-C-N 121.018 -1.051 . . . . 0.0 109.094 168.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.67 -36.79 79.59 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -62.03 -42.96 99.73 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 118.83 -0.605 . . . . 0.0 111.313 169.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.14 -45.61 91.0 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-N 119.936 1.244 . . . . 0.0 110.907 -176.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -63.09 -39.98 96.31 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 117.934 0.867 . . . . 0.0 109.364 172.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.28 -35.82 76.43 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 119.58 1.082 . . . . 0.0 111.561 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -81.93 -13.91 56.85 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 120.311 1.414 . . . . 0.0 113.244 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.9 m -78.18 -50.69 11.47 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.229 1.412 . . . . 0.0 109.397 169.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.3 mt -89.56 -27.4 20.28 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.16 1.384 . . . . 0.0 112.423 -169.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.78 14.63 57.47 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 126.661 2.077 . . . . 0.0 111.685 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.34 120.45 9.32 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.579 1.151 . . . . 0.0 110.054 -172.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.58 9.5 86.13 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 119.81 -0.439 . . . . 0.0 113.467 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -123.27 -24.87 4.56 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 125.159 1.384 . . . . 0.0 109.701 -177.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.716 HG22 ' HG2' ' A' ' 2' ' ' LYS . 13.1 pt -144.29 172.0 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 125.962 1.705 . . . . 0.0 110.42 175.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.31 144.71 38.62 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 103.836 -2.653 . . . . 0.0 103.836 168.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 t -135.59 140.42 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 123.47 0.708 . . . . 0.0 110.743 -168.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.6 160.63 42.49 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.127 0.971 . . . . 0.0 109.939 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.5 p -139.02 163.64 31.85 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 120.288 1.404 . . . . 0.0 111.221 174.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.7 p -149.64 160.49 43.46 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.151 0.58 . . . . 0.0 111.339 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.24 -87.16 0.43 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 54.65 50.97 14.73 Favored 'General case' 0 C--N 1.344 0.34 0 C-N-CA 125.264 1.425 . . . . 0.0 109.829 -175.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -61.69 -13.06 19.5 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.85 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 p -71.3 6.41 1.74 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 172.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.4 m 63.05 -20.62 0.05 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 129.641 3.176 . . . . 0.0 115.141 -177.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.91 178.63 10.14 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 127.548 2.339 . . . . 0.0 106.601 174.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.27 159.16 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.417 ' CE1' HD21 ' A' ' 11' ' ' ASN . 70.6 t60 -121.28 111.28 33.71 Favored Pre-proline 0 N--CA 1.454 -0.268 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -169.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -66.08 -27.11 49.92 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.385 2.724 . . . . 0.0 112.343 -169.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.9 m -63.32 -37.11 85.99 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.64 0.655 . . . . 0.0 109.249 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.39 -44.15 88.43 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.08 -49.66 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.22 -42.86 99.34 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.487 0.585 . . . . 0.0 111.119 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 28.6 mmt -61.89 -24.75 67.14 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.353 -0.832 . . . . 0.0 111.967 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.454 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.6 OUTLIER -94.4 -27.61 15.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 119.151 0.887 . . . . 0.0 108.688 -179.194 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.59 -30.42 71.53 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.371 1.068 . . . . 0.0 110.408 170.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -56.84 -23.19 42.26 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.457 0.703 . . . . 0.0 112.098 171.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.8 m -123.64 12.01 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 125.445 1.498 . . . . 0.0 111.142 -175.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.36 39.65 87.46 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 123.815 0.722 . . . . 0.0 112.759 174.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.6 mt -122.98 154.56 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.428 1.491 . . . . 0.0 107.19 175.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -127.84 128.11 44.65 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 124.552 1.141 . . . . 0.0 108.795 -177.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 46.3 pt -134.64 15.31 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 126.661 1.984 . . . . 0.0 109.752 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.65 160.16 27.66 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 167.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.17 -15.86 2.34 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 118.958 -0.912 . . . . 0.0 112.456 -174.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -61.58 147.46 45.55 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.757 1.279 . . . . 0.0 107.903 169.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.06 169.64 17.73 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -169.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.3 m -73.06 145.11 46.8 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.663 1.585 . . . . 0.0 111.937 -170.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -166.32 123.8 1.03 Allowed Pre-proline 0 C--O 1.237 0.442 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 169.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -76.87 161.12 33.54 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.115 1.876 . . . . 0.0 111.454 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.8 tt -56.17 -37.79 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.217 1.007 . . . . 0.0 111.142 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -68.86 -21.27 64.28 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.586 0.754 . . . . 0.0 112.16 -176.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.79 -22.43 63.33 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 118.637 -0.697 . . . . 0.0 111.203 171.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -107.45 165.9 11.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 122.578 1.18 . . . . 0.0 112.018 -172.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.86 89.8 2.28 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 102.658 -3.09 . . . . 0.0 102.658 -170.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.481 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -49.4 -32.14 11.01 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.275 0.63 . . . . 0.0 112.283 -177.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.08 -28.29 10.18 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.26 1.024 . . . . 0.0 112.868 174.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.04 -23.2 61.34 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.366 0.666 . . . . 0.0 112.208 176.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -104.12 178.89 4.43 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.618 2.767 . . . . 0.0 108.659 -175.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -123.57 -17.4 6.47 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 118.601 -0.714 . . . . 0.0 112.579 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.769 HG12 HG13 ' A' ' 4' ' ' VAL . 17.5 t -143.72 124.25 9.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 -169.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.6 t -117.41 130.09 72.86 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.782 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.425 HG21 ' CE3' ' A' ' 99' ' ' TRP . 33.0 mm -119.35 92.44 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 103.026 -2.953 . . . . 0.0 103.026 169.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.446 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 16.9 t -72.42 161.38 30.9 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 169.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.6 mp -141.32 46.87 1.71 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 169.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 72.2 m -89.76 2.06 55.34 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.992 0.917 . . . . 0.0 110.682 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.12 42.69 5.22 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 172.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 29.2 p 37.75 44.72 0.59 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.321 2.248 . . . . 0.0 114.638 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -157.56 47.89 0.45 Allowed Glycine 0 C--N 1.34 0.757 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -172.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.9 p -128.09 161.92 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.873 1.669 . . . . 0.0 109.99 -172.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -123.21 45.31 2.45 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.177 2.191 . . . . 0.0 109.445 -170.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.8 mt -54.42 140.98 54.82 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.2 1.0 . . . . 0.0 109.245 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -53.88 153.39 20.13 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.596 2.197 . . . . 0.0 112.554 173.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -55.53 -26.82 56.43 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.515 2.143 . . . . 0.0 116.006 -173.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -64.75 -25.09 67.78 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.915 -1.116 . . . . 0.0 111.865 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.481 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 70.0 m95 -71.43 -9.19 57.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.661 1.184 . . . . 0.0 112.323 173.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.27 -29.8 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.663 1.585 . . . . 0.0 110.294 -173.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.0 p -75.25 -9.63 58.73 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.758 0.823 . . . . 0.0 112.738 -175.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -45.21 155.67 0.12 Allowed 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 129.916 3.287 . . . . 0.0 111.722 169.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -62.19 -39.23 92.0 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.803 1.641 . . . . 0.0 109.561 170.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.61 ' HB ' HG13 ' A' ' 75' ' ' VAL . 21.8 mm -122.56 134.64 65.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 169.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -137.92 111.78 8.33 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 103.892 -2.633 . . . . 0.0 103.892 166.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -137.39 165.72 25.54 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -133.41 105.04 6.71 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.441 1.096 . . . . 0.0 108.157 171.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.425 ' CE3' HG21 ' A' ' 77' ' ' ILE . 46.1 m0 -79.35 72.82 5.98 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.181 1.392 . . . . 0.0 108.613 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -51.94 34.05 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.952 1 C-N-CA 132.43 4.292 . . . . 0.0 116.015 169.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.87 -175.0 1.6 Allowed 'General case' 0 CA--C 1.544 0.742 0 O-C-N 120.958 -1.088 . . . . 0.0 110.162 -174.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.456 ' HB2' HG22 ' A' ' 115' ' ' VAL . 1.5 mp0 -42.21 164.51 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 127.735 2.414 . . . . 0.0 113.213 176.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -126.58 63.17 52.24 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 125.779 1.632 . . . . 0.0 112.802 -168.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -79.94 69.06 8.1 Favored 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 124.164 3.243 . . . . 0.0 112.549 -169.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.35 -38.56 89.99 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.799 -1.188 . . . . 0.0 112.404 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -162.8 42.56 0.35 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 125.259 1.409 . . . . 0.0 110.763 -176.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -71.88 171.58 11.47 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -169.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.3 m -69.25 154.2 42.43 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 113.103 -1.862 . . . . 0.0 108.194 168.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 24.6 mt -59.17 -32.48 69.94 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.911 -0.493 . . . . 0.0 111.438 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -62.81 -39.75 95.24 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 118.611 0.642 . . . . 0.0 111.005 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.621 ' O ' HG23 ' A' ' 115' ' ' VAL . 98.7 t -72.02 -42.13 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-O 116.37 -1.776 . . . . 0.0 108.526 177.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -50.38 -49.13 55.21 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 121.086 1.766 . . . . 0.0 111.1 172.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -58.67 -44.33 90.17 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.371 0.532 . . . . 0.0 110.762 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 88.0 m -66.15 -44.6 83.66 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 118.642 -0.694 . . . . 0.0 109.432 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 111' ' ' VAL . 17.3 t -67.36 -49.16 74.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -172.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -44.29 -56.36 4.22 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.332 1.453 . . . . 0.0 111.269 170.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.81 -42.77 96.9 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 119.231 0.923 . . . . 0.0 111.416 -175.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -62.2 -39.35 92.45 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.503 -0.998 . . . . 0.0 111.409 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.0 t -62.72 -41.52 92.68 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 CA-C-O 117.842 -1.075 . . . . 0.0 108.212 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -38.3 75.9 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 120.208 1.367 . . . . 0.0 111.048 -177.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -69.79 -43.76 71.47 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.988 -0.529 . . . . 0.0 110.219 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -66.36 -42.9 87.35 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.381 0.991 . . . . 0.0 110.357 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 50.8 t -52.72 -54.53 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 123.833 0.853 . . . . 0.0 108.983 172.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -65.1 -32.54 74.29 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 122.121 -0.362 . . . . 0.0 111.301 -174.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -62.41 -47.74 82.8 Favored 'General case' 0 C--O 1.225 -0.188 0 O-C-N 121.806 -0.559 . . . . 0.0 111.185 172.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.63 -47.57 79.41 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 176.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.2 mt -57.97 -42.71 83.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 123.895 0.878 . . . . 0.0 109.697 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.3 -32.0 71.85 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.961 0.801 . . . . 0.0 111.957 177.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -72.36 -42.25 65.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.611 173.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.3 pt -103.93 -44.7 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 118.942 2.941 . . . . 0.0 118.942 -168.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 71.8 m . . . . . 0 C--O 1.252 1.228 0 CA-C-N 119.733 1.152 . . . . 0.0 111.561 -169.336 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 tpt . . . . . 0 N--CA 1.498 1.942 0 CA-C-O 118.724 -0.655 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -64.31 128.13 34.47 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.892 1.678 . . . . 0.0 108.891 -174.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -94.24 145.8 24.47 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -170.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.753 HG13 HG12 ' A' ' 75' ' ' VAL . 12.2 t -124.28 153.52 30.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 O-C-N 124.495 1.122 . . . . 0.0 108.142 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 56.5 tpp -134.59 146.24 49.42 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 175.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -127.0 106.53 9.34 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.454 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 4.0 t -93.47 136.52 24.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -169.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.5 m -108.55 171.62 7.31 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.133 0.573 . . . . 0.0 110.748 -174.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -149.69 -52.36 0.15 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.451 0.7 . . . . 0.0 109.395 169.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.44 ' CG ' ' H ' ' A' ' 11' ' ' ASN . 30.9 ttm180 -103.92 -176.44 3.08 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.387 1.075 . . . . 0.0 108.293 169.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.483 HD21 ' CD2' ' A' ' 43' ' ' HIS . 27.4 t-20 -36.07 125.24 0.75 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 127.821 2.448 . . . . 0.0 113.65 -169.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.78 -19.56 6.65 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 129.243 3.017 . . . . 0.0 113.818 -173.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 p -58.17 -12.41 3.52 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 177.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -101.54 -43.91 5.75 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 120.597 1.544 . . . . 0.0 111.509 169.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.0 p -93.23 -52.88 4.34 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.964 1.306 . . . . 0.0 113.542 -168.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -65.87 -28.03 68.66 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.667 -1.271 . . . . 0.0 110.068 169.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.464 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.7 tpt -62.47 -39.81 94.61 Favored 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 121.267 -0.896 . . . . 0.0 110.741 169.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.03 -37.52 80.02 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 118.834 -0.603 . . . . 0.0 109.678 178.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -62.22 -41.29 98.25 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 118.721 -0.657 . . . . 0.0 110.915 169.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.87 -43.02 84.83 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 120.255 1.388 . . . . 0.0 111.686 -175.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -65.31 -37.53 87.41 Favored 'General case' 0 CA--C 1.517 -0.319 0 O-C-N 121.742 -0.858 . . . . 0.0 108.733 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.66 -38.0 67.76 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 119.752 1.16 . . . . 0.0 111.358 -174.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.418 ' HA ' HG21 ' A' ' 32' ' ' VAL . 54.6 pttt -68.42 -26.75 65.69 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.869 1.213 . . . . 0.0 111.627 175.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.0 m -77.21 -52.32 9.44 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.967 1.707 . . . . 0.0 110.235 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.1 mt -88.2 -26.44 22.38 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.008 1.323 . . . . 0.0 111.695 -169.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.13 13.77 58.63 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 126.431 1.967 . . . . 0.0 111.673 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.6 119.5 7.68 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.414 1.086 . . . . 0.0 109.548 -174.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.07 8.3 87.93 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 119.754 -0.47 . . . . 0.0 113.564 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.4 ' O ' ' HE2' ' A' ' 2' ' ' LYS . 75.6 mmtt -123.51 -26.22 4.25 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 125.568 1.547 . . . . 0.0 109.977 -177.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.512 HG21 HD12 ' A' ' 130' ' ' ILE . 9.1 pt -145.92 170.58 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 125.058 1.343 . . . . 0.0 109.589 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -109.12 145.82 35.08 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 167.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.457 HG22 HD12 ' A' ' 30' ' ' ILE . 1.7 t -136.43 140.24 43.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 119.05 0.841 . . . . 0.0 111.263 -167.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 m -150.7 160.78 43.61 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 124.209 1.003 . . . . 0.0 110.682 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 64.6 p -133.2 161.86 33.3 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.057 1.299 . . . . 0.0 109.746 169.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.8 p -154.39 169.8 22.87 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.063 0.459 . . . . 0.0 111.879 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.95 -51.43 2.76 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 125.471 1.51 . . . . 0.0 111.846 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 mp 50.47 -156.25 0.11 Allowed 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -168.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -73.07 11.89 0.63 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.079 1.352 . . . . 0.0 112.472 173.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.9 m 63.17 24.71 14.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.017 1.327 . . . . 0.0 110.714 -168.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 55.9 m -145.8 168.28 21.15 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 129.307 3.043 . . . . 0.0 106.013 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -70.53 178.79 2.8 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.34 0.656 . . . . 0.0 111.56 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 t -44.89 151.91 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 127.564 2.345 . . . . 0.0 112.285 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.483 ' CD2' HD21 ' A' ' 11' ' ' ASN . 85.9 t60 -127.74 114.62 20.79 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 125.76 1.624 . . . . 0.0 108.321 -172.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -68.35 -27.04 34.62 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 124.021 3.147 . . . . 0.0 113.241 -169.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.0 m -62.65 -34.37 76.94 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.134 0.879 . . . . 0.0 109.206 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.12 -45.97 86.23 Favored 'General case' 0 C--N 1.346 0.452 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.48 -46.7 92.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.128 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.96 -43.57 98.57 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 119.091 0.86 . . . . 0.0 111.077 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.4 mmt -59.74 -25.45 64.86 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.204 0.602 . . . . 0.0 111.986 175.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.464 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -93.09 -29.32 15.84 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -176.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -63.25 -31.47 72.63 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.328 1.451 . . . . 0.0 110.212 171.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -56.83 -20.81 24.79 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.794 0.838 . . . . 0.0 112.516 171.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.8 p -126.25 14.15 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 125.191 1.397 . . . . 0.0 110.253 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.8 33.76 66.32 Favored Glycine 0 CA--C 1.531 1.069 0 O-C-N 121.053 -1.029 . . . . 0.0 112.842 173.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 26.8 mt -121.01 159.04 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 126.08 1.752 . . . . 0.0 106.944 176.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -140.09 146.99 39.62 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.2 pt -135.15 8.77 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 126.262 1.825 . . . . 0.0 111.183 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.5 t -70.73 161.31 31.07 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 168.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 75.7 -25.53 1.43 Allowed Glycine 0 CA--C 1.533 1.199 0 CA-C-O 119.029 -0.873 . . . . 0.0 111.942 -173.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -76.85 137.95 39.5 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 103.397 -2.816 . . . . 0.0 103.397 168.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.4 p -146.84 165.19 30.45 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -168.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.1 m -68.0 141.37 56.27 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.961 2.105 . . . . 0.0 111.01 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -164.56 132.19 2.5 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.66 147.61 35.78 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.887 2.392 . . . . 0.0 113.753 -168.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.5 tt -60.48 -34.25 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.087 1.355 . . . . 0.0 111.238 -171.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.28 -13.17 61.44 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.211 0.604 . . . . 0.0 112.541 -171.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -91.58 -10.29 41.09 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.027 0.931 . . . . 0.0 112.173 171.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -84.0 171.07 13.3 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 122.015 0.912 . . . . 0.0 111.161 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.77 83.2 1.52 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.787 1.635 . . . . 0.0 107.638 -176.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.41 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -49.1 -30.96 7.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -50.65 -32.6 19.61 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.143 0.977 . . . . 0.0 112.627 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -71.11 -24.85 62.37 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -94.36 177.28 6.0 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 127.402 2.281 . . . . 0.0 109.064 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -116.14 -19.23 10.36 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 118.257 -0.878 . . . . 0.0 112.585 173.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.753 HG12 HG13 ' A' ' 4' ' ' VAL . 8.2 t -143.2 132.41 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 120.685 1.584 . . . . 0.0 106.939 -169.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.8 m -132.99 130.15 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.43 HG21 ' CE3' ' A' ' 99' ' ' TRP . 28.0 mm -116.96 99.96 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 N-CA-C 102.749 -3.056 . . . . 0.0 102.749 176.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.454 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 30.3 t -72.85 161.38 30.79 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 169.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.2 mp -140.1 34.29 1.92 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 169.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.541 ' HB3' HG21 ' A' ' 84' ' ' VAL . 85.5 m -74.01 -5.79 43.5 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.388 1.075 . . . . 0.0 111.6 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.33 27.32 18.41 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -173.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.501 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 3.1 t 53.96 -173.13 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.287 1.835 . . . . 0.0 111.095 -169.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.93 -34.4 1.25 Allowed Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.414 1.483 . . . . 0.0 114.818 173.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.541 HG21 ' HB3' ' A' ' 80' ' ' CYS . 78.2 t -58.67 126.07 15.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 118.502 1.151 . . . . 0.0 108.679 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -82.04 73.31 9.09 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.455 1.102 . . . . 0.0 110.317 -169.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.2 mt -58.9 143.01 84.16 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 118.28 -0.867 . . . . 0.0 108.871 177.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.1 156.59 9.76 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.208 2.605 . . . . 0.0 112.458 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.57 -20.46 65.67 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.72 1.613 . . . . 0.0 115.172 -169.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.83 -24.8 66.2 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 120.576 -1.328 . . . . 0.0 112.067 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.41 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 71.7 m95 -70.33 -8.9 54.1 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.215 1.006 . . . . 0.0 111.884 171.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.2 t -105.83 -30.56 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 119.831 1.196 . . . . 0.0 110.517 -174.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.8 p -73.8 -14.48 61.11 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.114 0.966 . . . . 0.0 112.911 -174.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.418 ' HG2' ' H ' ' A' ' 93' ' ' GLN . 79.2 mm-40 -44.25 154.19 0.12 Allowed 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 129.835 3.254 . . . . 0.0 112.075 169.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -63.01 -38.72 92.32 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.735 1.614 . . . . 0.0 109.45 169.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.498 ' HB ' HG13 ' A' ' 75' ' ' VAL . 2.5 mt -126.95 131.11 71.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 174.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -137.95 109.84 7.18 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 101.126 -3.657 . . . . 0.0 101.126 166.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.86 165.99 23.72 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.501 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 11.1 t70 -130.62 103.91 6.9 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 169.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.43 ' CE3' HG21 ' A' ' 77' ' ' ILE . 53.0 m0 -76.35 73.12 3.13 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 174.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -58.99 42.9 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.87 1 C-N-CA 131.865 4.066 . . . . 0.0 111.755 169.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.36 -172.69 1.2 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.714 1.206 . . . . 0.0 112.128 -168.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.486 ' HB2' HG22 ' A' ' 115' ' ' VAL . 39.0 mt-10 -50.96 161.64 0.35 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 125.344 1.458 . . . . 0.0 111.745 172.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -117.42 101.22 52.83 Favored Pre-proline 0 C--N 1.323 -0.557 0 C-N-CA 126.313 1.845 . . . . 0.0 108.766 -176.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -79.08 -4.5 13.91 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.071 2.514 . . . . 0.0 113.064 175.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.8 t70 23.26 -96.6 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 128.536 2.735 . . . . 0.0 114.238 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.84 38.31 1.83 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 127.105 2.288 . . . . 0.0 109.51 169.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -71.67 -178.0 2.09 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.238 1.815 . . . . 0.0 112.775 -174.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.0 m -62.55 155.2 26.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 113.52 -1.673 . . . . 0.0 109.047 172.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 27.0 mt -56.43 -30.82 63.3 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 123.09 0.556 . . . . 0.0 110.805 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.35 -40.04 92.81 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 118.636 0.653 . . . . 0.0 110.811 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.4 t -72.32 -44.02 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 117.361 -1.304 . . . . 0.0 108.781 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -48.01 -48.71 32.58 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 120.181 1.355 . . . . 0.0 111.383 170.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -60.64 -45.13 95.23 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.948 0.795 . . . . 0.0 111.364 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.7 m -68.58 -44.32 74.66 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -173.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.486 HG22 ' HB2' ' A' ' 102' ' ' GLU . 19.7 t -67.68 -43.47 86.65 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -174.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -47.37 -56.4 6.98 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 124.638 1.175 . . . . 0.0 110.825 171.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.66 -42.49 99.68 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 119.546 1.066 . . . . 0.0 111.869 -176.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -63.7 -38.74 92.26 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 121.317 -1.108 . . . . 0.0 111.803 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.5 t -62.52 -41.42 91.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 174.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -37.29 76.75 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 119.805 1.184 . . . . 0.0 111.184 -175.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -70.11 -41.05 74.5 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 118.695 -0.669 . . . . 0.0 110.722 176.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -64.4 -43.74 93.46 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 119.948 1.249 . . . . 0.0 110.214 177.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.497 HG12 HD12 ' A' ' 127' ' ' ILE . 66.7 t -54.38 -52.02 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 123.782 0.833 . . . . 0.0 109.536 173.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -66.29 -34.46 78.04 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 118.057 0.39 . . . . 0.0 111.634 -175.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -61.74 -48.91 78.58 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.313 0.645 . . . . 0.0 110.897 172.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.42 HD23 HG13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -58.5 -45.06 89.53 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 122.882 0.473 . . . . 0.0 109.937 176.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.497 HD12 HG12 ' A' ' 123' ' ' VAL . 6.6 mt -58.38 -42.71 84.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 123.489 0.715 . . . . 0.0 109.576 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.04 -28.11 68.61 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -68.19 -53.53 24.26 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.022 0.828 . . . . 0.0 110.431 172.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.512 HD12 HG21 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -84.33 -40.5 15.48 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 -169.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--O 1.255 1.345 0 CA-C-N 119.554 1.07 . . . . 0.0 112.486 -169.638 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.5 2.03 0 CA-C-O 117.491 -1.242 . . . . 0.0 109.208 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.705 ' HG2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -56.44 123.54 15.07 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 121.509 1.959 . . . . 0.0 109.812 -172.758 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -92.47 142.05 27.84 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -170.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.707 HG13 HG12 ' A' ' 75' ' ' VAL . 10.5 t -123.66 152.21 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 O-C-N 124.381 1.051 . . . . 0.0 108.385 -177.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 53.8 tpp -137.29 143.94 42.4 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -126.23 119.56 27.77 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.8 t -103.86 131.14 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -169.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.8 t -123.56 -174.76 3.04 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.624 1.57 . . . . 0.0 110.314 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -158.59 -63.63 0.08 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 169.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.3 ttm105 -70.66 135.15 48.15 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 122.333 0.253 . . . . 0.0 111.272 -175.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 65.4 t30 42.91 25.74 0.06 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.72 2.808 . . . . 0.0 115.877 168.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.4 m 29.45 64.87 0.13 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.177 2.191 . . . . 0.0 114.395 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 p -139.38 -71.88 0.39 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 116.593 -1.67 . . . . 0.0 115.129 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.262 20.0 ptt180 -44.18 -45.68 8.48 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 122.355 2.343 . . . . 0.0 116.035 -168.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.445 ' HB3' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -93.04 -30.69 15.17 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.486 -0.759 . . . . 0.0 111.215 -174.08 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -62.11 -37.14 83.97 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.857 -1.152 . . . . 0.0 108.677 169.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.423 ' SD ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -64.25 -39.49 94.06 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 121.146 -0.971 . . . . 0.0 110.681 172.203 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.56 -34.5 74.26 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 118.633 -0.699 . . . . 0.0 110.326 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -64.24 -40.78 96.72 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-N 118.979 0.809 . . . . 0.0 110.172 169.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.29 -43.55 98.92 Favored Glycine 0 C--N 1.339 0.697 0 CA-C-N 120.009 1.277 . . . . 0.0 111.33 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.423 ' CD2' ' SD ' ' A' ' 17' ' ' MET . 7.2 m-85 -68.24 -38.31 81.69 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-N 118.571 1.186 . . . . 0.0 109.847 172.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.83 -37.11 70.36 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 119.642 1.11 . . . . 0.0 111.171 -172.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.438 ' HA ' HG21 ' A' ' 32' ' ' VAL . 42.4 pttt -71.34 -27.14 63.16 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 119.868 1.213 . . . . 0.0 111.867 174.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.1 m -72.58 -50.8 22.98 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.184 1.794 . . . . 0.0 110.331 175.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.1 mt -88.76 -28.36 20.54 Favored 'General case' 0 CA--C 1.53 0.212 0 C-N-CA 124.74 1.216 . . . . 0.0 112.056 -169.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.59 15.14 60.17 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.878 2.18 . . . . 0.0 111.423 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.56 120.11 8.81 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.706 1.203 . . . . 0.0 110.012 -173.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.65 9.05 87.12 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 119.692 -0.504 . . . . 0.0 113.48 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -123.1 -24.02 4.81 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.348 1.459 . . . . 0.0 110.026 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.705 HG22 ' HG2' ' A' ' 2' ' ' LYS . 12.9 pt -146.08 171.85 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 125.972 1.709 . . . . 0.0 110.124 177.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.82 143.81 42.15 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 168.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.484 HG22 HD12 ' A' ' 30' ' ' ILE . 1.6 t -137.34 138.14 45.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 118.907 0.776 . . . . 0.0 111.178 -168.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.4 m -144.86 166.42 25.31 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.203 1.401 . . . . 0.0 109.841 178.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.5 p -136.37 161.78 34.87 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.594 -1.316 . . . . 0.0 108.899 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.4 p -159.07 176.27 12.47 Favored 'General case' 0 C--O 1.233 0.226 0 O-C-N 121.556 -0.715 . . . . 0.0 109.491 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.2 38.78 38.65 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -176.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.88 139.89 58.76 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 103.052 -2.944 . . . . 0.0 103.052 168.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -54.6 -23.86 18.75 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.24 1.016 . . . . 0.0 112.893 -174.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 89.2 p 129.46 -28.08 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 1 C-N-CA 132.468 4.307 . . . . 0.0 110.817 -169.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.0 m -72.13 141.0 49.14 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 113.448 -1.705 . . . . 0.0 107.606 169.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -83.67 112.32 19.94 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 175.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 m 46.63 -166.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 127.47 2.308 . . . . 0.0 114.423 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -149.55 116.17 3.62 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -65.35 -29.35 54.39 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.018 2.479 . . . . 0.0 112.176 -169.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.6 m -64.21 -37.5 87.69 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.91 -42.25 90.42 Favored 'General case' 0 C--O 1.219 -0.536 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.73 -48.4 86.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 118.457 -0.783 . . . . 0.0 109.286 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.98 -42.74 98.93 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 119.228 0.922 . . . . 0.0 110.992 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 24.6 mmt -64.87 -21.24 66.77 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.962 0.905 . . . . 0.0 112.102 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.1 mmt -91.49 -29.16 17.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 119.305 0.957 . . . . 0.0 110.175 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.24 -29.38 70.16 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.897 0.879 . . . . 0.0 110.491 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -56.39 -25.58 50.34 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.047 0.939 . . . . 0.0 112.489 170.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.5 m -121.95 12.74 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.987 1.315 . . . . 0.0 111.056 -173.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.2 37.4 81.25 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.361 -0.688 . . . . 0.0 112.385 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.6 mt -121.87 153.74 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -129.92 127.63 40.52 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 37.3 pt -132.02 9.73 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 C-N-CA 123.303 0.641 . . . . 0.0 111.931 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.16 -32.18 61.22 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.355 1.462 . . . . 0.0 112.456 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.06 3.83 69.33 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.551 -0.583 . . . . 0.0 112.841 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -76.1 -175.42 3.1 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.225 1.01 . . . . 0.0 111.847 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.43 171.14 1.14 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.013 2.525 . . . . 0.0 114.999 -169.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.2 m -144.74 21.55 1.63 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.426 1.49 . . . . 0.0 111.699 -169.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -139.59 160.13 62.63 Favored Pre-proline 0 N--CA 1.471 0.578 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -168.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.7 165.58 24.61 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 124.724 3.616 . . . . 0.0 112.454 175.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.4 tt -59.93 -34.55 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 125.384 1.474 . . . . 0.0 111.971 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -68.89 -21.56 64.23 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -169.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.49 -16.44 56.04 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.161 172.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -89.67 171.3 9.76 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.237 0.926 . . . . 0.0 110.706 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.24 88.57 1.73 Allowed 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.236 1.414 . . . . 0.0 108.912 -173.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.456 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -49.86 -29.71 8.59 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.805 0.842 . . . . 0.0 113.168 178.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -48.76 -33.98 11.35 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.282 1.033 . . . . 0.0 112.034 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -73.51 -23.11 59.98 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -99.43 -177.66 3.66 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 127.547 2.339 . . . . 0.0 109.796 -174.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -123.19 -20.52 5.67 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.707 HG12 HG13 ' A' ' 4' ' ' VAL . 17.1 t -142.86 130.09 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 -169.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 34.8 m -135.27 135.76 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 O-C-N 120.825 -1.172 . . . . 0.0 108.368 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.1 mm -130.37 100.27 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 -172.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 77.4 p -80.83 159.91 24.96 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 119.042 -1.063 . . . . 0.0 109.461 173.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.445 HD13 ' HB3' ' A' ' 15' ' ' SER . 3.4 mp -137.39 53.54 1.86 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 103.009 -2.96 . . . . 0.0 103.009 169.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 60.1 m -107.9 18.86 20.79 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.623 1.969 . . . . 0.0 108.774 -176.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.46 21.86 76.24 Favored Glycine 0 C--N 1.344 0.972 0 CA-C-O 118.785 -1.008 . . . . 0.0 112.548 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.4 p 53.52 -8.7 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.504 3.122 . . . . 0.0 117.418 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.97 -27.94 73.47 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 119.248 0.931 . . . . 0.0 112.005 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.0 t -65.99 113.63 2.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -76.19 105.59 7.32 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 104.154 -2.536 . . . . 0.0 104.154 168.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.5 mt -72.9 154.61 90.95 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.26 158.29 12.44 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.906 2.404 . . . . 0.0 112.487 173.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.84 -24.02 68.41 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 121.727 1.618 . . . . 0.0 115.717 -169.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -67.99 -24.3 65.12 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 120.705 -1.247 . . . . 0.0 111.835 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.456 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 65.6 m95 -72.6 -7.57 50.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.318 1.047 . . . . 0.0 111.756 172.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.2 t -105.34 -30.52 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 120.213 1.37 . . . . 0.0 110.309 -174.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.9 p -74.19 -13.11 60.75 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.242 1.017 . . . . 0.0 112.88 -175.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -45.29 154.64 0.16 Allowed 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 129.898 3.279 . . . . 0.0 112.468 169.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -64.33 -39.03 93.08 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.203 1.801 . . . . 0.0 109.347 170.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.575 ' HB ' HG13 ' A' ' 75' ' ' VAL . 31.1 mm -127.44 135.65 62.74 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 171.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -137.67 104.27 5.26 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 100.773 -3.788 . . . . 0.0 100.773 166.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -127.25 169.93 12.99 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 174.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' A' ' 78' ' ' SER . 8.3 t70 -142.44 137.12 30.13 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 169.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.421 ' CD2' ' HB3' ' A' ' 122' ' ' ARG . 54.0 m0 -107.19 6.29 28.57 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -172.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 42.88 -70.78 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 131.282 3.833 . . . . 0.0 112.678 -172.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.413 ' CD1' ' H ' ' A' ' 102' ' ' GLU 0.26 0.3 OUTLIER 52.69 -174.41 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.507 1 C-N-CA 132.977 4.511 . . . . 0.0 114.891 177.012 . . . . . . . . 5 4 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.44 ' HB2' HG22 ' A' ' 115' ' ' VAL . 27.0 mt-10 -62.19 172.28 1.51 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.065 1.746 . . . . 0.0 109.867 -175.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -129.15 72.23 81.99 Favored Pre-proline 0 C--N 1.323 -0.556 0 C-N-CA 125.135 1.374 . . . . 0.0 111.249 -168.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.6 68.25 5.43 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 124.481 3.454 . . . . 0.0 113.489 -172.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -64.68 -33.01 74.95 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.348 1.059 . . . . 0.0 112.902 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 154.46 92.35 0.09 OUTLIER Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.933 1.73 . . . . 0.0 109.209 -175.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.85 -167.94 1.8 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.458 1.503 . . . . 0.0 111.451 -169.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.2 p -70.89 157.92 37.32 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 113.424 -1.717 . . . . 0.0 108.162 168.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 38.1 mt -61.07 -31.63 71.29 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 121.842 -0.536 . . . . 0.0 111.292 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -58.58 -38.61 78.26 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.279 0.632 . . . . 0.0 111.088 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.667 ' O ' HG23 ' A' ' 115' ' ' VAL . 42.9 t -72.93 -43.6 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 117.172 -1.394 . . . . 0.0 108.594 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -52.78 -46.73 67.73 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.757 1.617 . . . . 0.0 111.591 171.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -58.86 -43.68 90.88 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 118.758 0.708 . . . . 0.0 111.04 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.0 m -68.13 -44.23 76.55 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -175.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 111' ' ' VAL . 60.1 t -62.5 -52.82 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -173.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -42.25 -58.99 1.96 Allowed 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 126.1 1.76 . . . . 0.0 110.974 169.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.46 -43.23 99.6 Favored Glycine 0 CA--C 1.524 0.607 0 CA-C-N 119.796 1.18 . . . . 0.0 111.632 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -63.93 -38.87 92.69 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 120.616 -1.52 . . . . 0.0 111.563 177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.5 t -60.28 -40.48 83.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 118.374 -0.822 . . . . 0.0 108.835 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -42.58 76.62 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 119.623 1.101 . . . . 0.0 110.425 -177.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -65.86 -43.34 88.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 119.426 -0.321 . . . . 0.0 110.385 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.421 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 5.5 mpt_? -70.55 -41.2 72.8 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.919 0.782 . . . . 0.0 109.844 -176.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 64.8 t -53.37 -52.92 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 123.31 0.644 . . . . 0.0 109.486 172.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.99 -33.1 75.23 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 122.212 -0.305 . . . . 0.0 111.491 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -61.81 -47.54 84.65 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.078 0.551 . . . . 0.0 111.135 172.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -46.93 84.39 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 118.259 0.482 . . . . 0.0 110.089 176.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -57.81 -42.22 81.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 C-N-CA 123.473 0.709 . . . . 0.0 109.557 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.03 -30.26 70.84 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 118.909 0.777 . . . . 0.0 111.798 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -72.89 -44.23 61.53 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 118.346 -0.835 . . . . 0.0 111.623 172.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 21.3 pt -101.96 -43.85 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 118.465 2.765 . . . . 0.0 118.465 -168.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.0 m . . . . . 0 C--O 1.254 1.317 0 CA-C-O 116.692 -1.623 . . . . 0.0 111.536 -169.236 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.498 1.958 0 CA-C-O 118.91 -0.566 . . . . 0.0 109.848 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -64.65 128.58 36.39 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.565 1.53 . . . . 0.0 107.967 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -94.89 143.06 26.77 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -173.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.778 HG13 HG12 ' A' ' 75' ' ' VAL . 11.3 t -121.78 153.23 25.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 O-C-N 124.457 1.098 . . . . 0.0 108.631 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.4 mmt -129.13 138.78 52.0 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -119.7 100.09 7.05 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 170.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.43 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 2.7 t -84.64 116.78 28.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -168.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.9 m -82.75 167.5 18.11 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.848 0.833 . . . . 0.0 112.339 -171.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.0 mtpp -159.02 170.88 21.09 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 127.57 2.348 . . . . 0.0 105.6 169.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.02 -143.66 0.73 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.081 0.952 . . . . 0.0 108.49 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.427 HD21 ' CG ' ' A' ' 43' ' ' HIS . 60.6 t30 -72.67 1.78 7.72 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.405 -0.809 . . . . 0.0 112.426 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.3 m 65.57 -1.49 1.0 Allowed 'General case' 0 C--N 1.348 0.526 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 169.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 p -59.02 -45.94 89.46 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 119.953 1.251 . . . . 0.0 111.613 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -58.38 -35.34 71.84 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 119.406 1.003 . . . . 0.0 113.039 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.79 -40.49 10.17 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.565 1.146 . . . . 0.0 110.942 -169.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -64.53 -35.05 79.71 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.511 0.724 . . . . 0.0 110.01 169.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.459 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.6 tpt -63.05 -39.77 95.73 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 121.394 -0.816 . . . . 0.0 110.983 169.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.48 -36.98 79.58 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 118.439 -0.791 . . . . 0.0 109.647 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -63.11 -42.5 99.56 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.938 0.79 . . . . 0.0 110.373 169.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.24 -42.14 99.72 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-N 120.385 1.448 . . . . 0.0 112.226 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -69.26 -41.18 77.25 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 117.983 0.891 . . . . 0.0 109.322 172.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.439 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -71.63 -35.44 70.43 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 119.747 1.158 . . . . 0.0 111.565 -172.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.426 ' HA ' HG21 ' A' ' 32' ' ' VAL . 45.2 pttt -72.58 -21.89 61.07 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.809 1.186 . . . . 0.0 112.177 175.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 m -80.68 -50.63 9.66 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.352 1.861 . . . . 0.0 109.693 176.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.1 mt -88.55 -26.96 21.7 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.13 1.372 . . . . 0.0 111.599 -169.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.05 17.71 47.81 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 127.121 2.296 . . . . 0.0 111.525 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.74 121.56 12.57 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.628 1.171 . . . . 0.0 109.739 -172.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.38 9.29 85.91 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 119.869 -0.406 . . . . 0.0 113.54 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.406 ' O ' ' HE2' ' A' ' 2' ' ' LYS . 31.3 mmtp -124.44 -28.51 3.62 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 125.868 1.667 . . . . 0.0 110.532 -176.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.439 HD12 HG22 ' A' ' 32' ' ' VAL . 6.2 pt -141.55 162.32 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 124.308 1.043 . . . . 0.0 109.222 173.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.25 144.43 29.28 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 103.339 -2.838 . . . . 0.0 103.339 167.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.439 HG11 ' HB3' ' A' ' 22' ' ' ALA . 2.0 t -133.43 142.06 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 118.821 0.737 . . . . 0.0 111.275 -167.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.31 148.96 28.8 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.936 0.894 . . . . 0.0 110.202 -175.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.7 p -131.75 117.01 18.02 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 175.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.1 m -141.93 165.46 27.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 119.186 0.903 . . . . 0.0 111.044 -169.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.33 33.73 27.85 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -169.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mp -67.05 120.17 13.22 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 101.359 -3.571 . . . . 0.0 101.359 169.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.95 86.91 0.36 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.532 1.06 . . . . 0.0 113.262 -168.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.5 m 48.81 34.1 4.99 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.743 2.017 . . . . 0.0 112.233 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.8 m -144.83 165.94 26.68 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.545 1.538 . . . . 0.0 108.985 -170.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -97.53 -174.99 3.06 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.085 0.954 . . . . 0.0 109.684 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 m -58.09 172.25 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.253 0 C-N-CA 124.308 1.043 . . . . 0.0 111.4 172.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.427 ' CG ' HD21 ' A' ' 11' ' ' ASN . 85.0 t60 -133.45 120.78 15.99 Favored Pre-proline 0 N--CA 1.448 -0.562 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -66.69 -26.16 46.05 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.559 2.839 . . . . 0.0 112.321 -169.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.6 m -61.01 -37.05 81.18 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.004 0.82 . . . . 0.0 109.154 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.18 -44.12 84.94 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.499 HG12 ' HB3' ' A' ' 58' ' ' SER . 1.8 mp -58.3 -48.08 85.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 CA-C-O 118.278 -0.868 . . . . 0.0 108.874 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.92 98.3 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.293 0.951 . . . . 0.0 111.182 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.5 mmt -60.66 -25.22 66.18 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.395 1.078 . . . . 0.0 112.974 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.459 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -95.39 -33.1 12.63 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -178.074 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -61.77 -37.23 83.55 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.305 1.042 . . . . 0.0 110.158 174.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -71.64 0.37 8.86 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.7 m -130.14 13.87 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 125.983 1.713 . . . . 0.0 111.435 169.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.26 33.56 48.68 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 121.134 -0.979 . . . . 0.0 114.159 171.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.7 mt -125.41 160.79 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.994 1.718 . . . . 0.0 107.367 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -139.98 140.52 36.32 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.221 1.008 . . . . 0.0 108.928 175.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.8 pt -138.27 11.96 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 126.633 1.973 . . . . 0.0 110.001 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.499 ' HB3' HG12 ' A' ' 47' ' ' ILE . 63.9 p -62.27 145.01 54.86 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.945 0.793 . . . . 0.0 110.669 175.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.23 8.21 6.23 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 117.094 -1.948 . . . . 0.0 114.659 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -50.08 -61.03 2.39 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-N 120.067 1.933 . . . . 0.0 113.08 -172.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -159.01 159.33 34.65 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.461 1.104 . . . . 0.0 108.794 -169.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 66.5 m -163.04 43.96 0.12 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.862 1.665 . . . . 0.0 107.699 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -134.8 149.68 71.31 Favored Pre-proline 0 N--CA 1.47 0.563 0 O-C-N 121.493 -0.754 . . . . 0.0 111.847 -168.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -83.12 158.33 15.29 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 124.144 3.229 . . . . 0.0 112.282 -176.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.4 tt -62.98 -35.64 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 125.235 1.414 . . . . 0.0 112.198 -175.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -70.0 -20.55 63.28 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.611 0.364 . . . . 0.0 111.917 -171.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.51 -13.98 59.57 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 118.853 -0.594 . . . . 0.0 112.236 172.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -101.2 168.79 9.34 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.26 1.024 . . . . 0.0 110.853 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.73 91.67 2.33 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 -170.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.494 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -50.96 -31.94 19.44 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.52 -28.46 13.66 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.379 1.072 . . . . 0.0 112.177 176.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -70.88 -20.85 62.47 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.204 0.601 . . . . 0.0 112.368 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -106.9 175.13 5.6 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 128.624 2.77 . . . . 0.0 108.292 -174.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -118.64 -17.09 9.35 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.778 HG12 HG13 ' A' ' 4' ' ' VAL . 6.3 t -142.19 129.01 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -169.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.6 t -124.44 128.4 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.418 HG21 ' CE3' ' A' ' 99' ' ' TRP . 38.7 mm -121.68 96.63 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 102.119 -3.289 . . . . 0.0 102.119 169.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.43 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 20.4 p -72.66 164.11 27.01 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 118.019 -1.472 . . . . 0.0 107.884 169.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.6 mp -135.66 36.29 2.9 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 172.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.551 ' HB3' HG21 ' A' ' 84' ' ' VAL . 35.5 m -90.92 5.65 47.77 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.76 1.624 . . . . 0.0 110.761 -172.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.55 22.29 26.89 Favored Glycine 0 C--N 1.339 0.725 0 CA-C-O 119.565 -0.575 . . . . 0.0 111.955 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.429 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 5.4 t 46.88 40.68 9.49 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.941 1.696 . . . . 0.0 112.344 -177.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -149.79 35.33 1.02 Allowed Glycine 0 C--N 1.34 0.759 0 C-N-CA 123.793 0.711 . . . . 0.0 111.661 -171.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.551 HG21 ' HB3' ' A' ' 80' ' ' CYS . 73.2 t -121.18 130.09 75.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 124.965 1.306 . . . . 0.0 107.948 177.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -78.93 70.58 5.29 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 173.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.28 145.46 81.31 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-O 118.488 -0.768 . . . . 0.0 109.1 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -54.07 157.07 11.55 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.973 2.448 . . . . 0.0 111.924 172.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.3 -24.42 65.03 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 121.866 1.71 . . . . 0.0 114.949 -169.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -64.71 -23.68 67.33 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 120.63 -1.293 . . . . 0.0 111.974 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.494 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 77.4 m95 -73.42 -11.34 60.44 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.649 1.18 . . . . 0.0 112.866 176.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.2 m -118.53 -14.84 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 119.715 1.143 . . . . 0.0 112.822 -176.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.1 p -77.56 -11.12 59.82 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 118.968 0.804 . . . . 0.0 112.061 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -47.15 156.29 0.24 Allowed 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 129.675 3.19 . . . . 0.0 111.138 169.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -64.04 -38.43 91.03 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.828 1.651 . . . . 0.0 109.872 171.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.516 ' HB ' HG13 ' A' ' 75' ' ' VAL . 2.1 mt -122.35 133.98 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 173.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -142.96 111.64 6.35 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 103.555 -2.757 . . . . 0.0 103.555 167.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -138.99 170.6 15.69 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 173.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.8 t70 -136.62 108.35 7.03 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 169.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.418 ' CE3' HG21 ' A' ' 77' ' ' ILE . 49.2 m0 -81.85 70.57 8.78 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -49.49 13.86 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 131.488 3.915 . . . . 0.0 115.916 170.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -60.02 124.69 20.98 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 126.075 1.75 . . . . 0.0 112.622 -168.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 48.08 -161.44 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.344 2.258 . . . . 0.0 114.915 169.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -156.48 77.95 4.18 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 128.371 2.668 . . . . 0.0 107.448 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.71 -15.03 15.48 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.495 2.13 . . . . 0.0 112.99 -172.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.3 t0 27.56 -101.7 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.565 2.346 . . . . 0.0 113.092 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.51 43.43 1.28 Allowed Glycine 0 CA--C 1.532 1.129 0 C-N-CA 126.734 2.111 . . . . 0.0 109.431 171.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -67.5 -176.73 0.64 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.881 1.672 . . . . 0.0 112.614 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.5 m -59.54 154.12 18.12 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.884 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.4 mt -56.67 -30.33 63.28 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 122.957 0.503 . . . . 0.0 111.038 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.93 -40.66 96.24 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 118.677 -0.678 . . . . 0.0 110.926 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 42.0 t -72.81 -41.35 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-O 117.803 -1.094 . . . . 0.0 108.867 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -49.37 -51.68 33.27 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.717 1.144 . . . . 0.0 110.921 169.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -59.45 -45.14 92.42 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.799 0.727 . . . . 0.0 111.37 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 94.5 m -69.78 -45.76 67.27 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -171.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.6 t -69.6 -42.16 80.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 -172.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.9 ttp180 -48.09 -53.63 15.9 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 124.853 1.261 . . . . 0.0 110.612 169.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.86 -40.58 99.42 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 119.296 0.953 . . . . 0.0 112.042 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -65.37 -38.51 90.27 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.321 -1.105 . . . . 0.0 111.066 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 48.5 t -62.69 -41.65 93.1 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -38.33 84.59 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 119.779 1.172 . . . . 0.0 111.661 -173.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -68.82 -42.77 76.77 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 119.101 -0.475 . . . . 0.0 109.762 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 21.2 mtt180 -65.93 -40.3 91.29 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 119.187 0.903 . . . . 0.0 111.156 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.456 HG12 HD12 ' A' ' 127' ' ' ILE . 47.4 t -54.82 -51.7 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 172.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -64.84 -33.55 76.26 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 122.099 -0.375 . . . . 0.0 111.822 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -65.08 -46.06 82.67 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 123.002 0.521 . . . . 0.0 111.269 174.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.433 HD23 HG13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -59.49 -45.63 91.14 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.456 HD12 HG12 ' A' ' 123' ' ' VAL . 6.7 mt -58.47 -39.94 76.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.32 -26.65 68.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.924 0.784 . . . . 0.0 112.488 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -72.52 -46.32 55.15 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 119.163 0.892 . . . . 0.0 111.783 173.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.8 pt -103.67 -33.89 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 117.75 2.5 . . . . 0.0 117.75 -168.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 C--O 1.255 1.392 0 CA-C-N 119.529 1.059 . . . . 0.0 111.066 -174.747 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.927 0 CA-C-O 118.868 -0.587 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.449 ' HE2' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -66.11 137.63 57.18 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 120.641 1.564 . . . . 0.0 107.59 175.328 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -105.99 140.93 38.23 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -171.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.699 HG13 HG12 ' A' ' 75' ' ' VAL . 12.8 t -118.31 151.73 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.5 tpp -137.94 141.55 40.55 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 177.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -116.54 150.29 38.2 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 172.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.499 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 6.6 t -134.18 137.77 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 120.491 1.496 . . . . 0.0 107.118 -170.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 t -126.47 156.39 40.76 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.522 0.729 . . . . 0.0 110.601 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -135.84 33.02 2.94 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.176 1.39 . . . . 0.0 109.474 170.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.57 -178.77 6.74 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 127.95 2.5 . . . . 0.0 106.186 -175.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -48.51 124.06 7.6 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 170.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.0 m -33.7 -30.06 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 129.592 3.157 . . . . 0.0 117.711 -174.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.3 m -38.87 -61.0 0.78 Allowed 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 126.714 2.006 . . . . 0.0 114.69 -169.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.259 39.4 ptt180 -63.17 -46.37 87.47 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 120.229 1.377 . . . . 0.0 113.161 -169.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.63 -28.53 19.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 118.776 0.716 . . . . 0.0 111.368 -172.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.461 ' HG3' HE21 ' A' ' 60' ' ' GLN . 39.0 tt0 -74.0 -27.95 61.21 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 120.828 -1.17 . . . . 0.0 110.605 171.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.461 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.8 tpt -64.49 -40.67 96.09 Favored 'General case' 0 CA--C 1.51 -0.586 0 O-C-N 120.844 -1.16 . . . . 0.0 108.37 169.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.48 -38.26 83.71 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -61.26 -39.96 92.29 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 118.63 -0.7 . . . . 0.0 111.156 169.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.07 -44.91 86.69 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 120.448 1.476 . . . . 0.0 112.392 -177.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -65.32 -39.98 93.14 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.43 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -72.06 -37.09 69.72 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 118.951 0.796 . . . . 0.0 111.221 -173.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.42 ' HA ' HG21 ' A' ' 32' ' ' VAL . 46.5 pttt -68.97 -28.61 66.78 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.076 1.307 . . . . 0.0 111.74 174.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.8 m -74.76 -51.73 13.38 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.845 1.658 . . . . 0.0 110.35 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.4 mt -88.22 -26.51 22.33 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.727 1.211 . . . . 0.0 112.057 -169.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.65 17.21 50.5 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.796 2.141 . . . . 0.0 111.454 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.35 120.8 9.98 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.909 1.284 . . . . 0.0 109.954 -172.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.53 11.42 84.38 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 119.505 -0.608 . . . . 0.0 113.439 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.449 ' O ' ' HE2' ' A' ' 2' ' ' LYS . 74.6 mmtt -127.11 -26.95 3.04 Favored 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 125.346 1.459 . . . . 0.0 110.535 -176.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.5 HD12 HG22 ' A' ' 32' ' ' VAL . 6.6 pt -141.37 161.09 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 124.531 1.132 . . . . 0.0 108.66 172.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.6 144.55 27.78 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 167.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.5 HG22 HD12 ' A' ' 30' ' ' ILE . 2.1 t -135.42 142.56 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 118.93 0.786 . . . . 0.0 111.333 -168.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.26 159.5 40.08 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.097 -174.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.4 p -136.88 162.65 32.67 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 121.433 1.924 . . . . 0.0 110.106 169.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.3 p -151.22 165.39 34.08 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.761 1.164 . . . . 0.0 111.262 -177.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.83 -85.72 0.41 Allowed Glycine 0 C--N 1.332 0.34 0 N-CA-C 105.51 -3.036 . . . . 0.0 105.51 -172.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 51.9 59.11 4.78 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.376 1.07 . . . . 0.0 108.24 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -66.27 -14.41 61.93 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.282 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.6 p -81.52 19.94 0.95 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.753 0.787 . . . . 0.0 112.202 169.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.6 m 66.46 -38.81 0.32 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 130.857 3.663 . . . . 0.0 114.503 177.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -143.52 -178.97 6.15 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.836 1.654 . . . . 0.0 108.145 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.7 t -48.29 150.83 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 125.269 1.428 . . . . 0.0 110.317 169.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -127.07 115.37 21.89 Favored Pre-proline 0 N--CA 1.448 -0.53 0 C-N-CA 125.332 1.453 . . . . 0.0 107.683 -173.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -69.16 -24.96 31.82 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.429 2.753 . . . . 0.0 113.257 -168.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.5 m -62.75 -39.49 94.29 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-N 119.94 1.245 . . . . 0.0 108.415 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.72 98.78 Favored 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.14 -48.92 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 118.297 -0.858 . . . . 0.0 109.544 177.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.75 -43.64 85.56 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 119.08 0.855 . . . . 0.0 110.627 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -20.21 65.17 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.483 0.713 . . . . 0.0 110.635 -175.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.461 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -96.38 -28.43 14.47 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.355 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.25 -29.23 70.6 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.755 1.222 . . . . 0.0 110.376 170.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -56.6 -23.18 39.0 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.855 0.862 . . . . 0.0 112.301 170.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.0 m -126.71 13.7 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 125.963 1.705 . . . . 0.0 111.166 -175.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.58 37.93 78.2 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 119.16 -0.8 . . . . 0.0 113.209 174.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.4 mt -125.76 154.61 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.708 1.603 . . . . 0.0 107.403 176.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -126.8 143.92 51.12 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.702 1.601 . . . . 0.0 108.639 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.3 pt -138.07 9.06 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 125.551 1.54 . . . . 0.0 110.915 174.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.47 151.39 45.17 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.624 1.17 . . . . 0.0 107.944 168.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.04 -3.24 14.24 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.585 -1.119 . . . . 0.0 113.474 -175.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.461 HE21 ' HG3' ' A' ' 16' ' ' GLN . 26.4 mt-30 -69.46 -175.96 0.91 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.498 1.649 . . . . 0.0 109.956 169.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.4 p -50.46 164.54 0.12 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.887 2.475 . . . . 0.0 114.766 -173.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.0 p -156.91 39.99 0.32 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.306 1.842 . . . . 0.0 109.769 177.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -141.03 150.01 57.72 Favored Pre-proline 0 CA--C 1.542 0.67 0 O-C-N 121.354 -0.841 . . . . 0.0 111.683 -169.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.38 165.53 23.16 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.892 3.061 . . . . 0.0 112.518 -174.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.5 tt -57.8 -39.32 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 125.073 1.349 . . . . 0.0 110.843 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.92 -18.13 61.43 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -170.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.23 -22.23 58.06 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 118.858 -0.591 . . . . 0.0 111.446 169.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -92.14 168.38 11.4 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.875 0.845 . . . . 0.0 110.64 -178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -142.34 94.6 2.68 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 103.336 -2.839 . . . . 0.0 103.336 -174.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.481 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -55.31 -28.01 50.77 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -176.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.36 -28.35 19.11 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.995 0.918 . . . . 0.0 112.415 175.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -70.74 -22.63 62.39 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.16 0.436 . . . . 0.0 112.086 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -106.07 -178.7 3.72 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 129.352 3.061 . . . . 0.0 108.286 -174.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -131.74 -2.44 3.74 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 171.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.699 HG12 HG13 ' A' ' 4' ' ' VAL . 23.8 t -141.71 126.92 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 -177.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.8 m -131.28 135.45 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.444 0 O-C-N 120.868 -1.145 . . . . 0.0 108.246 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.7 mm -134.61 80.69 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -169.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.499 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 17.8 t -68.41 164.51 20.8 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.818 177.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -140.75 55.46 1.58 Allowed 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 169.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 81.8 m -106.12 8.9 32.39 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.854 1.262 . . . . 0.0 109.705 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.7 31.5 10.14 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-O 119.209 -0.773 . . . . 0.0 111.639 169.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.415 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 8.8 p 46.59 -10.1 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 130.391 3.476 . . . . 0.0 119.244 -174.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.82 -13.87 82.65 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 120.133 1.333 . . . . 0.0 113.065 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 p -58.9 151.07 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 122.817 1.294 . . . . 0.0 109.202 172.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -124.39 81.28 1.92 Allowed 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 103.741 -2.689 . . . . 0.0 103.741 178.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.8 mt -62.65 150.09 87.38 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.28 158.69 11.67 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.659 2.239 . . . . 0.0 113.316 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -51.01 -36.3 53.55 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.964 2.443 . . . . 0.0 116.716 -169.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.2 pm0 -67.34 -25.82 66.19 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.323 -0.861 . . . . 0.0 112.133 -176.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.481 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 58.3 m95 -70.44 -9.73 57.23 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.93 1.292 . . . . 0.0 112.088 174.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.2 t -96.62 -29.59 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 119.225 0.921 . . . . 0.0 109.438 175.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.7 p -86.2 56.71 4.11 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.68 1.192 . . . . 0.0 110.502 -174.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -130.47 156.32 44.97 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 128.762 2.825 . . . . 0.0 107.96 -169.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -65.71 -39.23 91.0 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 125.752 1.621 . . . . 0.0 109.005 169.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.551 ' HB ' HG13 ' A' ' 75' ' ' VAL . 25.9 mm -128.7 137.17 58.02 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-O 121.113 0.482 . . . . 0.0 110.294 170.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -135.14 110.03 8.74 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 100.833 -3.765 . . . . 0.0 100.833 166.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.91 165.04 24.79 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 176.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.8 t70 -139.52 105.45 5.18 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 170.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -77.52 87.25 3.85 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 125.223 1.409 . . . . 0.0 107.475 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -65.75 23.07 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 126.613 1.965 . . . . 0.0 114.045 -175.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.16 176.39 0.6 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.628 1.971 . . . . 0.0 111.763 -170.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -54.3 162.44 1.07 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 123.444 1.593 . . . . 0.0 113.582 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -117.68 105.97 46.97 Favored Pre-proline 0 C--N 1.316 -0.866 0 C-N-CA 126.376 1.87 . . . . 0.0 108.396 -170.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.76 16.84 1.23 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.475 2.117 . . . . 0.0 112.181 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -24.84 85.02 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 129.584 3.154 . . . . 0.0 115.441 174.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 44.8 32.03 2.91 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 124.633 1.111 . . . . 0.0 113.959 -174.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -79.72 -179.7 7.05 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 122.492 1.139 . . . . 0.0 112.813 -169.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.1 p -61.07 160.04 10.72 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 113.55 -1.659 . . . . 0.0 109.602 172.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.6 mt -58.03 -30.27 66.0 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 122.667 0.387 . . . . 0.0 110.597 175.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -64.24 -40.0 95.11 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 118.532 -0.746 . . . . 0.0 111.157 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.0 t -72.61 -40.15 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 118.923 -1.111 . . . . 0.0 109.513 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -50.27 -50.68 49.5 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 119.45 1.023 . . . . 0.0 110.524 169.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -60.91 -44.99 96.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.549 0.739 . . . . 0.0 111.31 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.5 m -69.5 -45.59 68.57 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -172.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 49.3 t -65.75 -46.84 87.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -171.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -42.74 -56.47 3.17 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 125.061 1.344 . . . . 0.0 111.041 169.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.84 -40.93 98.89 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 119.79 1.177 . . . . 0.0 111.908 -175.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -67.55 -38.24 83.86 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 121.298 -1.119 . . . . 0.0 110.941 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.3 t -61.34 -43.0 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 172.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.48 -39.31 87.19 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 119.923 1.238 . . . . 0.0 111.827 -172.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -68.99 -42.03 77.03 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.749 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.7 mtt180 -65.61 -41.7 92.42 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.282 0.946 . . . . 0.0 111.197 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.463 HG12 HD12 ' A' ' 127' ' ' ILE . 47.2 t -54.83 -51.58 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 173.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -65.94 -33.73 76.5 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 122.134 -0.354 . . . . 0.0 111.826 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -63.33 -48.71 76.88 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 123.1 0.56 . . . . 0.0 110.345 174.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.404 HD23 HG13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -58.85 -45.7 89.48 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 109.614 -0.514 . . . . 0.0 109.614 177.368 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.463 HD12 HG12 ' A' ' 123' ' ' VAL . 9.3 mt -57.48 -43.01 82.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 123.599 0.759 . . . . 0.0 109.537 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.16 -26.64 68.62 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -71.17 -51.93 22.06 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.57 0.623 . . . . 0.0 110.446 173.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.427 HD12 HG21 ' A' ' 30' ' ' ILE . 1.3 pt -87.65 -46.1 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 -169.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 63.0 m . . . . . 0 C--O 1.254 1.334 0 CA-C-N 119.057 0.844 . . . . 0.0 110.678 -170.233 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 tpt . . . . . 0 N--CA 1.5 2.049 0 CA-C-O 118.33 -0.843 . . . . 0.0 109.659 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.464 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -57.75 118.62 5.48 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 120.727 1.603 . . . . 0.0 110.074 -169.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -87.89 137.61 32.18 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -171.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.786 HG13 HG12 ' A' ' 75' ' ' VAL . 11.2 t -117.9 154.05 19.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 124.398 1.079 . . . . 0.0 108.364 174.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 40.9 tpp -137.63 139.68 40.44 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -120.18 114.61 22.2 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.416 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 8.3 t -101.68 138.81 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 119.621 1.1 . . . . 0.0 108.361 -169.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -125.11 164.77 19.51 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 122.009 0.909 . . . . 0.0 111.808 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -150.27 156.0 40.75 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 129.648 3.179 . . . . 0.0 103.842 169.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 58.1 -153.66 0.37 Allowed 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -169.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.475 HD21 ' CD2' ' A' ' 43' ' ' HIS . 29.5 t-20 -59.13 123.63 17.28 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.317 0.647 . . . . 0.0 110.114 -169.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.2 m -49.84 -27.93 5.76 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.675 1.99 . . . . 0.0 113.98 -178.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 26.3 p -48.55 -48.01 38.89 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-O 117.954 -1.022 . . . . 0.0 112.98 -169.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -60.3 -45.99 91.43 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.987 1.267 . . . . 0.0 112.721 -170.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.485 ' HB3' HD13 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -93.8 -28.27 15.99 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.077 0.853 . . . . 0.0 111.595 -174.205 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -68.87 -33.0 73.07 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.045 -1.034 . . . . 0.0 109.769 171.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.474 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.7 tpt -65.68 -40.15 92.08 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 121.18 -0.95 . . . . 0.0 109.63 169.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.93 -40.67 89.72 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -60.52 -42.45 96.46 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.7 169.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.45 -45.21 80.33 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 120.598 1.545 . . . . 0.0 111.514 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -63.4 -40.34 96.94 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.504 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -71.34 -36.13 71.42 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 119.313 0.961 . . . . 0.0 111.517 -174.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -73.32 -22.91 60.22 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 120.757 1.617 . . . . 0.0 111.921 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 m -77.02 -50.85 12.2 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.818 1.647 . . . . 0.0 110.285 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.1 mt -86.32 -27.39 24.34 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.882 1.273 . . . . 0.0 112.039 -169.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -103.07 13.0 55.88 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 126.918 2.199 . . . . 0.0 111.523 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.98 121.85 12.23 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.041 1.336 . . . . 0.0 109.861 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.81 8.82 87.22 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-O 119.769 -0.462 . . . . 0.0 113.462 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -124.01 -31.5 3.37 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.42 1.488 . . . . 0.0 109.068 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.7 pt -142.74 176.46 3.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 125.527 1.531 . . . . 0.0 109.508 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -118.25 149.06 41.76 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 168.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.504 HG11 ' HB3' ' A' ' 22' ' ' ALA . 1.9 t -137.82 143.24 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 123.172 0.589 . . . . 0.0 111.412 -167.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.9 m -150.77 161.44 42.65 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.943 1.297 . . . . 0.0 109.745 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.468 ' H ' HG21 ' A' ' 61' ' ' THR . 61.8 p -130.24 163.33 26.97 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.907 1.23 . . . . 0.0 110.241 169.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.6 p -155.45 168.26 27.68 Favored 'General case' 0 N--CA 1.463 0.193 0 O-C-N 121.112 -0.992 . . . . 0.0 110.806 178.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.97 40.24 52.23 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mp -72.79 62.19 0.57 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.003 1.321 . . . . 0.0 109.851 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 52.11 27.09 4.27 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.797 1.639 . . . . 0.0 112.749 -175.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.7 m 55.7 31.06 16.67 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.214 1.406 . . . . 0.0 111.914 -175.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.6 m -144.25 -171.98 3.69 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.985 2.114 . . . . 0.0 109.509 -169.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.43 -179.25 3.36 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.346 0.593 . . . . 0.0 110.795 172.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.6 m -56.16 170.89 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.947 1.299 . . . . 0.0 111.517 169.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.475 ' CD2' HD21 ' A' ' 11' ' ' ASN . 86.5 t60 -125.7 116.53 24.62 Favored Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -175.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -66.48 -26.09 47.73 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.657 2.905 . . . . 0.0 112.692 -169.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.7 m -60.63 -36.16 77.95 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.15 0.886 . . . . 0.0 109.122 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.427 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . . . -65.38 -45.13 85.27 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -58.69 -47.41 88.98 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.189 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.73 -43.16 98.24 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.923 0.783 . . . . 0.0 111.032 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.4 mmt -61.81 -22.51 65.53 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.367 1.067 . . . . 0.0 112.866 177.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.474 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.3 OUTLIER -99.53 -31.34 11.67 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -177.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -63.94 -35.92 82.25 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 121.437 -0.79 . . . . 0.0 109.786 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.62 6.82 3.47 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.186 0.595 . . . . 0.0 112.542 175.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.6 t -113.32 -43.03 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 126.355 1.862 . . . . 0.0 108.71 169.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.73 26.86 1.86 Allowed Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.088 1.328 . . . . 0.0 111.894 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 21.5 mt -123.62 158.92 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 125.952 1.701 . . . . 0.0 106.939 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -137.91 125.94 22.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -176.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.6 pt -133.76 5.42 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.326 0 C-N-CA 124.392 1.077 . . . . 0.0 111.404 -171.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.16 143.91 56.32 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.764 1.225 . . . . 0.0 109.376 174.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.06 4.57 11.82 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 117.591 -1.672 . . . . 0.0 113.894 -177.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -53.55 -57.43 10.75 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-N 120.044 1.922 . . . . 0.0 111.785 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.468 HG21 ' H ' ' A' ' 34' ' ' SER . 2.9 p -151.43 162.39 41.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.032 -167.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.1 m -167.13 42.47 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.089 1.755 . . . . 0.0 109.192 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -137.63 150.04 66.88 Favored Pre-proline 0 N--CA 1.475 0.802 0 O-C-N 120.885 -1.135 . . . . 0.0 112.629 -169.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -83.72 162.89 14.27 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 124.213 3.275 . . . . 0.0 112.342 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.2 tt -59.21 -37.69 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.253 1.421 . . . . 0.0 111.351 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.68 -22.71 62.45 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 122.969 0.507 . . . . 0.0 111.93 -171.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -21.19 60.09 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 118.653 -0.689 . . . . 0.0 111.548 172.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -92.34 167.88 11.69 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.865 0.84 . . . . 0.0 111.272 -174.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.44 82.18 1.77 Allowed 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.648 1.579 . . . . 0.0 108.288 -170.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.477 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -52.31 -27.91 17.1 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.811 1.244 . . . . 0.0 113.712 -175.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -54.25 -33.75 59.21 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 123.459 0.475 . . . . 0.0 111.048 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -71.32 -15.73 62.41 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -106.78 160.77 15.24 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.546 1.938 . . . . 0.0 109.541 -173.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -101.35 -18.76 15.91 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 118.931 -0.557 . . . . 0.0 111.977 -177.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.786 HG12 HG13 ' A' ' 4' ' ' VAL . 30.8 t -147.77 129.85 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 120.716 1.598 . . . . 0.0 106.949 -170.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.2 t -125.65 135.08 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.2 mm -133.65 85.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 -177.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.416 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 12.0 t -69.28 160.17 31.73 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.175 -0.953 . . . . 0.0 108.503 171.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.485 HD13 ' HB3' ' A' ' 15' ' ' SER . 6.6 mp -129.46 21.41 5.61 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 169.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 73.6 m -69.27 -8.88 50.06 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.29 1.036 . . . . 0.0 112.237 -175.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 108.11 23.22 6.81 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 119.15 0.887 . . . . 0.0 111.742 174.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.502 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 2.0 t 55.24 173.63 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.176 2.191 . . . . 0.0 112.685 -169.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.03 16.66 33.65 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.851 1.215 . . . . 0.0 114.423 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.421 HG12 ' H ' ' A' ' 84' ' ' VAL . 1.7 p -72.32 136.42 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 125.155 1.382 . . . . 0.0 108.021 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -79.1 61.52 3.27 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.527 1.131 . . . . 0.0 108.547 173.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.1 mt -59.52 148.31 74.45 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 172.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -54.98 155.38 18.69 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.166 1.911 . . . . 0.0 111.919 174.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.81 -1.19 8.1 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.003 2.469 . . . . 0.0 115.853 -169.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -84.62 -24.93 28.89 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.788 1.176 . . . . 0.0 112.155 169.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.477 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 24.7 m95 -77.21 24.31 0.18 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.642 1.177 . . . . 0.0 112.164 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.0 m -127.92 -2.74 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 125.489 1.516 . . . . 0.0 112.779 169.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.8 p -84.37 -12.32 54.72 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 120.773 1.624 . . . . 0.0 113.516 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.437 ' H ' ' CD ' ' A' ' 93' ' ' GLN . 19.4 mp0 -62.16 160.78 12.19 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 129.808 3.243 . . . . 0.0 110.892 -176.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -64.62 -41.97 95.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.796 1.639 . . . . 0.0 109.137 169.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.55 ' HB ' HG13 ' A' ' 75' ' ' VAL . 33.1 mm -119.15 135.69 58.73 Favored 'Isoleucine or valine' 0 C--N 1.341 0.199 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 170.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -135.45 110.95 9.14 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 100.977 -3.712 . . . . 0.0 100.977 166.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.11 164.67 26.82 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.0 t70 -137.1 99.97 4.15 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 122.118 0.961 . . . . 0.0 108.542 172.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -75.4 73.45 2.46 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.344 1.458 . . . . 0.0 107.811 174.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -54.92 44.3 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 131.278 3.831 . . . . 0.0 114.402 172.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -77.85 -174.15 3.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.337 1.455 . . . . 0.0 111.223 -169.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -50.27 160.94 0.33 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.611 1.565 . . . . 0.0 111.28 176.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -130.1 85.0 58.59 Favored Pre-proline 0 C--N 1.322 -0.59 0 C-N-CA 126.719 2.008 . . . . 0.0 108.364 -169.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.64 67.33 8.43 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 124.9 3.734 . . . . 0.0 111.472 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -64.1 81.05 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.483 1.913 . . . . 0.0 110.874 173.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 59.22 37.42 91.77 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.775 0.702 . . . . 0.0 112.441 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -64.96 170.06 4.69 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -170.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.8 m -68.13 151.89 46.33 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 113.301 -1.772 . . . . 0.0 108.293 168.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.3 mt -57.56 -32.96 67.64 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.91 -0.494 . . . . 0.0 111.808 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.07 -38.63 86.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.533 0.606 . . . . 0.0 111.182 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.595 ' O ' HG23 ' A' ' 115' ' ' VAL . 57.8 t -75.18 -40.58 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 116.456 -1.735 . . . . 0.0 108.88 178.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -50.47 -48.49 56.67 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 121.141 1.792 . . . . 0.0 110.636 170.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -58.84 -43.18 90.66 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.535 0.607 . . . . 0.0 110.81 176.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 92.8 m -69.22 -43.6 73.77 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -174.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 111' ' ' VAL . 25.8 t -66.28 -46.53 86.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -173.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -47.79 -56.16 8.03 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.016 1.326 . . . . 0.0 110.89 170.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.99 -40.65 99.56 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 119.795 1.179 . . . . 0.0 111.68 -175.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -64.64 -40.11 94.88 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.321 -1.105 . . . . 0.0 111.428 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.0 t -61.08 -42.09 91.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 174.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.06 -37.95 78.26 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 119.904 1.229 . . . . 0.0 111.448 -175.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -70.0 -42.3 73.22 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.136 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -64.24 -42.83 96.35 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 119.252 0.933 . . . . 0.0 110.14 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.5 t -54.36 -53.71 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 123.901 0.88 . . . . 0.0 109.385 173.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -65.31 -33.09 75.16 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 122.283 -0.261 . . . . 0.0 111.541 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -62.15 -49.17 76.9 Favored 'General case' 0 C--O 1.225 -0.206 0 C-N-CA 123.03 0.532 . . . . 0.0 110.787 173.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.42 -46.05 83.93 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 122.987 0.515 . . . . 0.0 110.046 177.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.3 mt -57.92 -44.0 85.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 124.395 1.078 . . . . 0.0 110.272 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.07 -28.23 67.63 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.98 0.809 . . . . 0.0 112.151 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -75.95 -44.71 38.68 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 118.379 0.536 . . . . 0.0 111.605 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.9 pt -94.37 -42.36 12.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -169.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 C--O 1.252 1.232 0 CA-C-N 119.168 0.895 . . . . 0.0 109.929 -172.808 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.0 mmm . . . . . 0 N--CA 1.502 2.142 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.765 ' HG2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -57.54 134.9 56.51 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 119.503 1.047 . . . . 0.0 108.891 169.871 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 53.9 mtpt -101.07 140.97 34.63 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.758 1.223 . . . . 0.0 107.757 -169.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.684 HG13 HG12 ' A' ' 75' ' ' VAL . 14.9 t -129.02 152.18 36.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -175.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 58.6 tpp -137.73 145.29 42.32 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -121.81 150.2 42.23 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 171.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 6.2 t -132.46 134.73 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 120.333 -1.479 . . . . 0.0 108.219 -171.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -131.98 100.09 4.95 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.258 0.935 . . . . 0.0 111.626 -170.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -79.17 -30.76 43.69 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -129.88 141.53 50.8 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 176.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 29.06 101.78 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 129.972 3.309 . . . . 0.0 113.619 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.4 m -33.28 -33.64 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.212 0 C-N-CA 128.671 2.788 . . . . 0.0 115.327 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.4 t -36.52 -64.16 0.35 Allowed 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 125.884 1.673 . . . . 0.0 114.067 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.298 36.1 ptt180 -60.15 -43.66 95.59 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 120.333 1.424 . . . . 0.0 114.127 -168.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.604 ' HB3' HD13 ' A' ' 79' ' ' LEU . 0.7 OUTLIER -95.22 -29.0 14.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 119.374 0.988 . . . . 0.0 112.092 -172.707 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.643 HE22 HG12 ' A' ' 42' ' ' VAL . 50.0 tt0 -72.09 -25.45 61.76 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.79 -1.194 . . . . 0.0 109.924 169.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.47 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.0 tpt -68.97 -42.77 76.15 Favored 'General case' 0 CA--C 1.512 -0.514 0 O-C-N 120.812 -1.18 . . . . 0.0 108.508 168.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.95 -39.41 81.59 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -60.43 -41.41 93.92 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.19 1.396 . . . . 0.0 111.4 169.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.74 -40.36 58.53 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 120.651 1.569 . . . . 0.0 112.895 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -69.96 -38.04 76.0 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 118.527 1.164 . . . . 0.0 109.279 172.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.51 -40.88 66.49 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 120.434 1.47 . . . . 0.0 111.145 -175.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -61.35 -32.27 72.16 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.325 1.42 . . . . 0.0 110.842 175.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 m -75.39 -51.13 13.85 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.262 2.225 . . . . 0.0 111.131 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.1 mt -88.19 -26.22 22.52 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.494 1.118 . . . . 0.0 111.631 -169.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.69 12.71 62.79 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 126.542 2.02 . . . . 0.0 111.248 177.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.16 121.34 10.47 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.549 1.139 . . . . 0.0 110.241 -173.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.03 9.24 86.87 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 119.864 -0.409 . . . . 0.0 113.325 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -123.82 -31.73 3.39 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 125.222 1.409 . . . . 0.0 109.511 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.765 HG22 ' HG2' ' A' ' 2' ' ' LYS . 19.0 pt -142.6 168.39 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.539 1.536 . . . . 0.0 109.954 178.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.35 139.48 46.71 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 168.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.3 t -127.54 146.11 33.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 125.279 1.432 . . . . 0.0 111.207 -170.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.33 160.39 43.76 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.052 1.741 . . . . 0.0 109.725 -174.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -132.99 165.49 24.6 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 120.334 1.424 . . . . 0.0 109.227 170.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.1 p -158.78 168.8 25.88 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.796 -0.565 . . . . 0.0 111.299 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.39 -73.79 2.55 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 -175.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.406 HD21 ' NE2' ' A' ' 16' ' ' GLN . 7.6 mp 44.83 41.7 5.38 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.622 1.169 . . . . 0.0 110.904 -176.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 59.76 16.41 5.54 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.587 1.155 . . . . 0.0 113.911 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.9 m 66.59 31.99 7.48 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.418 1.887 . . . . 0.0 111.473 -171.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.1 m -138.48 -168.9 2.48 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.519 2.328 . . . . 0.0 109.091 -175.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -97.99 -165.28 1.23 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.873 1.269 . . . . 0.0 109.092 -176.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.643 HG12 HE22 ' A' ' 16' ' ' GLN . 2.8 m -57.8 170.65 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.511 1.125 . . . . 0.0 111.486 171.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -133.07 117.67 14.9 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -174.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -66.03 -30.18 47.95 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.319 2.679 . . . . 0.0 112.432 -169.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.0 m -61.89 -37.04 83.12 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 177.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.45 -44.52 86.98 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.98 -47.8 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.32 -43.04 99.54 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-N 118.938 0.79 . . . . 0.0 111.141 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.7 mmt -61.94 -23.75 66.56 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.553 -0.736 . . . . 0.0 111.828 177.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.47 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.3 OUTLIER -94.98 -27.93 15.4 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.705 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -64.55 -29.4 70.43 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.808 1.243 . . . . 0.0 110.693 171.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -56.2 -24.71 43.58 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.641 0.776 . . . . 0.0 112.487 170.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -126.23 16.3 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.712 0 C-N-CA 125.527 1.531 . . . . 0.0 111.087 -172.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.79 35.69 66.21 Favored Glycine 0 CA--C 1.529 0.952 0 O-C-N 121.516 -0.74 . . . . 0.0 113.395 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.9 mt -125.1 155.85 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -134.42 144.69 48.31 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 170.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.6 pt -137.56 11.17 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 126.513 1.925 . . . . 0.0 110.477 -175.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.2 t -65.69 151.44 46.56 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.529 -0.732 . . . . 0.0 109.496 170.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.98 -0.02 1.31 Allowed Glycine 0 CA--C 1.534 1.223 0 CA-C-O 117.691 -1.616 . . . . 0.0 115.084 -177.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -57.78 -55.47 34.4 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 120.162 1.981 . . . . 0.0 112.633 -171.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.98 161.22 42.76 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.802 -168.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.8 p -170.48 27.02 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.228 0.611 . . . . 0.0 112.288 -171.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -140.48 151.28 63.43 Favored Pre-proline 0 N--CA 1.476 0.847 0 O-C-N 120.818 -1.177 . . . . 0.0 112.828 -169.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.35 160.78 29.04 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 124.062 3.175 . . . . 0.0 112.791 -173.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.2 tt -59.17 -36.78 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.141 1.376 . . . . 0.0 111.671 -176.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -70.45 -22.23 62.72 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.042 0.537 . . . . 0.0 112.27 -172.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.61 -17.61 59.08 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 119.033 -0.508 . . . . 0.0 111.711 171.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -95.89 173.53 7.4 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.146 0.978 . . . . 0.0 110.129 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.83 101.7 3.21 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 125.137 1.375 . . . . 0.0 108.193 -177.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.47 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -49.45 -24.94 2.25 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.801 0.84 . . . . 0.0 113.156 171.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -51.4 -21.53 2.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.044 0.938 . . . . 0.0 112.218 172.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -115.66 17.05 16.37 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.617 1.167 . . . . 0.0 114.009 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.45 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 29.4 m-85 -133.04 112.47 11.83 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 119.968 1.258 . . . . 0.0 108.414 170.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -62.99 -14.62 50.06 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -169.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.684 HG12 HG13 ' A' ' 4' ' ' VAL . 7.9 t -145.31 123.05 4.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.455 -2.424 . . . . 0.0 104.455 -169.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.86 133.34 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 O-C-N 121.085 -1.009 . . . . 0.0 108.406 -174.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.8 mm -130.17 92.45 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -168.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.48 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 28.8 t -70.08 161.54 29.95 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.549 175.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.604 HD13 ' HB3' ' A' ' 15' ' ' SER . 5.7 mp -142.2 52.9 1.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 169.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 59.9 m -114.4 18.35 16.93 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.616 1.566 . . . . 0.0 109.577 -174.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.72 25.3 46.67 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-O 119.356 -0.691 . . . . 0.0 111.999 172.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.422 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 5.7 t 44.37 39.6 3.21 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.947 1.699 . . . . 0.0 112.595 -176.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.85 45.07 0.51 Allowed Glycine 0 C--N 1.34 0.797 0 C-N-CA 123.586 0.612 . . . . 0.0 111.86 -169.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.0 p -124.13 -0.8 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -173.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.8 t30 47.16 60.71 3.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.689 1.596 . . . . 0.0 109.433 175.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.2 mt -56.46 148.09 46.04 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.143 -175.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -55.27 156.01 18.16 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.701 2.267 . . . . 0.0 113.11 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -54.89 -30.11 66.92 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.756 2.304 . . . . 0.0 116.734 -170.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -65.88 -25.03 66.99 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 121.009 -1.057 . . . . 0.0 111.478 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.47 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 72.3 m95 -73.35 -4.46 33.51 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 117.669 -1.158 . . . . 0.0 113.133 178.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.4 m -118.58 -5.48 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 120.757 1.617 . . . . 0.0 113.41 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.3 p -88.73 -17.99 28.75 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.761 0.824 . . . . 0.0 112.416 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -52.59 161.82 0.65 Allowed 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 129.37 3.068 . . . . 0.0 113.906 175.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -64.35 -39.45 93.9 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.493 1.517 . . . . 0.0 108.901 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.508 ' HB ' HG13 ' A' ' 75' ' ' VAL . 33.2 mm -124.95 138.54 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 169.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -137.84 113.89 9.97 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 100.284 -3.969 . . . . 0.0 100.284 167.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -136.09 171.05 15.04 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 172.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.422 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.0 t70 -140.1 122.77 16.33 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 169.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -101.36 77.2 1.76 Allowed 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.4 ' CD ' ' H ' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -56.24 16.8 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 129.638 3.175 . . . . 0.0 115.06 179.21 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -61.22 126.28 26.77 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.673 1.589 . . . . 0.0 111.343 -168.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 52.11 -155.44 0.17 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.3 1.44 . . . . 0.0 112.564 169.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -163.7 57.37 0.61 Allowed Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 127.509 2.324 . . . . 0.0 109.842 -173.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -79.2 59.02 7.22 Favored 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 122.752 2.301 . . . . 0.0 112.251 -169.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -51.46 -46.87 63.22 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.078 -1.014 . . . . 0.0 110.726 176.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -173.23 44.38 0.16 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.714 1.626 . . . . 0.0 110.323 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -68.54 176.42 2.92 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 122.543 1.163 . . . . 0.0 112.633 -177.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.2 m -57.83 152.51 15.69 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 113.956 -1.475 . . . . 0.0 109.857 171.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.3 mt -57.58 -31.59 66.32 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 122.727 0.411 . . . . 0.0 111.228 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.72 -39.64 92.22 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 118.427 0.558 . . . . 0.0 110.968 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 66.1 t -70.53 -45.54 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-O 117.304 -1.332 . . . . 0.0 108.507 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -48.95 -47.95 43.4 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 120.401 1.455 . . . . 0.0 110.93 172.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -59.81 -45.78 91.29 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.539 0.736 . . . . 0.0 111.303 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 94.2 m -68.36 -45.76 71.95 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -174.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 76.9 t -65.03 -47.58 87.4 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -173.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -44.65 -55.05 5.56 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 125.225 1.41 . . . . 0.0 110.89 169.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.44 -40.85 99.28 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 119.43 1.014 . . . . 0.0 111.737 -177.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -64.93 -38.46 91.03 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 121.376 -1.073 . . . . 0.0 110.86 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.0 t -62.72 -42.19 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -38.72 84.03 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 120.152 1.342 . . . . 0.0 111.535 -174.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -69.11 -41.31 77.58 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 119.087 -0.482 . . . . 0.0 109.825 177.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -67.24 -38.94 86.0 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 119.299 0.954 . . . . 0.0 111.135 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 48.8 t -53.85 -54.97 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 169.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -64.86 -32.46 74.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 121.99 -0.444 . . . . 0.0 111.895 -174.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -63.66 -47.41 81.41 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 123.405 0.682 . . . . 0.0 110.713 172.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -46.6 83.52 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 122.9 0.48 . . . . 0.0 110.062 176.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.0 mt -58.23 -43.18 85.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 124.292 1.037 . . . . 0.0 109.606 176.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.65 -30.22 70.58 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.101 0.864 . . . . 0.0 111.694 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -72.18 -42.6 65.69 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.635 172.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.1 pt -103.73 -44.8 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 118.902 2.927 . . . . 0.0 118.902 -168.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 65.3 m . . . . . 0 C--O 1.254 1.299 0 CA-C-O 116.582 -1.675 . . . . 0.0 111.838 -169.084 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 tpt . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.501 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -61.63 121.47 12.85 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 121.227 1.83 . . . . 0.0 108.43 -177.149 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.44 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 34.2 mtpt -92.88 134.4 35.12 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -169.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.876 HG13 HG12 ' A' ' 75' ' ' VAL . 19.1 t -120.7 154.33 24.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -174.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 63.2 tpp -139.15 144.84 38.79 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -126.78 125.97 42.62 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 174.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.4 t -118.07 130.68 72.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -169.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 t -118.16 161.01 20.58 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.574 1.149 . . . . 0.0 111.207 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -141.97 34.54 1.56 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.101 1.36 . . . . 0.0 109.483 172.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.1 mmt-85 -141.9 168.13 20.5 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.235 1.414 . . . . 0.0 109.247 -175.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -46.05 121.8 3.48 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.317 1.447 . . . . 0.0 108.458 170.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.5 m -40.44 98.04 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.317 2.247 . . . . 0.0 114.098 -169.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.5 t -158.35 -84.85 0.04 OUTLIER 'General case' 0 C--N 1.343 0.317 0 CA-C-O 118.369 -0.824 . . . . 0.0 112.457 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.347 35.9 ptt180 -45.76 -52.6 10.82 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -167.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.452 ' HB3' HD13 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -84.62 -27.02 27.47 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.413 1.006 . . . . 0.0 112.047 -174.206 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -65.98 -40.72 91.45 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.119 -0.988 . . . . 0.0 109.304 171.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.447 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.1 tpt -62.9 -40.66 98.26 Favored 'General case' 0 CA--C 1.512 -0.489 0 O-C-N 121.735 -0.603 . . . . 0.0 109.821 171.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.34 -36.88 79.0 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 118.969 -0.539 . . . . 0.0 110.017 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -65.95 -39.91 90.85 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.504 170.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.49 -44.98 95.86 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 120.332 1.424 . . . . 0.0 111.055 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -65.49 -41.54 93.14 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 118.022 0.911 . . . . 0.0 109.067 173.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.04 -35.25 74.14 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 119.824 1.193 . . . . 0.0 111.741 -173.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -79.6 -15.83 56.95 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.184 1.356 . . . . 0.0 112.886 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.9 m -79.65 -50.91 9.94 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.896 1.678 . . . . 0.0 109.239 171.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 75.4 mt -88.48 -28.02 21.11 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.101 1.361 . . . . 0.0 112.384 -169.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.71 12.24 61.1 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.484 1.993 . . . . 0.0 111.751 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.52 121.52 12.34 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.939 1.295 . . . . 0.0 109.762 -172.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.86 11.05 85.79 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 119.755 -0.469 . . . . 0.0 113.538 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -124.9 -29.22 3.39 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.511 1.524 . . . . 0.0 109.153 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.2 pt -143.82 173.03 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.696 1.598 . . . . 0.0 109.677 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.69 144.59 44.24 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 103.836 -2.653 . . . . 0.0 103.836 168.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -133.78 148.64 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 118.536 0.607 . . . . 0.0 111.688 -167.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.95 158.33 44.09 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.342 1.457 . . . . 0.0 110.299 -174.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.4 p -131.17 153.23 49.64 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.633 1.573 . . . . 0.0 109.365 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.2 t -145.9 149.04 33.5 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -174.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 113.36 -107.3 1.92 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 107.086 -2.406 . . . . 0.0 107.086 -175.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 62' ' ' SER . 5.3 tp 64.65 50.45 2.1 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -58.17 -23.99 57.4 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 124.767 1.227 . . . . 0.0 111.124 -173.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.7 m -78.65 15.85 0.96 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 m 59.45 -12.44 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 129.705 3.202 . . . . 0.0 115.137 -173.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.59 -173.69 4.41 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.206 2.203 . . . . 0.0 106.965 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.2 m -62.41 173.11 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.329 1.052 . . . . 0.0 111.091 172.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -132.9 117.89 15.18 Favored Pre-proline 0 N--CA 1.453 -0.309 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -173.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -63.33 -27.53 71.63 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.327 2.685 . . . . 0.0 113.721 -169.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.4 m -61.56 -41.25 97.1 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.231 0.923 . . . . 0.0 109.474 171.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.79 -42.71 97.67 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 120.091 1.314 . . . . 0.0 108.958 178.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -56.33 -49.55 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 118.728 -0.654 . . . . 0.0 109.346 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.79 -41.32 90.89 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-N 118.723 0.692 . . . . 0.0 111.014 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.446 ' HG3' ' HB3' ' A' ' 112' ' ' PHE . 32.7 mmt -65.34 -22.29 66.8 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 123.457 0.703 . . . . 0.0 112.032 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.447 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 1.5 mmt -98.06 -28.41 13.78 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -62.6 -32.43 73.43 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.448 1.099 . . . . 0.0 110.258 170.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -59.24 -16.2 19.81 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.768 1.627 . . . . 0.0 112.292 172.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.3 m -129.07 15.02 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 125.953 1.701 . . . . 0.0 111.37 177.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.79 38.95 86.03 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 119.064 -0.853 . . . . 0.0 113.675 173.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.9 mt -121.13 152.52 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -118.73 126.59 52.22 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 124.865 1.266 . . . . 0.0 108.002 176.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.9 pt -128.23 17.87 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 124.064 0.946 . . . . 0.0 111.746 171.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.3 -33.07 59.07 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.671 1.188 . . . . 0.0 112.157 173.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.22 -3.47 81.93 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 123.302 0.477 . . . . 0.0 112.873 177.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -67.15 153.0 44.72 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.165 0.986 . . . . 0.0 111.185 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.0 p -147.1 157.76 43.72 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.97 1.708 . . . . 0.0 107.601 169.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . 7.2 m -154.47 173.48 16.21 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.166 1.386 . . . . 0.0 108.41 -169.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -154.8 167.55 13.76 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-O 117.778 -1.106 . . . . 0.0 108.186 -176.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.06 165.25 21.83 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.286 1.991 . . . . 0.0 112.853 -171.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.6 tt -63.78 -34.4 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 123.716 0.806 . . . . 0.0 110.622 -170.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.49 -19.04 61.62 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.757 0.823 . . . . 0.0 112.608 -174.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.85 -24.67 58.63 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.091 0.556 . . . . 0.0 110.945 169.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -95.79 169.77 9.78 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 122.199 0.999 . . . . 0.0 111.245 -169.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.16 97.13 2.73 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.876 1.671 . . . . 0.0 107.183 -178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.457 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -50.45 -23.07 2.19 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.039 0.936 . . . . 0.0 113.501 173.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -50.65 -22.92 2.27 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.802 0.841 . . . . 0.0 111.908 171.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -114.27 16.16 17.99 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.087 1.355 . . . . 0.0 113.226 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.44 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 23.5 m-85 -134.12 112.92 11.53 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 120.526 -1.359 . . . . 0.0 109.598 170.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -67.67 -8.99 39.42 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -169.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.876 HG12 HG13 ' A' ' 4' ' ' VAL . 18.2 t -146.65 119.64 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 -171.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.4 m -133.85 130.97 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 O-C-N 120.409 -1.432 . . . . 0.0 107.962 -174.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.3 mm -126.11 102.16 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 -173.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.7 p -78.03 157.54 29.57 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 171.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.452 HD13 ' HB3' ' A' ' 15' ' ' SER . 6.0 mp -133.43 44.38 2.8 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 169.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 69.0 m -93.16 10.51 31.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.81 1.644 . . . . 0.0 110.227 -174.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.41 29.39 33.27 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 170.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 4.9 t 39.33 43.66 0.97 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.705 2.002 . . . . 0.0 112.83 -171.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -144.18 44.13 0.94 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.688 1.137 . . . . 0.0 110.449 -171.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.2 p -134.99 165.06 32.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.38 1.872 . . . . 0.0 109.19 -173.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -129.58 71.54 1.44 Allowed 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 38.8 mt -60.77 149.45 79.8 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.63 153.75 17.87 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.511 2.141 . . . . 0.0 111.611 169.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.33 -18.67 55.67 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.787 1.658 . . . . 0.0 114.79 -169.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.05 -25.69 68.22 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 120.904 -1.122 . . . . 0.0 111.22 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.457 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 68.2 m95 -70.48 -11.12 60.71 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 117.224 -1.37 . . . . 0.0 113.235 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.6 m -110.36 -8.54 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 121.204 1.82 . . . . 0.0 113.285 -175.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.6 p -90.99 -11.2 39.64 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.892 0.877 . . . . 0.0 112.953 -174.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -61.67 167.27 3.64 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 128.763 2.825 . . . . 0.0 112.681 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -68.19 -38.71 82.27 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.217 1.007 . . . . 0.0 108.539 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.479 ' CG2' HG13 ' A' ' 75' ' ' VAL . 3.5 mt -119.91 135.47 60.11 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 CA-C-O 121.488 0.661 . . . . 0.0 109.632 169.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -148.39 114.84 5.93 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 166.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -143.73 167.51 22.1 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 173.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -126.08 124.56 40.88 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 169.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -100.53 77.4 1.91 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -177.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.46 ' CD ' ' H ' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -62.51 33.51 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 128.962 2.905 . . . . 0.0 114.19 178.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.58 -177.8 1.62 Allowed 'General case' 0 CA--C 1.535 0.394 0 O-C-N 120.789 -1.194 . . . . 0.0 110.67 -171.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -55.1 161.84 1.57 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 123.814 1.769 . . . . 0.0 113.356 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -115.19 103.06 54.74 Favored Pre-proline 0 C--N 1.318 -0.766 0 C-N-CA 128.853 2.861 . . . . 0.0 107.85 -169.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -82.04 18.58 1.37 Allowed 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.761 2.307 . . . . 0.0 112.477 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -39.61 96.35 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.539 1.935 . . . . 0.0 113.974 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 42.51 31.98 1.15 Allowed Glycine 0 CA--C 1.541 1.663 0 C-N-CA 125.095 1.331 . . . . 0.0 114.172 -172.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -76.85 177.51 7.61 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 122.496 1.141 . . . . 0.0 113.404 -169.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 p -59.88 154.65 18.13 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 113.731 -1.577 . . . . 0.0 109.355 170.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.8 mt -58.73 -29.49 66.75 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.797 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.62 -40.82 97.86 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 118.676 -0.678 . . . . 0.0 111.044 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.4 t -71.23 -39.96 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 119.469 1.031 . . . . 0.0 109.082 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.446 ' HB3' ' HG3' ' A' ' 49' ' ' MET . 29.7 m-85 -52.08 -51.33 58.4 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.527 1.058 . . . . 0.0 111.624 169.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -59.16 -45.23 91.51 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.935 0.789 . . . . 0.0 110.584 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.3 m -69.4 -45.19 69.83 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -173.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.5 t -65.31 -47.95 85.2 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -172.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 21.3 ttp180 -45.53 -53.34 9.12 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 124.732 1.213 . . . . 0.0 110.949 171.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.29 -42.25 97.89 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 119.334 0.97 . . . . 0.0 111.91 -177.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -64.99 -37.3 87.2 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.213 -1.169 . . . . 0.0 110.765 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.7 t -63.14 -42.74 97.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -39.25 83.47 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.201 1.364 . . . . 0.0 111.364 -173.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.27 -42.53 75.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 119.205 -0.426 . . . . 0.0 110.322 177.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -68.03 -39.46 83.1 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.401 1.0 . . . . 0.0 111.469 178.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 46.3 t -54.97 -52.97 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 171.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -64.37 -32.91 74.71 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.744 -0.597 . . . . 0.0 111.923 -176.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -63.44 -48.43 77.8 Favored 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 121.615 -0.678 . . . . 0.0 110.719 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -46.57 77.37 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 123.429 0.692 . . . . 0.0 109.659 177.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.1 mt -58.72 -44.3 89.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 124.432 1.093 . . . . 0.0 109.584 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.24 -29.31 68.69 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.876 0.762 . . . . 0.0 111.927 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -74.27 -42.32 59.8 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.478 0.581 . . . . 0.0 111.533 175.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 pt -98.85 -44.12 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 -168.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 C--O 1.255 1.343 0 CA-C-N 118.997 0.817 . . . . 0.0 110.223 -170.842 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.2 mmm . . . . . 0 N--CA 1.501 2.112 0 CA-C-O 119.937 -0.078 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.493 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -58.5 129.59 42.77 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 173.267 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -91.49 133.45 35.49 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.709 HG13 HG12 ' A' ' 75' ' ' VAL . 13.8 t -112.34 154.08 13.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 51.4 tpp -136.11 145.59 46.07 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -125.35 119.37 28.18 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 175.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.1 t -103.06 126.81 57.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -171.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 m -112.5 156.92 21.79 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.627 0.771 . . . . 0.0 110.628 -172.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -150.44 153.49 36.03 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 169.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.564 ' HG2' ' H ' ' A' ' 11' ' ' ASN . 53.5 ttm-85 58.61 -169.31 0.13 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.456 1.102 . . . . 0.0 108.472 -168.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.564 ' H ' ' HG2' ' A' ' 10' ' ' ARG . 50.9 t-20 -47.29 105.99 0.08 Allowed 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 124.008 0.923 . . . . 0.0 108.671 174.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.409 ' HB2' HD23 ' A' ' 37' ' ' LEU . 50.0 m -77.34 7.5 5.22 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.379 1.072 . . . . 0.0 112.378 -170.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.4 p -44.33 -56.75 3.95 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 124.309 1.044 . . . . 0.0 110.135 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 25.7 ptt85 -52.49 -44.66 65.78 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.795 1.238 . . . . 0.0 113.57 -177.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.6 -32.58 13.36 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.338 -0.851 . . . . 0.0 112.406 -168.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -71.48 -30.24 65.74 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.719 -1.238 . . . . 0.0 109.106 169.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.466 ' SD ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -64.05 -37.79 88.73 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 120.784 -1.198 . . . . 0.0 109.364 168.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.8 -36.77 75.01 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 119.077 -0.487 . . . . 0.0 110.008 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -63.15 -40.0 96.31 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.517 -0.754 . . . . 0.0 110.891 169.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.71 -44.4 92.48 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 120.609 1.549 . . . . 0.0 111.797 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.466 ' CD2' ' SD ' ' A' ' 17' ' ' MET . 5.4 m-85 -62.39 -40.93 98.07 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 118.562 1.181 . . . . 0.0 109.382 170.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.435 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -70.06 -36.19 74.8 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 119.574 1.079 . . . . 0.0 110.632 -173.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -73.84 -18.35 60.95 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 120.359 1.436 . . . . 0.0 112.584 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 m -82.84 -50.94 8.1 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.745 1.618 . . . . 0.0 109.473 176.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.8 mt -88.07 -26.52 22.5 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.301 1.44 . . . . 0.0 111.672 -169.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -99.96 11.73 60.65 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.574 2.035 . . . . 0.0 112.218 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.65 124.54 21.27 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.819 1.247 . . . . 0.0 109.179 -171.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.61 8.81 87.45 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 119.47 -0.628 . . . . 0.0 113.806 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -127.52 -31.06 2.53 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.566 1.546 . . . . 0.0 108.56 -177.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.47 HD12 HG22 ' A' ' 32' ' ' VAL . 12.1 pt -143.74 165.87 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 125.767 1.627 . . . . 0.0 110.22 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -110.58 146.62 35.78 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 103.469 -2.789 . . . . 0.0 103.469 168.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.47 HG22 HD12 ' A' ' 30' ' ' ILE . 1.8 t -134.76 146.25 31.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-N 118.922 0.783 . . . . 0.0 111.488 -168.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.8 162.64 40.7 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.656 1.582 . . . . 0.0 109.545 -174.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.5 p -136.58 165.43 25.89 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 120.395 -1.441 . . . . 0.0 110.215 173.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.3 p -149.78 150.75 32.49 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 123.515 0.726 . . . . 0.0 109.745 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 116.8 -99.08 0.83 Allowed Glycine 0 CA--C 1.522 0.484 0 N-CA-C 106.861 -2.496 . . . . 0.0 106.861 -170.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 37' ' ' LEU . 9.0 mt 53.12 48.18 22.84 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 122.008 0.909 . . . . 0.0 109.02 -172.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -67.16 -17.36 64.81 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.176 0.99 . . . . 0.0 111.032 -178.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.82 30.28 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 127.645 2.378 . . . . 0.0 113.237 172.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.4 m 57.13 65.18 1.43 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.258 1.823 . . . . 0.0 111.065 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 61.04 -153.54 0.37 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.334 1.054 . . . . 0.0 109.009 -173.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.7 t -54.41 147.23 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.648 1.179 . . . . 0.0 110.378 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -129.67 110.97 17.5 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.722 1.209 . . . . 0.0 108.984 -169.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.3 -30.44 54.08 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.956 3.104 . . . . 0.0 114.701 -168.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.0 m -59.52 -36.61 76.43 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.661 1.119 . . . . 0.0 109.743 175.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.13 -43.8 90.74 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.47 -44.11 92.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.52 -41.93 98.06 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.169 0.895 . . . . 0.0 111.664 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 39.1 mmt -63.77 -29.77 70.94 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 118.943 -0.551 . . . . 0.0 111.682 178.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -85.27 -32.5 22.53 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -62.92 -33.77 76.05 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.275 1.03 . . . . 0.0 109.994 174.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -62.35 -12.54 21.75 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.72 1.208 . . . . 0.0 112.119 173.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.1 m -127.66 13.51 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 125.937 1.695 . . . . 0.0 111.863 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.48 35.61 59.52 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 121.003 -1.06 . . . . 0.0 114.563 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.3 mt -122.35 156.23 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 171.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -131.57 140.82 49.55 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.723 1.209 . . . . 0.0 108.479 171.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 27.6 pt -133.7 17.4 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.55 1.54 . . . . 0.0 111.146 -175.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 46.3 p -78.64 -28.64 45.54 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.574 1.15 . . . . 0.0 112.664 171.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.6 -8.12 66.5 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 123.136 0.398 . . . . 0.0 112.234 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -85.84 146.57 26.69 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.478 1.111 . . . . 0.0 108.335 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.4 p -143.16 154.52 43.98 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 169.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.99 166.03 32.83 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 -169.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -147.61 162.67 31.02 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.185 1.794 . . . . 0.0 106.762 -171.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.84 160.14 48.66 Favored 'Trans proline' 0 C--N 1.347 0.488 0 CA-C-N 123.052 2.126 . . . . 0.0 112.728 -170.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.9 tt -57.06 -32.73 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.736 1.214 . . . . 0.0 111.95 -175.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -68.73 -22.66 64.31 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.59 0.756 . . . . 0.0 112.145 -173.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -13.34 59.89 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 118.808 -0.615 . . . . 0.0 112.177 171.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -110.76 172.59 6.78 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 122.274 1.035 . . . . 0.0 112.211 -170.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.77 103.23 2.91 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 126.78 2.032 . . . . 0.0 107.065 -172.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.444 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -54.87 -24.43 23.25 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 123.757 0.823 . . . . 0.0 112.988 177.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -50.64 -32.42 18.98 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.04 0.936 . . . . 0.0 111.585 172.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -86.6 12.0 11.55 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -136.0 177.68 7.65 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.064 2.146 . . . . 0.0 108.557 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -120.45 -21.88 6.67 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.709 HG12 HG13 ' A' ' 4' ' ' VAL . 20.2 t -142.21 128.34 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 -170.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.58 129.74 61.9 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 O-C-N 120.666 -1.271 . . . . 0.0 108.221 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.1 mm -117.9 134.54 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 N-CA-C 104.663 -2.347 . . . . 0.0 104.663 176.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.4 t -115.06 156.76 24.57 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 175.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.5 mp -134.06 36.38 3.25 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 173.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 60.2 m -96.7 14.0 26.48 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.395 1.478 . . . . 0.0 110.025 -176.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.94 15.45 81.16 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-O 119.361 -0.689 . . . . 0.0 112.447 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 3.9 t 60.35 -20.07 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.234 2.614 . . . . 0.0 115.632 -178.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.13 -26.76 73.95 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 119.457 1.026 . . . . 0.0 112.829 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.8 t -63.21 116.59 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 174.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -66.14 138.17 57.54 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 172.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.4 mt -120.99 141.15 32.13 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.57 157.65 6.94 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.645 2.897 . . . . 0.0 113.163 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.7 -22.4 69.85 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 121.889 1.726 . . . . 0.0 115.222 -169.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -65.73 -24.02 66.88 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 120.188 -1.57 . . . . 0.0 111.746 176.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.444 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 70.7 m95 -70.0 -7.93 44.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 117.344 -1.312 . . . . 0.0 112.487 175.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.5 m -115.32 -12.25 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 121.273 1.851 . . . . 0.0 113.481 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.8 p -81.83 -13.3 57.84 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.158 0.89 . . . . 0.0 112.23 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -44.29 155.22 0.09 Allowed 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 130.979 3.712 . . . . 0.0 113.009 169.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -62.38 -38.33 89.19 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.673 1.989 . . . . 0.0 108.771 169.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.673 ' HB ' HG13 ' A' ' 75' ' ' VAL . 33.6 mm -130.44 138.11 54.59 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.173 0 C-N-CA 123.055 0.542 . . . . 0.0 109.847 171.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -135.42 117.49 15.38 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 100.707 -3.812 . . . . 0.0 100.707 166.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.65 165.75 26.77 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 175.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -141.85 132.75 25.87 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 169.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.4 ' CE3' ' HB3' ' A' ' 122' ' ' ARG . 54.1 m0 -102.35 2.22 36.5 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -172.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 47.19 -68.78 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 131.086 3.754 . . . . 0.0 111.833 -169.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . 0.258 0.8 OUTLIER 45.29 -172.73 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.238 1 C-N-CA 133.294 4.638 . . . . 0.0 114.369 -174.429 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -64.83 174.89 1.67 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.356 1.462 . . . . 0.0 113.34 -169.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -132.63 66.62 77.06 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 126.483 1.913 . . . . 0.0 109.75 -169.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -79.21 61.8 8.28 Favored 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 124.276 3.317 . . . . 0.0 111.294 -169.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -55.68 -42.6 75.37 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.026 -1.046 . . . . 0.0 112.521 -175.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -163.69 42.68 0.32 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.0 1.762 . . . . 0.0 109.753 -177.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -69.37 171.5 8.53 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -169.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 45.5 p -64.8 158.74 24.12 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 113.22 -1.809 . . . . 0.0 109.001 169.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 27.8 mt -60.24 -32.81 71.49 Favored 'General case' 0 C--O 1.22 -0.449 0 O-C-N 122.007 -0.433 . . . . 0.0 110.295 172.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -65.19 -43.93 90.04 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 118.484 0.584 . . . . 0.0 110.958 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 63.2 t -68.09 -43.79 84.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 119.156 -1.018 . . . . 0.0 108.47 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -48.41 -48.44 37.11 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.674 1.124 . . . . 0.0 111.739 173.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -62.94 -48.19 79.97 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.622 0.769 . . . . 0.0 111.016 176.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.1 m -65.48 -45.61 82.97 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -171.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.5 t -59.32 -42.73 88.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 124.095 0.958 . . . . 0.0 108.764 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -52.57 -51.67 58.67 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 118.444 0.566 . . . . 0.0 110.249 173.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.38 -38.42 95.8 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 119.544 1.066 . . . . 0.0 112.143 -177.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -63.79 -40.36 96.48 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 120.851 -1.382 . . . . 0.0 110.511 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.9 t -62.04 -39.2 82.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-O 118.443 -0.789 . . . . 0.0 109.147 173.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -39.49 76.27 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.495 1.043 . . . . 0.0 110.881 -176.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -70.44 -42.26 71.78 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 119.043 -0.504 . . . . 0.0 110.565 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.4 ' HB3' ' CE3' ' A' ' 99' ' ' TRP . 9.4 mpt_? -65.44 -42.0 92.9 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.427 1.012 . . . . 0.0 110.559 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.2 t -55.16 -52.69 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 123.322 0.649 . . . . 0.0 109.728 173.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -63.5 -32.65 74.17 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 122.049 -0.407 . . . . 0.0 111.609 -175.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -62.56 -45.9 90.82 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.375 0.67 . . . . 0.0 111.991 172.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -47.4 81.91 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 174.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -58.74 -43.05 87.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.46 -35.32 78.94 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.526 0.603 . . . . 0.0 111.823 -176.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -77.44 -37.49 51.46 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 117.664 -1.16 . . . . 0.0 112.435 174.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.8 pt -93.32 -41.97 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -171.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 C--O 1.252 1.226 0 CA-C-N 119.19 0.904 . . . . 0.0 110.055 -171.513 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 tpt . . . . . 0 N--CA 1.499 1.977 0 CA-C-O 117.623 -1.18 . . . . 0.0 109.607 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.559 ' HB2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -47.52 118.19 2.12 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 120.708 1.595 . . . . 0.0 110.188 -171.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 33.5 mtpt -93.51 134.22 36.01 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -169.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.775 HG13 HG12 ' A' ' 75' ' ' VAL . 10.1 t -112.87 153.54 14.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 58.2 tpp -136.6 143.58 43.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -127.58 106.75 9.38 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.452 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 4.2 t -94.7 141.93 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.298 1.039 . . . . 0.0 108.249 -172.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.66 162.81 30.41 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.74 1.155 . . . . 0.0 113.598 175.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -142.36 30.0 1.58 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.378 1.871 . . . . 0.0 109.111 169.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -155.57 -174.76 5.1 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.807 2.043 . . . . 0.0 106.956 -170.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.473 HD21 ' CD2' ' A' ' 43' ' ' HIS . 9.3 t-20 -52.16 141.5 18.57 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 125.016 1.326 . . . . 0.0 111.579 174.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.2 p -67.26 -17.14 64.67 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.109 1.364 . . . . 0.0 113.205 -176.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 32.0 p -61.91 -11.43 13.06 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 117.542 -1.218 . . . . 0.0 113.858 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.252 21.7 ptt180 -100.69 -37.99 8.5 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 120.032 1.287 . . . . 0.0 111.567 169.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.8 p -98.43 -54.34 3.07 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 120.757 1.617 . . . . 0.0 114.891 -169.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -66.58 -23.18 66.16 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.137 -0.977 . . . . 0.0 108.652 170.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.473 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 1.9 tpt -67.56 -44.05 79.19 Favored 'General case' 0 C--O 1.224 -0.251 0 O-C-N 120.791 -1.193 . . . . 0.0 109.978 168.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.14 -39.8 87.6 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.507 ' HG2' HG12 ' A' ' 32' ' ' VAL . 12.0 tm-20 -58.61 -44.55 89.95 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.377 1.071 . . . . 0.0 110.623 169.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.53 -39.35 61.09 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 120.594 1.543 . . . . 0.0 112.092 -174.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -66.45 -36.78 83.63 Favored 'General case' 0 C--O 1.223 -0.315 0 O-C-N 121.489 -1.007 . . . . 0.0 108.958 170.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.485 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -72.68 -39.92 66.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.978 1.263 . . . . 0.0 110.899 -174.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -66.3 -27.18 67.72 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 120.664 1.575 . . . . 0.0 111.36 175.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.6 m -75.43 -50.91 14.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.982 1.713 . . . . 0.0 110.477 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 72.9 mt -89.48 -27.66 20.19 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.007 1.323 . . . . 0.0 112.485 -169.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.28 12.45 63.49 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 127.064 2.269 . . . . 0.0 111.904 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.52 123.43 17.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.14 1.376 . . . . 0.0 110.012 -171.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.95 8.49 86.77 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.465 -0.631 . . . . 0.0 113.636 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -124.7 -41.18 2.15 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.18 1.392 . . . . 0.0 109.201 -175.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.559 HG22 ' HB2' ' A' ' 2' ' ' LYS . 2.7 pp -140.44 156.06 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.731 1.213 . . . . 0.0 109.437 176.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.95 154.66 17.17 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 173.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.507 HG12 ' HG2' ' A' ' 19' ' ' GLU . 2.1 t -140.55 146.14 24.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-N 119.116 0.871 . . . . 0.0 111.585 -168.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.43 158.24 39.68 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.588 1.155 . . . . 0.0 110.418 -176.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.4 p -133.26 156.08 48.21 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.039 1.29 . . . . 0.0 110.906 176.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.457 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 8.1 p -146.78 145.79 30.05 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.05 0.841 . . . . 0.0 109.759 176.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.7 129.6 0.16 Allowed Glycine 0 CA--C 1.532 1.118 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 -169.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.8 tp -151.1 52.99 0.85 Allowed 'General case' 0 CA--C 1.533 0.291 0 O-C-N 120.718 -1.46 . . . . 0.0 109.445 -169.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 59.72 -80.27 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.696 2.398 . . . . 0.0 111.049 -169.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 p -169.66 26.56 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.723 2.009 . . . . 0.0 110.893 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.9 m -139.53 164.05 30.92 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.577 1.151 . . . . 0.0 110.327 -169.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -74.68 -25.33 59.1 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 118.96 -0.543 . . . . 0.0 111.756 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -171.4 171.49 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 127.09 2.156 . . . . 0.0 106.843 177.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.473 ' CD2' HD21 ' A' ' 11' ' ' ASN . 82.3 t60 -139.99 112.69 7.51 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -172.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -64.34 -30.19 63.26 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.352 2.701 . . . . 0.0 112.751 -169.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.7 m -64.98 -37.5 87.87 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.98 -44.12 90.37 Favored 'General case' 0 C--N 1.346 0.426 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.87 -49.25 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.12 -42.16 98.03 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 118.523 0.601 . . . . 0.0 110.808 -177.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.9 mmt -63.44 -24.5 67.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.802 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.473 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -94.92 -31.68 13.56 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -176.63 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -60.56 -34.1 73.67 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.603 1.161 . . . . 0.0 110.054 169.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -63.8 -9.59 15.55 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.419 1.488 . . . . 0.0 112.39 173.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.73 14.32 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 125.949 1.7 . . . . 0.0 111.329 172.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.81 37.94 88.95 Favored Glycine 0 CA--C 1.532 1.121 0 O-C-N 121.452 -0.78 . . . . 0.0 112.982 175.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.4 mt -120.16 152.75 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 125.706 1.602 . . . . 0.0 106.95 174.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -127.79 124.47 37.72 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -176.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 35.9 pt -129.12 12.91 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 124.246 1.018 . . . . 0.0 111.232 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.95 -31.31 50.87 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.9 1.68 . . . . 0.0 113.577 -178.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.37 -9.69 73.48 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -83.19 159.27 22.04 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.256 1.022 . . . . 0.0 111.528 -173.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.2 p -146.77 158.67 43.96 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 128.373 2.669 . . . . 0.0 105.71 169.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.5 m -147.98 167.75 24.09 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -142.5 162.19 45.97 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -169.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.58 164.25 36.16 Favored 'Trans proline' 0 C--N 1.348 0.504 0 CA-C-N 122.686 1.995 . . . . 0.0 113.163 -169.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.5 tt -57.11 -35.87 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.364 1.465 . . . . 0.0 111.118 -173.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.95 -18.42 62.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.298 0.639 . . . . 0.0 112.699 -169.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -82.18 -16.37 49.95 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 118.729 -0.653 . . . . 0.0 111.482 170.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 35' ' ' CYS . 46.4 m-85 -96.35 168.84 10.33 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.272 1.029 . . . . 0.0 110.842 -177.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -145.08 93.57 2.41 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 -169.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.508 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -52.97 -25.03 10.7 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 177.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.87 -21.95 13.12 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.123 0.42 . . . . 0.0 111.275 173.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -99.52 6.72 45.79 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.513 1.525 . . . . 0.0 113.248 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.443 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 22.7 m-85 -136.77 113.58 10.36 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 120.284 1.402 . . . . 0.0 108.932 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.5 -17.37 59.53 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -169.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.775 HG12 HG13 ' A' ' 4' ' ' VAL . 9.7 t -144.22 122.03 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 -171.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.0 m -129.64 131.36 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 O-C-N 120.845 -1.159 . . . . 0.0 108.763 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.9 mm -126.19 96.72 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 102.977 -2.971 . . . . 0.0 102.977 -170.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.452 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 33.5 t -70.81 166.16 21.6 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -147.38 49.44 1.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 173.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.525 ' HB3' HG21 ' A' ' 84' ' ' VAL . 38.5 m -115.68 10.87 15.59 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.739 1.216 . . . . 0.0 110.786 -170.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.62 21.48 16.53 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 118.486 0.585 . . . . 0.0 112.563 173.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 4.3 t 47.4 41.15 12.16 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.049 1.74 . . . . 0.0 111.771 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -162.51 36.31 0.35 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-O 119.601 -0.555 . . . . 0.0 112.452 -170.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.525 HG21 ' HB3' ' A' ' 80' ' ' CYS . 57.9 t -117.83 137.4 51.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 173.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -82.72 69.07 9.43 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.131 0.972 . . . . 0.0 109.947 -171.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 18.4 mt -59.57 144.81 84.16 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -52.97 154.99 11.95 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.764 2.309 . . . . 0.0 111.846 170.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.65 -19.48 53.88 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 121.649 1.566 . . . . 0.0 114.362 -170.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.08 -25.95 68.33 Favored 'General case' 0 C--O 1.226 -0.162 0 O-C-N 120.938 -1.101 . . . . 0.0 111.224 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.508 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 72.3 m95 -68.57 -5.31 19.05 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.271 -0.893 . . . . 0.0 112.554 174.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.8 t -108.07 -28.5 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 119.67 1.123 . . . . 0.0 111.184 -174.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.1 p -77.07 -19.05 57.58 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.87 0.868 . . . . 0.0 113.123 -169.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -49.99 159.55 0.41 Allowed 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 129.2 3.0 . . . . 0.0 113.964 174.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -63.34 -38.83 92.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.674 1.59 . . . . 0.0 109.118 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.582 ' HB ' HG13 ' A' ' 75' ' ' VAL . 36.5 mm -125.71 138.89 53.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 169.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -139.3 112.19 7.93 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 102.641 -3.096 . . . . 0.0 102.641 167.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -134.68 171.0 14.97 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 174.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -139.49 116.0 10.64 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 170.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -93.74 68.74 3.97 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -36.99 -50.05 0.86 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.856 1.663 . . . . 0.0 110.108 169.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . 0.254 0.5 OUTLIER 38.04 -158.39 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 129.936 3.294 . . . . 0.0 112.734 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -60.4 166.6 2.96 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 122.35 1.071 . . . . 0.0 109.181 169.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -133.17 70.45 77.86 Favored Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 126.362 1.865 . . . . 0.0 109.952 -168.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -77.21 49.74 2.93 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.498 3.465 . . . . 0.0 114.738 -169.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -62.69 102.43 0.34 Allowed 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.981 -1.074 . . . . 0.0 109.424 169.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.55 26.34 66.45 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 123.967 0.794 . . . . 0.0 114.203 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -63.93 167.48 6.16 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -176.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 37.1 m -67.22 154.07 42.15 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 113.228 -1.806 . . . . 0.0 109.219 169.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 25.7 mt -59.03 -34.88 72.41 Favored 'General case' 0 C--O 1.222 -0.366 0 O-C-N 122.08 -0.387 . . . . 0.0 111.519 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -61.11 -39.79 91.29 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.339 0.518 . . . . 0.0 110.615 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.656 ' O ' HG23 ' A' ' 115' ' ' VAL . 61.9 t -72.96 -40.3 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-O 116.75 -1.595 . . . . 0.0 108.998 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -51.63 -47.23 63.77 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 121.207 1.821 . . . . 0.0 111.033 170.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -59.17 -43.96 92.15 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 118.626 0.648 . . . . 0.0 110.441 177.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 86.7 m -69.27 -42.05 76.05 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -174.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 111' ' ' VAL . 67.5 t -65.02 -48.68 83.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -174.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -47.21 -51.58 18.2 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.957 1.303 . . . . 0.0 110.69 170.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.81 -43.85 97.06 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 119.764 1.165 . . . . 0.0 112.409 -177.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -66.69 -33.96 76.8 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.838 1.319 . . . . 0.0 111.42 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.4 t -62.94 -41.1 91.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 172.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.47 -37.56 81.42 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 120.245 1.384 . . . . 0.0 111.166 -177.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -70.17 -40.19 74.85 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 118.865 -0.588 . . . . 0.0 110.733 175.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -60.76 -46.28 91.08 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.515 1.052 . . . . 0.0 110.078 175.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.48 HG12 HD12 ' A' ' 127' ' ' ILE . 69.8 t -57.19 -51.42 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 124.224 1.01 . . . . 0.0 109.451 176.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -67.02 -33.0 74.59 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 119.473 -0.299 . . . . 0.0 111.347 -175.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -61.59 -49.26 77.34 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 123.41 0.684 . . . . 0.0 110.679 172.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.415 HD23 HG13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -58.51 -46.14 87.34 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 122.93 0.492 . . . . 0.0 110.219 177.594 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.48 HD12 HG12 ' A' ' 123' ' ' VAL . 10.1 mt -59.36 -41.0 82.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 124.691 1.196 . . . . 0.0 109.813 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.08 -27.59 67.11 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.068 0.849 . . . . 0.0 111.933 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -75.88 -39.73 55.85 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.776 -0.578 . . . . 0.0 111.786 176.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.1 pt -102.89 -33.14 3.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 116.66 2.096 . . . . 0.0 116.66 -168.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 C--O 1.254 1.3 0 C-N-CA 124.755 1.222 . . . . 0.0 111.679 -171.426 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 tpt . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 118.273 -0.87 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.522 ' HB2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -50.72 116.14 1.81 Allowed 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 120.285 1.402 . . . . 0.0 110.135 -173.123 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.5 mtpt -91.86 142.29 27.72 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 119.263 0.938 . . . . 0.0 108.693 -170.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.439 HG11 ' CZ ' ' A' ' 6' ' ' PHE . 21.3 t -111.67 154.32 13.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 170.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -138.81 131.95 29.81 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.439 ' CZ ' HG11 ' A' ' 4' ' ' VAL . 86.2 m-85 -113.65 132.35 55.8 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.4 t -123.19 112.02 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 120.802 1.637 . . . . 0.0 110.164 -169.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.79 170.78 12.86 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 122.76 1.267 . . . . 0.0 112.835 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.0 mmtp -148.47 148.67 30.53 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 130.971 3.708 . . . . 0.0 101.706 168.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.433 ' HG2' ' H ' ' A' ' 11' ' ' ASN . 26.1 ttm-85 57.51 -160.51 0.24 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.743 1.156 . . . . 0.0 107.908 -168.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.433 ' H ' ' HG2' ' A' ' 10' ' ' ARG . 20.2 t-20 -55.77 133.96 51.32 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 119.221 0.919 . . . . 0.0 112.308 -169.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.4 m -48.06 -24.96 1.24 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 130.286 3.434 . . . . 0.0 115.125 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.0 m -50.2 -49.41 52.72 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 125.713 1.605 . . . . 0.0 114.107 -169.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.27 34.0 ptt180 -70.02 -42.12 73.4 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 118.23 -0.89 . . . . 0.0 113.21 -168.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 87.9 p -78.38 -39.4 39.29 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 120.528 1.513 . . . . 0.0 110.114 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -70.76 -27.68 64.12 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.628 -0.67 . . . . 0.0 110.003 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.471 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.1 tpt -66.72 -41.76 87.44 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 121.149 -0.97 . . . . 0.0 109.51 169.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.57 -38.46 84.65 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -61.33 -42.55 98.87 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.902 169.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.54 -44.88 88.97 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 120.643 1.565 . . . . 0.0 111.798 -175.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -64.98 -40.83 95.56 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 117.937 0.868 . . . . 0.0 108.836 173.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.517 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -71.19 -37.31 72.14 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 119.622 1.101 . . . . 0.0 111.286 -173.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -69.56 -24.77 63.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 120.567 1.53 . . . . 0.0 111.891 177.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.3 m -78.06 -49.98 12.95 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.345 2.258 . . . . 0.0 110.328 175.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.6 mt -88.01 -27.98 21.69 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.732 1.213 . . . . 0.0 112.355 -169.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.34 12.32 58.47 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 127.251 2.358 . . . . 0.0 111.96 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.06 122.83 15.97 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.264 1.426 . . . . 0.0 109.511 -170.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.94 8.41 87.84 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 119.536 -0.591 . . . . 0.0 113.764 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -124.85 -41.94 2.08 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.998 1.319 . . . . 0.0 108.832 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.522 HG22 ' HB2' ' A' ' 2' ' ' LYS . 2.8 pp -140.99 162.08 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.979 1.312 . . . . 0.0 109.124 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.84 155.53 18.54 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.517 HG11 ' HB3' ' A' ' 22' ' ' ALA . 2.4 t -143.9 139.4 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 118.622 0.646 . . . . 0.0 111.2 -168.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.5 m -150.09 165.85 31.53 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.232 1.413 . . . . 0.0 108.271 177.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.419 ' H ' HG21 ' A' ' 61' ' ' THR . 66.1 p -139.21 169.67 17.35 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.684 -1.26 . . . . 0.0 110.552 171.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.6 p -160.69 -178.31 6.77 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.103 0.961 . . . . 0.0 109.349 176.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.34 34.57 57.51 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 mt -76.03 57.0 1.04 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.368 1.067 . . . . 0.0 110.895 -174.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 53.28 8.03 0.1 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 128.157 2.583 . . . . 0.0 115.495 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.5 m 58.85 26.75 15.23 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.075 0.95 . . . . 0.0 110.922 -168.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 38.0 m -135.26 10.58 3.52 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.321 1.849 . . . . 0.0 111.957 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? 59.34 -158.51 0.31 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.596 1.159 . . . . 0.0 110.45 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.3 m -67.1 172.38 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.208 1.003 . . . . 0.0 111.886 -172.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.414 ' CG ' HD21 ' A' ' 11' ' ' ASN . 82.5 t60 -141.08 119.65 8.1 Favored Pre-proline 0 N--CA 1.451 -0.397 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -176.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -66.68 -26.69 45.73 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.534 2.823 . . . . 0.0 113.116 -169.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.8 m -61.85 -35.37 78.08 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.973 0.806 . . . . 0.0 109.464 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.3 -43.71 90.25 Favored 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -59.09 -47.24 90.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 118.566 -0.731 . . . . 0.0 109.041 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.04 -42.5 99.25 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 118.759 0.709 . . . . 0.0 110.919 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.2 mmt -61.41 -24.94 66.87 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 123.615 0.766 . . . . 0.0 111.936 176.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.471 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 0.4 OUTLIER -95.45 -26.96 15.63 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 119.052 0.842 . . . . 0.0 108.965 -179.371 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.29 -29.05 70.44 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.996 0.919 . . . . 0.0 110.149 170.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -56.7 -26.23 56.23 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.24 0.616 . . . . 0.0 111.517 169.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.89 -15.95 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 126.744 2.018 . . . . 0.0 109.874 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.65 29.49 52.11 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.153 0.882 . . . . 0.0 111.099 -169.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.0 mt -109.4 156.91 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.259 1.423 . . . . 0.0 107.884 177.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.63 132.65 51.19 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 126.31 1.844 . . . . 0.0 107.669 -173.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.3 pt -140.71 4.48 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.628 1.171 . . . . 0.0 111.883 175.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.83 144.89 55.12 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.712 1.205 . . . . 0.0 110.262 176.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.82 3.68 4.84 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 117.926 -1.485 . . . . 0.0 114.67 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -56.62 -58.42 8.16 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-N 119.589 1.694 . . . . 0.0 112.745 -172.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.419 HG21 ' H ' ' A' ' 34' ' ' SER . 1.0 OUTLIER -141.8 165.49 27.32 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.317 -167.344 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 26.3 m -163.13 19.7 0.08 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -173.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -141.89 154.0 64.9 Favored Pre-proline 0 N--CA 1.476 0.831 0 CA-C-N 120.803 1.638 . . . . 0.0 113.135 -169.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.13 -177.5 3.54 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 125.241 3.961 . . . . 0.0 113.373 174.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.9 tt -77.21 -33.15 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 126.015 1.726 . . . . 0.0 113.756 -173.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -68.92 -27.75 66.05 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -168.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.54 -7.48 57.56 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 117.579 -1.2 . . . . 0.0 112.776 171.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -102.93 166.13 10.63 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.692 1.587 . . . . 0.0 111.894 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -140.43 88.53 2.21 Favored 'General case' 0 CA--C 1.52 -0.19 0 C-N-CA 125.383 1.473 . . . . 0.0 108.884 -169.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.43 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -52.02 -27.75 14.66 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 124.028 0.931 . . . . 0.0 113.009 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -50.48 -32.51 18.29 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.346 1.058 . . . . 0.0 112.312 174.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -72.1 -20.83 61.58 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -101.68 175.03 5.69 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.104 2.562 . . . . 0.0 109.211 -175.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -117.06 -18.54 10.04 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 117.608 -1.187 . . . . 0.0 113.064 174.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.663 HG13 ' HB ' ' A' ' 95' ' ' ILE . 22.3 t -138.06 133.08 43.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 121.478 1.945 . . . . 0.0 108.672 -178.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.9 t -117.65 138.42 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 6' ' ' PHE . 49.2 mm -131.54 92.12 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 103.004 -2.961 . . . . 0.0 103.004 172.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.7 t -69.63 164.58 23.04 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 169.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.8 mp -139.24 32.0 2.13 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.7 1.6 . . . . 0.0 106.892 173.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 87.7 m -74.39 -3.06 28.19 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.383 1.073 . . . . 0.0 111.908 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.48 34.36 6.09 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 119.585 1.084 . . . . 0.0 110.864 176.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . 0.25 30.3 p 38.91 45.14 0.93 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 128.003 2.521 . . . . 0.0 113.809 -178.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -142.88 36.55 1.6 Allowed Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.404 1.478 . . . . 0.0 111.037 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.14 161.94 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 127.202 2.201 . . . . 0.0 108.949 -177.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -134.98 85.65 2.19 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 174.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.5 HD22 ' H ' ' A' ' 86' ' ' LEU . 1.3 mm? -62.08 153.85 72.13 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.708 -171.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.41 157.36 18.54 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.002 1.801 . . . . 0.0 112.272 174.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -52.13 -36.92 68.16 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.772 2.315 . . . . 0.0 116.152 -170.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -67.06 -23.79 65.91 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 120.982 -1.074 . . . . 0.0 112.288 -175.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.43 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 63.8 m95 -75.86 -11.65 60.01 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.745 1.218 . . . . 0.0 112.622 177.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.3 m -115.76 -16.67 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 120.032 1.287 . . . . 0.0 112.314 -177.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.6 p -76.72 -13.46 60.03 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.282 0.946 . . . . 0.0 112.342 177.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -41.67 154.17 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 129.982 3.313 . . . . 0.0 111.793 169.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -60.68 -36.91 79.93 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.096 1.758 . . . . 0.0 109.729 172.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.663 ' HB ' HG13 ' A' ' 75' ' ' VAL . 29.1 mm -130.18 136.35 58.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 170.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -133.69 123.03 24.27 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 102.92 -2.993 . . . . 0.0 102.92 166.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.46 167.04 23.43 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 173.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -130.51 102.24 6.07 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 169.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -76.86 80.81 3.44 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.898 1.679 . . . . 0.0 108.807 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.77 22.4 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.263 2.625 . . . . 0.0 115.234 175.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.72 164.91 13.6 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.062 -1.024 . . . . 0.0 111.219 -169.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -51.71 146.86 7.29 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -168.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -80.89 110.29 16.87 Favored Pre-proline 0 C--N 1.321 -0.669 0 C-N-CA 127.72 2.408 . . . . 0.0 109.531 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -84.16 -7.14 10.17 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.882 2.388 . . . . 0.0 112.378 176.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.6 t70 19.8 -101.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 128.758 2.823 . . . . 0.0 113.508 -176.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -130.81 39.76 1.74 Allowed Glycine 0 CA--C 1.533 1.191 0 C-N-CA 127.138 2.304 . . . . 0.0 108.059 169.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -70.03 -179.51 1.93 Allowed 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.987 1.715 . . . . 0.0 112.397 -173.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.2 p -60.27 154.47 19.94 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 113.142 -1.844 . . . . 0.0 109.04 169.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 27.6 mt -57.35 -29.74 64.25 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 122.799 0.44 . . . . 0.0 110.406 176.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -61.4 -41.08 96.56 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 118.527 -0.749 . . . . 0.0 110.948 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.5 t -72.17 -40.19 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 117.705 -1.14 . . . . 0.0 109.59 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -51.35 -51.31 55.62 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.934 1.243 . . . . 0.0 111.425 169.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 80.2 mtt180 -59.65 -44.27 93.6 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.847 0.749 . . . . 0.0 110.99 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 95.8 m -67.03 -45.93 75.98 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -175.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.1 t -64.95 -48.89 82.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -172.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -43.97 -53.58 6.1 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 125.374 1.47 . . . . 0.0 111.262 169.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.82 -40.41 95.57 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 120.104 1.32 . . . . 0.0 112.526 -177.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -66.05 -37.22 85.28 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 120.819 -1.4 . . . . 0.0 110.261 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.9 t -63.41 -43.7 98.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.458 0 CA-C-O 117.997 -1.002 . . . . 0.0 108.439 173.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.52 -40.22 82.31 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.716 1.598 . . . . 0.0 110.842 -175.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -71.26 -44.46 65.22 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 125.382 1.473 . . . . 0.0 109.084 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -66.24 -41.87 89.41 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 120.011 1.278 . . . . 0.0 111.582 177.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.504 HG12 HD12 ' A' ' 127' ' ' ILE . 48.7 t -53.98 -50.13 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 173.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -66.67 -34.4 77.79 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -176.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -61.68 -48.28 81.54 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 118.46 0.573 . . . . 0.0 110.394 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.416 HD11 HG11 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -59.58 -45.92 90.46 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 123.049 0.54 . . . . 0.0 109.829 177.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.504 HD12 HG12 ' A' ' 123' ' ' VAL . 12.4 mt -58.43 -42.2 83.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.735 1.214 . . . . 0.0 110.195 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.13 -28.38 67.83 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.296 0.498 . . . . 0.0 112.085 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -75.79 -43.54 45.81 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.418 0.554 . . . . 0.0 111.873 174.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.0 pt -91.92 -37.53 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -169.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.6 m . . . . . 0 C--O 1.255 1.348 0 CA-C-N 120.266 1.393 . . . . 0.0 110.352 179.36 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 tpt . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 118.524 -0.75 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.489 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -61.54 119.7 9.12 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 121.128 1.785 . . . . 0.0 108.035 -176.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 37.1 mtpt -92.25 137.97 31.92 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -170.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.747 HG13 HG12 ' A' ' 75' ' ' VAL . 14.5 t -122.06 153.77 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 58.9 tpp -138.44 145.12 40.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -129.42 121.82 28.12 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 t -118.5 113.35 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 119.644 1.111 . . . . 0.0 109.252 -169.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.96 167.42 18.92 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 123.32 1.533 . . . . 0.0 113.476 178.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -152.94 141.03 20.37 Favored 'General case' 0 C--O 1.238 0.479 2 N-CA-C 100.032 -4.062 . . . . 0.0 100.032 168.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 62.16 -179.36 0.13 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 120.331 1.423 . . . . 0.0 108.644 -167.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.502 HD21 ' CD2' ' A' ' 43' ' ' HIS . 28.8 t-20 -41.52 123.0 2.07 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 125.131 1.372 . . . . 0.0 112.129 -169.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.3 m -45.78 -26.71 0.7 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 127.868 2.467 . . . . 0.0 115.108 -176.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.5 t -39.78 -54.08 2.15 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 125.557 1.543 . . . . 0.0 112.859 -178.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.289 33.5 ptt180 -65.84 -44.35 85.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 117.784 -1.103 . . . . 0.0 113.454 -168.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 97.5 p -77.3 -41.67 39.79 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 121.094 1.77 . . . . 0.0 110.304 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -70.06 -34.91 73.81 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -172.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.46 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 3.4 tpt -63.72 -41.76 98.03 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 123.496 0.718 . . . . 0.0 110.363 170.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.58 -37.66 82.06 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.494 -177.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -62.51 -42.73 99.7 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 117.94 -1.028 . . . . 0.0 111.204 170.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.58 -45.23 93.62 Favored Glycine 0 C--N 1.341 0.837 0 CA-C-N 120.746 1.612 . . . . 0.0 111.284 -175.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -66.77 -40.49 88.22 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.203 172.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.96 78.44 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 120.295 1.407 . . . . 0.0 111.6 -176.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -81.91 -13.82 57.01 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 120.46 1.482 . . . . 0.0 113.11 176.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.6 m -79.95 -52.01 8.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.698 1.199 . . . . 0.0 108.533 169.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.1 mt -84.44 -27.44 27.54 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.899 1.28 . . . . 0.0 111.859 -169.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.87 12.66 57.73 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.675 2.084 . . . . 0.0 111.889 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.53 121.98 12.91 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.585 1.154 . . . . 0.0 109.861 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.38 9.41 86.84 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 119.853 -0.415 . . . . 0.0 113.559 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -123.2 -32.56 3.42 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.849 1.66 . . . . 0.0 109.012 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.4 pt -142.64 174.57 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 125.305 1.442 . . . . 0.0 109.785 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -116.56 145.27 43.48 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 169.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 t -134.13 143.88 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 118.542 0.61 . . . . 0.0 111.279 -168.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.76 156.18 42.0 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.934 1.294 . . . . 0.0 109.74 -173.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.3 p -139.65 155.34 47.46 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 120.364 1.438 . . . . 0.0 111.069 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.2 p -160.11 -178.54 7.06 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.93 0.892 . . . . 0.0 110.313 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.43 33.32 72.42 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.0 mp -61.2 128.21 35.28 Favored 'General case' 0 C--N 1.344 0.338 0 N-CA-C 102.272 -3.232 . . . . 0.0 102.272 169.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -70.15 80.4 0.51 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-O 123.184 1.468 . . . . 0.0 113.415 -169.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.0 m 50.74 30.99 5.42 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 127.924 2.49 . . . . 0.0 112.758 174.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.0 m -149.87 167.01 27.81 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.517 1.527 . . . . 0.0 108.81 -170.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -78.48 -174.18 3.69 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 169.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.2 m -55.57 162.74 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 124.564 1.146 . . . . 0.0 112.06 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.502 ' CD2' HD21 ' A' ' 11' ' ' ASN . 81.5 t60 -119.74 110.07 37.29 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.623 -169.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -59.88 -29.1 88.68 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.07 2.513 . . . . 0.0 113.67 -169.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -60.33 -37.49 80.78 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.475 1.034 . . . . 0.0 110.847 175.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.21 -45.82 72.29 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.5 -45.81 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.5 -43.74 93.27 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.373 0.533 . . . . 0.0 111.438 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.3 mmt -65.86 -19.64 65.95 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 118.969 -0.539 . . . . 0.0 112.1 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.46 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 2.0 mmt -98.63 -28.65 13.45 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.93 -33.67 75.84 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.557 1.143 . . . . 0.0 109.547 169.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -58.51 -15.17 10.01 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.792 1.637 . . . . 0.0 112.067 172.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.0 m -132.45 14.3 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 C-N-CA 126.439 1.896 . . . . 0.0 111.753 177.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.51 43.54 76.9 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-O 118.944 -0.92 . . . . 0.0 114.31 174.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.1 mt -124.25 151.61 29.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.133 1.373 . . . . 0.0 107.872 171.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -113.81 129.86 56.53 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.293 1.437 . . . . 0.0 109.073 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 57' ' ' ILE . 30.1 pt -129.76 14.12 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 125.568 1.547 . . . . 0.0 111.017 171.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.54 -28.1 31.24 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.372 1.469 . . . . 0.0 113.107 175.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -77.05 -9.5 86.74 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-N 118.372 0.533 . . . . 0.0 112.902 178.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -71.79 157.99 36.9 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.63 1.572 . . . . 0.0 109.614 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.48 165.15 31.15 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.54 144.84 49.43 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.682 1.993 . . . . 0.0 112.005 -172.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.65 139.41 1.67 Allowed Pre-proline 0 C--O 1.237 0.409 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 169.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -79.39 158.64 25.94 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.271 1.981 . . . . 0.0 110.845 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.6 tt -57.92 -37.2 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 124.707 1.203 . . . . 0.0 110.641 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -69.76 -21.87 63.4 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.357 0.663 . . . . 0.0 112.344 -174.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -22.2 60.94 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.28 0.491 . . . . 0.0 111.069 171.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -94.01 168.95 10.62 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 122.072 0.939 . . . . 0.0 110.646 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.39 93.41 2.43 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 125.451 1.5 . . . . 0.0 107.516 -175.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.478 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -50.0 -24.31 2.54 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 124.306 1.042 . . . . 0.0 113.392 175.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -50.81 -28.99 10.52 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.136 0.574 . . . . 0.0 111.318 173.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -91.92 -9.34 43.48 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.454 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 12.8 m-85 -120.2 112.93 19.69 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 120.595 1.543 . . . . 0.0 109.332 -173.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -65.54 -14.48 61.16 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 -169.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.747 HG12 HG13 ' A' ' 4' ' ' VAL . 13.0 t -143.85 118.19 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 105.307 -2.109 . . . . 0.0 105.307 -171.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.3 m -128.19 134.2 65.46 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 O-C-N 120.875 -1.14 . . . . 0.0 108.718 -174.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 43.4 mm -127.5 97.14 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 104.203 -2.518 . . . . 0.0 104.203 -169.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.0 t -72.81 166.29 23.21 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 169.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.8 mp -144.27 40.19 1.33 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 173.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.499 ' HB3' HG21 ' A' ' 84' ' ' VAL . 60.9 m -100.04 12.0 37.96 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.334 1.054 . . . . 0.0 111.358 -172.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.7 23.53 28.04 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.512 -0.605 . . . . 0.0 111.862 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.44 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 4.0 t 45.65 45.7 11.1 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.857 1.663 . . . . 0.0 111.945 -177.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -153.53 35.9 0.75 Allowed Glycine 0 C--N 1.341 0.821 0 C-N-CA 123.405 0.526 . . . . 0.0 111.928 -171.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.499 HG21 ' HB3' ' A' ' 80' ' ' CYS . 78.5 t -122.43 133.16 69.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 125.039 1.335 . . . . 0.0 107.737 177.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -78.42 72.42 4.95 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 172.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.3 mt -57.73 145.98 68.15 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -55.1 155.24 19.65 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.046 1.831 . . . . 0.0 112.432 176.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -54.18 -29.28 55.61 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.549 2.166 . . . . 0.0 115.94 -173.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -66.25 -27.06 67.66 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 120.986 -1.071 . . . . 0.0 111.159 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.478 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 71.0 m95 -71.47 -3.63 22.12 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 117.91 -1.043 . . . . 0.0 113.165 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.0 m -120.71 -7.17 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 120.575 1.534 . . . . 0.0 113.471 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.8 p -87.28 -16.25 35.7 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.448 1.022 . . . . 0.0 112.632 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -54.02 163.33 0.79 Allowed 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 129.153 2.981 . . . . 0.0 113.605 175.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -64.89 -41.72 95.37 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.673 1.189 . . . . 0.0 108.708 176.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.497 ' HB ' HG13 ' A' ' 75' ' ' VAL . 32.7 mm -121.64 140.48 45.53 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 CA-C-O 121.58 0.705 . . . . 0.0 110.097 169.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -140.71 114.3 8.8 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 100.946 -3.724 . . . . 0.0 100.946 166.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -135.9 170.28 16.24 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 170.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.44 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 10.2 t70 -137.31 106.24 5.95 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 172.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.429 ' C ' ' H ' ' A' ' 101' ' ' LEU . 48.7 m0 -85.13 70.48 10.89 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -48.03 7.91 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.208 1 C-N-CA 131.836 4.054 . . . . 0.0 115.324 169.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.429 ' H ' ' C ' ' A' ' 99' ' ' TRP . 3.8 mm? -61.48 126.39 27.17 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 126.798 2.039 . . . . 0.0 111.338 -168.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 51.01 -160.04 0.09 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.826 2.051 . . . . 0.0 113.765 169.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -165.48 70.76 1.32 Allowed Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 128.101 2.561 . . . . 0.0 108.061 -172.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.95 -4.8 16.01 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 122.526 2.15 . . . . 0.0 114.215 -169.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -56.61 -34.19 66.99 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -173.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.35 40.65 1.94 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.651 1.119 . . . . 0.0 112.737 -174.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.415 ' HB3' ' H ' ' A' ' 108' ' ' SER . 16.5 mm-40 -116.13 -157.62 0.66 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.085 0.954 . . . . 0.0 111.89 -175.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.415 ' H ' ' HB3' ' A' ' 107' ' ' GLN . 9.9 m -131.11 173.56 10.9 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 128.662 2.785 . . . . 0.0 107.542 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 35.4 mt -54.7 -36.06 64.3 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.962 0.905 . . . . 0.0 110.785 -172.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -60.13 -40.0 88.22 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 123.031 0.532 . . . . 0.0 110.269 -175.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.61 -37.82 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.091 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -53.68 -42.73 68.27 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.948 1.249 . . . . 0.0 111.255 170.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -63.44 -43.76 96.5 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 119.607 1.094 . . . . 0.0 111.141 174.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.1 m -71.91 -43.39 65.42 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -171.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 57.9 t -64.48 -47.19 90.33 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -173.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 10.3 ttp180 -45.08 -50.38 11.06 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 125.475 1.51 . . . . 0.0 111.026 169.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -58.69 -43.4 96.34 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 119.576 1.08 . . . . 0.0 112.696 177.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -75.91 -31.68 59.27 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 120.956 -1.32 . . . . 0.0 110.652 -175.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.2 -37.75 80.27 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 170.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.415 ' HE2' ' HB3' ' A' ' 120' ' ' LYS . 5.7 mtpt -57.8 -47.79 81.57 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 120.595 1.543 . . . . 0.0 110.876 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -62.05 -38.25 88.03 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.021 0.826 . . . . 0.0 109.011 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -68.13 -47.18 68.81 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.404 0.681 . . . . 0.0 110.878 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 43.6 t -56.49 -52.51 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 124.87 1.268 . . . . 0.0 108.738 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -68.66 -33.37 73.87 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -171.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -62.16 -49.43 75.87 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 123.099 0.56 . . . . 0.0 110.852 171.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.87 -46.14 78.33 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 122.978 0.511 . . . . 0.0 109.876 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.7 mt -58.85 -43.84 89.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 124.807 1.243 . . . . 0.0 110.687 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.71 -29.06 67.85 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 118.782 0.719 . . . . 0.0 111.726 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -74.71 -40.64 61.2 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 118.538 0.608 . . . . 0.0 112.032 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.9 pt -100.62 -42.38 9.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 116.976 2.213 . . . . 0.0 116.976 -168.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.254 1.307 0 CA-C-N 119.195 0.907 . . . . 0.0 110.304 -171.909 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 tpt . . . . . 0 N--CA 1.499 1.977 0 CA-C-O 117.706 -1.14 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.512 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -54.96 118.02 3.93 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 121.337 1.881 . . . . 0.0 110.377 -169.69 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.495 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 56.2 mtpt -86.19 135.47 33.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -170.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.75 HG13 HG12 ' A' ' 75' ' ' VAL . 9.0 t -125.36 153.71 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 61.4 tpp -140.59 131.91 26.69 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -176.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.409 ' HE1' HG13 ' A' ' 32' ' ' VAL . 92.5 m-85 -116.17 107.27 14.68 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.452 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 3.9 t -94.39 144.31 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -169.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.4 t -128.0 -177.76 4.26 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.38 1.072 . . . . 0.0 110.185 172.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -152.4 -45.93 0.1 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.63 1.572 . . . . 0.0 108.688 176.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -167.7 0.17 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.187 0.995 . . . . 0.0 109.017 169.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.484 HD21 ' CD2' ' A' ' 43' ' ' HIS . 26.6 t-20 -47.94 139.58 7.69 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.698 0.799 . . . . 0.0 109.614 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -55.22 -22.9 19.63 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.504 1.522 . . . . 0.0 114.396 -169.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.9 m -42.2 -67.5 0.26 Allowed 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 127.21 2.204 . . . . 0.0 114.318 -172.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.272 34.9 ptt180 -56.19 -47.67 77.87 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.451 1.478 . . . . 0.0 114.715 -167.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.43 -29.98 21.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 119.005 0.82 . . . . 0.0 111.315 -171.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -70.09 -27.01 64.26 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.112 -0.992 . . . . 0.0 110.023 170.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.473 ' SD ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -69.03 -42.25 76.6 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 120.574 -1.329 . . . . 0.0 109.789 169.439 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.08 -40.21 84.54 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -59.65 -39.09 83.26 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.42 169.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.19 -43.08 56.77 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 120.715 1.598 . . . . 0.0 112.587 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.473 ' CD2' ' SD ' ' A' ' 17' ' ' MET . 10.6 m-85 -64.68 -37.52 87.88 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 119.075 1.438 . . . . 0.0 108.989 170.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.526 ' HB3' HG11 ' A' ' 32' ' ' VAL . . . -72.45 -39.17 68.0 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 119.497 1.044 . . . . 0.0 111.118 -173.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -65.27 -33.79 76.81 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 120.371 1.441 . . . . 0.0 110.915 174.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.8 m -69.06 -50.98 43.6 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.285 1.834 . . . . 0.0 110.232 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 77.0 mt -90.06 -25.83 20.58 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.55 1.14 . . . . 0.0 112.129 -169.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -101.23 14.84 58.15 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 126.748 2.118 . . . . 0.0 111.903 -178.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.66 120.82 10.77 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.908 1.283 . . . . 0.0 110.091 -171.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.11 8.53 86.93 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-O 119.811 -0.439 . . . . 0.0 113.511 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -123.1 -28.45 4.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.413 1.485 . . . . 0.0 109.583 -176.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.6 pt -143.35 175.87 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 125.832 1.653 . . . . 0.0 109.386 176.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -119.56 145.12 46.66 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 103.868 -2.641 . . . . 0.0 103.868 168.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.526 HG11 ' HB3' ' A' ' 22' ' ' ALA . 2.1 t -132.17 144.04 38.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 123.851 0.86 . . . . 0.0 111.316 -167.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.75 161.97 41.18 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.799 1.24 . . . . 0.0 109.723 -173.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.428 ' H ' HG21 ' A' ' 61' ' ' THR . 22.9 t -142.18 154.76 45.09 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.688 1.586 . . . . 0.0 109.524 172.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.6 p -157.11 171.03 21.18 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 118.509 0.595 . . . . 0.0 112.312 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.18 47.36 90.28 Favored Glycine 0 N--CA 1.472 1.091 0 N-CA-C 107.786 -2.126 . . . . 0.0 107.786 -169.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.92 56.89 3.25 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.114 1.766 . . . . 0.0 109.097 -168.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 60.98 -67.43 0.05 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 129.759 3.224 . . . . 0.0 111.381 -168.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.3 m -155.0 40.93 0.44 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.385 2.274 . . . . 0.0 107.995 -175.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.3 m 58.36 48.66 12.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.489 1.116 . . . . 0.0 113.129 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.79 142.75 22.2 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.503 -0.748 . . . . 0.0 111.725 171.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.4 m -71.47 177.81 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 124.668 1.187 . . . . 0.0 110.528 175.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.484 ' CD2' HD21 ' A' ' 11' ' ' ASN . 20.9 t-80 -139.75 119.52 9.09 Favored Pre-proline 0 N--CA 1.451 -0.403 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -176.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -67.11 -27.28 42.06 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.057 2.505 . . . . 0.0 112.555 -169.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.7 m -62.43 -35.48 79.38 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.967 0.803 . . . . 0.0 109.53 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.23 -43.03 92.77 Favored 'General case' 0 C--O 1.221 -0.447 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.57 -47.84 89.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 118.206 -0.902 . . . . 0.0 109.382 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.35 -42.69 99.1 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 119.633 1.106 . . . . 0.0 110.878 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.0 mmt -64.32 -18.2 64.39 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.765 0.826 . . . . 0.0 112.112 176.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 3.9 mmt -95.02 -28.03 15.33 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 119.387 0.994 . . . . 0.0 110.992 173.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -63.6 -30.01 71.18 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 123.62 0.768 . . . . 0.0 109.694 172.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -57.96 -21.13 42.73 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.535 1.134 . . . . 0.0 113.101 170.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.4 p -121.44 9.03 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 125.229 1.412 . . . . 0.0 110.386 -177.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.32 36.88 85.5 Favored Glycine 0 CA--C 1.531 1.072 0 O-C-N 121.148 -0.97 . . . . 0.0 111.808 177.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 35.3 mt -121.83 157.93 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 126.2 1.8 . . . . 0.0 106.153 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -140.33 145.08 36.73 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 172.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 27.6 pt -138.55 7.7 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 126.354 1.862 . . . . 0.0 111.023 -174.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.3 t -64.28 145.67 55.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.612 -0.68 . . . . 0.0 109.289 172.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.63 3.52 5.75 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 117.802 -1.555 . . . . 0.0 114.552 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -54.6 -58.7 6.49 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-N 119.776 1.788 . . . . 0.0 111.481 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.428 HG21 ' H ' ' A' ' 34' ' ' SER . 1.0 OUTLIER -154.77 154.03 32.16 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 125.57 1.548 . . . . 0.0 106.986 -169.331 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.0 m -163.43 68.03 0.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 102.428 -3.175 . . . . 0.0 102.428 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -142.46 141.44 20.82 Favored Pre-proline 0 C--O 1.236 0.347 0 CA-C-O 119.152 -0.451 . . . . 0.0 112.195 -167.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -82.66 159.99 16.58 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.522 2.815 . . . . 0.0 111.268 173.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.1 tt -63.63 -36.87 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 124.463 1.105 . . . . 0.0 111.778 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -70.46 -19.96 62.92 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.277 0.631 . . . . 0.0 112.16 -173.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.25 -23.9 62.98 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 118.763 -0.637 . . . . 0.0 111.6 170.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -99.82 169.71 9.04 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 122.128 0.966 . . . . 0.0 111.093 -174.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -142.59 90.69 2.25 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 -170.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.508 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -54.26 -22.79 12.67 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.4 -21.07 5.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 122.943 0.497 . . . . 0.0 111.301 171.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -111.31 17.09 20.54 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.881 2.072 . . . . 0.0 112.346 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.495 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 28.4 m-85 -132.82 107.57 8.43 Favored 'General case' 0 C--N 1.345 0.407 0 O-C-N 120.685 -1.259 . . . . 0.0 107.787 170.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -58.94 -18.86 37.45 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -169.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.75 HG12 HG13 ' A' ' 4' ' ' VAL . 10.5 t -143.07 123.43 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -170.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.5 t -118.06 134.45 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.8 mm -131.98 87.69 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.452 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 29.1 t -68.31 165.8 17.84 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.988 -1.07 . . . . 0.0 108.653 169.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 mp -144.5 53.03 1.25 Allowed 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 170.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.527 ' HB3' HG21 ' A' ' 84' ' ' VAL . 43.3 m -113.53 15.73 18.93 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.11 0.964 . . . . 0.0 110.583 -176.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.68 24.7 29.73 Favored Glycine 0 C--N 1.339 0.723 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 172.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.412 ' H ' ' CG ' ' A' ' 98' ' ' ASP . 6.7 t 44.54 42.44 5.62 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.311 1.844 . . . . 0.0 112.327 -176.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -151.66 37.88 0.82 Allowed Glycine 0 C--N 1.339 0.72 0 C-N-CA 123.53 0.586 . . . . 0.0 112.012 -171.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.527 HG21 ' HB3' ' A' ' 80' ' ' CYS . 94.5 t -120.24 141.67 39.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 C-N-CA 124.753 1.221 . . . . 0.0 108.612 178.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -82.03 55.95 2.97 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.588 1.155 . . . . 0.0 110.159 -178.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.4 mt -57.15 133.64 80.73 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.59 154.6 19.6 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.666 2.244 . . . . 0.0 112.758 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -55.0 -27.98 57.33 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.619 2.213 . . . . 0.0 116.208 -172.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -65.45 -25.36 67.48 Favored 'General case' 0 C--O 1.226 -0.147 0 O-C-N 121.284 -0.885 . . . . 0.0 111.288 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.508 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 61.7 m95 -67.93 -8.66 38.76 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.251 -0.906 . . . . 0.0 112.813 175.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.3 t -107.78 -30.54 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.022 1.329 . . . . 0.0 111.122 -170.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.7 p -74.65 -16.77 60.76 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.37 1.068 . . . . 0.0 113.688 -169.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -50.56 160.76 0.38 Allowed 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 130.213 3.405 . . . . 0.0 114.308 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -60.11 -39.41 86.08 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.414 1.486 . . . . 0.0 108.591 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.612 ' HB ' HG13 ' A' ' 75' ' ' VAL . 36.2 mm -126.32 137.07 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 169.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -137.49 113.09 9.48 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 102.156 -3.276 . . . . 0.0 102.156 166.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -140.75 166.66 24.15 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 82' ' ' CYS . 9.5 t70 -139.67 110.56 6.83 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 169.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -83.04 81.98 8.44 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.401 ' H ' ' CD ' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -61.33 25.6 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 127.337 2.255 . . . . 0.0 114.564 178.355 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.57 175.64 2.77 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.696 -1.253 . . . . 0.0 110.372 -172.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.79 160.46 2.62 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 123.238 1.494 . . . . 0.0 114.542 -170.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -103.91 108.08 58.73 Favored Pre-proline 0 C--N 1.322 -0.608 0 C-N-CA 127.01 2.124 . . . . 0.0 108.717 -178.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -80.85 -6.65 13.32 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.609 2.206 . . . . 0.0 112.014 177.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.7 t0 22.9 -99.33 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 128.389 2.676 . . . . 0.0 113.336 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -133.64 39.91 1.66 Allowed Glycine 0 CA--C 1.531 1.084 0 C-N-CA 127.119 2.295 . . . . 0.0 108.7 169.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -70.38 -178.07 1.63 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.397 1.879 . . . . 0.0 112.635 -175.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.3 m -61.3 153.67 25.88 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 113.376 -1.738 . . . . 0.0 108.731 171.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 32.7 mt -56.68 -29.73 62.66 Favored 'General case' 0 C--O 1.221 -0.396 0 C-N-CA 122.954 0.502 . . . . 0.0 110.82 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -61.24 -39.68 91.21 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.058 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.5 t -73.72 -40.02 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.257 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -51.13 -51.45 53.4 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.738 1.154 . . . . 0.0 111.326 169.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -59.05 -45.18 91.41 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.441 0.696 . . . . 0.0 110.958 178.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.1 m -67.58 -45.71 74.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -173.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.3 t -66.02 -48.24 82.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -171.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -44.1 -56.83 3.76 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.783 1.233 . . . . 0.0 110.575 169.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.94 -41.76 99.82 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 119.968 1.258 . . . . 0.0 111.948 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -63.75 -41.73 97.97 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 121.516 -0.99 . . . . 0.0 110.263 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.35 -39.07 82.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -41.45 83.41 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 120.013 1.279 . . . . 0.0 110.642 -175.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.69 -40.41 80.07 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.633 0.373 . . . . 0.0 110.063 177.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -64.49 -47.11 80.15 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.618 0.644 . . . . 0.0 110.292 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.1 t -56.05 -51.38 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 124.049 0.939 . . . . 0.0 108.469 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -66.01 -32.36 73.79 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 119.353 -0.356 . . . . 0.0 111.5 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -62.51 -48.07 81.16 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 118.612 0.642 . . . . 0.0 111.013 173.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -42.98 91.55 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 123.247 0.619 . . . . 0.0 110.624 176.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.0 mt -62.26 -43.09 97.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 123.102 0.561 . . . . 0.0 110.116 175.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.35 -31.68 71.57 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.311 0.959 . . . . 0.0 112.039 -175.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.478 ' HE2' HD11 ' A' ' 95' ' ' ILE . 14.1 ptmt -81.37 -35.08 31.26 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 117.763 -1.113 . . . . 0.0 112.978 175.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 pt -96.52 -43.66 12.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 115.421 1.638 . . . . 0.0 115.421 -173.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.2 m . . . . . 0 C--O 1.256 1.444 0 C-N-CA 124.636 1.174 . . . . 0.0 111.586 -171.165 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mmm . . . . . 0 N--CA 1.502 2.131 0 CA-C-O 119.257 -0.402 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.727 ' HG2' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -59.31 137.74 57.87 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 169.463 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.43 ' HB2' ' HA ' ' A' ' 73' ' ' TYR . 25.0 mtpt -112.19 142.06 45.13 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 -169.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.753 HG13 HG12 ' A' ' 75' ' ' VAL . 11.5 t -122.86 155.29 28.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -174.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 57.0 tpp -136.68 134.25 37.05 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -115.74 112.07 21.49 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.448 ' HB ' ' HA ' ' A' ' 78' ' ' SER . 3.4 t -96.32 136.72 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -169.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.3 m -109.72 149.95 29.02 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.258 1.023 . . . . 0.0 112.237 -169.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.7 mmtt -150.07 146.09 26.74 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.372 1.869 . . . . 0.0 106.054 169.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.468 ' CG ' ' H ' ' A' ' 11' ' ' ASN . 27.0 ttm180 57.01 -172.44 0.08 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.544 1.138 . . . . 0.0 109.307 -168.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.475 HD21 ' CD2' ' A' ' 43' ' ' HIS . 37.0 t-20 -49.95 105.36 0.09 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.418 1.487 . . . . 0.0 107.857 -177.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 m -62.06 0.15 0.44 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 117.137 2.273 . . . . 0.0 117.137 -167.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.1 m -38.22 -50.57 1.43 Allowed 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 126.36 1.864 . . . . 0.0 111.923 173.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -65.23 -43.25 92.03 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.243 0.545 . . . . 0.0 111.329 -171.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.1 p -88.45 -37.75 15.57 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 124.422 1.089 . . . . 0.0 111.1 -170.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -72.13 -32.08 66.61 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.552 -0.717 . . . . 0.0 109.545 174.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.415 ' SD ' ' SD ' ' A' ' 50' ' ' MET . 2.5 tpt -62.09 -39.22 91.72 Favored 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 121.158 -0.964 . . . . 0.0 109.685 169.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.07 92.1 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -62.94 -39.16 93.76 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.204 170.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.77 -43.07 68.5 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 120.852 1.66 . . . . 0.0 111.275 -174.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -63.53 -40.4 96.94 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 170.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.29 -40.27 81.84 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 119.58 1.082 . . . . 0.0 111.464 -176.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.479 ' HA ' HG21 ' A' ' 32' ' ' VAL . 13.4 pttp -70.84 -22.72 62.28 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 120.455 1.48 . . . . 0.0 112.373 176.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.9 m -77.79 -52.13 9.4 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.763 1.625 . . . . 0.0 110.23 175.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 71.1 mt -85.33 -26.49 26.51 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.017 1.327 . . . . 0.0 111.606 -169.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -102.63 15.27 55.97 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 126.74 2.114 . . . . 0.0 111.707 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.91 121.94 12.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.668 1.187 . . . . 0.0 109.936 -175.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.04 8.05 87.46 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 119.752 -0.471 . . . . 0.0 113.385 178.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -122.6 -32.25 3.61 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 125.234 1.414 . . . . 0.0 109.36 -177.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.727 HG22 ' HG2' ' A' ' 2' ' ' LYS . 12.6 pt -141.55 163.92 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 125.018 1.327 . . . . 0.0 110.54 177.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.74 144.18 31.43 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 168.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.479 HG21 ' HA ' ' A' ' 23' ' ' LYS . 2.2 t -136.27 135.12 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.472 0.709 . . . . 0.0 110.512 -168.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.7 m -147.31 161.4 41.04 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.776 1.231 . . . . 0.0 109.501 -178.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.5 p -128.09 161.67 28.67 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.726 1.21 . . . . 0.0 109.491 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.5 p -152.31 147.56 26.48 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 121.328 -0.858 . . . . 0.0 111.709 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.82 140.26 1.78 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 105.154 -3.178 . . . . 0.0 105.154 -168.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -162.74 118.39 1.84 Allowed 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 104.343 -2.466 . . . . 0.0 104.343 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.01 116.59 2.65 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 122.111 0.958 . . . . 0.0 110.043 -170.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.4 m 52.94 31.53 11.05 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.387 1.475 . . . . 0.0 113.157 -178.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.5 m 64.67 3.68 2.06 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.674 2.39 . . . . 0.0 115.601 169.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.8 148.54 50.45 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 120.273 1.397 . . . . 0.0 110.121 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.6 m -68.66 177.84 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 124.539 1.135 . . . . 0.0 111.287 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.475 ' CD2' HD21 ' A' ' 11' ' ' ASN . 82.9 t60 -134.15 116.23 13.22 Favored Pre-proline 0 N--CA 1.446 -0.671 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 -175.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -64.75 -24.26 62.05 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 123.714 2.942 . . . . 0.0 112.7 -169.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.0 m -61.27 -36.64 80.61 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.106 0.867 . . . . 0.0 109.731 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.15 -45.1 82.17 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -56.37 -49.24 77.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.49 -42.93 99.53 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.41 0.55 . . . . 0.0 111.024 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.6 mmt -61.51 -23.99 66.3 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 124.251 1.021 . . . . 0.0 113.337 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.415 ' SD ' ' SD ' ' A' ' 17' ' ' MET . 4.3 mmt -101.98 -24.11 14.03 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.084 0.856 . . . . 0.0 108.958 178.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -64.94 -34.75 79.15 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 118.952 0.796 . . . . 0.0 109.435 171.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -72.6 7.1 2.04 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 173.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.3 t -119.29 -39.56 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 127.23 2.212 . . . . 0.0 110.023 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.94 24.14 2.58 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.375 1.464 . . . . 0.0 112.884 -176.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.7 mt -124.42 161.6 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 125.879 1.671 . . . . 0.0 107.222 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -108.19 -61.5 1.58 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -169.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . 0.421 28.7 pt 56.17 1.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 118.245 2.683 . . . . 0.0 118.245 -177.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.76 147.93 43.03 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 120.899 1.681 . . . . 0.0 109.39 169.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.69 1.42 11.45 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 118.248 -1.307 . . . . 0.0 114.777 176.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -48.47 -65.32 0.59 Allowed 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.258 1.529 . . . . 0.0 113.23 -177.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.9 166.15 25.74 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 123.672 0.608 . . . . 0.0 112.548 -168.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.9 p -169.56 22.81 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.91 0.884 . . . . 0.0 112.565 -171.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -139.47 150.36 63.46 Favored Pre-proline 0 N--CA 1.475 0.821 0 CA-C-N 119.895 1.225 . . . . 0.0 112.193 -169.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -84.25 162.54 13.23 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 124.095 3.196 . . . . 0.0 112.909 -170.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.1 tt -57.43 -36.4 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.99 1.716 . . . . 0.0 111.269 -176.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -73.86 -16.37 61.13 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -170.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.16 -17.07 44.19 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 118.691 -0.671 . . . . 0.0 111.793 170.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -88.79 170.47 10.73 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.195 0.907 . . . . 0.0 110.721 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.7 89.91 2.24 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.451 1.501 . . . . 0.0 107.921 -177.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.496 ' HB2' ' CD2' ' A' ' 90' ' ' TRP . . . -52.39 -23.16 5.52 Favored 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 176.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -50.86 -30.2 13.85 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.349 0.66 . . . . 0.0 111.398 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -91.71 4.18 53.35 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.43 ' HA ' ' HB2' ' A' ' 3' ' ' LYS . 22.2 m-85 -131.83 114.8 15.14 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 120.437 1.471 . . . . 0.0 109.454 -177.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -69.78 -6.91 35.33 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -169.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.753 HG12 HG13 ' A' ' 4' ' ' VAL . 24.7 t -145.02 123.31 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -171.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.0 t -118.51 127.39 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.8 mm -121.45 94.3 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 171.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.448 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 18.2 p -73.95 167.52 21.32 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 118.252 -1.379 . . . . 0.0 107.747 168.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 mp -143.02 41.82 1.53 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 173.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.419 ' HB3' HG21 ' A' ' 84' ' ' VAL . 59.1 m -101.03 -5.49 25.71 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.523 1.529 . . . . 0.0 112.188 -168.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 116.15 15.64 7.09 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-N 119.543 1.065 . . . . 0.0 113.985 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 6.0 t 45.5 56.06 6.07 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.77 1.628 . . . . 0.0 111.172 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -175.52 -26.18 0.03 OUTLIER Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.479 -172.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.419 HG21 ' HB3' ' A' ' 80' ' ' CYS . 78.5 t -56.6 121.21 4.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 169.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -65.41 136.45 56.5 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 173.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.5 mt -123.71 144.34 44.27 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 176.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.25 156.72 9.96 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.6 2.2 . . . . 0.0 112.997 176.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -53.91 -30.39 58.08 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.824 2.349 . . . . 0.0 116.399 -170.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -67.04 -26.0 66.54 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.377 -0.827 . . . . 0.0 111.328 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.496 ' CD2' ' HB2' ' A' ' 70' ' ' ALA . 66.2 m95 -69.67 -13.25 62.21 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 120.87 -1.144 . . . . 0.0 113.388 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.0 m -117.96 -9.35 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 119.721 1.146 . . . . 0.0 112.957 -169.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.1 p -85.79 -10.26 55.76 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.253 1.021 . . . . 0.0 112.714 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -60.46 167.94 2.35 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 128.974 2.91 . . . . 0.0 113.18 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.88 -40.96 87.95 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.651 1.181 . . . . 0.0 108.951 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.535 ' HB ' HG13 ' A' ' 75' ' ' VAL . 26.7 mm -119.93 139.27 47.79 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 CA-C-O 121.163 0.506 . . . . 0.0 109.717 170.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -144.66 106.5 4.29 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 102.16 -3.274 . . . . 0.0 102.16 166.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -132.84 168.21 18.81 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 175.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -139.67 111.66 7.45 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 171.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.451 ' CD2' ' HB3' ' A' ' 122' ' ' ARG . 45.5 m0 -92.13 65.65 4.76 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 179.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -33.19 -52.07 0.35 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.52 1.928 . . . . 0.0 111.773 177.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 40.1 -170.56 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 129.851 3.261 . . . . 0.0 114.371 -175.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -63.56 175.61 1.02 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 122.79 1.281 . . . . 0.0 111.887 170.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -127.28 103.83 22.63 Favored Pre-proline 0 C--N 1.321 -0.657 0 C-N-CA 128.232 2.613 . . . . 0.0 107.418 -170.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.3 -4.2 14.49 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.648 2.232 . . . . 0.0 112.602 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.3 t0 20.13 -95.06 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.784 2.834 . . . . 0.0 113.791 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -135.67 40.39 1.55 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 127.141 2.305 . . . . 0.0 109.151 169.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -75.16 179.01 5.31 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.722 1.609 . . . . 0.0 113.098 -170.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.3 p -62.35 157.38 19.99 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 113.148 -1.842 . . . . 0.0 109.634 171.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 21.7 mt -57.68 -30.42 65.44 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.602 176.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -62.34 -41.3 98.46 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 118.695 -0.669 . . . . 0.0 111.099 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.2 t -71.78 -40.81 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 117.705 -1.141 . . . . 0.0 109.238 178.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -50.7 -51.42 49.74 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.909 1.232 . . . . 0.0 111.725 169.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -59.05 -45.52 90.57 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.025 0.829 . . . . 0.0 110.931 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 97.7 m -68.09 -43.01 79.5 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -174.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.9 t -64.83 -49.75 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -175.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -48.08 -56.12 8.55 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.963 1.305 . . . . 0.0 111.017 173.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.09 -41.73 99.72 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 119.111 0.869 . . . . 0.0 111.519 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -66.78 -37.77 85.24 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.205 -1.173 . . . . 0.0 110.532 -178.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.4 t -62.87 -42.71 97.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 173.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -35.95 75.59 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 119.819 1.191 . . . . 0.0 111.352 -174.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -69.01 -43.08 75.52 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.512 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.451 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 10.4 mpt_? -64.18 -41.66 97.02 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.923 1.238 . . . . 0.0 110.559 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 54.7 t -54.23 -54.35 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 173.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -64.93 -32.65 74.47 Favored 'General case' 0 N--CA 1.445 -0.689 0 O-C-N 122.012 -0.43 . . . . 0.0 111.599 -174.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -62.34 -48.25 80.65 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 123.368 0.667 . . . . 0.0 111.363 171.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -48.35 75.09 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 118.56 0.618 . . . . 0.0 109.562 175.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.7 mt -58.09 -42.19 82.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 123.804 0.842 . . . . 0.0 109.287 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.93 -31.43 71.75 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.797 0.726 . . . . 0.0 111.74 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -72.3 -42.77 65.1 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.554 173.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 17.2 pt -103.28 -46.2 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 118.607 2.817 . . . . 0.0 118.607 -168.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.5 m . . . . . 0 C--O 1.253 1.247 0 C-N-CA 124.06 0.944 . . . . 0.0 111.883 -169.177 . . . . . . . . 0 0 . 1 stop_ save_